*********** PTASSAMj00 ******** FILEIN user.vek ../../CSA/PIK_SPRITE/ ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 1 3 # 1 A 49 ASP A 13 ASP~? 20.85 CL CL A 278 A 86 HIS A 12 HIS~? 14.78 CL CL A 278 A 250 ALA A 251 ALA~? 12.40 CL CL A 278 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 3.80 -37.83 -7.42 4.89 -38.66 -9.05 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 9.03 -33.35 -4.93 10.37 -31.88 -5.56 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 14.98 -35.41 -7.43 14.47 -33.98 -7.30 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 2 3 # 2 A 49 ASP A 13 ASP~? 20.85 CL CL A 278 A 86 HIS A 12 HIS~? 14.78 CL CL A 278 A 250 ALA A 252 ALA~? 17.52 CL CL A 278 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 3.80 -37.83 -7.42 4.89 -38.66 -9.05 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 9.03 -33.35 -4.93 10.37 -31.88 -5.56 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 12.87 -37.24 -4.82 11.40 -37.55 -4.97 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 3 3 # 3 A 49 ASP B 13 ASP~? 21.13 CL CL B 278 A 86 HIS B 12 HIS~? 15.42 CL CL B 278 A 250 ALA B 251 ALA~? 13.13 CL CL B 278 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -10.18 -14.51 -22.80 -8.49 -13.29 -22.60 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -11.21 -8.27 -20.82 -9.88 -9.02 -21.02 2wwt_o00 source 2WWT INTRACELLULAR SUBTILISIN PROTEASE : 3 hits 2wwt_o00 naa= 3 ULMN 4 13pk_c01 3-PHOSPHOGLYCERATE KINASE user 1 4 # 1 B 39 ARG B 196 ARG.? 16.18 CL CL B 278 B 219 LYS B 210 LYS~? 12.46 CL CL B 278 B 376 GLY B 195 GLY.? 10.21 CL CL B 278 B 399 GLY B 200 GLY.? 15.32 CL CL B 278 coo -2.66 39.94 47.71 -4.08 39.67 44.99 -8.42 4.93 -17.56 -9.12 6.53 -20.07 coo -12.62 42.34 36.27 -8.73 43.54 40.31 -2.49 -8.60 -10.03 0.77 -12.84 -8.24 coo -6.85 37.45 46.42 -7.20 36.92 45.92 -7.22 -0.77 -17.24 -6.51 -0.37 -17.47 coo -4.26 38.64 36.66 -3.61 38.69 37.17 -5.78 0.30 -5.65 -5.20 0.90 -5.77 13pk_c01 source 13pk 3-PHOSPHOGLYCERATE KINASE : 1 hits 13pk_c01 naa= 4 ULMN 4 13pk_c02 3-PHOSPHOGLYCERATE KINASE user 1 4 # 1 C 39 ARG A 209 ARG~? 8.75 CL CL A 278 C 219 LYS B 64 LYS^? 6.39 CL CL B 278 C 376 GLY B 41 GLY~? 14.81 CL CL A 278 C 399 GLY B 68 GLY.? 16.43 CL CL B 278 coo -3.47 26.80 67.67 -1.24 26.00 69.62 12.19 -22.36 -19.55 12.55 -20.19 -17.38 coo 5.22 26.79 80.32 0.48 26.84 77.06 5.21 -10.68 -27.95 4.80 -8.81 -21.96 coo 1.35 28.76 68.50 2.09 28.66 68.61 10.75 -18.81 -23.86 10.10 -18.46 -24.26 coo 2.85 20.10 73.72 2.25 20.01 73.15 15.79 -11.51 -23.95 15.19 -11.07 -24.30 ULMN 4 13pk_c02 3-PHOSPHOGLYCERATE KINASE user 2 4 # 2 C 39 ARG B 209 ARG~? 8.42 CL CL B 278 C 219 LYS A 64 LYS^? 6.64 CL CL A 278 C 376 GLY A 41 GLY~? 14.53 CL CL B 278 C 399 GLY A 68 GLY.? 16.36 CL CL B 278 coo -3.47 26.80 67.67 -1.24 26.00 69.62 2.92 -11.07 -10.38 5.18 -10.70 -12.48 coo 5.22 26.79 80.32 0.48 26.84 77.06 14.97 -18.21 -2.39 15.88 -19.33 -8.52 coo 1.35 28.76 68.50 2.09 28.66 68.61 6.94 -12.26 -6.18 7.28 -12.90 -5.74 coo 2.85 20.10 73.72 2.25 20.01 73.15 14.64 -8.15 -7.71 15.04 -8.75 -7.32 13pk_c02 source 13pk 3-PHOSPHOGLYCERATE KINASE : 2 hits 13pk_c02 naa= 4 ULMN 4 1aj8_c02 CITRATE SYNTHASE user 1 4 # 1 A 193 SER A 8 SER.? 12.69 CL CL A 278 A 223 HIS A 12 HIS~? 14.78 CL CL A 278 A 262 HIS A 29 HIS.? 25.16 CL CL A 278 A 312 ASP A 13 ASP~? 20.85 CL CL A 278 coo 28.44 32.05 73.53 28.64 31.12 71.24 8.88 -27.17 -3.98 8.36 -25.65 -5.80 coo 29.33 36.13 69.70 30.07 34.20 70.11 9.03 -33.35 -4.93 10.37 -31.88 -5.56 coo 38.54 36.60 66.38 37.88 34.77 67.15 7.41 -38.44 3.20 5.56 -39.41 3.04 coo 30.62 37.23 61.07 30.08 35.73 62.49 3.80 -37.83 -7.42 4.89 -38.66 -9.05 ULMN 4 1aj8_c02 CITRATE SYNTHASE user 2 4 # 2 A 193 SER B 8 SER.? 14.26 CL CL B 278 A 223 HIS B 12 HIS~? 15.42 CL CL B 278 A 262 HIS B 29 HIS.? 25.42 CL CL B 278 A 312 ASP B 13 ASP~? 21.13 CL CL B 278 coo 28.44 32.05 73.53 28.64 31.12 71.24 -4.13 -15.22 -24.13 -4.29 -16.76 -22.25 coo 29.33 36.13 69.70 30.07 34.20 70.11 -10.18 -14.51 -22.80 -8.49 -13.29 -22.60 coo 38.54 36.60 66.38 37.88 34.77 67.15 -16.16 -16.38 -29.82 -17.24 -18.07 -29.20 coo 30.62 37.23 61.07 30.08 35.73 62.49 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 1aj8_c02 source 1aj8 CITRATE SYNTHASE : 2 hits 1aj8_c02 naa= 4 ULMN 4 1aj8_c03 CITRATE SYNTHASE user 1 4 # 1 B 193 SER A 8 SER.? 12.69 CL CL A 278 B 223 HIS A 12 HIS~? 14.78 CL CL A 278 B 262 HIS A 29 HIS.? 25.16 CL CL A 278 B 312 ASP A 13 ASP~? 20.85 CL CL A 278 coo 24.20 33.47 87.18 22.82 34.14 89.12 8.88 -27.17 -3.98 8.36 -25.65 -5.80 coo 23.86 29.50 91.20 24.12 31.58 91.00 9.03 -33.35 -4.93 10.37 -31.88 -5.56 coo 29.35 31.42 99.15 28.72 33.09 98.04 7.41 -38.44 3.20 5.56 -39.41 3.04 coo 20.42 28.25 99.26 20.25 29.62 97.63 3.80 -37.83 -7.42 4.89 -38.66 -9.05 ULMN 4 1aj8_c03 CITRATE SYNTHASE user 2 4 # 2 B 193 SER B 8 SER.? 14.26 CL CL B 278 B 223 HIS B 12 HIS~? 15.42 CL CL B 278 B 262 HIS B 29 HIS.? 25.42 CL CL B 278 B 312 ASP B 13 ASP~? 21.13 CL CL B 278 coo 24.20 33.47 87.18 22.82 34.14 89.12 -4.13 -15.22 -24.13 -4.29 -16.76 -22.25 coo 23.86 29.50 91.20 24.12 31.58 91.00 -10.18 -14.51 -22.80 -8.49 -13.29 -22.60 coo 29.35 31.42 99.15 28.72 33.09 98.04 -16.16 -16.38 -29.82 -17.24 -18.07 -29.20 coo 20.42 28.25 99.26 20.25 29.62 97.63 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 1aj8_c03 source 1aj8 CITRATE SYNTHASE : 2 hits 1aj8_c03 naa= 4 ULMN 4 1al6_c01 CITRATE SYNTHASE user 1 4 # 1 244 SER A 8 SER.? 12.69 CL CL A 278 274 HIS A 12 HIS~? 14.78 CL CL A 278 320 HIS A 29 HIS.? 25.16 CL CL A 278 375 ASP A 13 ASP~? 20.85 CL CL A 278 coo 7.28 -2.66 -2.02 9.55 -2.28 -2.78 8.88 -27.17 -3.98 8.36 -25.65 -5.80 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 9.03 -33.35 -4.93 10.37 -31.88 -5.56 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 7.41 -38.44 3.20 5.56 -39.41 3.04 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 3.80 -37.83 -7.42 4.89 -38.66 -9.05 ULMN 4 1al6_c01 CITRATE SYNTHASE user 2 4 # 2 244 SER B 8 SER.? 14.26 CL CL B 278 274 HIS B 12 HIS~? 15.42 CL CL B 278 320 HIS B 29 HIS.? 25.42 CL CL B 278 375 ASP B 13 ASP~? 21.13 CL CL B 278 coo 7.28 -2.66 -2.02 9.55 -2.28 -2.78 -4.13 -15.22 -24.13 -4.29 -16.76 -22.25 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 -10.18 -14.51 -22.80 -8.49 -13.29 -22.60 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 -16.16 -16.38 -29.82 -17.24 -18.07 -29.20 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 1al6_c01 source 1al6 CITRATE SYNTHASE : 2 hits 1al6_c01 naa= 4 ULMN 4 1am5_c05 PEPSIN user 1 4 # 1 32 ASP A 268 ASP.? 26.73 CL CL A 278 35 SER A 28 SER.? 27.02 CL CL A 278 75 TYR A 24 TYR~? 29.31 CL CL A 278 215 ASP A 267 ASP.? 31.09 CL CL A 278 coo -7.18 8.92 145.10 -8.77 8.81 143.59 9.60 -34.57 10.49 9.97 -36.28 9.26 coo -12.30 10.35 145.24 -10.75 8.55 145.88 6.29 -36.11 7.11 4.57 -37.31 5.85 coo -13.30 2.78 144.49 -12.77 1.96 147.02 0.87 -31.89 7.51 0.76 -33.22 9.95 coo -8.20 12.64 138.30 -8.86 10.97 139.38 11.77 -37.21 15.47 13.23 -35.63 15.60 ULMN 4 1am5_c05 PEPSIN user 2 4 # 2 32 ASP B 268 ASP.? 26.26 CL CL B 278 35 SER B 28 SER.? 27.87 CL CL B 278 75 TYR B 24 TYR~? 29.69 CL CL B 278 215 ASP B 267 ASP.? 32.55 CL CL B 278 coo -7.18 8.92 145.10 -8.77 8.81 143.59 -14.31 -16.11 -36.83 -14.03 -14.11 -36.24 coo -12.30 10.35 145.24 -10.75 8.55 145.88 -14.66 -18.25 -33.71 -14.43 -20.67 -33.62 coo -13.30 2.78 144.49 -12.77 1.96 147.02 -10.93 -24.23 -34.16 -12.79 -24.53 -36.20 coo -8.20 12.64 138.30 -8.86 10.97 139.38 -15.25 -13.37 -42.11 -14.97 -14.80 -43.57 1am5_c05 source 1am5 PEPSIN : 2 hits 1am5_c05 naa= 4 ULMN 4 1bwl_c00 NADPH DEHYDROGENASE 1 user 1 4 # 1 37 THR A 213 THR.? 5.23 CL CL A 278 191 ASN A 254 ASN~? 16.17 CL CL A 278 194 HIS A 216 HIS.? 18.50 CL CL A 278 196 TYR A 217 TYR.? 13.45 CL CL A 278 coo 30.43 73.37 22.91 31.95 74.71 22.14 17.89 -30.02 -14.53 16.90 -28.34 -13.63 coo 40.94 71.26 25.74 40.29 70.59 23.82 18.50 -38.45 -6.68 18.86 -39.34 -8.59 coo 38.86 67.47 19.31 37.78 65.73 19.79 17.97 -41.33 -12.21 17.58 -42.84 -10.82 coo 41.10 73.64 20.13 38.52 73.39 19.02 22.77 -37.42 -9.36 23.40 -34.73 -9.58 ULMN 4 1bwl_c00 NADPH DEHYDROGENASE 1 user 2 4 # 2 37 THR B 213 THR.? 5.93 CL CL B 278 191 ASN B 254 ASN~? 16.98 CL CL B 278 194 HIS B 216 HIS.? 19.24 CL CL B 278 196 TYR B 217 TYR.? 13.94 CL CL B 278 coo 30.43 73.37 22.91 31.95 74.71 22.14 -4.66 -4.97 -14.91 -3.30 -6.36 -15.86 coo 40.94 71.26 25.74 40.29 70.59 23.82 -14.04 -4.32 -21.65 -14.71 -3.72 -19.71 coo 38.86 67.47 19.31 37.78 65.73 19.79 -16.22 -3.98 -15.80 -17.90 -4.46 -16.96 coo 41.10 73.64 20.13 38.52 73.39 19.02 -12.06 -0.05 -19.78 -9.32 0.42 -19.98 1bwl_c00 source 1bwl NADPH DEHYDROGENASE 1 : 2 hits 1bwl_c00 naa= 4 ULMN 4 1cd5_c00 GLUCOSAMINE 6-PHOSPHATE DEAMINASE user 1 4 # 1 A 72 ASP A 36 ASP~? 8.69 CL CL A 278 A 141 ASP A 168 ASP^? 12.27 CL CL A 278 A 143 HIS A 194 HIS.? 4.68 CL CL A 278 A 148 GLU A 138 GLU^? 6.67 CL CL A 278 coo 86.21 51.78 11.27 86.87 50.27 12.61 11.67 -20.98 -6.16 13.43 -22.16 -5.96 coo 77.92 48.13 25.32 78.70 49.17 23.61 26.46 -30.73 -8.22 26.92 -32.42 -9.39 coo 79.83 48.98 19.95 81.76 49.72 20.33 21.59 -27.03 -10.13 21.31 -25.37 -8.87 coo 76.11 54.71 19.44 77.75 55.81 18.59 23.86 -20.99 -6.84 22.60 -22.69 -7.03 ULMN 4 1cd5_c00 GLUCOSAMINE 6-PHOSPHATE DEAMINASE user 2 4 # 2 A 72 ASP B 36 ASP~? 8.83 CL CL B 278 A 141 ASP B 168 ASP^? 12.80 CL CL B 278 A 143 HIS B 194 HIS.? 5.13 CL CL B 278 A 148 GLU B 138 GLU^? 6.70 CL CL B 278 coo 86.21 51.78 11.27 86.87 50.27 12.61 2.64 -13.17 -23.36 1.59 -11.35 -23.67 coo 77.92 48.13 25.32 78.70 49.17 23.61 -5.42 2.81 -22.11 -6.82 3.76 -20.83 coo 79.83 48.98 19.95 81.76 49.72 20.33 -1.92 -2.21 -20.05 -0.53 -2.75 -21.52 coo 76.11 54.71 19.44 77.75 55.81 18.59 3.87 -1.10 -24.33 2.09 -2.15 -23.84 1cd5_c00 source 1cd5 GLUCOSAMINE 6-PHOSPHATE DEAMINASE : 2 hits 1cd5_c00 naa= 4 ULMN 4 1e6e_c00 ADRENODOXIN user 1 4 # 1 A 55 HIS A 194 HIS.? 4.68 CL CL A 278 A 159 ASP A 168 ASP^? 12.27 CL CL A 278 A 376 ILE A 172 ILE.? 11.95 CL CL A 278 A 377 THR A 174 THR.? 12.59 CL CL A 278 coo 17.95 58.52 112.81 17.29 59.41 111.03 21.59 -27.03 -10.13 21.31 -25.37 -8.87 coo 11.32 57.46 110.35 12.85 58.48 111.39 26.46 -30.73 -8.22 26.92 -32.42 -9.39 coo 15.00 65.23 121.40 15.42 63.95 122.00 27.44 -26.24 -20.38 26.66 -27.07 -21.14 coo 15.65 69.77 121.40 17.38 70.64 120.41 30.19 -22.00 -21.14 28.07 -22.46 -21.10 ULMN 4 1e6e_c00 ADRENODOXIN user 2 4 # 2 A 55 HIS B 194 HIS.? 5.13 CL CL B 278 A 159 ASP B 168 ASP^? 12.80 CL CL B 278 A 376 ILE B 172 ILE.? 11.79 CL CL B 278 A 377 THR B 174 THR.? 12.09 CL CL B 278 coo 17.95 58.52 112.81 17.29 59.41 111.03 -1.92 -2.21 -20.05 -0.53 -2.75 -21.52 coo 11.32 57.46 110.35 12.85 58.48 111.39 -5.42 2.81 -22.11 -6.82 3.76 -20.83 coo 15.00 65.23 121.40 15.42 63.95 122.00 0.88 4.45 -10.86 0.10 3.96 -9.86 coo 15.65 69.77 121.40 17.38 70.64 120.41 5.52 6.88 -11.20 4.94 4.78 -10.98 1e6e_c00 source 1e6e ADRENODOXIN : 2 hits 1e6e_c00 naa= 4 ULMN 4 1e6e_c01 ADRENODOXIN user 1 4 # 1 C 55 HIS A 194 HIS.? 4.68 CL CL A 278 C 159 ASP A 168 ASP^? 12.27 CL CL A 278 C 376 ILE A 172 ILE.? 11.95 CL CL A 278 C 377 THR A 174 THR.? 12.59 CL CL A 278 coo -29.07 40.56 142.27 -27.79 41.91 141.29 21.59 -27.03 -10.13 21.31 -25.37 -8.87 coo -23.44 38.39 138.46 -25.44 39.03 138.64 26.46 -30.73 -8.22 26.92 -32.42 -9.39 coo -37.08 37.01 134.95 -37.09 36.11 136.10 27.44 -26.24 -20.38 26.66 -27.07 -21.14 coo -39.65 39.67 132.35 -40.33 41.62 133.03 30.19 -22.00 -21.14 28.07 -22.46 -21.10 ULMN 4 1e6e_c01 ADRENODOXIN user 2 4 # 2 C 55 HIS B 194 HIS.? 5.13 CL CL B 278 C 159 ASP B 168 ASP^? 12.80 CL CL B 278 C 376 ILE B 172 ILE.? 11.79 CL CL B 278 C 377 THR B 174 THR.? 12.09 CL CL B 278 coo -29.07 40.56 142.27 -27.79 41.91 141.29 -1.92 -2.21 -20.05 -0.53 -2.75 -21.52 coo -23.44 38.39 138.46 -25.44 39.03 138.64 -5.42 2.81 -22.11 -6.82 3.76 -20.83 coo -37.08 37.01 134.95 -37.09 36.11 136.10 0.88 4.45 -10.86 0.10 3.96 -9.86 coo -39.65 39.67 132.35 -40.33 41.62 133.03 5.52 6.88 -11.20 4.94 4.78 -10.98 1e6e_c01 source 1e6e ADRENODOXIN : 2 hits 1e6e_c01 naa= 4 ULMN 4 1ecl_c00 MOLECULE: ESCHERICHIA COLI TOPOISOMEuser 1 4 # 1 9 GLU B 253 GLU~? 21.95 CL CL B 278 111 ASP B 250 ASP~? 16.15 CL CL B 278 319 TYR B 215 TYR.? 14.28 CL CL B 278 365 HIS B 194 HIS.? 5.13 CL CL B 278 coo 40.90 33.12 50.07 39.32 31.72 50.03 -18.69 -7.91 -20.45 -19.54 -8.29 -18.53 coo 38.20 29.86 46.47 38.01 31.94 46.26 -13.35 -7.01 -16.89 -13.59 -7.26 -14.81 coo 35.52 29.82 41.60 37.98 29.12 42.65 -10.18 -0.68 -14.85 -11.32 1.86 -14.73 coo 32.44 22.36 39.83 33.57 21.39 41.30 -1.92 -2.21 -20.05 -0.53 -2.75 -21.52 1ecl_c00 source 1ecl MOLECULE: ESCHERICHIA COLI TOPOISOMERASE I : 1 hits 1ecl_c00 naa= 4 ULMN 4 1exp_c00 BETA-1,4-D-GLYCANASE CEX-CD user 1 4 # 1 127 GLU A 34 GLU^? 8.78 CL CL A 278 205 HIS A 194 HIS.? 4.68 CL CL A 278 233 GLU A 138 GLU^? 6.67 CL CL A 278 235 ASP A 168 ASP^? 12.27 CL CL A 278 coo 21.30 74.05 33.80 19.79 72.64 33.96 14.76 -23.90 -2.78 16.42 -23.89 -4.11 coo 23.08 64.94 33.21 22.54 65.31 35.19 21.59 -27.03 -10.13 21.31 -25.37 -8.87 coo 25.12 67.63 37.99 23.29 68.70 37.64 23.86 -20.99 -6.84 22.60 -22.69 -7.03 coo 24.30 59.55 35.21 23.07 61.13 34.61 26.46 -30.73 -8.22 26.92 -32.42 -9.39 ULMN 4 1exp_c00 BETA-1,4-D-GLYCANASE CEX-CD user 2 4 # 2 127 GLU B 34 GLU^? 8.94 CL CL B 278 205 HIS B 194 HIS.? 5.13 CL CL B 278 233 GLU B 138 GLU^? 6.70 CL CL B 278 235 ASP B 168 ASP^? 12.80 CL CL B 278 coo 21.30 74.05 33.80 19.79 72.64 33.96 -0.25 -10.10 -26.69 0.15 -8.25 -25.75 coo 23.08 64.94 33.21 22.54 65.31 35.19 -1.92 -2.21 -20.05 -0.53 -2.75 -21.52 coo 25.12 67.63 37.99 23.29 68.70 37.64 3.87 -1.10 -24.33 2.09 -2.15 -23.84 coo 24.30 59.55 35.21 23.07 61.13 34.61 -5.42 2.81 -22.11 -6.82 3.76 -20.83 1exp_c00 source 1exp BETA-1,4-D-GLYCANASE CEX-CD : 2 hits 1exp_c00 naa= 4 ULMN 4 1eyp_c00 CHALCONE-FLAVONONE ISOMERASE 1 user 1 4 # 1 A 48 THR A 16 THR~? 23.56 CL CL A 278 A 106 TYR A 14 TYR~? 21.87 CL CL A 278 A 113 ASN A 246 ASN.? 12.85 CL CL A 278 A 190 THR A 7 THR^? 8.89 CL CL A 278 coo 22.06 26.20 31.80 23.25 24.42 31.55 4.16 -38.93 -1.16 3.39 -36.96 -0.84 coo 25.78 19.82 28.38 24.53 18.95 30.74 9.67 -41.27 -5.56 11.11 -43.55 -4.85 coo 31.98 16.71 37.61 32.38 18.76 37.14 12.83 -32.17 -9.87 11.11 -33.32 -9.30 coo 28.27 16.17 41.32 28.66 15.49 39.31 12.66 -27.68 -4.47 14.06 -27.36 -6.07 ULMN 4 1eyp_c00 CHALCONE-FLAVONONE ISOMERASE 1 user 2 4 # 2 A 48 THR B 16 THR~? 24.23 CL CL B 278 A 106 TYR B 14 TYR~? 22.44 CL CL B 278 A 113 ASN B 246 ASN.? 13.30 CL CL B 278 A 190 THR B 7 THR^? 9.20 CL CL B 278 coo 22.06 26.20 31.80 23.25 24.42 31.55 -16.39 -19.02 -25.27 -14.79 -20.44 -25.32 coo 25.78 19.82 28.38 24.53 18.95 30.74 -17.87 -12.84 -21.07 -19.82 -11.02 -21.91 coo 31.98 16.71 37.61 32.38 18.76 37.14 -7.71 -10.36 -18.40 -9.09 -11.94 -18.78 coo 28.27 16.17 41.32 28.66 15.49 39.31 -4.08 -11.42 -24.47 -3.39 -9.92 -23.07 1eyp_c00 source 1eyp CHALCONE-FLAVONONE ISOMERASE 1 : 2 hits 1eyp_c00 naa= 4 ULMN 4 1eyp_c01 CHALCONE-FLAVONONE ISOMERASE 1 user 1 4 # 1 B 48 THR A 16 THR~? 23.56 CL CL A 278 B 106 TYR A 14 TYR~? 21.87 CL CL A 278 B 113 ASN A 246 ASN.? 12.85 CL CL A 278 B 190 THR A 7 THR^? 8.89 CL CL A 278 coo 31.55 -18.10 62.71 31.91 -16.02 63.16 4.16 -38.93 -1.16 3.39 -36.96 -0.84 coo 31.39 -11.16 66.20 30.18 -10.84 63.67 9.67 -41.27 -5.56 11.11 -43.55 -4.85 coo 36.52 -5.01 57.74 37.90 -6.60 58.02 12.83 -32.17 -9.87 11.11 -33.32 -9.30 coo 32.92 -6.00 53.75 33.40 -5.89 55.87 12.66 -27.68 -4.47 14.06 -27.36 -6.07 ULMN 4 1eyp_c01 CHALCONE-FLAVONONE ISOMERASE 1 user 2 4 # 2 B 48 THR B 16 THR~? 24.23 CL CL B 278 B 106 TYR B 14 TYR~? 22.44 CL CL B 278 B 113 ASN B 246 ASN.? 13.30 CL CL B 278 B 190 THR B 7 THR^? 9.20 CL CL B 278 coo 31.55 -18.10 62.71 31.91 -16.02 63.16 -16.39 -19.02 -25.27 -14.79 -20.44 -25.32 coo 31.39 -11.16 66.20 30.18 -10.84 63.67 -17.87 -12.84 -21.07 -19.82 -11.02 -21.91 coo 36.52 -5.01 57.74 37.90 -6.60 58.02 -7.71 -10.36 -18.40 -9.09 -11.94 -18.78 coo 32.92 -6.00 53.75 33.40 -5.89 55.87 -4.08 -11.42 -24.47 -3.39 -9.92 -23.07 1eyp_c01 source 1eyp CHALCONE-FLAVONONE ISOMERASE 1 : 2 hits 1eyp_c01 naa= 4 ULMN 4 1gox_c01 GLYCOLATE OXIDASE user 1 4 # 1 129 TYR A 215 TYR.? 13.87 CL CL A 278 157 ASP A 168 ASP^? 12.27 CL CL A 278 254 HIS A 194 HIS.? 4.68 CL CL A 278 257 ARG A 140 ARG.? 3.74 CL CL A 278 coo 42.78 52.38 24.86 44.83 53.69 23.54 21.62 -36.04 -14.58 23.93 -37.55 -14.90 coo 49.25 58.21 29.45 50.12 57.23 27.75 26.46 -30.73 -8.22 26.92 -32.42 -9.39 coo 50.92 56.96 24.04 49.24 56.15 23.09 21.59 -27.03 -10.13 21.31 -25.37 -8.87 coo 53.31 58.10 18.81 51.90 57.61 16.26 24.77 -21.68 -10.23 22.52 -23.37 -11.49 ULMN 4 1gox_c01 GLYCOLATE OXIDASE user 2 4 # 2 129 TYR A 215 TYR.? 13.87 CL CL A 278 157 ASP A 168 ASP^? 12.27 CL CL A 278 254 HIS A 194 HIS.? 4.68 CL CL A 278 257 ARG A 212 ARG~? 4.63 CL CL A 278 coo 42.78 52.38 24.86 44.83 53.69 23.54 21.62 -36.04 -14.58 23.93 -37.55 -14.90 coo 49.25 58.21 29.45 50.12 57.23 27.75 26.46 -30.73 -8.22 26.92 -32.42 -9.39 coo 50.92 56.96 24.04 49.24 56.15 23.09 21.59 -27.03 -10.13 21.31 -25.37 -8.87 coo 53.31 58.10 18.81 51.90 57.61 16.26 18.59 -24.77 -16.89 17.13 -22.12 -16.49 ULMN 4 1gox_c01 GLYCOLATE OXIDASE user 3 4 # 3 129 TYR B 215 TYR.? 14.28 CL CL B 278 157 ASP B 168 ASP^? 12.80 CL CL B 278 254 HIS B 194 HIS.? 5.13 CL CL B 278 257 ARG B 140 ARG.? -3.53 CL CL B 278s coo 42.78 52.38 24.86 44.83 53.69 23.54 -10.18 -0.68 -14.85 -11.32 1.86 -14.73 coo 49.25 58.21 29.45 50.12 57.23 27.75 -5.42 2.81 -22.11 -6.82 3.76 -20.83 coo 50.92 56.96 24.04 49.24 56.15 23.09 -1.92 -2.21 -20.05 -0.53 -2.75 -21.52 coo 53.31 58.10 18.81 51.90 57.61 16.26 3.71 0.22 -21.03 2.09 -1.69 -19.26 ULMN 4 1gox_c01 GLYCOLATE OXIDASE user 4 4 # 4 129 TYR B 215 TYR.? 14.28 CL CL B 278 157 ASP B 168 ASP^? 12.80 CL CL B 278 254 HIS B 194 HIS.? 5.13 CL CL B 278 257 ARG B 192 ARG^? 6.13 CL CL B 278 coo 42.78 52.38 24.86 44.83 53.69 23.54 -10.18 -0.68 -14.85 -11.32 1.86 -14.73 coo 49.25 58.21 29.45 50.12 57.23 27.75 -5.42 2.81 -22.11 -6.82 3.76 -20.83 coo 50.92 56.96 24.04 49.24 56.15 23.09 -1.92 -2.21 -20.05 -0.53 -2.75 -21.52 coo 53.31 58.10 18.81 51.90 57.61 16.26 -0.17 -3.93 -26.09 1.00 -5.48 -23.71 ULMN 4 1gox_c01 GLYCOLATE OXIDASE user 5 4 # 5 129 TYR B 215 TYR.? 14.28 CL CL B 278 157 ASP B 168 ASP^? 12.80 CL CL B 278 254 HIS B 194 HIS.? 5.13 CL CL B 278 257 ARG B 212 ARG~? 4.30 CL CL B 278 coo 42.78 52.38 24.86 44.83 53.69 23.54 -10.18 -0.68 -14.85 -11.32 1.86 -14.73 coo 49.25 58.21 29.45 50.12 57.23 27.75 -5.42 2.81 -22.11 -6.82 3.76 -20.83 coo 50.92 56.96 24.04 49.24 56.15 23.09 -1.92 -2.21 -20.05 -0.53 -2.75 -21.52 coo 53.31 58.10 18.81 51.90 57.61 16.26 1.13 -4.70 -13.40 3.58 -6.46 -14.00 1gox_c01 source 1gox GLYCOLATE OXIDASE : 5 hits 1gox_c01 naa= 4 ULMN 4 1grc_c01 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 1 4 # 1 B 106 ASN A 246 ASN.? 12.85 CL CL A 278 B 108 HIS A 12 HIS~? 14.78 CL CL A 278 B 135 SER A 10 SER.? 17.45 CL CL A 278 B 144 ASP A 36 ASP~? 8.69 CL CL A 278 coo 36.64 101.02 13.15 38.55 101.84 12.78 12.83 -32.17 -9.87 11.11 -33.32 -9.30 coo 41.00 107.18 12.86 42.70 107.82 11.96 9.03 -33.35 -4.93 10.37 -31.88 -5.56 coo 36.51 108.90 17.50 37.10 110.80 16.19 3.77 -30.46 -4.30 3.68 -28.35 -5.48 coo 31.60 110.69 6.14 29.69 109.74 5.94 11.67 -20.98 -6.16 13.43 -22.16 -5.96 ULMN 4 1grc_c01 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 2 4 # 2 B 106 ASN B 246 ASN.? 13.30 CL CL B 278 B 108 HIS B 12 HIS~? 15.42 CL CL B 278 B 135 SER B 10 SER.? 17.86 CL CL B 278 B 144 ASP B 36 ASP~? 8.83 CL CL B 278 coo 36.64 101.02 13.15 38.55 101.84 12.78 -7.71 -10.36 -18.40 -9.09 -11.94 -18.78 coo 41.00 107.18 12.86 42.70 107.82 11.96 -10.18 -14.51 -22.80 -8.49 -13.29 -22.60 coo 36.51 108.90 17.50 37.10 110.80 16.19 -7.63 -19.97 -23.27 -5.38 -20.37 -22.44 coo 31.60 110.69 6.14 29.69 109.74 5.94 2.64 -13.17 -23.36 1.59 -11.35 -23.67 1grc_c01 source 1grc GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE (E.C: 2 hits 1grc_c01 naa= 4 ULMN 4 1l7d_c00 NICOTINAMIDE NUCLEOTIDE TRANSHYDROGEuser 1 4 # 1 A 127 ARG B 196 ARG.? 16.18 CL CL B 278 A 132 GLN B 220 GLN~? 25.32 CL CL B 278 A 135 ASP B 224 ASP~? 22.83 CL CL B 278 A 138 SER B 226 SER~? 21.81 CL CL B 278 coo -5.87 -32.14 16.05 -5.08 -34.04 18.31 -8.42 4.93 -17.56 -9.12 6.53 -20.07 coo 0.32 -23.63 17.28 -0.45 -21.67 17.61 -17.87 7.98 -19.75 -18.70 9.08 -21.40 coo 2.58 -27.93 13.18 1.12 -28.64 11.82 -13.88 7.87 -23.86 -15.40 8.87 -22.81 coo 1.28 -26.11 8.70 -0.28 -25.96 10.56 -13.98 3.57 -29.04 -15.68 2.01 -28.29 1l7d_c00 source 1l7d NICOTINAMIDE NUCLEOTIDE TRANSHYDROGENASE, SUBU: 1 hits 1l7d_c00 naa= 4 ULMN 4 1o04_c00 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 1 4 # 1 A 192 LYS A 64 LYS^? 6.64 CL CL A 278 A 268 GLU A 11 GLU.? 13.55 CL CL A 278 A 302 SER A 21 SER.? 21.88 CL CL A 278 A 399 GLU A 25 GLU~? 26.70 CL CL A 278 coo 85.01 60.31 56.44 83.15 64.89 56.44 14.97 -18.21 -2.39 15.88 -19.33 -8.52 coo 71.86 54.60 60.61 70.38 53.71 61.84 7.22 -30.95 -8.53 7.59 -29.14 -7.55 coo 68.68 62.06 66.08 69.52 59.75 65.97 1.16 -33.17 -2.24 2.71 -34.86 -3.05 coo 66.34 67.16 63.84 67.47 65.57 63.06 0.23 -35.14 2.73 -1.02 -35.12 1.03 ULMN 4 1o04_c00 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 2 4 # 2 A 192 LYS B 64 LYS^? 6.39 CL CL B 278 A 268 GLU B 11 GLU.? 12.74 CL CL B 278 A 302 SER B 21 SER.? 21.23 CL CL B 278 A 399 GLU B 25 GLU~? 26.94 CL CL B 278 coo 85.01 60.31 56.44 83.15 64.89 56.44 5.21 -10.68 -27.95 4.80 -8.81 -21.96 coo 71.86 54.60 60.61 70.38 53.71 61.84 -6.91 -15.96 -19.89 -5.75 -14.85 -18.47 coo 68.68 62.06 66.08 69.52 59.75 65.97 -10.65 -22.68 -24.42 -10.99 -20.31 -24.03 coo 66.34 67.16 63.84 67.47 65.57 63.06 -13.37 -23.90 -28.96 -13.41 -24.80 -27.04 1o04_c00 source 1o04 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAL PRECURSO: 2 hits 1o04_c00 naa= 4 ULMN 4 1o04_c01 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 1 4 # 1 B 192 LYS A 64 LYS^? 6.64 CL CL A 278 B 268 GLU A 11 GLU.? 13.55 CL CL A 278 B 302 SER A 21 SER.? 21.88 CL CL A 278 B 399 GLU A 25 GLU~? 26.70 CL CL A 278 coo 54.45 47.08 36.74 56.53 48.29 32.40 14.97 -18.21 -2.39 15.88 -19.33 -8.52 coo 67.17 40.71 41.61 68.49 39.13 42.13 7.22 -30.95 -8.53 7.59 -29.14 -7.55 coo 70.41 37.34 33.01 69.41 36.86 35.23 1.16 -33.17 -2.24 2.71 -34.86 -3.05 coo 73.06 40.82 28.87 71.88 41.23 30.58 0.23 -35.14 2.73 -1.02 -35.12 1.03 ULMN 4 1o04_c01 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 2 4 # 2 B 192 LYS B 64 LYS^? 6.39 CL CL B 278 B 268 GLU B 11 GLU.? 12.74 CL CL B 278 B 302 SER B 21 SER.? 21.23 CL CL B 278 B 399 GLU B 25 GLU~? 26.94 CL CL B 278 coo 54.45 47.08 36.74 56.53 48.29 32.40 5.21 -10.68 -27.95 4.80 -8.81 -21.96 coo 67.17 40.71 41.61 68.49 39.13 42.13 -6.91 -15.96 -19.89 -5.75 -14.85 -18.47 coo 70.41 37.34 33.01 69.41 36.86 35.23 -10.65 -22.68 -24.42 -10.99 -20.31 -24.03 coo 73.06 40.82 28.87 71.88 41.23 30.58 -13.37 -23.90 -28.96 -13.41 -24.80 -27.04 1o04_c01 source 1o04 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAL PRECURSO: 2 hits 1o04_c01 naa= 4 ULMN 4 1o04_c02 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 1 4 # 1 C 192 LYS A 64 LYS^? 6.64 CL CL A 278 C 268 GLU A 11 GLU.? 13.55 CL CL A 278 C 302 SER A 21 SER.? 21.88 CL CL A 278 C 399 GLU A 25 GLU~? 26.70 CL CL A 278 coo 83.30 16.28 88.61 85.25 11.75 88.79 14.97 -18.21 -2.39 15.88 -19.33 -8.52 coo 79.88 15.02 74.11 80.06 15.36 72.02 7.22 -30.95 -8.53 7.59 -29.14 -7.55 coo 87.46 9.36 71.39 86.33 11.53 71.37 1.16 -33.17 -2.24 2.71 -34.86 -3.05 coo 87.65 3.44 72.32 86.49 4.99 73.13 0.23 -35.14 2.73 -1.02 -35.12 1.03 ULMN 4 1o04_c02 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 2 4 # 2 C 192 LYS B 64 LYS^? 6.39 CL CL B 278 C 268 GLU B 11 GLU.? 12.74 CL CL B 278 C 302 SER B 21 SER.? 21.23 CL CL B 278 C 399 GLU B 25 GLU~? 26.94 CL CL B 278 coo 83.30 16.28 88.61 85.25 11.75 88.79 5.21 -10.68 -27.95 4.80 -8.81 -21.96 coo 79.88 15.02 74.11 80.06 15.36 72.02 -6.91 -15.96 -19.89 -5.75 -14.85 -18.47 coo 87.46 9.36 71.39 86.33 11.53 71.37 -10.65 -22.68 -24.42 -10.99 -20.31 -24.03 coo 87.65 3.44 72.32 86.49 4.99 73.13 -13.37 -23.90 -28.96 -13.41 -24.80 -27.04 1o04_c02 source 1o04 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAL PRECURSO: 2 hits 1o04_c02 naa= 4 ULMN 4 1o04_c03 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 1 4 # 1 D 192 LYS A 64 LYS^? 6.64 CL CL A 278 D 268 GLU A 11 GLU.? 13.55 CL CL A 278 D 302 SER A 21 SER.? 21.88 CL CL A 278 D 399 GLU A 25 GLU~? 26.70 CL CL A 278 coo 51.91 3.68 69.52 49.61 2.30 73.71 14.97 -18.21 -2.39 15.88 -19.33 -8.52 coo 55.94 16.93 75.09 55.86 19.04 75.37 7.22 -30.95 -8.53 7.59 -29.14 -7.55 coo 48.09 18.43 80.84 49.40 18.94 78.77 1.16 -33.17 -2.24 2.71 -34.86 -3.05 coo 47.32 15.81 86.19 48.62 15.41 84.58 0.23 -35.14 2.73 -1.02 -35.12 1.03 ULMN 4 1o04_c03 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 2 4 # 2 D 192 LYS B 64 LYS^? 6.39 CL CL B 278 D 268 GLU B 11 GLU.? 12.74 CL CL B 278 D 302 SER B 21 SER.? 21.23 CL CL B 278 D 399 GLU B 25 GLU~? 26.94 CL CL B 278 coo 51.91 3.68 69.52 49.61 2.30 73.71 5.21 -10.68 -27.95 4.80 -8.81 -21.96 coo 55.94 16.93 75.09 55.86 19.04 75.37 -6.91 -15.96 -19.89 -5.75 -14.85 -18.47 coo 48.09 18.43 80.84 49.40 18.94 78.77 -10.65 -22.68 -24.42 -10.99 -20.31 -24.03 coo 47.32 15.81 86.19 48.62 15.41 84.58 -13.37 -23.90 -28.96 -13.41 -24.80 -27.04 1o04_c03 source 1o04 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAL PRECURSO: 2 hits 1o04_c03 naa= 4 ULMN 4 1o04_c04 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 1 4 # 1 E 192 LYS A 64 LYS^? 6.64 CL CL A 278 E 268 GLU A 11 GLU.? 13.55 CL CL A 278 E 302 SER A 21 SER.? 21.88 CL CL A 278 E 399 GLU A 25 GLU~? 26.70 CL CL A 278 coo 52.46 147.49 107.94 50.14 148.75 103.77 14.97 -18.21 -2.39 15.88 -19.33 -8.52 coo 57.01 134.41 102.36 57.01 132.29 102.10 7.22 -30.95 -8.53 7.59 -29.14 -7.55 coo 49.26 132.62 96.59 50.54 132.08 98.67 1.16 -33.17 -2.24 2.71 -34.86 -3.05 coo 48.52 135.25 91.24 49.73 135.67 92.87 0.23 -35.14 2.73 -1.02 -35.12 1.03 ULMN 4 1o04_c04 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 2 4 # 2 E 192 LYS B 64 LYS^? 6.39 CL CL B 278 E 268 GLU B 11 GLU.? 12.74 CL CL B 278 E 302 SER B 21 SER.? 21.23 CL CL B 278 E 399 GLU B 25 GLU~? 26.94 CL CL B 278 coo 52.46 147.49 107.94 50.14 148.75 103.77 5.21 -10.68 -27.95 4.80 -8.81 -21.96 coo 57.01 134.41 102.36 57.01 132.29 102.10 -6.91 -15.96 -19.89 -5.75 -14.85 -18.47 coo 49.26 132.62 96.59 50.54 132.08 98.67 -10.65 -22.68 -24.42 -10.99 -20.31 -24.03 coo 48.52 135.25 91.24 49.73 135.67 92.87 -13.37 -23.90 -28.96 -13.41 -24.80 -27.04 1o04_c04 source 1o04 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAL PRECURSO: 2 hits 1o04_c04 naa= 4 ULMN 4 1o04_c05 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 1 4 # 1 F 192 LYS A 64 LYS^? 6.64 CL CL A 278 F 268 GLU A 11 GLU.? 13.55 CL CL A 278 F 302 SER A 21 SER.? 21.88 CL CL A 278 F 399 GLU A 25 GLU~? 26.70 CL CL A 278 coo 84.18 136.24 88.80 85.96 140.90 88.66 14.97 -18.21 -2.39 15.88 -19.33 -8.52 coo 80.72 137.29 103.27 80.90 136.95 105.39 7.22 -30.95 -8.53 7.59 -29.14 -7.55 coo 87.99 143.28 106.06 86.95 141.03 106.01 1.16 -33.17 -2.24 2.71 -34.86 -3.05 coo 87.94 149.19 105.12 86.87 147.57 104.33 0.23 -35.14 2.73 -1.02 -35.12 1.03 ULMN 4 1o04_c05 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 2 4 # 2 F 192 LYS B 64 LYS^? 6.39 CL CL B 278 F 268 GLU B 11 GLU.? 12.74 CL CL B 278 F 302 SER B 21 SER.? 21.23 CL CL B 278 F 399 GLU B 25 GLU~? 26.94 CL CL B 278 coo 84.18 136.24 88.80 85.96 140.90 88.66 5.21 -10.68 -27.95 4.80 -8.81 -21.96 coo 80.72 137.29 103.27 80.90 136.95 105.39 -6.91 -15.96 -19.89 -5.75 -14.85 -18.47 coo 87.99 143.28 106.06 86.95 141.03 106.01 -10.65 -22.68 -24.42 -10.99 -20.31 -24.03 coo 87.94 149.19 105.12 86.87 147.57 104.33 -13.37 -23.90 -28.96 -13.41 -24.80 -27.04 1o04_c05 source 1o04 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAL PRECURSO: 2 hits 1o04_c05 naa= 4 ULMN 4 1o04_c06 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 1 4 # 1 G 192 LYS A 64 LYS^? 6.64 CL CL A 278 G 268 GLU A 11 GLU.? 13.55 CL CL A 278 G 302 SER A 21 SER.? 21.88 CL CL A 278 G 399 GLU A 25 GLU~? 26.70 CL CL A 278 coo 56.79 103.91 140.42 58.85 102.76 144.77 14.97 -18.21 -2.39 15.88 -19.33 -8.52 coo 69.06 110.82 135.59 70.39 112.47 135.16 7.22 -30.95 -8.53 7.59 -29.14 -7.55 coo 72.18 114.35 144.24 71.25 114.81 141.99 1.16 -33.17 -2.24 2.71 -34.86 -3.05 coo 75.14 110.89 148.28 73.91 110.46 146.63 0.23 -35.14 2.73 -1.02 -35.12 1.03 ULMN 4 1o04_c06 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 2 4 # 2 G 192 LYS B 64 LYS^? 6.39 CL CL B 278 G 268 GLU B 11 GLU.? 12.74 CL CL B 278 G 302 SER B 21 SER.? 21.23 CL CL B 278 G 399 GLU B 25 GLU~? 26.94 CL CL B 278 coo 56.79 103.91 140.42 58.85 102.76 144.77 5.21 -10.68 -27.95 4.80 -8.81 -21.96 coo 69.06 110.82 135.59 70.39 112.47 135.16 -6.91 -15.96 -19.89 -5.75 -14.85 -18.47 coo 72.18 114.35 144.24 71.25 114.81 141.99 -10.65 -22.68 -24.42 -10.99 -20.31 -24.03 coo 75.14 110.89 148.28 73.91 110.46 146.63 -13.37 -23.90 -28.96 -13.41 -24.80 -27.04 1o04_c06 source 1o04 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAL PRECURSO: 2 hits 1o04_c06 naa= 4 ULMN 4 1o04_c07 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 1 4 # 1 H 192 LYS A 64 LYS^? 6.64 CL CL A 278 H 268 GLU A 11 GLU.? 13.55 CL CL A 278 H 302 SER A 21 SER.? 21.88 CL CL A 278 H 399 GLU A 25 GLU~? 26.70 CL CL A 278 coo 87.99 92.28 120.76 86.42 87.51 120.70 14.97 -18.21 -2.39 15.88 -19.33 -8.52 coo 74.53 97.35 116.61 73.03 98.14 115.35 7.22 -30.95 -8.53 7.59 -29.14 -7.55 coo 71.83 89.76 111.02 72.57 92.08 111.26 1.16 -33.17 -2.24 2.71 -34.86 -3.05 coo 69.74 84.60 113.28 70.77 86.22 114.09 0.23 -35.14 2.73 -1.02 -35.12 1.03 ULMN 4 1o04_c07 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 2 4 # 2 H 192 LYS B 64 LYS^? 6.39 CL CL B 278 H 268 GLU B 11 GLU.? 12.74 CL CL B 278 H 302 SER B 21 SER.? 21.23 CL CL B 278 H 399 GLU B 25 GLU~? 26.94 CL CL B 278 coo 87.99 92.28 120.76 86.42 87.51 120.70 5.21 -10.68 -27.95 4.80 -8.81 -21.96 coo 74.53 97.35 116.61 73.03 98.14 115.35 -6.91 -15.96 -19.89 -5.75 -14.85 -18.47 coo 71.83 89.76 111.02 72.57 92.08 111.26 -10.65 -22.68 -24.42 -10.99 -20.31 -24.03 coo 69.74 84.60 113.28 70.77 86.22 114.09 -13.37 -23.90 -28.96 -13.41 -24.80 -27.04 1o04_c07 source 1o04 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAL PRECURSO: 2 hits 1o04_c07 naa= 4 ULMN 4 1pma_c26 PROTEASOME user 1 4 # 1 N 35 SER B 70 SER.? 11.46 CL CL B 278 N 66 LYS B 64 LYS^? 6.39 CL CL B 278 N 80 GLY B 73 GLY.? 14.67 CL CL A 278 N 167 SER B 110 SER.? 9.89 CL CL B 278 coo 221.83 73.23 140.73 220.76 74.32 142.57 13.00 -6.56 -24.86 11.13 -7.93 -24.10 coo 213.28 75.80 142.62 219.38 77.84 142.76 5.21 -10.68 -27.95 4.80 -8.81 -21.96 coo 218.97 70.56 134.12 218.60 71.29 134.44 15.57 -11.40 -19.83 15.87 -10.68 -20.14 coo 225.82 69.04 140.40 227.65 70.67 140.39 10.33 -2.26 -18.93 11.59 -2.13 -16.86 1pma_c26 source 1pma PROTEASOME : 1 hits 1pma_c26 naa= 4 ULMN 4 1qh9_c01 2-HALOACID DEHALOGENASE user 1 4 # 1 A 10 ASP A 267 ASP.? 31.09 CL CL A 278 A 41 ARG A 3 ARG^? 24.49 CL CL A 278 A 118 SER A 265 SER.? 30.92 CL CL A 278 A 180 ASP A 268 ASP.? 26.73 CL CL A 278 coo 20.70 13.03 9.13 22.27 11.81 9.81 11.77 -37.21 15.47 13.23 -35.63 15.60 coo 23.00 19.17 17.85 22.49 17.70 15.19 17.45 -29.65 8.35 18.11 -29.19 11.33 coo 17.70 9.25 13.10 16.68 11.30 13.99 16.53 -40.85 10.53 17.64 -42.38 12.05 coo 26.47 11.43 10.70 25.16 9.82 11.06 9.60 -34.57 10.49 9.97 -36.28 9.26 ULMN 4 1qh9_c01 2-HALOACID DEHALOGENASE user 2 4 # 2 A 10 ASP A 268 ASP.? 26.73 CL CL A 278 A 41 ARG A 3 ARG^? 24.49 CL CL A 278 A 118 SER A 28 SER.? 27.02 CL CL A 278 A 180 ASP A 267 ASP.? 31.09 CL CL A 278 coo 20.70 13.03 9.13 22.27 11.81 9.81 9.60 -34.57 10.49 9.97 -36.28 9.26 coo 23.00 19.17 17.85 22.49 17.70 15.19 17.45 -29.65 8.35 18.11 -29.19 11.33 coo 17.70 9.25 13.10 16.68 11.30 13.99 6.29 -36.11 7.11 4.57 -37.31 5.85 coo 26.47 11.43 10.70 25.16 9.82 11.06 11.77 -37.21 15.47 13.23 -35.63 15.60 ULMN 4 1qh9_c01 2-HALOACID DEHALOGENASE user 3 4 # 3 A 10 ASP B 267 ASP.? 32.55 CL CL B 278 A 41 ARG B 3 ARG^? 24.44 CL CL B 278 A 118 SER B 265 SER.? 31.33 CL CL B 278 A 180 ASP B 268 ASP.? 26.26 CL CL B 278 coo 20.70 13.03 9.13 22.27 11.81 9.81 -15.25 -13.37 -42.11 -14.97 -14.80 -43.57 coo 23.00 19.17 17.85 22.49 17.70 15.19 -7.40 -8.36 -37.36 -6.70 -7.91 -40.31 coo 17.70 9.25 13.10 16.68 11.30 13.99 -18.83 -7.98 -38.03 -20.02 -6.85 -39.79 coo 26.47 11.43 10.70 25.16 9.82 11.06 -14.31 -16.11 -36.83 -14.03 -14.11 -36.24 1qh9_c01 source 1qh9 2-HALOACID DEHALOGENASE : 3 hits 1qh9_c01 naa= 4 ULMN 4 1qho_c06 ALPHA-AMYLASE user 1 4 # 1 A 228 ASP B 224 ASP~? 22.83 CL CL B 278 A 256 GLU B 221 GLU~? 17.56 CL CL B 278 A 258 TYR B 217 TYR.? 13.94 CL CL B 278 A 329 ASP B 168 ASP^? 12.80 CL CL B 278 coo 28.46 69.88 26.74 30.40 70.70 26.53 -13.88 7.87 -23.86 -15.40 8.87 -22.81 coo 30.54 71.65 32.58 31.73 72.26 30.92 -13.90 4.76 -18.50 -13.25 3.58 -16.87 coo 34.49 75.01 33.70 36.97 73.92 34.33 -12.06 -0.05 -19.78 -9.32 0.42 -19.98 coo 37.87 70.12 31.80 36.61 69.74 30.15 -5.42 2.81 -22.11 -6.82 3.76 -20.83 1qho_c06 source 1qho ALPHA-AMYLASE : 1 hits 1qho_c06 naa= 4 ULMN 4 1qq5_c02 L-2-HALOACID DEHALOGENASE user 1 4 # 1 A 8 ASP A 267 ASP.? 31.09 CL CL A 278 A 39 ARG A 3 ARG^? 24.49 CL CL A 278 A 114 SER A 265 SER.? 30.92 CL CL A 278 A 176 ASP A 268 ASP.? 26.73 CL CL A 278 coo 11.74 10.89 36.46 11.22 9.07 35.52 11.77 -37.21 15.47 13.23 -35.63 15.60 coo 9.95 2.30 29.39 10.16 4.06 31.89 17.45 -29.65 8.35 18.11 -29.19 11.33 coo 14.04 6.15 40.29 15.11 4.90 38.49 16.53 -40.85 10.53 17.64 -42.38 12.05 coo 6.71 9.84 37.08 8.21 10.00 38.54 9.60 -34.57 10.49 9.97 -36.28 9.26 ULMN 4 1qq5_c02 L-2-HALOACID DEHALOGENASE user 2 4 # 2 A 8 ASP A 268 ASP.? 26.73 CL CL A 278 A 39 ARG A 3 ARG^? 24.49 CL CL A 278 A 114 SER A 28 SER.? 27.02 CL CL A 278 A 176 ASP A 267 ASP.? 31.09 CL CL A 278 coo 11.74 10.89 36.46 11.22 9.07 35.52 9.60 -34.57 10.49 9.97 -36.28 9.26 coo 9.95 2.30 29.39 10.16 4.06 31.89 17.45 -29.65 8.35 18.11 -29.19 11.33 coo 14.04 6.15 40.29 15.11 4.90 38.49 6.29 -36.11 7.11 4.57 -37.31 5.85 coo 6.71 9.84 37.08 8.21 10.00 38.54 11.77 -37.21 15.47 13.23 -35.63 15.60 ULMN 4 1qq5_c02 L-2-HALOACID DEHALOGENASE user 3 4 # 3 A 8 ASP B 267 ASP.? 32.55 CL CL B 278 A 39 ARG B 3 ARG^? 24.44 CL CL B 278 A 114 SER B 265 SER.? 31.33 CL CL B 278 A 176 ASP B 268 ASP.? 26.26 CL CL B 278 coo 11.74 10.89 36.46 11.22 9.07 35.52 -15.25 -13.37 -42.11 -14.97 -14.80 -43.57 coo 9.95 2.30 29.39 10.16 4.06 31.89 -7.40 -8.36 -37.36 -6.70 -7.91 -40.31 coo 14.04 6.15 40.29 15.11 4.90 38.49 -18.83 -7.98 -38.03 -20.02 -6.85 -39.79 coo 6.71 9.84 37.08 8.21 10.00 38.54 -14.31 -16.11 -36.83 -14.03 -14.11 -36.24 1qq5_c02 source 1qq5 L-2-HALOACID DEHALOGENASE : 3 hits 1qq5_c02 naa= 4 ULMN 4 1qq5_c03 L-2-HALOACID DEHALOGENASE user 1 4 # 1 B 8 ASP A 267 ASP.? 31.09 CL CL A 278 B 39 ARG A 3 ARG^? 24.49 CL CL A 278 B 114 SER A 265 SER.? 30.92 CL CL A 278 B 176 ASP A 268 ASP.? 26.73 CL CL A 278 coo -12.56 -11.18 35.50 -11.97 -9.35 34.62 11.77 -37.21 15.47 13.23 -35.63 15.60 coo -10.21 -2.50 28.59 -10.64 -4.26 31.07 17.45 -29.65 8.35 18.11 -29.19 11.33 coo -15.18 -6.47 39.05 -16.09 -5.31 37.09 16.53 -40.85 10.53 17.64 -42.38 12.05 coo -7.57 -10.16 36.43 -9.20 -10.33 37.73 9.60 -34.57 10.49 9.97 -36.28 9.26 ULMN 4 1qq5_c03 L-2-HALOACID DEHALOGENASE user 2 4 # 2 B 8 ASP A 268 ASP.? 26.73 CL CL A 278 B 39 ARG A 3 ARG^? 24.49 CL CL A 278 B 114 SER A 28 SER.? 27.02 CL CL A 278 B 176 ASP A 267 ASP.? 31.09 CL CL A 278 coo -12.56 -11.18 35.50 -11.97 -9.35 34.62 9.60 -34.57 10.49 9.97 -36.28 9.26 coo -10.21 -2.50 28.59 -10.64 -4.26 31.07 17.45 -29.65 8.35 18.11 -29.19 11.33 coo -15.18 -6.47 39.05 -16.09 -5.31 37.09 6.29 -36.11 7.11 4.57 -37.31 5.85 coo -7.57 -10.16 36.43 -9.20 -10.33 37.73 11.77 -37.21 15.47 13.23 -35.63 15.60 ULMN 4 1qq5_c03 L-2-HALOACID DEHALOGENASE user 3 4 # 3 B 8 ASP B 267 ASP.? 32.55 CL CL B 278 B 39 ARG B 3 ARG^? 24.44 CL CL B 278 B 114 SER B 265 SER.? 31.33 CL CL B 278 B 176 ASP B 268 ASP.? 26.26 CL CL B 278 coo -12.56 -11.18 35.50 -11.97 -9.35 34.62 -15.25 -13.37 -42.11 -14.97 -14.80 -43.57 coo -10.21 -2.50 28.59 -10.64 -4.26 31.07 -7.40 -8.36 -37.36 -6.70 -7.91 -40.31 coo -15.18 -6.47 39.05 -16.09 -5.31 37.09 -18.83 -7.98 -38.03 -20.02 -6.85 -39.79 coo -7.57 -10.16 36.43 -9.20 -10.33 37.73 -14.31 -16.11 -36.83 -14.03 -14.11 -36.24 1qq5_c03 source 1qq5 L-2-HALOACID DEHALOGENASE : 3 hits 1qq5_c03 naa= 4 ULMN 4 1tml_c00 ENDO-1,4-BETA-D-GLUCANASE (E.C.3.2.1user 1 4 # 1 73 TYR A 215 TYR.? 13.87 CL CL A 278 78 ARG A 196 ARG.? 15.95 CL CL A 278 79 ASP A 224 ASP~? 22.21 CL CL A 278 117 ASP A 168 ASP^? 12.27 CL CL A 278 coo 10.99 48.36 -19.15 9.49 50.64 -18.98 21.62 -36.04 -14.58 23.93 -37.55 -14.90 coo 5.43 50.57 -21.55 6.80 47.80 -21.46 27.49 -34.87 -12.70 29.46 -35.46 -10.43 coo 3.03 55.03 -27.07 4.16 56.12 -25.64 30.83 -39.35 -6.18 31.71 -41.01 -7.15 coo 3.35 49.90 -16.55 3.54 50.44 -14.49 26.46 -30.73 -8.22 26.92 -32.42 -9.39 ULMN 4 1tml_c00 ENDO-1,4-BETA-D-GLUCANASE (E.C.3.2.1user 2 4 # 2 73 TYR B 215 TYR.? 14.28 CL CL B 278 78 ARG B 196 ARG.? 16.18 CL CL B 278 79 ASP B 224 ASP~? 22.83 CL CL B 278 117 ASP B 168 ASP^? 12.80 CL CL B 278 coo 10.99 48.36 -19.15 9.49 50.64 -18.98 -10.18 -0.68 -14.85 -11.32 1.86 -14.73 coo 5.43 50.57 -21.55 6.80 47.80 -21.46 -8.42 4.93 -17.56 -9.12 6.53 -20.07 coo 3.03 55.03 -27.07 4.16 56.12 -25.64 -13.88 7.87 -23.86 -15.40 8.87 -22.81 coo 3.35 49.90 -16.55 3.54 50.44 -14.49 -5.42 2.81 -22.11 -6.82 3.76 -20.83 1tml_c00 source 1tml ENDO-1,4-BETA-D-GLUCANASE (E.C.3.2.1.4) : 2 hits 1tml_c00 naa= 4 ULMN 4 1x9h_c00 GLUCOSE-6-PHOSPHATE ISOMERASE user 1 4 # 1 A 135 ARG A 140 ARG.? 3.74 CL CL A 278 A 203 GLU A 169 GLU.? 7.63 CL CL A 278 A 219 HIS A -1 HIS.? 31.67 CL CL A 278 A 298 LYS A 211 LYS~? 14.92 CL CL A 278 coo 46.78 3.24 25.36 49.46 4.02 24.06 24.77 -21.68 -10.23 22.52 -23.37 -11.49 coo 45.62 7.41 24.38 46.18 6.66 26.27 26.74 -26.14 -12.80 26.49 -24.16 -13.47 coo 17.74 16.81 28.99 16.41 15.60 30.09 23.28 -34.51 17.18 21.28 -34.97 16.73 coo 54.03 15.54 30.62 51.73 9.72 31.19 17.07 -30.19 -20.07 15.73 -30.42 -25.42 1x9h_c00 source 1x9h GLUCOSE-6-PHOSPHATE ISOMERASE : 1 hits 1x9h_c00 naa= 4 ULMN 4 1x9h_c01 GLUCOSE-6-PHOSPHATE ISOMERASE user 1 4 # 1 B 135 ARG A 140 ARG.? 3.74 CL CL A 278 B 203 GLU A 169 GLU.? 7.63 CL CL A 278 B 219 HIS A -1 HIS.? 31.67 CL CL A 278 B 298 LYS A 211 LYS~? 14.92 CL CL A 278 coo 18.36 26.71 24.52 15.92 26.01 22.78 24.77 -21.68 -10.23 22.52 -23.37 -11.49 coo 19.67 22.60 23.25 18.70 23.07 25.03 26.74 -26.14 -12.80 26.49 -24.16 -13.47 coo 46.63 12.38 30.98 47.80 13.39 32.39 23.28 -34.51 17.18 21.28 -34.97 16.73 coo 10.17 13.56 26.79 12.26 19.06 29.15 17.07 -30.19 -20.07 15.73 -30.42 -25.42 1x9h_c01 source 1x9h GLUCOSE-6-PHOSPHATE ISOMERASE : 1 hits 1x9h_c01 naa= 4 ULMN 4 1xyz_c00 1,4-BETA-D-XYLAN-XYLANOHYDROLASE user 1 4 # 1 A 645 GLU A 34 GLU^? 8.78 CL CL A 278 A 723 HIS A 194 HIS.? 4.68 CL CL A 278 A 754 GLU A 138 GLU^? 6.67 CL CL A 278 A 756 ASP A 168 ASP^? 12.27 CL CL A 278 coo 8.52 14.29 34.54 9.38 13.03 33.07 14.76 -23.90 -2.78 16.42 -23.89 -4.11 coo 14.75 17.66 28.95 15.62 16.26 30.25 21.59 -27.03 -10.13 21.31 -25.37 -8.87 coo 16.72 16.24 34.49 15.11 14.90 34.21 23.86 -20.99 -6.84 22.60 -22.69 -7.03 coo 20.22 18.04 27.00 18.34 17.09 27.29 26.46 -30.73 -8.22 26.92 -32.42 -9.39 ULMN 4 1xyz_c00 1,4-BETA-D-XYLAN-XYLANOHYDROLASE user 2 4 # 2 A 645 GLU B 34 GLU^? 8.94 CL CL B 278 A 723 HIS B 194 HIS.? 5.13 CL CL B 278 A 754 GLU B 138 GLU^? 6.70 CL CL B 278 A 756 ASP B 168 ASP^? 12.80 CL CL B 278 coo 8.52 14.29 34.54 9.38 13.03 33.07 -0.25 -10.10 -26.69 0.15 -8.25 -25.75 coo 14.75 17.66 28.95 15.62 16.26 30.25 -1.92 -2.21 -20.05 -0.53 -2.75 -21.52 coo 16.72 16.24 34.49 15.11 14.90 34.21 3.87 -1.10 -24.33 2.09 -2.15 -23.84 coo 20.22 18.04 27.00 18.34 17.09 27.29 -5.42 2.81 -22.11 -6.82 3.76 -20.83 1xyz_c00 source 1xyz 1,4-BETA-D-XYLAN-XYLANOHYDROLASE : 2 hits 1xyz_c00 naa= 4 ULMN 4 1xyz_c01 1,4-BETA-D-XYLAN-XYLANOHYDROLASE user 1 4 # 1 B 645 GLU A 34 GLU^? 8.78 CL CL A 278 B 723 HIS A 194 HIS.? 4.68 CL CL A 278 B 754 GLU A 138 GLU^? 6.67 CL CL A 278 B 756 ASP A 168 ASP^? 12.27 CL CL A 278 coo 15.60 30.64 69.31 14.72 29.15 68.11 14.76 -23.90 -2.78 16.42 -23.89 -4.11 coo 9.08 25.15 72.84 8.18 26.43 71.44 21.59 -27.03 -10.13 21.31 -25.37 -8.87 coo 7.29 30.67 71.38 8.86 30.34 70.00 23.86 -20.99 -6.84 22.60 -22.69 -7.03 coo 3.67 23.22 73.36 5.48 23.51 72.37 26.46 -30.73 -8.22 26.92 -32.42 -9.39 ULMN 4 1xyz_c01 1,4-BETA-D-XYLAN-XYLANOHYDROLASE user 2 4 # 2 B 645 GLU B 34 GLU^? 8.94 CL CL B 278 B 723 HIS B 194 HIS.? 5.13 CL CL B 278 B 754 GLU B 138 GLU^? 6.70 CL CL B 278 B 756 ASP B 168 ASP^? 12.80 CL CL B 278 coo 15.60 30.64 69.31 14.72 29.15 68.11 -0.25 -10.10 -26.69 0.15 -8.25 -25.75 coo 9.08 25.15 72.84 8.18 26.43 71.44 -1.92 -2.21 -20.05 -0.53 -2.75 -21.52 coo 7.29 30.67 71.38 8.86 30.34 70.00 3.87 -1.10 -24.33 2.09 -2.15 -23.84 coo 3.67 23.22 73.36 5.48 23.51 72.37 -5.42 2.81 -22.11 -6.82 3.76 -20.83 1xyz_c01 source 1xyz 1,4-BETA-D-XYLAN-XYLANOHYDROLASE : 2 hits 1xyz_c01 naa= 4 ULMN 4 2nmt_c00 MYRISTOYL-COA:PROTEIN N-MYRISTOYLTRAuser 1 4 # 1 A 169 ASN A 254 ASN~? 16.17 CL CL A 278 A 170 PHE A 243 PHE^? 14.37 CL CL A 278 A 171 LEU A 225 LEU~? 16.21 CL CL A 278 A 455 LEU A 256 LEU~? 21.64 CL CL A 278 coo 29.34 24.41 78.19 29.76 25.72 76.57 18.50 -38.45 -6.68 18.86 -39.34 -8.59 coo 30.60 22.78 74.02 32.69 24.70 74.02 18.82 -34.33 -4.40 20.85 -36.01 -3.52 coo 23.47 21.19 75.19 21.55 20.19 75.05 26.75 -36.55 -4.37 26.44 -35.43 -6.22 coo 34.24 28.84 77.53 36.19 29.18 78.46 14.72 -41.24 -0.83 12.83 -40.46 -0.04 ULMN 4 2nmt_c00 MYRISTOYL-COA:PROTEIN N-MYRISTOYLTRAuser 2 4 # 2 A 169 ASN B 254 ASN~? 16.98 CL CL B 278 A 170 PHE B 243 PHE^? 14.91 CL CL B 278 A 171 LEU B 225 LEU~? 16.69 CL CL B 278 A 455 LEU B 256 LEU~? 22.33 CL CL B 278 coo 29.34 24.41 78.19 29.76 25.72 76.57 -14.04 -4.32 -21.65 -14.71 -3.72 -19.71 coo 30.60 22.78 74.02 32.69 24.70 74.02 -10.13 -4.72 -24.34 -11.77 -2.66 -25.27 coo 23.47 21.19 75.19 21.55 20.19 75.05 -11.60 3.29 -25.22 -10.17 3.06 -23.58 coo 34.24 28.84 77.53 36.19 29.18 78.46 -17.94 -8.45 -26.71 -17.33 -10.44 -27.39 2nmt_c00 source 2nmt MYRISTOYL-COA:PROTEIN N-MYRISTOYLTRANSFERASE : 2 hits 2nmt_c00 naa= 4 ULMN 4 2xis_c01 XYLOSE ISOMERASE (E.C.5.3.1.5) COMPLuser 1 4 # 1 54 HIS B 194 HIS.? 5.13 CL CL B 278 57 ASP B 168 ASP^? 12.80 CL CL B 278 181 GLU B 34 GLU^? 8.94 CL CL B 278 183 LYS B 64 LYS^? 6.39 CL CL B 278 coo 14.76 26.44 45.64 13.75 28.28 45.57 -1.92 -2.21 -20.05 -0.53 -2.75 -21.52 coo 13.28 22.33 42.65 12.61 24.09 43.52 -5.42 2.81 -22.11 -6.82 3.76 -20.83 coo 15.43 37.69 46.28 14.58 36.11 45.10 -0.25 -10.10 -26.69 0.15 -8.25 -25.75 coo 11.94 40.77 50.56 7.67 36.15 49.76 5.21 -10.68 -27.95 4.80 -8.81 -21.96 2xis_c01 source 2xis XYLOSE ISOMERASE (E.C.5.3.1.5) COMPLEX WITH XY: 1 hits 2xis_c01 naa= 4 ULMN 3 12as_c00 ASPARAGINE SYNTHETASE user 1 3 # 1 A 46 ASP A 168 ASP^? 12.27 CL CL A 278 A 100 ARG A 196 ARG.? 15.95 CL CL A 278 A 116 GLN A 171 GLN.? 12.96 CL CL A 278 coo 32.24 20.09 5.34 30.38 19.04 5.27 26.46 -30.73 -8.22 26.92 -32.42 -9.39 coo 26.40 25.34 6.28 26.15 22.33 7.25 27.49 -34.87 -12.70 29.46 -35.46 -10.43 coo 26.74 21.94 13.78 27.57 20.97 12.08 30.97 -29.89 -15.03 31.06 -28.02 -13.98 12as_c00 source 12as ASPARAGINE SYNTHETASE : 1 hits 12as_c00 naa= 3 ULMN 3 12as_c01 ASPARAGINE SYNTHETASE user 1 3 # 1 B 46 ASP A 36 ASP~? 8.69 CL CL A 278 B 100 ARG A 192 ARG^? 5.91 CL CL A 278 B 116 GLN A 108 GLN^? 4.62 CL CL A 278 coo 32.18 48.37 12.48 33.96 49.46 12.97 11.67 -20.98 -6.16 13.43 -22.16 -5.96 coo 39.04 43.25 11.37 38.30 45.35 13.56 20.84 -24.38 -4.40 19.02 -23.24 -6.62 coo 37.43 42.63 19.41 36.76 44.08 17.97 20.72 -19.01 -8.40 19.38 -20.33 -9.34 ULMN 3 12as_c01 ASPARAGINE SYNTHETASE user 2 3 # 2 B 46 ASP B 36 ASP~? 8.83 CL CL B 278 B 100 ARG B 192 ARG^? 6.13 CL CL B 278 B 116 GLN B 108 GLN^? -4.21 CL CL B 278s coo 32.18 48.37 12.48 33.96 49.46 12.97 2.64 -13.17 -23.36 1.59 -11.35 -23.67 coo 39.04 43.25 11.37 38.30 45.35 13.56 -0.17 -3.93 -26.09 1.00 -5.48 -23.71 coo 37.43 42.63 19.41 36.76 44.08 17.97 5.69 -4.28 -22.53 4.39 -5.36 -21.22 12as_c01 source 12as ASPARAGINE SYNTHETASE : 2 hits 12as_c01 naa= 3 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 1 3 # 1 A 140 TYR A 24 TYR~? 29.31 CL CL A 278 B 190 LYS A 272 LYS.? 33.16 CL CL A 278 B 222 ASP A 275 ASP.? 34.16 CL CL A 278 coo 7.17 16.59 41.26 8.01 19.20 40.73 0.87 -31.89 7.51 0.76 -33.22 9.95 coo 13.38 20.00 35.06 11.43 22.49 39.53 -2.40 -40.27 7.96 -3.06 -34.63 9.73 coo 9.76 26.58 38.10 11.63 25.78 38.76 -7.58 -36.49 2.30 -8.60 -35.44 3.90 1a05_c00 source 1a05 3-ISOPROPYLMALATE DEHYDROGENASE : 1 hits 1a05_c00 naa= 3 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 1 3 # 1 A 190 LYS A 272 LYS.? 33.16 CL CL A 278 A 222 ASP A 275 ASP.? 34.16 CL CL A 278 B 140 TYR A 24 TYR~? 29.31 CL CL A 278 coo -4.61 20.12 30.34 -2.74 22.65 25.95 -2.40 -40.27 7.96 -3.06 -34.63 9.73 coo -1.04 26.60 27.37 -2.94 25.93 26.69 -7.58 -36.49 2.30 -8.60 -35.44 3.90 coo 1.51 16.60 24.17 0.82 19.23 24.79 0.87 -31.89 7.51 0.76 -33.22 9.95 1a05_c01 source 1a05 3-ISOPROPYLMALATE DEHYDROGENASE : 1 hits 1a05_c01 naa= 3 ULMN 3 1a0j_c00 TRYPSIN user 1 3 # 1 A 57 HIS A 12 HIS~? 14.78 CL CL A 278 A 102 ASP A 13 ASP~? 20.85 CL CL A 278 A 195 SER A 10 SER.? 17.45 CL CL A 278 coo 25.57 41.22 61.68 24.18 39.98 62.50 9.03 -33.35 -4.93 10.37 -31.88 -5.56 coo 22.33 45.48 59.73 23.35 43.67 60.06 3.80 -37.83 -7.42 4.89 -38.66 -9.05 coo 20.90 36.72 61.65 22.18 37.53 63.52 3.77 -30.46 -4.30 3.68 -28.35 -5.48 ULMN 3 1a0j_c00 TRYPSIN user 2 3 # 2 A 57 HIS A 12 HIS~? 14.78 CL CL A 278 A 102 ASP A 13 ASP~? 20.85 CL CL A 278 A 195 SER A 21 SER.? 21.88 CL CL A 278 coo 25.57 41.22 61.68 24.18 39.98 62.50 9.03 -33.35 -4.93 10.37 -31.88 -5.56 coo 22.33 45.48 59.73 23.35 43.67 60.06 3.80 -37.83 -7.42 4.89 -38.66 -9.05 coo 20.90 36.72 61.65 22.18 37.53 63.52 1.16 -33.17 -2.24 2.71 -34.86 -3.05 ULMN 3 1a0j_c00 TRYPSIN user 3 3 # 3 A 57 HIS B 12 HIS~? 15.42 CL CL B 278 A 102 ASP B 13 ASP~? 21.13 CL CL B 278 A 195 SER B 10 SER.? 17.86 CL CL B 278 coo 25.57 41.22 61.68 24.18 39.98 62.50 -10.18 -14.51 -22.80 -8.49 -13.29 -22.60 coo 22.33 45.48 59.73 23.35 43.67 60.06 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 coo 20.90 36.72 61.65 22.18 37.53 63.52 -7.63 -19.97 -23.27 -5.38 -20.37 -22.44 ULMN 3 1a0j_c00 TRYPSIN user 4 3 # 4 A 57 HIS B 12 HIS~? 15.42 CL CL B 278 A 102 ASP B 13 ASP~? 21.13 CL CL B 278 A 195 SER B 21 SER.? 21.23 CL CL B 278 coo 25.57 41.22 61.68 24.18 39.98 62.50 -10.18 -14.51 -22.80 -8.49 -13.29 -22.60 coo 22.33 45.48 59.73 23.35 43.67 60.06 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 coo 20.90 36.72 61.65 22.18 37.53 63.52 -10.65 -22.68 -24.42 -10.99 -20.31 -24.03 1a0j_c00 source 1a0j TRYPSIN : 4 hits 1a0j_c00 naa= 3 ULMN 3 1a0j_c01 TRYPSIN user 1 3 # 1 B 57 HIS A 12 HIS~? 14.78 CL CL A 278 B 102 ASP A 13 ASP~? 20.85 CL CL A 278 B 195 SER A 10 SER.? 17.45 CL CL A 278 coo 44.08 45.58 52.81 45.86 46.55 52.85 9.03 -33.35 -4.93 10.37 -31.88 -5.56 coo 43.04 44.75 47.18 43.31 45.51 49.13 3.80 -37.83 -7.42 4.89 -38.66 -9.05 coo 48.11 50.52 52.24 48.62 48.46 53.13 3.77 -30.46 -4.30 3.68 -28.35 -5.48 ULMN 3 1a0j_c01 TRYPSIN user 2 3 # 2 B 57 HIS A 12 HIS~? 14.78 CL CL A 278 B 102 ASP A 13 ASP~? 20.85 CL CL A 278 B 195 SER A 21 SER.? 21.88 CL CL A 278 coo 44.08 45.58 52.81 45.86 46.55 52.85 9.03 -33.35 -4.93 10.37 -31.88 -5.56 coo 43.04 44.75 47.18 43.31 45.51 49.13 3.80 -37.83 -7.42 4.89 -38.66 -9.05 coo 48.11 50.52 52.24 48.62 48.46 53.13 1.16 -33.17 -2.24 2.71 -34.86 -3.05 ULMN 3 1a0j_c01 TRYPSIN user 3 3 # 3 B 57 HIS B 12 HIS~? 15.42 CL CL B 278 B 102 ASP B 13 ASP~? 21.13 CL CL B 278 B 195 SER B 10 SER.? 17.86 CL CL B 278 coo 44.08 45.58 52.81 45.86 46.55 52.85 -10.18 -14.51 -22.80 -8.49 -13.29 -22.60 coo 43.04 44.75 47.18 43.31 45.51 49.13 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 coo 48.11 50.52 52.24 48.62 48.46 53.13 -7.63 -19.97 -23.27 -5.38 -20.37 -22.44 ULMN 3 1a0j_c01 TRYPSIN user 4 3 # 4 B 57 HIS B 12 HIS~? 15.42 CL CL B 278 B 102 ASP B 13 ASP~? 21.13 CL CL B 278 B 195 SER B 21 SER.? 21.23 CL CL B 278 coo 44.08 45.58 52.81 45.86 46.55 52.85 -10.18 -14.51 -22.80 -8.49 -13.29 -22.60 coo 43.04 44.75 47.18 43.31 45.51 49.13 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 coo 48.11 50.52 52.24 48.62 48.46 53.13 -10.65 -22.68 -24.42 -10.99 -20.31 -24.03 1a0j_c01 source 1a0j TRYPSIN : 4 hits 1a0j_c01 naa= 3 ULMN 3 1a0j_c02 TRYPSIN user 1 3 # 1 C 57 HIS A 12 HIS~? 14.78 CL CL A 278 C 102 ASP A 13 ASP~? 20.85 CL CL A 278 C 195 SER A 10 SER.? 17.45 CL CL A 278 coo 34.37 41.18 73.21 34.04 43.09 73.87 9.03 -33.35 -4.93 10.37 -31.88 -5.56 coo 34.89 38.34 78.12 35.11 39.59 76.42 3.80 -37.83 -7.42 4.89 -38.66 -9.05 coo 36.16 46.87 75.66 34.01 46.43 74.59 3.77 -30.46 -4.30 3.68 -28.35 -5.48 ULMN 3 1a0j_c02 TRYPSIN user 2 3 # 2 C 57 HIS A 12 HIS~? 14.78 CL CL A 278 C 102 ASP A 13 ASP~? 20.85 CL CL A 278 C 195 SER A 21 SER.? 21.88 CL CL A 278 coo 34.37 41.18 73.21 34.04 43.09 73.87 9.03 -33.35 -4.93 10.37 -31.88 -5.56 coo 34.89 38.34 78.12 35.11 39.59 76.42 3.80 -37.83 -7.42 4.89 -38.66 -9.05 coo 36.16 46.87 75.66 34.01 46.43 74.59 1.16 -33.17 -2.24 2.71 -34.86 -3.05 ULMN 3 1a0j_c02 TRYPSIN user 3 3 # 3 C 57 HIS B 12 HIS~? 15.42 CL CL B 278 C 102 ASP B 13 ASP~? 21.13 CL CL B 278 C 195 SER B 10 SER.? 17.86 CL CL B 278 coo 34.37 41.18 73.21 34.04 43.09 73.87 -10.18 -14.51 -22.80 -8.49 -13.29 -22.60 coo 34.89 38.34 78.12 35.11 39.59 76.42 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 coo 36.16 46.87 75.66 34.01 46.43 74.59 -7.63 -19.97 -23.27 -5.38 -20.37 -22.44 ULMN 3 1a0j_c02 TRYPSIN user 4 3 # 4 C 57 HIS B 12 HIS~? 15.42 CL CL B 278 C 102 ASP B 13 ASP~? 21.13 CL CL B 278 C 195 SER B 21 SER.? 21.23 CL CL B 278 coo 34.37 41.18 73.21 34.04 43.09 73.87 -10.18 -14.51 -22.80 -8.49 -13.29 -22.60 coo 34.89 38.34 78.12 35.11 39.59 76.42 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 coo 36.16 46.87 75.66 34.01 46.43 74.59 -10.65 -22.68 -24.42 -10.99 -20.31 -24.03 1a0j_c02 source 1a0j TRYPSIN : 4 hits 1a0j_c02 naa= 3 ULMN 3 1a0j_c03 TRYPSIN user 1 3 # 1 D 57 HIS A 12 HIS~? 14.78 CL CL A 278 D 102 ASP A 13 ASP~? 20.85 CL CL A 278 D 195 SER A 10 SER.? 17.45 CL CL A 278 coo 8.19 15.01 95.72 7.78 16.53 97.01 9.03 -33.35 -4.93 10.37 -31.88 -5.56 coo 13.53 16.28 93.98 11.45 16.21 94.40 3.80 -37.83 -7.42 4.89 -38.66 -9.05 coo 6.63 21.03 97.42 6.71 19.20 98.95 3.77 -30.46 -4.30 3.68 -28.35 -5.48 ULMN 3 1a0j_c03 TRYPSIN user 2 3 # 2 D 57 HIS A 12 HIS~? 14.78 CL CL A 278 D 102 ASP A 13 ASP~? 20.85 CL CL A 278 D 195 SER A 21 SER.? 21.88 CL CL A 278 coo 8.19 15.01 95.72 7.78 16.53 97.01 9.03 -33.35 -4.93 10.37 -31.88 -5.56 coo 13.53 16.28 93.98 11.45 16.21 94.40 3.80 -37.83 -7.42 4.89 -38.66 -9.05 coo 6.63 21.03 97.42 6.71 19.20 98.95 1.16 -33.17 -2.24 2.71 -34.86 -3.05 ULMN 3 1a0j_c03 TRYPSIN user 3 3 # 3 D 57 HIS B 12 HIS~? 15.42 CL CL B 278 D 102 ASP B 13 ASP~? 21.13 CL CL B 278 D 195 SER B 10 SER.? 17.86 CL CL B 278 coo 8.19 15.01 95.72 7.78 16.53 97.01 -10.18 -14.51 -22.80 -8.49 -13.29 -22.60 coo 13.53 16.28 93.98 11.45 16.21 94.40 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 coo 6.63 21.03 97.42 6.71 19.20 98.95 -7.63 -19.97 -23.27 -5.38 -20.37 -22.44 ULMN 3 1a0j_c03 TRYPSIN user 4 3 # 4 D 57 HIS B 12 HIS~? 15.42 CL CL B 278 D 102 ASP B 13 ASP~? 21.13 CL CL B 278 D 195 SER B 21 SER.? 21.23 CL CL B 278 coo 8.19 15.01 95.72 7.78 16.53 97.01 -10.18 -14.51 -22.80 -8.49 -13.29 -22.60 coo 13.53 16.28 93.98 11.45 16.21 94.40 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 coo 6.63 21.03 97.42 6.71 19.20 98.95 -10.65 -22.68 -24.42 -10.99 -20.31 -24.03 1a0j_c03 source 1a0j TRYPSIN : 4 hits 1a0j_c03 naa= 3 ULMN 3 1a0j_c12 TRYPSIN user 1 3 # 1 A 57 HIS A 12 HIS~? 14.78 CL CL A 278 A 102 ASP A 13 ASP~? 20.85 CL CL A 278 A 193 GLY A 5 GLY^? 15.84 CL CL A 278 coo 25.57 41.22 61.68 24.18 39.98 62.50 9.03 -33.35 -4.93 10.37 -31.88 -5.56 coo 22.33 45.48 59.73 23.35 43.67 60.06 3.80 -37.83 -7.42 4.89 -38.66 -9.05 coo 22.57 32.23 64.13 21.98 32.82 64.22 15.52 -31.61 0.74 16.07 -31.86 0.19 ULMN 3 1a0j_c12 TRYPSIN user 2 3 # 2 A 57 HIS B 12 HIS~? 15.42 CL CL B 278 A 102 ASP B 13 ASP~? 21.13 CL CL B 278 A 193 GLY B 5 GLY^? 16.39 CL CL B 278 coo 25.57 41.22 61.68 24.18 39.98 62.50 -10.18 -14.51 -22.80 -8.49 -13.29 -22.60 coo 22.33 45.48 59.73 23.35 43.67 60.06 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 coo 22.57 32.23 64.13 21.98 32.82 64.22 -8.44 -9.04 -29.52 -8.55 -8.38 -29.05 ULMN 3 1a0j_c12 TRYPSIN user 3 3 # 3 A 57 HIS B 29 HIS.? 25.42 CL CL B 278 A 102 ASP B 268 ASP.? 26.26 CL CL B 278 A 193 GLY B 17 GLY~? 26.14 CL CL B 278 coo 25.57 41.22 61.68 24.18 39.98 62.50 -16.16 -16.38 -29.82 -17.24 -18.07 -29.20 coo 22.33 45.48 59.73 23.35 43.67 60.06 -14.31 -16.11 -36.83 -14.03 -14.11 -36.24 coo 22.57 32.23 64.13 21.98 32.82 64.22 -18.23 -20.62 -22.29 -17.41 -20.69 -22.32 1a0j_c12 source 1a0j TRYPSIN : 3 hits 1a0j_c12 naa= 3 ULMN 3 1a0j_c13 TRYPSIN user 1 3 # 1 B 57 HIS A 12 HIS~? 14.78 CL CL A 278 B 102 ASP A 13 ASP~? 20.85 CL CL A 278 B 193 GLY A 5 GLY^? 15.84 CL CL A 278 coo 44.08 45.58 52.81 45.86 46.55 52.85 9.03 -33.35 -4.93 10.37 -31.88 -5.56 coo 43.04 44.75 47.18 43.31 45.51 49.13 3.80 -37.83 -7.42 4.89 -38.66 -9.05 coo 50.46 51.91 56.90 50.65 51.62 56.14 15.52 -31.61 0.74 16.07 -31.86 0.19 ULMN 3 1a0j_c13 TRYPSIN user 2 3 # 2 B 57 HIS B 12 HIS~? 15.42 CL CL B 278 B 102 ASP B 13 ASP~? 21.13 CL CL B 278 B 193 GLY B 5 GLY^? 16.39 CL CL B 278 coo 44.08 45.58 52.81 45.86 46.55 52.85 -10.18 -14.51 -22.80 -8.49 -13.29 -22.60 coo 43.04 44.75 47.18 43.31 45.51 49.13 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 coo 50.46 51.91 56.90 50.65 51.62 56.14 -8.44 -9.04 -29.52 -8.55 -8.38 -29.05 ULMN 3 1a0j_c13 TRYPSIN user 3 3 # 3 B 57 HIS B 29 HIS.? 25.42 CL CL B 278 B 102 ASP B 268 ASP.? 26.26 CL CL B 278 B 193 GLY B 17 GLY~? 26.14 CL CL B 278 coo 44.08 45.58 52.81 45.86 46.55 52.85 -16.16 -16.38 -29.82 -17.24 -18.07 -29.20 coo 43.04 44.75 47.18 43.31 45.51 49.13 -14.31 -16.11 -36.83 -14.03 -14.11 -36.24 coo 50.46 51.91 56.90 50.65 51.62 56.14 -18.23 -20.62 -22.29 -17.41 -20.69 -22.32 1a0j_c13 source 1a0j TRYPSIN : 3 hits 1a0j_c13 naa= 3 ULMN 3 1a0j_c14 TRYPSIN user 1 3 # 1 C 57 HIS A 12 HIS~? 14.78 CL CL A 278 C 102 ASP A 13 ASP~? 20.85 CL CL A 278 C 193 GLY A 5 GLY^? 15.84 CL CL A 278 coo 34.37 41.18 73.21 34.04 43.09 73.87 9.03 -33.35 -4.93 10.37 -31.88 -5.56 coo 34.89 38.34 78.12 35.11 39.59 76.42 3.80 -37.83 -7.42 4.89 -38.66 -9.05 coo 35.43 51.03 72.12 35.20 50.72 72.87 15.52 -31.61 0.74 16.07 -31.86 0.19 ULMN 3 1a0j_c14 TRYPSIN user 2 3 # 2 C 57 HIS B 12 HIS~? 15.42 CL CL B 278 C 102 ASP B 13 ASP~? 21.13 CL CL B 278 C 193 GLY B 5 GLY^? 16.39 CL CL B 278 coo 34.37 41.18 73.21 34.04 43.09 73.87 -10.18 -14.51 -22.80 -8.49 -13.29 -22.60 coo 34.89 38.34 78.12 35.11 39.59 76.42 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 coo 35.43 51.03 72.12 35.20 50.72 72.87 -8.44 -9.04 -29.52 -8.55 -8.38 -29.05 ULMN 3 1a0j_c14 TRYPSIN user 3 3 # 3 C 57 HIS B 29 HIS.? 25.42 CL CL B 278 C 102 ASP B 268 ASP.? 26.26 CL CL B 278 C 193 GLY B 17 GLY~? 26.14 CL CL B 278 coo 34.37 41.18 73.21 34.04 43.09 73.87 -16.16 -16.38 -29.82 -17.24 -18.07 -29.20 coo 34.89 38.34 78.12 35.11 39.59 76.42 -14.31 -16.11 -36.83 -14.03 -14.11 -36.24 coo 35.43 51.03 72.12 35.20 50.72 72.87 -18.23 -20.62 -22.29 -17.41 -20.69 -22.32 1a0j_c14 source 1a0j TRYPSIN : 3 hits 1a0j_c14 naa= 3 ULMN 3 1a0j_c15 TRYPSIN user 1 3 # 1 D 57 HIS A 12 HIS~? 14.78 CL CL A 278 D 102 ASP A 13 ASP~? 20.85 CL CL A 278 D 193 GLY A 5 GLY^? 15.84 CL CL A 278 coo 8.19 15.01 95.72 7.78 16.53 97.01 9.03 -33.35 -4.93 10.37 -31.88 -5.56 coo 13.53 16.28 93.98 11.45 16.21 94.40 3.80 -37.83 -7.42 4.89 -38.66 -9.05 coo 1.80 21.25 100.04 2.61 21.42 100.18 15.52 -31.61 0.74 16.07 -31.86 0.19 ULMN 3 1a0j_c15 TRYPSIN user 2 3 # 2 D 57 HIS B 12 HIS~? 15.42 CL CL B 278 D 102 ASP B 13 ASP~? 21.13 CL CL B 278 D 193 GLY B 5 GLY^? 16.39 CL CL B 278 coo 8.19 15.01 95.72 7.78 16.53 97.01 -10.18 -14.51 -22.80 -8.49 -13.29 -22.60 coo 13.53 16.28 93.98 11.45 16.21 94.40 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 coo 1.80 21.25 100.04 2.61 21.42 100.18 -8.44 -9.04 -29.52 -8.55 -8.38 -29.05 ULMN 3 1a0j_c15 TRYPSIN user 3 3 # 3 D 57 HIS B 29 HIS.? 25.42 CL CL B 278 D 102 ASP B 268 ASP.? 26.26 CL CL B 278 D 193 GLY B 17 GLY~? 26.14 CL CL B 278 coo 8.19 15.01 95.72 7.78 16.53 97.01 -16.16 -16.38 -29.82 -17.24 -18.07 -29.20 coo 13.53 16.28 93.98 11.45 16.21 94.40 -14.31 -16.11 -36.83 -14.03 -14.11 -36.24 coo 1.80 21.25 100.04 2.61 21.42 100.18 -18.23 -20.62 -22.29 -17.41 -20.69 -22.32 1a0j_c15 source 1a0j TRYPSIN : 3 hits 1a0j_c15 naa= 3 ULMN 3 1a41_c01 TOPOISOMERASE I user 1 3 # 1 223 ARG A 196 ARG.? 15.95 CL CL A 278 265 HIS A 194 HIS.? 4.68 CL CL A 278 274 TYR A 180 TYR.? 19.77 CL CL A 278 coo -15.18 55.46 8.55 -14.82 52.98 10.38 27.49 -34.87 -12.70 29.46 -35.46 -10.43 coo -14.48 45.59 11.18 -14.02 47.49 10.42 21.59 -27.03 -10.13 21.31 -25.37 -8.87 coo 0.94 52.26 9.16 1.95 54.78 9.91 35.72 -25.25 -4.91 38.35 -24.47 -4.37 ULMN 3 1a41_c01 TOPOISOMERASE I user 2 3 # 2 223 ARG B 196 ARG.? 16.18 CL CL B 278 265 HIS B 194 HIS.? 5.13 CL CL B 278 274 TYR B 180 TYR.? 19.79 CL CL B 278 coo -15.18 55.46 8.55 -14.82 52.98 10.38 -8.42 4.93 -17.56 -9.12 6.53 -20.07 coo -14.48 45.59 11.18 -14.02 47.49 10.42 -1.92 -2.21 -20.05 -0.53 -2.75 -21.52 coo 0.94 52.26 9.16 1.95 54.78 9.91 0.34 10.88 -27.32 1.25 13.08 -28.75 1a41_c01 source 1a41 TOPOISOMERASE I : 2 hits 1a41_c01 naa= 3 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 1 3 # 1 A 49 GLU A 25 GLU~? 26.70 CL CL A 278 A 60 ASP A 13 ASP~? 20.85 CL CL A 278 A 175 TYR A 26 TYR~? 18.66 CL CL A 278 coo 46.10 28.27 19.27 45.48 26.99 20.84 0.23 -35.14 2.73 -1.02 -35.12 1.03 coo 56.42 28.06 12.93 55.01 27.92 14.50 3.80 -37.83 -7.42 4.89 -38.66 -9.05 coo 45.02 22.04 15.38 46.16 24.00 13.76 7.77 -31.94 1.38 10.47 -31.53 0.90 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 2 3 # 2 A 49 GLU B 25 GLU~? 26.94 CL CL B 278 A 60 ASP B 13 ASP~? 21.13 CL CL B 278 A 175 TYR B 26 TYR~? 19.09 CL CL B 278 coo 46.10 28.27 19.27 45.48 26.99 20.84 -13.37 -23.90 -28.96 -13.41 -24.80 -27.04 coo 56.42 28.06 12.93 55.01 27.92 14.50 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 coo 45.02 22.04 15.38 46.16 24.00 13.76 -9.51 -16.67 -28.98 -9.06 -13.93 -28.84 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 3 3 # 3 A 49 GLU B 25 GLU~? 26.94 CL CL B 278 A 60 ASP B 275 ASP.? 37.37 CL CL B 278 A 175 TYR B 24 TYR~? 29.69 CL CL B 278 coo 46.10 28.27 19.27 45.48 26.99 20.84 -13.37 -23.90 -28.96 -13.41 -24.80 -27.04 coo 56.42 28.06 12.93 55.01 27.92 14.50 -15.60 -35.07 -27.87 -14.73 -36.02 -29.60 coo 45.02 22.04 15.38 46.16 24.00 13.76 -10.93 -24.23 -34.16 -12.79 -24.53 -36.20 1a50_c03 source 1a50 TRYPTOPHAN SYNTHASE : 3 hits 1a50_c03 naa= 3 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 1 3 # 1 22 ASN B 244 ASN.? 5.94 CL CL B 278 63 ARG B 192 ARG^? 6.13 CL CL B 278 255 ARG B 212 ARG~? 4.30 CL CL B 278 coo 42.10 13.02 11.14 41.85 11.12 10.23 -3.88 -6.12 -21.35 -2.47 -7.43 -20.48 coo 44.36 11.24 3.39 41.81 12.78 4.00 -0.17 -3.93 -26.09 1.00 -5.48 -23.71 coo 38.40 3.83 10.26 40.02 6.30 9.25 1.13 -4.70 -13.40 3.58 -6.46 -14.00 1aj0_c00 source 1aj0 DIHYDROPTEROATE SYNTHASE : 1 hits 1aj0_c00 naa= 3 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 1 3 # 1 A 223 HIS A 12 HIS~? 14.78 CL CL A 278 A 262 HIS A 29 HIS.? 25.16 CL CL A 278 A 312 ASP A 13 ASP~? 20.85 CL CL A 278 coo 29.33 36.13 69.70 30.07 34.20 70.11 9.03 -33.35 -4.93 10.37 -31.88 -5.56 coo 38.54 36.60 66.38 37.88 34.77 67.15 7.41 -38.44 3.20 5.56 -39.41 3.04 coo 30.62 37.23 61.07 30.08 35.73 62.49 3.80 -37.83 -7.42 4.89 -38.66 -9.05 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 2 3 # 2 A 223 HIS B 12 HIS~? 15.42 CL CL B 278 A 262 HIS B 29 HIS.? 25.42 CL CL B 278 A 312 ASP B 13 ASP~? 21.13 CL CL B 278 coo 29.33 36.13 69.70 30.07 34.20 70.11 -10.18 -14.51 -22.80 -8.49 -13.29 -22.60 coo 38.54 36.60 66.38 37.88 34.77 67.15 -16.16 -16.38 -29.82 -17.24 -18.07 -29.20 coo 30.62 37.23 61.07 30.08 35.73 62.49 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 1aj8_c00 source 1aj8 CITRATE SYNTHASE : 2 hits 1aj8_c00 naa= 3 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 1 3 # 1 B 223 HIS A 12 HIS~? 14.78 CL CL A 278 B 262 HIS A 29 HIS.? 25.16 CL CL A 278 B 312 ASP A 13 ASP~? 20.85 CL CL A 278 coo 23.86 29.50 91.20 24.12 31.58 91.00 9.03 -33.35 -4.93 10.37 -31.88 -5.56 coo 29.35 31.42 99.15 28.72 33.09 98.04 7.41 -38.44 3.20 5.56 -39.41 3.04 coo 20.42 28.25 99.26 20.25 29.62 97.63 3.80 -37.83 -7.42 4.89 -38.66 -9.05 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 2 3 # 2 B 223 HIS B 12 HIS~? 15.42 CL CL B 278 B 262 HIS B 29 HIS.? 25.42 CL CL B 278 B 312 ASP B 13 ASP~? 21.13 CL CL B 278 coo 23.86 29.50 91.20 24.12 31.58 91.00 -10.18 -14.51 -22.80 -8.49 -13.29 -22.60 coo 29.35 31.42 99.15 28.72 33.09 98.04 -16.16 -16.38 -29.82 -17.24 -18.07 -29.20 coo 20.42 28.25 99.26 20.25 29.62 97.63 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 1aj8_c01 source 1aj8 CITRATE SYNTHASE : 2 hits 1aj8_c01 naa= 3 ULMN 3 1akd_c01 CYTOCHROME P450CAM user 1 3 # 1 252 THR A 112 THR.? 13.33 CL CL A 278 350 PHE A 109 PHE.? 13.59 CL CL A 278 357 CYH A 71 CYH.? 16.56 CL CL A 278 coo 17.85 20.47 14.62 16.85 19.84 12.80 26.24 -13.20 -16.26 24.44 -12.42 -17.13 coo 7.92 21.96 13.27 8.57 20.30 15.42 24.11 -13.43 -7.67 24.08 -11.73 -5.48 coo 8.82 20.77 7.90 10.59 19.75 9.80 19.04 -8.88 -9.96 21.14 -7.72 -8.59 ULMN 3 1akd_c01 CYTOCHROME P450CAM user 2 3 # 2 252 THR B 112 THR.? 12.77 CL CL B 278 350 PHE B 109 PHE.? 13.18 CL CL B 278 357 CYH B 71 CYH.? 16.15 CL CL B 278 coo 17.85 20.47 14.62 16.85 19.84 12.80 13.02 1.47 -16.42 13.78 -0.22 -15.35 coo 7.92 21.96 13.27 8.57 20.30 15.42 11.45 -1.55 -24.49 13.03 -2.08 -26.71 coo 8.82 20.77 7.90 10.59 19.75 9.80 15.78 -6.77 -22.17 17.11 -4.88 -23.73 1akd_c01 source 1akd CYTOCHROME P450CAM : 2 hits 1akd_c01 naa= 3 ULMN 3 1al6_c00 CITRATE SYNTHASE user 1 3 # 1 274 HIS A 12 HIS~? 14.78 CL CL A 278 320 HIS A 29 HIS.? 25.16 CL CL A 278 375 ASP A 13 ASP~? 20.85 CL CL A 278 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 9.03 -33.35 -4.93 10.37 -31.88 -5.56 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 7.41 -38.44 3.20 5.56 -39.41 3.04 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 3.80 -37.83 -7.42 4.89 -38.66 -9.05 ULMN 3 1al6_c00 CITRATE SYNTHASE user 2 3 # 2 274 HIS B 12 HIS~? 15.42 CL CL B 278 320 HIS B 29 HIS.? 25.42 CL CL B 278 375 ASP B 13 ASP~? 21.13 CL CL B 278 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 -10.18 -14.51 -22.80 -8.49 -13.29 -22.60 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 -16.16 -16.38 -29.82 -17.24 -18.07 -29.20 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 1al6_c00 source 1al6 CITRATE SYNTHASE : 2 hits 1al6_c00 naa= 3 ULMN 3 1am5_c04 PEPSIN user 1 3 # 1 32 ASP A 268 ASP.? 26.73 CL CL A 278 35 SER A 28 SER.? 27.02 CL CL A 278 215 ASP A 267 ASP.? 31.09 CL CL A 278 coo -7.18 8.92 145.10 -8.77 8.81 143.59 9.60 -34.57 10.49 9.97 -36.28 9.26 coo -12.30 10.35 145.24 -10.75 8.55 145.88 6.29 -36.11 7.11 4.57 -37.31 5.85 coo -8.20 12.64 138.30 -8.86 10.97 139.38 11.77 -37.21 15.47 13.23 -35.63 15.60 ULMN 3 1am5_c04 PEPSIN user 2 3 # 2 32 ASP B 268 ASP.? 26.26 CL CL B 278 35 SER B 28 SER.? 27.87 CL CL B 278 215 ASP B 267 ASP.? 32.55 CL CL B 278 coo -7.18 8.92 145.10 -8.77 8.81 143.59 -14.31 -16.11 -36.83 -14.03 -14.11 -36.24 coo -12.30 10.35 145.24 -10.75 8.55 145.88 -14.66 -18.25 -33.71 -14.43 -20.67 -33.62 coo -8.20 12.64 138.30 -8.86 10.97 139.38 -15.25 -13.37 -42.11 -14.97 -14.80 -43.57 1am5_c04 source 1am5 PEPSIN : 2 hits 1am5_c04 naa= 3 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 3 # 1 179 ASP A 224 ASP~? 22.21 CL CL A 278 204 GLU A 221 GLU~? 17.05 CL CL A 278 289 ASP A 168 ASP^? 12.27 CL CL A 278 coo -0.62 65.95 29.97 0.31 67.47 31.05 30.83 -39.35 -6.18 31.71 -41.01 -7.15 coo 4.34 62.44 32.05 4.22 64.48 32.53 27.14 -39.98 -10.94 25.92 -39.21 -12.48 coo 9.42 68.07 30.27 7.35 68.27 30.10 26.46 -30.73 -8.22 26.92 -32.42 -9.39 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 2 3 # 2 179 ASP B 224 ASP~? 22.83 CL CL B 278 204 GLU B 221 GLU~? 17.56 CL CL B 278 289 ASP B 168 ASP^? 12.80 CL CL B 278 coo -0.62 65.95 29.97 0.31 67.47 31.05 -13.88 7.87 -23.86 -15.40 8.87 -22.81 coo 4.34 62.44 32.05 4.22 64.48 32.53 -13.90 4.76 -18.50 -13.25 3.58 -16.87 coo 9.42 68.07 30.27 7.35 68.27 30.10 -5.42 2.81 -22.11 -6.82 3.76 -20.83 1amy_c05 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 2 hits 1amy_c05 naa= 3 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 3 # 1 179 ASP A 168 ASP^? 12.27 CL CL A 278 227 GLU A 253 GLU~? 21.30 CL CL A 278 289 ASP A 224 ASP~? 22.21 CL CL A 278 coo -0.62 65.95 29.97 0.31 67.47 31.05 26.46 -30.73 -8.22 26.92 -32.42 -9.39 coo 3.96 55.76 41.24 4.83 57.69 41.17 14.60 -42.99 -6.59 14.44 -44.06 -8.42 coo 9.42 68.07 30.27 7.35 68.27 30.10 30.83 -39.35 -6.18 31.71 -41.01 -7.15 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 2 3 # 2 179 ASP A 224 ASP~? 22.21 CL CL A 278 227 GLU A 235 GLU~? 25.79 CL CL A 278 289 ASP A 168 ASP^? 12.27 CL CL A 278 coo -0.62 65.95 29.97 0.31 67.47 31.05 30.83 -39.35 -6.18 31.71 -41.01 -7.15 coo 3.96 55.76 41.24 4.83 57.69 41.17 35.32 -29.84 7.74 36.12 -29.26 5.88 coo 9.42 68.07 30.27 7.35 68.27 30.10 26.46 -30.73 -8.22 26.92 -32.42 -9.39 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 3 3 # 3 179 ASP A 224 ASP~? 22.21 CL CL A 278 227 GLU A 253 GLU~? 21.30 CL CL A 278 289 ASP A 168 ASP^? 12.27 CL CL A 278 coo -0.62 65.95 29.97 0.31 67.47 31.05 30.83 -39.35 -6.18 31.71 -41.01 -7.15 coo 3.96 55.76 41.24 4.83 57.69 41.17 14.60 -42.99 -6.59 14.44 -44.06 -8.42 coo 9.42 68.07 30.27 7.35 68.27 30.10 26.46 -30.73 -8.22 26.92 -32.42 -9.39 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 4 3 # 4 179 ASP A 250 ASP~? 15.45 CL CL A 278 227 GLU A 34 GLU^? 8.78 CL CL A 278 289 ASP A 13 ASP~? 20.85 CL CL A 278 coo -0.62 65.95 29.97 0.31 67.47 31.05 15.24 -38.09 -11.21 14.62 -38.47 -13.19 coo 3.96 55.76 41.24 4.83 57.69 41.17 14.76 -23.90 -2.78 16.42 -23.89 -4.11 coo 9.42 68.07 30.27 7.35 68.27 30.10 3.80 -37.83 -7.42 4.89 -38.66 -9.05 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 5 3 # 5 179 ASP B 168 ASP^? 12.80 CL CL B 278 227 GLU B 253 GLU~? 21.95 CL CL B 278 289 ASP B 224 ASP~? 22.83 CL CL B 278 coo -0.62 65.95 29.97 0.31 67.47 31.05 -5.42 2.81 -22.11 -6.82 3.76 -20.83 coo 3.96 55.76 41.24 4.83 57.69 41.17 -18.69 -7.91 -20.45 -19.54 -8.29 -18.53 coo 9.42 68.07 30.27 7.35 68.27 30.10 -13.88 7.87 -23.86 -15.40 8.87 -22.81 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 6 3 # 6 179 ASP B 224 ASP~? 22.83 CL CL B 278 227 GLU B 235 GLU.? 26.01 CL CL B 278 289 ASP B 168 ASP^? 12.80 CL CL B 278 coo -0.62 65.95 29.97 0.31 67.47 31.05 -13.88 7.87 -23.86 -15.40 8.87 -22.81 coo 3.96 55.76 41.24 4.83 57.69 41.17 -5.56 9.78 -39.05 -4.91 10.76 -37.29 coo 9.42 68.07 30.27 7.35 68.27 30.10 -5.42 2.81 -22.11 -6.82 3.76 -20.83 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 7 3 # 7 179 ASP B 224 ASP~? 22.83 CL CL B 278 227 GLU B 253 GLU~? 21.95 CL CL B 278 289 ASP B 168 ASP^? 12.80 CL CL B 278 coo -0.62 65.95 29.97 0.31 67.47 31.05 -13.88 7.87 -23.86 -15.40 8.87 -22.81 coo 3.96 55.76 41.24 4.83 57.69 41.17 -18.69 -7.91 -20.45 -19.54 -8.29 -18.53 coo 9.42 68.07 30.27 7.35 68.27 30.10 -5.42 2.81 -22.11 -6.82 3.76 -20.83 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 8 3 # 8 179 ASP B 250 ASP~? 16.15 CL CL B 278 227 GLU B 34 GLU^? 8.94 CL CL B 278 289 ASP B 13 ASP~? 21.13 CL CL B 278 coo -0.62 65.95 29.97 0.31 67.47 31.05 -13.35 -7.01 -16.89 -13.59 -7.26 -14.81 coo 3.96 55.76 41.24 4.83 57.69 41.17 -0.25 -10.10 -26.69 0.15 -8.25 -25.75 coo 9.42 68.07 30.27 7.35 68.27 30.10 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 1amy_c06 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 8 hits 1amy_c06 naa= 3 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 1 3 # 1 E 33 ASP A 268 ASP.? 26.73 CL CL A 278 E 36 SER A 28 SER.? 27.02 CL CL A 278 E 213 ASP A 267 ASP.? 31.09 CL CL A 278 coo 26.30 12.96 16.78 25.46 12.99 18.72 9.60 -34.57 10.49 9.97 -36.28 9.26 coo 28.33 15.15 21.27 28.70 13.12 19.97 6.29 -36.11 7.11 4.57 -37.31 5.85 coo 20.15 16.04 19.79 21.65 14.49 19.86 11.77 -37.21 15.47 13.23 -35.63 15.60 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 2 3 # 2 E 33 ASP B 268 ASP.? 26.26 CL CL B 278 E 36 SER B 28 SER.? 27.87 CL CL B 278 E 213 ASP B 267 ASP.? 32.55 CL CL B 278 coo 26.30 12.96 16.78 25.46 12.99 18.72 -14.31 -16.11 -36.83 -14.03 -14.11 -36.24 coo 28.33 15.15 21.27 28.70 13.12 19.97 -14.66 -18.25 -33.71 -14.43 -20.67 -33.62 coo 20.15 16.04 19.79 21.65 14.49 19.86 -15.25 -13.37 -42.11 -14.97 -14.80 -43.57 1apt_c04 source 1apt ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET (LYSTA IS : 2 hits 1apt_c04 naa= 3 ULMN 3 1apx_c00 CYTOSOLIC ASCORBATE PEROXIDASE user 1 3 # 1 A 38 ARG A 192 ARG^? 5.91 CL CL A 278 A 42 HIS A 194 HIS.? 4.68 CL CL A 278 A 71 ASN A 244 ASN.? 5.40 CL CL A 278 coo 15.53 3.67 5.89 15.40 6.73 5.59 20.84 -24.38 -4.40 19.02 -23.24 -6.62 coo 20.65 4.50 6.93 19.74 4.89 5.08 21.59 -27.03 -10.13 21.31 -25.37 -8.87 coo 19.78 9.98 8.03 21.51 8.73 8.26 17.85 -28.42 -8.05 16.64 -26.87 -8.84 ULMN 3 1apx_c00 CYTOSOLIC ASCORBATE PEROXIDASE user 2 3 # 2 A 38 ARG B 140 ARG.? -3.53 CL CL B 278s A 42 HIS B 194 HIS.? 5.13 CL CL B 278 A 71 ASN B 244 ASN.? 5.94 CL CL B 278 coo 15.53 3.67 5.89 15.40 6.73 5.59 3.71 0.22 -21.03 2.09 -1.69 -19.26 coo 20.65 4.50 6.93 19.74 4.89 5.08 -1.92 -2.21 -20.05 -0.53 -2.75 -21.52 coo 19.78 9.98 8.03 21.51 8.73 8.26 -3.88 -6.12 -21.35 -2.47 -7.43 -20.48 ULMN 3 1apx_c00 CYTOSOLIC ASCORBATE PEROXIDASE user 3 3 # 3 A 38 ARG B 192 ARG^? 6.13 CL CL B 278 A 42 HIS B 194 HIS.? 5.13 CL CL B 278 A 71 ASN B 244 ASN.? 5.94 CL CL B 278 coo 15.53 3.67 5.89 15.40 6.73 5.59 -0.17 -3.93 -26.09 1.00 -5.48 -23.71 coo 20.65 4.50 6.93 19.74 4.89 5.08 -1.92 -2.21 -20.05 -0.53 -2.75 -21.52 coo 19.78 9.98 8.03 21.51 8.73 8.26 -3.88 -6.12 -21.35 -2.47 -7.43 -20.48 1apx_c00 source 1apx CYTOSOLIC ASCORBATE PEROXIDASE : 3 hits 1apx_c00 naa= 3 ULMN 3 1apx_c01 CYTOSOLIC ASCORBATE PEROXIDASE user 1 3 # 1 B 38 ARG A 192 ARG^? 5.91 CL CL A 278 B 42 HIS A 194 HIS.? 4.68 CL CL A 278 B 71 ASN A 244 ASN.? 5.40 CL CL A 278 coo -9.60 -18.19 23.08 -12.38 -18.82 21.94 20.84 -24.38 -4.40 19.02 -23.24 -6.62 coo -9.36 -23.33 24.70 -10.73 -22.14 25.75 21.59 -27.03 -10.13 21.31 -25.37 -8.87 coo -13.50 -24.69 21.19 -12.38 -25.89 22.55 17.85 -28.42 -8.05 16.64 -26.87 -8.84 ULMN 3 1apx_c01 CYTOSOLIC ASCORBATE PEROXIDASE user 2 3 # 2 B 38 ARG B 192 ARG^? 6.13 CL CL B 278 B 42 HIS B 194 HIS.? 5.13 CL CL B 278 B 71 ASN B 244 ASN.? 5.94 CL CL B 278 coo -9.60 -18.19 23.08 -12.38 -18.82 21.94 -0.17 -3.93 -26.09 1.00 -5.48 -23.71 coo -9.36 -23.33 24.70 -10.73 -22.14 25.75 -1.92 -2.21 -20.05 -0.53 -2.75 -21.52 coo -13.50 -24.69 21.19 -12.38 -25.89 22.55 -3.88 -6.12 -21.35 -2.47 -7.43 -20.48 1apx_c01 source 1apx CYTOSOLIC ASCORBATE PEROXIDASE : 2 hits 1apx_c01 naa= 3 ULMN 3 1apx_c02 CYTOSOLIC ASCORBATE PEROXIDASE user 1 3 # 1 C 38 ARG A 192 ARG^? 5.91 CL CL A 278 C 42 HIS A 194 HIS.? 4.68 CL CL A 278 C 71 ASN A 244 ASN.? 5.40 CL CL A 278 coo 30.92 18.62 52.11 32.84 21.02 52.26 20.84 -24.38 -4.40 19.02 -23.24 -6.62 coo 34.83 15.89 54.93 35.12 16.59 52.97 21.59 -27.03 -10.13 21.31 -25.37 -8.87 coo 37.12 20.79 56.54 37.65 18.79 57.02 17.85 -28.42 -8.05 16.64 -26.87 -8.84 ULMN 3 1apx_c02 CYTOSOLIC ASCORBATE PEROXIDASE user 2 3 # 2 C 38 ARG B 140 ARG.? -3.53 CL CL B 278s C 42 HIS B 194 HIS.? 5.13 CL CL B 278 C 71 ASN B 244 ASN.? 5.94 CL CL B 278 coo 30.92 18.62 52.11 32.84 21.02 52.26 3.71 0.22 -21.03 2.09 -1.69 -19.26 coo 34.83 15.89 54.93 35.12 16.59 52.97 -1.92 -2.21 -20.05 -0.53 -2.75 -21.52 coo 37.12 20.79 56.54 37.65 18.79 57.02 -3.88 -6.12 -21.35 -2.47 -7.43 -20.48 ULMN 3 1apx_c02 CYTOSOLIC ASCORBATE PEROXIDASE user 3 3 # 3 C 38 ARG B 192 ARG^? 6.13 CL CL B 278 C 42 HIS B 194 HIS.? 5.13 CL CL B 278 C 71 ASN B 244 ASN.? 5.94 CL CL B 278 coo 30.92 18.62 52.11 32.84 21.02 52.26 -0.17 -3.93 -26.09 1.00 -5.48 -23.71 coo 34.83 15.89 54.93 35.12 16.59 52.97 -1.92 -2.21 -20.05 -0.53 -2.75 -21.52 coo 37.12 20.79 56.54 37.65 18.79 57.02 -3.88 -6.12 -21.35 -2.47 -7.43 -20.48 1apx_c02 source 1apx CYTOSOLIC ASCORBATE PEROXIDASE : 3 hits 1apx_c02 naa= 3 ULMN 3 1apx_c03 CYTOSOLIC ASCORBATE PEROXIDASE user 1 3 # 1 D 38 ARG A 140 ARG.? 3.74 CL CL A 278 D 42 HIS A 194 HIS.? 4.68 CL CL A 278 D 71 ASN A 244 ASN.? 5.40 CL CL A 278 coo -6.22 19.15 57.90 -8.28 20.35 55.95 24.77 -21.68 -10.23 22.52 -23.37 -11.49 coo -9.68 15.08 58.37 -9.88 17.07 58.99 21.59 -27.03 -10.13 21.31 -25.37 -8.87 coo -12.42 16.33 53.67 -12.99 14.86 55.12 17.85 -28.42 -8.05 16.64 -26.87 -8.84 ULMN 3 1apx_c03 CYTOSOLIC ASCORBATE PEROXIDASE user 2 3 # 2 D 38 ARG A 192 ARG^? 5.91 CL CL A 278 D 42 HIS A 194 HIS.? 4.68 CL CL A 278 D 71 ASN A 244 ASN.? 5.40 CL CL A 278 coo -6.22 19.15 57.90 -8.28 20.35 55.95 20.84 -24.38 -4.40 19.02 -23.24 -6.62 coo -9.68 15.08 58.37 -9.88 17.07 58.99 21.59 -27.03 -10.13 21.31 -25.37 -8.87 coo -12.42 16.33 53.67 -12.99 14.86 55.12 17.85 -28.42 -8.05 16.64 -26.87 -8.84 ULMN 3 1apx_c03 CYTOSOLIC ASCORBATE PEROXIDASE user 3 3 # 3 D 38 ARG B 140 ARG.? -3.53 CL CL B 278s D 42 HIS B 194 HIS.? 5.13 CL CL B 278 D 71 ASN B 244 ASN.? 5.94 CL CL B 278 coo -6.22 19.15 57.90 -8.28 20.35 55.95 3.71 0.22 -21.03 2.09 -1.69 -19.26 coo -9.68 15.08 58.37 -9.88 17.07 58.99 -1.92 -2.21 -20.05 -0.53 -2.75 -21.52 coo -12.42 16.33 53.67 -12.99 14.86 55.12 -3.88 -6.12 -21.35 -2.47 -7.43 -20.48 ULMN 3 1apx_c03 CYTOSOLIC ASCORBATE PEROXIDASE user 4 3 # 4 D 38 ARG B 192 ARG^? 6.13 CL CL B 278 D 42 HIS B 194 HIS.? 5.13 CL CL B 278 D 71 ASN B 244 ASN.? 5.94 CL CL B 278 coo -6.22 19.15 57.90 -8.28 20.35 55.95 -0.17 -3.93 -26.09 1.00 -5.48 -23.71 coo -9.68 15.08 58.37 -9.88 17.07 58.99 -1.92 -2.21 -20.05 -0.53 -2.75 -21.52 coo -12.42 16.33 53.67 -12.99 14.86 55.12 -3.88 -6.12 -21.35 -2.47 -7.43 -20.48 1apx_c03 source 1apx CYTOSOLIC ASCORBATE PEROXIDASE : 4 hits 1apx_c03 naa= 3 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 1 3 # 1 A 194 SER A 8 SER.? 12.69 CL CL A 278 A 292 ASP A 275 ASP.? 34.16 CL CL A 278 A 322 HIS A 194 HIS.? 4.68 CL CL A 278 coo 36.34 32.23 39.60 36.43 34.62 39.93 8.88 -27.17 -3.98 8.36 -25.65 -5.80 coo 19.73 19.18 41.39 21.50 18.65 40.34 -7.58 -36.49 2.30 -8.60 -35.44 3.90 coo 41.69 45.14 46.60 41.78 47.19 46.18 21.59 -27.03 -10.13 21.31 -25.37 -8.87 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 2 3 # 2 A 194 SER A 265 SER.? 30.92 CL CL A 278 A 292 ASP A 13 ASP~? 20.85 CL CL A 278 A 322 HIS A 0 HIS.? 29.82 CL CL A 278 coo 36.34 32.23 39.60 36.43 34.62 39.93 16.53 -40.85 10.53 17.64 -42.38 12.05 coo 19.73 19.18 41.39 21.50 18.65 40.34 3.80 -37.83 -7.42 4.89 -38.66 -9.05 coo 41.69 45.14 46.60 41.78 47.19 46.18 28.39 -31.84 13.78 30.11 -32.89 14.37 1aql_c02 source 1aql BILE-SALT ACTIVATED LIPASE : 2 hits 1aql_c02 naa= 3 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 1 3 # 1 B 194 SER A 8 SER.? 12.69 CL CL A 278 B 292 ASP A 275 ASP.? 34.16 CL CL A 278 B 322 HIS A 194 HIS.? 4.68 CL CL A 278 coo 35.42 71.28 22.94 36.24 69.06 22.37 8.88 -27.17 -3.98 8.36 -25.65 -5.80 coo 24.74 78.07 5.59 24.32 79.03 7.46 -7.58 -36.49 2.30 -8.60 -35.44 3.90 coo 48.81 64.16 26.34 49.30 62.16 26.73 21.59 -27.03 -10.13 21.31 -25.37 -8.87 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 2 3 # 2 B 194 SER A 265 SER.? 30.92 CL CL A 278 B 292 ASP A 13 ASP~? 20.85 CL CL A 278 B 322 HIS A 0 HIS.? 29.82 CL CL A 278 coo 35.42 71.28 22.94 36.24 69.06 22.37 16.53 -40.85 10.53 17.64 -42.38 12.05 coo 24.74 78.07 5.59 24.32 79.03 7.46 3.80 -37.83 -7.42 4.89 -38.66 -9.05 coo 48.81 64.16 26.34 49.30 62.16 26.73 28.39 -31.84 13.78 30.11 -32.89 14.37 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 3 3 # 3 B 194 SER B 8 SER.? 14.26 CL CL B 278 B 292 ASP B 275 ASP.? 37.37 CL CL B 278 B 322 HIS B 194 HIS.? 5.13 CL CL B 278 coo 35.42 71.28 22.94 36.24 69.06 22.37 -4.13 -15.22 -24.13 -4.29 -16.76 -22.25 coo 24.74 78.07 5.59 24.32 79.03 7.46 -15.60 -35.07 -27.87 -14.73 -36.02 -29.60 coo 48.81 64.16 26.34 49.30 62.16 26.73 -1.92 -2.21 -20.05 -0.53 -2.75 -21.52 1aql_c03 source 1aql BILE-SALT ACTIVATED LIPASE : 3 hits 1aql_c03 naa= 3 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 1 3 # 1 B 325 ARG A 47 ARG~? 19.53 CL CL B 278 B 342 ASP A 36 ASP~? 8.69 CL CL A 278 B 531 ARG B 209 ARG~? 8.42 CL CL B 278 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 1.19 -18.60 0.09 1.74 -17.18 -2.58 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 11.67 -20.98 -6.16 13.43 -22.16 -5.96 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 2.92 -11.07 -10.38 5.18 -10.70 -12.48 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 2 3 # 2 B 325 ARG A 140 ARG.? 3.74 CL CL A 278 B 342 ASP A 36 ASP~? 8.69 CL CL A 278 B 531 ARG A 212 ARG~? 4.63 CL CL A 278 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 24.77 -21.68 -10.23 22.52 -23.37 -11.49 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 11.67 -20.98 -6.16 13.43 -22.16 -5.96 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 18.59 -24.77 -16.89 17.13 -22.12 -16.49 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 3 3 # 3 B 325 ARG A 192 ARG^? 5.91 CL CL A 278 B 342 ASP A 36 ASP~? 8.69 CL CL A 278 B 531 ARG A 212 ARG~? 4.63 CL CL A 278 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 20.84 -24.38 -4.40 19.02 -23.24 -6.62 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 11.67 -20.98 -6.16 13.43 -22.16 -5.96 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 18.59 -24.77 -16.89 17.13 -22.12 -16.49 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 4 3 # 4 B 325 ARG A 209 ARG~? 8.75 CL CL A 278 B 342 ASP A 205 ASP.? 14.79 CL CL A 278 B 531 ARG B 47 ARG~? 19.59 CL CL A 278 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 12.19 -22.36 -19.55 12.55 -20.19 -17.38 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 19.11 -25.60 -27.15 17.47 -26.92 -26.86 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 3.13 -24.42 -28.62 4.84 -23.96 -26.11 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 5 3 # 5 B 325 ARG A 212 ARG~? 4.63 CL CL A 278 B 342 ASP A 36 ASP~? 8.69 CL CL A 278 B 531 ARG A 140 ARG.? 3.74 CL CL A 278 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 18.59 -24.77 -16.89 17.13 -22.12 -16.49 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 11.67 -20.98 -6.16 13.43 -22.16 -5.96 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 24.77 -21.68 -10.23 22.52 -23.37 -11.49 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 6 3 # 6 B 325 ARG B 47 ARG~? 19.59 CL CL A 278 B 342 ASP B 36 ASP~? 8.83 CL CL B 278 B 531 ARG A 209 ARG~? 8.75 CL CL A 278 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 3.13 -24.42 -28.62 4.84 -23.96 -26.11 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 2.64 -13.17 -23.36 1.59 -11.35 -23.67 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 12.19 -22.36 -19.55 12.55 -20.19 -17.38 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 7 3 # 7 B 325 ARG B 140 ARG.? -3.53 CL CL B 278s B 342 ASP B 36 ASP~? 8.83 CL CL B 278 B 531 ARG B 212 ARG~? 4.30 CL CL B 278 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 3.71 0.22 -21.03 2.09 -1.69 -19.26 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 2.64 -13.17 -23.36 1.59 -11.35 -23.67 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 1.13 -4.70 -13.40 3.58 -6.46 -14.00 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 8 3 # 8 B 325 ARG B 192 ARG^? 6.13 CL CL B 278 B 342 ASP B 36 ASP~? 8.83 CL CL B 278 B 531 ARG B 212 ARG~? 4.30 CL CL B 278 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -0.17 -3.93 -26.09 1.00 -5.48 -23.71 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 2.64 -13.17 -23.36 1.59 -11.35 -23.67 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 1.13 -4.70 -13.40 3.58 -6.46 -14.00 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 9 3 # 9 B 325 ARG B 209 ARG~? 8.42 CL CL B 278 B 342 ASP B 205 ASP.? 14.85 CL CL B 278 B 531 ARG A 47 ARG~? 19.53 CL CL B 278 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 2.92 -11.07 -10.38 5.18 -10.70 -12.48 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 1.45 -2.78 -3.16 -0.06 -4.27 -3.04 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 1.19 -18.60 0.09 1.74 -17.18 -2.58 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 10 3 # 10 B 325 ARG B 212 ARG~? 4.30 CL CL B 278 B 342 ASP B 36 ASP~? 8.83 CL CL B 278 B 531 ARG B 140 ARG.? -3.53 CL CL B 278s coo 68.60 41.07 -12.62 69.17 40.45 -9.67 1.13 -4.70 -13.40 3.58 -6.46 -14.00 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 2.64 -13.17 -23.36 1.59 -11.35 -23.67 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 3.71 0.22 -21.03 2.09 -1.69 -19.26 1asy_c00 source 1asy TRANSFER RIBONUCLEIC ACID (TRNAASP) : 10 hits 1asy_c00 naa= 3 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 1 3 # 1 A 325 ARG A 47 ARG~? 19.53 CL CL B 278 A 342 ASP A 36 ASP~? 8.69 CL CL A 278 A 531 ARG B 209 ARG~? 8.42 CL CL B 278 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 1.19 -18.60 0.09 1.74 -17.18 -2.58 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 11.67 -20.98 -6.16 13.43 -22.16 -5.96 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 2.92 -11.07 -10.38 5.18 -10.70 -12.48 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 2 3 # 2 A 325 ARG A 212 ARG~? 4.63 CL CL A 278 A 342 ASP A 250 ASP~? 15.45 CL CL A 278 A 531 ARG A 192 ARG^? 5.91 CL CL A 278 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 18.59 -24.77 -16.89 17.13 -22.12 -16.49 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 15.24 -38.09 -11.21 14.62 -38.47 -13.19 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 20.84 -24.38 -4.40 19.02 -23.24 -6.62 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 3 3 # 3 A 325 ARG B 47 ARG~? 19.59 CL CL A 278 A 342 ASP B 36 ASP~? 8.83 CL CL B 278 A 531 ARG A 209 ARG~? 8.75 CL CL A 278 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 3.13 -24.42 -28.62 4.84 -23.96 -26.11 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 2.64 -13.17 -23.36 1.59 -11.35 -23.67 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 12.19 -22.36 -19.55 12.55 -20.19 -17.38 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 4 3 # 4 A 325 ARG B 212 ARG~? 4.30 CL CL B 278 A 342 ASP B 250 ASP~? 16.15 CL CL B 278 A 531 ARG B 192 ARG^? 6.13 CL CL B 278 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 1.13 -4.70 -13.40 3.58 -6.46 -14.00 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -13.35 -7.01 -16.89 -13.59 -7.26 -14.81 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -0.17 -3.93 -26.09 1.00 -5.48 -23.71 1asy_c01 source 1asy TRANSFER RIBONUCLEIC ACID (TRNAASP) : 4 hits 1asy_c01 naa= 3 ULMN 3 1avf_c05 GASTRICSIN user 1 3 # 1 J 32 ASP A 268 ASP.? 26.73 CL CL A 278 J 35 SER A 28 SER.? 27.02 CL CL A 278 J 217 ASP A 267 ASP.? 31.09 CL CL A 278 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 9.60 -34.57 10.49 9.97 -36.28 9.26 coo -40.93 -20.91 21.81 -38.85 -21.36 20.65 6.29 -36.11 7.11 4.57 -37.31 5.85 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 11.77 -37.21 15.47 13.23 -35.63 15.60 ULMN 3 1avf_c05 GASTRICSIN user 2 3 # 2 J 32 ASP B 268 ASP.? 26.26 CL CL B 278 J 35 SER B 28 SER.? 27.87 CL CL B 278 J 217 ASP B 267 ASP.? 32.55 CL CL B 278 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 -14.31 -16.11 -36.83 -14.03 -14.11 -36.24 coo -40.93 -20.91 21.81 -38.85 -21.36 20.65 -14.66 -18.25 -33.71 -14.43 -20.67 -33.62 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 -15.25 -13.37 -42.11 -14.97 -14.80 -43.57 1avf_c05 source 1avf GASTRICSIN : 2 hits 1avf_c05 naa= 3 ULMN 3 1ax4_c04 TRYPTOPHANASE user 1 3 # 1 A 130 PHE A 61 PHE^? 20.50 CL CL A 278 A 223 ASP A 268 ASP.? 26.73 CL CL A 278 A 265 LYS A 272 LYS.? 33.16 CL CL A 278 coo 39.74 52.86 65.74 41.15 55.14 66.52 10.78 -23.35 5.38 8.23 -24.31 5.99 coo 30.70 47.50 67.53 29.83 49.47 67.39 9.60 -34.57 10.49 9.97 -36.28 9.26 coo 19.99 54.53 64.11 20.55 58.78 68.33 -2.40 -40.27 7.96 -3.06 -34.63 9.73 ULMN 3 1ax4_c04 TRYPTOPHANASE user 2 3 # 2 A 130 PHE B 9 PHE.? 19.22 CL CL B 278 A 223 ASP B 36 ASP~? 8.83 CL CL B 278 A 265 LYS B 210 LYS~? 12.46 CL CL B 278 coo 39.74 52.86 65.74 41.15 55.14 66.52 -5.53 -19.06 -27.20 -3.79 -21.22 -27.20 coo 30.70 47.50 67.53 29.83 49.47 67.39 2.64 -13.17 -23.36 1.59 -11.35 -23.67 coo 19.99 54.53 64.11 20.55 58.78 68.33 -2.49 -8.60 -10.03 0.77 -12.84 -8.24 1ax4_c04 source 1ax4 TRYPTOPHANASE : 2 hits 1ax4_c04 naa= 3 ULMN 3 1ax4_c05 TRYPTOPHANASE user 1 3 # 1 B 130 PHE A 61 PHE^? 20.50 CL CL A 278 B 223 ASP A 268 ASP.? 26.73 CL CL A 278 B 265 LYS A 272 LYS.? 33.16 CL CL A 278 coo 7.48 54.94 99.62 7.67 52.27 100.42 10.78 -23.35 5.38 8.23 -24.31 5.99 coo 10.43 61.66 91.81 9.80 60.04 90.61 9.60 -34.57 10.49 9.97 -36.28 9.26 coo 5.43 58.06 80.08 8.57 53.00 79.37 -2.40 -40.27 7.96 -3.06 -34.63 9.73 ULMN 3 1ax4_c05 TRYPTOPHANASE user 2 3 # 2 B 130 PHE B 9 PHE.? 19.22 CL CL B 278 B 223 ASP B 36 ASP~? 8.83 CL CL B 278 B 265 LYS B 210 LYS~? 12.46 CL CL B 278 coo 7.48 54.94 99.62 7.67 52.27 100.42 -5.53 -19.06 -27.20 -3.79 -21.22 -27.20 coo 10.43 61.66 91.81 9.80 60.04 90.61 2.64 -13.17 -23.36 1.59 -11.35 -23.67 coo 5.43 58.06 80.08 8.57 53.00 79.37 -2.49 -8.60 -10.03 0.77 -12.84 -8.24 1ax4_c05 source 1ax4 TRYPTOPHANASE : 2 hits 1ax4_c05 naa= 3 ULMN 3 1ax4_c06 TRYPTOPHANASE user 1 3 # 1 C 130 PHE A 61 PHE^? 20.50 CL CL A 278 C 223 ASP A 268 ASP.? 26.73 CL CL A 278 C 265 LYS A 272 LYS.? 33.16 CL CL A 278 coo -6.55 73.45 23.60 -6.77 71.48 21.66 10.78 -23.35 5.38 8.23 -24.31 5.99 coo -9.52 75.74 33.62 -8.85 73.74 33.93 9.60 -34.57 10.49 9.97 -36.28 9.26 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -2.40 -40.27 7.96 -3.06 -34.63 9.73 ULMN 3 1ax4_c06 TRYPTOPHANASE user 2 3 # 2 C 130 PHE B 9 PHE.? 19.22 CL CL B 278 C 223 ASP B 36 ASP~? 8.83 CL CL B 278 C 265 LYS B 210 LYS~? 12.46 CL CL B 278 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -5.53 -19.06 -27.20 -3.79 -21.22 -27.20 coo -9.52 75.74 33.62 -8.85 73.74 33.93 2.64 -13.17 -23.36 1.59 -11.35 -23.67 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -2.49 -8.60 -10.03 0.77 -12.84 -8.24 1ax4_c06 source 1ax4 TRYPTOPHANASE : 2 hits 1ax4_c06 naa= 3 ULMN 3 1ax4_c07 TRYPTOPHANASE user 1 3 # 1 D 130 PHE A 61 PHE^? 20.50 CL CL A 278 D 223 ASP A 268 ASP.? 26.73 CL CL A 278 D 265 LYS A 272 LYS.? 33.16 CL CL A 278 coo -38.60 55.38 52.70 -40.06 57.72 53.04 10.78 -23.35 5.38 8.23 -24.31 5.99 coo -29.46 51.67 48.51 -28.63 53.31 49.56 9.60 -34.57 10.49 9.97 -36.28 9.26 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -2.40 -40.27 7.96 -3.06 -34.63 9.73 ULMN 3 1ax4_c07 TRYPTOPHANASE user 2 3 # 2 D 130 PHE B 9 PHE.? 19.22 CL CL B 278 D 223 ASP B 36 ASP~? 8.83 CL CL B 278 D 265 LYS B 210 LYS~? 12.46 CL CL B 278 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -5.53 -19.06 -27.20 -3.79 -21.22 -27.20 coo -29.46 51.67 48.51 -28.63 53.31 49.56 2.64 -13.17 -23.36 1.59 -11.35 -23.67 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -2.49 -8.60 -10.03 0.77 -12.84 -8.24 1ax4_c07 source 1ax4 TRYPTOPHANASE : 2 hits 1ax4_c07 naa= 3 ULMN 3 1azw_c00 PROLINE IMINOPEPTIDASE user 1 3 # 1 A 110 SER A 10 SER.? 17.45 CL CL A 278 A 266 ASP A 13 ASP~? 20.85 CL CL A 278 A 294 HIS A 12 HIS~? 14.78 CL CL A 278 coo 32.07 25.76 77.83 34.46 26.05 77.46 3.77 -30.46 -4.30 3.68 -28.35 -5.48 coo 33.07 35.01 79.81 33.39 33.02 79.13 3.80 -37.83 -7.42 4.89 -38.66 -9.05 coo 35.53 30.26 79.89 34.62 28.71 78.80 9.03 -33.35 -4.93 10.37 -31.88 -5.56 ULMN 3 1azw_c00 PROLINE IMINOPEPTIDASE user 2 3 # 2 A 110 SER B 10 SER.? 17.86 CL CL B 278 A 266 ASP B 13 ASP~? 21.13 CL CL B 278 A 294 HIS B 12 HIS~? 15.42 CL CL B 278 coo 32.07 25.76 77.83 34.46 26.05 77.46 -7.63 -19.97 -23.27 -5.38 -20.37 -22.44 coo 33.07 35.01 79.81 33.39 33.02 79.13 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 coo 35.53 30.26 79.89 34.62 28.71 78.80 -10.18 -14.51 -22.80 -8.49 -13.29 -22.60 1azw_c00 source 1azw PROLINE IMINOPEPTIDASE : 2 hits 1azw_c00 naa= 3 ULMN 3 1b2m_c00 5'-R(*GP*(CH2)U)-3' user 1 3 # 1 A 40 HIS A 216 HIS.? 18.50 CL CL A 278 A 58 GLU A 253 GLU~? 21.30 CL CL A 278 A 92 HIS A 12 HIS~? 14.78 CL CL A 278 coo 12.70 27.74 1.76 10.77 27.11 1.24 17.97 -41.33 -12.21 17.58 -42.84 -10.82 coo 11.38 23.30 3.20 9.27 23.34 3.13 14.60 -42.99 -6.59 14.44 -44.06 -8.42 coo 2.67 19.36 1.56 3.51 21.24 1.94 9.03 -33.35 -4.93 10.37 -31.88 -5.56 ULMN 3 1b2m_c00 5'-R(*GP*(CH2)U)-3' user 2 3 # 2 A 40 HIS B 216 HIS.? 19.24 CL CL B 278 A 58 GLU B 253 GLU~? 21.95 CL CL B 278 A 92 HIS B 12 HIS~? 15.42 CL CL B 278 coo 12.70 27.74 1.76 10.77 27.11 1.24 -16.22 -3.98 -15.80 -17.90 -4.46 -16.96 coo 11.38 23.30 3.20 9.27 23.34 3.13 -18.69 -7.91 -20.45 -19.54 -8.29 -18.53 coo 2.67 19.36 1.56 3.51 21.24 1.94 -10.18 -14.51 -22.80 -8.49 -13.29 -22.60 1b2m_c00 source 1b2m 5'-R(*GP*(CH2)U)-3' : 2 hits 1b2m_c00 naa= 3 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 1 3 # 1 A 109 ASP A 168 ASP^? 12.27 CL CL A 278 A 182 GLU A 138 GLU^? 6.67 CL CL A 278 A 286 ASN A 244 ASN.? 5.40 CL CL A 278 coo 26.03 44.66 108.90 25.67 42.61 108.82 26.46 -30.73 -8.22 26.92 -32.42 -9.39 coo 18.06 44.02 105.38 18.08 45.37 107.03 23.86 -20.99 -6.84 22.60 -22.69 -7.03 coo 25.47 38.28 112.06 27.26 39.30 111.54 17.85 -28.42 -8.05 16.64 -26.87 -8.84 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 2 3 # 2 A 109 ASP A 168 ASP^? 12.27 CL CL A 278 A 182 GLU A 221 GLU~? 17.05 CL CL A 278 A 286 ASN A 245 ASN.? 11.79 CL CL A 278 coo 26.03 44.66 108.90 25.67 42.61 108.82 26.46 -30.73 -8.22 26.92 -32.42 -9.39 coo 18.06 44.02 105.38 18.08 45.37 107.03 27.14 -39.98 -10.94 25.92 -39.21 -12.48 coo 25.47 38.28 112.06 27.26 39.30 111.54 18.48 -33.48 -10.76 18.30 -34.93 -9.15 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 3 3 # 3 A 109 ASP A 250 ASP~? 15.45 CL CL A 278 A 182 GLU A 253 GLU~? 21.30 CL CL A 278 A 286 ASN A 245 ASN.? 11.79 CL CL A 278 coo 26.03 44.66 108.90 25.67 42.61 108.82 15.24 -38.09 -11.21 14.62 -38.47 -13.19 coo 18.06 44.02 105.38 18.08 45.37 107.03 14.60 -42.99 -6.59 14.44 -44.06 -8.42 coo 25.47 38.28 112.06 27.26 39.30 111.54 18.48 -33.48 -10.76 18.30 -34.93 -9.15 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 4 3 # 4 A 109 ASP A 250 ASP~? 15.45 CL CL A 278 A 182 GLU A 253 GLU~? 21.30 CL CL A 278 A 286 ASN A 246 ASN.? 12.85 CL CL A 278 coo 26.03 44.66 108.90 25.67 42.61 108.82 15.24 -38.09 -11.21 14.62 -38.47 -13.19 coo 18.06 44.02 105.38 18.08 45.37 107.03 14.60 -42.99 -6.59 14.44 -44.06 -8.42 coo 25.47 38.28 112.06 27.26 39.30 111.54 12.83 -32.17 -9.87 11.11 -33.32 -9.30 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 5 3 # 5 A 109 ASP B 168 ASP^? 12.80 CL CL B 278 A 182 GLU B 138 GLU^? 6.70 CL CL B 278 A 286 ASN B 244 ASN.? 5.94 CL CL B 278 coo 26.03 44.66 108.90 25.67 42.61 108.82 -5.42 2.81 -22.11 -6.82 3.76 -20.83 coo 18.06 44.02 105.38 18.08 45.37 107.03 3.87 -1.10 -24.33 2.09 -2.15 -23.84 coo 25.47 38.28 112.06 27.26 39.30 111.54 -3.88 -6.12 -21.35 -2.47 -7.43 -20.48 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 6 3 # 6 A 109 ASP B 168 ASP^? 12.80 CL CL B 278 A 182 GLU B 221 GLU~? 17.56 CL CL B 278 A 286 ASN B 245 ASN.? 12.34 CL CL B 278 coo 26.03 44.66 108.90 25.67 42.61 108.82 -5.42 2.81 -22.11 -6.82 3.76 -20.83 coo 18.06 44.02 105.38 18.08 45.37 107.03 -13.90 4.76 -18.50 -13.25 3.58 -16.87 coo 25.47 38.28 112.06 27.26 39.30 111.54 -8.45 -4.50 -18.19 -10.06 -4.59 -19.62 1b57_c00 source 1b57 FRUCTOSE-BISPHOSPHATE ALDOLASE II : 6 hits 1b57_c00 naa= 3 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 1 3 # 1 B 109 ASP A 168 ASP^? 12.27 CL CL A 278 B 182 GLU A 221 GLU~? 17.05 CL CL A 278 B 286 ASN A 245 ASN.? 11.79 CL CL A 278 coo 13.82 69.26 132.27 11.87 70.14 132.51 26.46 -30.73 -8.22 26.92 -32.42 -9.39 coo 8.74 63.05 136.42 9.87 62.19 134.79 27.14 -39.98 -10.94 25.92 -39.21 -12.48 coo 8.26 72.60 129.22 10.14 73.45 129.80 18.48 -33.48 -10.76 18.30 -34.93 -9.15 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 2 3 # 2 B 109 ASP B 168 ASP^? 12.80 CL CL B 278 B 182 GLU B 221 GLU~? 17.56 CL CL B 278 B 286 ASN B 245 ASN.? 12.34 CL CL B 278 coo 13.82 69.26 132.27 11.87 70.14 132.51 -5.42 2.81 -22.11 -6.82 3.76 -20.83 coo 8.74 63.05 136.42 9.87 62.19 134.79 -13.90 4.76 -18.50 -13.25 3.58 -16.87 coo 8.26 72.60 129.22 10.14 73.45 129.80 -8.45 -4.50 -18.19 -10.06 -4.59 -19.62 1b57_c01 source 1b57 FRUCTOSE-BISPHOSPHATE ALDOLASE II : 2 hits 1b57_c01 naa= 3 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 1 3 # 1 A 133 GLU A 235 GLU~? 25.79 CL CL A 278 B 88 ASP B 250 ASP~? 16.15 CL CL B 278 B 89 HIS B 216 HIS.? 19.24 CL CL B 278 coo 44.53 38.98 5.35 43.53 40.60 6.22 35.32 -29.84 7.74 36.12 -29.26 5.88 coo 58.74 13.49 55.78 58.72 14.38 57.67 -13.35 -7.01 -16.89 -13.59 -7.26 -14.81 coo 60.89 12.20 60.42 60.43 13.81 61.68 -16.22 -3.98 -15.80 -17.90 -4.46 -16.96 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 2 3 # 2 A 133 GLU B 227 GLU~? 26.46 CL CL B 278 B 88 ASP A 250 ASP~? 15.45 CL CL A 278 B 89 HIS A 216 HIS.? 18.50 CL CL A 278 coo 44.53 38.98 5.35 43.53 40.60 6.22 -14.61 9.61 -30.38 -15.43 11.23 -29.27 coo 58.74 13.49 55.78 58.72 14.38 57.67 15.24 -38.09 -11.21 14.62 -38.47 -13.19 coo 60.89 12.20 60.42 60.43 13.81 61.68 17.97 -41.33 -12.21 17.58 -42.84 -10.82 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 3 3 # 3 A 133 GLU B 235 GLU.? 26.01 CL CL B 278 B 88 ASP A 250 ASP~? 15.45 CL CL A 278 B 89 HIS A 216 HIS.? 18.50 CL CL A 278 coo 44.53 38.98 5.35 43.53 40.60 6.22 -5.56 9.78 -39.05 -4.91 10.76 -37.29 coo 58.74 13.49 55.78 58.72 14.38 57.67 15.24 -38.09 -11.21 14.62 -38.47 -13.19 coo 60.89 12.20 60.42 60.43 13.81 61.68 17.97 -41.33 -12.21 17.58 -42.84 -10.82 1b66_c00 source 1b66 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASE : 3 hits 1b66_c00 naa= 3 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 1 3 # 1 A 133 GLU A 235 GLU~? 25.79 CL CL A 278 B 88 ASP B 250 ASP~? 16.15 CL CL B 278 B 89 HIS B 216 HIS.? 19.24 CL CL B 278 coo 44.53 38.98 5.35 43.53 40.60 6.22 35.32 -29.84 7.74 36.12 -29.26 5.88 coo 58.74 13.49 55.78 58.72 14.38 57.67 -13.35 -7.01 -16.89 -13.59 -7.26 -14.81 coo 60.89 12.20 60.42 60.43 13.81 61.68 -16.22 -3.98 -15.80 -17.90 -4.46 -16.96 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 2 3 # 2 A 133 GLU B 227 GLU~? 26.46 CL CL B 278 B 88 ASP A 250 ASP~? 15.45 CL CL A 278 B 89 HIS A 216 HIS.? 18.50 CL CL A 278 coo 44.53 38.98 5.35 43.53 40.60 6.22 -14.61 9.61 -30.38 -15.43 11.23 -29.27 coo 58.74 13.49 55.78 58.72 14.38 57.67 15.24 -38.09 -11.21 14.62 -38.47 -13.19 coo 60.89 12.20 60.42 60.43 13.81 61.68 17.97 -41.33 -12.21 17.58 -42.84 -10.82 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 3 3 # 3 A 133 GLU B 235 GLU.? 26.01 CL CL B 278 B 88 ASP A 250 ASP~? 15.45 CL CL A 278 B 89 HIS A 216 HIS.? 18.50 CL CL A 278 coo 44.53 38.98 5.35 43.53 40.60 6.22 -5.56 9.78 -39.05 -4.91 10.76 -37.29 coo 58.74 13.49 55.78 58.72 14.38 57.67 15.24 -38.09 -11.21 14.62 -38.47 -13.19 coo 60.89 12.20 60.42 60.43 13.81 61.68 17.97 -41.33 -12.21 17.58 -42.84 -10.82 1b66_c02 source 1b66 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASE : 3 hits 1b66_c02 naa= 3 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 1 3 # 1 A 145 TYR B 26 TYR~? 19.09 CL CL B 278 A 230 ASP B 268 ASP.? 26.26 CL CL B 278 A 273 LYS B 53 LYS~? 32.92 CL CL B 278 coo 9.23 21.44 106.88 10.18 19.34 105.31 -9.51 -16.67 -28.98 -9.06 -13.93 -28.84 coo 1.45 22.80 104.16 2.58 21.02 104.01 -14.31 -16.11 -36.83 -14.03 -14.11 -36.24 coo 2.97 11.64 107.87 6.59 15.13 107.03 -3.36 -23.95 -38.76 0.61 -28.64 -40.43 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 2 3 # 2 A 145 TYR B 215 TYR.? 14.28 CL CL B 278 A 230 ASP B 250 ASP~? 16.15 CL CL B 278 A 273 LYS B 210 LYS~? 12.46 CL CL B 278 coo 9.23 21.44 106.88 10.18 19.34 105.31 -10.18 -0.68 -14.85 -11.32 1.86 -14.73 coo 1.45 22.80 104.16 2.58 21.02 104.01 -13.35 -7.01 -16.89 -13.59 -7.26 -14.81 coo 2.97 11.64 107.87 6.59 15.13 107.03 -2.49 -8.60 -10.03 0.77 -12.84 -8.24 1b8g_c04 source 1b8g 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYNTHASE : 2 hits 1b8g_c04 naa= 3 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 1 3 # 1 B 145 TYR B 26 TYR~? 19.09 CL CL B 278 B 230 ASP B 268 ASP.? 26.26 CL CL B 278 B 273 LYS B 53 LYS~? 32.92 CL CL B 278 coo 11.81 13.41 73.03 10.00 13.03 75.12 -9.51 -16.67 -28.98 -9.06 -13.93 -28.84 coo 19.17 11.01 76.14 17.26 10.42 76.77 -14.31 -16.11 -36.83 -14.03 -14.11 -36.24 coo 11.10 2.31 76.60 10.24 7.24 75.62 -3.36 -23.95 -38.76 0.61 -28.64 -40.43 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 2 3 # 2 B 145 TYR B 215 TYR.? 14.28 CL CL B 278 B 230 ASP B 250 ASP~? 16.15 CL CL B 278 B 273 LYS B 210 LYS~? 12.46 CL CL B 278 coo 11.81 13.41 73.03 10.00 13.03 75.12 -10.18 -0.68 -14.85 -11.32 1.86 -14.73 coo 19.17 11.01 76.14 17.26 10.42 76.77 -13.35 -7.01 -16.89 -13.59 -7.26 -14.81 coo 11.10 2.31 76.60 10.24 7.24 75.62 -2.49 -8.60 -10.03 0.77 -12.84 -8.24 1b8g_c05 source 1b8g 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYNTHASE : 2 hits 1b8g_c05 naa= 3 ULMN 3 1bbs_c06 RENIN user 1 3 # 1 32 ASP A 268 ASP.? 26.73 CL CL A 278 35 SER A 28 SER.? 27.02 CL CL A 278 215 ASP A 267 ASP.? 31.09 CL CL A 278 coo 61.19 45.85 78.73 62.86 45.48 77.48 9.60 -34.57 10.49 9.97 -36.28 9.26 coo 66.00 46.17 80.29 64.31 47.92 79.91 6.29 -36.11 7.11 4.57 -37.31 5.85 coo 63.61 40.10 74.06 64.05 42.07 74.70 11.77 -37.21 15.47 13.23 -35.63 15.60 ULMN 3 1bbs_c06 RENIN user 2 3 # 2 32 ASP B 268 ASP.? 26.26 CL CL B 278 35 SER B 28 SER.? 27.87 CL CL B 278 215 ASP B 267 ASP.? 32.55 CL CL B 278 coo 61.19 45.85 78.73 62.86 45.48 77.48 -14.31 -16.11 -36.83 -14.03 -14.11 -36.24 coo 66.00 46.17 80.29 64.31 47.92 79.91 -14.66 -18.25 -33.71 -14.43 -20.67 -33.62 coo 63.61 40.10 74.06 64.05 42.07 74.70 -15.25 -13.37 -42.11 -14.97 -14.80 -43.57 1bbs_c06 source 1bbs RENIN : 2 hits 1bbs_c06 naa= 3 ULMN 3 1bbs_c07 RENIN user 1 3 # 1 32 ASP A 268 ASP.? 26.73 CL CL A 278 35 SER A 28 SER.? 27.02 CL CL A 278 215 ASP A 267 ASP.? 31.09 CL CL A 278 coo 61.19 45.85 78.73 62.86 45.48 77.48 9.60 -34.57 10.49 9.97 -36.28 9.26 coo 66.00 46.17 80.29 64.31 47.92 79.91 6.29 -36.11 7.11 4.57 -37.31 5.85 coo 63.61 40.10 74.06 64.05 42.07 74.70 11.77 -37.21 15.47 13.23 -35.63 15.60 ULMN 3 1bbs_c07 RENIN user 2 3 # 2 32 ASP B 268 ASP.? 26.26 CL CL B 278 35 SER B 28 SER.? 27.87 CL CL B 278 215 ASP B 267 ASP.? 32.55 CL CL B 278 coo 61.19 45.85 78.73 62.86 45.48 77.48 -14.31 -16.11 -36.83 -14.03 -14.11 -36.24 coo 66.00 46.17 80.29 64.31 47.92 79.91 -14.66 -18.25 -33.71 -14.43 -20.67 -33.62 coo 63.61 40.10 74.06 64.05 42.07 74.70 -15.25 -13.37 -42.11 -14.97 -14.80 -43.57 1bbs_c07 source 1bbs RENIN : 2 hits 1bbs_c07 naa= 3 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 A 137 ARG A 209 ARG~? 8.75 CL CL A 278 A 141 THR B 77 THR~? 9.42 CL CL A 278 A 235 ASP B 36 ASP~? 8.83 CL CL B 278 coo 6.21 93.81 36.58 4.58 96.33 37.17 12.19 -22.36 -19.55 12.55 -20.19 -17.38 coo 6.80 92.87 28.33 4.91 92.74 27.40 20.96 -17.51 -20.66 19.31 -17.16 -19.33 coo 12.98 90.36 47.57 11.26 89.62 46.62 2.64 -13.17 -23.36 1.59 -11.35 -23.67 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 A 137 ARG A 212 ARG~? 4.63 CL CL A 278 A 141 THR B 77 THR~? 9.42 CL CL A 278 A 235 ASP A 168 ASP^? 12.27 CL CL A 278 coo 6.21 93.81 36.58 4.58 96.33 37.17 18.59 -24.77 -16.89 17.13 -22.12 -16.49 coo 6.80 92.87 28.33 4.91 92.74 27.40 20.96 -17.51 -20.66 19.31 -17.16 -19.33 coo 12.98 90.36 47.57 11.26 89.62 46.62 26.46 -30.73 -8.22 26.92 -32.42 -9.39 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 3 3 # 3 A 137 ARG B 209 ARG~? 8.42 CL CL B 278 A 141 THR A 77 THR~? 8.85 CL CL B 278 A 235 ASP A 36 ASP~? 8.69 CL CL A 278 coo 6.21 93.81 36.58 4.58 96.33 37.17 2.92 -11.07 -10.38 5.18 -10.70 -12.48 coo 6.80 92.87 28.33 4.91 92.74 27.40 8.85 -2.84 -10.84 8.85 -4.68 -11.96 coo 12.98 90.36 47.57 11.26 89.62 46.62 11.67 -20.98 -6.16 13.43 -22.16 -5.96 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 4 3 # 4 A 137 ARG B 212 ARG~? 4.30 CL CL B 278 A 141 THR A 77 THR~? 8.85 CL CL B 278 A 235 ASP B 168 ASP^? 12.80 CL CL B 278 coo 6.21 93.81 36.58 4.58 96.33 37.17 1.13 -4.70 -13.40 3.58 -6.46 -14.00 coo 6.80 92.87 28.33 4.91 92.74 27.40 8.85 -2.84 -10.84 8.85 -4.68 -11.96 coo 12.98 90.36 47.57 11.26 89.62 46.62 -5.42 2.81 -22.11 -6.82 3.76 -20.83 1bd3_c00 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 4 hits 1bd3_c00 naa= 3 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 D 137 ARG A 140 ARG.? 3.74 CL CL A 278 D 141 THR A 112 THR.? 13.33 CL CL A 278 D 235 ASP A 36 ASP~? 8.69 CL CL A 278 coo -8.33 92.80 100.06 -7.71 95.33 98.44 24.77 -21.68 -10.23 22.52 -23.37 -11.49 coo -9.24 93.49 108.77 -7.37 94.21 109.61 26.24 -13.20 -16.26 24.44 -12.42 -17.13 coo -14.64 87.74 89.51 -12.89 87.43 90.65 11.67 -20.98 -6.16 13.43 -22.16 -5.96 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 D 137 ARG A 209 ARG~? 8.75 CL CL A 278 D 141 THR B 77 THR~? 9.42 CL CL A 278 D 235 ASP B 36 ASP~? 8.83 CL CL B 278 coo -8.33 92.80 100.06 -7.71 95.33 98.44 12.19 -22.36 -19.55 12.55 -20.19 -17.38 coo -9.24 93.49 108.77 -7.37 94.21 109.61 20.96 -17.51 -20.66 19.31 -17.16 -19.33 coo -14.64 87.74 89.51 -12.89 87.43 90.65 2.64 -13.17 -23.36 1.59 -11.35 -23.67 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 3 3 # 3 D 137 ARG A 212 ARG~? 4.63 CL CL A 278 D 141 THR B 77 THR~? 9.42 CL CL A 278 D 235 ASP A 168 ASP^? 12.27 CL CL A 278 coo -8.33 92.80 100.06 -7.71 95.33 98.44 18.59 -24.77 -16.89 17.13 -22.12 -16.49 coo -9.24 93.49 108.77 -7.37 94.21 109.61 20.96 -17.51 -20.66 19.31 -17.16 -19.33 coo -14.64 87.74 89.51 -12.89 87.43 90.65 26.46 -30.73 -8.22 26.92 -32.42 -9.39 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 4 3 # 4 D 137 ARG B 140 ARG.? -3.53 CL CL B 278s D 141 THR B 112 THR.? 12.77 CL CL B 278 D 235 ASP B 36 ASP~? 8.83 CL CL B 278 coo -8.33 92.80 100.06 -7.71 95.33 98.44 3.71 0.22 -21.03 2.09 -1.69 -19.26 coo -9.24 93.49 108.77 -7.37 94.21 109.61 13.02 1.47 -16.42 13.78 -0.22 -15.35 coo -14.64 87.74 89.51 -12.89 87.43 90.65 2.64 -13.17 -23.36 1.59 -11.35 -23.67 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 5 3 # 5 D 137 ARG B 209 ARG~? 8.42 CL CL B 278 D 141 THR A 77 THR~? 8.85 CL CL B 278 D 235 ASP A 36 ASP~? 8.69 CL CL A 278 coo -8.33 92.80 100.06 -7.71 95.33 98.44 2.92 -11.07 -10.38 5.18 -10.70 -12.48 coo -9.24 93.49 108.77 -7.37 94.21 109.61 8.85 -2.84 -10.84 8.85 -4.68 -11.96 coo -14.64 87.74 89.51 -12.89 87.43 90.65 11.67 -20.98 -6.16 13.43 -22.16 -5.96 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 6 3 # 6 D 137 ARG B 212 ARG~? 4.30 CL CL B 278 D 141 THR A 77 THR~? 8.85 CL CL B 278 D 235 ASP B 168 ASP^? 12.80 CL CL B 278 coo -8.33 92.80 100.06 -7.71 95.33 98.44 1.13 -4.70 -13.40 3.58 -6.46 -14.00 coo -9.24 93.49 108.77 -7.37 94.21 109.61 8.85 -2.84 -10.84 8.85 -4.68 -11.96 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -5.42 2.81 -22.11 -6.82 3.76 -20.83 1bd3_c01 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 6 hits 1bd3_c01 naa= 3 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 C 137 ARG A 140 ARG.? 3.74 CL CL A 278 C 141 THR A 112 THR.? 13.33 CL CL A 278 C 235 ASP A 36 ASP~? 8.69 CL CL A 278 coo -5.79 67.26 36.83 -4.57 64.58 37.74 24.77 -21.68 -10.23 22.52 -23.37 -11.49 coo -6.81 68.31 28.28 -4.82 68.47 27.57 26.24 -13.20 -16.26 24.44 -12.42 -17.13 coo -13.01 70.96 47.58 -11.44 71.65 46.34 11.67 -20.98 -6.16 13.43 -22.16 -5.96 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 C 137 ARG A 209 ARG~? 8.75 CL CL A 278 C 141 THR B 77 THR~? 9.42 CL CL A 278 C 235 ASP B 36 ASP~? 8.83 CL CL B 278 coo -5.79 67.26 36.83 -4.57 64.58 37.74 12.19 -22.36 -19.55 12.55 -20.19 -17.38 coo -6.81 68.31 28.28 -4.82 68.47 27.57 20.96 -17.51 -20.66 19.31 -17.16 -19.33 coo -13.01 70.96 47.58 -11.44 71.65 46.34 2.64 -13.17 -23.36 1.59 -11.35 -23.67 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 3 3 # 3 C 137 ARG A 212 ARG~? 4.63 CL CL A 278 C 141 THR B 77 THR~? 9.42 CL CL A 278 C 235 ASP A 168 ASP^? 12.27 CL CL A 278 coo -5.79 67.26 36.83 -4.57 64.58 37.74 18.59 -24.77 -16.89 17.13 -22.12 -16.49 coo -6.81 68.31 28.28 -4.82 68.47 27.57 20.96 -17.51 -20.66 19.31 -17.16 -19.33 coo -13.01 70.96 47.58 -11.44 71.65 46.34 26.46 -30.73 -8.22 26.92 -32.42 -9.39 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 4 3 # 4 C 137 ARG B 140 ARG.? -3.53 CL CL B 278s C 141 THR B 112 THR.? 12.77 CL CL B 278 C 235 ASP B 36 ASP~? 8.83 CL CL B 278 coo -5.79 67.26 36.83 -4.57 64.58 37.74 3.71 0.22 -21.03 2.09 -1.69 -19.26 coo -6.81 68.31 28.28 -4.82 68.47 27.57 13.02 1.47 -16.42 13.78 -0.22 -15.35 coo -13.01 70.96 47.58 -11.44 71.65 46.34 2.64 -13.17 -23.36 1.59 -11.35 -23.67 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 5 3 # 5 C 137 ARG B 209 ARG~? 8.42 CL CL B 278 C 141 THR A 77 THR~? 8.85 CL CL B 278 C 235 ASP A 36 ASP~? 8.69 CL CL A 278 coo -5.79 67.26 36.83 -4.57 64.58 37.74 2.92 -11.07 -10.38 5.18 -10.70 -12.48 coo -6.81 68.31 28.28 -4.82 68.47 27.57 8.85 -2.84 -10.84 8.85 -4.68 -11.96 coo -13.01 70.96 47.58 -11.44 71.65 46.34 11.67 -20.98 -6.16 13.43 -22.16 -5.96 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 6 3 # 6 C 137 ARG B 212 ARG~? 4.30 CL CL B 278 C 141 THR A 77 THR~? 8.85 CL CL B 278 C 235 ASP B 168 ASP^? 12.80 CL CL B 278 coo -5.79 67.26 36.83 -4.57 64.58 37.74 1.13 -4.70 -13.40 3.58 -6.46 -14.00 coo -6.81 68.31 28.28 -4.82 68.47 27.57 8.85 -2.84 -10.84 8.85 -4.68 -11.96 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -5.42 2.81 -22.11 -6.82 3.76 -20.83 1bd3_c02 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 6 hits 1bd3_c02 naa= 3 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 B 137 ARG B 140 ARG.? -3.53 CL CL B 278s B 141 THR B 112 THR.? 12.77 CL CL B 278 B 235 ASP B 36 ASP~? 8.83 CL CL B 278 coo 8.13 67.41 100.27 7.18 68.35 97.45 3.71 0.22 -21.03 2.09 -1.69 -19.26 coo 8.28 67.78 108.81 6.22 67.65 109.43 13.02 1.47 -16.42 13.78 -0.22 -15.35 coo 14.55 73.52 89.47 12.81 73.95 90.56 2.64 -13.17 -23.36 1.59 -11.35 -23.67 1bd3_c03 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 1 hits 1bd3_c03 naa= 3 ULMN 3 1bf2_c00 ISOAMYLASE user 1 3 # 1 375 ASP A 224 ASP~? 22.21 CL CL A 278 435 GLU A 221 GLU~? 17.05 CL CL A 278 510 ASP A 168 ASP^? 12.27 CL CL A 278 coo 88.62 69.90 41.16 89.05 70.67 43.04 30.83 -39.35 -6.18 31.71 -41.01 -7.15 coo 89.52 76.11 40.17 89.01 75.16 41.97 27.14 -39.98 -10.94 25.92 -39.21 -12.48 coo 84.89 77.60 46.67 85.63 75.79 46.03 26.46 -30.73 -8.22 26.92 -32.42 -9.39 ULMN 3 1bf2_c00 ISOAMYLASE user 2 3 # 2 375 ASP B 224 ASP~? 22.83 CL CL B 278 435 GLU B 221 GLU~? 17.56 CL CL B 278 510 ASP B 168 ASP^? 12.80 CL CL B 278 coo 88.62 69.90 41.16 89.05 70.67 43.04 -13.88 7.87 -23.86 -15.40 8.87 -22.81 coo 89.52 76.11 40.17 89.01 75.16 41.97 -13.90 4.76 -18.50 -13.25 3.58 -16.87 coo 84.89 77.60 46.67 85.63 75.79 46.03 -5.42 2.81 -22.11 -6.82 3.76 -20.83 1bf2_c00 source 1bf2 ISOAMYLASE : 2 hits 1bf2_c00 naa= 3 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 1 3 # 1 28 GLU A 11 GLU.? 13.55 CL CL A 278 70 HIS A 12 HIS~? 14.78 CL CL A 278 281 HIS A 128 HIS~? 28.74 CL CL A 278 coo 66.09 46.17 155.81 66.77 48.19 155.70 7.22 -30.95 -8.53 7.59 -29.14 -7.55 coo 69.05 50.55 157.03 68.00 52.29 156.51 9.03 -33.35 -4.93 10.37 -31.88 -5.56 coo 100.93 36.73 156.02 100.47 38.42 157.18 23.83 -2.68 5.16 23.03 -1.15 6.34 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 2 3 # 2 28 GLU A 138 GLU^? 6.67 CL CL A 278 70 HIS A 194 HIS.? 4.68 CL CL A 278 281 HIS A -3 HIS.? 40.66 CL CL A 278 coo 66.09 46.17 155.81 66.77 48.19 155.70 23.86 -20.99 -6.84 22.60 -22.69 -7.03 coo 69.05 50.55 157.03 68.00 52.29 156.51 21.59 -27.03 -10.13 21.31 -25.37 -8.87 coo 100.93 36.73 156.02 100.47 38.42 157.18 24.94 -32.70 25.65 25.77 -32.60 27.58 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 3 3 # 3 28 GLU A 138 GLU^? 6.67 CL CL A 278 70 HIS A 194 HIS.? 4.68 CL CL A 278 281 HIS B 128 HIS~? 28.44 CL CL B 278 coo 66.09 46.17 155.81 66.77 48.19 155.70 23.86 -20.99 -6.84 22.60 -22.69 -7.03 coo 69.05 50.55 157.03 68.00 52.29 156.51 21.59 -27.03 -10.13 21.31 -25.37 -8.87 coo 100.93 36.73 156.02 100.47 38.42 157.18 20.44 -4.42 -38.33 21.74 -5.60 -39.48 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 4 3 # 4 28 GLU A 138 GLU^? 6.67 CL CL A 278 70 HIS A 194 HIS.? 4.68 CL CL A 278 281 HIS B 194 HIS.? 5.13 CL CL B 278 coo 66.09 46.17 155.81 66.77 48.19 155.70 23.86 -20.99 -6.84 22.60 -22.69 -7.03 coo 69.05 50.55 157.03 68.00 52.29 156.51 21.59 -27.03 -10.13 21.31 -25.37 -8.87 coo 100.93 36.73 156.02 100.47 38.42 157.18 -1.92 -2.21 -20.05 -0.53 -2.75 -21.52 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 5 3 # 5 28 GLU A 169 GLU.? 7.63 CL CL A 278 70 HIS A 194 HIS.? 4.68 CL CL A 278 281 HIS B 128 HIS~? 28.44 CL CL B 278 coo 66.09 46.17 155.81 66.77 48.19 155.70 26.74 -26.14 -12.80 26.49 -24.16 -13.47 coo 69.05 50.55 157.03 68.00 52.29 156.51 21.59 -27.03 -10.13 21.31 -25.37 -8.87 coo 100.93 36.73 156.02 100.47 38.42 157.18 20.44 -4.42 -38.33 21.74 -5.60 -39.48 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 6 3 # 6 28 GLU A 169 GLU.? 7.63 CL CL A 278 70 HIS A 194 HIS.? 4.68 CL CL A 278 281 HIS B 194 HIS.? 5.13 CL CL B 278 coo 66.09 46.17 155.81 66.77 48.19 155.70 26.74 -26.14 -12.80 26.49 -24.16 -13.47 coo 69.05 50.55 157.03 68.00 52.29 156.51 21.59 -27.03 -10.13 21.31 -25.37 -8.87 coo 100.93 36.73 156.02 100.47 38.42 157.18 -1.92 -2.21 -20.05 -0.53 -2.75 -21.52 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 7 3 # 7 28 GLU B 11 GLU.? 12.74 CL CL B 278 70 HIS B 12 HIS~? 15.42 CL CL B 278 281 HIS B 128 HIS~? 28.44 CL CL B 278 coo 66.09 46.17 155.81 66.77 48.19 155.70 -6.91 -15.96 -19.89 -5.75 -14.85 -18.47 coo 69.05 50.55 157.03 68.00 52.29 156.51 -10.18 -14.51 -22.80 -8.49 -13.29 -22.60 coo 100.93 36.73 156.02 100.47 38.42 157.18 20.44 -4.42 -38.33 21.74 -5.60 -39.48 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 8 3 # 8 28 GLU B 138 GLU^? 6.70 CL CL B 278 70 HIS B 194 HIS.? 5.13 CL CL B 278 281 HIS A 12 HIS~? 14.78 CL CL A 278 coo 66.09 46.17 155.81 66.77 48.19 155.70 3.87 -1.10 -24.33 2.09 -2.15 -23.84 coo 69.05 50.55 157.03 68.00 52.29 156.51 -1.92 -2.21 -20.05 -0.53 -2.75 -21.52 coo 100.93 36.73 156.02 100.47 38.42 157.18 9.03 -33.35 -4.93 10.37 -31.88 -5.56 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 9 3 # 9 28 GLU B 138 GLU^? 6.70 CL CL B 278 70 HIS B 194 HIS.? 5.13 CL CL B 278 281 HIS A 128 HIS~? 28.74 CL CL A 278 coo 66.09 46.17 155.81 66.77 48.19 155.70 3.87 -1.10 -24.33 2.09 -2.15 -23.84 coo 69.05 50.55 157.03 68.00 52.29 156.51 -1.92 -2.21 -20.05 -0.53 -2.75 -21.52 coo 100.93 36.73 156.02 100.47 38.42 157.18 23.83 -2.68 5.16 23.03 -1.15 6.34 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 10 3 # 10 28 GLU B 138 GLU^? 6.70 CL CL B 278 70 HIS B 194 HIS.? 5.13 CL CL B 278 281 HIS A 194 HIS.? 4.68 CL CL A 278 coo 66.09 46.17 155.81 66.77 48.19 155.70 3.87 -1.10 -24.33 2.09 -2.15 -23.84 coo 69.05 50.55 157.03 68.00 52.29 156.51 -1.92 -2.21 -20.05 -0.53 -2.75 -21.52 coo 100.93 36.73 156.02 100.47 38.42 157.18 21.59 -27.03 -10.13 21.31 -25.37 -8.87 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 11 3 # 11 28 GLU B 169 GLU.? 7.43 CL CL B 278 70 HIS B 194 HIS.? 5.13 CL CL B 278 281 HIS A 194 HIS.? 4.68 CL CL A 278 coo 66.09 46.17 155.81 66.77 48.19 155.70 0.06 3.03 -18.46 2.10 2.57 -18.04 coo 69.05 50.55 157.03 68.00 52.29 156.51 -1.92 -2.21 -20.05 -0.53 -2.75 -21.52 coo 100.93 36.73 156.02 100.47 38.42 157.18 21.59 -27.03 -10.13 21.31 -25.37 -8.87 1bfd_c00 source 1bfd BENZOYLFORMATE DECARBOXYLASE : 11 hits 1bfd_c00 naa= 3 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 1 3 # 1 A 461 GLU A 82 GLU~? 22.17 CL CL B 278 A 503 TYR A 79 TYR.? 15.56 CL CL B 278 A 537 GLU A 84 GLU~? 21.00 CL CL B 278 coo 24.06 146.21 11.09 22.89 146.18 9.36 18.08 -1.27 -4.95 20.15 -1.66 -5.22 coo 15.91 140.69 8.32 15.71 143.39 9.13 9.48 -3.09 -3.95 8.21 -5.52 -3.44 coo 16.65 144.44 13.24 18.34 145.22 12.33 10.99 1.60 0.86 10.52 3.31 -0.28 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 2 3 # 2 A 461 GLU A 83 GLU~? 26.70 CL CL B 278 A 503 TYR A 79 TYR.? 15.56 CL CL B 278 A 537 GLU A 84 GLU~? 21.00 CL CL B 278 coo 24.06 146.21 11.09 22.89 146.18 9.36 17.51 1.49 1.14 18.83 0.42 2.44 coo 15.91 140.69 8.32 15.71 143.39 9.13 9.48 -3.09 -3.95 8.21 -5.52 -3.44 coo 16.65 144.44 13.24 18.34 145.22 12.33 10.99 1.60 0.86 10.52 3.31 -0.28 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 3 3 # 3 A 461 GLU B 82 GLU~? 22.63 CL CL A 278 A 503 TYR B 79 TYR.? 15.95 CL CL A 278 A 537 GLU B 84 GLU~? 21.19 CL CL A 278 coo 24.06 146.21 11.09 22.89 146.18 9.36 22.63 -9.38 -27.83 22.57 -7.28 -27.71 coo 15.91 140.69 8.32 15.71 143.39 9.13 19.67 -17.68 -27.47 17.12 -18.78 -27.53 coo 16.65 144.44 13.24 18.34 145.22 12.33 23.98 -17.25 -32.88 25.62 -18.13 -31.85 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 4 3 # 4 A 461 GLU B 83 GLU~? 26.47 CL CL A 278 A 503 TYR B 79 TYR.? 15.95 CL CL A 278 A 537 GLU B 84 GLU~? 21.19 CL CL A 278 coo 24.06 146.21 11.09 22.89 146.18 9.36 24.57 -10.93 -33.84 23.46 -9.16 -34.20 coo 15.91 140.69 8.32 15.71 143.39 9.13 19.67 -17.68 -27.47 17.12 -18.78 -27.53 coo 16.65 144.44 13.24 18.34 145.22 12.33 23.98 -17.25 -32.88 25.62 -18.13 -31.85 1bgl_c08 source 1bgl BETA-GALACTOSIDASE : 4 hits 1bgl_c08 naa= 3 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 1 3 # 1 A 451 GLU A 83 GLU~? 26.70 CL CL B 278 A 504 TYR A 79 TYR.? 15.56 CL CL B 278 A 540 GLU A 84 GLU~? 21.00 CL CL B 278 coo 81.34 87.29 87.22 82.36 86.09 88.61 17.51 1.49 1.14 18.83 0.42 2.44 coo 80.85 81.34 94.77 81.70 80.16 92.41 9.48 -3.09 -3.95 8.21 -5.52 -3.44 coo 79.94 80.46 88.84 81.11 81.36 87.27 10.99 1.60 0.86 10.52 3.31 -0.28 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 2 3 # 2 A 451 GLU B 83 GLU~? 26.47 CL CL A 278 A 504 TYR B 79 TYR.? 15.95 CL CL A 278 A 540 GLU B 84 GLU~? 21.19 CL CL A 278 coo 81.34 87.29 87.22 82.36 86.09 88.61 24.57 -10.93 -33.84 23.46 -9.16 -34.20 coo 80.85 81.34 94.77 81.70 80.16 92.41 19.67 -17.68 -27.47 17.12 -18.78 -27.53 coo 79.94 80.46 88.84 81.11 81.36 87.27 23.98 -17.25 -32.88 25.62 -18.13 -31.85 1bhg_c02 source 1bhg BETA-GLUCURONIDASE : 2 hits 1bhg_c02 naa= 3 ULMN 3 1bhg_c03 BETA-GLUCURONIDASE user 1 3 # 1 B 451 GLU A 83 GLU~? 26.70 CL CL B 278 B 504 TYR A 79 TYR.? 15.56 CL CL B 278 B 540 GLU A 82 GLU~? 22.17 CL CL B 278 coo 86.52 35.28 112.74 87.08 36.38 110.99 17.51 1.49 1.14 18.83 0.42 2.44 coo 84.93 40.21 105.31 85.72 41.45 107.72 9.48 -3.09 -3.95 8.21 -5.52 -3.44 coo 83.38 41.19 112.55 85.47 40.59 112.72 18.08 -1.27 -4.95 20.15 -1.66 -5.22 ULMN 3 1bhg_c03 BETA-GLUCURONIDASE user 2 3 # 2 B 451 GLU A 83 GLU~? 26.70 CL CL B 278 B 504 TYR A 79 TYR.? 15.56 CL CL B 278 B 540 GLU A 84 GLU~? 21.00 CL CL B 278 coo 86.52 35.28 112.74 87.08 36.38 110.99 17.51 1.49 1.14 18.83 0.42 2.44 coo 84.93 40.21 105.31 85.72 41.45 107.72 9.48 -3.09 -3.95 8.21 -5.52 -3.44 coo 83.38 41.19 112.55 85.47 40.59 112.72 10.99 1.60 0.86 10.52 3.31 -0.28 ULMN 3 1bhg_c03 BETA-GLUCURONIDASE user 3 3 # 3 B 451 GLU B 83 GLU~? 26.47 CL CL A 278 B 504 TYR B 79 TYR.? 15.95 CL CL A 278 B 540 GLU B 82 GLU~? 22.63 CL CL A 278 coo 86.52 35.28 112.74 87.08 36.38 110.99 24.57 -10.93 -33.84 23.46 -9.16 -34.20 coo 84.93 40.21 105.31 85.72 41.45 107.72 19.67 -17.68 -27.47 17.12 -18.78 -27.53 coo 83.38 41.19 112.55 85.47 40.59 112.72 22.63 -9.38 -27.83 22.57 -7.28 -27.71 ULMN 3 1bhg_c03 BETA-GLUCURONIDASE user 4 3 # 4 B 451 GLU B 83 GLU~? 26.47 CL CL A 278 B 504 TYR B 79 TYR.? 15.95 CL CL A 278 B 540 GLU B 84 GLU~? 21.19 CL CL A 278 coo 86.52 35.28 112.74 87.08 36.38 110.99 24.57 -10.93 -33.84 23.46 -9.16 -34.20 coo 84.93 40.21 105.31 85.72 41.45 107.72 19.67 -17.68 -27.47 17.12 -18.78 -27.53 coo 83.38 41.19 112.55 85.47 40.59 112.72 23.98 -17.25 -32.88 25.62 -18.13 -31.85 1bhg_c03 source 1bhg BETA-GLUCURONIDASE : 4 hits 1bhg_c03 naa= 3 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 1 3 # 1 A 382 ARG A 47 ARG~? 19.53 CL CL B 278 A 451 GLU A 46 GLU~? 24.48 CL CL B 278 A 540 GLU A 50 GLU~? 27.20 CL CL B 278 coo 79.04 80.20 80.81 79.58 81.40 83.63 1.19 -18.60 0.09 1.74 -17.18 -2.58 coo 81.34 87.29 87.22 82.36 86.09 88.61 -1.94 -12.84 6.51 -1.20 -10.99 5.75 coo 79.94 80.46 88.84 81.11 81.36 87.27 -1.40 -20.04 6.08 -2.65 -20.05 4.33 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 2 3 # 2 A 382 ARG B 47 ARG~? 19.59 CL CL A 278 A 451 GLU B 46 GLU~? 24.28 CL CL A 278 A 540 GLU B 50 GLU~? 26.89 CL CL A 278 coo 79.04 80.20 80.81 79.58 81.40 83.63 3.13 -24.42 -28.62 4.84 -23.96 -26.11 coo 81.34 87.29 87.22 82.36 86.09 88.61 7.71 -28.83 -35.20 9.60 -28.18 -34.47 coo 79.94 80.46 88.84 81.11 81.36 87.27 0.53 -27.55 -33.66 0.79 -28.51 -31.75 1bhg_c04 source 1bhg BETA-GLUCURONIDASE : 2 hits 1bhg_c04 naa= 3 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 1 3 # 1 B 382 ARG A 47 ARG~? 19.53 CL CL B 278 B 451 GLU A 46 GLU~? 24.48 CL CL B 278 B 540 GLU A 50 GLU~? 27.20 CL CL B 278 coo 82.21 41.07 119.14 83.95 40.66 116.59 1.19 -18.60 0.09 1.74 -17.18 -2.58 coo 86.52 35.28 112.74 87.08 36.38 110.99 -1.94 -12.84 6.51 -1.20 -10.99 5.75 coo 83.38 41.19 112.55 85.47 40.59 112.72 -1.40 -20.04 6.08 -2.65 -20.05 4.33 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 2 3 # 2 B 382 ARG A 192 ARG^? 5.91 CL CL A 278 B 451 GLU A 169 GLU.? 7.63 CL CL A 278 B 540 GLU A 138 GLU^? 6.67 CL CL A 278 coo 82.21 41.07 119.14 83.95 40.66 116.59 20.84 -24.38 -4.40 19.02 -23.24 -6.62 coo 86.52 35.28 112.74 87.08 36.38 110.99 26.74 -26.14 -12.80 26.49 -24.16 -13.47 coo 83.38 41.19 112.55 85.47 40.59 112.72 23.86 -20.99 -6.84 22.60 -22.69 -7.03 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 3 3 # 3 B 382 ARG B 47 ARG~? 19.59 CL CL A 278 B 451 GLU B 46 GLU~? 24.28 CL CL A 278 B 540 GLU B 50 GLU~? 26.89 CL CL A 278 coo 82.21 41.07 119.14 83.95 40.66 116.59 3.13 -24.42 -28.62 4.84 -23.96 -26.11 coo 86.52 35.28 112.74 87.08 36.38 110.99 7.71 -28.83 -35.20 9.60 -28.18 -34.47 coo 83.38 41.19 112.55 85.47 40.59 112.72 0.53 -27.55 -33.66 0.79 -28.51 -31.75 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 4 3 # 4 B 382 ARG B 192 ARG^? 6.13 CL CL B 278 B 451 GLU B 169 GLU.? 7.43 CL CL B 278 B 540 GLU B 138 GLU^? 6.70 CL CL B 278 coo 82.21 41.07 119.14 83.95 40.66 116.59 -0.17 -3.93 -26.09 1.00 -5.48 -23.71 coo 86.52 35.28 112.74 87.08 36.38 110.99 0.06 3.03 -18.46 2.10 2.57 -18.04 coo 83.38 41.19 112.55 85.47 40.59 112.72 3.87 -1.10 -24.33 2.09 -2.15 -23.84 1bhg_c05 source 1bhg BETA-GLUCURONIDASE : 4 hits 1bhg_c05 naa= 3 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 1 3 # 1 118 ARG A 47 ARG~? 19.53 CL CL B 278 183 LYS A 64 LYS^? 6.64 CL CL A 278 317 ARG A 209 ARG~? 8.75 CL CL A 278 coo 76.57 109.19 73.41 73.86 110.26 72.16 1.19 -18.60 0.09 1.74 -17.18 -2.58 coo 82.09 117.51 66.37 80.60 114.32 71.44 14.97 -18.21 -2.39 15.88 -19.33 -8.52 coo 65.21 120.62 58.76 63.62 123.14 59.66 12.19 -22.36 -19.55 12.55 -20.19 -17.38 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 2 3 # 2 118 ARG B 3 ARG^? 24.44 CL CL B 278 183 LYS B 237 LYS.? 30.29 CL CL B 278 317 ARG B 127 ARG~? 22.49 CL CL B 278 coo 76.57 109.19 73.41 73.86 110.26 72.16 -7.40 -8.36 -37.36 -6.70 -7.91 -40.31 coo 82.09 117.51 66.37 80.60 114.32 71.44 -4.88 0.83 -42.64 -0.61 0.76 -47.36 coo 65.21 120.62 58.76 63.62 123.14 59.66 13.11 -0.63 -38.30 10.87 -2.72 -38.33 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 3 3 # 3 118 ARG B 47 ARG~? 19.59 CL CL A 278 183 LYS B 64 LYS^? 6.39 CL CL B 278 317 ARG B 209 ARG~? 8.42 CL CL B 278 coo 76.57 109.19 73.41 73.86 110.26 72.16 3.13 -24.42 -28.62 4.84 -23.96 -26.11 coo 82.09 117.51 66.37 80.60 114.32 71.44 5.21 -10.68 -27.95 4.80 -8.81 -21.96 coo 65.21 120.62 58.76 63.62 123.14 59.66 2.92 -11.07 -10.38 5.18 -10.70 -12.48 1bib_c00 source 1bib BIRA BIFUNCTIONAL PROTEIN (ACTS AS BIOTIN OPER: 3 hits 1bib_c00 naa= 3 ULMN 3 1bmt_c05 METHIONINE SYNTHASE (B12-BINDING DOMuser 1 3 # 1 B 757 ASP A 13 ASP~? 20.85 CL CL A 278 B 759 HIS A 12 HIS~? 14.78 CL CL A 278 B 810 SER A 21 SER.? 21.88 CL CL A 278 coo -2.30 64.08 6.41 -0.36 64.72 6.26 3.80 -37.83 -7.42 4.89 -38.66 -9.05 coo 1.96 66.39 3.07 2.10 68.48 3.58 9.03 -33.35 -4.93 10.37 -31.88 -5.56 coo -1.50 63.90 11.86 -1.31 64.33 9.52 1.16 -33.17 -2.24 2.71 -34.86 -3.05 ULMN 3 1bmt_c05 METHIONINE SYNTHASE (B12-BINDING DOMuser 2 3 # 2 B 757 ASP A 250 ASP~? 15.45 CL CL A 278 B 759 HIS A 216 HIS.? 18.50 CL CL A 278 B 810 SER A 247 SER.? 8.71 CL CL A 278 coo -2.30 64.08 6.41 -0.36 64.72 6.26 15.24 -38.09 -11.21 14.62 -38.47 -13.19 coo 1.96 66.39 3.07 2.10 68.48 3.58 17.97 -41.33 -12.21 17.58 -42.84 -10.82 coo -1.50 63.90 11.86 -1.31 64.33 9.52 12.77 -32.05 -14.75 14.22 -30.30 -15.59 1bmt_c05 source 1bmt METHIONINE SYNTHASE (B12-BINDING DOMAINS) (E.C: 2 hits 1bmt_c05 naa= 3 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 1 3 # 1 30 GLY A 5 GLY^? 15.84 CL CL A 278 48 HIS A 12 HIS~? 14.78 CL CL A 278 99 ASP A 13 ASP~? 20.85 CL CL A 278 coo 12.38 5.55 24.25 13.27 5.59 24.39 15.52 -31.61 0.74 16.07 -31.86 0.19 coo 18.80 12.68 24.53 17.69 13.54 26.08 9.03 -33.35 -4.93 10.37 -31.88 -5.56 coo 17.07 18.51 26.62 16.67 17.07 28.09 3.80 -37.83 -7.42 4.89 -38.66 -9.05 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 2 3 # 2 30 GLY B 5 GLY^? 16.39 CL CL B 278 48 HIS B 12 HIS~? 15.42 CL CL B 278 99 ASP B 13 ASP~? 21.13 CL CL B 278 coo 12.38 5.55 24.25 13.27 5.59 24.39 -8.44 -9.04 -29.52 -8.55 -8.38 -29.05 coo 18.80 12.68 24.53 17.69 13.54 26.08 -10.18 -14.51 -22.80 -8.49 -13.29 -22.60 coo 17.07 18.51 26.62 16.67 17.07 28.09 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 3 3 # 3 30 GLY B 17 GLY~? 26.14 CL CL B 278 48 HIS B 29 HIS.? 25.42 CL CL B 278 99 ASP B 268 ASP.? 26.26 CL CL B 278 coo 12.38 5.55 24.25 13.27 5.59 24.39 -18.23 -20.62 -22.29 -17.41 -20.69 -22.32 coo 18.80 12.68 24.53 17.69 13.54 26.08 -16.16 -16.38 -29.82 -17.24 -18.07 -29.20 coo 17.07 18.51 26.62 16.67 17.07 28.09 -14.31 -16.11 -36.83 -14.03 -14.11 -36.24 1bp2_c00 source 1bp2 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSPHATIDE AC: 3 hits 1bp2_c00 naa= 3 ULMN 3 1bqc_c01 BETA-MANNANASE user 1 3 # 1 A 50 ARG A 47 ARG~? 19.53 CL CL B 278 A 128 GLU A 46 GLU~? 24.48 CL CL B 278 A 225 GLU A 50 GLU~? 27.20 CL CL B 278 coo 38.56 19.11 14.83 37.12 21.00 16.76 1.19 -18.60 0.09 1.74 -17.18 -2.58 coo 36.48 24.43 22.02 36.86 26.34 21.13 -1.94 -12.84 6.51 -1.20 -10.99 5.75 coo 40.16 23.71 17.01 38.52 24.96 17.40 -1.40 -20.04 6.08 -2.65 -20.05 4.33 ULMN 3 1bqc_c01 BETA-MANNANASE user 2 3 # 2 A 50 ARG B 47 ARG~? 19.59 CL CL A 278 A 128 GLU B 46 GLU~? 24.28 CL CL A 278 A 225 GLU B 50 GLU~? 26.89 CL CL A 278 coo 38.56 19.11 14.83 37.12 21.00 16.76 3.13 -24.42 -28.62 4.84 -23.96 -26.11 coo 36.48 24.43 22.02 36.86 26.34 21.13 7.71 -28.83 -35.20 9.60 -28.18 -34.47 coo 40.16 23.71 17.01 38.52 24.96 17.40 0.53 -27.55 -33.66 0.79 -28.51 -31.75 ULMN 3 1bqc_c01 BETA-MANNANASE user 3 3 # 3 A 50 ARG B 192 ARG^? 6.13 CL CL B 278 A 128 GLU B 169 GLU.? 7.43 CL CL B 278 A 225 GLU B 138 GLU^? 6.70 CL CL B 278 coo 38.56 19.11 14.83 37.12 21.00 16.76 -0.17 -3.93 -26.09 1.00 -5.48 -23.71 coo 36.48 24.43 22.02 36.86 26.34 21.13 0.06 3.03 -18.46 2.10 2.57 -18.04 coo 40.16 23.71 17.01 38.52 24.96 17.40 3.87 -1.10 -24.33 2.09 -2.15 -23.84 1bqc_c01 source 1bqc BETA-MANNANASE : 3 hits 1bqc_c01 naa= 3 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 1 3 # 1 A 109 PHE A 9 PHE.? 19.14 CL CL A 278 A 205 ASP A 268 ASP.? 26.73 CL CL A 278 A 236 LYS A 101 LYS.? 27.96 CL CL A 278 coo 4.14 2.10 36.34 6.69 3.08 36.92 5.29 -28.19 -0.70 3.37 -26.19 -0.65 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 9.60 -34.57 10.49 9.97 -36.28 9.26 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 12.62 -22.66 11.02 6.99 -25.01 12.73 1bs0_c01 source 1bs0 8-AMINO-7-OXONANOATE SYNTHASE : 1 hits 1bs0_c01 naa= 3 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 1 3 # 1 A 50 GLN B 234 GLN~? 28.91 CL CL B 278 A 91 LEU B 230 LEU~? 26.20 CL CL B 278 A 133 GLU B 235 GLU.? 26.01 CL CL B 278 coo 43.58 43.67 66.73 42.32 42.78 68.15 -11.28 8.81 -40.26 -12.74 7.98 -38.94 coo 38.58 45.09 70.44 38.28 45.21 72.59 -13.71 5.44 -34.34 -15.27 5.65 -35.85 coo 44.05 36.87 70.65 43.15 38.64 69.97 -5.56 9.78 -39.05 -4.91 10.76 -37.29 1bs4_c00 source 1bs4 PEPTIDE DEFORMYLASE : 1 hits 1bs4_c00 naa= 3 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 1 3 # 1 B 550 GLN B 234 GLN~? 28.91 CL CL B 278 B 591 LEU B 230 LEU~? 26.20 CL CL B 278 B 633 GLU B 235 GLU.? 26.01 CL CL B 278 coo 88.06 44.34 57.19 89.06 45.53 55.74 -11.28 8.81 -40.26 -12.74 7.98 -38.94 coo 86.70 48.66 52.61 87.15 48.69 50.51 -13.71 5.44 -34.34 -15.27 5.65 -35.85 coo 95.42 44.52 54.43 93.46 45.31 54.70 -5.56 9.78 -39.05 -4.91 10.76 -37.29 1bs4_c01 source 1bs4 PEPTIDE DEFORMYLASE : 1 hits 1bs4_c01 naa= 3 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 1 3 # 1 C1050 GLN B 234 GLN~? 28.91 CL CL B 278 C1091 LEU B 230 LEU~? 26.20 CL CL B 278 C1133 GLU B 235 GLU.? 26.01 CL CL B 278 coo 68.29 34.44 43.03 66.67 34.74 44.37 -11.28 8.81 -40.26 -12.74 7.98 -38.94 coo 65.83 38.95 47.05 65.46 38.90 49.20 -13.71 5.44 -34.34 -15.27 5.65 -35.85 coo 63.14 29.39 46.25 63.84 31.31 45.74 -5.56 9.78 -39.05 -4.91 10.76 -37.29 1bs4_c02 source 1bs4 PEPTIDE DEFORMYLASE : 1 hits 1bs4_c02 naa= 3 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 1 3 # 1 A 50 GLN A 124 GLN~? 26.45 CL CL A 278 A 91 LEU A 123 LEU~? 18.76 CL CL A 278 A 133 GLU A 159 GLU~? 29.28 CL CL A 278 coo 38.23 53.34 67.59 38.84 53.87 69.56 31.04 -6.29 0.80 32.77 -5.14 0.34 coo 35.40 53.22 73.30 35.37 54.87 74.74 28.60 -9.74 -2.51 28.66 -11.31 -4.04 coo 45.08 56.04 70.60 43.15 55.19 70.77 36.97 -12.08 5.95 38.35 -10.71 5.18 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 2 3 # 2 A 50 GLN B 124 GLN~? 26.18 CL CL B 278 A 91 LEU B 123 LEU~? 18.26 CL CL B 278 A 133 GLU B 159 GLU~? 28.71 CL CL B 278 coo 38.23 53.34 67.59 38.84 53.87 69.56 18.23 3.51 -34.23 19.72 5.01 -34.40 coo 35.40 53.22 73.30 35.37 54.87 74.74 14.91 1.85 -30.41 13.36 2.10 -28.89 coo 45.08 56.04 70.60 43.15 55.19 70.77 12.56 9.29 -39.58 14.23 10.36 -38.83 1bsj_c00 source 1bsj PEPTIDE DEFORMYLASE : 2 hits 1bsj_c00 naa= 3 ULMN 3 1bu7_c02 CYTOCHROME P450 user 1 3 # 1 A 268 THR A 112 THR.? 13.33 CL CL A 278 A 393 PHE A 109 PHE.? 13.59 CL CL A 278 A 400 CYH A 71 CYH.? 16.56 CL CL A 278 coo 45.81 71.19 43.26 47.70 70.19 43.25 26.24 -13.20 -16.26 24.44 -12.42 -17.13 coo 48.54 63.17 48.16 46.74 64.99 49.22 24.11 -13.43 -7.67 24.08 -11.73 -5.48 coo 53.76 64.39 46.87 52.06 66.55 47.33 19.04 -8.88 -9.96 21.14 -7.72 -8.59 ULMN 3 1bu7_c02 CYTOCHROME P450 user 2 3 # 2 A 268 THR B 112 THR.? 12.77 CL CL B 278 A 393 PHE B 109 PHE.? 13.18 CL CL B 278 A 400 CYH B 71 CYH.? 16.15 CL CL B 278 coo 45.81 71.19 43.26 47.70 70.19 43.25 13.02 1.47 -16.42 13.78 -0.22 -15.35 coo 48.54 63.17 48.16 46.74 64.99 49.22 11.45 -1.55 -24.49 13.03 -2.08 -26.71 coo 53.76 64.39 46.87 52.06 66.55 47.33 15.78 -6.77 -22.17 17.11 -4.88 -23.73 1bu7_c02 source 1bu7 CYTOCHROME P450 : 2 hits 1bu7_c02 naa= 3 ULMN 3 1bu7_c03 CYTOCHROME P450 user 1 3 # 1 B 268 THR A 112 THR.? 13.33 CL CL A 278 B 393 PHE A 109 PHE.? 13.59 CL CL A 278 B 400 CYH A 71 CYH.? 16.56 CL CL A 278 coo 37.20 116.32 52.00 35.18 117.07 52.13 26.24 -13.20 -16.26 24.44 -12.42 -17.13 coo 33.81 121.65 59.26 35.49 119.55 59.81 24.11 -13.43 -7.67 24.08 -11.73 -5.48 coo 28.79 121.15 57.00 30.51 118.99 56.70 19.04 -8.88 -9.96 21.14 -7.72 -8.59 ULMN 3 1bu7_c03 CYTOCHROME P450 user 2 3 # 2 B 268 THR B 112 THR.? 12.77 CL CL B 278 B 393 PHE B 109 PHE.? 13.18 CL CL B 278 B 400 CYH B 71 CYH.? 16.15 CL CL B 278 coo 37.20 116.32 52.00 35.18 117.07 52.13 13.02 1.47 -16.42 13.78 -0.22 -15.35 coo 33.81 121.65 59.26 35.49 119.55 59.81 11.45 -1.55 -24.49 13.03 -2.08 -26.71 coo 28.79 121.15 57.00 30.51 118.99 56.70 15.78 -6.77 -22.17 17.11 -4.88 -23.73 1bu7_c03 source 1bu7 CYTOCHROME P450 : 2 hits 1bu7_c03 naa= 3 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 1 3 # 1 A 325 ASP A 13 ASP~? 20.85 CL CL A 278 A 354 GLU A 11 GLU.? 13.55 CL CL A 278 A 421 ASP A 250 ASP~? 15.45 CL CL A 278 coo 31.05 49.37 64.51 31.97 51.11 63.85 3.80 -37.83 -7.42 4.89 -38.66 -9.05 coo 29.07 50.42 58.36 29.02 52.18 59.49 7.22 -30.95 -8.53 7.59 -29.14 -7.55 coo 30.82 59.76 58.47 31.12 59.02 60.40 15.24 -38.09 -11.21 14.62 -38.47 -13.19 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 2 3 # 2 A 325 ASP B 13 ASP~? 21.13 CL CL B 278 A 354 GLU B 11 GLU.? 12.74 CL CL B 278 A 421 ASP B 250 ASP~? 16.15 CL CL B 278 coo 31.05 49.37 64.51 31.97 51.11 63.85 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 coo 29.07 50.42 58.36 29.02 52.18 59.49 -6.91 -15.96 -19.89 -5.75 -14.85 -18.47 coo 30.82 59.76 58.47 31.12 59.02 60.40 -13.35 -7.01 -16.89 -13.59 -7.26 -14.81 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 3 3 # 3 A 325 ASP B 224 ASP~? 22.83 CL CL B 278 A 354 GLU B 221 GLU~? 17.56 CL CL B 278 A 421 ASP B 168 ASP^? 12.80 CL CL B 278 coo 31.05 49.37 64.51 31.97 51.11 63.85 -13.88 7.87 -23.86 -15.40 8.87 -22.81 coo 29.07 50.42 58.36 29.02 52.18 59.49 -13.90 4.76 -18.50 -13.25 3.58 -16.87 coo 30.82 59.76 58.47 31.12 59.02 60.40 -5.42 2.81 -22.11 -6.82 3.76 -20.83 1bvz_c08 source 1bvz ALPHA-AMYLASE II : 3 hits 1bvz_c08 naa= 3 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 1 3 # 1 B 325 ASP A 13 ASP~? 20.85 CL CL A 278 B 354 GLU A 11 GLU.? 13.55 CL CL A 278 B 421 ASP A 250 ASP~? 15.45 CL CL A 278 coo 25.90 8.19 53.87 25.36 6.97 52.29 3.80 -37.83 -7.42 4.89 -38.66 -9.05 coo 27.87 10.66 47.95 27.82 8.60 48.27 7.22 -30.95 -8.53 7.59 -29.14 -7.55 coo 26.02 1.87 43.38 25.90 1.97 45.49 15.24 -38.09 -11.21 14.62 -38.47 -13.19 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 2 3 # 2 B 325 ASP A 250 ASP~? 15.45 CL CL A 278 B 354 GLU A 253 GLU~? 21.30 CL CL A 278 B 421 ASP A 13 ASP~? 20.85 CL CL A 278 coo 25.90 8.19 53.87 25.36 6.97 52.29 15.24 -38.09 -11.21 14.62 -38.47 -13.19 coo 27.87 10.66 47.95 27.82 8.60 48.27 14.60 -42.99 -6.59 14.44 -44.06 -8.42 coo 26.02 1.87 43.38 25.90 1.97 45.49 3.80 -37.83 -7.42 4.89 -38.66 -9.05 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 3 3 # 3 B 325 ASP B 13 ASP~? 21.13 CL CL B 278 B 354 GLU B 11 GLU.? 12.74 CL CL B 278 B 421 ASP B 250 ASP~? 16.15 CL CL B 278 coo 25.90 8.19 53.87 25.36 6.97 52.29 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 coo 27.87 10.66 47.95 27.82 8.60 48.27 -6.91 -15.96 -19.89 -5.75 -14.85 -18.47 coo 26.02 1.87 43.38 25.90 1.97 45.49 -13.35 -7.01 -16.89 -13.59 -7.26 -14.81 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 4 3 # 4 B 325 ASP B 250 ASP~? 16.15 CL CL B 278 B 354 GLU B 253 GLU~? 21.95 CL CL B 278 B 421 ASP B 13 ASP~? 21.13 CL CL B 278 coo 25.90 8.19 53.87 25.36 6.97 52.29 -13.35 -7.01 -16.89 -13.59 -7.26 -14.81 coo 27.87 10.66 47.95 27.82 8.60 48.27 -18.69 -7.91 -20.45 -19.54 -8.29 -18.53 coo 26.02 1.87 43.38 25.90 1.97 45.49 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 1bvz_c09 source 1bvz ALPHA-AMYLASE II : 4 hits 1bvz_c09 naa= 3 ULMN 3 1bwl_c01 NADPH DEHYDROGENASE 1 user 1 3 # 1 191 ASN A 218 ASN~? 20.82 CL CL A 278 194 HIS A 216 HIS.? 18.50 CL CL A 278 196 TYR A 217 TYR.? 13.45 CL CL A 278 coo 40.94 71.26 25.74 40.29 70.59 23.82 24.13 -43.84 -11.70 26.14 -43.18 -11.76 coo 38.86 67.47 19.31 37.78 65.73 19.79 17.97 -41.33 -12.21 17.58 -42.84 -10.82 coo 41.10 73.64 20.13 38.52 73.39 19.02 22.77 -37.42 -9.36 23.40 -34.73 -9.58 ULMN 3 1bwl_c01 NADPH DEHYDROGENASE 1 user 2 3 # 2 191 ASN A 245 ASN.? 11.79 CL CL A 278 194 HIS A 216 HIS.? 18.50 CL CL A 278 196 TYR A 215 TYR.? 13.87 CL CL A 278 coo 40.94 71.26 25.74 40.29 70.59 23.82 18.48 -33.48 -10.76 18.30 -34.93 -9.15 coo 38.86 67.47 19.31 37.78 65.73 19.79 17.97 -41.33 -12.21 17.58 -42.84 -10.82 coo 41.10 73.64 20.13 38.52 73.39 19.02 21.62 -36.04 -14.58 23.93 -37.55 -14.90 ULMN 3 1bwl_c01 NADPH DEHYDROGENASE 1 user 3 3 # 3 191 ASN A 245 ASN.? 11.79 CL CL A 278 194 HIS A 216 HIS.? 18.50 CL CL A 278 196 TYR A 217 TYR.? 13.45 CL CL A 278 coo 40.94 71.26 25.74 40.29 70.59 23.82 18.48 -33.48 -10.76 18.30 -34.93 -9.15 coo 38.86 67.47 19.31 37.78 65.73 19.79 17.97 -41.33 -12.21 17.58 -42.84 -10.82 coo 41.10 73.64 20.13 38.52 73.39 19.02 22.77 -37.42 -9.36 23.40 -34.73 -9.58 ULMN 3 1bwl_c01 NADPH DEHYDROGENASE 1 user 4 3 # 4 191 ASN A 254 ASN~? 16.17 CL CL A 278 194 HIS A 216 HIS.? 18.50 CL CL A 278 196 TYR A 217 TYR.? 13.45 CL CL A 278 coo 40.94 71.26 25.74 40.29 70.59 23.82 18.50 -38.45 -6.68 18.86 -39.34 -8.59 coo 38.86 67.47 19.31 37.78 65.73 19.79 17.97 -41.33 -12.21 17.58 -42.84 -10.82 coo 41.10 73.64 20.13 38.52 73.39 19.02 22.77 -37.42 -9.36 23.40 -34.73 -9.58 ULMN 3 1bwl_c01 NADPH DEHYDROGENASE 1 user 5 3 # 5 191 ASN B 218 ASN~? 21.19 CL CL B 278 194 HIS B 216 HIS.? 19.24 CL CL B 278 196 TYR B 217 TYR.? 13.94 CL CL B 278 coo 40.94 71.26 25.74 40.29 70.59 23.82 -17.80 2.35 -16.65 -17.00 4.26 -17.12 coo 38.86 67.47 19.31 37.78 65.73 19.79 -16.22 -3.98 -15.80 -17.90 -4.46 -16.96 coo 41.10 73.64 20.13 38.52 73.39 19.02 -12.06 -0.05 -19.78 -9.32 0.42 -19.98 ULMN 3 1bwl_c01 NADPH DEHYDROGENASE 1 user 6 3 # 6 191 ASN B 245 ASN.? 12.34 CL CL B 278 194 HIS B 216 HIS.? 19.24 CL CL B 278 196 TYR B 215 TYR.? 14.28 CL CL B 278 coo 40.94 71.26 25.74 40.29 70.59 23.82 -8.45 -4.50 -18.19 -10.06 -4.59 -19.62 coo 38.86 67.47 19.31 37.78 65.73 19.79 -16.22 -3.98 -15.80 -17.90 -4.46 -16.96 coo 41.10 73.64 20.13 38.52 73.39 19.02 -10.18 -0.68 -14.85 -11.32 1.86 -14.73 ULMN 3 1bwl_c01 NADPH DEHYDROGENASE 1 user 7 3 # 7 191 ASN B 245 ASN.? 12.34 CL CL B 278 194 HIS B 216 HIS.? 19.24 CL CL B 278 196 TYR B 217 TYR.? 13.94 CL CL B 278 coo 40.94 71.26 25.74 40.29 70.59 23.82 -8.45 -4.50 -18.19 -10.06 -4.59 -19.62 coo 38.86 67.47 19.31 37.78 65.73 19.79 -16.22 -3.98 -15.80 -17.90 -4.46 -16.96 coo 41.10 73.64 20.13 38.52 73.39 19.02 -12.06 -0.05 -19.78 -9.32 0.42 -19.98 ULMN 3 1bwl_c01 NADPH DEHYDROGENASE 1 user 8 3 # 8 191 ASN B 254 ASN~? 16.98 CL CL B 278 194 HIS B 216 HIS.? 19.24 CL CL B 278 196 TYR B 217 TYR.? 13.94 CL CL B 278 coo 40.94 71.26 25.74 40.29 70.59 23.82 -14.04 -4.32 -21.65 -14.71 -3.72 -19.71 coo 38.86 67.47 19.31 37.78 65.73 19.79 -16.22 -3.98 -15.80 -17.90 -4.46 -16.96 coo 41.10 73.64 20.13 38.52 73.39 19.02 -12.06 -0.05 -19.78 -9.32 0.42 -19.98 1bwl_c01 source 1bwl NADPH DEHYDROGENASE 1 : 8 hits 1bwl_c01 naa= 3 ULMN 3 1bwp_c01 PLATELET-ACTIVATING FACTOR ACETYLHYDuser 1 3 # 1 104 ASN A 245 ASN.? 11.79 CL CL A 278 192 ASP A 13 ASP~? 20.85 CL CL A 278 195 HIS A 12 HIS~? 14.78 CL CL A 278 coo 48.26 -8.64 25.32 50.17 -7.72 25.52 18.48 -33.48 -10.76 18.30 -34.93 -9.15 coo 56.18 0.19 32.76 56.16 -1.23 31.19 3.80 -37.83 -7.42 4.89 -38.66 -9.05 coo 56.71 -3.36 28.21 54.80 -3.08 27.37 9.03 -33.35 -4.93 10.37 -31.88 -5.56 ULMN 3 1bwp_c01 PLATELET-ACTIVATING FACTOR ACETYLHYDuser 2 3 # 2 104 ASN A 246 ASN.? 12.85 CL CL A 278 192 ASP A 168 ASP^? 12.27 CL CL A 278 195 HIS A 194 HIS.? 4.68 CL CL A 278 coo 48.26 -8.64 25.32 50.17 -7.72 25.52 12.83 -32.17 -9.87 11.11 -33.32 -9.30 coo 56.18 0.19 32.76 56.16 -1.23 31.19 26.46 -30.73 -8.22 26.92 -32.42 -9.39 coo 56.71 -3.36 28.21 54.80 -3.08 27.37 21.59 -27.03 -10.13 21.31 -25.37 -8.87 ULMN 3 1bwp_c01 PLATELET-ACTIVATING FACTOR ACETYLHYDuser 3 3 # 3 104 ASN A 254 ASN~? 16.17 CL CL A 278 192 ASP A 13 ASP~? 20.85 CL CL A 278 195 HIS A 12 HIS~? 14.78 CL CL A 278 coo 48.26 -8.64 25.32 50.17 -7.72 25.52 18.50 -38.45 -6.68 18.86 -39.34 -8.59 coo 56.18 0.19 32.76 56.16 -1.23 31.19 3.80 -37.83 -7.42 4.89 -38.66 -9.05 coo 56.71 -3.36 28.21 54.80 -3.08 27.37 9.03 -33.35 -4.93 10.37 -31.88 -5.56 ULMN 3 1bwp_c01 PLATELET-ACTIVATING FACTOR ACETYLHYDuser 4 3 # 4 104 ASN B 245 ASN.? 12.34 CL CL B 278 192 ASP B 13 ASP~? 21.13 CL CL B 278 195 HIS B 12 HIS~? 15.42 CL CL B 278 coo 48.26 -8.64 25.32 50.17 -7.72 25.52 -8.45 -4.50 -18.19 -10.06 -4.59 -19.62 coo 56.18 0.19 32.76 56.16 -1.23 31.19 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 coo 56.71 -3.36 28.21 54.80 -3.08 27.37 -10.18 -14.51 -22.80 -8.49 -13.29 -22.60 ULMN 3 1bwp_c01 PLATELET-ACTIVATING FACTOR ACETYLHYDuser 5 3 # 5 104 ASN B 246 ASN.? 13.30 CL CL B 278 192 ASP B 168 ASP^? 12.80 CL CL B 278 195 HIS B 194 HIS.? 5.13 CL CL B 278 coo 48.26 -8.64 25.32 50.17 -7.72 25.52 -7.71 -10.36 -18.40 -9.09 -11.94 -18.78 coo 56.18 0.19 32.76 56.16 -1.23 31.19 -5.42 2.81 -22.11 -6.82 3.76 -20.83 coo 56.71 -3.36 28.21 54.80 -3.08 27.37 -1.92 -2.21 -20.05 -0.53 -2.75 -21.52 ULMN 3 1bwp_c01 PLATELET-ACTIVATING FACTOR ACETYLHYDuser 6 3 # 6 104 ASN B 254 ASN~? 16.98 CL CL B 278 192 ASP B 13 ASP~? 21.13 CL CL B 278 195 HIS B 12 HIS~? 15.42 CL CL B 278 coo 48.26 -8.64 25.32 50.17 -7.72 25.52 -14.04 -4.32 -21.65 -14.71 -3.72 -19.71 coo 56.18 0.19 32.76 56.16 -1.23 31.19 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 coo 56.71 -3.36 28.21 54.80 -3.08 27.37 -10.18 -14.51 -22.80 -8.49 -13.29 -22.60 1bwp_c01 source 1bwp PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE : 6 hits 1bwp_c01 naa= 3 ULMN 3 1c2t_c02 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 1 3 # 1 A 106 ASN A 245 ASN.? 11.79 CL CL A 278 A 108 HIS A 216 HIS.? 18.50 CL CL A 278 A 144 ASP A 250 ASP~? 15.45 CL CL A 278 coo 16.88 2.43 18.09 16.20 3.65 19.72 18.48 -33.48 -10.76 18.30 -34.93 -9.15 coo 16.00 9.54 19.61 16.53 10.80 21.20 17.97 -41.33 -12.21 17.58 -42.84 -10.82 coo 20.15 8.89 19.42 18.82 8.12 20.82 15.24 -38.09 -11.21 14.62 -38.47 -13.19 ULMN 3 1c2t_c02 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 2 3 # 2 A 106 ASN A 254 ASN~? 16.17 CL CL A 278 A 108 HIS A 216 HIS.? 18.50 CL CL A 278 A 144 ASP A 250 ASP~? 15.45 CL CL A 278 coo 16.88 2.43 18.09 16.20 3.65 19.72 18.50 -38.45 -6.68 18.86 -39.34 -8.59 coo 16.00 9.54 19.61 16.53 10.80 21.20 17.97 -41.33 -12.21 17.58 -42.84 -10.82 coo 20.15 8.89 19.42 18.82 8.12 20.82 15.24 -38.09 -11.21 14.62 -38.47 -13.19 ULMN 3 1c2t_c02 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 3 3 # 3 A 106 ASN B 245 ASN.? 12.34 CL CL B 278 A 108 HIS B 216 HIS.? 19.24 CL CL B 278 A 144 ASP B 250 ASP~? 16.15 CL CL B 278 coo 16.88 2.43 18.09 16.20 3.65 19.72 -8.45 -4.50 -18.19 -10.06 -4.59 -19.62 coo 16.00 9.54 19.61 16.53 10.80 21.20 -16.22 -3.98 -15.80 -17.90 -4.46 -16.96 coo 20.15 8.89 19.42 18.82 8.12 20.82 -13.35 -7.01 -16.89 -13.59 -7.26 -14.81 ULMN 3 1c2t_c02 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 4 3 # 4 A 106 ASN B 254 ASN~? 16.98 CL CL B 278 A 108 HIS B 216 HIS.? 19.24 CL CL B 278 A 144 ASP B 250 ASP~? 16.15 CL CL B 278 coo 16.88 2.43 18.09 16.20 3.65 19.72 -14.04 -4.32 -21.65 -14.71 -3.72 -19.71 coo 16.00 9.54 19.61 16.53 10.80 21.20 -16.22 -3.98 -15.80 -17.90 -4.46 -16.96 coo 20.15 8.89 19.42 18.82 8.12 20.82 -13.35 -7.01 -16.89 -13.59 -7.26 -14.81 1c2t_c02 source 1c2t GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE : 4 hits 1c2t_c02 naa= 3 ULMN 3 1c2t_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 1 3 # 1 B 106 ASN A 245 ASN.? 11.79 CL CL A 278 B 108 HIS A 216 HIS.? 18.50 CL CL A 278 B 144 ASP A 250 ASP~? 15.45 CL CL A 278 coo 35.24 22.62 -1.00 36.98 21.40 -1.03 18.48 -33.48 -10.76 18.30 -34.93 -9.15 coo 37.11 15.55 -1.20 38.41 14.30 -0.14 17.97 -41.33 -12.21 17.58 -42.84 -10.82 coo 35.12 16.22 2.69 37.05 17.04 2.40 15.24 -38.09 -11.21 14.62 -38.47 -13.19 ULMN 3 1c2t_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 2 3 # 2 B 106 ASN A 254 ASN~? 16.17 CL CL A 278 B 108 HIS A 216 HIS.? 18.50 CL CL A 278 B 144 ASP A 250 ASP~? 15.45 CL CL A 278 coo 35.24 22.62 -1.00 36.98 21.40 -1.03 18.50 -38.45 -6.68 18.86 -39.34 -8.59 coo 37.11 15.55 -1.20 38.41 14.30 -0.14 17.97 -41.33 -12.21 17.58 -42.84 -10.82 coo 35.12 16.22 2.69 37.05 17.04 2.40 15.24 -38.09 -11.21 14.62 -38.47 -13.19 ULMN 3 1c2t_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 3 3 # 3 B 106 ASN B 245 ASN.? 12.34 CL CL B 278 B 108 HIS B 216 HIS.? 19.24 CL CL B 278 B 144 ASP B 250 ASP~? 16.15 CL CL B 278 coo 35.24 22.62 -1.00 36.98 21.40 -1.03 -8.45 -4.50 -18.19 -10.06 -4.59 -19.62 coo 37.11 15.55 -1.20 38.41 14.30 -0.14 -16.22 -3.98 -15.80 -17.90 -4.46 -16.96 coo 35.12 16.22 2.69 37.05 17.04 2.40 -13.35 -7.01 -16.89 -13.59 -7.26 -14.81 ULMN 3 1c2t_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 4 3 # 4 B 106 ASN B 254 ASN~? 16.98 CL CL B 278 B 108 HIS B 216 HIS.? 19.24 CL CL B 278 B 144 ASP B 250 ASP~? 16.15 CL CL B 278 coo 35.24 22.62 -1.00 36.98 21.40 -1.03 -14.04 -4.32 -21.65 -14.71 -3.72 -19.71 coo 37.11 15.55 -1.20 38.41 14.30 -0.14 -16.22 -3.98 -15.80 -17.90 -4.46 -16.96 coo 35.12 16.22 2.69 37.05 17.04 2.40 -13.35 -7.01 -16.89 -13.59 -7.26 -14.81 1c2t_c03 source 1c2t GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE : 4 hits 1c2t_c03 naa= 3 ULMN 3 1c82_c00 HYALURONATE LYASE user 1 3 # 1 A 349 ASN A 218 ASN~? 20.82 CL CL A 278 A 399 HIS A 216 HIS.? 18.50 CL CL A 278 A 408 TYR A 215 TYR.? 13.87 CL CL A 278 coo 11.39 -18.14 26.77 11.56 -16.76 28.37 24.13 -43.84 -11.70 26.14 -43.18 -11.76 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 17.97 -41.33 -12.21 17.58 -42.84 -10.82 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 21.62 -36.04 -14.58 23.93 -37.55 -14.90 ULMN 3 1c82_c00 HYALURONATE LYASE user 2 3 # 2 A 349 ASN A 218 ASN~? 20.82 CL CL A 278 A 399 HIS A 216 HIS.? 18.50 CL CL A 278 A 408 TYR A 217 TYR.? 13.45 CL CL A 278 coo 11.39 -18.14 26.77 11.56 -16.76 28.37 24.13 -43.84 -11.70 26.14 -43.18 -11.76 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 17.97 -41.33 -12.21 17.58 -42.84 -10.82 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 22.77 -37.42 -9.36 23.40 -34.73 -9.58 ULMN 3 1c82_c00 HYALURONATE LYASE user 3 3 # 3 A 349 ASN A 245 ASN.? 11.79 CL CL A 278 A 399 HIS A 216 HIS.? 18.50 CL CL A 278 A 408 TYR A 215 TYR.? 13.87 CL CL A 278 coo 11.39 -18.14 26.77 11.56 -16.76 28.37 18.48 -33.48 -10.76 18.30 -34.93 -9.15 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 17.97 -41.33 -12.21 17.58 -42.84 -10.82 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 21.62 -36.04 -14.58 23.93 -37.55 -14.90 ULMN 3 1c82_c00 HYALURONATE LYASE user 4 3 # 4 A 349 ASN A 245 ASN.? 11.79 CL CL A 278 A 399 HIS A 216 HIS.? 18.50 CL CL A 278 A 408 TYR A 217 TYR.? 13.45 CL CL A 278 coo 11.39 -18.14 26.77 11.56 -16.76 28.37 18.48 -33.48 -10.76 18.30 -34.93 -9.15 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 17.97 -41.33 -12.21 17.58 -42.84 -10.82 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 22.77 -37.42 -9.36 23.40 -34.73 -9.58 ULMN 3 1c82_c00 HYALURONATE LYASE user 5 3 # 5 A 349 ASN B 245 ASN.? 12.34 CL CL B 278 A 399 HIS B 216 HIS.? 19.24 CL CL B 278 A 408 TYR B 215 TYR.? 14.28 CL CL B 278 coo 11.39 -18.14 26.77 11.56 -16.76 28.37 -8.45 -4.50 -18.19 -10.06 -4.59 -19.62 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 -16.22 -3.98 -15.80 -17.90 -4.46 -16.96 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 -10.18 -0.68 -14.85 -11.32 1.86 -14.73 ULMN 3 1c82_c00 HYALURONATE LYASE user 6 3 # 6 A 349 ASN B 245 ASN.? 12.34 CL CL B 278 A 399 HIS B 216 HIS.? 19.24 CL CL B 278 A 408 TYR B 217 TYR.? 13.94 CL CL B 278 coo 11.39 -18.14 26.77 11.56 -16.76 28.37 -8.45 -4.50 -18.19 -10.06 -4.59 -19.62 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 -16.22 -3.98 -15.80 -17.90 -4.46 -16.96 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 -12.06 -0.05 -19.78 -9.32 0.42 -19.98 1c82_c00 source 1c82 HYALURONATE LYASE : 6 hits 1c82_c00 naa= 3 ULMN 3 1c82_c02 HYALURONATE LYASE user 1 3 # 1 A 399 HIS A 29 HIS.? 25.16 CL CL A 278 A 408 TYR A 26 TYR~? 18.66 CL CL A 278 A 480 ARG A 47 ARG~? 19.53 CL CL B 278 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 7.41 -38.44 3.20 5.56 -39.41 3.04 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 7.77 -31.94 1.38 10.47 -31.53 0.90 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 1.19 -18.60 0.09 1.74 -17.18 -2.58 ULMN 3 1c82_c02 HYALURONATE LYASE user 2 3 # 2 A 399 HIS A 29 HIS.? 25.16 CL CL A 278 A 408 TYR A 26 TYR~? 18.66 CL CL A 278 A 480 ARG A 192 ARG^? 5.91 CL CL A 278 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 7.41 -38.44 3.20 5.56 -39.41 3.04 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 7.77 -31.94 1.38 10.47 -31.53 0.90 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 20.84 -24.38 -4.40 19.02 -23.24 -6.62 ULMN 3 1c82_c02 HYALURONATE LYASE user 3 3 # 3 A 399 HIS A 216 HIS.? 18.50 CL CL A 278 A 408 TYR A 215 TYR.? 13.87 CL CL A 278 A 480 ARG A 140 ARG.? 3.74 CL CL A 278 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 17.97 -41.33 -12.21 17.58 -42.84 -10.82 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 21.62 -36.04 -14.58 23.93 -37.55 -14.90 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 24.77 -21.68 -10.23 22.52 -23.37 -11.49 ULMN 3 1c82_c02 HYALURONATE LYASE user 4 3 # 4 A 399 HIS A 216 HIS.? 18.50 CL CL A 278 A 408 TYR A 215 TYR.? 13.87 CL CL A 278 A 480 ARG A 209 ARG~? 8.75 CL CL A 278 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 17.97 -41.33 -12.21 17.58 -42.84 -10.82 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 21.62 -36.04 -14.58 23.93 -37.55 -14.90 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 12.19 -22.36 -19.55 12.55 -20.19 -17.38 ULMN 3 1c82_c02 HYALURONATE LYASE user 5 3 # 5 A 399 HIS A 216 HIS.? 18.50 CL CL A 278 A 408 TYR A 217 TYR.? 13.45 CL CL A 278 A 480 ARG A 140 ARG.? 3.74 CL CL A 278 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 17.97 -41.33 -12.21 17.58 -42.84 -10.82 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 22.77 -37.42 -9.36 23.40 -34.73 -9.58 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 24.77 -21.68 -10.23 22.52 -23.37 -11.49 ULMN 3 1c82_c02 HYALURONATE LYASE user 6 3 # 6 A 399 HIS B 29 HIS.? 25.42 CL CL B 278 A 408 TYR B 26 TYR~? 19.09 CL CL B 278 A 480 ARG B 47 ARG~? 19.59 CL CL A 278 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 -16.16 -16.38 -29.82 -17.24 -18.07 -29.20 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 -9.51 -16.67 -28.98 -9.06 -13.93 -28.84 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 3.13 -24.42 -28.62 4.84 -23.96 -26.11 ULMN 3 1c82_c02 HYALURONATE LYASE user 7 3 # 7 A 399 HIS B 29 HIS.? 25.42 CL CL B 278 A 408 TYR B 26 TYR~? 19.09 CL CL B 278 A 480 ARG B 192 ARG^? 6.13 CL CL B 278 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 -16.16 -16.38 -29.82 -17.24 -18.07 -29.20 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 -9.51 -16.67 -28.98 -9.06 -13.93 -28.84 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 -0.17 -3.93 -26.09 1.00 -5.48 -23.71 ULMN 3 1c82_c02 HYALURONATE LYASE user 8 3 # 8 A 399 HIS B 216 HIS.? 19.24 CL CL B 278 A 408 TYR B 215 TYR.? 14.28 CL CL B 278 A 480 ARG B 140 ARG.? -3.53 CL CL B 278s coo 13.02 -18.02 35.24 12.75 -16.25 34.15 -16.22 -3.98 -15.80 -17.90 -4.46 -16.96 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 -10.18 -0.68 -14.85 -11.32 1.86 -14.73 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 3.71 0.22 -21.03 2.09 -1.69 -19.26 ULMN 3 1c82_c02 HYALURONATE LYASE user 9 3 # 9 A 399 HIS B 216 HIS.? 19.24 CL CL B 278 A 408 TYR B 215 TYR.? 14.28 CL CL B 278 A 480 ARG B 209 ARG~? 8.42 CL CL B 278 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 -16.22 -3.98 -15.80 -17.90 -4.46 -16.96 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 -10.18 -0.68 -14.85 -11.32 1.86 -14.73 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 2.92 -11.07 -10.38 5.18 -10.70 -12.48 ULMN 3 1c82_c02 HYALURONATE LYASE user 10 3 # 10 A 399 HIS B 216 HIS.? 19.24 CL CL B 278 A 408 TYR B 217 TYR.? 13.94 CL CL B 278 A 480 ARG B 140 ARG.? -3.53 CL CL B 278s coo 13.02 -18.02 35.24 12.75 -16.25 34.15 -16.22 -3.98 -15.80 -17.90 -4.46 -16.96 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 -12.06 -0.05 -19.78 -9.32 0.42 -19.98 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 3.71 0.22 -21.03 2.09 -1.69 -19.26 1c82_c02 source 1c82 HYALURONATE LYASE : 10 hits 1c82_c02 naa= 3 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 1 3 # 1 C 14 ASP B 250 ASP~? 16.15 CL CL B 278 C 16 HIS B 216 HIS.? 19.24 CL CL B 278 C 67 GLY B 195 GLY.? 10.21 CL CL B 278 coo 10.04 44.27 88.44 9.47 42.32 89.03 -13.35 -7.01 -16.89 -13.59 -7.26 -14.81 coo 6.38 39.80 88.71 6.88 38.89 86.87 -16.22 -3.98 -15.80 -17.90 -4.46 -16.96 coo 17.63 42.50 89.25 18.11 42.29 88.64 -7.22 -0.77 -17.24 -6.51 -0.37 -17.47 1cb7_c07 source 1cb7 GLUTAMATE MUTASE : 1 hits 1cb7_c07 naa= 3 ULMN 3 1cb8_c00 CHONDROITINASE AC user 1 3 # 1 A 175 ASN A 245 ASN.? 11.79 CL CL A 278 A 225 HIS A 216 HIS.? 18.50 CL CL A 278 A 234 TYR A 217 TYR.? 13.45 CL CL A 278 coo 26.32 35.76 46.63 26.28 33.63 46.67 18.48 -33.48 -10.76 18.30 -34.93 -9.15 coo 27.04 28.61 41.75 26.86 28.65 43.84 17.97 -41.33 -12.21 17.58 -42.84 -10.82 coo 21.80 30.48 43.67 23.70 29.06 45.12 22.77 -37.42 -9.36 23.40 -34.73 -9.58 ULMN 3 1cb8_c00 CHONDROITINASE AC user 2 3 # 2 A 175 ASN B 245 ASN.? 12.34 CL CL B 278 A 225 HIS B 216 HIS.? 19.24 CL CL B 278 A 234 TYR B 217 TYR.? 13.94 CL CL B 278 coo 26.32 35.76 46.63 26.28 33.63 46.67 -8.45 -4.50 -18.19 -10.06 -4.59 -19.62 coo 27.04 28.61 41.75 26.86 28.65 43.84 -16.22 -3.98 -15.80 -17.90 -4.46 -16.96 coo 21.80 30.48 43.67 23.70 29.06 45.12 -12.06 -0.05 -19.78 -9.32 0.42 -19.98 1cb8_c00 source 1cb8 CHONDROITINASE AC : 2 hits 1cb8_c00 naa= 3 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 1 3 # 1 71 ARG A 3 ARG^? 24.49 CL CL A 278 127 ARG A 60 ARG^? 25.80 CL CL A 278 270 GLU A 34 GLU^? 8.78 CL CL A 278 coo -0.83 25.63 1.57 0.97 28.05 0.90 17.45 -29.65 8.35 18.11 -29.19 11.33 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 16.05 -25.08 10.06 15.12 -25.70 12.91 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 14.76 -23.90 -2.78 16.42 -23.89 -4.11 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 2 3 # 2 71 ARG A 60 ARG^? 25.80 CL CL A 278 127 ARG A 3 ARG^? 24.49 CL CL A 278 270 GLU A 34 GLU^? 8.78 CL CL A 278 coo -0.83 25.63 1.57 0.97 28.05 0.90 16.05 -25.08 10.06 15.12 -25.70 12.91 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 17.45 -29.65 8.35 18.11 -29.19 11.33 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 14.76 -23.90 -2.78 16.42 -23.89 -4.11 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 3 3 # 3 71 ARG A 209 ARG~? 8.75 CL CL A 278 127 ARG A 212 ARG~? 4.63 CL CL A 278 270 GLU B 74 GLU~? 12.92 CL CL A 278 coo -0.83 25.63 1.57 0.97 28.05 0.90 12.19 -22.36 -19.55 12.55 -20.19 -17.38 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 18.59 -24.77 -16.89 17.13 -22.12 -16.49 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 20.28 -11.36 -18.58 21.63 -11.86 -17.04 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 4 3 # 4 71 ARG A 212 ARG~? 4.63 CL CL A 278 127 ARG A 209 ARG~? 8.75 CL CL A 278 270 GLU B 74 GLU~? 12.92 CL CL A 278 coo -0.83 25.63 1.57 0.97 28.05 0.90 18.59 -24.77 -16.89 17.13 -22.12 -16.49 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 12.19 -22.36 -19.55 12.55 -20.19 -17.38 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 20.28 -11.36 -18.58 21.63 -11.86 -17.04 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 5 3 # 5 71 ARG B 3 ARG^? 24.44 CL CL B 278 127 ARG B 60 ARG^? 26.12 CL CL B 278 270 GLU B 34 GLU^? 8.94 CL CL B 278 coo -0.83 25.63 1.57 0.97 28.05 0.90 -7.40 -8.36 -37.36 -6.70 -7.91 -40.31 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 -3.16 -10.36 -39.52 -4.20 -11.54 -42.16 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 -0.25 -10.10 -26.69 0.15 -8.25 -25.75 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 6 3 # 6 71 ARG B 60 ARG^? 26.12 CL CL B 278 127 ARG B 3 ARG^? 24.44 CL CL B 278 270 GLU B 34 GLU^? 8.94 CL CL B 278 coo -0.83 25.63 1.57 0.97 28.05 0.90 -3.16 -10.36 -39.52 -4.20 -11.54 -42.16 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 -7.40 -8.36 -37.36 -6.70 -7.91 -40.31 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 -0.25 -10.10 -26.69 0.15 -8.25 -25.75 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 7 3 # 7 71 ARG B 209 ARG~? 8.42 CL CL B 278 127 ARG B 212 ARG~? 4.30 CL CL B 278 270 GLU A 74 GLU~? 12.23 CL CL B 278 coo -0.83 25.63 1.57 0.97 28.05 0.90 2.92 -11.07 -10.38 5.18 -10.70 -12.48 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 1.13 -4.70 -13.40 3.58 -6.46 -14.00 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 14.45 -4.40 -13.52 13.94 -3.10 -15.11 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 8 3 # 8 71 ARG B 212 ARG~? 4.30 CL CL B 278 127 ARG B 209 ARG~? 8.42 CL CL B 278 270 GLU A 74 GLU~? 12.23 CL CL B 278 coo -0.83 25.63 1.57 0.97 28.05 0.90 1.13 -4.70 -13.40 3.58 -6.46 -14.00 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 2.92 -11.07 -10.38 5.18 -10.70 -12.48 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 14.45 -4.40 -13.52 13.94 -3.10 -15.11 1cbx_c01 source 1cbx CARBOXYPEPTIDASE A (E.C.3.4.17.1) COMPLEX WITH: 8 hits 1cbx_c01 naa= 3 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 1 3 # 1 A 232 HIS A 128 HIS~? 28.74 CL CL A 278 A 262 GLU A 83 GLU~? 26.70 CL CL B 278 A 358 GLU A 82 GLU~? 22.17 CL CL B 278 coo 26.19 60.87 43.98 27.48 59.27 43.30 23.83 -2.68 5.16 23.03 -1.15 6.34 coo 27.13 54.07 50.45 26.96 54.19 48.35 17.51 1.49 1.14 18.83 0.42 2.44 coo 27.06 50.43 44.36 27.99 52.27 44.74 18.08 -1.27 -4.95 20.15 -1.66 -5.22 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 2 3 # 2 A 232 HIS B 128 HIS~? 28.44 CL CL B 278 A 262 GLU B 83 GLU~? 26.47 CL CL A 278 A 358 GLU B 82 GLU~? 22.63 CL CL A 278 coo 26.19 60.87 43.98 27.48 59.27 43.30 20.44 -4.42 -38.33 21.74 -5.60 -39.48 coo 27.13 54.07 50.45 26.96 54.19 48.35 24.57 -10.93 -33.84 23.46 -9.16 -34.20 coo 27.06 50.43 44.36 27.99 52.27 44.74 22.63 -9.38 -27.83 22.57 -7.28 -27.71 1chm_c00 source 1chm CREATINE AMIDINOHYDROLASE (E.C.3.5.3.3) : 2 hits 1chm_c00 naa= 3 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 1 3 # 1 B 232 HIS A 128 HIS~? 28.74 CL CL A 278 B 262 GLU A 83 GLU~? 26.70 CL CL B 278 B 358 GLU A 82 GLU~? 22.17 CL CL B 278 coo 44.98 77.01 48.39 44.42 78.67 47.18 23.83 -2.68 5.16 23.03 -1.15 6.34 coo 41.60 83.57 54.16 42.46 83.24 52.25 17.51 1.49 1.14 18.83 0.42 2.44 coo 44.05 87.61 48.73 43.15 85.67 48.52 18.08 -1.27 -4.95 20.15 -1.66 -5.22 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 2 3 # 2 B 232 HIS B 128 HIS~? 28.44 CL CL B 278 B 262 GLU B 83 GLU~? 26.47 CL CL A 278 B 358 GLU B 82 GLU~? 22.63 CL CL A 278 coo 44.98 77.01 48.39 44.42 78.67 47.18 20.44 -4.42 -38.33 21.74 -5.60 -39.48 coo 41.60 83.57 54.16 42.46 83.24 52.25 24.57 -10.93 -33.84 23.46 -9.16 -34.20 coo 44.05 87.61 48.73 43.15 85.67 48.52 22.63 -9.38 -27.83 22.57 -7.28 -27.71 1chm_c01 source 1chm CREATINE AMIDINOHYDROLASE (E.C.3.5.3.3) : 2 hits 1chm_c01 naa= 3 ULMN 3 1cms_c04 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 1 3 # 1 34 ASP A 268 ASP.? 26.73 CL CL A 278 37 SER A 28 SER.? 27.02 CL CL A 278 216 ASP A 267 ASP.? 31.09 CL CL A 278 coo 16.90 26.20 29.49 16.22 24.50 28.41 9.60 -34.57 10.49 9.97 -36.28 9.26 coo 12.23 24.31 30.40 14.55 23.96 31.03 6.29 -36.11 7.11 4.57 -37.31 5.85 coo 13.93 25.52 22.10 14.75 24.44 23.75 11.77 -37.21 15.47 13.23 -35.63 15.60 ULMN 3 1cms_c04 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 2 3 # 2 34 ASP B 268 ASP.? 26.26 CL CL B 278 37 SER B 28 SER.? 27.87 CL CL B 278 216 ASP B 267 ASP.? 32.55 CL CL B 278 coo 16.90 26.20 29.49 16.22 24.50 28.41 -14.31 -16.11 -36.83 -14.03 -14.11 -36.24 coo 12.23 24.31 30.40 14.55 23.96 31.03 -14.66 -18.25 -33.71 -14.43 -20.67 -33.62 coo 13.93 25.52 22.10 14.75 24.44 23.75 -15.25 -13.37 -42.11 -14.97 -14.80 -43.57 1cms_c04 source 1cms CHYMOSIN B (FORMERLY KNOWN AS RENNIN) (E.C.3.4: 2 hits 1cms_c04 naa= 3 ULMN 3 1cns_c00 CHITINASE user 1 3 # 1 A 67 GLU A 74 GLU~? 12.23 CL CL B 278 A 89 GLU A 82 GLU~? 22.17 CL CL B 278 A 120 SER A 70 SER.? 11.73 CL CL A 278 coo -24.35 9.53 67.64 -25.07 11.29 68.60 14.45 -4.40 -13.52 13.94 -3.10 -15.11 coo -31.18 6.91 75.60 -32.39 8.51 74.91 18.08 -1.27 -4.95 20.15 -1.66 -5.22 coo -34.73 8.57 68.21 -33.63 9.08 70.28 19.33 -11.34 -7.00 17.75 -13.05 -7.65 ULMN 3 1cns_c00 CHITINASE user 2 3 # 2 A 67 GLU A 74 GLU~? 12.23 CL CL B 278 A 89 GLU B 74 GLU~? 12.92 CL CL A 278 A 120 SER B 67 SER.? 13.79 CL CL B 278 coo -24.35 9.53 67.64 -25.07 11.29 68.60 14.45 -4.40 -13.52 13.94 -3.10 -15.11 coo -31.18 6.91 75.60 -32.39 8.51 74.91 20.28 -11.36 -18.58 21.63 -11.86 -17.04 coo -34.73 8.57 68.21 -33.63 9.08 70.28 12.14 -11.19 -22.93 12.67 -12.95 -21.38 ULMN 3 1cns_c00 CHITINASE user 3 3 # 3 A 67 GLU A 82 GLU~? 22.17 CL CL B 278 A 89 GLU A 74 GLU~? 12.23 CL CL B 278 A 120 SER A 67 SER.? 14.21 CL CL A 278 coo -24.35 9.53 67.64 -25.07 11.29 68.60 18.08 -1.27 -4.95 20.15 -1.66 -5.22 coo -31.18 6.91 75.60 -32.39 8.51 74.91 14.45 -4.40 -13.52 13.94 -3.10 -15.11 coo -34.73 8.57 68.21 -33.63 9.08 70.28 14.35 -11.91 -8.16 12.43 -11.38 -9.50 ULMN 3 1cns_c00 CHITINASE user 4 3 # 4 A 67 GLU A 207 GLU~? 15.26 CL CL A 278 A 89 GLU B 46 GLU~? 24.28 CL CL A 278 A 120 SER B 92 SER~? 22.36 CL CL A 278 coo -24.35 9.53 67.64 -25.07 11.29 68.60 13.18 -27.21 -26.28 11.29 -26.78 -25.35 coo -31.18 6.91 75.60 -32.39 8.51 74.91 7.71 -28.83 -35.20 9.60 -28.18 -34.47 coo -34.73 8.57 68.21 -33.63 9.08 70.28 10.76 -20.18 -34.61 9.57 -19.95 -32.48 ULMN 3 1cns_c00 CHITINASE user 5 3 # 5 A 67 GLU B 74 GLU~? 12.92 CL CL A 278 A 89 GLU A 74 GLU~? 12.23 CL CL B 278 A 120 SER A 67 SER.? 14.21 CL CL A 278 coo -24.35 9.53 67.64 -25.07 11.29 68.60 20.28 -11.36 -18.58 21.63 -11.86 -17.04 coo -31.18 6.91 75.60 -32.39 8.51 74.91 14.45 -4.40 -13.52 13.94 -3.10 -15.11 coo -34.73 8.57 68.21 -33.63 9.08 70.28 14.35 -11.91 -8.16 12.43 -11.38 -9.50 ULMN 3 1cns_c00 CHITINASE user 6 3 # 6 A 67 GLU B 82 GLU~? 22.63 CL CL A 278 A 89 GLU B 74 GLU~? 12.92 CL CL A 278 A 120 SER B 67 SER.? 13.79 CL CL B 278 coo -24.35 9.53 67.64 -25.07 11.29 68.60 22.63 -9.38 -27.83 22.57 -7.28 -27.71 coo -31.18 6.91 75.60 -32.39 8.51 74.91 20.28 -11.36 -18.58 21.63 -11.86 -17.04 coo -34.73 8.57 68.21 -33.63 9.08 70.28 12.14 -11.19 -22.93 12.67 -12.95 -21.38 ULMN 3 1cns_c00 CHITINASE user 7 3 # 7 A 67 GLU B 207 GLU~? 15.42 CL CL B 278 A 89 GLU A 46 GLU~? 24.48 CL CL B 278 A 120 SER A 92 SER~? 22.12 CL CL B 278 coo -24.35 9.53 67.64 -25.07 11.29 68.60 -0.89 -8.41 -2.97 -0.49 -10.43 -3.58 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -1.94 -12.84 6.51 -1.20 -10.99 5.75 coo -34.73 8.57 68.21 -33.63 9.08 70.28 6.98 -10.92 4.56 6.84 -12.34 2.56 ULMN 3 1cns_c00 CHITINASE user 8 3 # 8 A 67 GLU B 227 GLU~? 26.46 CL CL B 278 A 89 GLU B 235 GLU.? 26.01 CL CL B 278 A 120 SER B 233 SER~? 25.59 CL CL B 278 coo -24.35 9.53 67.64 -25.07 11.29 68.60 -14.61 9.61 -30.38 -15.43 11.23 -29.27 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -5.56 9.78 -39.05 -4.91 10.76 -37.29 coo -34.73 8.57 68.21 -33.63 9.08 70.28 -8.72 4.06 -38.15 -11.10 4.13 -37.70 1cns_c00 source 1cns CHITINASE : 8 hits 1cns_c00 naa= 3 ULMN 3 1cns_c01 CHITINASE user 1 3 # 1 B 67 GLU A 74 GLU~? 12.23 CL CL B 278 B 89 GLU A 82 GLU~? 22.17 CL CL B 278 B 120 SER A 70 SER.? 11.73 CL CL A 278 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 14.45 -4.40 -13.52 13.94 -3.10 -15.11 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 18.08 -1.27 -4.95 20.15 -1.66 -5.22 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 19.33 -11.34 -7.00 17.75 -13.05 -7.65 ULMN 3 1cns_c01 CHITINASE user 2 3 # 2 B 67 GLU A 74 GLU~? 12.23 CL CL B 278 B 89 GLU B 74 GLU~? 12.92 CL CL A 278 B 120 SER B 67 SER.? 13.79 CL CL B 278 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 14.45 -4.40 -13.52 13.94 -3.10 -15.11 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 20.28 -11.36 -18.58 21.63 -11.86 -17.04 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 12.14 -11.19 -22.93 12.67 -12.95 -21.38 ULMN 3 1cns_c01 CHITINASE user 3 3 # 3 B 67 GLU A 74 GLU~? 12.23 CL CL B 278 B 89 GLU B 74 GLU~? 12.92 CL CL A 278 B 120 SER B 70 SER.? 11.46 CL CL B 278 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 14.45 -4.40 -13.52 13.94 -3.10 -15.11 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 20.28 -11.36 -18.58 21.63 -11.86 -17.04 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 13.00 -6.56 -24.86 11.13 -7.93 -24.10 ULMN 3 1cns_c01 CHITINASE user 4 3 # 4 B 67 GLU A 82 GLU~? 22.17 CL CL B 278 B 89 GLU A 74 GLU~? 12.23 CL CL B 278 B 120 SER A 67 SER.? 14.21 CL CL A 278 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 18.08 -1.27 -4.95 20.15 -1.66 -5.22 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 14.45 -4.40 -13.52 13.94 -3.10 -15.11 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 14.35 -11.91 -8.16 12.43 -11.38 -9.50 ULMN 3 1cns_c01 CHITINASE user 5 3 # 5 B 67 GLU A 82 GLU~? 22.17 CL CL B 278 B 89 GLU A 74 GLU~? 12.23 CL CL B 278 B 120 SER A 70 SER.? 11.73 CL CL A 278 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 18.08 -1.27 -4.95 20.15 -1.66 -5.22 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 14.45 -4.40 -13.52 13.94 -3.10 -15.11 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 19.33 -11.34 -7.00 17.75 -13.05 -7.65 ULMN 3 1cns_c01 CHITINASE user 6 3 # 6 B 67 GLU A 207 GLU~? 15.26 CL CL A 278 B 89 GLU B 46 GLU~? 24.28 CL CL A 278 B 120 SER B 92 SER~? 22.36 CL CL A 278 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 13.18 -27.21 -26.28 11.29 -26.78 -25.35 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 7.71 -28.83 -35.20 9.60 -28.18 -34.47 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 10.76 -20.18 -34.61 9.57 -19.95 -32.48 ULMN 3 1cns_c01 CHITINASE user 7 3 # 7 B 67 GLU B 74 GLU~? 12.92 CL CL A 278 B 89 GLU A 74 GLU~? 12.23 CL CL B 278 B 120 SER A 67 SER.? 14.21 CL CL A 278 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 20.28 -11.36 -18.58 21.63 -11.86 -17.04 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 14.45 -4.40 -13.52 13.94 -3.10 -15.11 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 14.35 -11.91 -8.16 12.43 -11.38 -9.50 ULMN 3 1cns_c01 CHITINASE user 8 3 # 8 B 67 GLU B 74 GLU~? 12.92 CL CL A 278 B 89 GLU A 74 GLU~? 12.23 CL CL B 278 B 120 SER A 70 SER.? 11.73 CL CL A 278 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 20.28 -11.36 -18.58 21.63 -11.86 -17.04 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 14.45 -4.40 -13.52 13.94 -3.10 -15.11 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 19.33 -11.34 -7.00 17.75 -13.05 -7.65 ULMN 3 1cns_c01 CHITINASE user 9 3 # 9 B 67 GLU B 74 GLU~? 12.92 CL CL A 278 B 89 GLU B 82 GLU~? 22.63 CL CL A 278 B 120 SER B 70 SER.? 11.46 CL CL B 278 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 20.28 -11.36 -18.58 21.63 -11.86 -17.04 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 22.63 -9.38 -27.83 22.57 -7.28 -27.71 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 13.00 -6.56 -24.86 11.13 -7.93 -24.10 ULMN 3 1cns_c01 CHITINASE user 10 3 # 10 B 67 GLU B 82 GLU~? 22.63 CL CL A 278 B 89 GLU B 74 GLU~? 12.92 CL CL A 278 B 120 SER B 67 SER.? 13.79 CL CL B 278 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 22.63 -9.38 -27.83 22.57 -7.28 -27.71 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 20.28 -11.36 -18.58 21.63 -11.86 -17.04 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 12.14 -11.19 -22.93 12.67 -12.95 -21.38 ULMN 3 1cns_c01 CHITINASE user 11 3 # 11 B 67 GLU B 82 GLU~? 22.63 CL CL A 278 B 89 GLU B 74 GLU~? 12.92 CL CL A 278 B 120 SER B 70 SER.? 11.46 CL CL B 278 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 22.63 -9.38 -27.83 22.57 -7.28 -27.71 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 20.28 -11.36 -18.58 21.63 -11.86 -17.04 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 13.00 -6.56 -24.86 11.13 -7.93 -24.10 ULMN 3 1cns_c01 CHITINASE user 12 3 # 12 B 67 GLU B 207 GLU~? 15.42 CL CL B 278 B 89 GLU A 46 GLU~? 24.48 CL CL B 278 B 120 SER A 92 SER~? 22.12 CL CL B 278 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 -0.89 -8.41 -2.97 -0.49 -10.43 -3.58 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 -1.94 -12.84 6.51 -1.20 -10.99 5.75 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 6.98 -10.92 4.56 6.84 -12.34 2.56 1cns_c01 source 1cns CHITINASE : 12 hits 1cns_c01 naa= 3 ULMN 3 1coy_c00 CHOLESTEROL OXIDASE (E.C.1.1.3.6) COuser 1 3 # 1 361 GLU A 34 GLU^? 8.78 CL CL A 278 447 HIS A 194 HIS.? 4.68 CL CL A 278 485 ASN A 244 ASN.? 5.40 CL CL A 278 coo -7.99 19.51 30.67 -8.74 17.98 29.42 14.76 -23.90 -2.78 16.42 -23.89 -4.11 coo -15.81 17.12 25.99 -13.91 16.92 26.88 21.59 -27.03 -10.13 21.31 -25.37 -8.87 coo -13.17 13.85 30.36 -11.76 15.41 30.53 17.85 -28.42 -8.05 16.64 -26.87 -8.84 ULMN 3 1coy_c00 CHOLESTEROL OXIDASE (E.C.1.1.3.6) COuser 2 3 # 2 361 GLU B 34 GLU^? 8.94 CL CL B 278 447 HIS B 194 HIS.? 5.13 CL CL B 278 485 ASN B 244 ASN.? 5.94 CL CL B 278 coo -7.99 19.51 30.67 -8.74 17.98 29.42 -0.25 -10.10 -26.69 0.15 -8.25 -25.75 coo -15.81 17.12 25.99 -13.91 16.92 26.88 -1.92 -2.21 -20.05 -0.53 -2.75 -21.52 coo -13.17 13.85 30.36 -11.76 15.41 30.53 -3.88 -6.12 -21.35 -2.47 -7.43 -20.48 ULMN 3 1coy_c00 CHOLESTEROL OXIDASE (E.C.1.1.3.6) COuser 3 3 # 3 361 GLU B 221 GLU~? 17.56 CL CL B 278 447 HIS B 216 HIS.? 19.24 CL CL B 278 485 ASN B 254 ASN~? 16.98 CL CL B 278 coo -7.99 19.51 30.67 -8.74 17.98 29.42 -13.90 4.76 -18.50 -13.25 3.58 -16.87 coo -15.81 17.12 25.99 -13.91 16.92 26.88 -16.22 -3.98 -15.80 -17.90 -4.46 -16.96 coo -13.17 13.85 30.36 -11.76 15.41 30.53 -14.04 -4.32 -21.65 -14.71 -3.72 -19.71 1coy_c00 source 1coy CHOLESTEROL OXIDASE (E.C.1.1.3.6) COMPLEX WITH: 3 hits 1coy_c00 naa= 3 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 101 TYR A 40 TYR~? 11.37 CL CL A 278 A 173 ASP A 36 ASP~? 8.69 CL CL A 278 C 48 ARG B 209 ARG~? 8.42 CL CL B 278 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 8.64 -16.83 -9.73 10.24 -18.83 -10.81 coo 24.35 4.55 25.11 25.94 3.23 25.53 11.67 -20.98 -6.16 13.43 -22.16 -5.96 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 2.92 -11.07 -10.38 5.18 -10.70 -12.48 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 101 TYR B 40 TYR~? 11.18 CL CL B 278 A 173 ASP B 36 ASP~? 8.83 CL CL B 278 C 48 ARG A 209 ARG~? 8.75 CL CL A 278 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 6.88 -16.14 -20.02 5.01 -14.26 -19.13 coo 24.35 4.55 25.11 25.94 3.23 25.53 2.64 -13.17 -23.36 1.59 -11.35 -23.67 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 12.19 -22.36 -19.55 12.55 -20.19 -17.38 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 101 TYR B 40 TYR~? 11.18 CL CL B 278 A 173 ASP B 36 ASP~? 8.83 CL CL B 278 C 48 ARG B 209 ARG~? 8.42 CL CL B 278 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 6.88 -16.14 -20.02 5.01 -14.26 -19.13 coo 24.35 4.55 25.11 25.94 3.23 25.53 2.64 -13.17 -23.36 1.59 -11.35 -23.67 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 2.92 -11.07 -10.38 5.18 -10.70 -12.48 1cs1_c00 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1cs1_c00 naa= 3 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 48 ARG A 209 ARG~? 8.75 CL CL A 278 C 101 TYR B 40 TYR~? 11.18 CL CL B 278 C 173 ASP B 36 ASP~? 8.83 CL CL B 278 coo 32.27 5.62 48.15 31.93 6.48 51.06 12.19 -22.36 -19.55 12.55 -20.19 -17.38 coo 29.64 3.64 57.39 31.22 5.14 55.65 6.88 -16.14 -20.02 5.01 -14.26 -19.13 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 2.64 -13.17 -23.36 1.59 -11.35 -23.67 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 48 ARG B 209 ARG~? 8.42 CL CL B 278 C 101 TYR A 40 TYR~? 11.37 CL CL A 278 C 173 ASP A 36 ASP~? 8.69 CL CL A 278 coo 32.27 5.62 48.15 31.93 6.48 51.06 2.92 -11.07 -10.38 5.18 -10.70 -12.48 coo 29.64 3.64 57.39 31.22 5.14 55.65 8.64 -16.83 -9.73 10.24 -18.83 -10.81 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 11.67 -20.98 -6.16 13.43 -22.16 -5.96 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 48 ARG B 209 ARG~? 8.42 CL CL B 278 C 101 TYR B 40 TYR~? 11.18 CL CL B 278 C 173 ASP B 36 ASP~? 8.83 CL CL B 278 coo 32.27 5.62 48.15 31.93 6.48 51.06 2.92 -11.07 -10.38 5.18 -10.70 -12.48 coo 29.64 3.64 57.39 31.22 5.14 55.65 6.88 -16.14 -20.02 5.01 -14.26 -19.13 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 2.64 -13.17 -23.36 1.59 -11.35 -23.67 1cs1_c01 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1cs1_c01 naa= 3 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 48 ARG A 209 ARG~? 8.75 CL CL A 278 D 101 TYR B 40 TYR~? 11.18 CL CL B 278 D 173 ASP B 36 ASP~? 8.83 CL CL B 278 coo 69.08 8.58 32.60 69.70 10.81 30.58 12.19 -22.36 -19.55 12.55 -20.19 -17.38 coo 71.77 11.86 24.26 70.23 12.22 26.56 6.88 -16.14 -20.02 5.01 -14.26 -19.13 coo 71.60 6.14 19.25 70.26 6.87 20.69 2.64 -13.17 -23.36 1.59 -11.35 -23.67 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 48 ARG B 209 ARG~? 8.42 CL CL B 278 D 101 TYR A 40 TYR~? 11.37 CL CL A 278 D 173 ASP A 36 ASP~? 8.69 CL CL A 278 coo 69.08 8.58 32.60 69.70 10.81 30.58 2.92 -11.07 -10.38 5.18 -10.70 -12.48 coo 71.77 11.86 24.26 70.23 12.22 26.56 8.64 -16.83 -9.73 10.24 -18.83 -10.81 coo 71.60 6.14 19.25 70.26 6.87 20.69 11.67 -20.98 -6.16 13.43 -22.16 -5.96 1cs1_c02 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1cs1_c02 naa= 3 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 101 TYR A 40 TYR~? 11.37 CL CL A 278 B 173 ASP A 36 ASP~? 8.69 CL CL A 278 D 48 ARG A 209 ARG~? 8.75 CL CL A 278 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 8.64 -16.83 -9.73 10.24 -18.83 -10.81 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 11.67 -20.98 -6.16 13.43 -22.16 -5.96 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 12.19 -22.36 -19.55 12.55 -20.19 -17.38 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 101 TYR A 40 TYR~? 11.37 CL CL A 278 B 173 ASP A 36 ASP~? 8.69 CL CL A 278 D 48 ARG B 209 ARG~? 8.42 CL CL B 278 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 8.64 -16.83 -9.73 10.24 -18.83 -10.81 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 11.67 -20.98 -6.16 13.43 -22.16 -5.96 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 2.92 -11.07 -10.38 5.18 -10.70 -12.48 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 101 TYR A 215 TYR.? 13.87 CL CL A 278 B 173 ASP A 168 ASP^? 12.27 CL CL A 278 D 48 ARG A 212 ARG~? 4.63 CL CL A 278 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 21.62 -36.04 -14.58 23.93 -37.55 -14.90 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 26.46 -30.73 -8.22 26.92 -32.42 -9.39 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 18.59 -24.77 -16.89 17.13 -22.12 -16.49 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 B 101 TYR A 215 TYR.? 13.87 CL CL A 278 B 173 ASP A 250 ASP~? 15.45 CL CL A 278 D 48 ARG A 212 ARG~? 4.63 CL CL A 278 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 21.62 -36.04 -14.58 23.93 -37.55 -14.90 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 15.24 -38.09 -11.21 14.62 -38.47 -13.19 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 18.59 -24.77 -16.89 17.13 -22.12 -16.49 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 B 101 TYR B 40 TYR~? 11.18 CL CL B 278 B 173 ASP B 36 ASP~? 8.83 CL CL B 278 D 48 ARG A 209 ARG~? 8.75 CL CL A 278 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 6.88 -16.14 -20.02 5.01 -14.26 -19.13 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 2.64 -13.17 -23.36 1.59 -11.35 -23.67 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 12.19 -22.36 -19.55 12.55 -20.19 -17.38 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 B 101 TYR B 40 TYR~? 11.18 CL CL B 278 B 173 ASP B 36 ASP~? 8.83 CL CL B 278 D 48 ARG B 209 ARG~? 8.42 CL CL B 278 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 6.88 -16.14 -20.02 5.01 -14.26 -19.13 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 2.64 -13.17 -23.36 1.59 -11.35 -23.67 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 2.92 -11.07 -10.38 5.18 -10.70 -12.48 1cs1_c03 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 6 hits 1cs1_c03 naa= 3 ULMN 3 1ct9_c04 ASPARAGINE SYNTHETASE B user 1 3 # 1 A 1 ALA A 198 ALA.? 14.21 CL CL A 278 A 74 ASN A 197 ASN.? 12.86 CL CL A 278 A 75 GLY A 195 GLY.? 9.62 CL CL A 278 coo -1.80 62.71 122.76 -1.88 63.70 123.92 26.04 -31.95 -20.22 27.48 -32.27 -19.92 coo 1.20 66.40 122.20 2.03 64.53 121.46 21.52 -32.98 -18.45 20.55 -33.92 -20.09 coo 4.68 65.84 125.52 4.11 65.60 126.05 22.19 -32.71 -12.39 22.72 -32.07 -12.32 ULMN 3 1ct9_c04 ASPARAGINE SYNTHETASE B user 2 3 # 2 A 1 ALA A 198 ALA.? 14.21 CL CL A 278 A 74 ASN A 197 ASN.? 12.86 CL CL A 278 A 75 GLY A 200 GLY.? 15.16 CL CL A 278 coo -1.80 62.71 122.76 -1.88 63.70 123.92 26.04 -31.95 -20.22 27.48 -32.27 -19.92 coo 1.20 66.40 122.20 2.03 64.53 121.46 21.52 -32.98 -18.45 20.55 -33.92 -20.09 coo 4.68 65.84 125.52 4.11 65.60 126.05 21.66 -32.83 -24.27 22.35 -32.33 -24.28 ULMN 3 1ct9_c04 ASPARAGINE SYNTHETASE B user 3 3 # 3 A 1 ALA A 251 ALA~? 12.40 CL CL A 278 A 74 ASN A 245 ASN.? 11.79 CL CL A 278 A 75 GLY A 195 GLY.? 9.62 CL CL A 278 coo -1.80 62.71 122.76 -1.88 63.70 123.92 14.98 -35.41 -7.43 14.47 -33.98 -7.30 coo 1.20 66.40 122.20 2.03 64.53 121.46 18.48 -33.48 -10.76 18.30 -34.93 -9.15 coo 4.68 65.84 125.52 4.11 65.60 126.05 22.19 -32.71 -12.39 22.72 -32.07 -12.32 ULMN 3 1ct9_c04 ASPARAGINE SYNTHETASE B user 4 3 # 4 A 1 ALA A 251 ALA~? 12.40 CL CL A 278 A 74 ASN A 246 ASN.? 12.85 CL CL A 278 A 75 GLY A 248 GLY.? 14.14 CL CL A 278 coo -1.80 62.71 122.76 -1.88 63.70 123.92 14.98 -35.41 -7.43 14.47 -33.98 -7.30 coo 1.20 66.40 122.20 2.03 64.53 121.46 12.83 -32.17 -9.87 11.11 -33.32 -9.30 coo 4.68 65.84 125.52 4.11 65.60 126.05 12.18 -35.81 -15.03 12.11 -35.46 -14.29 ULMN 3 1ct9_c04 ASPARAGINE SYNTHETASE B user 5 3 # 5 A 1 ALA A 251 ALA~? 12.40 CL CL A 278 A 74 ASN A 246 ASN.? 12.85 CL CL A 278 A 75 GLY A 249 GLY.? 14.98 CL CL A 278 coo -1.80 62.71 122.76 -1.88 63.70 123.92 14.98 -35.41 -7.43 14.47 -33.98 -7.30 coo 1.20 66.40 122.20 2.03 64.53 121.46 12.83 -32.17 -9.87 11.11 -33.32 -9.30 coo 4.68 65.84 125.52 4.11 65.60 126.05 10.85 -36.22 -11.47 11.63 -36.38 -11.65 ULMN 3 1ct9_c04 ASPARAGINE SYNTHETASE B user 6 3 # 6 A 1 ALA B 198 ALA.? 14.47 CL CL B 278 A 74 ASN B 197 ASN.? 13.10 CL CL B 278 A 75 GLY B 195 GLY.? 10.21 CL CL B 278 coo -1.80 62.71 122.76 -1.88 63.70 123.92 -5.00 4.00 -10.23 -5.24 5.42 -10.67 coo 1.20 66.40 122.20 2.03 64.53 121.46 -6.63 -0.56 -11.26 -7.23 -1.17 -9.32 coo 4.68 65.84 125.52 4.11 65.60 126.05 -7.22 -0.77 -17.24 -6.51 -0.37 -17.47 ULMN 3 1ct9_c04 ASPARAGINE SYNTHETASE B user 7 3 # 7 A 1 ALA B 198 ALA.? 14.47 CL CL B 278 A 74 ASN B 197 ASN.? 13.10 CL CL B 278 A 75 GLY B 200 GLY.? 15.32 CL CL B 278 coo -1.80 62.71 122.76 -1.88 63.70 123.92 -5.00 4.00 -10.23 -5.24 5.42 -10.67 coo 1.20 66.40 122.20 2.03 64.53 121.46 -6.63 -0.56 -11.26 -7.23 -1.17 -9.32 coo 4.68 65.84 125.52 4.11 65.60 126.05 -5.78 0.30 -5.65 -5.20 0.90 -5.77 ULMN 3 1ct9_c04 ASPARAGINE SYNTHETASE B user 8 3 # 8 A 1 ALA B 251 ALA~? 13.13 CL CL B 278 A 74 ASN B 245 ASN.? 12.34 CL CL B 278 A 75 GLY B 195 GLY.? 10.21 CL CL B 278 coo -1.80 62.71 122.76 -1.88 63.70 123.92 -11.21 -8.27 -20.82 -9.88 -9.02 -21.02 coo 1.20 66.40 122.20 2.03 64.53 121.46 -8.45 -4.50 -18.19 -10.06 -4.59 -19.62 coo 4.68 65.84 125.52 4.11 65.60 126.05 -7.22 -0.77 -17.24 -6.51 -0.37 -17.47 ULMN 3 1ct9_c04 ASPARAGINE SYNTHETASE B user 9 3 # 9 A 1 ALA B 251 ALA~? 13.13 CL CL B 278 A 74 ASN B 246 ASN.? 13.30 CL CL B 278 A 75 GLY B 248 GLY.? 14.76 CL CL B 278 coo -1.80 62.71 122.76 -1.88 63.70 123.92 -11.21 -8.27 -20.82 -9.88 -9.02 -21.02 coo 1.20 66.40 122.20 2.03 64.53 121.46 -7.71 -10.36 -18.40 -9.09 -11.94 -18.78 coo 4.68 65.84 125.52 4.11 65.60 126.05 -10.88 -9.81 -12.81 -10.61 -10.09 -13.55 ULMN 3 1ct9_c04 ASPARAGINE SYNTHETASE B user 10 3 # 10 A 1 ALA B 251 ALA~? 13.13 CL CL B 278 A 74 ASN B 246 ASN.? 13.30 CL CL B 278 A 75 GLY B 249 GLY.? 15.61 CL CL B 278 coo -1.80 62.71 122.76 -1.88 63.70 123.92 -11.21 -8.27 -20.82 -9.88 -9.02 -21.02 coo 1.20 66.40 122.20 2.03 64.53 121.46 -7.71 -10.36 -18.40 -9.09 -11.94 -18.78 coo 4.68 65.84 125.52 4.11 65.60 126.05 -11.90 -11.51 -16.09 -11.99 -10.68 -16.03 1ct9_c04 source 1ct9 ASPARAGINE SYNTHETASE B : 10 hits 1ct9_c04 naa= 3 ULMN 3 1ct9_c05 ASPARAGINE SYNTHETASE B user 1 3 # 1 B 1 ALA A 198 ALA.? 14.21 CL CL A 278 B 74 ASN A 197 ASN.? 12.86 CL CL A 278 B 75 GLY A 195 GLY.? 9.62 CL CL A 278 coo 39.21 14.97 27.55 40.19 16.01 27.08 26.04 -31.95 -20.22 27.48 -32.27 -19.92 coo 43.06 12.94 25.74 42.26 11.81 27.44 21.52 -32.98 -18.45 20.55 -33.92 -20.09 coo 46.38 13.54 29.18 46.14 14.29 29.26 22.19 -32.71 -12.39 22.72 -32.07 -12.32 ULMN 3 1ct9_c05 ASPARAGINE SYNTHETASE B user 2 3 # 2 B 1 ALA A 198 ALA.? 14.21 CL CL A 278 B 74 ASN A 197 ASN.? 12.86 CL CL A 278 B 75 GLY A 200 GLY.? 15.16 CL CL A 278 coo 39.21 14.97 27.55 40.19 16.01 27.08 26.04 -31.95 -20.22 27.48 -32.27 -19.92 coo 43.06 12.94 25.74 42.26 11.81 27.44 21.52 -32.98 -18.45 20.55 -33.92 -20.09 coo 46.38 13.54 29.18 46.14 14.29 29.26 21.66 -32.83 -24.27 22.35 -32.33 -24.28 ULMN 3 1ct9_c05 ASPARAGINE SYNTHETASE B user 3 3 # 3 B 1 ALA A 251 ALA~? 12.40 CL CL A 278 B 74 ASN A 245 ASN.? 11.79 CL CL A 278 B 75 GLY A 195 GLY.? 9.62 CL CL A 278 coo 39.21 14.97 27.55 40.19 16.01 27.08 14.98 -35.41 -7.43 14.47 -33.98 -7.30 coo 43.06 12.94 25.74 42.26 11.81 27.44 18.48 -33.48 -10.76 18.30 -34.93 -9.15 coo 46.38 13.54 29.18 46.14 14.29 29.26 22.19 -32.71 -12.39 22.72 -32.07 -12.32 ULMN 3 1ct9_c05 ASPARAGINE SYNTHETASE B user 4 3 # 4 B 1 ALA A 251 ALA~? 12.40 CL CL A 278 B 74 ASN A 246 ASN.? 12.85 CL CL A 278 B 75 GLY A 248 GLY.? 14.14 CL CL A 278 coo 39.21 14.97 27.55 40.19 16.01 27.08 14.98 -35.41 -7.43 14.47 -33.98 -7.30 coo 43.06 12.94 25.74 42.26 11.81 27.44 12.83 -32.17 -9.87 11.11 -33.32 -9.30 coo 46.38 13.54 29.18 46.14 14.29 29.26 12.18 -35.81 -15.03 12.11 -35.46 -14.29 ULMN 3 1ct9_c05 ASPARAGINE SYNTHETASE B user 5 3 # 5 B 1 ALA A 251 ALA~? 12.40 CL CL A 278 B 74 ASN A 246 ASN.? 12.85 CL CL A 278 B 75 GLY A 249 GLY.? 14.98 CL CL A 278 coo 39.21 14.97 27.55 40.19 16.01 27.08 14.98 -35.41 -7.43 14.47 -33.98 -7.30 coo 43.06 12.94 25.74 42.26 11.81 27.44 12.83 -32.17 -9.87 11.11 -33.32 -9.30 coo 46.38 13.54 29.18 46.14 14.29 29.26 10.85 -36.22 -11.47 11.63 -36.38 -11.65 ULMN 3 1ct9_c05 ASPARAGINE SYNTHETASE B user 6 3 # 6 B 1 ALA B 198 ALA.? 14.47 CL CL B 278 B 74 ASN B 197 ASN.? 13.10 CL CL B 278 B 75 GLY B 195 GLY.? 10.21 CL CL B 278 coo 39.21 14.97 27.55 40.19 16.01 27.08 -5.00 4.00 -10.23 -5.24 5.42 -10.67 coo 43.06 12.94 25.74 42.26 11.81 27.44 -6.63 -0.56 -11.26 -7.23 -1.17 -9.32 coo 46.38 13.54 29.18 46.14 14.29 29.26 -7.22 -0.77 -17.24 -6.51 -0.37 -17.47 ULMN 3 1ct9_c05 ASPARAGINE SYNTHETASE B user 7 3 # 7 B 1 ALA B 198 ALA.? 14.47 CL CL B 278 B 74 ASN B 197 ASN.? 13.10 CL CL B 278 B 75 GLY B 200 GLY.? 15.32 CL CL B 278 coo 39.21 14.97 27.55 40.19 16.01 27.08 -5.00 4.00 -10.23 -5.24 5.42 -10.67 coo 43.06 12.94 25.74 42.26 11.81 27.44 -6.63 -0.56 -11.26 -7.23 -1.17 -9.32 coo 46.38 13.54 29.18 46.14 14.29 29.26 -5.78 0.30 -5.65 -5.20 0.90 -5.77 ULMN 3 1ct9_c05 ASPARAGINE SYNTHETASE B user 8 3 # 8 B 1 ALA B 251 ALA~? 13.13 CL CL B 278 B 74 ASN B 245 ASN.? 12.34 CL CL B 278 B 75 GLY B 195 GLY.? 10.21 CL CL B 278 coo 39.21 14.97 27.55 40.19 16.01 27.08 -11.21 -8.27 -20.82 -9.88 -9.02 -21.02 coo 43.06 12.94 25.74 42.26 11.81 27.44 -8.45 -4.50 -18.19 -10.06 -4.59 -19.62 coo 46.38 13.54 29.18 46.14 14.29 29.26 -7.22 -0.77 -17.24 -6.51 -0.37 -17.47 ULMN 3 1ct9_c05 ASPARAGINE SYNTHETASE B user 9 3 # 9 B 1 ALA B 251 ALA~? 13.13 CL CL B 278 B 74 ASN B 246 ASN.? 13.30 CL CL B 278 B 75 GLY B 248 GLY.? 14.76 CL CL B 278 coo 39.21 14.97 27.55 40.19 16.01 27.08 -11.21 -8.27 -20.82 -9.88 -9.02 -21.02 coo 43.06 12.94 25.74 42.26 11.81 27.44 -7.71 -10.36 -18.40 -9.09 -11.94 -18.78 coo 46.38 13.54 29.18 46.14 14.29 29.26 -10.88 -9.81 -12.81 -10.61 -10.09 -13.55 ULMN 3 1ct9_c05 ASPARAGINE SYNTHETASE B user 10 3 # 10 B 1 ALA B 251 ALA~? 13.13 CL CL B 278 B 74 ASN B 246 ASN.? 13.30 CL CL B 278 B 75 GLY B 249 GLY.? 15.61 CL CL B 278 coo 39.21 14.97 27.55 40.19 16.01 27.08 -11.21 -8.27 -20.82 -9.88 -9.02 -21.02 coo 43.06 12.94 25.74 42.26 11.81 27.44 -7.71 -10.36 -18.40 -9.09 -11.94 -18.78 coo 46.38 13.54 29.18 46.14 14.29 29.26 -11.90 -11.51 -16.09 -11.99 -10.68 -16.03 1ct9_c05 source 1ct9 ASPARAGINE SYNTHETASE B : 10 hits 1ct9_c05 naa= 3 ULMN 3 1ct9_c06 ASPARAGINE SYNTHETASE B user 1 3 # 1 C 1 ALA A 198 ALA.? 14.21 CL CL A 278 C 74 ASN A 197 ASN.? 12.86 CL CL A 278 C 75 GLY A 195 GLY.? 9.62 CL CL A 278 coo 16.14 15.08 36.63 15.28 14.65 37.81 26.04 -31.95 -20.22 27.48 -32.27 -19.92 coo 11.60 16.13 36.70 12.80 17.74 35.96 21.52 -32.98 -18.45 20.55 -33.92 -20.09 coo 10.99 19.23 40.32 11.50 18.77 40.74 22.19 -32.71 -12.39 22.72 -32.07 -12.32 ULMN 3 1ct9_c06 ASPARAGINE SYNTHETASE B user 2 3 # 2 C 1 ALA A 198 ALA.? 14.21 CL CL A 278 C 74 ASN A 197 ASN.? 12.86 CL CL A 278 C 75 GLY A 200 GLY.? 15.16 CL CL A 278 coo 16.14 15.08 36.63 15.28 14.65 37.81 26.04 -31.95 -20.22 27.48 -32.27 -19.92 coo 11.60 16.13 36.70 12.80 17.74 35.96 21.52 -32.98 -18.45 20.55 -33.92 -20.09 coo 10.99 19.23 40.32 11.50 18.77 40.74 21.66 -32.83 -24.27 22.35 -32.33 -24.28 ULMN 3 1ct9_c06 ASPARAGINE SYNTHETASE B user 3 3 # 3 C 1 ALA A 251 ALA~? 12.40 CL CL A 278 C 74 ASN A 245 ASN.? 11.79 CL CL A 278 C 75 GLY A 195 GLY.? 9.62 CL CL A 278 coo 16.14 15.08 36.63 15.28 14.65 37.81 14.98 -35.41 -7.43 14.47 -33.98 -7.30 coo 11.60 16.13 36.70 12.80 17.74 35.96 18.48 -33.48 -10.76 18.30 -34.93 -9.15 coo 10.99 19.23 40.32 11.50 18.77 40.74 22.19 -32.71 -12.39 22.72 -32.07 -12.32 ULMN 3 1ct9_c06 ASPARAGINE SYNTHETASE B user 4 3 # 4 C 1 ALA A 251 ALA~? 12.40 CL CL A 278 C 74 ASN A 246 ASN.? 12.85 CL CL A 278 C 75 GLY A 248 GLY.? 14.14 CL CL A 278 coo 16.14 15.08 36.63 15.28 14.65 37.81 14.98 -35.41 -7.43 14.47 -33.98 -7.30 coo 11.60 16.13 36.70 12.80 17.74 35.96 12.83 -32.17 -9.87 11.11 -33.32 -9.30 coo 10.99 19.23 40.32 11.50 18.77 40.74 12.18 -35.81 -15.03 12.11 -35.46 -14.29 ULMN 3 1ct9_c06 ASPARAGINE SYNTHETASE B user 5 3 # 5 C 1 ALA A 251 ALA~? 12.40 CL CL A 278 C 74 ASN A 246 ASN.? 12.85 CL CL A 278 C 75 GLY A 249 GLY.? 14.98 CL CL A 278 coo 16.14 15.08 36.63 15.28 14.65 37.81 14.98 -35.41 -7.43 14.47 -33.98 -7.30 coo 11.60 16.13 36.70 12.80 17.74 35.96 12.83 -32.17 -9.87 11.11 -33.32 -9.30 coo 10.99 19.23 40.32 11.50 18.77 40.74 10.85 -36.22 -11.47 11.63 -36.38 -11.65 ULMN 3 1ct9_c06 ASPARAGINE SYNTHETASE B user 6 3 # 6 C 1 ALA B 198 ALA.? 14.47 CL CL B 278 C 74 ASN B 197 ASN.? 13.10 CL CL B 278 C 75 GLY B 195 GLY.? 10.21 CL CL B 278 coo 16.14 15.08 36.63 15.28 14.65 37.81 -5.00 4.00 -10.23 -5.24 5.42 -10.67 coo 11.60 16.13 36.70 12.80 17.74 35.96 -6.63 -0.56 -11.26 -7.23 -1.17 -9.32 coo 10.99 19.23 40.32 11.50 18.77 40.74 -7.22 -0.77 -17.24 -6.51 -0.37 -17.47 ULMN 3 1ct9_c06 ASPARAGINE SYNTHETASE B user 7 3 # 7 C 1 ALA B 198 ALA.? 14.47 CL CL B 278 C 74 ASN B 197 ASN.? 13.10 CL CL B 278 C 75 GLY B 200 GLY.? 15.32 CL CL B 278 coo 16.14 15.08 36.63 15.28 14.65 37.81 -5.00 4.00 -10.23 -5.24 5.42 -10.67 coo 11.60 16.13 36.70 12.80 17.74 35.96 -6.63 -0.56 -11.26 -7.23 -1.17 -9.32 coo 10.99 19.23 40.32 11.50 18.77 40.74 -5.78 0.30 -5.65 -5.20 0.90 -5.77 ULMN 3 1ct9_c06 ASPARAGINE SYNTHETASE B user 8 3 # 8 C 1 ALA B 251 ALA~? 13.13 CL CL B 278 C 74 ASN B 245 ASN.? 12.34 CL CL B 278 C 75 GLY B 195 GLY.? 10.21 CL CL B 278 coo 16.14 15.08 36.63 15.28 14.65 37.81 -11.21 -8.27 -20.82 -9.88 -9.02 -21.02 coo 11.60 16.13 36.70 12.80 17.74 35.96 -8.45 -4.50 -18.19 -10.06 -4.59 -19.62 coo 10.99 19.23 40.32 11.50 18.77 40.74 -7.22 -0.77 -17.24 -6.51 -0.37 -17.47 ULMN 3 1ct9_c06 ASPARAGINE SYNTHETASE B user 9 3 # 9 C 1 ALA B 251 ALA~? 13.13 CL CL B 278 C 74 ASN B 246 ASN.? 13.30 CL CL B 278 C 75 GLY B 248 GLY.? 14.76 CL CL B 278 coo 16.14 15.08 36.63 15.28 14.65 37.81 -11.21 -8.27 -20.82 -9.88 -9.02 -21.02 coo 11.60 16.13 36.70 12.80 17.74 35.96 -7.71 -10.36 -18.40 -9.09 -11.94 -18.78 coo 10.99 19.23 40.32 11.50 18.77 40.74 -10.88 -9.81 -12.81 -10.61 -10.09 -13.55 ULMN 3 1ct9_c06 ASPARAGINE SYNTHETASE B user 10 3 # 10 C 1 ALA B 251 ALA~? 13.13 CL CL B 278 C 74 ASN B 246 ASN.? 13.30 CL CL B 278 C 75 GLY B 249 GLY.? 15.61 CL CL B 278 coo 16.14 15.08 36.63 15.28 14.65 37.81 -11.21 -8.27 -20.82 -9.88 -9.02 -21.02 coo 11.60 16.13 36.70 12.80 17.74 35.96 -7.71 -10.36 -18.40 -9.09 -11.94 -18.78 coo 10.99 19.23 40.32 11.50 18.77 40.74 -11.90 -11.51 -16.09 -11.99 -10.68 -16.03 1ct9_c06 source 1ct9 ASPARAGINE SYNTHETASE B : 10 hits 1ct9_c06 naa= 3 ULMN 3 1ct9_c07 ASPARAGINE SYNTHETASE B user 1 3 # 1 D 1 ALA A 198 ALA.? 14.21 CL CL A 278 D 74 ASN A 197 ASN.? 12.86 CL CL A 278 D 75 GLY A 195 GLY.? 9.62 CL CL A 278 coo -13.31 41.90 116.45 -13.05 40.39 116.25 26.04 -31.95 -20.22 27.48 -32.27 -19.92 coo -16.85 39.36 115.26 -17.55 40.58 116.90 21.52 -32.98 -18.45 20.55 -33.92 -20.09 coo -17.65 36.37 119.00 -16.85 36.22 119.00 22.19 -32.71 -12.39 22.72 -32.07 -12.32 ULMN 3 1ct9_c07 ASPARAGINE SYNTHETASE B user 2 3 # 2 D 1 ALA A 198 ALA.? 14.21 CL CL A 278 D 74 ASN A 197 ASN.? 12.86 CL CL A 278 D 75 GLY A 200 GLY.? 15.16 CL CL A 278 coo -13.31 41.90 116.45 -13.05 40.39 116.25 26.04 -31.95 -20.22 27.48 -32.27 -19.92 coo -16.85 39.36 115.26 -17.55 40.58 116.90 21.52 -32.98 -18.45 20.55 -33.92 -20.09 coo -17.65 36.37 119.00 -16.85 36.22 119.00 21.66 -32.83 -24.27 22.35 -32.33 -24.28 ULMN 3 1ct9_c07 ASPARAGINE SYNTHETASE B user 3 3 # 3 D 1 ALA A 251 ALA~? 12.40 CL CL A 278 D 74 ASN A 245 ASN.? 11.79 CL CL A 278 D 75 GLY A 195 GLY.? 9.62 CL CL A 278 coo -13.31 41.90 116.45 -13.05 40.39 116.25 14.98 -35.41 -7.43 14.47 -33.98 -7.30 coo -16.85 39.36 115.26 -17.55 40.58 116.90 18.48 -33.48 -10.76 18.30 -34.93 -9.15 coo -17.65 36.37 119.00 -16.85 36.22 119.00 22.19 -32.71 -12.39 22.72 -32.07 -12.32 ULMN 3 1ct9_c07 ASPARAGINE SYNTHETASE B user 4 3 # 4 D 1 ALA A 251 ALA~? 12.40 CL CL A 278 D 74 ASN A 246 ASN.? 12.85 CL CL A 278 D 75 GLY A 248 GLY.? 14.14 CL CL A 278 coo -13.31 41.90 116.45 -13.05 40.39 116.25 14.98 -35.41 -7.43 14.47 -33.98 -7.30 coo -16.85 39.36 115.26 -17.55 40.58 116.90 12.83 -32.17 -9.87 11.11 -33.32 -9.30 coo -17.65 36.37 119.00 -16.85 36.22 119.00 12.18 -35.81 -15.03 12.11 -35.46 -14.29 ULMN 3 1ct9_c07 ASPARAGINE SYNTHETASE B user 5 3 # 5 D 1 ALA A 251 ALA~? 12.40 CL CL A 278 D 74 ASN A 246 ASN.? 12.85 CL CL A 278 D 75 GLY A 249 GLY.? 14.98 CL CL A 278 coo -13.31 41.90 116.45 -13.05 40.39 116.25 14.98 -35.41 -7.43 14.47 -33.98 -7.30 coo -16.85 39.36 115.26 -17.55 40.58 116.90 12.83 -32.17 -9.87 11.11 -33.32 -9.30 coo -17.65 36.37 119.00 -16.85 36.22 119.00 10.85 -36.22 -11.47 11.63 -36.38 -11.65 ULMN 3 1ct9_c07 ASPARAGINE SYNTHETASE B user 6 3 # 6 D 1 ALA B 198 ALA.? 14.47 CL CL B 278 D 74 ASN B 197 ASN.? 13.10 CL CL B 278 D 75 GLY B 195 GLY.? 10.21 CL CL B 278 coo -13.31 41.90 116.45 -13.05 40.39 116.25 -5.00 4.00 -10.23 -5.24 5.42 -10.67 coo -16.85 39.36 115.26 -17.55 40.58 116.90 -6.63 -0.56 -11.26 -7.23 -1.17 -9.32 coo -17.65 36.37 119.00 -16.85 36.22 119.00 -7.22 -0.77 -17.24 -6.51 -0.37 -17.47 ULMN 3 1ct9_c07 ASPARAGINE SYNTHETASE B user 7 3 # 7 D 1 ALA B 198 ALA.? 14.47 CL CL B 278 D 74 ASN B 197 ASN.? 13.10 CL CL B 278 D 75 GLY B 200 GLY.? 15.32 CL CL B 278 coo -13.31 41.90 116.45 -13.05 40.39 116.25 -5.00 4.00 -10.23 -5.24 5.42 -10.67 coo -16.85 39.36 115.26 -17.55 40.58 116.90 -6.63 -0.56 -11.26 -7.23 -1.17 -9.32 coo -17.65 36.37 119.00 -16.85 36.22 119.00 -5.78 0.30 -5.65 -5.20 0.90 -5.77 ULMN 3 1ct9_c07 ASPARAGINE SYNTHETASE B user 8 3 # 8 D 1 ALA B 251 ALA~? 13.13 CL CL B 278 D 74 ASN B 245 ASN.? 12.34 CL CL B 278 D 75 GLY B 195 GLY.? 10.21 CL CL B 278 coo -13.31 41.90 116.45 -13.05 40.39 116.25 -11.21 -8.27 -20.82 -9.88 -9.02 -21.02 coo -16.85 39.36 115.26 -17.55 40.58 116.90 -8.45 -4.50 -18.19 -10.06 -4.59 -19.62 coo -17.65 36.37 119.00 -16.85 36.22 119.00 -7.22 -0.77 -17.24 -6.51 -0.37 -17.47 ULMN 3 1ct9_c07 ASPARAGINE SYNTHETASE B user 9 3 # 9 D 1 ALA B 251 ALA~? 13.13 CL CL B 278 D 74 ASN B 246 ASN.? 13.30 CL CL B 278 D 75 GLY B 248 GLY.? 14.76 CL CL B 278 coo -13.31 41.90 116.45 -13.05 40.39 116.25 -11.21 -8.27 -20.82 -9.88 -9.02 -21.02 coo -16.85 39.36 115.26 -17.55 40.58 116.90 -7.71 -10.36 -18.40 -9.09 -11.94 -18.78 coo -17.65 36.37 119.00 -16.85 36.22 119.00 -10.88 -9.81 -12.81 -10.61 -10.09 -13.55 ULMN 3 1ct9_c07 ASPARAGINE SYNTHETASE B user 10 3 # 10 D 1 ALA B 251 ALA~? 13.13 CL CL B 278 D 74 ASN B 246 ASN.? 13.30 CL CL B 278 D 75 GLY B 249 GLY.? 15.61 CL CL B 278 coo -13.31 41.90 116.45 -13.05 40.39 116.25 -11.21 -8.27 -20.82 -9.88 -9.02 -21.02 coo -16.85 39.36 115.26 -17.55 40.58 116.90 -7.71 -10.36 -18.40 -9.09 -11.94 -18.78 coo -17.65 36.37 119.00 -16.85 36.22 119.00 -11.90 -11.51 -16.09 -11.99 -10.68 -16.03 1ct9_c07 source 1ct9 ASPARAGINE SYNTHETASE B : 10 hits 1ct9_c07 naa= 3 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 1 3 # 1 313 ASP A 36 ASP~? 8.69 CL CL A 278 315 GLU A 34 GLU^? 8.78 CL CL A 278 390 TYR A 26 TYR~? 18.66 CL CL A 278 coo 32.46 99.13 19.34 30.94 100.38 20.07 11.67 -20.98 -6.16 13.43 -22.16 -5.96 coo 32.04 94.22 18.23 30.57 94.75 16.88 14.76 -23.90 -2.78 16.42 -23.89 -4.11 coo 21.10 94.74 18.36 23.09 96.71 18.59 7.77 -31.94 1.38 10.47 -31.53 0.90 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 2 3 # 2 313 ASP A 168 ASP^? 12.27 CL CL A 278 315 GLU A 169 GLU.? 7.63 CL CL A 278 390 TYR A 145 TYR~? 15.40 CL CL A 278 coo 32.46 99.13 19.34 30.94 100.38 20.07 26.46 -30.73 -8.22 26.92 -32.42 -9.39 coo 32.04 94.22 18.23 30.57 94.75 16.88 26.74 -26.14 -12.80 26.49 -24.16 -13.47 coo 21.10 94.74 18.36 23.09 96.71 18.59 34.36 -21.23 -8.52 32.31 -21.44 -6.65 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 3 3 # 3 313 ASP A 168 ASP^? 12.27 CL CL A 278 315 GLU A 169 GLU.? 7.63 CL CL A 278 390 TYR A 180 TYR.? 19.77 CL CL A 278 coo 32.46 99.13 19.34 30.94 100.38 20.07 26.46 -30.73 -8.22 26.92 -32.42 -9.39 coo 32.04 94.22 18.23 30.57 94.75 16.88 26.74 -26.14 -12.80 26.49 -24.16 -13.47 coo 21.10 94.74 18.36 23.09 96.71 18.59 35.72 -25.25 -4.91 38.35 -24.47 -4.37 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 4 3 # 4 313 ASP A 205 ASP.? 14.79 CL CL A 278 315 GLU A 207 GLU~? 15.26 CL CL A 278 390 TYR B 66 TYR.? 15.55 CL CL A 278 coo 32.46 99.13 19.34 30.94 100.38 20.07 19.11 -25.60 -27.15 17.47 -26.92 -26.86 coo 32.04 94.22 18.23 30.57 94.75 16.88 13.18 -27.21 -26.28 11.29 -26.78 -25.35 coo 21.10 94.74 18.36 23.09 96.71 18.59 13.28 -14.60 -25.62 14.79 -15.90 -23.67 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 5 3 # 5 313 ASP B 36 ASP~? 8.83 CL CL B 278 315 GLU B 34 GLU^? 8.94 CL CL B 278 390 TYR B 26 TYR~? 19.09 CL CL B 278 coo 32.46 99.13 19.34 30.94 100.38 20.07 2.64 -13.17 -23.36 1.59 -11.35 -23.67 coo 32.04 94.22 18.23 30.57 94.75 16.88 -0.25 -10.10 -26.69 0.15 -8.25 -25.75 coo 21.10 94.74 18.36 23.09 96.71 18.59 -9.51 -16.67 -28.98 -9.06 -13.93 -28.84 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 6 3 # 6 313 ASP B 168 ASP^? 12.80 CL CL B 278 315 GLU B 169 GLU.? 7.43 CL CL B 278 390 TYR B 145 TYR.? 15.21 CL CL B 278 coo 32.46 99.13 19.34 30.94 100.38 20.07 -5.42 2.81 -22.11 -6.82 3.76 -20.83 coo 32.04 94.22 18.23 30.57 94.75 16.88 0.06 3.03 -18.46 2.10 2.57 -18.04 coo 21.10 94.74 18.36 23.09 96.71 18.59 5.06 9.55 -24.01 4.48 7.22 -25.41 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 7 3 # 7 313 ASP B 168 ASP^? 12.80 CL CL B 278 315 GLU B 169 GLU.? 7.43 CL CL B 278 390 TYR B 180 TYR.? 19.79 CL CL B 278 coo 32.46 99.13 19.34 30.94 100.38 20.07 -5.42 2.81 -22.11 -6.82 3.76 -20.83 coo 32.04 94.22 18.23 30.57 94.75 16.88 0.06 3.03 -18.46 2.10 2.57 -18.04 coo 21.10 94.74 18.36 23.09 96.71 18.59 0.34 10.88 -27.32 1.25 13.08 -28.75 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 8 3 # 8 313 ASP B 205 ASP.? 14.85 CL CL B 278 315 GLU B 207 GLU~? 15.42 CL CL B 278 390 TYR A 66 TYR.? 15.11 CL CL B 278 coo 32.46 99.13 19.34 30.94 100.38 20.07 1.45 -2.78 -3.16 -0.06 -4.27 -3.04 coo 32.04 94.22 18.23 30.57 94.75 16.88 -0.89 -8.41 -2.97 -0.49 -10.43 -3.58 coo 21.10 94.74 18.36 23.09 96.71 18.59 11.56 -10.03 -5.26 10.21 -8.56 -7.21 1ctn_c00 source 1ctn CHITINASE A (E.C.3.2.1.14) (PH 5.5, 4 DEGREES : 8 hits 1ctn_c00 naa= 3 ULMN 3 1cwy_c00 AMYLOMALTASE user 1 3 # 1 A 293 ASP A 224 ASP~? 22.21 CL CL A 278 A 340 GLU A 221 GLU~? 17.05 CL CL A 278 A 395 ASP A 168 ASP^? 12.27 CL CL A 278 coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 30.83 -39.35 -6.18 31.71 -41.01 -7.15 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 27.14 -39.98 -10.94 25.92 -39.21 -12.48 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 26.46 -30.73 -8.22 26.92 -32.42 -9.39 ULMN 3 1cwy_c00 AMYLOMALTASE user 2 3 # 2 A 293 ASP B 224 ASP~? 22.83 CL CL B 278 A 340 GLU B 221 GLU~? 17.56 CL CL B 278 A 395 ASP B 168 ASP^? 12.80 CL CL B 278 coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 -13.88 7.87 -23.86 -15.40 8.87 -22.81 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 -13.90 4.76 -18.50 -13.25 3.58 -16.87 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 -5.42 2.81 -22.11 -6.82 3.76 -20.83 1cwy_c00 source 1cwy AMYLOMALTASE : 2 hits 1cwy_c00 naa= 3 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 1 3 # 1 A 37 ASP A 36 ASP~? 8.69 CL CL A 278 A 56 ILE A 42 ILE.? 18.07 CL CL B 278 A 82 TYR A 66 TYR.? 15.11 CL CL B 278 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 11.67 -20.98 -6.16 13.43 -22.16 -5.96 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 7.65 -10.18 -1.85 8.63 -9.47 -1.00 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 11.56 -10.03 -5.26 10.21 -8.56 -7.21 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 2 3 # 2 A 37 ASP A 36 ASP~? 8.69 CL CL A 278 A 56 ILE A 69 ILE.? 17.27 CL CL A 278 A 82 TYR A 66 TYR.? 15.11 CL CL B 278 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 11.67 -20.98 -6.16 13.43 -22.16 -5.96 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 16.98 -9.45 -3.63 16.78 -9.43 -2.23 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 11.56 -10.03 -5.26 10.21 -8.56 -7.21 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 3 3 # 3 A 37 ASP A 205 ASP.? 14.79 CL CL A 278 A 56 ILE B 42 ILE.? 18.42 CL CL A 278 A 82 TYR B 66 TYR.? 15.55 CL CL A 278 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 19.11 -25.60 -27.15 17.47 -26.92 -26.86 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 12.27 -18.84 -28.51 12.99 -18.07 -29.52 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 13.28 -14.60 -25.62 14.79 -15.90 -23.67 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 4 3 # 4 A 37 ASP B 36 ASP~? 8.83 CL CL B 278 A 56 ILE B 42 ILE.? 18.42 CL CL A 278 A 82 TYR B 66 TYR.? 15.55 CL CL A 278 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 2.64 -13.17 -23.36 1.59 -11.35 -23.67 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 12.27 -18.84 -28.51 12.99 -18.07 -29.52 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 13.28 -14.60 -25.62 14.79 -15.90 -23.67 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 5 3 # 5 A 37 ASP B 36 ASP~? 8.83 CL CL B 278 A 56 ILE B 69 ILE.? 16.98 CL CL B 278 A 82 TYR B 66 TYR.? 15.55 CL CL A 278 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 2.64 -13.17 -23.36 1.59 -11.35 -23.67 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 14.20 -9.47 -28.08 14.00 -9.81 -29.44 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 13.28 -14.60 -25.62 14.79 -15.90 -23.67 1d6o_c00 source 1d6o FK506-BINDING PROTEIN : 5 hits 1d6o_c00 naa= 3 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 1 3 # 1 B 37 ASP A 36 ASP~? 8.69 CL CL A 278 B 56 ILE A 42 ILE.? 18.07 CL CL B 278 B 82 TYR A 66 TYR.? 15.11 CL CL B 278 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 11.67 -20.98 -6.16 13.43 -22.16 -5.96 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 7.65 -10.18 -1.85 8.63 -9.47 -1.00 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 11.56 -10.03 -5.26 10.21 -8.56 -7.21 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 2 3 # 2 B 37 ASP A 36 ASP~? 8.69 CL CL A 278 B 56 ILE A 69 ILE.? 17.27 CL CL A 278 B 82 TYR A 66 TYR.? 15.11 CL CL B 278 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 11.67 -20.98 -6.16 13.43 -22.16 -5.96 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 16.98 -9.45 -3.63 16.78 -9.43 -2.23 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 11.56 -10.03 -5.26 10.21 -8.56 -7.21 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 3 3 # 3 B 37 ASP B 36 ASP~? 8.83 CL CL B 278 B 56 ILE B 42 ILE.? 18.42 CL CL A 278 B 82 TYR B 66 TYR.? 15.55 CL CL A 278 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 2.64 -13.17 -23.36 1.59 -11.35 -23.67 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 12.27 -18.84 -28.51 12.99 -18.07 -29.52 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 13.28 -14.60 -25.62 14.79 -15.90 -23.67 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 4 3 # 4 B 37 ASP B 36 ASP~? 8.83 CL CL B 278 B 56 ILE B 69 ILE.? 16.98 CL CL B 278 B 82 TYR B 66 TYR.? 15.55 CL CL A 278 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 2.64 -13.17 -23.36 1.59 -11.35 -23.67 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 14.20 -9.47 -28.08 14.00 -9.81 -29.44 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 13.28 -14.60 -25.62 14.79 -15.90 -23.67 1d6o_c01 source 1d6o FK506-BINDING PROTEIN : 4 hits 1d6o_c01 naa= 3 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 1 3 # 1 A 173 TYR A 122 TYR~? 19.12 CL CL A 278 A 243 ASP B 205 ASP.? 14.85 CL CL B 278 A 272 LYS B 210 LYS~? 12.46 CL CL B 278 coo 2.03 68.31 21.46 0.66 68.36 23.90 24.48 -6.24 -5.60 21.71 -6.48 -5.39 coo 16.93 55.67 9.65 17.16 54.23 11.19 1.45 -2.78 -3.16 -0.06 -4.27 -3.04 coo 14.13 45.79 13.40 14.25 49.41 18.30 -2.49 -8.60 -10.03 0.77 -12.84 -8.24 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 2 3 # 2 A 173 TYR A 217 TYR.? 13.45 CL CL A 278 A 243 ASP A 268 ASP.? 26.73 CL CL A 278 A 272 LYS A 101 LYS.? 27.96 CL CL A 278 coo 2.03 68.31 21.46 0.66 68.36 23.90 22.77 -37.42 -9.36 23.40 -34.73 -9.58 coo 16.93 55.67 9.65 17.16 54.23 11.19 9.60 -34.57 10.49 9.97 -36.28 9.26 coo 14.13 45.79 13.40 14.25 49.41 18.30 12.62 -22.66 11.02 6.99 -25.01 12.73 1d7r_c02 source 1d7r 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYRUVATE) : 2 hits 1d7r_c02 naa= 3 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 1 3 # 1 A 145 LYS A 64 LYS^? 6.64 CL CL A 278 A 177 GLU A 138 GLU^? 6.67 CL CL A 278 A 201 LEU A 106 LEU^? 10.71 CL CL A 278 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 14.97 -18.21 -2.39 15.88 -19.33 -8.52 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 23.86 -20.99 -6.84 22.60 -22.69 -7.03 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 18.65 -19.68 -1.57 19.62 -20.77 -3.18 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 2 3 # 2 A 145 LYS A 101 LYS.? 27.96 CL CL A 278 A 177 GLU A 98 GLU~? 31.00 CL CL A 278 A 201 LEU A 96 LEU~? 21.92 CL CL A 278 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 12.62 -22.66 11.02 6.99 -25.01 12.73 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 10.05 -13.15 14.17 8.31 -11.94 14.15 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 9.99 -17.72 7.56 10.93 -19.38 6.53 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 3 3 # 3 A 145 LYS B 64 LYS^? 6.39 CL CL B 278 A 177 GLU B 138 GLU^? 6.70 CL CL B 278 A 201 LEU B 106 LEU^? 10.66 CL CL B 278 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 5.21 -10.68 -27.95 4.80 -8.81 -21.96 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 3.87 -1.10 -24.33 2.09 -2.15 -23.84 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 4.03 -6.95 -28.94 3.26 -5.63 -27.40 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 4 3 # 4 A 145 LYS B 101 LYS.? 28.03 CL CL B 278 A 177 GLU B 98 GLU~? 31.23 CL CL B 278 A 201 LEU B 96 LEU~? 22.08 CL CL B 278 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -1.11 -13.90 -40.24 -4.27 -19.39 -40.83 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 7.37 -18.38 -44.19 8.11 -20.35 -44.16 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 3.77 -16.76 -37.17 2.31 -15.47 -36.20 1daa_c00 source 1daa D-AMINO ACID AMINOTRANSFERASE : 4 hits 1daa_c00 naa= 3 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 1 3 # 1 B 145 LYS A 64 LYS^? 6.64 CL CL A 278 B 177 GLU A 138 GLU^? 6.67 CL CL A 278 B 201 LEU A 106 LEU^? 10.71 CL CL A 278 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 14.97 -18.21 -2.39 15.88 -19.33 -8.52 coo 27.00 6.35 51.01 26.30 4.53 50.18 23.86 -20.99 -6.84 22.60 -22.69 -7.03 coo 23.74 1.68 49.50 22.87 -0.24 49.97 18.65 -19.68 -1.57 19.62 -20.77 -3.18 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 2 3 # 2 B 145 LYS B 64 LYS^? 6.39 CL CL B 278 B 177 GLU B 138 GLU^? 6.70 CL CL B 278 B 201 LEU B 106 LEU^? 10.66 CL CL B 278 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 5.21 -10.68 -27.95 4.80 -8.81 -21.96 coo 27.00 6.35 51.01 26.30 4.53 50.18 3.87 -1.10 -24.33 2.09 -2.15 -23.84 coo 23.74 1.68 49.50 22.87 -0.24 49.97 4.03 -6.95 -28.94 3.26 -5.63 -27.40 1daa_c01 source 1daa D-AMINO ACID AMINOTRANSFERASE : 2 hits 1daa_c01 naa= 3 ULMN 3 1db3_c01 GDP-MANNOSE 4,6-DEHYDRATASE user 1 3 # 1 A 132 THR A 37 THR~? 16.54 CL CL A 278 A 156 TYR A 39 TYR~? 9.76 CL CL A 278 A 160 LYS A 64 LYS^? 6.64 CL CL A 278 coo 10.50 56.87 17.73 11.24 57.93 19.43 7.80 -18.70 -4.30 6.04 -19.24 -3.16 coo 11.64 63.07 23.95 11.76 62.47 21.20 13.19 -16.19 -7.99 14.85 -15.73 -10.18 coo 5.78 61.30 21.65 8.04 62.89 17.54 14.97 -18.21 -2.39 15.88 -19.33 -8.52 ULMN 3 1db3_c01 GDP-MANNOSE 4,6-DEHYDRATASE user 2 3 # 2 A 132 THR B 37 THR~? 16.55 CL CL B 278 A 156 TYR B 39 TYR~? 9.53 CL CL B 278 A 160 LYS B 64 LYS^? 6.39 CL CL B 278 coo 10.50 56.87 17.73 11.24 57.93 19.43 4.16 -17.50 -24.96 3.23 -19.26 -25.80 coo 11.64 63.07 23.95 11.76 62.47 21.20 7.70 -12.06 -22.38 8.73 -10.22 -20.60 coo 5.78 61.30 21.65 8.04 62.89 17.54 5.21 -10.68 -27.95 4.80 -8.81 -21.96 1db3_c01 source 1db3 GDP-MANNOSE 4,6-DEHYDRATASE : 2 hits 1db3_c01 naa= 3 ULMN 3 1ddj_c12 PLASMINOGEN user 1 3 # 1 A 603 HIS A 194 HIS.? 4.68 CL CL A 278 A 646 ASP A 168 ASP^? 12.27 CL CL A 278 A 739 GLY A 5 GLY^? 15.84 CL CL A 278 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 21.59 -27.03 -10.13 21.31 -25.37 -8.87 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 26.46 -30.73 -8.22 26.92 -32.42 -9.39 coo 11.37 50.89 2.29 11.05 51.63 2.25 15.52 -31.61 0.74 16.07 -31.86 0.19 ULMN 3 1ddj_c12 PLASMINOGEN user 2 3 # 2 A 603 HIS A 194 HIS.? 4.68 CL CL A 278 A 646 ASP A 168 ASP^? 12.27 CL CL A 278 A 739 GLY A 111 GLY.? 9.84 CL CL A 278 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 21.59 -27.03 -10.13 21.31 -25.37 -8.87 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 26.46 -30.73 -8.22 26.92 -32.42 -9.39 coo 11.37 50.89 2.29 11.05 51.63 2.25 25.43 -16.70 -15.06 25.21 -15.89 -15.01 ULMN 3 1ddj_c12 PLASMINOGEN user 3 3 # 3 A 603 HIS A 194 HIS.? 4.68 CL CL A 278 A 646 ASP A 168 ASP^? 12.27 CL CL A 278 A 739 GLY A 240 GLY^? 17.38 CL CL A 278 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 21.59 -27.03 -10.13 21.31 -25.37 -8.87 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 26.46 -30.73 -8.22 26.92 -32.42 -9.39 coo 11.37 50.89 2.29 11.05 51.63 2.25 21.72 -28.69 3.88 22.49 -28.89 3.61 ULMN 3 1ddj_c12 PLASMINOGEN user 4 3 # 4 A 603 HIS B 194 HIS.? 5.13 CL CL B 278 A 646 ASP B 168 ASP^? 12.80 CL CL B 278 A 739 GLY B 5 GLY^? 16.39 CL CL B 278 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -1.92 -2.21 -20.05 -0.53 -2.75 -21.52 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -5.42 2.81 -22.11 -6.82 3.76 -20.83 coo 11.37 50.89 2.29 11.05 51.63 2.25 -8.44 -9.04 -29.52 -8.55 -8.38 -29.05 ULMN 3 1ddj_c12 PLASMINOGEN user 5 3 # 5 A 603 HIS B 194 HIS.? 5.13 CL CL B 278 A 646 ASP B 168 ASP^? 12.80 CL CL B 278 A 739 GLY B 111 GLY.? 9.20 CL CL B 278 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -1.92 -2.21 -20.05 -0.53 -2.75 -21.52 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -5.42 2.81 -22.11 -6.82 3.76 -20.83 coo 11.37 50.89 2.29 11.05 51.63 2.25 9.34 0.80 -16.95 10.11 0.51 -17.10 ULMN 3 1ddj_c12 PLASMINOGEN user 6 3 # 6 A 603 HIS B 194 HIS.? 5.13 CL CL B 278 A 646 ASP B 168 ASP^? 12.80 CL CL B 278 A 739 GLY B 240 GLY^? 17.65 CL CL B 278 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -1.92 -2.21 -20.05 -0.53 -2.75 -21.52 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -5.42 2.81 -22.11 -6.82 3.76 -20.83 coo 11.37 50.89 2.29 11.05 51.63 2.25 -5.33 -3.65 -33.67 -5.41 -2.84 -33.48 1ddj_c12 source 1ddj PLASMINOGEN : 6 hits 1ddj_c12 naa= 3 ULMN 3 1ddj_c13 PLASMINOGEN user 1 3 # 1 B 603 HIS A 194 HIS.? 4.68 CL CL A 278 B 646 ASP A 168 ASP^? 12.27 CL CL A 278 B 739 GLY A 5 GLY^? 15.84 CL CL A 278 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 21.59 -27.03 -10.13 21.31 -25.37 -8.87 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 26.46 -30.73 -8.22 26.92 -32.42 -9.39 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 15.52 -31.61 0.74 16.07 -31.86 0.19 ULMN 3 1ddj_c13 PLASMINOGEN user 2 3 # 2 B 603 HIS A 194 HIS.? 4.68 CL CL A 278 B 646 ASP A 168 ASP^? 12.27 CL CL A 278 B 739 GLY A 111 GLY.? 9.84 CL CL A 278 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 21.59 -27.03 -10.13 21.31 -25.37 -8.87 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 26.46 -30.73 -8.22 26.92 -32.42 -9.39 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 25.43 -16.70 -15.06 25.21 -15.89 -15.01 ULMN 3 1ddj_c13 PLASMINOGEN user 3 3 # 3 B 603 HIS A 194 HIS.? 4.68 CL CL A 278 B 646 ASP A 168 ASP^? 12.27 CL CL A 278 B 739 GLY A 240 GLY^? 17.38 CL CL A 278 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 21.59 -27.03 -10.13 21.31 -25.37 -8.87 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 26.46 -30.73 -8.22 26.92 -32.42 -9.39 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 21.72 -28.69 3.88 22.49 -28.89 3.61 ULMN 3 1ddj_c13 PLASMINOGEN user 4 3 # 4 B 603 HIS B 194 HIS.? 5.13 CL CL B 278 B 646 ASP B 168 ASP^? 12.80 CL CL B 278 B 739 GLY B 5 GLY^? 16.39 CL CL B 278 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -1.92 -2.21 -20.05 -0.53 -2.75 -21.52 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -5.42 2.81 -22.11 -6.82 3.76 -20.83 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -8.44 -9.04 -29.52 -8.55 -8.38 -29.05 ULMN 3 1ddj_c13 PLASMINOGEN user 5 3 # 5 B 603 HIS B 194 HIS.? 5.13 CL CL B 278 B 646 ASP B 168 ASP^? 12.80 CL CL B 278 B 739 GLY B 111 GLY.? 9.20 CL CL B 278 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -1.92 -2.21 -20.05 -0.53 -2.75 -21.52 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -5.42 2.81 -22.11 -6.82 3.76 -20.83 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 9.34 0.80 -16.95 10.11 0.51 -17.10 ULMN 3 1ddj_c13 PLASMINOGEN user 6 3 # 6 B 603 HIS B 194 HIS.? 5.13 CL CL B 278 B 646 ASP B 168 ASP^? 12.80 CL CL B 278 B 739 GLY B 240 GLY^? 17.65 CL CL B 278 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -1.92 -2.21 -20.05 -0.53 -2.75 -21.52 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -5.42 2.81 -22.11 -6.82 3.76 -20.83 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -5.33 -3.65 -33.67 -5.41 -2.84 -33.48 1ddj_c13 source 1ddj PLASMINOGEN : 6 hits 1ddj_c13 naa= 3 ULMN 3 1ddj_c14 PLASMINOGEN user 1 3 # 1 C 603 HIS A 194 HIS.? 4.68 CL CL A 278 C 646 ASP A 168 ASP^? 12.27 CL CL A 278 C 739 GLY A 5 GLY^? 15.84 CL CL A 278 coo 15.33 59.81 59.60 13.98 60.99 60.69 21.59 -27.03 -10.13 21.31 -25.37 -8.87 coo 16.06 55.72 54.73 15.97 56.49 56.70 26.46 -30.73 -8.22 26.92 -32.42 -9.39 coo 9.38 49.29 65.28 9.01 50.03 65.31 15.52 -31.61 0.74 16.07 -31.86 0.19 ULMN 3 1ddj_c14 PLASMINOGEN user 2 3 # 2 C 603 HIS A 194 HIS.? 4.68 CL CL A 278 C 646 ASP A 168 ASP^? 12.27 CL CL A 278 C 739 GLY A 111 GLY.? 9.84 CL CL A 278 coo 15.33 59.81 59.60 13.98 60.99 60.69 21.59 -27.03 -10.13 21.31 -25.37 -8.87 coo 16.06 55.72 54.73 15.97 56.49 56.70 26.46 -30.73 -8.22 26.92 -32.42 -9.39 coo 9.38 49.29 65.28 9.01 50.03 65.31 25.43 -16.70 -15.06 25.21 -15.89 -15.01 ULMN 3 1ddj_c14 PLASMINOGEN user 3 3 # 3 C 603 HIS A 194 HIS.? 4.68 CL CL A 278 C 646 ASP A 168 ASP^? 12.27 CL CL A 278 C 739 GLY A 240 GLY^? 17.38 CL CL A 278 coo 15.33 59.81 59.60 13.98 60.99 60.69 21.59 -27.03 -10.13 21.31 -25.37 -8.87 coo 16.06 55.72 54.73 15.97 56.49 56.70 26.46 -30.73 -8.22 26.92 -32.42 -9.39 coo 9.38 49.29 65.28 9.01 50.03 65.31 21.72 -28.69 3.88 22.49 -28.89 3.61 ULMN 3 1ddj_c14 PLASMINOGEN user 4 3 # 4 C 603 HIS B 194 HIS.? 5.13 CL CL B 278 C 646 ASP B 168 ASP^? 12.80 CL CL B 278 C 739 GLY B 5 GLY^? 16.39 CL CL B 278 coo 15.33 59.81 59.60 13.98 60.99 60.69 -1.92 -2.21 -20.05 -0.53 -2.75 -21.52 coo 16.06 55.72 54.73 15.97 56.49 56.70 -5.42 2.81 -22.11 -6.82 3.76 -20.83 coo 9.38 49.29 65.28 9.01 50.03 65.31 -8.44 -9.04 -29.52 -8.55 -8.38 -29.05 ULMN 3 1ddj_c14 PLASMINOGEN user 5 3 # 5 C 603 HIS B 194 HIS.? 5.13 CL CL B 278 C 646 ASP B 168 ASP^? 12.80 CL CL B 278 C 739 GLY B 111 GLY.? 9.20 CL CL B 278 coo 15.33 59.81 59.60 13.98 60.99 60.69 -1.92 -2.21 -20.05 -0.53 -2.75 -21.52 coo 16.06 55.72 54.73 15.97 56.49 56.70 -5.42 2.81 -22.11 -6.82 3.76 -20.83 coo 9.38 49.29 65.28 9.01 50.03 65.31 9.34 0.80 -16.95 10.11 0.51 -17.10 ULMN 3 1ddj_c14 PLASMINOGEN user 6 3 # 6 C 603 HIS B 194 HIS.? 5.13 CL CL B 278 C 646 ASP B 168 ASP^? 12.80 CL CL B 278 C 739 GLY B 240 GLY^? 17.65 CL CL B 278 coo 15.33 59.81 59.60 13.98 60.99 60.69 -1.92 -2.21 -20.05 -0.53 -2.75 -21.52 coo 16.06 55.72 54.73 15.97 56.49 56.70 -5.42 2.81 -22.11 -6.82 3.76 -20.83 coo 9.38 49.29 65.28 9.01 50.03 65.31 -5.33 -3.65 -33.67 -5.41 -2.84 -33.48 1ddj_c14 source 1ddj PLASMINOGEN : 6 hits 1ddj_c14 naa= 3 ULMN 3 1ddj_c15 PLASMINOGEN user 1 3 # 1 D 603 HIS A 194 HIS.? 4.68 CL CL A 278 D 646 ASP A 168 ASP^? 12.27 CL CL A 278 D 739 GLY A 5 GLY^? 15.84 CL CL A 278 coo -30.51 33.83 43.05 -30.50 33.12 45.03 21.59 -27.03 -10.13 21.31 -25.37 -8.87 coo -25.73 33.05 39.28 -27.50 34.05 39.88 26.46 -30.73 -8.22 26.92 -32.42 -9.39 coo -27.66 47.32 40.66 -27.81 47.01 41.41 15.52 -31.61 0.74 16.07 -31.86 0.19 ULMN 3 1ddj_c15 PLASMINOGEN user 2 3 # 2 D 603 HIS A 194 HIS.? 4.68 CL CL A 278 D 646 ASP A 168 ASP^? 12.27 CL CL A 278 D 739 GLY A 111 GLY.? 9.84 CL CL A 278 coo -30.51 33.83 43.05 -30.50 33.12 45.03 21.59 -27.03 -10.13 21.31 -25.37 -8.87 coo -25.73 33.05 39.28 -27.50 34.05 39.88 26.46 -30.73 -8.22 26.92 -32.42 -9.39 coo -27.66 47.32 40.66 -27.81 47.01 41.41 25.43 -16.70 -15.06 25.21 -15.89 -15.01 ULMN 3 1ddj_c15 PLASMINOGEN user 3 3 # 3 D 603 HIS A 194 HIS.? 4.68 CL CL A 278 D 646 ASP A 168 ASP^? 12.27 CL CL A 278 D 739 GLY A 240 GLY^? 17.38 CL CL A 278 coo -30.51 33.83 43.05 -30.50 33.12 45.03 21.59 -27.03 -10.13 21.31 -25.37 -8.87 coo -25.73 33.05 39.28 -27.50 34.05 39.88 26.46 -30.73 -8.22 26.92 -32.42 -9.39 coo -27.66 47.32 40.66 -27.81 47.01 41.41 21.72 -28.69 3.88 22.49 -28.89 3.61 ULMN 3 1ddj_c15 PLASMINOGEN user 4 3 # 4 D 603 HIS A 216 HIS.? 18.50 CL CL A 278 D 646 ASP A 250 ASP~? 15.45 CL CL A 278 D 739 GLY A 200 GLY.? 15.16 CL CL A 278 coo -30.51 33.83 43.05 -30.50 33.12 45.03 17.97 -41.33 -12.21 17.58 -42.84 -10.82 coo -25.73 33.05 39.28 -27.50 34.05 39.88 15.24 -38.09 -11.21 14.62 -38.47 -13.19 coo -27.66 47.32 40.66 -27.81 47.01 41.41 21.66 -32.83 -24.27 22.35 -32.33 -24.28 ULMN 3 1ddj_c15 PLASMINOGEN user 5 3 # 5 D 603 HIS B 194 HIS.? 5.13 CL CL B 278 D 646 ASP B 168 ASP^? 12.80 CL CL B 278 D 739 GLY B 5 GLY^? 16.39 CL CL B 278 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -1.92 -2.21 -20.05 -0.53 -2.75 -21.52 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -5.42 2.81 -22.11 -6.82 3.76 -20.83 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -8.44 -9.04 -29.52 -8.55 -8.38 -29.05 ULMN 3 1ddj_c15 PLASMINOGEN user 6 3 # 6 D 603 HIS B 194 HIS.? 5.13 CL CL B 278 D 646 ASP B 168 ASP^? 12.80 CL CL B 278 D 739 GLY B 111 GLY.? 9.20 CL CL B 278 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -1.92 -2.21 -20.05 -0.53 -2.75 -21.52 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -5.42 2.81 -22.11 -6.82 3.76 -20.83 coo -27.66 47.32 40.66 -27.81 47.01 41.41 9.34 0.80 -16.95 10.11 0.51 -17.10 ULMN 3 1ddj_c15 PLASMINOGEN user 7 3 # 7 D 603 HIS B 194 HIS.? 5.13 CL CL B 278 D 646 ASP B 168 ASP^? 12.80 CL CL B 278 D 739 GLY B 240 GLY^? 17.65 CL CL B 278 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -1.92 -2.21 -20.05 -0.53 -2.75 -21.52 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -5.42 2.81 -22.11 -6.82 3.76 -20.83 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -5.33 -3.65 -33.67 -5.41 -2.84 -33.48 ULMN 3 1ddj_c15 PLASMINOGEN user 8 3 # 8 D 603 HIS B 216 HIS.? 19.24 CL CL B 278 D 646 ASP B 250 ASP~? 16.15 CL CL B 278 D 739 GLY B 200 GLY.? 15.32 CL CL B 278 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -16.22 -3.98 -15.80 -17.90 -4.46 -16.96 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -13.35 -7.01 -16.89 -13.59 -7.26 -14.81 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -5.78 0.30 -5.65 -5.20 0.90 -5.77 1ddj_c15 source 1ddj PLASMINOGEN : 8 hits 1ddj_c15 naa= 3 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 A 57 GLU A 11 GLU.? 13.55 CL CL A 278 A 226 THR B 37 THR~? 16.55 CL CL B 278 A 229 LYS B 64 LYS^? 6.39 CL CL B 278 coo 9.66 102.78 70.07 9.79 101.18 71.42 7.22 -30.95 -8.53 7.59 -29.14 -7.55 coo 7.24 97.46 49.60 8.11 95.69 48.80 4.16 -17.50 -24.96 3.23 -19.26 -25.80 coo 10.53 97.56 43.71 9.33 93.71 47.17 5.21 -10.68 -27.95 4.80 -8.81 -21.96 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 A 57 GLU B 11 GLU.? 12.74 CL CL B 278 A 226 THR A 37 THR~? 16.54 CL CL A 278 A 229 LYS A 64 LYS^? 6.64 CL CL A 278 coo 9.66 102.78 70.07 9.79 101.18 71.42 -6.91 -15.96 -19.89 -5.75 -14.85 -18.47 coo 7.24 97.46 49.60 8.11 95.69 48.80 7.80 -18.70 -4.30 6.04 -19.24 -3.16 coo 10.53 97.56 43.71 9.33 93.71 47.17 14.97 -18.21 -2.39 15.88 -19.33 -8.52 1dfo_c04 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 2 hits 1dfo_c04 naa= 3 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 B 57 GLU A 11 GLU.? 13.55 CL CL A 278 B 226 THR B 37 THR~? 16.55 CL CL B 278 B 229 LYS B 64 LYS^? 6.39 CL CL B 278 coo 15.90 87.61 49.61 13.92 86.96 49.36 7.22 -30.95 -8.53 7.59 -29.14 -7.55 coo 20.74 95.78 68.68 19.29 96.84 69.83 4.16 -17.50 -24.96 3.23 -19.26 -25.80 coo 22.32 101.61 71.64 17.89 98.63 71.55 5.21 -10.68 -27.95 4.80 -8.81 -21.96 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 B 57 GLU B 11 GLU.? 12.74 CL CL B 278 B 226 THR A 37 THR~? 16.54 CL CL A 278 B 229 LYS A 64 LYS^? 6.64 CL CL A 278 coo 15.90 87.61 49.61 13.92 86.96 49.36 -6.91 -15.96 -19.89 -5.75 -14.85 -18.47 coo 20.74 95.78 68.68 19.29 96.84 69.83 7.80 -18.70 -4.30 6.04 -19.24 -3.16 coo 22.32 101.61 71.64 17.89 98.63 71.55 14.97 -18.21 -2.39 15.88 -19.33 -8.52 1dfo_c05 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 2 hits 1dfo_c05 naa= 3 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 C 57 GLU A 11 GLU.? 13.55 CL CL A 278 C 226 THR B 37 THR~? 16.55 CL CL B 278 C 229 LYS B 64 LYS^? 6.39 CL CL B 278 coo 5.43 40.40 61.63 4.27 41.99 60.90 7.22 -30.95 -8.53 7.59 -29.14 -7.55 coo 22.16 45.88 73.63 23.23 47.70 73.25 4.16 -17.50 -24.96 3.23 -19.26 -25.80 coo 28.90 45.91 73.55 25.22 49.72 72.97 5.21 -10.68 -27.95 4.80 -8.81 -21.96 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 C 57 GLU B 11 GLU.? 12.74 CL CL B 278 C 226 THR A 37 THR~? 16.54 CL CL A 278 C 229 LYS A 64 LYS^? 6.64 CL CL A 278 coo 5.43 40.40 61.63 4.27 41.99 60.90 -6.91 -15.96 -19.89 -5.75 -14.85 -18.47 coo 22.16 45.88 73.63 23.23 47.70 73.25 7.80 -18.70 -4.30 6.04 -19.24 -3.16 coo 28.90 45.91 73.55 25.22 49.72 72.97 14.97 -18.21 -2.39 15.88 -19.33 -8.52 1dfo_c06 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 2 hits 1dfo_c06 naa= 3 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 D 57 GLU A 11 GLU.? 13.55 CL CL A 278 D 226 THR B 37 THR~? 16.55 CL CL B 278 D 229 LYS B 64 LYS^? 6.39 CL CL B 278 coo 26.07 55.89 66.14 25.33 56.50 68.01 7.22 -30.95 -8.53 7.59 -29.14 -7.55 coo 11.79 47.62 52.67 10.10 46.51 53.39 4.16 -17.50 -24.96 3.23 -19.26 -25.80 coo 10.05 41.79 49.80 7.94 44.71 53.76 5.21 -10.68 -27.95 4.80 -8.81 -21.96 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 D 57 GLU B 11 GLU.? 12.74 CL CL B 278 D 226 THR A 37 THR~? 16.54 CL CL A 278 D 229 LYS A 64 LYS^? 6.64 CL CL A 278 coo 26.07 55.89 66.14 25.33 56.50 68.01 -6.91 -15.96 -19.89 -5.75 -14.85 -18.47 coo 11.79 47.62 52.67 10.10 46.51 53.39 7.80 -18.70 -4.30 6.04 -19.24 -3.16 coo 10.05 41.79 49.80 7.94 44.71 53.76 14.97 -18.21 -2.39 15.88 -19.33 -8.52 1dfo_c07 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 2 hits 1dfo_c07 naa= 3 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 1 3 # 1 146 TYR A 122 TYR~? 19.12 CL CL A 278 150 LYS A 125 LYS~? 24.29 CL CL A 278 186 ASN A 141 ASN~? 14.40 CL CL A 278 coo 32.88 50.55 24.33 31.89 51.78 26.65 24.48 -6.24 -5.60 21.71 -6.48 -5.39 coo 27.04 52.42 22.30 26.88 49.99 27.00 25.36 -4.44 0.04 23.96 -1.21 -4.73 coo 36.98 50.30 37.29 35.85 50.29 35.50 29.69 -16.58 -13.36 30.76 -15.83 -15.01 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 2 3 # 2 146 TYR B 122 TYR~? 18.80 CL CL B 278 150 LYS B 125 LYS~? 24.18 CL CL B 278 186 ASN B 141 ASN.? 13.90 CL CL B 278 coo 32.88 50.55 24.33 31.89 51.78 26.65 18.54 -2.08 -27.38 17.99 -4.80 -27.12 coo 27.04 52.42 22.30 26.88 49.99 27.00 19.42 -2.26 -33.24 23.44 -3.28 -29.02 coo 36.98 50.30 37.29 35.85 50.29 35.50 9.53 4.91 -19.46 10.65 6.11 -18.14 1dhr_c00 source 1dhr DIHYDROPTERIDINE REDUCTASE (DHPR) (E.C.1.6.99.: 2 hits 1dhr_c00 naa= 3 ULMN 3 1diz_c00 3-METHYLADENINE DNA GLYCOSYLASE II user 1 3 # 1 A 222 TYR A 78 TYR~? 9.12 CL CL B 278 A 238 ASP B 205 ASP.? 14.85 CL CL B 278 A 272 TRP B 201 TRP.? 13.52 CL CL B 278 coo -17.92 42.46 111.37 -18.35 40.11 109.91 5.93 -5.00 -8.22 4.93 -6.54 -10.31 coo -25.50 44.84 112.68 -25.52 43.37 111.17 1.45 -2.78 -3.16 -0.06 -4.27 -3.04 coo -27.19 39.29 113.01 -23.27 39.61 112.78 0.88 1.31 -7.64 2.07 4.49 -5.69 ULMN 3 1diz_c00 3-METHYLADENINE DNA GLYCOSYLASE II user 2 3 # 2 A 222 TYR A 79 TYR.? 15.56 CL CL B 278 A 238 ASP B 205 ASP.? 14.85 CL CL B 278 A 272 TRP B 201 TRP.? 13.52 CL CL B 278 coo -17.92 42.46 111.37 -18.35 40.11 109.91 9.48 -3.09 -3.95 8.21 -5.52 -3.44 coo -25.50 44.84 112.68 -25.52 43.37 111.17 1.45 -2.78 -3.16 -0.06 -4.27 -3.04 coo -27.19 39.29 113.01 -23.27 39.61 112.78 0.88 1.31 -7.64 2.07 4.49 -5.69 ULMN 3 1diz_c00 3-METHYLADENINE DNA GLYCOSYLASE II user 3 3 # 3 A 222 TYR A 79 TYR.? 15.56 CL CL B 278 A 238 ASP B 205 ASP.? 14.85 CL CL B 278 A 272 TRP B 208 TRP~? 8.76 CL CL B 278 coo -17.92 42.46 111.37 -18.35 40.11 109.91 9.48 -3.09 -3.95 8.21 -5.52 -3.44 coo -25.50 44.84 112.68 -25.52 43.37 111.17 1.45 -2.78 -3.16 -0.06 -4.27 -3.04 coo -27.19 39.29 113.01 -23.27 39.61 112.78 1.83 -2.22 -9.85 -1.69 -0.52 -10.03 ULMN 3 1diz_c00 3-METHYLADENINE DNA GLYCOSYLASE II user 4 3 # 4 A 222 TYR B 78 TYR~? 9.41 CL CL A 278 A 238 ASP A 205 ASP.? 14.79 CL CL A 278 A 272 TRP A 201 TRP.? 13.52 CL CL A 278 coo -17.92 42.46 111.37 -18.35 40.11 109.91 18.05 -20.46 -22.54 16.77 -21.06 -20.14 coo -25.50 44.84 112.68 -25.52 43.37 111.17 19.11 -25.60 -27.15 17.47 -26.92 -26.86 coo -27.19 39.29 113.01 -23.27 39.61 112.78 23.75 -26.25 -23.03 26.68 -25.49 -25.54 ULMN 3 1diz_c00 3-METHYLADENINE DNA GLYCOSYLASE II user 5 3 # 5 A 222 TYR B 79 TYR.? 15.95 CL CL A 278 A 238 ASP A 205 ASP.? 14.79 CL CL A 278 A 272 TRP A 201 TRP.? 13.52 CL CL A 278 coo -17.92 42.46 111.37 -18.35 40.11 109.91 19.67 -17.68 -27.47 17.12 -18.78 -27.53 coo -25.50 44.84 112.68 -25.52 43.37 111.17 19.11 -25.60 -27.15 17.47 -26.92 -26.86 coo -27.19 39.29 113.01 -23.27 39.61 112.78 23.75 -26.25 -23.03 26.68 -25.49 -25.54 ULMN 3 1diz_c00 3-METHYLADENINE DNA GLYCOSYLASE II user 6 3 # 6 A 222 TYR B 79 TYR.? 15.95 CL CL A 278 A 238 ASP A 205 ASP.? 14.79 CL CL A 278 A 272 TRP A 208 TRP~? 8.71 CL CL A 278 coo -17.92 42.46 111.37 -18.35 40.11 109.91 19.67 -17.68 -27.47 17.12 -18.78 -27.53 coo -25.50 44.84 112.68 -25.52 43.37 111.17 19.11 -25.60 -27.15 17.47 -26.92 -26.86 coo -27.19 39.29 113.01 -23.27 39.61 112.78 20.67 -24.61 -20.65 22.06 -28.25 -20.17 1diz_c00 source 1diz 3-METHYLADENINE DNA GLYCOSYLASE II : 6 hits 1diz_c00 naa= 3 ULMN 3 1diz_c01 3-METHYLADENINE DNA GLYCOSYLASE II user 1 3 # 1 B 222 TYR A 78 TYR~? 9.12 CL CL B 278 B 238 ASP B 205 ASP.? 14.85 CL CL B 278 B 272 TRP B 201 TRP.? 13.52 CL CL B 278 coo 17.91 42.42 121.64 18.26 40.06 123.11 5.93 -5.00 -8.22 4.93 -6.54 -10.31 coo 25.38 44.99 120.20 25.38 43.50 121.71 1.45 -2.78 -3.16 -0.06 -4.27 -3.04 coo 27.19 39.35 120.02 23.28 39.60 120.23 0.88 1.31 -7.64 2.07 4.49 -5.69 ULMN 3 1diz_c01 3-METHYLADENINE DNA GLYCOSYLASE II user 2 3 # 2 B 222 TYR A 79 TYR.? 15.56 CL CL B 278 B 238 ASP B 205 ASP.? 14.85 CL CL B 278 B 272 TRP B 201 TRP.? 13.52 CL CL B 278 coo 17.91 42.42 121.64 18.26 40.06 123.11 9.48 -3.09 -3.95 8.21 -5.52 -3.44 coo 25.38 44.99 120.20 25.38 43.50 121.71 1.45 -2.78 -3.16 -0.06 -4.27 -3.04 coo 27.19 39.35 120.02 23.28 39.60 120.23 0.88 1.31 -7.64 2.07 4.49 -5.69 ULMN 3 1diz_c01 3-METHYLADENINE DNA GLYCOSYLASE II user 3 3 # 3 B 222 TYR A 79 TYR.? 15.56 CL CL B 278 B 238 ASP B 205 ASP.? 14.85 CL CL B 278 B 272 TRP B 208 TRP~? 8.76 CL CL B 278 coo 17.91 42.42 121.64 18.26 40.06 123.11 9.48 -3.09 -3.95 8.21 -5.52 -3.44 coo 25.38 44.99 120.20 25.38 43.50 121.71 1.45 -2.78 -3.16 -0.06 -4.27 -3.04 coo 27.19 39.35 120.02 23.28 39.60 120.23 1.83 -2.22 -9.85 -1.69 -0.52 -10.03 ULMN 3 1diz_c01 3-METHYLADENINE DNA GLYCOSYLASE II user 4 3 # 4 B 222 TYR B 78 TYR~? 9.41 CL CL A 278 B 238 ASP A 205 ASP.? 14.79 CL CL A 278 B 272 TRP A 201 TRP.? 13.52 CL CL A 278 coo 17.91 42.42 121.64 18.26 40.06 123.11 18.05 -20.46 -22.54 16.77 -21.06 -20.14 coo 25.38 44.99 120.20 25.38 43.50 121.71 19.11 -25.60 -27.15 17.47 -26.92 -26.86 coo 27.19 39.35 120.02 23.28 39.60 120.23 23.75 -26.25 -23.03 26.68 -25.49 -25.54 ULMN 3 1diz_c01 3-METHYLADENINE DNA GLYCOSYLASE II user 5 3 # 5 B 222 TYR B 79 TYR.? 15.95 CL CL A 278 B 238 ASP A 205 ASP.? 14.79 CL CL A 278 B 272 TRP A 201 TRP.? 13.52 CL CL A 278 coo 17.91 42.42 121.64 18.26 40.06 123.11 19.67 -17.68 -27.47 17.12 -18.78 -27.53 coo 25.38 44.99 120.20 25.38 43.50 121.71 19.11 -25.60 -27.15 17.47 -26.92 -26.86 coo 27.19 39.35 120.02 23.28 39.60 120.23 23.75 -26.25 -23.03 26.68 -25.49 -25.54 ULMN 3 1diz_c01 3-METHYLADENINE DNA GLYCOSYLASE II user 6 3 # 6 B 222 TYR B 79 TYR.? 15.95 CL CL A 278 B 238 ASP A 205 ASP.? 14.79 CL CL A 278 B 272 TRP A 208 TRP~? 8.71 CL CL A 278 coo 17.91 42.42 121.64 18.26 40.06 123.11 19.67 -17.68 -27.47 17.12 -18.78 -27.53 coo 25.38 44.99 120.20 25.38 43.50 121.71 19.11 -25.60 -27.15 17.47 -26.92 -26.86 coo 27.19 39.35 120.02 23.28 39.60 120.23 20.67 -24.61 -20.65 22.06 -28.25 -20.17 1diz_c01 source 1diz 3-METHYLADENINE DNA GLYCOSYLASE II : 6 hits 1diz_c01 naa= 3 ULMN 3 1dj1_c00 CYTOCHROME C PEROXIDASE user 1 3 # 1 A 48 ALA A 27 ALA~? 23.88 CL CL A 278 A 52 HIS A 29 HIS.? 25.16 CL CL A 278 A 191 TRP A 51 TRP~? 20.62 CL CL A 278 coo 0.32 19.13 2.10 -0.45 20.12 1.22 7.18 -32.62 5.90 6.84 -31.31 6.60 coo 0.08 14.87 -2.02 -1.94 15.16 -2.48 7.41 -38.44 3.20 5.56 -39.41 3.04 coo -12.27 21.19 4.26 -8.94 21.66 2.22 3.52 -22.19 2.91 5.64 -19.43 1.11 ULMN 3 1dj1_c00 CYTOCHROME C PEROXIDASE user 2 3 # 2 A 48 ALA B 27 ALA~? 24.20 CL CL B 278 A 52 HIS B 29 HIS.? 25.42 CL CL B 278 A 191 TRP B 51 TRP~? 20.79 CL CL B 278 coo 0.32 19.13 2.10 -0.45 20.12 1.22 -10.91 -17.58 -33.32 -9.74 -18.04 -34.19 coo 0.08 14.87 -2.02 -1.94 15.16 -2.48 -16.16 -16.38 -29.82 -17.24 -18.07 -29.20 coo -12.27 21.19 4.26 -8.94 21.66 2.22 -0.60 -22.09 -31.19 2.61 -20.13 -30.08 1dj1_c00 source 1dj1 CYTOCHROME C PEROXIDASE : 2 hits 1dj1_c00 naa= 3 ULMN 3 1do8_c00 MALIC ENZYME user 1 3 # 1 A 112 TYR A 24 TYR~? 29.31 CL CL A 278 A 183 LYS A 272 LYS.? 33.16 CL CL A 278 A 278 ASP A 275 ASP.? 34.16 CL CL A 278 coo 19.43 18.53 42.32 17.66 18.80 40.15 0.87 -31.89 7.51 0.76 -33.22 9.95 coo 21.92 15.80 36.19 17.64 19.44 36.35 -2.40 -40.27 7.96 -3.06 -34.63 9.73 coo 15.46 19.03 31.40 15.01 18.25 33.31 -7.58 -36.49 2.30 -8.60 -35.44 3.90 1do8_c00 source 1do8 MALIC ENZYME : 1 hits 1do8_c00 naa= 3 ULMN 3 1do8_c01 MALIC ENZYME user 1 3 # 1 B 112 TYR A 24 TYR~? 29.31 CL CL A 278 B 183 LYS A 272 LYS.? 33.16 CL CL A 278 B 278 ASP A 275 ASP.? 34.16 CL CL A 278 coo 58.62 15.99 58.34 60.98 14.60 58.93 0.87 -31.89 7.51 0.76 -33.22 9.95 coo 60.11 10.60 53.63 62.59 10.74 58.67 -2.40 -40.27 7.96 -3.06 -34.63 9.73 coo 66.50 7.32 58.45 66.26 9.42 58.23 -7.58 -36.49 2.30 -8.60 -35.44 3.90 1do8_c01 source 1do8 MALIC ENZYME : 1 hits 1do8_c01 naa= 3 ULMN 3 1do8_c02 MALIC ENZYME user 1 3 # 1 C 112 TYR A 24 TYR~? 29.31 CL CL A 278 C 183 LYS A 272 LYS.? 33.16 CL CL A 278 C 278 ASP A 275 ASP.? 34.16 CL CL A 278 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 0.87 -31.89 7.51 0.76 -33.22 9.95 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 -2.40 -40.27 7.96 -3.06 -34.63 9.73 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 -7.58 -36.49 2.30 -8.60 -35.44 3.90 1do8_c02 source 1do8 MALIC ENZYME : 1 hits 1do8_c02 naa= 3 ULMN 3 1do8_c03 MALIC ENZYME user 1 3 # 1 D 112 TYR A 24 TYR~? 29.31 CL CL A 278 D 183 LYS A 272 LYS.? 33.16 CL CL A 278 D 278 ASP A 275 ASP.? 34.16 CL CL A 278 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 0.87 -31.89 7.51 0.76 -33.22 9.95 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 -2.40 -40.27 7.96 -3.06 -34.63 9.73 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 -7.58 -36.49 2.30 -8.60 -35.44 3.90 1do8_c03 source 1do8 MALIC ENZYME : 1 hits 1do8_c03 naa= 3 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 1 3 # 1 E 57 HIS A 12 HIS~? 14.78 CL CL A 278 E 102 ASP A 13 ASP~? 20.85 CL CL A 278 E 193 GLY A 5 GLY^? 15.84 CL CL A 278 coo 11.39 26.86 25.95 9.85 26.64 27.36 9.03 -33.35 -4.93 10.37 -31.88 -5.56 coo 10.90 32.83 25.96 10.83 30.68 25.98 3.80 -37.83 -7.42 4.89 -38.66 -9.05 coo 4.57 20.60 30.29 4.74 21.36 30.66 15.52 -31.61 0.74 16.07 -31.86 0.19 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 2 3 # 2 E 57 HIS A 194 HIS.? 4.68 CL CL A 278 E 102 ASP A 168 ASP^? 12.27 CL CL A 278 E 193 GLY A 111 GLY.? 9.84 CL CL A 278 coo 11.39 26.86 25.95 9.85 26.64 27.36 21.59 -27.03 -10.13 21.31 -25.37 -8.87 coo 10.90 32.83 25.96 10.83 30.68 25.98 26.46 -30.73 -8.22 26.92 -32.42 -9.39 coo 4.57 20.60 30.29 4.74 21.36 30.66 25.43 -16.70 -15.06 25.21 -15.89 -15.01 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 3 3 # 3 E 57 HIS B 12 HIS~? 15.42 CL CL B 278 E 102 ASP B 13 ASP~? 21.13 CL CL B 278 E 193 GLY B 5 GLY^? 16.39 CL CL B 278 coo 11.39 26.86 25.95 9.85 26.64 27.36 -10.18 -14.51 -22.80 -8.49 -13.29 -22.60 coo 10.90 32.83 25.96 10.83 30.68 25.98 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 coo 4.57 20.60 30.29 4.74 21.36 30.66 -8.44 -9.04 -29.52 -8.55 -8.38 -29.05 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 4 3 # 4 E 57 HIS B 29 HIS.? 25.42 CL CL B 278 E 102 ASP B 268 ASP.? 26.26 CL CL B 278 E 193 GLY B 17 GLY~? 26.14 CL CL B 278 coo 11.39 26.86 25.95 9.85 26.64 27.36 -16.16 -16.38 -29.82 -17.24 -18.07 -29.20 coo 10.90 32.83 25.96 10.83 30.68 25.98 -14.31 -16.11 -36.83 -14.03 -14.11 -36.24 coo 4.57 20.60 30.29 4.74 21.36 30.66 -18.23 -20.62 -22.29 -17.41 -20.69 -22.32 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 5 3 # 5 E 57 HIS B 194 HIS.? 5.13 CL CL B 278 E 102 ASP B 168 ASP^? 12.80 CL CL B 278 E 193 GLY B 111 GLY.? 9.20 CL CL B 278 coo 11.39 26.86 25.95 9.85 26.64 27.36 -1.92 -2.21 -20.05 -0.53 -2.75 -21.52 coo 10.90 32.83 25.96 10.83 30.68 25.98 -5.42 2.81 -22.11 -6.82 3.76 -20.83 coo 4.57 20.60 30.29 4.74 21.36 30.66 9.34 0.80 -16.95 10.11 0.51 -17.10 1ds2_c02 source 1ds2 PROTEINASE B (SGPB : 5 hits 1ds2_c02 naa= 3 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 1 3 # 1 A 131 LYS B 64 LYS^? 6.39 CL CL B 278 A 215 LYS B 101 LYS.? 28.03 CL CL B 278 A 277 LYS B 53 LYS~? 32.92 CL CL B 278 coo 0.50 24.09 51.68 1.51 29.34 52.35 5.21 -10.68 -27.95 4.80 -8.81 -21.96 coo 13.06 30.79 51.73 11.40 35.76 53.48 -1.11 -13.90 -40.24 -4.27 -19.39 -40.83 coo 13.04 31.88 60.72 10.57 35.34 57.49 -3.36 -23.95 -38.76 0.61 -28.64 -40.43 1e19_c00 source 1e19 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPHATE SYNTH: 1 hits 1e19_c00 naa= 3 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 1 3 # 1 B 41 HIS A -1 HIS.? 31.67 CL CL A 278 B 43 HIS A 0 HIS.? 29.82 CL CL A 278 B 65 GLU A 238 GLU^? 24.84 CL CL A 278 coo 20.15 22.08 34.36 20.84 20.10 34.21 23.28 -34.51 17.18 21.28 -34.97 16.73 coo 19.55 18.91 30.27 18.21 18.65 31.84 28.39 -31.84 13.78 30.11 -32.89 14.37 coo 10.90 21.31 28.81 12.14 22.15 30.31 22.87 -26.18 11.53 21.04 -27.14 11.99 1e7l_c01 source 1e7l RECOMBINATION ENDONUCLEASE VII : 1 hits 1e7l_c01 naa= 3 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 1 3 # 1 A 107 ALA A 38 ALA~? 16.23 CL CL A 278 A 136 TYR A 39 TYR~? 9.76 CL CL A 278 A 140 LYS A 64 LYS^? 6.64 CL CL A 278 coo 55.90 7.49 23.83 56.71 8.23 22.76 9.29 -15.37 -3.22 10.06 -15.14 -1.93 coo 59.38 10.02 17.51 59.95 9.89 20.21 13.19 -16.19 -7.99 14.85 -15.73 -10.18 coo 59.52 3.69 18.67 62.31 6.19 22.58 14.97 -18.21 -2.39 15.88 -19.33 -8.52 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 2 3 # 2 A 107 ALA A 121 ALA~? 24.76 CL CL A 278 A 136 TYR A 122 TYR~? 19.12 CL CL A 278 A 140 LYS A 125 LYS~? 24.29 CL CL A 278 coo 55.90 7.49 23.83 56.71 8.23 22.76 30.16 -4.33 -3.87 30.19 -3.04 -4.66 coo 59.38 10.02 17.51 59.95 9.89 20.21 24.48 -6.24 -5.60 21.71 -6.48 -5.39 coo 59.52 3.69 18.67 62.31 6.19 22.58 25.36 -4.44 0.04 23.96 -1.21 -4.73 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 3 3 # 3 A 107 ALA B 38 ALA~? 16.19 CL CL B 278 A 136 TYR B 39 TYR~? 9.53 CL CL B 278 A 140 LYS B 64 LYS^? 6.39 CL CL B 278 coo 55.90 7.49 23.83 56.71 8.23 22.76 7.44 -16.58 -26.65 7.55 -16.04 -28.09 coo 59.38 10.02 17.51 59.95 9.89 20.21 7.70 -12.06 -22.38 8.73 -10.22 -20.60 coo 59.52 3.69 18.67 62.31 6.19 22.58 5.21 -10.68 -27.95 4.80 -8.81 -21.96 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 4 3 # 4 A 107 ALA B 121 ALA~? 24.54 CL CL B 278 A 136 TYR B 122 TYR~? 18.80 CL CL B 278 A 140 LYS B 125 LYS~? 24.18 CL CL B 278 coo 55.90 7.49 23.83 56.71 8.23 22.76 20.49 3.04 -30.30 21.93 3.10 -29.82 coo 59.38 10.02 17.51 59.95 9.89 20.21 18.54 -2.08 -27.38 17.99 -4.80 -27.12 coo 59.52 3.69 18.67 62.31 6.19 22.58 19.42 -2.26 -33.24 23.44 -3.28 -29.02 1e7q_c01 source 1e7q GDP-FUCOSE SYNTHETASE : 4 hits 1e7q_c01 naa= 3 ULMN 3 1eag_c04 PEPTIDE INHIBITOR user 1 3 # 1 A 32 ASP A 268 ASP.? 26.73 CL CL A 278 A 35 SER A 28 SER.? 27.02 CL CL A 278 A 218 ASP A 267 ASP.? 31.09 CL CL A 278 coo 47.22 22.34 8.57 45.16 22.02 9.13 9.60 -34.57 10.49 9.97 -36.28 9.26 coo 43.58 20.85 5.15 44.62 23.01 5.76 6.29 -36.11 7.11 4.57 -37.31 5.85 coo 44.05 16.99 12.67 44.05 18.89 11.74 11.77 -37.21 15.47 13.23 -35.63 15.60 ULMN 3 1eag_c04 PEPTIDE INHIBITOR user 2 3 # 2 A 32 ASP B 268 ASP.? 26.26 CL CL B 278 A 35 SER B 28 SER.? 27.87 CL CL B 278 A 218 ASP B 267 ASP.? 32.55 CL CL B 278 coo 47.22 22.34 8.57 45.16 22.02 9.13 -14.31 -16.11 -36.83 -14.03 -14.11 -36.24 coo 43.58 20.85 5.15 44.62 23.01 5.76 -14.66 -18.25 -33.71 -14.43 -20.67 -33.62 coo 44.05 16.99 12.67 44.05 18.89 11.74 -15.25 -13.37 -42.11 -14.97 -14.80 -43.57 1eag_c04 source 1eag PEPTIDE INHIBITOR : 2 hits 1eag_c04 naa= 3 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 1 3 # 1 A 99 HIS A 29 HIS.? 25.16 CL CL A 278 A 177 ASP A 268 ASP.? 26.73 CL CL A 278 A 203 LYS A 272 LYS.? 33.16 CL CL A 278 coo 8.74 45.76 47.19 9.33 46.93 45.56 7.41 -38.44 3.20 5.56 -39.41 3.04 coo 11.68 42.31 52.96 12.05 43.92 51.65 9.60 -34.57 10.49 9.97 -36.28 9.26 coo 18.07 52.81 49.62 14.17 49.99 48.07 -2.40 -40.27 7.96 -3.06 -34.63 9.73 1ecx_c02 source 1ecx AMINOTRANSFERASE : 1 hits 1ecx_c02 naa= 3 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 1 3 # 1 B 99 HIS A 29 HIS.? 25.16 CL CL A 278 B 177 ASP A 268 ASP.? 26.73 CL CL A 278 B 203 LYS A 272 LYS.? 33.16 CL CL A 278 coo 14.87 88.04 21.51 13.64 87.90 19.81 7.41 -38.44 3.20 5.56 -39.41 3.04 coo 15.87 92.46 27.37 14.46 91.76 25.94 9.60 -34.57 10.49 9.97 -36.28 9.26 coo 3.60 91.42 23.52 8.20 89.55 22.63 -2.40 -40.27 7.96 -3.06 -34.63 9.73 1ecx_c03 source 1ecx AMINOTRANSFERASE : 1 hits 1ecx_c03 naa= 3 ULMN 3 1eed_c04 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 1 3 # 1 P 32 ASP A 268 ASP.? 26.73 CL CL A 278 P 35 SER A 28 SER.? 27.02 CL CL A 278 P 215 ASP A 267 ASP.? 31.09 CL CL A 278 coo 10.15 33.41 11.98 7.98 33.66 12.07 9.60 -34.57 10.49 9.97 -36.28 9.26 coo 7.57 37.60 10.00 8.86 37.02 12.03 6.29 -36.11 7.11 4.57 -37.31 5.85 coo 4.04 29.97 8.82 4.78 31.15 10.46 11.77 -37.21 15.47 13.23 -35.63 15.60 ULMN 3 1eed_c04 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 2 3 # 2 P 32 ASP B 268 ASP.? 26.26 CL CL B 278 P 35 SER B 28 SER.? 27.87 CL CL B 278 P 215 ASP B 267 ASP.? 32.55 CL CL B 278 coo 10.15 33.41 11.98 7.98 33.66 12.07 -14.31 -16.11 -36.83 -14.03 -14.11 -36.24 coo 7.57 37.60 10.00 8.86 37.02 12.03 -14.66 -18.25 -33.71 -14.43 -20.67 -33.62 coo 4.04 29.97 8.82 4.78 31.15 10.46 -15.25 -13.37 -42.11 -14.97 -14.80 -43.57 1eed_c04 source 1eed ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLEX WITH TH: 2 hits 1eed_c04 naa= 3 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 1 3 # 1 B 107 ASP A 13 ASP~? 20.85 CL CL A 278 B 246 ASP A 36 ASP~? 8.69 CL CL A 278 B 275 HIS A 12 HIS~? 14.78 CL CL A 278 coo 34.84 56.77 81.62 34.95 54.74 82.03 3.80 -37.83 -7.42 4.89 -38.66 -9.05 coo 43.18 49.30 68.39 44.75 49.87 69.78 11.67 -20.98 -6.16 13.43 -22.16 -5.96 coo 38.73 55.10 77.62 36.80 55.01 78.46 9.03 -33.35 -4.93 10.37 -31.88 -5.56 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 2 3 # 2 B 107 ASP A 168 ASP^? 12.27 CL CL A 278 B 246 ASP A 36 ASP~? 8.69 CL CL A 278 B 275 HIS A 194 HIS.? 4.68 CL CL A 278 coo 34.84 56.77 81.62 34.95 54.74 82.03 26.46 -30.73 -8.22 26.92 -32.42 -9.39 coo 43.18 49.30 68.39 44.75 49.87 69.78 11.67 -20.98 -6.16 13.43 -22.16 -5.96 coo 38.73 55.10 77.62 36.80 55.01 78.46 21.59 -27.03 -10.13 21.31 -25.37 -8.87 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 3 3 # 3 B 107 ASP B 13 ASP~? 21.13 CL CL B 278 B 246 ASP B 36 ASP~? 8.83 CL CL B 278 B 275 HIS B 12 HIS~? 15.42 CL CL B 278 coo 34.84 56.77 81.62 34.95 54.74 82.03 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 coo 43.18 49.30 68.39 44.75 49.87 69.78 2.64 -13.17 -23.36 1.59 -11.35 -23.67 coo 38.73 55.10 77.62 36.80 55.01 78.46 -10.18 -14.51 -22.80 -8.49 -13.29 -22.60 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 4 3 # 4 B 107 ASP B 168 ASP^? 12.80 CL CL B 278 B 246 ASP B 36 ASP~? 8.83 CL CL B 278 B 275 HIS B 194 HIS.? 5.13 CL CL B 278 coo 34.84 56.77 81.62 34.95 54.74 82.03 -5.42 2.81 -22.11 -6.82 3.76 -20.83 coo 43.18 49.30 68.39 44.75 49.87 69.78 2.64 -13.17 -23.36 1.59 -11.35 -23.67 coo 38.73 55.10 77.62 36.80 55.01 78.46 -1.92 -2.21 -20.05 -0.53 -2.75 -21.52 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 5 3 # 5 B 107 ASP B 268 ASP.? 26.26 CL CL B 278 B 246 ASP B 13 ASP~? 21.13 CL CL B 278 B 275 HIS B 29 HIS.? 25.42 CL CL B 278 coo 34.84 56.77 81.62 34.95 54.74 82.03 -14.31 -16.11 -36.83 -14.03 -14.11 -36.24 coo 43.18 49.30 68.39 44.75 49.87 69.78 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 coo 38.73 55.10 77.62 36.80 55.01 78.46 -16.16 -16.38 -29.82 -17.24 -18.07 -29.20 1ehy_c01 source 1ehy SOLUBLE EPOXIDE HYDROLASE : 5 hits 1ehy_c01 naa= 3 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 1 3 # 1 C 107 ASP A 13 ASP~? 20.85 CL CL A 278 C 246 ASP A 36 ASP~? 8.69 CL CL A 278 C 275 HIS A 12 HIS~? 14.78 CL CL A 278 coo 1.90 35.26 72.76 3.20 35.74 71.18 3.80 -37.83 -7.42 4.89 -38.66 -9.05 coo 12.03 20.33 71.56 10.48 19.25 70.56 11.67 -20.98 -6.16 13.43 -22.16 -5.96 coo 3.92 29.96 71.75 4.22 31.96 72.31 9.03 -33.35 -4.93 10.37 -31.88 -5.56 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 2 3 # 2 C 107 ASP A 168 ASP^? 12.27 CL CL A 278 C 246 ASP A 36 ASP~? 8.69 CL CL A 278 C 275 HIS A 194 HIS.? 4.68 CL CL A 278 coo 1.90 35.26 72.76 3.20 35.74 71.18 26.46 -30.73 -8.22 26.92 -32.42 -9.39 coo 12.03 20.33 71.56 10.48 19.25 70.56 11.67 -20.98 -6.16 13.43 -22.16 -5.96 coo 3.92 29.96 71.75 4.22 31.96 72.31 21.59 -27.03 -10.13 21.31 -25.37 -8.87 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 3 3 # 3 C 107 ASP A 250 ASP~? 15.45 CL CL A 278 C 246 ASP A 224 ASP~? 22.21 CL CL A 278 C 275 HIS A 216 HIS.? 18.50 CL CL A 278 coo 1.90 35.26 72.76 3.20 35.74 71.18 15.24 -38.09 -11.21 14.62 -38.47 -13.19 coo 12.03 20.33 71.56 10.48 19.25 70.56 30.83 -39.35 -6.18 31.71 -41.01 -7.15 coo 3.92 29.96 71.75 4.22 31.96 72.31 17.97 -41.33 -12.21 17.58 -42.84 -10.82 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 4 3 # 4 C 107 ASP B 13 ASP~? 21.13 CL CL B 278 C 246 ASP B 36 ASP~? 8.83 CL CL B 278 C 275 HIS B 12 HIS~? 15.42 CL CL B 278 coo 1.90 35.26 72.76 3.20 35.74 71.18 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 coo 12.03 20.33 71.56 10.48 19.25 70.56 2.64 -13.17 -23.36 1.59 -11.35 -23.67 coo 3.92 29.96 71.75 4.22 31.96 72.31 -10.18 -14.51 -22.80 -8.49 -13.29 -22.60 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 5 3 # 5 C 107 ASP B 168 ASP^? 12.80 CL CL B 278 C 246 ASP B 36 ASP~? 8.83 CL CL B 278 C 275 HIS B 194 HIS.? 5.13 CL CL B 278 coo 1.90 35.26 72.76 3.20 35.74 71.18 -5.42 2.81 -22.11 -6.82 3.76 -20.83 coo 12.03 20.33 71.56 10.48 19.25 70.56 2.64 -13.17 -23.36 1.59 -11.35 -23.67 coo 3.92 29.96 71.75 4.22 31.96 72.31 -1.92 -2.21 -20.05 -0.53 -2.75 -21.52 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 6 3 # 6 C 107 ASP B 250 ASP~? 16.15 CL CL B 278 C 246 ASP B 224 ASP~? 22.83 CL CL B 278 C 275 HIS B 216 HIS.? 19.24 CL CL B 278 coo 1.90 35.26 72.76 3.20 35.74 71.18 -13.35 -7.01 -16.89 -13.59 -7.26 -14.81 coo 12.03 20.33 71.56 10.48 19.25 70.56 -13.88 7.87 -23.86 -15.40 8.87 -22.81 coo 3.92 29.96 71.75 4.22 31.96 72.31 -16.22 -3.98 -15.80 -17.90 -4.46 -16.96 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 7 3 # 7 C 107 ASP B 268 ASP.? 26.26 CL CL B 278 C 246 ASP B 13 ASP~? 21.13 CL CL B 278 C 275 HIS B 29 HIS.? 25.42 CL CL B 278 coo 1.90 35.26 72.76 3.20 35.74 71.18 -14.31 -16.11 -36.83 -14.03 -14.11 -36.24 coo 12.03 20.33 71.56 10.48 19.25 70.56 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 coo 3.92 29.96 71.75 4.22 31.96 72.31 -16.16 -16.38 -29.82 -17.24 -18.07 -29.20 1ehy_c02 source 1ehy SOLUBLE EPOXIDE HYDROLASE : 7 hits 1ehy_c02 naa= 3 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 1 3 # 1 D 107 ASP A 13 ASP~? 20.85 CL CL A 278 D 246 ASP A 36 ASP~? 8.69 CL CL A 278 D 275 HIS A 12 HIS~? 14.78 CL CL A 278 coo 37.41 19.89 81.58 37.64 21.98 81.53 3.80 -37.83 -7.42 4.89 -38.66 -9.05 coo 23.50 26.43 88.52 24.76 26.47 90.29 11.67 -20.98 -6.16 13.43 -22.16 -5.96 coo 33.16 21.44 85.29 34.07 21.53 83.40 9.03 -33.35 -4.93 10.37 -31.88 -5.56 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 2 3 # 2 D 107 ASP A 168 ASP^? 12.27 CL CL A 278 D 246 ASP A 36 ASP~? 8.69 CL CL A 278 D 275 HIS A 194 HIS.? 4.68 CL CL A 278 coo 37.41 19.89 81.58 37.64 21.98 81.53 26.46 -30.73 -8.22 26.92 -32.42 -9.39 coo 23.50 26.43 88.52 24.76 26.47 90.29 11.67 -20.98 -6.16 13.43 -22.16 -5.96 coo 33.16 21.44 85.29 34.07 21.53 83.40 21.59 -27.03 -10.13 21.31 -25.37 -8.87 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 3 3 # 3 D 107 ASP B 13 ASP~? 21.13 CL CL B 278 D 246 ASP B 36 ASP~? 8.83 CL CL B 278 D 275 HIS B 12 HIS~? 15.42 CL CL B 278 coo 37.41 19.89 81.58 37.64 21.98 81.53 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 coo 23.50 26.43 88.52 24.76 26.47 90.29 2.64 -13.17 -23.36 1.59 -11.35 -23.67 coo 33.16 21.44 85.29 34.07 21.53 83.40 -10.18 -14.51 -22.80 -8.49 -13.29 -22.60 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 4 3 # 4 D 107 ASP B 168 ASP^? 12.80 CL CL B 278 D 246 ASP B 36 ASP~? 8.83 CL CL B 278 D 275 HIS B 194 HIS.? 5.13 CL CL B 278 coo 37.41 19.89 81.58 37.64 21.98 81.53 -5.42 2.81 -22.11 -6.82 3.76 -20.83 coo 23.50 26.43 88.52 24.76 26.47 90.29 2.64 -13.17 -23.36 1.59 -11.35 -23.67 coo 33.16 21.44 85.29 34.07 21.53 83.40 -1.92 -2.21 -20.05 -0.53 -2.75 -21.52 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 5 3 # 5 D 107 ASP B 268 ASP.? 26.26 CL CL B 278 D 246 ASP B 13 ASP~? 21.13 CL CL B 278 D 275 HIS B 29 HIS.? 25.42 CL CL B 278 coo 37.41 19.89 81.58 37.64 21.98 81.53 -14.31 -16.11 -36.83 -14.03 -14.11 -36.24 coo 23.50 26.43 88.52 24.76 26.47 90.29 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 coo 33.16 21.44 85.29 34.07 21.53 83.40 -16.16 -16.38 -29.82 -17.24 -18.07 -29.20 1ehy_c03 source 1ehy SOLUBLE EPOXIDE HYDROLASE : 5 hits 1ehy_c03 naa= 3 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 1 3 # 1 A 114 HIS A 29 HIS.? 25.16 CL CL A 278 A 197 ASP A 268 ASP.? 26.73 CL CL A 278 A 223 LYS A 272 LYS.? 33.16 CL CL A 278 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 7.41 -38.44 3.20 5.56 -39.41 3.04 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 9.60 -34.57 10.49 9.97 -36.28 9.26 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -2.40 -40.27 7.96 -3.06 -34.63 9.73 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 2 3 # 2 A 114 HIS B 194 HIS.? 5.13 CL CL B 278 A 197 ASP B 168 ASP^? 12.80 CL CL B 278 A 223 LYS B 211 LYS~? 15.02 CL CL B 278 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -1.92 -2.21 -20.05 -0.53 -2.75 -21.52 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -5.42 2.81 -22.11 -6.82 3.76 -20.83 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -4.12 -5.20 -9.45 -3.45 -5.07 -3.77 1elq_c02 source 1elq L-CYSTEINE/L-CYSTINE C-S LYASE : 2 hits 1elq_c02 naa= 3 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 1 3 # 1 B 114 HIS A 29 HIS.? 25.16 CL CL A 278 B 197 ASP A 268 ASP.? 26.73 CL CL A 278 B 223 LYS A 272 LYS.? 33.16 CL CL A 278 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 7.41 -38.44 3.20 5.56 -39.41 3.04 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 9.60 -34.57 10.49 9.97 -36.28 9.26 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -2.40 -40.27 7.96 -3.06 -34.63 9.73 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 2 3 # 2 B 114 HIS B 194 HIS.? 5.13 CL CL B 278 B 197 ASP B 168 ASP^? 12.80 CL CL B 278 B 223 LYS B 211 LYS~? 15.02 CL CL B 278 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -1.92 -2.21 -20.05 -0.53 -2.75 -21.52 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 -5.42 2.81 -22.11 -6.82 3.76 -20.83 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -4.12 -5.20 -9.45 -3.45 -5.07 -3.77 1elq_c03 source 1elq L-CYSTEINE/L-CYSTINE C-S LYASE : 2 hits 1elq_c03 naa= 3 ULMN 3 1emd_c01 MALATE DEHYDROGENASE (E.C.1.1.1.37) user 1 3 # 1 150 ASP A 168 ASP^? 12.27 CL CL A 278 153 ARG A 196 ARG.? 15.95 CL CL A 278 177 HIS A 194 HIS.? 4.68 CL CL A 278 coo 6.83 2.75 19.17 7.40 0.75 19.11 26.46 -30.73 -8.22 26.92 -32.42 -9.39 coo 1.78 0.50 17.43 2.55 -2.31 16.44 27.49 -34.87 -12.70 29.46 -35.46 -10.43 coo 9.81 -2.34 18.22 7.84 -2.69 17.56 21.59 -27.03 -10.13 21.31 -25.37 -8.87 ULMN 3 1emd_c01 MALATE DEHYDROGENASE (E.C.1.1.1.37) user 2 3 # 2 150 ASP B 168 ASP^? 12.80 CL CL B 278 153 ARG B 196 ARG.? 16.18 CL CL B 278 177 HIS B 194 HIS.? 5.13 CL CL B 278 coo 6.83 2.75 19.17 7.40 0.75 19.11 -5.42 2.81 -22.11 -6.82 3.76 -20.83 coo 1.78 0.50 17.43 2.55 -2.31 16.44 -8.42 4.93 -17.56 -9.12 6.53 -20.07 coo 9.81 -2.34 18.22 7.84 -2.69 17.56 -1.92 -2.21 -20.05 -0.53 -2.75 -21.52 1emd_c01 source 1emd MALATE DEHYDROGENASE (E.C.1.1.1.37) : 2 hits 1emd_c01 naa= 3 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 1 3 # 1 A 229 ALA A 251 ALA~? 12.40 CL CL A 278 A 257 ALA A 252 ALA~? 17.52 CL CL A 278 A 328 ASP A 13 ASP~? 20.85 CL CL A 278 coo 39.84 24.12 8.44 38.50 24.23 9.11 14.98 -35.41 -7.43 14.47 -33.98 -7.30 coo 43.22 26.73 5.37 41.81 27.09 5.79 12.87 -37.24 -4.82 11.40 -37.55 -4.97 coo 38.17 34.10 6.67 37.72 32.06 6.84 3.80 -37.83 -7.42 4.89 -38.66 -9.05 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 2 3 # 2 A 229 ALA B 251 ALA~? 13.13 CL CL B 278 A 257 ALA B 252 ALA~? 18.17 CL CL B 278 A 328 ASP B 13 ASP~? 21.13 CL CL B 278 coo 39.84 24.12 8.44 38.50 24.23 9.11 -11.21 -8.27 -20.82 -9.88 -9.02 -21.02 coo 43.22 26.73 5.37 41.81 27.09 5.79 -13.56 -10.31 -23.05 -13.89 -11.76 -22.86 coo 38.17 34.10 6.67 37.72 32.06 6.84 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 1eo7_c00 source 1eo7 CYCLODEXTRIN GLYCOSYLTRANSFERASE : 2 hits 1eo7_c00 naa= 3 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 1 3 # 1 A 159 LYS A 64 LYS^? 6.64 CL CL A 278 A 193 GLU A 138 GLU^? 6.67 CL CL A 278 A 217 VAL A 107 VAL^? 13.29 CL CL A 278 coo 2.10 10.68 61.44 -2.14 13.16 60.61 14.97 -18.21 -2.39 15.88 -19.33 -8.52 coo -5.33 11.71 69.72 -4.62 11.92 67.73 23.86 -20.99 -6.84 22.60 -22.69 -7.03 coo 0.07 12.29 66.53 -0.24 11.95 64.38 20.51 -15.74 -3.18 20.99 -13.73 -2.46 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 2 3 # 2 A 159 LYS B 64 LYS^? 6.39 CL CL B 278 A 193 GLU B 138 GLU^? 6.70 CL CL B 278 A 217 VAL B 107 VAL^? 13.05 CL CL B 278 coo 2.10 10.68 61.44 -2.14 13.16 60.61 5.21 -10.68 -27.95 4.80 -8.81 -21.96 coo -5.33 11.71 69.72 -4.62 11.92 67.73 3.87 -1.10 -24.33 2.09 -2.15 -23.84 coo 0.07 12.29 66.53 -0.24 11.95 64.38 8.31 -5.32 -28.11 10.23 -5.07 -29.17 1et0_c00 source 1et0 4-AMINO-4-DEOXYCHORISMATE LYASE : 2 hits 1et0_c00 naa= 3 ULMN 3 1euu_c00 SIALIDASE user 1 3 # 1 92 ASP A 13 ASP~? 20.85 CL CL A 278 260 GLU A 25 GLU~? 26.70 CL CL A 278 370 TYR A 26 TYR~? 18.66 CL CL A 278 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 3.80 -37.83 -7.42 4.89 -38.66 -9.05 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 0.23 -35.14 2.73 -1.02 -35.12 1.03 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 7.77 -31.94 1.38 10.47 -31.53 0.90 ULMN 3 1euu_c00 SIALIDASE user 2 3 # 2 92 ASP A 168 ASP^? 12.27 CL CL A 278 260 GLU A 221 GLU~? 17.05 CL CL A 278 370 TYR A 215 TYR.? 13.87 CL CL A 278 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 26.46 -30.73 -8.22 26.92 -32.42 -9.39 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 27.14 -39.98 -10.94 25.92 -39.21 -12.48 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 21.62 -36.04 -14.58 23.93 -37.55 -14.90 ULMN 3 1euu_c00 SIALIDASE user 3 3 # 3 92 ASP A 268 ASP.? 26.73 CL CL A 278 260 GLU A 25 GLU~? 26.70 CL CL A 278 370 TYR A 24 TYR~? 29.31 CL CL A 278 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 9.60 -34.57 10.49 9.97 -36.28 9.26 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 0.23 -35.14 2.73 -1.02 -35.12 1.03 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 0.87 -31.89 7.51 0.76 -33.22 9.95 ULMN 3 1euu_c00 SIALIDASE user 4 3 # 4 92 ASP A 268 ASP.? 26.73 CL CL A 278 260 GLU A 25 GLU~? 26.70 CL CL A 278 370 TYR A 26 TYR~? 18.66 CL CL A 278 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 9.60 -34.57 10.49 9.97 -36.28 9.26 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 0.23 -35.14 2.73 -1.02 -35.12 1.03 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 7.77 -31.94 1.38 10.47 -31.53 0.90 ULMN 3 1euu_c00 SIALIDASE user 5 3 # 5 92 ASP B 13 ASP~? 21.13 CL CL B 278 260 GLU B 25 GLU~? 26.94 CL CL B 278 370 TYR B 26 TYR~? 19.09 CL CL B 278 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 -13.37 -23.90 -28.96 -13.41 -24.80 -27.04 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 -9.51 -16.67 -28.98 -9.06 -13.93 -28.84 ULMN 3 1euu_c00 SIALIDASE user 6 3 # 6 92 ASP B 168 ASP^? 12.80 CL CL B 278 260 GLU B 221 GLU~? 17.56 CL CL B 278 370 TYR B 215 TYR.? 14.28 CL CL B 278 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 -5.42 2.81 -22.11 -6.82 3.76 -20.83 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 -13.90 4.76 -18.50 -13.25 3.58 -16.87 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 -10.18 -0.68 -14.85 -11.32 1.86 -14.73 ULMN 3 1euu_c00 SIALIDASE user 7 3 # 7 92 ASP B 268 ASP.? 26.26 CL CL B 278 260 GLU B 25 GLU~? 26.94 CL CL B 278 370 TYR B 24 TYR~? 29.69 CL CL B 278 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 -14.31 -16.11 -36.83 -14.03 -14.11 -36.24 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 -13.37 -23.90 -28.96 -13.41 -24.80 -27.04 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 -10.93 -24.23 -34.16 -12.79 -24.53 -36.20 ULMN 3 1euu_c00 SIALIDASE user 8 3 # 8 92 ASP B 268 ASP.? 26.26 CL CL B 278 260 GLU B 25 GLU~? 26.94 CL CL B 278 370 TYR B 26 TYR~? 19.09 CL CL B 278 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 -14.31 -16.11 -36.83 -14.03 -14.11 -36.24 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 -13.37 -23.90 -28.96 -13.41 -24.80 -27.04 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 -9.51 -16.67 -28.98 -9.06 -13.93 -28.84 1euu_c00 source 1euu SIALIDASE : 8 hits 1euu_c00 naa= 3 ULMN 3 1eyi_c00 FRUCTOSE-1,6-BISPHOSPHATASE user 1 3 # 1 A 68 ASP A 168 ASP^? 12.27 CL CL A 278 A 74 ASP A 224 ASP~? 22.21 CL CL A 278 A 98 GLU A 221 GLU~? 17.05 CL CL A 278 coo 17.19 9.05 25.28 15.77 9.98 26.53 26.46 -30.73 -8.22 26.92 -32.42 -9.39 coo 15.99 8.54 17.36 14.96 7.80 19.05 30.83 -39.35 -6.18 31.71 -41.01 -7.15 coo 16.31 12.85 18.11 16.71 11.79 19.90 27.14 -39.98 -10.94 25.92 -39.21 -12.48 1eyi_c00 source 1eyi FRUCTOSE-1,6-BISPHOSPHATASE : 1 hits 1eyi_c00 naa= 3 ULMN 3 1f6d_c02 UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE user 1 3 # 1 C 95 ASP B 224 ASP~? 22.83 CL CL B 278 C 117 GLU B 227 GLU~? 26.46 CL CL B 278 C 131 GLU B 221 GLU~? 17.56 CL CL B 278 coo 68.01 56.37 72.57 68.42 56.10 70.51 -13.88 7.87 -23.86 -15.40 8.87 -22.81 coo 66.59 62.50 67.44 67.57 60.64 67.12 -14.61 9.61 -30.38 -15.43 11.23 -29.27 coo 69.24 52.27 71.96 69.91 50.26 71.89 -13.90 4.76 -18.50 -13.25 3.58 -16.87 1f6d_c02 source 1f6d UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE : 1 hits 1f6d_c02 naa= 3 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 1 3 # 1 A 105 HIS A 194 HIS.? 4.68 CL CL A 278 C 62 LYS A 211 LYS~? 14.92 CL CL A 278 F 35 ASP A 168 ASP^? 12.27 CL CL A 278 coo 15.40 22.79 16.66 13.93 24.10 15.98 21.59 -27.03 -10.13 21.31 -25.37 -8.87 coo 19.95 18.98 4.81 18.82 20.94 10.49 17.07 -30.19 -20.07 15.73 -30.42 -25.42 coo 16.32 15.30 17.19 17.71 14.73 18.69 26.46 -30.73 -8.22 26.92 -32.42 -9.39 1f80_c03 source 1f80 ACYL CARRIER PROTEIN : 1 hits 1f80_c03 naa= 3 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 1 3 # 1 B 62 LYS A 211 LYS~? 14.92 CL CL A 278 C 105 HIS A 194 HIS.? 4.68 CL CL A 278 D 35 ASP A 168 ASP^? 12.27 CL CL A 278 coo 38.76 28.25 7.87 36.33 26.41 13.58 17.07 -30.19 -20.07 15.73 -30.42 -25.42 coo 34.93 19.72 17.37 34.72 18.17 15.98 21.59 -27.03 -10.13 21.31 -25.37 -8.87 coo 41.01 23.02 20.83 40.65 24.26 22.55 26.46 -30.73 -8.22 26.92 -32.42 -9.39 1f80_c04 source 1f80 ACYL CARRIER PROTEIN : 1 hits 1f80_c04 naa= 3 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 A 112 PHE A 105 PHE^? 19.30 CL CL A 278 A 210 ASP A 132 ASP.? 29.97 CL CL A 278 A 244 LYS A 125 LYS~? 24.29 CL CL A 278 coo 9.23 46.77 25.11 11.48 48.39 24.76 16.59 -15.31 3.58 14.42 -14.59 5.14 coo 10.51 37.86 19.71 9.07 39.38 20.04 22.31 -10.85 12.65 23.22 -9.04 13.30 coo -1.20 42.34 17.67 3.19 45.13 19.06 25.36 -4.44 0.04 23.96 -1.21 -4.73 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 A 112 PHE B 105 PHE^? 19.26 CL CL B 278 A 210 ASP B 132 ASP.? 29.62 CL CL B 278 A 244 LYS B 125 LYS~? 24.18 CL CL B 278 coo 9.23 46.77 25.11 11.48 48.39 24.76 7.42 -10.10 -34.30 7.71 -12.44 -35.78 coo 10.51 37.86 19.71 9.07 39.38 20.04 11.22 -5.69 -44.39 12.86 -4.72 -45.32 coo -1.20 42.34 17.67 3.19 45.13 19.06 19.42 -2.26 -33.24 23.44 -3.28 -29.02 1fc4_c02 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 2 hits 1fc4_c02 naa= 3 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 B 112 PHE A 105 PHE^? 19.30 CL CL A 278 B 210 ASP A 132 ASP.? 29.97 CL CL A 278 B 244 LYS A 125 LYS~? 24.29 CL CL A 278 coo 8.76 47.85 34.91 11.08 46.36 35.41 16.59 -15.31 3.58 14.42 -14.59 5.14 coo 9.06 56.85 40.30 7.71 55.27 39.90 22.31 -10.85 12.65 23.22 -9.04 13.30 coo -2.38 51.82 41.62 2.07 49.19 40.42 25.36 -4.44 0.04 23.96 -1.21 -4.73 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 B 112 PHE B 105 PHE^? 19.26 CL CL B 278 B 210 ASP B 132 ASP.? 29.62 CL CL B 278 B 244 LYS B 125 LYS~? 24.18 CL CL B 278 coo 8.76 47.85 34.91 11.08 46.36 35.41 7.42 -10.10 -34.30 7.71 -12.44 -35.78 coo 9.06 56.85 40.30 7.71 55.27 39.90 11.22 -5.69 -44.39 12.86 -4.72 -45.32 coo -2.38 51.82 41.62 2.07 49.19 40.42 19.42 -2.26 -33.24 23.44 -3.28 -29.02 1fc4_c03 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 2 hits 1fc4_c03 naa= 3 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 A 136 HIS A 29 HIS.? 25.16 CL CL A 278 A 210 ASP A 268 ASP.? 26.73 CL CL A 278 A 244 LYS A 272 LYS.? 33.16 CL CL A 278 coo 11.28 44.53 18.60 9.91 46.00 19.20 7.41 -38.44 3.20 5.56 -39.41 3.04 coo 10.51 37.86 19.71 9.07 39.38 20.04 9.60 -34.57 10.49 9.97 -36.28 9.26 coo -1.20 42.34 17.67 3.19 45.13 19.06 -2.40 -40.27 7.96 -3.06 -34.63 9.73 1fc4_c04 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 1 hits 1fc4_c04 naa= 3 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 B 136 HIS A 29 HIS.? 25.16 CL CL A 278 B 210 ASP A 268 ASP.? 26.73 CL CL A 278 B 244 LYS A 272 LYS.? 33.16 CL CL A 278 coo 10.08 50.18 41.78 8.91 48.61 41.04 7.41 -38.44 3.20 5.56 -39.41 3.04 coo 9.06 56.85 40.30 7.71 55.27 39.90 9.60 -34.57 10.49 9.97 -36.28 9.26 coo -2.38 51.82 41.62 2.07 49.19 40.42 -2.40 -40.27 7.96 -3.06 -34.63 9.73 1fc4_c05 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 1 hits 1fc4_c05 naa= 3 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 A 47 SER A 21 SER.? 21.88 CL CL A 278 A 48 THR A 22 THR~? 25.76 CL CL A 278 A 165 LYS A 272 LYS.? 33.16 CL CL A 278 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 1.16 -33.17 -2.24 2.71 -34.86 -3.05 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 0.68 -30.75 0.65 -0.98 -31.46 1.84 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -2.40 -40.27 7.96 -3.06 -34.63 9.73 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 A 47 SER B 163 SER^? 17.90 CL CL B 278 A 48 THR B 184 THR.? 19.82 CL CL B 278 A 165 LYS B 237 LYS.? 30.29 CL CL B 278 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 4.21 1.28 -34.77 1.92 0.43 -34.82 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 3.58 6.57 -36.17 4.31 5.82 -34.27 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -4.88 0.83 -42.64 -0.61 0.76 -47.36 1fdy_c04 source 1fdy N-ACETYLNEURAMINATE LYASE : 2 hits 1fdy_c04 naa= 3 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 B 47 SER A 21 SER.? 21.88 CL CL A 278 B 48 THR A 22 THR~? 25.76 CL CL A 278 B 165 LYS A 272 LYS.? 33.16 CL CL A 278 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 1.16 -33.17 -2.24 2.71 -34.86 -3.05 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 0.68 -30.75 0.65 -0.98 -31.46 1.84 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -2.40 -40.27 7.96 -3.06 -34.63 9.73 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 B 47 SER B 163 SER^? 17.90 CL CL B 278 B 48 THR B 184 THR.? 19.82 CL CL B 278 B 165 LYS B 237 LYS.? 30.29 CL CL B 278 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 4.21 1.28 -34.77 1.92 0.43 -34.82 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 3.58 6.57 -36.17 4.31 5.82 -34.27 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -4.88 0.83 -42.64 -0.61 0.76 -47.36 1fdy_c05 source 1fdy N-ACETYLNEURAMINATE LYASE : 2 hits 1fdy_c05 naa= 3 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 C 47 SER A 21 SER.? 21.88 CL CL A 278 C 48 THR A 22 THR~? 25.76 CL CL A 278 C 165 LYS A 272 LYS.? 33.16 CL CL A 278 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 1.16 -33.17 -2.24 2.71 -34.86 -3.05 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 0.68 -30.75 0.65 -0.98 -31.46 1.84 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -2.40 -40.27 7.96 -3.06 -34.63 9.73 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 C 47 SER B 163 SER^? 17.90 CL CL B 278 C 48 THR B 184 THR.? 19.82 CL CL B 278 C 165 LYS B 237 LYS.? 30.29 CL CL B 278 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 4.21 1.28 -34.77 1.92 0.43 -34.82 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 3.58 6.57 -36.17 4.31 5.82 -34.27 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -4.88 0.83 -42.64 -0.61 0.76 -47.36 1fdy_c06 source 1fdy N-ACETYLNEURAMINATE LYASE : 2 hits 1fdy_c06 naa= 3 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 D 47 SER A 21 SER.? 21.88 CL CL A 278 D 48 THR A 22 THR~? 25.76 CL CL A 278 D 165 LYS A 272 LYS.? 33.16 CL CL A 278 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 1.16 -33.17 -2.24 2.71 -34.86 -3.05 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 0.68 -30.75 0.65 -0.98 -31.46 1.84 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -2.40 -40.27 7.96 -3.06 -34.63 9.73 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 D 47 SER B 163 SER^? 17.90 CL CL B 278 D 48 THR B 184 THR.? 19.82 CL CL B 278 D 165 LYS B 237 LYS.? 30.29 CL CL B 278 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 4.21 1.28 -34.77 1.92 0.43 -34.82 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 3.58 6.57 -36.17 4.31 5.82 -34.27 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -4.88 0.83 -42.64 -0.61 0.76 -47.36 1fdy_c07 source 1fdy N-ACETYLNEURAMINATE LYASE : 2 hits 1fdy_c07 naa= 3 ULMN 3 1ff3_c00 PEPTIDE METHIONINE SULFOXIDE REDUCTAuser 1 3 # 1 A 94 GLU A 83 GLU~? 26.70 CL CL B 278 A 198 CYH A 71 CYH.? 16.56 CL CL A 278 A 206 CYH B 115 CYH.? 20.61 CL CL B 278 coo 49.92 26.66 0.19 51.26 25.02 0.19 17.51 1.49 1.14 18.83 0.42 2.44 coo 51.25 11.31 6.04 51.91 8.58 5.83 19.04 -8.88 -9.96 21.14 -7.72 -8.59 coo 38.98 17.42 20.63 38.42 14.68 20.70 14.78 7.95 -23.15 14.40 10.09 -24.83 ULMN 3 1ff3_c00 PEPTIDE METHIONINE SULFOXIDE REDUCTAuser 2 3 # 2 A 94 GLU A 84 GLU~? 21.00 CL CL B 278 A 198 CYH A 71 CYH.? 16.56 CL CL A 278 A 206 CYH B 115 CYH.? 20.61 CL CL B 278 coo 49.92 26.66 0.19 51.26 25.02 0.19 10.99 1.60 0.86 10.52 3.31 -0.28 coo 51.25 11.31 6.04 51.91 8.58 5.83 19.04 -8.88 -9.96 21.14 -7.72 -8.59 coo 38.98 17.42 20.63 38.42 14.68 20.70 14.78 7.95 -23.15 14.40 10.09 -24.83 ULMN 3 1ff3_c00 PEPTIDE METHIONINE SULFOXIDE REDUCTAuser 3 3 # 3 A 94 GLU A 169 GLU.? 7.63 CL CL A 278 A 198 CYH A 115 CYH.? 21.04 CL CL A 278 A 206 CYH B 71 CYH.? 16.15 CL CL B 278 coo 49.92 26.66 0.19 51.26 25.02 0.19 26.74 -26.14 -12.80 26.49 -24.16 -13.47 coo 51.25 11.31 6.04 51.91 8.58 5.83 33.67 -11.53 -10.65 35.99 -11.79 -9.16 coo 38.98 17.42 20.63 38.42 14.68 20.70 15.78 -6.77 -22.17 17.11 -4.88 -23.73 ULMN 3 1ff3_c00 PEPTIDE METHIONINE SULFOXIDE REDUCTAuser 4 3 # 4 A 94 GLU B 83 GLU~? 26.47 CL CL A 278 A 198 CYH B 71 CYH.? 16.15 CL CL B 278 A 206 CYH A 115 CYH.? 21.04 CL CL A 278 coo 49.92 26.66 0.19 51.26 25.02 0.19 24.57 -10.93 -33.84 23.46 -9.16 -34.20 coo 51.25 11.31 6.04 51.91 8.58 5.83 15.78 -6.77 -22.17 17.11 -4.88 -23.73 coo 38.98 17.42 20.63 38.42 14.68 20.70 33.67 -11.53 -10.65 35.99 -11.79 -9.16 ULMN 3 1ff3_c00 PEPTIDE METHIONINE SULFOXIDE REDUCTAuser 5 3 # 5 A 94 GLU B 84 GLU~? 21.19 CL CL A 278 A 198 CYH B 71 CYH.? 16.15 CL CL B 278 A 206 CYH A 115 CYH.? 21.04 CL CL A 278 coo 49.92 26.66 0.19 51.26 25.02 0.19 23.98 -17.25 -32.88 25.62 -18.13 -31.85 coo 51.25 11.31 6.04 51.91 8.58 5.83 15.78 -6.77 -22.17 17.11 -4.88 -23.73 coo 38.98 17.42 20.63 38.42 14.68 20.70 33.67 -11.53 -10.65 35.99 -11.79 -9.16 ULMN 3 1ff3_c00 PEPTIDE METHIONINE SULFOXIDE REDUCTAuser 6 3 # 6 A 94 GLU B 169 GLU.? 7.43 CL CL B 278 A 198 CYH B 115 CYH.? 20.61 CL CL B 278 A 206 CYH A 71 CYH.? 16.56 CL CL A 278 coo 49.92 26.66 0.19 51.26 25.02 0.19 0.06 3.03 -18.46 2.10 2.57 -18.04 coo 51.25 11.31 6.04 51.91 8.58 5.83 14.78 7.95 -23.15 14.40 10.09 -24.83 coo 38.98 17.42 20.63 38.42 14.68 20.70 19.04 -8.88 -9.96 21.14 -7.72 -8.59 1ff3_c00 source 1ff3 PEPTIDE METHIONINE SULFOXIDE REDUCTASE : 6 hits 1ff3_c00 naa= 3 ULMN 3 1ff3_c01 PEPTIDE METHIONINE SULFOXIDE REDUCTAuser 1 3 # 1 A 94 GLU A 83 GLU~? 26.70 CL CL B 278 A 198 CYH A 71 CYH.? 16.56 CL CL A 278 A 206 CYH B 115 CYH.? 20.61 CL CL B 278 coo 49.92 26.66 0.19 51.26 25.02 0.19 17.51 1.49 1.14 18.83 0.42 2.44 coo 51.25 11.31 6.04 51.91 8.58 5.83 19.04 -8.88 -9.96 21.14 -7.72 -8.59 coo 38.98 17.42 20.63 38.42 14.68 20.70 14.78 7.95 -23.15 14.40 10.09 -24.83 ULMN 3 1ff3_c01 PEPTIDE METHIONINE SULFOXIDE REDUCTAuser 2 3 # 2 A 94 GLU A 84 GLU~? 21.00 CL CL B 278 A 198 CYH A 71 CYH.? 16.56 CL CL A 278 A 206 CYH B 115 CYH.? 20.61 CL CL B 278 coo 49.92 26.66 0.19 51.26 25.02 0.19 10.99 1.60 0.86 10.52 3.31 -0.28 coo 51.25 11.31 6.04 51.91 8.58 5.83 19.04 -8.88 -9.96 21.14 -7.72 -8.59 coo 38.98 17.42 20.63 38.42 14.68 20.70 14.78 7.95 -23.15 14.40 10.09 -24.83 ULMN 3 1ff3_c01 PEPTIDE METHIONINE SULFOXIDE REDUCTAuser 3 3 # 3 A 94 GLU A 169 GLU.? 7.63 CL CL A 278 A 198 CYH A 115 CYH.? 21.04 CL CL A 278 A 206 CYH B 71 CYH.? 16.15 CL CL B 278 coo 49.92 26.66 0.19 51.26 25.02 0.19 26.74 -26.14 -12.80 26.49 -24.16 -13.47 coo 51.25 11.31 6.04 51.91 8.58 5.83 33.67 -11.53 -10.65 35.99 -11.79 -9.16 coo 38.98 17.42 20.63 38.42 14.68 20.70 15.78 -6.77 -22.17 17.11 -4.88 -23.73 ULMN 3 1ff3_c01 PEPTIDE METHIONINE SULFOXIDE REDUCTAuser 4 3 # 4 A 94 GLU B 83 GLU~? 26.47 CL CL A 278 A 198 CYH B 71 CYH.? 16.15 CL CL B 278 A 206 CYH A 115 CYH.? 21.04 CL CL A 278 coo 49.92 26.66 0.19 51.26 25.02 0.19 24.57 -10.93 -33.84 23.46 -9.16 -34.20 coo 51.25 11.31 6.04 51.91 8.58 5.83 15.78 -6.77 -22.17 17.11 -4.88 -23.73 coo 38.98 17.42 20.63 38.42 14.68 20.70 33.67 -11.53 -10.65 35.99 -11.79 -9.16 ULMN 3 1ff3_c01 PEPTIDE METHIONINE SULFOXIDE REDUCTAuser 5 3 # 5 A 94 GLU B 84 GLU~? 21.19 CL CL A 278 A 198 CYH B 71 CYH.? 16.15 CL CL B 278 A 206 CYH A 115 CYH.? 21.04 CL CL A 278 coo 49.92 26.66 0.19 51.26 25.02 0.19 23.98 -17.25 -32.88 25.62 -18.13 -31.85 coo 51.25 11.31 6.04 51.91 8.58 5.83 15.78 -6.77 -22.17 17.11 -4.88 -23.73 coo 38.98 17.42 20.63 38.42 14.68 20.70 33.67 -11.53 -10.65 35.99 -11.79 -9.16 ULMN 3 1ff3_c01 PEPTIDE METHIONINE SULFOXIDE REDUCTAuser 6 3 # 6 A 94 GLU B 169 GLU.? 7.43 CL CL B 278 A 198 CYH B 115 CYH.? 20.61 CL CL B 278 A 206 CYH A 71 CYH.? 16.56 CL CL A 278 coo 49.92 26.66 0.19 51.26 25.02 0.19 0.06 3.03 -18.46 2.10 2.57 -18.04 coo 51.25 11.31 6.04 51.91 8.58 5.83 14.78 7.95 -23.15 14.40 10.09 -24.83 coo 38.98 17.42 20.63 38.42 14.68 20.70 19.04 -8.88 -9.96 21.14 -7.72 -8.59 1ff3_c01 source 1ff3 PEPTIDE METHIONINE SULFOXIDE REDUCTASE : 6 hits 1ff3_c01 naa= 3 ULMN 3 1fgj_c01 HYDROXYLAMINE OXIDOREDUCTASE user 1 3 # 1 B 267 ASP A 250 ASP~? 15.45 CL CL A 278 B 268 HIS A 216 HIS.? 18.50 CL CL A 278 B 334 TYR A 215 TYR.? 13.87 CL CL A 278 coo 34.92 32.34 -16.78 33.96 30.63 -15.98 15.24 -38.09 -11.21 14.62 -38.47 -13.19 coo 34.35 32.52 -12.02 33.62 30.54 -12.18 17.97 -41.33 -12.21 17.58 -42.84 -10.82 coo 31.28 36.97 -17.45 31.29 34.40 -16.38 21.62 -36.04 -14.58 23.93 -37.55 -14.90 ULMN 3 1fgj_c01 HYDROXYLAMINE OXIDOREDUCTASE user 2 3 # 2 B 267 ASP A 250 ASP~? 15.45 CL CL A 278 B 268 HIS A 216 HIS.? 18.50 CL CL A 278 B 334 TYR A 217 TYR.? 13.45 CL CL A 278 coo 34.92 32.34 -16.78 33.96 30.63 -15.98 15.24 -38.09 -11.21 14.62 -38.47 -13.19 coo 34.35 32.52 -12.02 33.62 30.54 -12.18 17.97 -41.33 -12.21 17.58 -42.84 -10.82 coo 31.28 36.97 -17.45 31.29 34.40 -16.38 22.77 -37.42 -9.36 23.40 -34.73 -9.58 ULMN 3 1fgj_c01 HYDROXYLAMINE OXIDOREDUCTASE user 3 3 # 3 B 267 ASP B 250 ASP~? 16.15 CL CL B 278 B 268 HIS B 216 HIS.? 19.24 CL CL B 278 B 334 TYR B 215 TYR.? 14.28 CL CL B 278 coo 34.92 32.34 -16.78 33.96 30.63 -15.98 -13.35 -7.01 -16.89 -13.59 -7.26 -14.81 coo 34.35 32.52 -12.02 33.62 30.54 -12.18 -16.22 -3.98 -15.80 -17.90 -4.46 -16.96 coo 31.28 36.97 -17.45 31.29 34.40 -16.38 -10.18 -0.68 -14.85 -11.32 1.86 -14.73 ULMN 3 1fgj_c01 HYDROXYLAMINE OXIDOREDUCTASE user 4 3 # 4 B 267 ASP B 250 ASP~? 16.15 CL CL B 278 B 268 HIS B 216 HIS.? 19.24 CL CL B 278 B 334 TYR B 217 TYR.? 13.94 CL CL B 278 coo 34.92 32.34 -16.78 33.96 30.63 -15.98 -13.35 -7.01 -16.89 -13.59 -7.26 -14.81 coo 34.35 32.52 -12.02 33.62 30.54 -12.18 -16.22 -3.98 -15.80 -17.90 -4.46 -16.96 coo 31.28 36.97 -17.45 31.29 34.40 -16.38 -12.06 -0.05 -19.78 -9.32 0.42 -19.98 1fgj_c01 source 1fgj HYDROXYLAMINE OXIDOREDUCTASE : 4 hits 1fgj_c01 naa= 3 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 1 3 # 1 A 45 ARG A 47 ARG~? 19.53 CL CL B 278 A 136 GLU A 46 GLU~? 24.48 CL CL B 278 A 246 GLU A 50 GLU~? 27.20 CL CL B 278 coo 13.48 30.30 107.06 11.75 30.99 109.44 1.19 -18.60 0.09 1.74 -17.18 -2.58 coo 9.46 32.37 115.82 8.50 34.20 115.47 -1.94 -12.84 6.51 -1.20 -10.99 5.75 coo 11.99 34.33 109.92 10.08 34.19 110.77 -1.40 -20.04 6.08 -2.65 -20.05 4.33 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 2 3 # 2 A 45 ARG A 192 ARG^? 5.91 CL CL A 278 A 136 GLU A 169 GLU.? 7.63 CL CL A 278 A 246 GLU A 138 GLU^? 6.67 CL CL A 278 coo 13.48 30.30 107.06 11.75 30.99 109.44 20.84 -24.38 -4.40 19.02 -23.24 -6.62 coo 9.46 32.37 115.82 8.50 34.20 115.47 26.74 -26.14 -12.80 26.49 -24.16 -13.47 coo 11.99 34.33 109.92 10.08 34.19 110.77 23.86 -20.99 -6.84 22.60 -22.69 -7.03 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 3 3 # 3 A 45 ARG B 47 ARG~? 19.59 CL CL A 278 A 136 GLU B 46 GLU~? 24.28 CL CL A 278 A 246 GLU B 50 GLU~? 26.89 CL CL A 278 coo 13.48 30.30 107.06 11.75 30.99 109.44 3.13 -24.42 -28.62 4.84 -23.96 -26.11 coo 9.46 32.37 115.82 8.50 34.20 115.47 7.71 -28.83 -35.20 9.60 -28.18 -34.47 coo 11.99 34.33 109.92 10.08 34.19 110.77 0.53 -27.55 -33.66 0.79 -28.51 -31.75 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 4 3 # 4 A 45 ARG B 192 ARG^? 6.13 CL CL B 278 A 136 GLU B 169 GLU.? 7.43 CL CL B 278 A 246 GLU B 138 GLU^? 6.70 CL CL B 278 coo 13.48 30.30 107.06 11.75 30.99 109.44 -0.17 -3.93 -26.09 1.00 -5.48 -23.71 coo 9.46 32.37 115.82 8.50 34.20 115.47 0.06 3.03 -18.46 2.10 2.57 -18.04 coo 11.99 34.33 109.92 10.08 34.19 110.77 3.87 -1.10 -24.33 2.09 -2.15 -23.84 1fhl_c00 source 1fhl BETA-1,4-GALACTANASE : 4 hits 1fhl_c00 naa= 3 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 1 3 # 1 A 45 ARG A 47 ARG~? 19.53 CL CL B 278 A 136 GLU A 46 GLU~? 24.48 CL CL B 278 A 246 GLU A 50 GLU~? 27.20 CL CL B 278 coo 13.94 29.84 106.80 11.67 30.40 108.79 1.19 -18.60 0.09 1.74 -17.18 -2.58 coo 9.52 31.97 115.23 8.45 33.74 114.72 -1.94 -12.84 6.51 -1.20 -10.99 5.75 coo 11.92 33.82 109.35 10.10 33.50 110.39 -1.40 -20.04 6.08 -2.65 -20.05 4.33 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 2 3 # 2 A 45 ARG A 192 ARG^? 5.91 CL CL A 278 A 136 GLU A 169 GLU.? 7.63 CL CL A 278 A 246 GLU A 138 GLU^? 6.67 CL CL A 278 coo 13.94 29.84 106.80 11.67 30.40 108.79 20.84 -24.38 -4.40 19.02 -23.24 -6.62 coo 9.52 31.97 115.23 8.45 33.74 114.72 26.74 -26.14 -12.80 26.49 -24.16 -13.47 coo 11.92 33.82 109.35 10.10 33.50 110.39 23.86 -20.99 -6.84 22.60 -22.69 -7.03 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 3 3 # 3 A 45 ARG B 47 ARG~? 19.59 CL CL A 278 A 136 GLU B 46 GLU~? 24.28 CL CL A 278 A 246 GLU B 50 GLU~? 26.89 CL CL A 278 coo 13.94 29.84 106.80 11.67 30.40 108.79 3.13 -24.42 -28.62 4.84 -23.96 -26.11 coo 9.52 31.97 115.23 8.45 33.74 114.72 7.71 -28.83 -35.20 9.60 -28.18 -34.47 coo 11.92 33.82 109.35 10.10 33.50 110.39 0.53 -27.55 -33.66 0.79 -28.51 -31.75 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 4 3 # 4 A 45 ARG B 192 ARG^? 6.13 CL CL B 278 A 136 GLU B 169 GLU.? 7.43 CL CL B 278 A 246 GLU B 138 GLU^? 6.70 CL CL B 278 coo 13.94 29.84 106.80 11.67 30.40 108.79 -0.17 -3.93 -26.09 1.00 -5.48 -23.71 coo 9.52 31.97 115.23 8.45 33.74 114.72 0.06 3.03 -18.46 2.10 2.57 -18.04 coo 11.92 33.82 109.35 10.10 33.50 110.39 3.87 -1.10 -24.33 2.09 -2.15 -23.84 1fob_c00 source 1fob BETA-1,4-GALACTANASE : 4 hits 1fob_c00 naa= 3 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 1 3 # 1 A 197 ARG A 3 ARG^? 24.49 CL CL A 278 A 201 HIS A 0 HIS.? 29.82 CL CL A 278 A 204 HIS A -1 HIS.? 31.67 CL CL A 278 coo -27.47 20.45 37.96 -26.70 17.86 36.51 17.45 -29.65 8.35 18.11 -29.19 11.33 coo -15.08 14.90 41.58 -16.70 13.64 42.02 28.39 -31.84 13.78 30.11 -32.89 14.37 coo -15.44 20.23 39.72 -16.43 18.87 38.47 23.28 -34.51 17.18 21.28 -34.97 16.73 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 2 3 # 2 A 197 ARG A 60 ARG^? 25.80 CL CL A 278 A 201 HIS A 0 HIS.? 29.82 CL CL A 278 A 204 HIS A -1 HIS.? 31.67 CL CL A 278 coo -27.47 20.45 37.96 -26.70 17.86 36.51 16.05 -25.08 10.06 15.12 -25.70 12.91 coo -15.08 14.90 41.58 -16.70 13.64 42.02 28.39 -31.84 13.78 30.11 -32.89 14.37 coo -15.44 20.23 39.72 -16.43 18.87 38.47 23.28 -34.51 17.18 21.28 -34.97 16.73 1g8f_c00 source 1g8f SULFATE ADENYLYLTRANSFERASE : 2 hits 1g8f_c00 naa= 3 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 1 3 # 1 A 314 TRP A 129 TRP~? 23.49 CL CL A 278 A 317 GLU A 83 GLU~? 26.70 CL CL B 278 A 365 ARG A 127 ARG~? 22.81 CL CL A 278 coo 79.91 26.87 38.77 78.95 23.18 37.81 20.10 -3.42 1.94 20.47 -4.28 -1.84 coo 85.55 26.30 41.25 85.59 24.97 39.65 17.51 1.49 1.14 18.83 0.42 2.44 coo 83.47 25.30 27.10 83.44 27.82 25.29 27.01 -10.28 5.58 24.68 -12.12 6.31 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 2 3 # 2 A 314 TRP B 129 TRP~? 23.11 CL CL B 278 A 317 GLU B 83 GLU~? 26.47 CL CL A 278 A 365 ARG B 127 ARG~? 22.49 CL CL B 278 coo 79.91 26.87 38.77 78.95 23.18 37.81 19.76 -7.70 -34.49 19.52 -6.98 -30.65 coo 85.55 26.30 41.25 85.59 24.97 39.65 24.57 -10.93 -33.84 23.46 -9.16 -34.20 coo 83.47 25.30 27.10 83.44 27.82 25.29 13.11 -0.63 -38.30 10.87 -2.72 -38.33 1g8o_c01 source 1g8o N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALACTOSYLTRA: 2 hits 1g8o_c01 naa= 3 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 1 3 # 1 412 GLU A 238 GLU^? 24.84 CL CL A 278 516 HIS A -1 HIS.? 31.67 CL CL A 278 559 HIS A 0 HIS.? 29.82 CL CL A 278 coo 49.01 14.50 52.53 46.99 14.61 52.78 22.87 -26.18 11.53 21.04 -27.14 11.99 coo 41.59 7.83 54.15 41.16 9.87 53.87 23.28 -34.51 17.18 21.28 -34.97 16.73 coo 42.22 14.55 52.50 43.91 14.87 53.60 28.39 -31.84 13.78 30.11 -32.89 14.37 1gal_c00 source 1gal GLUCOSE OXIDASE (E.C.1.1.3.4) : 1 hits 1gal_c00 naa= 3 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 1 3 # 1 A 36 GLU A 25 GLU~? 26.70 CL CL A 278 A 47 ASP A 13 ASP~? 20.85 CL CL A 278 A 161 TYR A 26 TYR~? 18.66 CL CL A 278 coo 37.12 18.35 73.76 37.09 16.69 72.44 0.23 -35.14 2.73 -1.02 -35.12 1.03 coo 29.81 8.06 73.13 30.21 10.11 72.95 3.80 -37.83 -7.42 4.89 -38.66 -9.05 coo 37.29 15.56 67.90 37.37 13.79 70.08 7.77 -31.94 1.38 10.47 -31.53 0.90 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 2 3 # 2 A 36 GLU B 25 GLU~? 26.94 CL CL B 278 A 47 ASP B 13 ASP~? 21.13 CL CL B 278 A 161 TYR B 26 TYR~? 19.09 CL CL B 278 coo 37.12 18.35 73.76 37.09 16.69 72.44 -13.37 -23.90 -28.96 -13.41 -24.80 -27.04 coo 29.81 8.06 73.13 30.21 10.11 72.95 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 coo 37.29 15.56 67.90 37.37 13.79 70.08 -9.51 -16.67 -28.98 -9.06 -13.93 -28.84 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 3 3 # 3 A 36 GLU B 25 GLU~? 26.94 CL CL B 278 A 47 ASP B 275 ASP.? 37.37 CL CL B 278 A 161 TYR B 24 TYR~? 29.69 CL CL B 278 coo 37.12 18.35 73.76 37.09 16.69 72.44 -13.37 -23.90 -28.96 -13.41 -24.80 -27.04 coo 29.81 8.06 73.13 30.21 10.11 72.95 -15.60 -35.07 -27.87 -14.73 -36.02 -29.60 coo 37.29 15.56 67.90 37.37 13.79 70.08 -10.93 -24.23 -34.16 -12.79 -24.53 -36.20 1geq_c02 source 1geq TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT : 3 hits 1geq_c02 naa= 3 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 1 3 # 1 B 36 GLU A 25 GLU~? 26.70 CL CL A 278 B 47 ASP A 13 ASP~? 20.85 CL CL A 278 B 161 TYR A 26 TYR~? 18.66 CL CL A 278 coo 53.87 35.49 53.22 55.44 35.72 54.61 0.23 -35.14 2.73 -1.02 -35.12 1.03 coo 63.47 43.65 53.95 61.45 43.07 54.06 3.80 -37.83 -7.42 4.89 -38.66 -9.05 coo 56.38 35.81 59.19 58.25 35.77 57.10 7.77 -31.94 1.38 10.47 -31.53 0.90 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 2 3 # 2 B 36 GLU B 25 GLU~? 26.94 CL CL B 278 B 47 ASP B 13 ASP~? 21.13 CL CL B 278 B 161 TYR B 26 TYR~? 19.09 CL CL B 278 coo 53.87 35.49 53.22 55.44 35.72 54.61 -13.37 -23.90 -28.96 -13.41 -24.80 -27.04 coo 63.47 43.65 53.95 61.45 43.07 54.06 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 coo 56.38 35.81 59.19 58.25 35.77 57.10 -9.51 -16.67 -28.98 -9.06 -13.93 -28.84 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 3 3 # 3 B 36 GLU B 25 GLU~? 26.94 CL CL B 278 B 47 ASP B 275 ASP.? 37.37 CL CL B 278 B 161 TYR B 24 TYR~? 29.69 CL CL B 278 coo 53.87 35.49 53.22 55.44 35.72 54.61 -13.37 -23.90 -28.96 -13.41 -24.80 -27.04 coo 63.47 43.65 53.95 61.45 43.07 54.06 -15.60 -35.07 -27.87 -14.73 -36.02 -29.60 coo 56.38 35.81 59.19 58.25 35.77 57.10 -10.93 -24.23 -34.16 -12.79 -24.53 -36.20 1geq_c03 source 1geq TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT : 3 hits 1geq_c03 naa= 3 ULMN 3 1gns_c00 SUBTILISIN BPN' user 1 3 # 1 A 32 ASP A 13 ASP~? 20.85 CL CL A 278 A 64 HIS A 12 HIS~? 14.78 CL CL A 278 A 155 ASN A 244 ASN.? 5.40 CL CL A 278 coo 3.12 38.70 24.20 3.24 38.59 26.33 3.80 -37.83 -7.42 4.89 -38.66 -9.05 coo 1.90 38.00 29.77 3.91 38.35 29.95 9.03 -33.35 -4.93 10.37 -31.88 -5.56 coo 9.89 36.55 37.38 9.27 37.99 36.08 17.85 -28.42 -8.05 16.64 -26.87 -8.84 ULMN 3 1gns_c00 SUBTILISIN BPN' user 2 3 # 2 A 32 ASP A 13 ASP~? 20.85 CL CL A 278 A 64 HIS A 12 HIS~? 14.78 CL CL A 278 A 155 ASN A 245 ASN.? 11.79 CL CL A 278 coo 3.12 38.70 24.20 3.24 38.59 26.33 3.80 -37.83 -7.42 4.89 -38.66 -9.05 coo 1.90 38.00 29.77 3.91 38.35 29.95 9.03 -33.35 -4.93 10.37 -31.88 -5.56 coo 9.89 36.55 37.38 9.27 37.99 36.08 18.48 -33.48 -10.76 18.30 -34.93 -9.15 ULMN 3 1gns_c00 SUBTILISIN BPN' user 3 3 # 3 A 32 ASP A 13 ASP~? 20.85 CL CL A 278 A 64 HIS A 12 HIS~? 14.78 CL CL A 278 A 155 ASN A 254 ASN~? 16.17 CL CL A 278 coo 3.12 38.70 24.20 3.24 38.59 26.33 3.80 -37.83 -7.42 4.89 -38.66 -9.05 coo 1.90 38.00 29.77 3.91 38.35 29.95 9.03 -33.35 -4.93 10.37 -31.88 -5.56 coo 9.89 36.55 37.38 9.27 37.99 36.08 18.50 -38.45 -6.68 18.86 -39.34 -8.59 ULMN 3 1gns_c00 SUBTILISIN BPN' user 4 3 # 4 A 32 ASP A 168 ASP^? 12.27 CL CL A 278 A 64 HIS A 194 HIS.? 4.68 CL CL A 278 A 155 ASN A 246 ASN.? 12.85 CL CL A 278 coo 3.12 38.70 24.20 3.24 38.59 26.33 26.46 -30.73 -8.22 26.92 -32.42 -9.39 coo 1.90 38.00 29.77 3.91 38.35 29.95 21.59 -27.03 -10.13 21.31 -25.37 -8.87 coo 9.89 36.55 37.38 9.27 37.99 36.08 12.83 -32.17 -9.87 11.11 -33.32 -9.30 ULMN 3 1gns_c00 SUBTILISIN BPN' user 5 3 # 5 A 32 ASP B 13 ASP~? 21.13 CL CL B 278 A 64 HIS B 12 HIS~? 15.42 CL CL B 278 A 155 ASN B 244 ASN.? 5.94 CL CL B 278 coo 3.12 38.70 24.20 3.24 38.59 26.33 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 coo 1.90 38.00 29.77 3.91 38.35 29.95 -10.18 -14.51 -22.80 -8.49 -13.29 -22.60 coo 9.89 36.55 37.38 9.27 37.99 36.08 -3.88 -6.12 -21.35 -2.47 -7.43 -20.48 ULMN 3 1gns_c00 SUBTILISIN BPN' user 6 3 # 6 A 32 ASP B 13 ASP~? 21.13 CL CL B 278 A 64 HIS B 12 HIS~? 15.42 CL CL B 278 A 155 ASN B 245 ASN.? 12.34 CL CL B 278 coo 3.12 38.70 24.20 3.24 38.59 26.33 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 coo 1.90 38.00 29.77 3.91 38.35 29.95 -10.18 -14.51 -22.80 -8.49 -13.29 -22.60 coo 9.89 36.55 37.38 9.27 37.99 36.08 -8.45 -4.50 -18.19 -10.06 -4.59 -19.62 ULMN 3 1gns_c00 SUBTILISIN BPN' user 7 3 # 7 A 32 ASP B 13 ASP~? 21.13 CL CL B 278 A 64 HIS B 12 HIS~? 15.42 CL CL B 278 A 155 ASN B 254 ASN~? 16.98 CL CL B 278 coo 3.12 38.70 24.20 3.24 38.59 26.33 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 coo 1.90 38.00 29.77 3.91 38.35 29.95 -10.18 -14.51 -22.80 -8.49 -13.29 -22.60 coo 9.89 36.55 37.38 9.27 37.99 36.08 -14.04 -4.32 -21.65 -14.71 -3.72 -19.71 ULMN 3 1gns_c00 SUBTILISIN BPN' user 8 3 # 8 A 32 ASP B 168 ASP^? 12.80 CL CL B 278 A 64 HIS B 194 HIS.? 5.13 CL CL B 278 A 155 ASN B 246 ASN.? 13.30 CL CL B 278 coo 3.12 38.70 24.20 3.24 38.59 26.33 -5.42 2.81 -22.11 -6.82 3.76 -20.83 coo 1.90 38.00 29.77 3.91 38.35 29.95 -1.92 -2.21 -20.05 -0.53 -2.75 -21.52 coo 9.89 36.55 37.38 9.27 37.99 36.08 -7.71 -10.36 -18.40 -9.09 -11.94 -18.78 1gns_c00 source 1gns SUBTILISIN BPN' : 8 hits 1gns_c00 naa= 3 ULMN 3 1grc_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 1 3 # 1 B 106 ASN A 245 ASN.? 11.79 CL CL A 278 B 108 HIS A 194 HIS.? 4.68 CL CL A 278 B 144 ASP A 36 ASP~? 8.69 CL CL A 278 coo 36.64 101.02 13.15 38.55 101.84 12.78 18.48 -33.48 -10.76 18.30 -34.93 -9.15 coo 41.00 107.18 12.86 42.70 107.82 11.96 21.59 -27.03 -10.13 21.31 -25.37 -8.87 coo 31.60 110.69 6.14 29.69 109.74 5.94 11.67 -20.98 -6.16 13.43 -22.16 -5.96 ULMN 3 1grc_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 2 3 # 2 B 106 ASN A 246 ASN.? 12.85 CL CL A 278 B 108 HIS A 12 HIS~? 14.78 CL CL A 278 B 144 ASP A 36 ASP~? 8.69 CL CL A 278 coo 36.64 101.02 13.15 38.55 101.84 12.78 12.83 -32.17 -9.87 11.11 -33.32 -9.30 coo 41.00 107.18 12.86 42.70 107.82 11.96 9.03 -33.35 -4.93 10.37 -31.88 -5.56 coo 31.60 110.69 6.14 29.69 109.74 5.94 11.67 -20.98 -6.16 13.43 -22.16 -5.96 ULMN 3 1grc_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 3 3 # 3 B 106 ASN B 245 ASN.? 12.34 CL CL B 278 B 108 HIS B 194 HIS.? 5.13 CL CL B 278 B 144 ASP B 36 ASP~? 8.83 CL CL B 278 coo 36.64 101.02 13.15 38.55 101.84 12.78 -8.45 -4.50 -18.19 -10.06 -4.59 -19.62 coo 41.00 107.18 12.86 42.70 107.82 11.96 -1.92 -2.21 -20.05 -0.53 -2.75 -21.52 coo 31.60 110.69 6.14 29.69 109.74 5.94 2.64 -13.17 -23.36 1.59 -11.35 -23.67 ULMN 3 1grc_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 4 3 # 4 B 106 ASN B 246 ASN.? 13.30 CL CL B 278 B 108 HIS B 12 HIS~? 15.42 CL CL B 278 B 144 ASP B 36 ASP~? 8.83 CL CL B 278 coo 36.64 101.02 13.15 38.55 101.84 12.78 -7.71 -10.36 -18.40 -9.09 -11.94 -18.78 coo 41.00 107.18 12.86 42.70 107.82 11.96 -10.18 -14.51 -22.80 -8.49 -13.29 -22.60 coo 31.60 110.69 6.14 29.69 109.74 5.94 2.64 -13.17 -23.36 1.59 -11.35 -23.67 1grc_c03 source 1grc GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE (E.C: 4 hits 1grc_c03 naa= 3 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 1 3 # 1 160 LYS A 64 LYS^? 6.64 CL CL A 278 210 ARG A 209 ARG~? 8.75 CL CL A 278 225 ARG A 212 ARG~? 4.63 CL CL A 278 coo 17.51 28.50 73.42 17.24 23.02 75.86 14.97 -18.21 -2.39 15.88 -19.33 -8.52 coo 24.74 11.56 73.05 25.29 14.32 71.80 12.19 -22.36 -19.55 12.55 -20.19 -17.38 coo 27.81 15.44 77.10 25.66 16.50 75.19 18.59 -24.77 -16.89 17.13 -22.12 -16.49 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 2 3 # 2 160 LYS A 211 LYS~? 14.92 CL CL A 278 210 ARG A 192 ARG^? 5.91 CL CL A 278 225 ARG A 140 ARG.? 3.74 CL CL A 278 coo 17.51 28.50 73.42 17.24 23.02 75.86 17.07 -30.19 -20.07 15.73 -30.42 -25.42 coo 24.74 11.56 73.05 25.29 14.32 71.80 20.84 -24.38 -4.40 19.02 -23.24 -6.62 coo 27.81 15.44 77.10 25.66 16.50 75.19 24.77 -21.68 -10.23 22.52 -23.37 -11.49 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 3 3 # 3 160 LYS B 64 LYS^? 6.39 CL CL B 278 210 ARG B 209 ARG~? 8.42 CL CL B 278 225 ARG B 212 ARG~? 4.30 CL CL B 278 coo 17.51 28.50 73.42 17.24 23.02 75.86 5.21 -10.68 -27.95 4.80 -8.81 -21.96 coo 24.74 11.56 73.05 25.29 14.32 71.80 2.92 -11.07 -10.38 5.18 -10.70 -12.48 coo 27.81 15.44 77.10 25.66 16.50 75.19 1.13 -4.70 -13.40 3.58 -6.46 -14.00 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 4 3 # 4 160 LYS B 210 LYS~? 12.46 CL CL B 278 210 ARG B 192 ARG^? 6.13 CL CL B 278 225 ARG B 140 ARG.? -3.53 CL CL B 278s coo 17.51 28.50 73.42 17.24 23.02 75.86 -2.49 -8.60 -10.03 0.77 -12.84 -8.24 coo 24.74 11.56 73.05 25.29 14.32 71.80 -0.17 -3.93 -26.09 1.00 -5.48 -23.71 coo 27.81 15.44 77.10 25.66 16.50 75.19 3.71 0.22 -21.03 2.09 -1.69 -19.26 1gsa_c00 source 1gsa GLUTATHIONE SYNTHETASE : 4 hits 1gsa_c00 naa= 3 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 1 3 # 1 A 271 GLN A 72 GLN.? 10.10 CL CL A 278 A 296 GLU B 74 GLU~? 12.92 CL CL A 278 A 383 TYR B 78 TYR~? 9.41 CL CL A 278 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 18.00 -13.55 -12.17 18.65 -13.84 -10.18 coo 40.93 4.45 2.36 38.91 3.75 2.26 20.28 -11.36 -18.58 21.63 -11.86 -17.04 coo 30.54 7.22 6.23 31.38 5.79 3.97 18.05 -20.46 -22.54 16.77 -21.06 -20.14 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 2 3 # 2 A 271 GLN A 76 GLN~? 15.56 CL CL B 278 A 296 GLU A 74 GLU~? 12.23 CL CL B 278 A 383 TYR A 66 TYR.? 15.11 CL CL B 278 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 13.60 0.77 -10.68 15.37 -0.40 -10.87 coo 40.93 4.45 2.36 38.91 3.75 2.26 14.45 -4.40 -13.52 13.94 -3.10 -15.11 coo 30.54 7.22 6.23 31.38 5.79 3.97 11.56 -10.03 -5.26 10.21 -8.56 -7.21 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 3 3 # 3 A 271 GLN A 76 GLN~? 15.56 CL CL B 278 A 296 GLU A 74 GLU~? 12.23 CL CL B 278 A 383 TYR A 78 TYR~? 9.12 CL CL B 278 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 13.60 0.77 -10.68 15.37 -0.40 -10.87 coo 40.93 4.45 2.36 38.91 3.75 2.26 14.45 -4.40 -13.52 13.94 -3.10 -15.11 coo 30.54 7.22 6.23 31.38 5.79 3.97 5.93 -5.00 -8.22 4.93 -6.54 -10.31 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 4 3 # 4 A 271 GLN A 76 GLN~? 15.56 CL CL B 278 A 296 GLU A 82 GLU~? 22.17 CL CL B 278 A 383 TYR A 66 TYR.? 15.11 CL CL B 278 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 13.60 0.77 -10.68 15.37 -0.40 -10.87 coo 40.93 4.45 2.36 38.91 3.75 2.26 18.08 -1.27 -4.95 20.15 -1.66 -5.22 coo 30.54 7.22 6.23 31.38 5.79 3.97 11.56 -10.03 -5.26 10.21 -8.56 -7.21 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 5 3 # 5 A 271 GLN A 76 GLN~? 15.56 CL CL B 278 A 296 GLU A 82 GLU~? 22.17 CL CL B 278 A 383 TYR A 78 TYR~? 9.12 CL CL B 278 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 13.60 0.77 -10.68 15.37 -0.40 -10.87 coo 40.93 4.45 2.36 38.91 3.75 2.26 18.08 -1.27 -4.95 20.15 -1.66 -5.22 coo 30.54 7.22 6.23 31.38 5.79 3.97 5.93 -5.00 -8.22 4.93 -6.54 -10.31 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 6 3 # 6 A 271 GLN A 171 GLN.? 12.96 CL CL A 278 A 296 GLU A 169 GLU.? 7.63 CL CL A 278 A 383 TYR A 145 TYR~? 15.40 CL CL A 278 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 30.97 -29.89 -15.03 31.06 -28.02 -13.98 coo 40.93 4.45 2.36 38.91 3.75 2.26 26.74 -26.14 -12.80 26.49 -24.16 -13.47 coo 30.54 7.22 6.23 31.38 5.79 3.97 34.36 -21.23 -8.52 32.31 -21.44 -6.65 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 7 3 # 7 A 271 GLN A 171 GLN.? 12.96 CL CL A 278 A 296 GLU A 169 GLU.? 7.63 CL CL A 278 A 383 TYR A 180 TYR.? 19.77 CL CL A 278 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 30.97 -29.89 -15.03 31.06 -28.02 -13.98 coo 40.93 4.45 2.36 38.91 3.75 2.26 26.74 -26.14 -12.80 26.49 -24.16 -13.47 coo 30.54 7.22 6.23 31.38 5.79 3.97 35.72 -25.25 -4.91 38.35 -24.47 -4.37 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 8 3 # 8 A 271 GLN A 171 GLN.? 12.96 CL CL A 278 A 296 GLU A 169 GLU.? 7.63 CL CL A 278 A 383 TYR A 215 TYR.? 13.87 CL CL A 278 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 30.97 -29.89 -15.03 31.06 -28.02 -13.98 coo 40.93 4.45 2.36 38.91 3.75 2.26 26.74 -26.14 -12.80 26.49 -24.16 -13.47 coo 30.54 7.22 6.23 31.38 5.79 3.97 21.62 -36.04 -14.58 23.93 -37.55 -14.90 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 9 3 # 9 A 271 GLN A 171 GLN.? 12.96 CL CL A 278 A 296 GLU A 169 GLU.? 7.63 CL CL A 278 A 383 TYR A 217 TYR.? 13.45 CL CL A 278 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 30.97 -29.89 -15.03 31.06 -28.02 -13.98 coo 40.93 4.45 2.36 38.91 3.75 2.26 26.74 -26.14 -12.80 26.49 -24.16 -13.47 coo 30.54 7.22 6.23 31.38 5.79 3.97 22.77 -37.42 -9.36 23.40 -34.73 -9.58 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 10 3 # 10 A 271 GLN B 72 GLN.? 9.50 CL CL B 278 A 296 GLU A 74 GLU~? 12.23 CL CL B 278 A 383 TYR A 78 TYR~? 9.12 CL CL B 278 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 11.42 -7.18 -19.22 10.79 -6.65 -21.16 coo 40.93 4.45 2.36 38.91 3.75 2.26 14.45 -4.40 -13.52 13.94 -3.10 -15.11 coo 30.54 7.22 6.23 31.38 5.79 3.97 5.93 -5.00 -8.22 4.93 -6.54 -10.31 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 11 3 # 11 A 271 GLN B 76 GLN~? 15.88 CL CL A 278 A 296 GLU B 74 GLU~? 12.92 CL CL A 278 A 383 TYR B 66 TYR.? 15.55 CL CL A 278 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 24.82 -13.19 -21.85 23.67 -11.43 -21.48 coo 40.93 4.45 2.36 38.91 3.75 2.26 20.28 -11.36 -18.58 21.63 -11.86 -17.04 coo 30.54 7.22 6.23 31.38 5.79 3.97 13.28 -14.60 -25.62 14.79 -15.90 -23.67 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 12 3 # 12 A 271 GLN B 76 GLN~? 15.88 CL CL A 278 A 296 GLU B 74 GLU~? 12.92 CL CL A 278 A 383 TYR B 78 TYR~? 9.41 CL CL A 278 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 24.82 -13.19 -21.85 23.67 -11.43 -21.48 coo 40.93 4.45 2.36 38.91 3.75 2.26 20.28 -11.36 -18.58 21.63 -11.86 -17.04 coo 30.54 7.22 6.23 31.38 5.79 3.97 18.05 -20.46 -22.54 16.77 -21.06 -20.14 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 13 3 # 13 A 271 GLN B 76 GLN~? 15.88 CL CL A 278 A 296 GLU B 82 GLU~? 22.63 CL CL A 278 A 383 TYR B 66 TYR.? 15.55 CL CL A 278 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 24.82 -13.19 -21.85 23.67 -11.43 -21.48 coo 40.93 4.45 2.36 38.91 3.75 2.26 22.63 -9.38 -27.83 22.57 -7.28 -27.71 coo 30.54 7.22 6.23 31.38 5.79 3.97 13.28 -14.60 -25.62 14.79 -15.90 -23.67 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 14 3 # 14 A 271 GLN B 76 GLN~? 15.88 CL CL A 278 A 296 GLU B 82 GLU~? 22.63 CL CL A 278 A 383 TYR B 78 TYR~? 9.41 CL CL A 278 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 24.82 -13.19 -21.85 23.67 -11.43 -21.48 coo 40.93 4.45 2.36 38.91 3.75 2.26 22.63 -9.38 -27.83 22.57 -7.28 -27.71 coo 30.54 7.22 6.23 31.38 5.79 3.97 18.05 -20.46 -22.54 16.77 -21.06 -20.14 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 15 3 # 15 A 271 GLN B 171 GLN.? 12.98 CL CL B 278 A 296 GLU B 169 GLU.? 7.43 CL CL B 278 A 383 TYR B 145 TYR.? 15.21 CL CL B 278 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 -3.04 7.96 -16.04 -1.40 7.63 -17.39 coo 40.93 4.45 2.36 38.91 3.75 2.26 0.06 3.03 -18.46 2.10 2.57 -18.04 coo 30.54 7.22 6.23 31.38 5.79 3.97 5.06 9.55 -24.01 4.48 7.22 -25.41 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 16 3 # 16 A 271 GLN B 171 GLN.? 12.98 CL CL B 278 A 296 GLU B 169 GLU.? 7.43 CL CL B 278 A 383 TYR B 180 TYR.? 19.79 CL CL B 278 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 -3.04 7.96 -16.04 -1.40 7.63 -17.39 coo 40.93 4.45 2.36 38.91 3.75 2.26 0.06 3.03 -18.46 2.10 2.57 -18.04 coo 30.54 7.22 6.23 31.38 5.79 3.97 0.34 10.88 -27.32 1.25 13.08 -28.75 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 17 3 # 17 A 271 GLN B 171 GLN.? 12.98 CL CL B 278 A 296 GLU B 169 GLU.? 7.43 CL CL B 278 A 383 TYR B 215 TYR.? 14.28 CL CL B 278 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 -3.04 7.96 -16.04 -1.40 7.63 -17.39 coo 40.93 4.45 2.36 38.91 3.75 2.26 0.06 3.03 -18.46 2.10 2.57 -18.04 coo 30.54 7.22 6.23 31.38 5.79 3.97 -10.18 -0.68 -14.85 -11.32 1.86 -14.73 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 18 3 # 18 A 271 GLN B 171 GLN.? 12.98 CL CL B 278 A 296 GLU B 169 GLU.? 7.43 CL CL B 278 A 383 TYR B 217 TYR.? 13.94 CL CL B 278 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 -3.04 7.96 -16.04 -1.40 7.63 -17.39 coo 40.93 4.45 2.36 38.91 3.75 2.26 0.06 3.03 -18.46 2.10 2.57 -18.04 coo 30.54 7.22 6.23 31.38 5.79 3.97 -12.06 -0.05 -19.78 -9.32 0.42 -19.98 1h19_c00 source 1h19 LEUKOTRIENE A-4 HYDROLASE : 18 hits 1h19_c00 naa= 3 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 1 3 # 1 A 50 ASP A 13 ASP~? 20.85 CL CL A 278 A 327 GLU B 221 GLU~? 17.56 CL CL B 278 A 339 ARG B 196 ARG.? 16.18 CL CL B 278 coo 85.81 57.99 116.01 86.03 55.86 115.89 3.80 -37.83 -7.42 4.89 -38.66 -9.05 coo 75.11 41.01 160.30 76.65 40.06 161.41 -13.90 4.76 -18.50 -13.25 3.58 -16.87 coo 82.23 40.35 159.87 85.09 40.67 161.01 -8.42 4.93 -17.56 -9.12 6.53 -20.07 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 2 3 # 2 A 50 ASP A 132 ASP.? 29.97 CL CL A 278 A 327 GLU B 221 GLU~? 17.56 CL CL B 278 A 339 ARG B 196 ARG.? 16.18 CL CL B 278 coo 85.81 57.99 116.01 86.03 55.86 115.89 22.31 -10.85 12.65 23.22 -9.04 13.30 coo 75.11 41.01 160.30 76.65 40.06 161.41 -13.90 4.76 -18.50 -13.25 3.58 -16.87 coo 82.23 40.35 159.87 85.09 40.67 161.01 -8.42 4.93 -17.56 -9.12 6.53 -20.07 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 3 3 # 3 A 50 ASP A 250 ASP~? 15.45 CL CL A 278 A 327 GLU B 238 GLU^? 25.19 CL CL B 278 A 339 ARG B 3 ARG^? 24.44 CL CL B 278 coo 85.81 57.99 116.01 86.03 55.86 115.89 15.24 -38.09 -11.21 14.62 -38.47 -13.19 coo 75.11 41.01 160.30 76.65 40.06 161.41 -3.49 -3.71 -41.35 -4.99 -5.08 -41.88 coo 82.23 40.35 159.87 85.09 40.67 161.01 -7.40 -8.36 -37.36 -6.70 -7.91 -40.31 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 4 3 # 4 A 50 ASP A 268 ASP.? 26.73 CL CL A 278 A 327 GLU B 138 GLU^? 6.70 CL CL B 278 A 339 ARG B 192 ARG^? 6.13 CL CL B 278 coo 85.81 57.99 116.01 86.03 55.86 115.89 9.60 -34.57 10.49 9.97 -36.28 9.26 coo 75.11 41.01 160.30 76.65 40.06 161.41 3.87 -1.10 -24.33 2.09 -2.15 -23.84 coo 82.23 40.35 159.87 85.09 40.67 161.01 -0.17 -3.93 -26.09 1.00 -5.48 -23.71 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 5 3 # 5 A 50 ASP A 268 ASP.? 26.73 CL CL A 278 A 327 GLU B 169 GLU.? 7.43 CL CL B 278 A 339 ARG B 140 ARG.? -3.53 CL CL B 278s coo 85.81 57.99 116.01 86.03 55.86 115.89 9.60 -34.57 10.49 9.97 -36.28 9.26 coo 75.11 41.01 160.30 76.65 40.06 161.41 0.06 3.03 -18.46 2.10 2.57 -18.04 coo 82.23 40.35 159.87 85.09 40.67 161.01 3.71 0.22 -21.03 2.09 -1.69 -19.26 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 6 3 # 6 A 50 ASP A 275 ASP.? 34.16 CL CL A 278 A 327 GLU B 221 GLU~? 17.56 CL CL B 278 A 339 ARG B 196 ARG.? 16.18 CL CL B 278 coo 85.81 57.99 116.01 86.03 55.86 115.89 -7.58 -36.49 2.30 -8.60 -35.44 3.90 coo 75.11 41.01 160.30 76.65 40.06 161.41 -13.90 4.76 -18.50 -13.25 3.58 -16.87 coo 82.23 40.35 159.87 85.09 40.67 161.01 -8.42 4.93 -17.56 -9.12 6.53 -20.07 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 7 3 # 7 A 50 ASP B 13 ASP~? 21.13 CL CL B 278 A 327 GLU A 221 GLU~? 17.05 CL CL A 278 A 339 ARG A 196 ARG.? 15.95 CL CL A 278 coo 85.81 57.99 116.01 86.03 55.86 115.89 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 coo 75.11 41.01 160.30 76.65 40.06 161.41 27.14 -39.98 -10.94 25.92 -39.21 -12.48 coo 82.23 40.35 159.87 85.09 40.67 161.01 27.49 -34.87 -12.70 29.46 -35.46 -10.43 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 8 3 # 8 A 50 ASP B 132 ASP.? 29.62 CL CL B 278 A 327 GLU A 221 GLU~? 17.05 CL CL A 278 A 339 ARG A 196 ARG.? 15.95 CL CL A 278 coo 85.81 57.99 116.01 86.03 55.86 115.89 11.22 -5.69 -44.39 12.86 -4.72 -45.32 coo 75.11 41.01 160.30 76.65 40.06 161.41 27.14 -39.98 -10.94 25.92 -39.21 -12.48 coo 82.23 40.35 159.87 85.09 40.67 161.01 27.49 -34.87 -12.70 29.46 -35.46 -10.43 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 9 3 # 9 A 50 ASP B 250 ASP~? 16.15 CL CL B 278 A 327 GLU A 238 GLU^? 24.84 CL CL A 278 A 339 ARG A 3 ARG^? 24.49 CL CL A 278 coo 85.81 57.99 116.01 86.03 55.86 115.89 -13.35 -7.01 -16.89 -13.59 -7.26 -14.81 coo 75.11 41.01 160.30 76.65 40.06 161.41 22.87 -26.18 11.53 21.04 -27.14 11.99 coo 82.23 40.35 159.87 85.09 40.67 161.01 17.45 -29.65 8.35 18.11 -29.19 11.33 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 10 3 # 10 A 50 ASP B 267 ASP.? 32.55 CL CL B 278 A 327 GLU A 46 GLU~? 24.48 CL CL B 278 A 339 ARG A 47 ARG~? 19.53 CL CL B 278 coo 85.81 57.99 116.01 86.03 55.86 115.89 -15.25 -13.37 -42.11 -14.97 -14.80 -43.57 coo 75.11 41.01 160.30 76.65 40.06 161.41 -1.94 -12.84 6.51 -1.20 -10.99 5.75 coo 82.23 40.35 159.87 85.09 40.67 161.01 1.19 -18.60 0.09 1.74 -17.18 -2.58 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 11 3 # 11 A 50 ASP B 267 ASP.? 32.55 CL CL B 278 A 327 GLU A 50 GLU~? 27.20 CL CL B 278 A 339 ARG A 47 ARG~? 19.53 CL CL B 278 coo 85.81 57.99 116.01 86.03 55.86 115.89 -15.25 -13.37 -42.11 -14.97 -14.80 -43.57 coo 75.11 41.01 160.30 76.65 40.06 161.41 -1.40 -20.04 6.08 -2.65 -20.05 4.33 coo 82.23 40.35 159.87 85.09 40.67 161.01 1.19 -18.60 0.09 1.74 -17.18 -2.58 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 12 3 # 12 A 50 ASP B 268 ASP.? 26.26 CL CL B 278 A 327 GLU A 169 GLU.? 7.63 CL CL A 278 A 339 ARG A 140 ARG.? 3.74 CL CL A 278 coo 85.81 57.99 116.01 86.03 55.86 115.89 -14.31 -16.11 -36.83 -14.03 -14.11 -36.24 coo 75.11 41.01 160.30 76.65 40.06 161.41 26.74 -26.14 -12.80 26.49 -24.16 -13.47 coo 82.23 40.35 159.87 85.09 40.67 161.01 24.77 -21.68 -10.23 22.52 -23.37 -11.49 1hto_c00 source 1hto GLUTAMINE SYNTHETASE : 12 hits 1hto_c00 naa= 3 ULMN 3 1i29_c01 CSDB user 1 3 # 1 A 123 HIS A 29 HIS.? 25.16 CL CL A 278 A 200 ASP A 268 ASP.? 26.73 CL CL A 278 A 226 LYS A 272 LYS.? 33.16 CL CL A 278 coo 23.24 46.58 4.39 24.43 46.59 2.66 7.41 -38.44 3.20 5.56 -39.41 3.04 coo 24.51 43.28 11.18 25.17 44.50 9.58 9.60 -34.57 10.49 9.97 -36.28 9.26 coo 34.47 51.09 7.19 28.58 51.18 7.53 -2.40 -40.27 7.96 -3.06 -34.63 9.73 ULMN 3 1i29_c01 CSDB user 2 3 # 2 A 123 HIS A 194 HIS.? 4.68 CL CL A 278 A 200 ASP A 168 ASP^? 12.27 CL CL A 278 A 226 LYS A 211 LYS~? 14.92 CL CL A 278 coo 23.24 46.58 4.39 24.43 46.59 2.66 21.59 -27.03 -10.13 21.31 -25.37 -8.87 coo 24.51 43.28 11.18 25.17 44.50 9.58 26.46 -30.73 -8.22 26.92 -32.42 -9.39 coo 34.47 51.09 7.19 28.58 51.18 7.53 17.07 -30.19 -20.07 15.73 -30.42 -25.42 ULMN 3 1i29_c01 CSDB user 3 3 # 3 A 123 HIS B 194 HIS.? 5.13 CL CL B 278 A 200 ASP B 168 ASP^? 12.80 CL CL B 278 A 226 LYS B 211 LYS~? 15.02 CL CL B 278 coo 23.24 46.58 4.39 24.43 46.59 2.66 -1.92 -2.21 -20.05 -0.53 -2.75 -21.52 coo 24.51 43.28 11.18 25.17 44.50 9.58 -5.42 2.81 -22.11 -6.82 3.76 -20.83 coo 34.47 51.09 7.19 28.58 51.18 7.53 -4.12 -5.20 -9.45 -3.45 -5.07 -3.77 1i29_c01 source 1i29 CSDB : 3 hits 1i29_c01 naa= 3 ULMN 3 1i29_c03 CSDB user 1 3 # 1 A 128 VAL A 33 VAL^? 16.22 CL CL A 278 A 200 ASP A 268 ASP.? 26.73 CL CL A 278 A 226 LYS A 272 LYS.? 33.16 CL CL A 278 coo 19.13 38.05 1.41 19.72 38.80 -0.53 12.76 -27.92 1.57 10.63 -27.34 1.31 coo 24.51 43.28 11.18 25.17 44.50 9.58 9.60 -34.57 10.49 9.97 -36.28 9.26 coo 34.47 51.09 7.19 28.58 51.18 7.53 -2.40 -40.27 7.96 -3.06 -34.63 9.73 ULMN 3 1i29_c03 CSDB user 2 3 # 2 A 128 VAL A 52 VAL~? 25.89 CL CL A 278 A 200 ASP A 268 ASP.? 26.73 CL CL A 278 A 226 LYS A 272 LYS.? 33.16 CL CL A 278 coo 19.13 38.05 1.41 19.72 38.80 -0.53 5.60 -22.39 9.28 6.61 -20.82 10.47 coo 24.51 43.28 11.18 25.17 44.50 9.58 9.60 -34.57 10.49 9.97 -36.28 9.26 coo 34.47 51.09 7.19 28.58 51.18 7.53 -2.40 -40.27 7.96 -3.06 -34.63 9.73 ULMN 3 1i29_c03 CSDB user 3 3 # 3 A 128 VAL B 107 VAL^? 13.05 CL CL B 278 A 200 ASP B 36 ASP~? 8.83 CL CL B 278 A 226 LYS B 210 LYS~? 12.46 CL CL B 278 coo 19.13 38.05 1.41 19.72 38.80 -0.53 8.31 -5.32 -28.11 10.23 -5.07 -29.17 coo 24.51 43.28 11.18 25.17 44.50 9.58 2.64 -13.17 -23.36 1.59 -11.35 -23.67 coo 34.47 51.09 7.19 28.58 51.18 7.53 -2.49 -8.60 -10.03 0.77 -12.84 -8.24 ULMN 3 1i29_c03 CSDB user 4 3 # 4 A 128 VAL B 241 VAL^? 15.85 CL CL B 278 A 200 ASP B 168 ASP^? 12.80 CL CL B 278 A 226 LYS B 211 LYS~? 15.02 CL CL B 278 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -6.76 -3.48 -30.18 -8.47 -2.14 -29.91 coo 24.51 43.28 11.18 25.17 44.50 9.58 -5.42 2.81 -22.11 -6.82 3.76 -20.83 coo 34.47 51.09 7.19 28.58 51.18 7.53 -4.12 -5.20 -9.45 -3.45 -5.07 -3.77 1i29_c03 source 1i29 CSDB : 4 hits 1i29_c03 naa= 3 ULMN 3 1ig8_c00 HEXOKINASE PII user 1 3 # 1 A 158 SER A 247 SER.? 8.71 CL CL A 278 A 173 ARG A 209 ARG~? 8.75 CL CL A 278 A 211 ASP A 250 ASP~? 15.45 CL CL A 278 coo 22.72 76.24 0.23 24.60 76.86 -1.25 12.77 -32.05 -14.75 14.22 -30.30 -15.59 coo 18.77 77.82 11.69 20.55 80.22 10.73 12.19 -22.36 -19.55 12.55 -20.19 -17.38 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 15.24 -38.09 -11.21 14.62 -38.47 -13.19 ULMN 3 1ig8_c00 HEXOKINASE PII user 2 3 # 2 A 158 SER B 247 SER.? 9.35 CL CL B 278 A 173 ARG B 209 ARG~? 8.42 CL CL B 278 A 211 ASP B 250 ASP~? 16.15 CL CL B 278 coo 22.72 76.24 0.23 24.60 76.86 -1.25 -7.15 -9.80 -13.65 -5.07 -8.65 -13.11 coo 18.77 77.82 11.69 20.55 80.22 10.73 2.92 -11.07 -10.38 5.18 -10.70 -12.48 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 -13.35 -7.01 -16.89 -13.59 -7.26 -14.81 1ig8_c00 source 1ig8 HEXOKINASE PII : 2 hits 1ig8_c00 naa= 3 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 1 3 # 1 54 ASP A 250 ASP~? 15.45 CL CL A 278 158 THR A 213 THR.? 5.23 CL CL A 278 317 ASP A 168 ASP^? 12.27 CL CL A 278 coo -2.63 8.40 35.07 -3.66 9.81 36.17 15.24 -38.09 -11.21 14.62 -38.47 -13.19 coo -5.30 12.75 41.86 -4.34 13.05 39.99 17.89 -30.02 -14.53 16.90 -28.34 -13.63 coo -12.63 17.64 33.66 -10.65 17.90 34.40 26.46 -30.73 -8.22 26.92 -32.42 -9.39 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 2 3 # 2 54 ASP A 275 ASP.? 34.16 CL CL A 278 158 THR A 22 THR~? 25.76 CL CL A 278 317 ASP A 13 ASP~? 20.85 CL CL A 278 coo -2.63 8.40 35.07 -3.66 9.81 36.17 -7.58 -36.49 2.30 -8.60 -35.44 3.90 coo -5.30 12.75 41.86 -4.34 13.05 39.99 0.68 -30.75 0.65 -0.98 -31.46 1.84 coo -12.63 17.64 33.66 -10.65 17.90 34.40 3.80 -37.83 -7.42 4.89 -38.66 -9.05 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 3 3 # 3 54 ASP B 250 ASP~? 16.15 CL CL B 278 158 THR B 213 THR.? 5.93 CL CL B 278 317 ASP B 168 ASP^? 12.80 CL CL B 278 coo -2.63 8.40 35.07 -3.66 9.81 36.17 -13.35 -7.01 -16.89 -13.59 -7.26 -14.81 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -4.66 -4.97 -14.91 -3.30 -6.36 -15.86 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -5.42 2.81 -22.11 -6.82 3.76 -20.83 1inp_c02 source 1inp INOSITOL POLYPHOSPHATE 1-PHOSPHATASE (1-PTASE): 3 hits 1inp_c02 naa= 3 ULMN 3 1iph_c00 CATALASE HPII user 1 3 # 1 A 128 HIS A 12 HIS~? 14.78 CL CL A 278 A 167 SER A 8 SER.? 12.69 CL CL A 278 A 201 ASN A 246 ASN.? 12.85 CL CL A 278 coo 12.95 4.49 19.05 14.87 4.39 19.77 9.03 -33.35 -4.93 10.37 -31.88 -5.56 coo 10.44 7.96 22.51 12.16 7.57 20.82 8.88 -27.17 -3.98 8.36 -25.65 -5.80 coo 19.43 6.74 22.83 19.09 5.15 21.60 12.83 -32.17 -9.87 11.11 -33.32 -9.30 ULMN 3 1iph_c00 CATALASE HPII user 2 3 # 2 A 128 HIS A 12 HIS~? 14.78 CL CL A 278 A 167 SER A 10 SER.? 17.45 CL CL A 278 A 201 ASN A 246 ASN.? 12.85 CL CL A 278 coo 12.95 4.49 19.05 14.87 4.39 19.77 9.03 -33.35 -4.93 10.37 -31.88 -5.56 coo 10.44 7.96 22.51 12.16 7.57 20.82 3.77 -30.46 -4.30 3.68 -28.35 -5.48 coo 19.43 6.74 22.83 19.09 5.15 21.60 12.83 -32.17 -9.87 11.11 -33.32 -9.30 ULMN 3 1iph_c00 CATALASE HPII user 3 3 # 3 A 128 HIS B 12 HIS~? 15.42 CL CL B 278 A 167 SER B 8 SER.? 14.26 CL CL B 278 A 201 ASN B 246 ASN.? 13.30 CL CL B 278 coo 12.95 4.49 19.05 14.87 4.39 19.77 -10.18 -14.51 -22.80 -8.49 -13.29 -22.60 coo 10.44 7.96 22.51 12.16 7.57 20.82 -4.13 -15.22 -24.13 -4.29 -16.76 -22.25 coo 19.43 6.74 22.83 19.09 5.15 21.60 -7.71 -10.36 -18.40 -9.09 -11.94 -18.78 ULMN 3 1iph_c00 CATALASE HPII user 4 3 # 4 A 128 HIS B 12 HIS~? 15.42 CL CL B 278 A 167 SER B 10 SER.? 17.86 CL CL B 278 A 201 ASN B 246 ASN.? 13.30 CL CL B 278 coo 12.95 4.49 19.05 14.87 4.39 19.77 -10.18 -14.51 -22.80 -8.49 -13.29 -22.60 coo 10.44 7.96 22.51 12.16 7.57 20.82 -7.63 -19.97 -23.27 -5.38 -20.37 -22.44 coo 19.43 6.74 22.83 19.09 5.15 21.60 -7.71 -10.36 -18.40 -9.09 -11.94 -18.78 1iph_c00 source 1iph CATALASE HPII : 4 hits 1iph_c00 naa= 3 ULMN 3 1iph_c01 CATALASE HPII user 1 3 # 1 B 128 HIS A 12 HIS~? 14.78 CL CL A 278 B 167 SER A 8 SER.? 12.69 CL CL A 278 B 201 ASN A 246 ASN.? 12.85 CL CL A 278 coo -12.95 -4.49 19.05 -14.87 -4.39 19.77 9.03 -33.35 -4.93 10.37 -31.88 -5.56 coo -10.44 -7.96 22.51 -12.16 -7.57 20.82 8.88 -27.17 -3.98 8.36 -25.65 -5.80 coo -19.43 -6.74 22.83 -19.09 -5.15 21.60 12.83 -32.17 -9.87 11.11 -33.32 -9.30 ULMN 3 1iph_c01 CATALASE HPII user 2 3 # 2 B 128 HIS A 12 HIS~? 14.78 CL CL A 278 B 167 SER A 10 SER.? 17.45 CL CL A 278 B 201 ASN A 246 ASN.? 12.85 CL CL A 278 coo -12.95 -4.49 19.05 -14.87 -4.39 19.77 9.03 -33.35 -4.93 10.37 -31.88 -5.56 coo -10.44 -7.96 22.51 -12.16 -7.57 20.82 3.77 -30.46 -4.30 3.68 -28.35 -5.48 coo -19.43 -6.74 22.83 -19.09 -5.15 21.60 12.83 -32.17 -9.87 11.11 -33.32 -9.30 ULMN 3 1iph_c01 CATALASE HPII user 3 3 # 3 B 128 HIS B 12 HIS~? 15.42 CL CL B 278 B 167 SER B 8 SER.? 14.26 CL CL B 278 B 201 ASN B 246 ASN.? 13.30 CL CL B 278 coo -12.95 -4.49 19.05 -14.87 -4.39 19.77 -10.18 -14.51 -22.80 -8.49 -13.29 -22.60 coo -10.44 -7.96 22.51 -12.16 -7.57 20.82 -4.13 -15.22 -24.13 -4.29 -16.76 -22.25 coo -19.43 -6.74 22.83 -19.09 -5.15 21.60 -7.71 -10.36 -18.40 -9.09 -11.94 -18.78 ULMN 3 1iph_c01 CATALASE HPII user 4 3 # 4 B 128 HIS B 12 HIS~? 15.42 CL CL B 278 B 167 SER B 10 SER.? 17.86 CL CL B 278 B 201 ASN B 246 ASN.? 13.30 CL CL B 278 coo -12.95 -4.49 19.05 -14.87 -4.39 19.77 -10.18 -14.51 -22.80 -8.49 -13.29 -22.60 coo -10.44 -7.96 22.51 -12.16 -7.57 20.82 -7.63 -19.97 -23.27 -5.38 -20.37 -22.44 coo -19.43 -6.74 22.83 -19.09 -5.15 21.60 -7.71 -10.36 -18.40 -9.09 -11.94 -18.78 1iph_c01 source 1iph CATALASE HPII : 4 hits 1iph_c01 naa= 3 ULMN 3 1iph_c02 CATALASE HPII user 1 3 # 1 C 128 HIS A 12 HIS~? 14.78 CL CL A 278 C 167 SER A 8 SER.? 12.69 CL CL A 278 C 201 ASN A 246 ASN.? 12.85 CL CL A 278 coo -12.95 4.49 -19.05 -14.87 4.39 -19.77 9.03 -33.35 -4.93 10.37 -31.88 -5.56 coo -10.44 7.96 -22.51 -12.16 7.57 -20.82 8.88 -27.17 -3.98 8.36 -25.65 -5.80 coo -19.43 6.74 -22.83 -19.09 5.15 -21.60 12.83 -32.17 -9.87 11.11 -33.32 -9.30 ULMN 3 1iph_c02 CATALASE HPII user 2 3 # 2 C 128 HIS A 12 HIS~? 14.78 CL CL A 278 C 167 SER A 10 SER.? 17.45 CL CL A 278 C 201 ASN A 246 ASN.? 12.85 CL CL A 278 coo -12.95 4.49 -19.05 -14.87 4.39 -19.77 9.03 -33.35 -4.93 10.37 -31.88 -5.56 coo -10.44 7.96 -22.51 -12.16 7.57 -20.82 3.77 -30.46 -4.30 3.68 -28.35 -5.48 coo -19.43 6.74 -22.83 -19.09 5.15 -21.60 12.83 -32.17 -9.87 11.11 -33.32 -9.30 ULMN 3 1iph_c02 CATALASE HPII user 3 3 # 3 C 128 HIS B 12 HIS~? 15.42 CL CL B 278 C 167 SER B 8 SER.? 14.26 CL CL B 278 C 201 ASN B 246 ASN.? 13.30 CL CL B 278 coo -12.95 4.49 -19.05 -14.87 4.39 -19.77 -10.18 -14.51 -22.80 -8.49 -13.29 -22.60 coo -10.44 7.96 -22.51 -12.16 7.57 -20.82 -4.13 -15.22 -24.13 -4.29 -16.76 -22.25 coo -19.43 6.74 -22.83 -19.09 5.15 -21.60 -7.71 -10.36 -18.40 -9.09 -11.94 -18.78 ULMN 3 1iph_c02 CATALASE HPII user 4 3 # 4 C 128 HIS B 12 HIS~? 15.42 CL CL B 278 C 167 SER B 10 SER.? 17.86 CL CL B 278 C 201 ASN B 246 ASN.? 13.30 CL CL B 278 coo -12.95 4.49 -19.05 -14.87 4.39 -19.77 -10.18 -14.51 -22.80 -8.49 -13.29 -22.60 coo -10.44 7.96 -22.51 -12.16 7.57 -20.82 -7.63 -19.97 -23.27 -5.38 -20.37 -22.44 coo -19.43 6.74 -22.83 -19.09 5.15 -21.60 -7.71 -10.36 -18.40 -9.09 -11.94 -18.78 1iph_c02 source 1iph CATALASE HPII : 4 hits 1iph_c02 naa= 3 ULMN 3 1iph_c03 CATALASE HPII user 1 3 # 1 D 128 HIS A 12 HIS~? 14.78 CL CL A 278 D 167 SER A 8 SER.? 12.69 CL CL A 278 D 201 ASN A 246 ASN.? 12.85 CL CL A 278 coo 12.95 -4.49 -19.05 14.87 -4.39 -19.77 9.03 -33.35 -4.93 10.37 -31.88 -5.56 coo 10.44 -7.96 -22.51 12.16 -7.57 -20.82 8.88 -27.17 -3.98 8.36 -25.65 -5.80 coo 19.43 -6.74 -22.83 19.09 -5.15 -21.60 12.83 -32.17 -9.87 11.11 -33.32 -9.30 ULMN 3 1iph_c03 CATALASE HPII user 2 3 # 2 D 128 HIS A 12 HIS~? 14.78 CL CL A 278 D 167 SER A 10 SER.? 17.45 CL CL A 278 D 201 ASN A 246 ASN.? 12.85 CL CL A 278 coo 12.95 -4.49 -19.05 14.87 -4.39 -19.77 9.03 -33.35 -4.93 10.37 -31.88 -5.56 coo 10.44 -7.96 -22.51 12.16 -7.57 -20.82 3.77 -30.46 -4.30 3.68 -28.35 -5.48 coo 19.43 -6.74 -22.83 19.09 -5.15 -21.60 12.83 -32.17 -9.87 11.11 -33.32 -9.30 ULMN 3 1iph_c03 CATALASE HPII user 3 3 # 3 D 128 HIS B 12 HIS~? 15.42 CL CL B 278 D 167 SER B 8 SER.? 14.26 CL CL B 278 D 201 ASN B 246 ASN.? 13.30 CL CL B 278 coo 12.95 -4.49 -19.05 14.87 -4.39 -19.77 -10.18 -14.51 -22.80 -8.49 -13.29 -22.60 coo 10.44 -7.96 -22.51 12.16 -7.57 -20.82 -4.13 -15.22 -24.13 -4.29 -16.76 -22.25 coo 19.43 -6.74 -22.83 19.09 -5.15 -21.60 -7.71 -10.36 -18.40 -9.09 -11.94 -18.78 ULMN 3 1iph_c03 CATALASE HPII user 4 3 # 4 D 128 HIS B 12 HIS~? 15.42 CL CL B 278 D 167 SER B 10 SER.? 17.86 CL CL B 278 D 201 ASN B 246 ASN.? 13.30 CL CL B 278 coo 12.95 -4.49 -19.05 14.87 -4.39 -19.77 -10.18 -14.51 -22.80 -8.49 -13.29 -22.60 coo 10.44 -7.96 -22.51 12.16 -7.57 -20.82 -7.63 -19.97 -23.27 -5.38 -20.37 -22.44 coo 19.43 -6.74 -22.83 19.09 -5.15 -21.60 -7.71 -10.36 -18.40 -9.09 -11.94 -18.78 1iph_c03 source 1iph CATALASE HPII : 4 hits 1iph_c03 naa= 3 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 1 3 # 1 A1132 ASP A 205 ASP.? 14.79 CL CL A 278 A1134 ALA A 203 ALA.? 17.55 CL CL A 278 A1137 ASN A 204 ASN.? 18.82 CL CL A 278 coo -27.05 34.58 17.12 -25.81 32.84 17.16 19.11 -25.60 -27.15 17.47 -26.92 -26.86 coo -20.53 36.39 15.81 -20.80 35.01 16.40 24.04 -24.00 -28.11 25.29 -23.60 -28.88 coo -23.72 34.69 12.49 -24.32 32.83 13.34 21.41 -21.13 -30.21 23.24 -20.09 -30.49 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 2 3 # 2 A1132 ASP A 250 ASP~? 15.45 CL CL A 278 A1134 ALA A 252 ALA~? 17.52 CL CL A 278 A1137 ASN A 254 ASN~? 16.17 CL CL A 278 coo -27.05 34.58 17.12 -25.81 32.84 17.16 15.24 -38.09 -11.21 14.62 -38.47 -13.19 coo -20.53 36.39 15.81 -20.80 35.01 16.40 12.87 -37.24 -4.82 11.40 -37.55 -4.97 coo -23.72 34.69 12.49 -24.32 32.83 13.34 18.50 -38.45 -6.68 18.86 -39.34 -8.59 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 3 3 # 3 A1132 ASP B 205 ASP.? 14.85 CL CL B 278 A1134 ALA B 203 ALA.? 17.55 CL CL B 278 A1137 ASN B 204 ASN.? 18.45 CL CL B 278 coo -27.05 34.58 17.12 -25.81 32.84 17.16 1.45 -2.78 -3.16 -0.06 -4.27 -3.04 coo -20.53 36.39 15.81 -20.80 35.01 16.40 3.79 1.97 -2.91 4.44 3.20 -2.30 coo -23.72 34.69 12.49 -24.32 32.83 13.34 6.62 -0.83 -1.08 7.92 0.83 -1.15 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 4 3 # 4 A1132 ASP B 250 ASP~? 16.15 CL CL B 278 A1134 ALA B 252 ALA~? 18.17 CL CL B 278 A1137 ASN B 254 ASN~? 16.98 CL CL B 278 coo -27.05 34.58 17.12 -25.81 32.84 17.16 -13.35 -7.01 -16.89 -13.59 -7.26 -14.81 coo -20.53 36.39 15.81 -20.80 35.01 16.40 -13.56 -10.31 -23.05 -13.89 -11.76 -22.86 coo -23.72 34.69 12.49 -24.32 32.83 13.34 -14.04 -4.32 -21.65 -14.71 -3.72 -19.71 1ir3_c02 source 1ir3 INSULIN RECEPTOR : 4 hits 1ir3_c02 naa= 3 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 1 3 # 1 A 202 ASP A 36 ASP~? 8.69 CL CL A 278 A 204 GLU A 34 GLU^? 8.78 CL CL A 278 A 279 TYR A 26 TYR~? 18.66 CL CL A 278 coo 5.85 5.60 30.32 5.00 7.49 29.88 11.67 -20.98 -6.16 13.43 -22.16 -5.96 coo 7.79 1.83 27.81 9.08 3.25 26.92 14.76 -23.90 -2.78 16.42 -23.89 -4.11 coo 8.22 7.77 18.64 7.58 8.47 21.28 7.77 -31.94 1.38 10.47 -31.53 0.90 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 2 3 # 2 A 202 ASP A 168 ASP^? 12.27 CL CL A 278 A 204 GLU A 169 GLU.? 7.63 CL CL A 278 A 279 TYR A 145 TYR~? 15.40 CL CL A 278 coo 5.85 5.60 30.32 5.00 7.49 29.88 26.46 -30.73 -8.22 26.92 -32.42 -9.39 coo 7.79 1.83 27.81 9.08 3.25 26.92 26.74 -26.14 -12.80 26.49 -24.16 -13.47 coo 8.22 7.77 18.64 7.58 8.47 21.28 34.36 -21.23 -8.52 32.31 -21.44 -6.65 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 3 3 # 3 A 202 ASP A 168 ASP^? 12.27 CL CL A 278 A 204 GLU A 169 GLU.? 7.63 CL CL A 278 A 279 TYR A 180 TYR.? 19.77 CL CL A 278 coo 5.85 5.60 30.32 5.00 7.49 29.88 26.46 -30.73 -8.22 26.92 -32.42 -9.39 coo 7.79 1.83 27.81 9.08 3.25 26.92 26.74 -26.14 -12.80 26.49 -24.16 -13.47 coo 8.22 7.77 18.64 7.58 8.47 21.28 35.72 -25.25 -4.91 38.35 -24.47 -4.37 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 4 3 # 4 A 202 ASP A 205 ASP.? 14.79 CL CL A 278 A 204 GLU A 207 GLU~? 15.26 CL CL A 278 A 279 TYR B 66 TYR.? 15.55 CL CL A 278 coo 5.85 5.60 30.32 5.00 7.49 29.88 19.11 -25.60 -27.15 17.47 -26.92 -26.86 coo 7.79 1.83 27.81 9.08 3.25 26.92 13.18 -27.21 -26.28 11.29 -26.78 -25.35 coo 8.22 7.77 18.64 7.58 8.47 21.28 13.28 -14.60 -25.62 14.79 -15.90 -23.67 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 5 3 # 5 A 202 ASP B 36 ASP~? 8.83 CL CL B 278 A 204 GLU B 34 GLU^? 8.94 CL CL B 278 A 279 TYR B 26 TYR~? 19.09 CL CL B 278 coo 5.85 5.60 30.32 5.00 7.49 29.88 2.64 -13.17 -23.36 1.59 -11.35 -23.67 coo 7.79 1.83 27.81 9.08 3.25 26.92 -0.25 -10.10 -26.69 0.15 -8.25 -25.75 coo 8.22 7.77 18.64 7.58 8.47 21.28 -9.51 -16.67 -28.98 -9.06 -13.93 -28.84 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 6 3 # 6 A 202 ASP B 168 ASP^? 12.80 CL CL B 278 A 204 GLU B 169 GLU.? 7.43 CL CL B 278 A 279 TYR B 145 TYR.? 15.21 CL CL B 278 coo 5.85 5.60 30.32 5.00 7.49 29.88 -5.42 2.81 -22.11 -6.82 3.76 -20.83 coo 7.79 1.83 27.81 9.08 3.25 26.92 0.06 3.03 -18.46 2.10 2.57 -18.04 coo 8.22 7.77 18.64 7.58 8.47 21.28 5.06 9.55 -24.01 4.48 7.22 -25.41 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 7 3 # 7 A 202 ASP B 168 ASP^? 12.80 CL CL B 278 A 204 GLU B 169 GLU.? 7.43 CL CL B 278 A 279 TYR B 180 TYR.? 19.79 CL CL B 278 coo 5.85 5.60 30.32 5.00 7.49 29.88 -5.42 2.81 -22.11 -6.82 3.76 -20.83 coo 7.79 1.83 27.81 9.08 3.25 26.92 0.06 3.03 -18.46 2.10 2.57 -18.04 coo 8.22 7.77 18.64 7.58 8.47 21.28 0.34 10.88 -27.32 1.25 13.08 -28.75 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 8 3 # 8 A 202 ASP B 205 ASP.? 14.85 CL CL B 278 A 204 GLU B 207 GLU~? 15.42 CL CL B 278 A 279 TYR A 66 TYR.? 15.11 CL CL B 278 coo 5.85 5.60 30.32 5.00 7.49 29.88 1.45 -2.78 -3.16 -0.06 -4.27 -3.04 coo 7.79 1.83 27.81 9.08 3.25 26.92 -0.89 -8.41 -2.97 -0.49 -10.43 -3.58 coo 8.22 7.77 18.64 7.58 8.47 21.28 11.56 -10.03 -5.26 10.21 -8.56 -7.21 1itx_c00 source 1itx GLYCOSYL HYDROLASE : 8 hits 1itx_c00 naa= 3 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 1 3 # 1 A 14 GLU A 238 GLU^? 24.84 CL CL A 278 A 61 GLU A 235 GLU~? 25.79 CL CL A 278 A 162 HIS A 0 HIS.? 29.82 CL CL A 278 coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 22.87 -26.18 11.53 21.04 -27.14 11.99 coo -4.89 20.85 5.22 -3.95 21.69 6.91 35.32 -29.84 7.74 36.12 -29.26 5.88 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 28.39 -31.84 13.78 30.11 -32.89 14.37 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 2 3 # 2 A 14 GLU A 253 GLU~? 21.30 CL CL A 278 A 61 GLU A 221 GLU~? 17.05 CL CL A 278 A 162 HIS A 216 HIS.? 18.50 CL CL A 278 coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 14.60 -42.99 -6.59 14.44 -44.06 -8.42 coo -4.89 20.85 5.22 -3.95 21.69 6.91 27.14 -39.98 -10.94 25.92 -39.21 -12.48 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 17.97 -41.33 -12.21 17.58 -42.84 -10.82 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 3 3 # 3 A 14 GLU B 253 GLU~? 21.95 CL CL B 278 A 61 GLU B 221 GLU~? 17.56 CL CL B 278 A 162 HIS B 216 HIS.? 19.24 CL CL B 278 coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 -18.69 -7.91 -20.45 -19.54 -8.29 -18.53 coo -4.89 20.85 5.22 -3.95 21.69 6.91 -13.90 4.76 -18.50 -13.25 3.58 -16.87 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 -16.22 -3.98 -15.80 -17.90 -4.46 -16.96 1j53_c00 source 1j53 DNA POLYMERASE III, EPSILON CHAIN : 3 hits 1j53_c00 naa= 3 ULMN 3 1j70_c00 ATP SULPHURYLASE user 1 3 # 1 A 197 ARG A 3 ARG^? 24.49 CL CL A 278 A 201 HIS A 0 HIS.? 29.82 CL CL A 278 A 204 HIS A -1 HIS.? 31.67 CL CL A 278 coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 17.45 -29.65 8.35 18.11 -29.19 11.33 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 28.39 -31.84 13.78 30.11 -32.89 14.37 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 23.28 -34.51 17.18 21.28 -34.97 16.73 ULMN 3 1j70_c00 ATP SULPHURYLASE user 2 3 # 2 A 197 ARG A 60 ARG^? 25.80 CL CL A 278 A 201 HIS A 0 HIS.? 29.82 CL CL A 278 A 204 HIS A -1 HIS.? 31.67 CL CL A 278 coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 16.05 -25.08 10.06 15.12 -25.70 12.91 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 28.39 -31.84 13.78 30.11 -32.89 14.37 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 23.28 -34.51 17.18 21.28 -34.97 16.73 1j70_c00 source 1j70 ATP SULPHURYLASE : 2 hits 1j70_c00 naa= 3 ULMN 3 1j70_c01 ATP SULPHURYLASE user 1 3 # 1 B 197 ARG A 3 ARG^? 24.49 CL CL A 278 B 201 HIS A 0 HIS.? 29.82 CL CL A 278 B 204 HIS A -1 HIS.? 31.67 CL CL A 278 coo -18.85 104.93 27.44 -18.03 106.58 29.88 17.45 -29.65 8.35 18.11 -29.19 11.33 coo -8.48 114.03 24.38 -10.47 114.55 23.97 28.39 -31.84 13.78 30.11 -32.89 14.37 coo -6.99 108.94 26.28 -8.54 109.57 27.55 23.28 -34.51 17.18 21.28 -34.97 16.73 ULMN 3 1j70_c01 ATP SULPHURYLASE user 2 3 # 2 B 197 ARG A 60 ARG^? 25.80 CL CL A 278 B 201 HIS A -1 HIS.? 31.67 CL CL A 278 B 204 HIS A 0 HIS.? 29.82 CL CL A 278 coo -18.85 104.93 27.44 -18.03 106.58 29.88 16.05 -25.08 10.06 15.12 -25.70 12.91 coo -8.48 114.03 24.38 -10.47 114.55 23.97 23.28 -34.51 17.18 21.28 -34.97 16.73 coo -6.99 108.94 26.28 -8.54 109.57 27.55 28.39 -31.84 13.78 30.11 -32.89 14.37 ULMN 3 1j70_c01 ATP SULPHURYLASE user 3 3 # 3 B 197 ARG A 60 ARG^? 25.80 CL CL A 278 B 201 HIS A 0 HIS.? 29.82 CL CL A 278 B 204 HIS A -1 HIS.? 31.67 CL CL A 278 coo -18.85 104.93 27.44 -18.03 106.58 29.88 16.05 -25.08 10.06 15.12 -25.70 12.91 coo -8.48 114.03 24.38 -10.47 114.55 23.97 28.39 -31.84 13.78 30.11 -32.89 14.37 coo -6.99 108.94 26.28 -8.54 109.57 27.55 23.28 -34.51 17.18 21.28 -34.97 16.73 1j70_c01 source 1j70 ATP SULPHURYLASE : 3 hits 1j70_c01 naa= 3 ULMN 3 1j70_c02 ATP SULPHURYLASE user 1 3 # 1 C 197 ARG A 3 ARG^? 24.49 CL CL A 278 C 201 HIS A 0 HIS.? 29.82 CL CL A 278 C 204 HIS A -1 HIS.? 31.67 CL CL A 278 coo 30.92 14.23 15.70 28.82 13.90 13.48 17.45 -29.65 8.35 18.11 -29.19 11.33 coo 20.16 5.55 18.86 20.00 7.59 19.34 28.39 -31.84 13.78 30.11 -32.89 14.37 coo 24.92 3.29 16.90 24.41 4.92 15.69 23.28 -34.51 17.18 21.28 -34.97 16.73 ULMN 3 1j70_c02 ATP SULPHURYLASE user 2 3 # 2 C 197 ARG A 60 ARG^? 25.80 CL CL A 278 C 201 HIS A 0 HIS.? 29.82 CL CL A 278 C 204 HIS A -1 HIS.? 31.67 CL CL A 278 coo 30.92 14.23 15.70 28.82 13.90 13.48 16.05 -25.08 10.06 15.12 -25.70 12.91 coo 20.16 5.55 18.86 20.00 7.59 19.34 28.39 -31.84 13.78 30.11 -32.89 14.37 coo 24.92 3.29 16.90 24.41 4.92 15.69 23.28 -34.51 17.18 21.28 -34.97 16.73 1j70_c02 source 1j70 ATP SULPHURYLASE : 2 hits 1j70_c02 naa= 3 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 1 3 # 1 A 55 ASP A 267 ASP.? 31.09 CL CL A 278 A 58 ASP A 268 ASP.? 26.73 CL CL A 278 A 424 GLU A 57 GLU.? 33.27 CL CL A 278 coo 58.42 47.76 20.67 58.01 49.10 19.12 11.77 -37.21 15.47 13.23 -35.63 15.60 coo 58.59 41.80 18.81 58.94 43.89 18.94 9.60 -34.57 10.49 9.97 -36.28 9.26 coo 52.85 46.34 13.34 54.09 44.97 14.42 10.55 -27.52 17.40 10.69 -28.24 19.39 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 2 3 # 2 A 55 ASP A 268 ASP.? 26.73 CL CL A 278 A 58 ASP A 267 ASP.? 31.09 CL CL A 278 A 424 GLU A 57 GLU.? 33.27 CL CL A 278 coo 58.42 47.76 20.67 58.01 49.10 19.12 9.60 -34.57 10.49 9.97 -36.28 9.26 coo 58.59 41.80 18.81 58.94 43.89 18.94 11.77 -37.21 15.47 13.23 -35.63 15.60 coo 52.85 46.34 13.34 54.09 44.97 14.42 10.55 -27.52 17.40 10.69 -28.24 19.39 1js4_c00 source 1js4 ENDO-EXOCELLULASE E4 : 2 hits 1js4_c00 naa= 3 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 1 3 # 1 B 55 ASP A 267 ASP.? 31.09 CL CL A 278 B 58 ASP A 268 ASP.? 26.73 CL CL A 278 B 424 GLU A 57 GLU.? 33.27 CL CL A 278 coo 112.10 61.46 19.99 111.82 60.65 18.07 11.77 -37.21 15.47 13.23 -35.63 15.60 coo 117.85 63.62 21.08 115.96 63.25 20.18 9.60 -34.57 10.49 9.97 -36.28 9.26 coo 118.47 57.23 15.57 119.32 58.77 16.73 10.55 -27.52 17.40 10.69 -28.24 19.39 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 2 3 # 2 B 55 ASP A 268 ASP.? 26.73 CL CL A 278 B 58 ASP A 267 ASP.? 31.09 CL CL A 278 B 424 GLU A 57 GLU.? 33.27 CL CL A 278 coo 112.10 61.46 19.99 111.82 60.65 18.07 9.60 -34.57 10.49 9.97 -36.28 9.26 coo 117.85 63.62 21.08 115.96 63.25 20.18 11.77 -37.21 15.47 13.23 -35.63 15.60 coo 118.47 57.23 15.57 119.32 58.77 16.73 10.55 -27.52 17.40 10.69 -28.24 19.39 1js4_c01 source 1js4 ENDO-EXOCELLULASE E4 : 2 hits 1js4_c01 naa= 3 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 A 2 GLU A 207 GLU~? 15.26 CL CL A 278 A 56 LYS A 211 LYS~? 14.92 CL CL A 278 A 258 ARG B 47 ARG~? 19.59 CL CL A 278 coo 42.33 1.56 26.99 42.38 2.91 28.66 13.18 -27.21 -26.28 11.29 -26.78 -25.35 coo 38.45 -0.44 19.89 37.36 0.90 25.90 17.07 -30.19 -20.07 15.73 -30.42 -25.42 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 3.13 -24.42 -28.62 4.84 -23.96 -26.11 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 A 2 GLU B 207 GLU~? 15.42 CL CL B 278 A 56 LYS B 210 LYS~? 12.46 CL CL B 278 A 258 ARG A 47 ARG~? 19.53 CL CL B 278 coo 42.33 1.56 26.99 42.38 2.91 28.66 -0.89 -8.41 -2.97 -0.49 -10.43 -3.58 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -2.49 -8.60 -10.03 0.77 -12.84 -8.24 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 1.19 -18.60 0.09 1.74 -17.18 -2.58 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 3 3 # 3 A 2 GLU B 207 GLU~? 15.42 CL CL B 278 A 56 LYS B 211 LYS~? 15.02 CL CL B 278 A 258 ARG A 47 ARG~? 19.53 CL CL B 278 coo 42.33 1.56 26.99 42.38 2.91 28.66 -0.89 -8.41 -2.97 -0.49 -10.43 -3.58 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -4.12 -5.20 -9.45 -3.45 -5.07 -3.77 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 1.19 -18.60 0.09 1.74 -17.18 -2.58 1k82_c00 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 3 hits 1k82_c00 naa= 3 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 B 2 GLU A 138 GLU^? 6.67 CL CL A 278 B 56 LYS A 64 LYS^? 6.64 CL CL A 278 B 258 ARG A 212 ARG~? 4.63 CL CL A 278 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 23.86 -20.99 -6.84 22.60 -22.69 -7.03 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 14.97 -18.21 -2.39 15.88 -19.33 -8.52 coo 2.64 1.83 34.81 1.56 1.13 32.02 18.59 -24.77 -16.89 17.13 -22.12 -16.49 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 B 2 GLU A 207 GLU~? 15.26 CL CL A 278 B 56 LYS A 211 LYS~? 14.92 CL CL A 278 B 258 ARG B 47 ARG~? 19.59 CL CL A 278 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 13.18 -27.21 -26.28 11.29 -26.78 -25.35 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 17.07 -30.19 -20.07 15.73 -30.42 -25.42 coo 2.64 1.83 34.81 1.56 1.13 32.02 3.13 -24.42 -28.62 4.84 -23.96 -26.11 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 3 3 # 3 B 2 GLU B 138 GLU^? 6.70 CL CL B 278 B 56 LYS B 64 LYS^? 6.39 CL CL B 278 B 258 ARG B 212 ARG~? 4.30 CL CL B 278 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 3.87 -1.10 -24.33 2.09 -2.15 -23.84 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 5.21 -10.68 -27.95 4.80 -8.81 -21.96 coo 2.64 1.83 34.81 1.56 1.13 32.02 1.13 -4.70 -13.40 3.58 -6.46 -14.00 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 4 3 # 4 B 2 GLU B 207 GLU~? 15.42 CL CL B 278 B 56 LYS B 210 LYS~? 12.46 CL CL B 278 B 258 ARG A 47 ARG~? 19.53 CL CL B 278 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 -0.89 -8.41 -2.97 -0.49 -10.43 -3.58 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 -2.49 -8.60 -10.03 0.77 -12.84 -8.24 coo 2.64 1.83 34.81 1.56 1.13 32.02 1.19 -18.60 0.09 1.74 -17.18 -2.58 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 5 3 # 5 B 2 GLU B 207 GLU~? 15.42 CL CL B 278 B 56 LYS B 211 LYS~? 15.02 CL CL B 278 B 258 ARG A 47 ARG~? 19.53 CL CL B 278 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 -0.89 -8.41 -2.97 -0.49 -10.43 -3.58 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 -4.12 -5.20 -9.45 -3.45 -5.07 -3.77 coo 2.64 1.83 34.81 1.56 1.13 32.02 1.19 -18.60 0.09 1.74 -17.18 -2.58 1k82_c01 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 5 hits 1k82_c01 naa= 3 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 C 2 GLU A 138 GLU^? 6.67 CL CL A 278 C 56 LYS A 64 LYS^? 6.64 CL CL A 278 C 258 ARG A 212 ARG~? 4.63 CL CL A 278 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 23.86 -20.99 -6.84 22.60 -22.69 -7.03 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 14.97 -18.21 -2.39 15.88 -19.33 -8.52 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 18.59 -24.77 -16.89 17.13 -22.12 -16.49 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 C 2 GLU A 207 GLU~? 15.26 CL CL A 278 C 56 LYS A 211 LYS~? 14.92 CL CL A 278 C 258 ARG B 47 ARG~? 19.59 CL CL A 278 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 13.18 -27.21 -26.28 11.29 -26.78 -25.35 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 17.07 -30.19 -20.07 15.73 -30.42 -25.42 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 3.13 -24.42 -28.62 4.84 -23.96 -26.11 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 3 3 # 3 C 2 GLU B 138 GLU^? 6.70 CL CL B 278 C 56 LYS B 64 LYS^? 6.39 CL CL B 278 C 258 ARG B 212 ARG~? 4.30 CL CL B 278 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 3.87 -1.10 -24.33 2.09 -2.15 -23.84 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 5.21 -10.68 -27.95 4.80 -8.81 -21.96 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 1.13 -4.70 -13.40 3.58 -6.46 -14.00 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 4 3 # 4 C 2 GLU B 207 GLU~? 15.42 CL CL B 278 C 56 LYS B 210 LYS~? 12.46 CL CL B 278 C 258 ARG A 47 ARG~? 19.53 CL CL B 278 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 -0.89 -8.41 -2.97 -0.49 -10.43 -3.58 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 -2.49 -8.60 -10.03 0.77 -12.84 -8.24 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 1.19 -18.60 0.09 1.74 -17.18 -2.58 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 5 3 # 5 C 2 GLU B 207 GLU~? 15.42 CL CL B 278 C 56 LYS B 211 LYS~? 15.02 CL CL B 278 C 258 ARG A 47 ARG~? 19.53 CL CL B 278 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 -0.89 -8.41 -2.97 -0.49 -10.43 -3.58 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 -4.12 -5.20 -9.45 -3.45 -5.07 -3.77 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 1.19 -18.60 0.09 1.74 -17.18 -2.58 1k82_c02 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 5 hits 1k82_c02 naa= 3 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 D 2 GLU A 138 GLU^? 6.67 CL CL A 278 D 56 LYS A 64 LYS^? 6.64 CL CL A 278 D 258 ARG A 212 ARG~? 4.63 CL CL A 278 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 23.86 -20.99 -6.84 22.60 -22.69 -7.03 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 14.97 -18.21 -2.39 15.88 -19.33 -8.52 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 18.59 -24.77 -16.89 17.13 -22.12 -16.49 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 D 2 GLU A 207 GLU~? 15.26 CL CL A 278 D 56 LYS A 211 LYS~? 14.92 CL CL A 278 D 258 ARG B 47 ARG~? 19.59 CL CL A 278 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 13.18 -27.21 -26.28 11.29 -26.78 -25.35 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 17.07 -30.19 -20.07 15.73 -30.42 -25.42 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 3.13 -24.42 -28.62 4.84 -23.96 -26.11 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 3 3 # 3 D 2 GLU B 138 GLU^? 6.70 CL CL B 278 D 56 LYS B 64 LYS^? 6.39 CL CL B 278 D 258 ARG B 212 ARG~? 4.30 CL CL B 278 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 3.87 -1.10 -24.33 2.09 -2.15 -23.84 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 5.21 -10.68 -27.95 4.80 -8.81 -21.96 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 1.13 -4.70 -13.40 3.58 -6.46 -14.00 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 4 3 # 4 D 2 GLU B 207 GLU~? 15.42 CL CL B 278 D 56 LYS B 210 LYS~? 12.46 CL CL B 278 D 258 ARG A 47 ARG~? 19.53 CL CL B 278 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 -0.89 -8.41 -2.97 -0.49 -10.43 -3.58 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 -2.49 -8.60 -10.03 0.77 -12.84 -8.24 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 1.19 -18.60 0.09 1.74 -17.18 -2.58 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 5 3 # 5 D 2 GLU B 207 GLU~? 15.42 CL CL B 278 D 56 LYS B 211 LYS~? 15.02 CL CL B 278 D 258 ARG A 47 ARG~? 19.53 CL CL B 278 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 -0.89 -8.41 -2.97 -0.49 -10.43 -3.58 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 -4.12 -5.20 -9.45 -3.45 -5.07 -3.77 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 1.19 -18.60 0.09 1.74 -17.18 -2.58 1k82_c03 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 5 hits 1k82_c03 naa= 3 ULMN 3 1kdg_c02 CELLOBIOSE DEHYDROGENASE user 1 3 # 1 A 609 TYR A 215 TYR.? 13.87 CL CL A 278 A 689 HIS A 216 HIS.? 18.50 CL CL A 278 A 732 ASN A 218 ASN~? 20.82 CL CL A 278 coo 22.52 29.89 18.33 23.85 28.06 20.03 21.62 -36.04 -14.58 23.93 -37.55 -14.90 coo 24.46 23.36 17.42 25.88 24.61 18.33 17.97 -41.33 -12.21 17.58 -42.84 -10.82 coo 27.06 24.40 21.98 27.51 26.43 21.46 24.13 -43.84 -11.70 26.14 -43.18 -11.76 ULMN 3 1kdg_c02 CELLOBIOSE DEHYDROGENASE user 2 3 # 2 A 609 TYR A 215 TYR.? 13.87 CL CL A 278 A 689 HIS A 216 HIS.? 18.50 CL CL A 278 A 732 ASN A 254 ASN~? 16.17 CL CL A 278 coo 22.52 29.89 18.33 23.85 28.06 20.03 21.62 -36.04 -14.58 23.93 -37.55 -14.90 coo 24.46 23.36 17.42 25.88 24.61 18.33 17.97 -41.33 -12.21 17.58 -42.84 -10.82 coo 27.06 24.40 21.98 27.51 26.43 21.46 18.50 -38.45 -6.68 18.86 -39.34 -8.59 ULMN 3 1kdg_c02 CELLOBIOSE DEHYDROGENASE user 3 3 # 3 A 609 TYR A 217 TYR.? 13.45 CL CL A 278 A 689 HIS A 216 HIS.? 18.50 CL CL A 278 A 732 ASN A 218 ASN~? 20.82 CL CL A 278 coo 22.52 29.89 18.33 23.85 28.06 20.03 22.77 -37.42 -9.36 23.40 -34.73 -9.58 coo 24.46 23.36 17.42 25.88 24.61 18.33 17.97 -41.33 -12.21 17.58 -42.84 -10.82 coo 27.06 24.40 21.98 27.51 26.43 21.46 24.13 -43.84 -11.70 26.14 -43.18 -11.76 ULMN 3 1kdg_c02 CELLOBIOSE DEHYDROGENASE user 4 3 # 4 A 609 TYR B 215 TYR.? 14.28 CL CL B 278 A 689 HIS B 216 HIS.? 19.24 CL CL B 278 A 732 ASN B 218 ASN~? 21.19 CL CL B 278 coo 22.52 29.89 18.33 23.85 28.06 20.03 -10.18 -0.68 -14.85 -11.32 1.86 -14.73 coo 24.46 23.36 17.42 25.88 24.61 18.33 -16.22 -3.98 -15.80 -17.90 -4.46 -16.96 coo 27.06 24.40 21.98 27.51 26.43 21.46 -17.80 2.35 -16.65 -17.00 4.26 -17.12 ULMN 3 1kdg_c02 CELLOBIOSE DEHYDROGENASE user 5 3 # 5 A 609 TYR B 215 TYR.? 14.28 CL CL B 278 A 689 HIS B 216 HIS.? 19.24 CL CL B 278 A 732 ASN B 254 ASN~? 16.98 CL CL B 278 coo 22.52 29.89 18.33 23.85 28.06 20.03 -10.18 -0.68 -14.85 -11.32 1.86 -14.73 coo 24.46 23.36 17.42 25.88 24.61 18.33 -16.22 -3.98 -15.80 -17.90 -4.46 -16.96 coo 27.06 24.40 21.98 27.51 26.43 21.46 -14.04 -4.32 -21.65 -14.71 -3.72 -19.71 ULMN 3 1kdg_c02 CELLOBIOSE DEHYDROGENASE user 6 3 # 6 A 609 TYR B 217 TYR.? 13.94 CL CL B 278 A 689 HIS B 216 HIS.? 19.24 CL CL B 278 A 732 ASN B 218 ASN~? 21.19 CL CL B 278 coo 22.52 29.89 18.33 23.85 28.06 20.03 -12.06 -0.05 -19.78 -9.32 0.42 -19.98 coo 24.46 23.36 17.42 25.88 24.61 18.33 -16.22 -3.98 -15.80 -17.90 -4.46 -16.96 coo 27.06 24.40 21.98 27.51 26.43 21.46 -17.80 2.35 -16.65 -17.00 4.26 -17.12 1kdg_c02 source 1kdg CELLOBIOSE DEHYDROGENASE : 6 hits 1kdg_c02 naa= 3 ULMN 3 1kdg_c03 CELLOBIOSE DEHYDROGENASE user 1 3 # 1 B 609 TYR A 215 TYR.? 13.87 CL CL A 278 B 689 HIS A 216 HIS.? 18.50 CL CL A 278 B 732 ASN A 218 ASN~? 20.82 CL CL A 278 coo 25.77 15.27 -24.02 28.47 14.70 -24.59 21.62 -36.04 -14.58 23.93 -37.55 -14.90 coo 31.55 17.32 -20.91 31.51 15.29 -21.43 17.97 -41.33 -12.21 17.58 -42.84 -10.82 coo 33.56 13.69 -24.17 31.95 12.28 -24.00 24.13 -43.84 -11.70 26.14 -43.18 -11.76 ULMN 3 1kdg_c03 CELLOBIOSE DEHYDROGENASE user 2 3 # 2 B 609 TYR A 215 TYR.? 13.87 CL CL A 278 B 689 HIS A 216 HIS.? 18.50 CL CL A 278 B 732 ASN A 254 ASN~? 16.17 CL CL A 278 coo 25.77 15.27 -24.02 28.47 14.70 -24.59 21.62 -36.04 -14.58 23.93 -37.55 -14.90 coo 31.55 17.32 -20.91 31.51 15.29 -21.43 17.97 -41.33 -12.21 17.58 -42.84 -10.82 coo 33.56 13.69 -24.17 31.95 12.28 -24.00 18.50 -38.45 -6.68 18.86 -39.34 -8.59 ULMN 3 1kdg_c03 CELLOBIOSE DEHYDROGENASE user 3 3 # 3 B 609 TYR A 217 TYR.? 13.45 CL CL A 278 B 689 HIS A 216 HIS.? 18.50 CL CL A 278 B 732 ASN A 218 ASN~? 20.82 CL CL A 278 coo 25.77 15.27 -24.02 28.47 14.70 -24.59 22.77 -37.42 -9.36 23.40 -34.73 -9.58 coo 31.55 17.32 -20.91 31.51 15.29 -21.43 17.97 -41.33 -12.21 17.58 -42.84 -10.82 coo 33.56 13.69 -24.17 31.95 12.28 -24.00 24.13 -43.84 -11.70 26.14 -43.18 -11.76 ULMN 3 1kdg_c03 CELLOBIOSE DEHYDROGENASE user 4 3 # 4 B 609 TYR B 215 TYR.? 14.28 CL CL B 278 B 689 HIS B 216 HIS.? 19.24 CL CL B 278 B 732 ASN B 218 ASN~? 21.19 CL CL B 278 coo 25.77 15.27 -24.02 28.47 14.70 -24.59 -10.18 -0.68 -14.85 -11.32 1.86 -14.73 coo 31.55 17.32 -20.91 31.51 15.29 -21.43 -16.22 -3.98 -15.80 -17.90 -4.46 -16.96 coo 33.56 13.69 -24.17 31.95 12.28 -24.00 -17.80 2.35 -16.65 -17.00 4.26 -17.12 ULMN 3 1kdg_c03 CELLOBIOSE DEHYDROGENASE user 5 3 # 5 B 609 TYR B 215 TYR.? 14.28 CL CL B 278 B 689 HIS B 216 HIS.? 19.24 CL CL B 278 B 732 ASN B 254 ASN~? 16.98 CL CL B 278 coo 25.77 15.27 -24.02 28.47 14.70 -24.59 -10.18 -0.68 -14.85 -11.32 1.86 -14.73 coo 31.55 17.32 -20.91 31.51 15.29 -21.43 -16.22 -3.98 -15.80 -17.90 -4.46 -16.96 coo 33.56 13.69 -24.17 31.95 12.28 -24.00 -14.04 -4.32 -21.65 -14.71 -3.72 -19.71 ULMN 3 1kdg_c03 CELLOBIOSE DEHYDROGENASE user 6 3 # 6 B 609 TYR B 217 TYR.? 13.94 CL CL B 278 B 689 HIS B 216 HIS.? 19.24 CL CL B 278 B 732 ASN B 218 ASN~? 21.19 CL CL B 278 coo 25.77 15.27 -24.02 28.47 14.70 -24.59 -12.06 -0.05 -19.78 -9.32 0.42 -19.98 coo 31.55 17.32 -20.91 31.51 15.29 -21.43 -16.22 -3.98 -15.80 -17.90 -4.46 -16.96 coo 33.56 13.69 -24.17 31.95 12.28 -24.00 -17.80 2.35 -16.65 -17.00 4.26 -17.12 1kdg_c03 source 1kdg CELLOBIOSE DEHYDROGENASE : 6 hits 1kdg_c03 naa= 3 ULMN 3 1kim_c00 THYMIDINE KINASE user 1 3 # 1 A 83 GLU A 138 GLU^? 6.67 CL CL A 278 A 163 ARG A 140 ARG.? 3.74 CL CL A 278 A 222 ARG A 192 ARG^? 5.91 CL CL A 278 coo 51.27 81.34 48.31 51.67 80.79 50.28 23.86 -20.99 -6.84 22.60 -22.69 -7.03 coo 48.06 78.22 50.94 48.51 78.27 53.98 24.77 -21.68 -10.23 22.52 -23.37 -11.49 coo 54.85 84.16 52.60 54.26 81.23 53.34 20.84 -24.38 -4.40 19.02 -23.24 -6.62 ULMN 3 1kim_c00 THYMIDINE KINASE user 2 3 # 2 A 83 GLU B 138 GLU^? 6.70 CL CL B 278 A 163 ARG B 140 ARG.? -3.53 CL CL B 278s A 222 ARG B 192 ARG^? 6.13 CL CL B 278 coo 51.27 81.34 48.31 51.67 80.79 50.28 3.87 -1.10 -24.33 2.09 -2.15 -23.84 coo 48.06 78.22 50.94 48.51 78.27 53.98 3.71 0.22 -21.03 2.09 -1.69 -19.26 coo 54.85 84.16 52.60 54.26 81.23 53.34 -0.17 -3.93 -26.09 1.00 -5.48 -23.71 1kim_c00 source 1kim THYMIDINE KINASE : 2 hits 1kim_c00 naa= 3 ULMN 3 1lcb_c00 THYMIDYLATE SYNTHASE user 1 3 # 1 198 CYH A 115 CYH.? 21.04 CL CL A 278 229 ASN A 141 ASN~? 14.40 CL CL A 278 232 SER A 110 SER.? 10.17 CL CL A 278 coo 9.92 49.50 -53.84 12.48 47.89 -53.69 33.67 -11.53 -10.65 35.99 -11.79 -9.16 coo 9.79 43.22 -47.74 11.15 44.81 -48.24 29.69 -16.58 -13.36 30.76 -15.83 -15.01 coo 7.03 45.16 -41.61 9.10 46.34 -42.68 22.72 -15.16 -12.90 22.28 -14.43 -15.17 ULMN 3 1lcb_c00 THYMIDYLATE SYNTHASE user 2 3 # 2 198 CYH B 115 CYH.? 20.61 CL CL B 278 229 ASN B 141 ASN.? 13.90 CL CL B 278 232 SER B 110 SER.? 9.89 CL CL B 278 coo 9.92 49.50 -53.84 12.48 47.89 -53.69 14.78 7.95 -23.15 14.40 10.09 -24.83 coo 9.79 43.22 -47.74 11.15 44.81 -48.24 9.53 4.91 -19.46 10.65 6.11 -18.14 coo 7.03 45.16 -41.61 9.10 46.34 -42.68 10.33 -2.26 -18.93 11.59 -2.13 -16.86 1lcb_c00 source 1lcb THYMIDYLATE SYNTHASE : 2 hits 1lcb_c00 naa= 3 ULMN 3 1lcb_c02 THYMIDYLATE SYNTHASE user 1 3 # 1 60 GLU A 138 GLU^? 6.67 CL CL A 278 198 CYH A 115 CYH.? 21.04 CL CL A 278 229 ASN A 141 ASN~? 14.40 CL CL A 278 coo 11.57 50.45 -41.48 12.95 49.39 -42.73 23.86 -20.99 -6.84 22.60 -22.69 -7.03 coo 9.92 49.50 -53.84 12.48 47.89 -53.69 33.67 -11.53 -10.65 35.99 -11.79 -9.16 coo 9.79 43.22 -47.74 11.15 44.81 -48.24 29.69 -16.58 -13.36 30.76 -15.83 -15.01 ULMN 3 1lcb_c02 THYMIDYLATE SYNTHASE user 2 3 # 2 60 GLU B 138 GLU^? 6.70 CL CL B 278 198 CYH B 115 CYH.? 20.61 CL CL B 278 229 ASN B 141 ASN.? 13.90 CL CL B 278 coo 11.57 50.45 -41.48 12.95 49.39 -42.73 3.87 -1.10 -24.33 2.09 -2.15 -23.84 coo 9.92 49.50 -53.84 12.48 47.89 -53.69 14.78 7.95 -23.15 14.40 10.09 -24.83 coo 9.79 43.22 -47.74 11.15 44.81 -48.24 9.53 4.91 -19.46 10.65 6.11 -18.14 1lcb_c02 source 1lcb THYMIDYLATE SYNTHASE : 2 hits 1lcb_c02 naa= 3 ULMN 3 1lci_c00 LUCIFERASE user 1 3 # 1 218 ARG A 196 ARG.? 15.95 CL CL A 278 245 HIS A 216 HIS.? 18.50 CL CL A 278 343 THR A 219 THR~? 24.46 CL CL A 278 coo 18.11 85.25 41.19 18.04 83.33 43.59 27.49 -34.87 -12.70 29.46 -35.46 -10.43 coo 5.34 86.23 43.48 6.16 87.26 45.12 17.97 -41.33 -12.21 17.58 -42.84 -10.82 coo 9.06 92.76 42.80 7.04 92.63 42.14 24.35 -45.10 -7.43 23.67 -47.15 -7.60 ULMN 3 1lci_c00 LUCIFERASE user 2 3 # 2 218 ARG A 209 ARG~? 8.75 CL CL A 278 245 HIS A 194 HIS.? 4.68 CL CL A 278 343 THR A 213 THR.? 5.23 CL CL A 278 coo 18.11 85.25 41.19 18.04 83.33 43.59 12.19 -22.36 -19.55 12.55 -20.19 -17.38 coo 5.34 86.23 43.48 6.16 87.26 45.12 21.59 -27.03 -10.13 21.31 -25.37 -8.87 coo 9.06 92.76 42.80 7.04 92.63 42.14 17.89 -30.02 -14.53 16.90 -28.34 -13.63 ULMN 3 1lci_c00 LUCIFERASE user 3 3 # 3 218 ARG B 196 ARG.? 16.18 CL CL B 278 245 HIS B 216 HIS.? 19.24 CL CL B 278 343 THR B 219 THR~? 25.43 CL CL B 278 coo 18.11 85.25 41.19 18.04 83.33 43.59 -8.42 4.93 -17.56 -9.12 6.53 -20.07 coo 5.34 86.23 43.48 6.16 87.26 45.12 -16.22 -3.98 -15.80 -17.90 -4.46 -16.96 coo 9.06 92.76 42.80 7.04 92.63 42.14 -19.93 2.01 -20.48 -22.02 2.59 -20.54 ULMN 3 1lci_c00 LUCIFERASE user 4 3 # 4 218 ARG B 209 ARG~? 8.42 CL CL B 278 245 HIS B 194 HIS.? 5.13 CL CL B 278 343 THR B 213 THR.? 5.93 CL CL B 278 coo 18.11 85.25 41.19 18.04 83.33 43.59 2.92 -11.07 -10.38 5.18 -10.70 -12.48 coo 5.34 86.23 43.48 6.16 87.26 45.12 -1.92 -2.21 -20.05 -0.53 -2.75 -21.52 coo 9.06 92.76 42.80 7.04 92.63 42.14 -4.66 -4.97 -14.91 -3.30 -6.36 -15.86 1lci_c00 source 1lci LUCIFERASE : 4 hits 1lci_c00 naa= 3 ULMN 3 1ldm_c01 M4 LACTATE DEHYDROGENASE user 1 3 # 1 166 ASP A 168 ASP^? 12.27 CL CL A 278 169 ARG A 196 ARG.? 15.95 CL CL A 278 193 HIS A 194 HIS.? 4.68 CL CL A 278 coo 20.88 15.91 3.60 20.25 17.72 4.50 26.46 -30.73 -8.22 26.92 -32.42 -9.39 coo 17.70 17.91 -0.80 15.74 19.74 0.84 27.49 -34.87 -12.70 29.46 -35.46 -10.43 coo 18.81 19.85 7.63 17.55 19.89 5.97 21.59 -27.03 -10.13 21.31 -25.37 -8.87 ULMN 3 1ldm_c01 M4 LACTATE DEHYDROGENASE user 2 3 # 2 166 ASP B 168 ASP^? 12.80 CL CL B 278 169 ARG B 196 ARG.? 16.18 CL CL B 278 193 HIS B 194 HIS.? 5.13 CL CL B 278 coo 20.88 15.91 3.60 20.25 17.72 4.50 -5.42 2.81 -22.11 -6.82 3.76 -20.83 coo 17.70 17.91 -0.80 15.74 19.74 0.84 -8.42 4.93 -17.56 -9.12 6.53 -20.07 coo 18.81 19.85 7.63 17.55 19.89 5.97 -1.92 -2.21 -20.05 -0.53 -2.75 -21.52 1ldm_c01 source 1ldm M4 LACTATE DEHYDROGENASE : 2 hits 1ldm_c01 naa= 3 ULMN 3 1lij_c01 ADENOSINE KINASE user 1 3 # 1 A 316 ALA B 251 ALA~? 13.13 CL CL B 278 A 317 GLY B 249 GLY.? 15.61 CL CL B 278 A 318 ASP B 250 ASP~? 16.15 CL CL B 278 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 -11.21 -8.27 -20.82 -9.88 -9.02 -21.02 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 -11.90 -11.51 -16.09 -11.99 -10.68 -16.03 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 -13.35 -7.01 -16.89 -13.59 -7.26 -14.81 1lij_c01 source 1lij ADENOSINE KINASE : 1 hits 1lij_c01 naa= 3 ULMN 3 1lio_c01 ADENOSINE KINASE user 1 3 # 1 A 316 ALA B 251 ALA~? 13.13 CL CL B 278 A 317 GLY B 249 GLY.? 15.61 CL CL B 278 A 318 ASP B 250 ASP~? 16.15 CL CL B 278 coo 27.04 23.54 41.85 25.72 24.19 42.18 -11.21 -8.27 -20.82 -9.88 -9.02 -21.02 coo 27.87 23.16 38.17 28.43 22.97 38.87 -11.90 -11.51 -16.09 -11.99 -10.68 -16.03 coo 32.11 22.71 40.58 33.42 24.22 39.78 -13.35 -7.01 -16.89 -13.59 -7.26 -14.81 1lio_c01 source 1lio ADENOSINE KINASE : 1 hits 1lio_c01 naa= 3 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 1 3 # 1 A 123 LYS A 64 LYS^? 6.64 CL CL A 278 A 202 SER A 67 SER.? 14.21 CL CL A 278 A 226 SER A 70 SER.? 11.73 CL CL A 278 coo 1.62 6.10 69.30 3.81 1.25 65.91 14.97 -18.21 -2.39 15.88 -19.33 -8.52 coo 4.43 1.89 61.79 4.31 0.09 63.40 14.35 -11.91 -8.16 12.43 -11.38 -9.50 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 19.33 -11.34 -7.00 17.75 -13.05 -7.65 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 2 3 # 2 A 123 LYS B 64 LYS^? 6.39 CL CL B 278 A 202 SER B 67 SER.? 13.79 CL CL B 278 A 226 SER B 70 SER.? 11.46 CL CL B 278 coo 1.62 6.10 69.30 3.81 1.25 65.91 5.21 -10.68 -27.95 4.80 -8.81 -21.96 coo 4.43 1.89 61.79 4.31 0.09 63.40 12.14 -11.19 -22.93 12.67 -12.95 -21.38 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 13.00 -6.56 -24.86 11.13 -7.93 -24.10 1m21_c00 source 1m21 PEPTIDE AMIDASE : 2 hits 1m21_c00 naa= 3 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 1 3 # 1 B 123 LYS A 64 LYS^? 6.64 CL CL A 278 B 202 SER A 67 SER.? 14.21 CL CL A 278 B 226 SER A 70 SER.? 11.73 CL CL A 278 coo 35.67 -0.01 18.11 33.47 4.84 14.73 14.97 -18.21 -2.39 15.88 -19.33 -8.52 coo 32.81 4.27 10.70 32.87 6.07 12.31 14.35 -11.91 -8.16 12.43 -11.38 -9.50 coo 28.77 6.36 12.44 30.83 7.25 11.75 19.33 -11.34 -7.00 17.75 -13.05 -7.65 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 2 3 # 2 B 123 LYS B 64 LYS^? 6.39 CL CL B 278 B 202 SER B 67 SER.? 13.79 CL CL B 278 B 226 SER B 70 SER.? 11.46 CL CL B 278 coo 35.67 -0.01 18.11 33.47 4.84 14.73 5.21 -10.68 -27.95 4.80 -8.81 -21.96 coo 32.81 4.27 10.70 32.87 6.07 12.31 12.14 -11.19 -22.93 12.67 -12.95 -21.38 coo 28.77 6.36 12.44 30.83 7.25 11.75 13.00 -6.56 -24.86 11.13 -7.93 -24.10 1m21_c01 source 1m21 PEPTIDE AMIDASE : 2 hits 1m21_c01 naa= 3 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 1 3 # 1 A 241 ASP A 224 ASP~? 22.21 CL CL A 278 A 295 GLU A 221 GLU~? 17.05 CL CL A 278 A 369 ASP A 168 ASP^? 12.27 CL CL A 278 coo 11.74 38.14 80.19 10.63 36.40 80.65 30.83 -39.35 -6.18 31.71 -41.01 -7.15 coo 16.11 33.72 80.99 14.10 33.54 81.63 27.14 -39.98 -10.94 25.92 -39.21 -12.48 coo 12.19 31.08 87.29 11.13 32.66 86.38 26.46 -30.73 -8.22 26.92 -32.42 -9.39 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 2 3 # 2 A 241 ASP B 224 ASP~? 22.83 CL CL B 278 A 295 GLU B 221 GLU~? 17.56 CL CL B 278 A 369 ASP B 168 ASP^? 12.80 CL CL B 278 coo 11.74 38.14 80.19 10.63 36.40 80.65 -13.88 7.87 -23.86 -15.40 8.87 -22.81 coo 16.11 33.72 80.99 14.10 33.54 81.63 -13.90 4.76 -18.50 -13.25 3.58 -16.87 coo 12.19 31.08 87.29 11.13 32.66 86.38 -5.42 2.81 -22.11 -6.82 3.76 -20.83 1m53_c03 source 1m53 ISOMALTULOSE SYNTHASE : 2 hits 1m53_c03 naa= 3 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 1 3 # 1 A 241 ASP A 168 ASP^? 12.27 CL CL A 278 A 265 GLU A 235 GLU~? 25.79 CL CL A 278 A 369 ASP A 224 ASP~? 22.21 CL CL A 278 coo 11.74 38.14 80.19 10.63 36.40 80.65 26.46 -30.73 -8.22 26.92 -32.42 -9.39 coo 17.36 23.57 72.04 18.68 21.92 71.98 35.32 -29.84 7.74 36.12 -29.26 5.88 coo 12.19 31.08 87.29 11.13 32.66 86.38 30.83 -39.35 -6.18 31.71 -41.01 -7.15 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 2 3 # 2 A 241 ASP A 168 ASP^? 12.27 CL CL A 278 A 265 GLU A 253 GLU~? 21.30 CL CL A 278 A 369 ASP A 224 ASP~? 22.21 CL CL A 278 coo 11.74 38.14 80.19 10.63 36.40 80.65 26.46 -30.73 -8.22 26.92 -32.42 -9.39 coo 17.36 23.57 72.04 18.68 21.92 71.98 14.60 -42.99 -6.59 14.44 -44.06 -8.42 coo 12.19 31.08 87.29 11.13 32.66 86.38 30.83 -39.35 -6.18 31.71 -41.01 -7.15 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 3 3 # 3 A 241 ASP A 224 ASP~? 22.21 CL CL A 278 A 265 GLU A 235 GLU~? 25.79 CL CL A 278 A 369 ASP A 168 ASP^? 12.27 CL CL A 278 coo 11.74 38.14 80.19 10.63 36.40 80.65 30.83 -39.35 -6.18 31.71 -41.01 -7.15 coo 17.36 23.57 72.04 18.68 21.92 71.98 35.32 -29.84 7.74 36.12 -29.26 5.88 coo 12.19 31.08 87.29 11.13 32.66 86.38 26.46 -30.73 -8.22 26.92 -32.42 -9.39 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 4 3 # 4 A 241 ASP A 224 ASP~? 22.21 CL CL A 278 A 265 GLU A 253 GLU~? 21.30 CL CL A 278 A 369 ASP A 168 ASP^? 12.27 CL CL A 278 coo 11.74 38.14 80.19 10.63 36.40 80.65 30.83 -39.35 -6.18 31.71 -41.01 -7.15 coo 17.36 23.57 72.04 18.68 21.92 71.98 14.60 -42.99 -6.59 14.44 -44.06 -8.42 coo 12.19 31.08 87.29 11.13 32.66 86.38 26.46 -30.73 -8.22 26.92 -32.42 -9.39 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 5 3 # 5 A 241 ASP B 168 ASP^? 12.80 CL CL B 278 A 265 GLU B 235 GLU.? 26.01 CL CL B 278 A 369 ASP B 224 ASP~? 22.83 CL CL B 278 coo 11.74 38.14 80.19 10.63 36.40 80.65 -5.42 2.81 -22.11 -6.82 3.76 -20.83 coo 17.36 23.57 72.04 18.68 21.92 71.98 -5.56 9.78 -39.05 -4.91 10.76 -37.29 coo 12.19 31.08 87.29 11.13 32.66 86.38 -13.88 7.87 -23.86 -15.40 8.87 -22.81 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 6 3 # 6 A 241 ASP B 168 ASP^? 12.80 CL CL B 278 A 265 GLU B 253 GLU~? 21.95 CL CL B 278 A 369 ASP B 224 ASP~? 22.83 CL CL B 278 coo 11.74 38.14 80.19 10.63 36.40 80.65 -5.42 2.81 -22.11 -6.82 3.76 -20.83 coo 17.36 23.57 72.04 18.68 21.92 71.98 -18.69 -7.91 -20.45 -19.54 -8.29 -18.53 coo 12.19 31.08 87.29 11.13 32.66 86.38 -13.88 7.87 -23.86 -15.40 8.87 -22.81 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 7 3 # 7 A 241 ASP B 224 ASP~? 22.83 CL CL B 278 A 265 GLU B 235 GLU.? 26.01 CL CL B 278 A 369 ASP B 168 ASP^? 12.80 CL CL B 278 coo 11.74 38.14 80.19 10.63 36.40 80.65 -13.88 7.87 -23.86 -15.40 8.87 -22.81 coo 17.36 23.57 72.04 18.68 21.92 71.98 -5.56 9.78 -39.05 -4.91 10.76 -37.29 coo 12.19 31.08 87.29 11.13 32.66 86.38 -5.42 2.81 -22.11 -6.82 3.76 -20.83 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 8 3 # 8 A 241 ASP B 224 ASP~? 22.83 CL CL B 278 A 265 GLU B 253 GLU~? 21.95 CL CL B 278 A 369 ASP B 168 ASP^? 12.80 CL CL B 278 coo 11.74 38.14 80.19 10.63 36.40 80.65 -13.88 7.87 -23.86 -15.40 8.87 -22.81 coo 17.36 23.57 72.04 18.68 21.92 71.98 -18.69 -7.91 -20.45 -19.54 -8.29 -18.53 coo 12.19 31.08 87.29 11.13 32.66 86.38 -5.42 2.81 -22.11 -6.82 3.76 -20.83 1m53_c05 source 1m53 ISOMALTULOSE SYNTHASE : 8 hits 1m53_c05 naa= 3 ULMN 3 1mas_c00 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 1 3 # 1 A 10 ASP A 36 ASP~? 8.69 CL CL A 278 A 168 ASN A 244 ASN.? 5.40 CL CL A 278 A 241 HIS A 12 HIS~? 14.78 CL CL A 278 coo 2.16 -17.86 7.84 1.13 -18.57 9.58 11.67 -20.98 -6.16 13.43 -22.16 -5.96 coo -3.08 -15.85 14.13 -2.55 -17.63 13.08 17.85 -28.42 -8.05 16.64 -26.87 -8.84 coo -5.32 -25.12 14.92 -4.53 -26.21 16.52 9.03 -33.35 -4.93 10.37 -31.88 -5.56 ULMN 3 1mas_c00 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 2 3 # 2 A 10 ASP A 168 ASP^? 12.27 CL CL A 278 A 168 ASN A 245 ASN.? 11.79 CL CL A 278 A 241 HIS A 216 HIS.? 18.50 CL CL A 278 coo 2.16 -17.86 7.84 1.13 -18.57 9.58 26.46 -30.73 -8.22 26.92 -32.42 -9.39 coo -3.08 -15.85 14.13 -2.55 -17.63 13.08 18.48 -33.48 -10.76 18.30 -34.93 -9.15 coo -5.32 -25.12 14.92 -4.53 -26.21 16.52 17.97 -41.33 -12.21 17.58 -42.84 -10.82 ULMN 3 1mas_c00 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 3 3 # 3 A 10 ASP A 250 ASP~? 15.45 CL CL A 278 A 168 ASN A 246 ASN.? 12.85 CL CL A 278 A 241 HIS A 194 HIS.? 4.68 CL CL A 278 coo 2.16 -17.86 7.84 1.13 -18.57 9.58 15.24 -38.09 -11.21 14.62 -38.47 -13.19 coo -3.08 -15.85 14.13 -2.55 -17.63 13.08 12.83 -32.17 -9.87 11.11 -33.32 -9.30 coo -5.32 -25.12 14.92 -4.53 -26.21 16.52 21.59 -27.03 -10.13 21.31 -25.37 -8.87 ULMN 3 1mas_c00 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 4 3 # 4 A 10 ASP A 267 ASP.? 31.09 CL CL A 278 A 168 ASN A 58 ASN.? 28.29 CL CL A 278 A 241 HIS A -1 HIS.? 31.67 CL CL A 278 coo 2.16 -17.86 7.84 1.13 -18.57 9.58 11.77 -37.21 15.47 13.23 -35.63 15.60 coo -3.08 -15.85 14.13 -2.55 -17.63 13.08 13.69 -30.36 14.12 12.82 -32.29 13.72 coo -5.32 -25.12 14.92 -4.53 -26.21 16.52 23.28 -34.51 17.18 21.28 -34.97 16.73 ULMN 3 1mas_c00 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 5 3 # 5 A 10 ASP A 267 ASP.? 31.09 CL CL A 278 A 168 ASN A 270 ASN.? 33.57 CL CL A 278 A 241 HIS A 29 HIS.? 25.16 CL CL A 278 coo 2.16 -17.86 7.84 1.13 -18.57 9.58 11.77 -37.21 15.47 13.23 -35.63 15.60 coo -3.08 -15.85 14.13 -2.55 -17.63 13.08 2.70 -38.53 12.07 1.72 -36.95 13.05 coo -5.32 -25.12 14.92 -4.53 -26.21 16.52 7.41 -38.44 3.20 5.56 -39.41 3.04 ULMN 3 1mas_c00 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 6 3 # 6 A 10 ASP B 36 ASP~? 8.83 CL CL B 278 A 168 ASN B 244 ASN.? 5.94 CL CL B 278 A 241 HIS B 12 HIS~? 15.42 CL CL B 278 coo 2.16 -17.86 7.84 1.13 -18.57 9.58 2.64 -13.17 -23.36 1.59 -11.35 -23.67 coo -3.08 -15.85 14.13 -2.55 -17.63 13.08 -3.88 -6.12 -21.35 -2.47 -7.43 -20.48 coo -5.32 -25.12 14.92 -4.53 -26.21 16.52 -10.18 -14.51 -22.80 -8.49 -13.29 -22.60 ULMN 3 1mas_c00 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 7 3 # 7 A 10 ASP B 168 ASP^? 12.80 CL CL B 278 A 168 ASN B 245 ASN.? 12.34 CL CL B 278 A 241 HIS B 216 HIS.? 19.24 CL CL B 278 coo 2.16 -17.86 7.84 1.13 -18.57 9.58 -5.42 2.81 -22.11 -6.82 3.76 -20.83 coo -3.08 -15.85 14.13 -2.55 -17.63 13.08 -8.45 -4.50 -18.19 -10.06 -4.59 -19.62 coo -5.32 -25.12 14.92 -4.53 -26.21 16.52 -16.22 -3.98 -15.80 -17.90 -4.46 -16.96 ULMN 3 1mas_c00 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 8 3 # 8 A 10 ASP B 250 ASP~? 16.15 CL CL B 278 A 168 ASN B 246 ASN.? 13.30 CL CL B 278 A 241 HIS B 194 HIS.? 5.13 CL CL B 278 coo 2.16 -17.86 7.84 1.13 -18.57 9.58 -13.35 -7.01 -16.89 -13.59 -7.26 -14.81 coo -3.08 -15.85 14.13 -2.55 -17.63 13.08 -7.71 -10.36 -18.40 -9.09 -11.94 -18.78 coo -5.32 -25.12 14.92 -4.53 -26.21 16.52 -1.92 -2.21 -20.05 -0.53 -2.75 -21.52 ULMN 3 1mas_c00 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 9 3 # 9 A 10 ASP B 267 ASP.? 32.55 CL CL B 278 A 168 ASN B 270 ASN.? 34.32 CL CL B 278 A 241 HIS B 29 HIS.? 25.42 CL CL B 278 coo 2.16 -17.86 7.84 1.13 -18.57 9.58 -15.25 -13.37 -42.11 -14.97 -14.80 -43.57 coo -3.08 -15.85 14.13 -2.55 -17.63 13.08 -18.26 -22.22 -38.09 -17.05 -23.10 -39.57 coo -5.32 -25.12 14.92 -4.53 -26.21 16.52 -16.16 -16.38 -29.82 -17.24 -18.07 -29.20 1mas_c00 source 1mas INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDROLASE : 9 hits 1mas_c00 naa= 3 ULMN 3 1mas_c01 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 1 3 # 1 B 10 ASP A 36 ASP~? 8.69 CL CL A 278 B 168 ASN A 244 ASN.? 5.40 CL CL A 278 B 241 HIS A 12 HIS~? 14.78 CL CL A 278 coo -17.05 -4.58 51.44 -17.53 -6.08 49.99 11.67 -20.98 -6.16 13.43 -22.16 -5.96 coo -13.80 -8.69 44.98 -15.38 -8.70 46.39 17.85 -28.42 -8.05 16.64 -26.87 -8.84 coo -21.48 -14.16 44.54 -22.74 -13.73 42.93 9.03 -33.35 -4.93 10.37 -31.88 -5.56 ULMN 3 1mas_c01 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 2 3 # 2 B 10 ASP A 168 ASP^? 12.27 CL CL A 278 B 168 ASN A 245 ASN.? 11.79 CL CL A 278 B 241 HIS A 216 HIS.? 18.50 CL CL A 278 coo -17.05 -4.58 51.44 -17.53 -6.08 49.99 26.46 -30.73 -8.22 26.92 -32.42 -9.39 coo -13.80 -8.69 44.98 -15.38 -8.70 46.39 18.48 -33.48 -10.76 18.30 -34.93 -9.15 coo -21.48 -14.16 44.54 -22.74 -13.73 42.93 17.97 -41.33 -12.21 17.58 -42.84 -10.82 ULMN 3 1mas_c01 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 3 3 # 3 B 10 ASP A 250 ASP~? 15.45 CL CL A 278 B 168 ASN A 246 ASN.? 12.85 CL CL A 278 B 241 HIS A 194 HIS.? 4.68 CL CL A 278 coo -17.05 -4.58 51.44 -17.53 -6.08 49.99 15.24 -38.09 -11.21 14.62 -38.47 -13.19 coo -13.80 -8.69 44.98 -15.38 -8.70 46.39 12.83 -32.17 -9.87 11.11 -33.32 -9.30 coo -21.48 -14.16 44.54 -22.74 -13.73 42.93 21.59 -27.03 -10.13 21.31 -25.37 -8.87 ULMN 3 1mas_c01 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 4 3 # 4 B 10 ASP A 267 ASP.? 31.09 CL CL A 278 B 168 ASN A 58 ASN.? 28.29 CL CL A 278 B 241 HIS A -1 HIS.? 31.67 CL CL A 278 coo -17.05 -4.58 51.44 -17.53 -6.08 49.99 11.77 -37.21 15.47 13.23 -35.63 15.60 coo -13.80 -8.69 44.98 -15.38 -8.70 46.39 13.69 -30.36 14.12 12.82 -32.29 13.72 coo -21.48 -14.16 44.54 -22.74 -13.73 42.93 23.28 -34.51 17.18 21.28 -34.97 16.73 ULMN 3 1mas_c01 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 5 3 # 5 B 10 ASP A 267 ASP.? 31.09 CL CL A 278 B 168 ASN A 270 ASN.? 33.57 CL CL A 278 B 241 HIS A 29 HIS.? 25.16 CL CL A 278 coo -17.05 -4.58 51.44 -17.53 -6.08 49.99 11.77 -37.21 15.47 13.23 -35.63 15.60 coo -13.80 -8.69 44.98 -15.38 -8.70 46.39 2.70 -38.53 12.07 1.72 -36.95 13.05 coo -21.48 -14.16 44.54 -22.74 -13.73 42.93 7.41 -38.44 3.20 5.56 -39.41 3.04 ULMN 3 1mas_c01 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 6 3 # 6 B 10 ASP B 36 ASP~? 8.83 CL CL B 278 B 168 ASN B 244 ASN.? 5.94 CL CL B 278 B 241 HIS B 12 HIS~? 15.42 CL CL B 278 coo -17.05 -4.58 51.44 -17.53 -6.08 49.99 2.64 -13.17 -23.36 1.59 -11.35 -23.67 coo -13.80 -8.69 44.98 -15.38 -8.70 46.39 -3.88 -6.12 -21.35 -2.47 -7.43 -20.48 coo -21.48 -14.16 44.54 -22.74 -13.73 42.93 -10.18 -14.51 -22.80 -8.49 -13.29 -22.60 ULMN 3 1mas_c01 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 7 3 # 7 B 10 ASP B 168 ASP^? 12.80 CL CL B 278 B 168 ASN B 245 ASN.? 12.34 CL CL B 278 B 241 HIS B 216 HIS.? 19.24 CL CL B 278 coo -17.05 -4.58 51.44 -17.53 -6.08 49.99 -5.42 2.81 -22.11 -6.82 3.76 -20.83 coo -13.80 -8.69 44.98 -15.38 -8.70 46.39 -8.45 -4.50 -18.19 -10.06 -4.59 -19.62 coo -21.48 -14.16 44.54 -22.74 -13.73 42.93 -16.22 -3.98 -15.80 -17.90 -4.46 -16.96 ULMN 3 1mas_c01 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 8 3 # 8 B 10 ASP B 250 ASP~? 16.15 CL CL B 278 B 168 ASN B 246 ASN.? 13.30 CL CL B 278 B 241 HIS B 194 HIS.? 5.13 CL CL B 278 coo -17.05 -4.58 51.44 -17.53 -6.08 49.99 -13.35 -7.01 -16.89 -13.59 -7.26 -14.81 coo -13.80 -8.69 44.98 -15.38 -8.70 46.39 -7.71 -10.36 -18.40 -9.09 -11.94 -18.78 coo -21.48 -14.16 44.54 -22.74 -13.73 42.93 -1.92 -2.21 -20.05 -0.53 -2.75 -21.52 ULMN 3 1mas_c01 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 9 3 # 9 B 10 ASP B 267 ASP.? 32.55 CL CL B 278 B 168 ASN B 270 ASN.? 34.32 CL CL B 278 B 241 HIS B 29 HIS.? 25.42 CL CL B 278 coo -17.05 -4.58 51.44 -17.53 -6.08 49.99 -15.25 -13.37 -42.11 -14.97 -14.80 -43.57 coo -13.80 -8.69 44.98 -15.38 -8.70 46.39 -18.26 -22.22 -38.09 -17.05 -23.10 -39.57 coo -21.48 -14.16 44.54 -22.74 -13.73 42.93 -16.16 -16.38 -29.82 -17.24 -18.07 -29.20 1mas_c01 source 1mas INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDROLASE : 9 hits 1mas_c01 naa= 3 ULMN 3 1mla_c00 MALONYL-COENZYME A ACYL CARRIER PROTuser 1 3 # 1 92 SER A 233 SER~? 24.97 CL CL A 278 201 HIS A 0 HIS.? 29.82 CL CL A 278 250 GLN A 234 GLN~? 29.00 CL CL A 278 coo 38.34 0.72 11.82 37.33 1.15 14.05 29.21 -32.26 7.91 28.90 -34.64 7.58 coo 37.34 -2.58 17.29 36.94 -1.26 15.79 28.39 -31.84 13.78 30.11 -32.89 14.37 coo 35.50 -3.51 11.88 35.27 -1.49 11.17 32.99 -35.47 9.43 34.28 -36.74 8.33 1mla_c00 source 1mla MALONYL-COENZYME A ACYL CARRIER PROTEIN TRANSA: 1 hits 1mla_c00 naa= 3 ULMN 3 1mpp_c04 PEPSIN (RENIN) (E.C.3.4.23.23) user 1 3 # 1 32 ASP A 268 ASP.? 26.73 CL CL A 278 35 SER A 28 SER.? 27.02 CL CL A 278 215 ASP A 267 ASP.? 31.09 CL CL A 278 coo 20.97 14.47 32.28 19.66 15.96 31.62 9.60 -34.57 10.49 9.97 -36.28 9.26 coo 16.04 14.72 33.82 17.27 13.71 31.95 6.29 -36.11 7.11 4.57 -37.31 5.85 coo 20.65 22.00 33.80 20.06 20.56 32.39 11.77 -37.21 15.47 13.23 -35.63 15.60 ULMN 3 1mpp_c04 PEPSIN (RENIN) (E.C.3.4.23.23) user 2 3 # 2 32 ASP B 268 ASP.? 26.26 CL CL B 278 35 SER B 28 SER.? 27.87 CL CL B 278 215 ASP B 267 ASP.? 32.55 CL CL B 278 coo 20.97 14.47 32.28 19.66 15.96 31.62 -14.31 -16.11 -36.83 -14.03 -14.11 -36.24 coo 16.04 14.72 33.82 17.27 13.71 31.95 -14.66 -18.25 -33.71 -14.43 -20.67 -33.62 coo 20.65 22.00 33.80 20.06 20.56 32.39 -15.25 -13.37 -42.11 -14.97 -14.80 -43.57 1mpp_c04 source 1mpp PEPSIN (RENIN) (E.C.3.4.23.23) : 2 hits 1mpp_c04 naa= 3 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 1 3 # 1 A 465 GLY A 41 GLY~? 14.53 CL CL B 278 A 501 ASP A 132 ASP.? 29.97 CL CL A 278 B 367 TYR A 14 TYR~? 21.87 CL CL A 278 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 6.94 -12.26 -6.18 7.28 -12.90 -5.74 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 22.31 -10.85 12.65 23.22 -9.04 13.30 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 9.67 -41.27 -5.56 11.11 -43.55 -4.85 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 2 3 # 2 A 465 GLY A 41 GLY~? 14.53 CL CL B 278 A 501 ASP A 132 ASP.? 29.97 CL CL A 278 B 367 TYR A 215 TYR.? 13.87 CL CL A 278 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 6.94 -12.26 -6.18 7.28 -12.90 -5.74 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 22.31 -10.85 12.65 23.22 -9.04 13.30 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 21.62 -36.04 -14.58 23.93 -37.55 -14.90 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 3 3 # 3 A 465 GLY A 41 GLY~? 14.53 CL CL B 278 A 501 ASP B 250 ASP~? 16.15 CL CL B 278 B 367 TYR B 79 TYR.? 15.95 CL CL A 278 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 6.94 -12.26 -6.18 7.28 -12.90 -5.74 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -13.35 -7.01 -16.89 -13.59 -7.26 -14.81 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 19.67 -17.68 -27.47 17.12 -18.78 -27.53 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 4 3 # 4 A 465 GLY A 248 GLY.? 14.14 CL CL A 278 A 501 ASP A 224 ASP~? 22.21 CL CL A 278 B 367 TYR A 66 TYR.? 15.11 CL CL B 278 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 12.18 -35.81 -15.03 12.11 -35.46 -14.29 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 30.83 -39.35 -6.18 31.71 -41.01 -7.15 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 11.56 -10.03 -5.26 10.21 -8.56 -7.21 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 5 3 # 5 A 465 GLY A 249 GLY.? 14.98 CL CL A 278 A 501 ASP A 224 ASP~? 22.21 CL CL A 278 B 367 TYR A 66 TYR.? 15.11 CL CL B 278 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 10.85 -36.22 -11.47 11.63 -36.38 -11.65 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 30.83 -39.35 -6.18 31.71 -41.01 -7.15 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 11.56 -10.03 -5.26 10.21 -8.56 -7.21 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 6 3 # 6 A 465 GLY A 249 GLY.? 14.98 CL CL A 278 A 501 ASP A 224 ASP~? 22.21 CL CL A 278 B 367 TYR B 66 TYR.? 15.55 CL CL A 278 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 10.85 -36.22 -11.47 11.63 -36.38 -11.65 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 30.83 -39.35 -6.18 31.71 -41.01 -7.15 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 13.28 -14.60 -25.62 14.79 -15.90 -23.67 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 7 3 # 7 A 465 GLY A 249 GLY.? 14.98 CL CL A 278 A 501 ASP A 275 ASP.? 34.16 CL CL A 278 B 367 TYR B 39 TYR~? 9.53 CL CL B 278 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 10.85 -36.22 -11.47 11.63 -36.38 -11.65 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -7.58 -36.49 2.30 -8.60 -35.44 3.90 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 7.70 -12.06 -22.38 8.73 -10.22 -20.60 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 8 3 # 8 A 465 GLY B 41 GLY~? 14.81 CL CL A 278 A 501 ASP A 250 ASP~? 15.45 CL CL A 278 B 367 TYR A 79 TYR.? 15.56 CL CL B 278 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 10.75 -18.81 -23.86 10.10 -18.46 -24.26 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 15.24 -38.09 -11.21 14.62 -38.47 -13.19 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 9.48 -3.09 -3.95 8.21 -5.52 -3.44 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 9 3 # 9 A 465 GLY B 41 GLY~? 14.81 CL CL A 278 A 501 ASP B 132 ASP.? 29.62 CL CL B 278 B 367 TYR B 215 TYR.? 14.28 CL CL B 278 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 10.75 -18.81 -23.86 10.10 -18.46 -24.26 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 11.22 -5.69 -44.39 12.86 -4.72 -45.32 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -10.18 -0.68 -14.85 -11.32 1.86 -14.73 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 10 3 # 10 A 465 GLY B 248 GLY.? 14.76 CL CL B 278 A 501 ASP B 224 ASP~? 22.83 CL CL B 278 B 367 TYR B 66 TYR.? 15.55 CL CL A 278 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -10.88 -9.81 -12.81 -10.61 -10.09 -13.55 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -13.88 7.87 -23.86 -15.40 8.87 -22.81 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 13.28 -14.60 -25.62 14.79 -15.90 -23.67 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 11 3 # 11 A 465 GLY B 249 GLY.? 15.61 CL CL B 278 A 501 ASP B 224 ASP~? 22.83 CL CL B 278 B 367 TYR A 66 TYR.? 15.11 CL CL B 278 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -11.90 -11.51 -16.09 -11.99 -10.68 -16.03 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -13.88 7.87 -23.86 -15.40 8.87 -22.81 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 11.56 -10.03 -5.26 10.21 -8.56 -7.21 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 12 3 # 12 A 465 GLY B 249 GLY.? 15.61 CL CL B 278 A 501 ASP B 224 ASP~? 22.83 CL CL B 278 B 367 TYR B 66 TYR.? 15.55 CL CL A 278 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -11.90 -11.51 -16.09 -11.99 -10.68 -16.03 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -13.88 7.87 -23.86 -15.40 8.87 -22.81 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 13.28 -14.60 -25.62 14.79 -15.90 -23.67 1mro_c00 source 1mro METHYL-COENZYME M REDUCTASE : 12 hits 1mro_c00 naa= 3 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 1 3 # 1 D 465 GLY A 41 GLY~? 14.53 CL CL B 278 D 501 ASP A 132 ASP.? 29.97 CL CL A 278 E 367 TYR A 14 TYR~? 21.87 CL CL A 278 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 6.94 -12.26 -6.18 7.28 -12.90 -5.74 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 22.31 -10.85 12.65 23.22 -9.04 13.30 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 9.67 -41.27 -5.56 11.11 -43.55 -4.85 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 2 3 # 2 D 465 GLY A 41 GLY~? 14.53 CL CL B 278 D 501 ASP A 132 ASP.? 29.97 CL CL A 278 E 367 TYR A 215 TYR.? 13.87 CL CL A 278 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 6.94 -12.26 -6.18 7.28 -12.90 -5.74 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 22.31 -10.85 12.65 23.22 -9.04 13.30 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 21.62 -36.04 -14.58 23.93 -37.55 -14.90 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 3 3 # 3 D 465 GLY A 41 GLY~? 14.53 CL CL B 278 D 501 ASP B 250 ASP~? 16.15 CL CL B 278 E 367 TYR B 79 TYR.? 15.95 CL CL A 278 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 6.94 -12.26 -6.18 7.28 -12.90 -5.74 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -13.35 -7.01 -16.89 -13.59 -7.26 -14.81 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 19.67 -17.68 -27.47 17.12 -18.78 -27.53 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 4 3 # 4 D 465 GLY A 248 GLY.? 14.14 CL CL A 278 D 501 ASP A 224 ASP~? 22.21 CL CL A 278 E 367 TYR A 66 TYR.? 15.11 CL CL B 278 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 12.18 -35.81 -15.03 12.11 -35.46 -14.29 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 30.83 -39.35 -6.18 31.71 -41.01 -7.15 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 11.56 -10.03 -5.26 10.21 -8.56 -7.21 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 5 3 # 5 D 465 GLY A 249 GLY.? 14.98 CL CL A 278 D 501 ASP A 224 ASP~? 22.21 CL CL A 278 E 367 TYR A 66 TYR.? 15.11 CL CL B 278 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 10.85 -36.22 -11.47 11.63 -36.38 -11.65 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 30.83 -39.35 -6.18 31.71 -41.01 -7.15 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 11.56 -10.03 -5.26 10.21 -8.56 -7.21 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 6 3 # 6 D 465 GLY A 249 GLY.? 14.98 CL CL A 278 D 501 ASP A 224 ASP~? 22.21 CL CL A 278 E 367 TYR B 66 TYR.? 15.55 CL CL A 278 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 10.85 -36.22 -11.47 11.63 -36.38 -11.65 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 30.83 -39.35 -6.18 31.71 -41.01 -7.15 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 13.28 -14.60 -25.62 14.79 -15.90 -23.67 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 7 3 # 7 D 465 GLY A 249 GLY.? 14.98 CL CL A 278 D 501 ASP A 275 ASP.? 34.16 CL CL A 278 E 367 TYR B 39 TYR~? 9.53 CL CL B 278 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 10.85 -36.22 -11.47 11.63 -36.38 -11.65 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -7.58 -36.49 2.30 -8.60 -35.44 3.90 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 7.70 -12.06 -22.38 8.73 -10.22 -20.60 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 8 3 # 8 D 465 GLY B 41 GLY~? 14.81 CL CL A 278 D 501 ASP A 250 ASP~? 15.45 CL CL A 278 E 367 TYR A 79 TYR.? 15.56 CL CL B 278 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 10.75 -18.81 -23.86 10.10 -18.46 -24.26 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 15.24 -38.09 -11.21 14.62 -38.47 -13.19 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 9.48 -3.09 -3.95 8.21 -5.52 -3.44 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 9 3 # 9 D 465 GLY B 41 GLY~? 14.81 CL CL A 278 D 501 ASP B 132 ASP.? 29.62 CL CL B 278 E 367 TYR B 215 TYR.? 14.28 CL CL B 278 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 10.75 -18.81 -23.86 10.10 -18.46 -24.26 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 11.22 -5.69 -44.39 12.86 -4.72 -45.32 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -10.18 -0.68 -14.85 -11.32 1.86 -14.73 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 10 3 # 10 D 465 GLY B 248 GLY.? 14.76 CL CL B 278 D 501 ASP B 224 ASP~? 22.83 CL CL B 278 E 367 TYR B 66 TYR.? 15.55 CL CL A 278 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -10.88 -9.81 -12.81 -10.61 -10.09 -13.55 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -13.88 7.87 -23.86 -15.40 8.87 -22.81 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 13.28 -14.60 -25.62 14.79 -15.90 -23.67 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 11 3 # 11 D 465 GLY B 249 GLY.? 15.61 CL CL B 278 D 501 ASP B 224 ASP~? 22.83 CL CL B 278 E 367 TYR A 66 TYR.? 15.11 CL CL B 278 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -11.90 -11.51 -16.09 -11.99 -10.68 -16.03 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -13.88 7.87 -23.86 -15.40 8.87 -22.81 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 11.56 -10.03 -5.26 10.21 -8.56 -7.21 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 12 3 # 12 D 465 GLY B 249 GLY.? 15.61 CL CL B 278 D 501 ASP B 224 ASP~? 22.83 CL CL B 278 E 367 TYR B 66 TYR.? 15.55 CL CL A 278 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -11.90 -11.51 -16.09 -11.99 -10.68 -16.03 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -13.88 7.87 -23.86 -15.40 8.87 -22.81 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 13.28 -14.60 -25.62 14.79 -15.90 -23.67 1mro_c01 source 1mro METHYL-COENZYME M REDUCTASE : 12 hits 1mro_c01 naa= 3 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 1 3 # 1 A 50 ASP A 205 ASP.? 14.79 CL CL A 278 A 55 TYR B 78 TYR~? 9.41 CL CL A 278 A 84 LYS A 211 LYS~? 14.92 CL CL A 278 coo 11.09 42.89 24.44 11.32 42.06 22.49 19.11 -25.60 -27.15 17.47 -26.92 -26.86 coo 4.60 40.33 20.42 7.25 39.50 20.05 18.05 -20.46 -22.54 16.77 -21.06 -20.14 coo 9.71 44.83 15.47 10.13 41.43 19.93 17.07 -30.19 -20.07 15.73 -30.42 -25.42 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 2 3 # 2 A 50 ASP B 205 ASP.? 14.85 CL CL B 278 A 55 TYR A 78 TYR~? 9.12 CL CL B 278 A 84 LYS B 210 LYS~? 12.46 CL CL B 278 coo 11.09 42.89 24.44 11.32 42.06 22.49 1.45 -2.78 -3.16 -0.06 -4.27 -3.04 coo 4.60 40.33 20.42 7.25 39.50 20.05 5.93 -5.00 -8.22 4.93 -6.54 -10.31 coo 9.71 44.83 15.47 10.13 41.43 19.93 -2.49 -8.60 -10.03 0.77 -12.84 -8.24 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 3 3 # 3 A 50 ASP B 205 ASP.? 14.85 CL CL B 278 A 55 TYR A 78 TYR~? 9.12 CL CL B 278 A 84 LYS B 211 LYS~? 15.02 CL CL B 278 coo 11.09 42.89 24.44 11.32 42.06 22.49 1.45 -2.78 -3.16 -0.06 -4.27 -3.04 coo 4.60 40.33 20.42 7.25 39.50 20.05 5.93 -5.00 -8.22 4.93 -6.54 -10.31 coo 9.71 44.83 15.47 10.13 41.43 19.93 -4.12 -5.20 -9.45 -3.45 -5.07 -3.77 1mrq_c02 source 1mrq ALDO-KETO REDUCTASE FAMILY 1 MEMBER C1 : 3 hits 1mrq_c02 naa= 3 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 A 142 LYS A 64 LYS^? 6.64 CL CL A 278 A 217 SER A 67 SER.? 14.21 CL CL A 278 A 241 SER A 70 SER.? 11.73 CL CL A 278 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 14.97 -18.21 -2.39 15.88 -19.33 -8.52 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 14.35 -11.91 -8.16 12.43 -11.38 -9.50 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 19.33 -11.34 -7.00 17.75 -13.05 -7.65 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 A 142 LYS B 64 LYS^? 6.39 CL CL B 278 A 217 SER B 67 SER.? 13.79 CL CL B 278 A 241 SER B 70 SER.? 11.46 CL CL B 278 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 5.21 -10.68 -27.95 4.80 -8.81 -21.96 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 12.14 -11.19 -22.93 12.67 -12.95 -21.38 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 13.00 -6.56 -24.86 11.13 -7.93 -24.10 1mt5_c00 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 2 hits 1mt5_c00 naa= 3 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 B 142 LYS A 64 LYS^? 6.64 CL CL A 278 B 217 SER A 67 SER.? 14.21 CL CL A 278 B 241 SER A 70 SER.? 11.73 CL CL A 278 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 14.97 -18.21 -2.39 15.88 -19.33 -8.52 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 14.35 -11.91 -8.16 12.43 -11.38 -9.50 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 19.33 -11.34 -7.00 17.75 -13.05 -7.65 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 B 142 LYS B 64 LYS^? 6.39 CL CL B 278 B 217 SER B 67 SER.? 13.79 CL CL B 278 B 241 SER B 70 SER.? 11.46 CL CL B 278 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 5.21 -10.68 -27.95 4.80 -8.81 -21.96 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 12.14 -11.19 -22.93 12.67 -12.95 -21.38 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 13.00 -6.56 -24.86 11.13 -7.93 -24.10 1mt5_c01 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 2 hits 1mt5_c01 naa= 3 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 C 142 LYS A 64 LYS^? 6.64 CL CL A 278 C 217 SER A 67 SER.? 14.21 CL CL A 278 C 241 SER A 70 SER.? 11.73 CL CL A 278 coo -12.07 2.83 63.52 -8.95 7.56 61.01 14.97 -18.21 -2.39 15.88 -19.33 -8.52 coo -11.64 10.12 58.62 -9.34 9.31 58.79 14.35 -11.91 -8.16 12.43 -11.38 -9.50 coo -9.31 12.91 61.58 -8.56 11.90 59.50 19.33 -11.34 -7.00 17.75 -13.05 -7.65 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 C 142 LYS B 64 LYS^? 6.39 CL CL B 278 C 217 SER B 67 SER.? 13.79 CL CL B 278 C 241 SER B 70 SER.? 11.46 CL CL B 278 coo -12.07 2.83 63.52 -8.95 7.56 61.01 5.21 -10.68 -27.95 4.80 -8.81 -21.96 coo -11.64 10.12 58.62 -9.34 9.31 58.79 12.14 -11.19 -22.93 12.67 -12.95 -21.38 coo -9.31 12.91 61.58 -8.56 11.90 59.50 13.00 -6.56 -24.86 11.13 -7.93 -24.10 1mt5_c02 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 2 hits 1mt5_c02 naa= 3 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 D 142 LYS A 64 LYS^? 6.64 CL CL A 278 D 217 SER A 67 SER.? 14.21 CL CL A 278 D 241 SER A 70 SER.? 11.73 CL CL A 278 coo 32.93 17.78 71.88 30.89 13.50 67.83 14.97 -18.21 -2.39 15.88 -19.33 -8.52 coo 34.38 11.17 66.10 32.18 12.14 65.65 14.35 -11.91 -8.16 12.43 -11.38 -9.50 coo 31.34 7.96 67.74 31.44 9.08 65.62 19.33 -11.34 -7.00 17.75 -13.05 -7.65 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 D 142 LYS B 64 LYS^? 6.39 CL CL B 278 D 217 SER B 67 SER.? 13.79 CL CL B 278 D 241 SER B 70 SER.? 11.46 CL CL B 278 coo 32.93 17.78 71.88 30.89 13.50 67.83 5.21 -10.68 -27.95 4.80 -8.81 -21.96 coo 34.38 11.17 66.10 32.18 12.14 65.65 12.14 -11.19 -22.93 12.67 -12.95 -21.38 coo 31.34 7.96 67.74 31.44 9.08 65.62 13.00 -6.56 -24.86 11.13 -7.93 -24.10 1mt5_c03 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 2 hits 1mt5_c03 naa= 3 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 E 142 LYS A 64 LYS^? 6.64 CL CL A 278 E 217 SER A 67 SER.? 14.21 CL CL A 278 E 241 SER A 70 SER.? 11.73 CL CL A 278 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 14.97 -18.21 -2.39 15.88 -19.33 -8.52 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 14.35 -11.91 -8.16 12.43 -11.38 -9.50 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 19.33 -11.34 -7.00 17.75 -13.05 -7.65 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 E 142 LYS B 64 LYS^? 6.39 CL CL B 278 E 217 SER B 67 SER.? 13.79 CL CL B 278 E 241 SER B 70 SER.? 11.46 CL CL B 278 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 5.21 -10.68 -27.95 4.80 -8.81 -21.96 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 12.14 -11.19 -22.93 12.67 -12.95 -21.38 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 13.00 -6.56 -24.86 11.13 -7.93 -24.10 1mt5_c04 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 2 hits 1mt5_c04 naa= 3 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 F 142 LYS A 64 LYS^? 6.64 CL CL A 278 F 217 SER A 67 SER.? 14.21 CL CL A 278 F 241 SER A 70 SER.? 11.73 CL CL A 278 coo 85.78 13.19 64.96 85.47 13.47 58.63 14.97 -18.21 -2.39 15.88 -19.33 -8.52 coo 87.43 17.13 57.15 85.84 15.39 56.76 14.35 -11.91 -8.16 12.43 -11.38 -9.50 coo 89.69 13.60 54.86 87.60 14.67 54.46 19.33 -11.34 -7.00 17.75 -13.05 -7.65 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 F 142 LYS B 64 LYS^? 6.39 CL CL B 278 F 217 SER B 67 SER.? 13.79 CL CL B 278 F 241 SER B 70 SER.? 11.46 CL CL B 278 coo 85.78 13.19 64.96 85.47 13.47 58.63 5.21 -10.68 -27.95 4.80 -8.81 -21.96 coo 87.43 17.13 57.15 85.84 15.39 56.76 12.14 -11.19 -22.93 12.67 -12.95 -21.38 coo 89.69 13.60 54.86 87.60 14.67 54.46 13.00 -6.56 -24.86 11.13 -7.93 -24.10 1mt5_c05 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 2 hits 1mt5_c05 naa= 3 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 G 142 LYS A 64 LYS^? 6.64 CL CL A 278 G 217 SER A 67 SER.? 14.21 CL CL A 278 G 241 SER A 70 SER.? 11.73 CL CL A 278 coo 89.44 13.59 -3.79 85.15 17.81 -2.15 14.97 -18.21 -2.39 15.88 -19.33 -8.52 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 14.35 -11.91 -8.16 12.43 -11.38 -9.50 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 19.33 -11.34 -7.00 17.75 -13.05 -7.65 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 G 142 LYS B 64 LYS^? 6.39 CL CL B 278 G 217 SER B 67 SER.? 13.79 CL CL B 278 G 241 SER B 70 SER.? 11.46 CL CL B 278 coo 89.44 13.59 -3.79 85.15 17.81 -2.15 5.21 -10.68 -27.95 4.80 -8.81 -21.96 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 12.14 -11.19 -22.93 12.67 -12.95 -21.38 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 13.00 -6.56 -24.86 11.13 -7.93 -24.10 1mt5_c06 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 2 hits 1mt5_c06 naa= 3 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 H 142 LYS A 64 LYS^? 6.64 CL CL A 278 H 217 SER A 67 SER.? 14.21 CL CL A 278 H 241 SER A 70 SER.? 11.73 CL CL A 278 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 14.97 -18.21 -2.39 15.88 -19.33 -8.52 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 14.35 -11.91 -8.16 12.43 -11.38 -9.50 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 19.33 -11.34 -7.00 17.75 -13.05 -7.65 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 H 142 LYS B 64 LYS^? 6.39 CL CL B 278 H 217 SER B 67 SER.? 13.79 CL CL B 278 H 241 SER B 70 SER.? 11.46 CL CL B 278 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 5.21 -10.68 -27.95 4.80 -8.81 -21.96 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 12.14 -11.19 -22.93 12.67 -12.95 -21.38 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 13.00 -6.56 -24.86 11.13 -7.93 -24.10 1mt5_c07 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 2 hits 1mt5_c07 naa= 3 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 I 142 LYS A 64 LYS^? 6.64 CL CL A 278 I 217 SER A 67 SER.? 14.21 CL CL A 278 I 241 SER A 70 SER.? 11.73 CL CL A 278 coo -5.05 91.11 27.04 -1.24 87.39 30.21 14.97 -18.21 -2.39 15.88 -19.33 -8.52 coo 2.83 88.63 29.54 1.30 86.82 30.03 14.35 -11.91 -8.16 12.43 -11.38 -9.50 coo 2.37 88.32 34.25 2.82 86.58 32.61 19.33 -11.34 -7.00 17.75 -13.05 -7.65 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 I 142 LYS B 64 LYS^? 6.39 CL CL B 278 I 217 SER B 67 SER.? 13.79 CL CL B 278 I 241 SER B 70 SER.? 11.46 CL CL B 278 coo -5.05 91.11 27.04 -1.24 87.39 30.21 5.21 -10.68 -27.95 4.80 -8.81 -21.96 coo 2.83 88.63 29.54 1.30 86.82 30.03 12.14 -11.19 -22.93 12.67 -12.95 -21.38 coo 2.37 88.32 34.25 2.82 86.58 32.61 13.00 -6.56 -24.86 11.13 -7.93 -24.10 1mt5_c08 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 2 hits 1mt5_c08 naa= 3 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 J 142 LYS A 64 LYS^? 6.64 CL CL A 278 J 217 SER A 67 SER.? 14.21 CL CL A 278 J 241 SER A 70 SER.? 11.73 CL CL A 278 coo -16.11 59.78 61.53 -15.92 58.68 55.43 14.97 -18.21 -2.39 15.88 -19.33 -8.52 coo -17.65 54.92 54.17 -15.81 56.46 53.79 14.35 -11.91 -8.16 12.43 -11.38 -9.50 coo -19.92 58.10 51.57 -17.75 57.08 51.34 19.33 -11.34 -7.00 17.75 -13.05 -7.65 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 J 142 LYS B 64 LYS^? 6.39 CL CL B 278 J 217 SER B 67 SER.? 13.79 CL CL B 278 J 241 SER B 70 SER.? 11.46 CL CL B 278 coo -16.11 59.78 61.53 -15.92 58.68 55.43 5.21 -10.68 -27.95 4.80 -8.81 -21.96 coo -17.65 54.92 54.17 -15.81 56.46 53.79 12.14 -11.19 -22.93 12.67 -12.95 -21.38 coo -19.92 58.10 51.57 -17.75 57.08 51.34 13.00 -6.56 -24.86 11.13 -7.93 -24.10 1mt5_c09 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 2 hits 1mt5_c09 naa= 3 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 K 142 LYS A 64 LYS^? 6.64 CL CL A 278 K 217 SER A 67 SER.? 14.21 CL CL A 278 K 241 SER A 70 SER.? 11.73 CL CL A 278 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 14.97 -18.21 -2.39 15.88 -19.33 -8.52 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 14.35 -11.91 -8.16 12.43 -11.38 -9.50 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 19.33 -11.34 -7.00 17.75 -13.05 -7.65 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 K 142 LYS B 64 LYS^? 6.39 CL CL B 278 K 217 SER B 67 SER.? 13.79 CL CL B 278 K 241 SER B 70 SER.? 11.46 CL CL B 278 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 5.21 -10.68 -27.95 4.80 -8.81 -21.96 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 12.14 -11.19 -22.93 12.67 -12.95 -21.38 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 13.00 -6.56 -24.86 11.13 -7.93 -24.10 1mt5_c10 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 2 hits 1mt5_c10 naa= 3 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 L 142 LYS A 64 LYS^? 6.64 CL CL A 278 L 217 SER A 67 SER.? 14.21 CL CL A 278 L 241 SER A 70 SER.? 11.73 CL CL A 278 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 14.97 -18.21 -2.39 15.88 -19.33 -8.52 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 14.35 -11.91 -8.16 12.43 -11.38 -9.50 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 19.33 -11.34 -7.00 17.75 -13.05 -7.65 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 L 142 LYS B 64 LYS^? 6.39 CL CL B 278 L 217 SER B 67 SER.? 13.79 CL CL B 278 L 241 SER B 70 SER.? 11.46 CL CL B 278 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 5.21 -10.68 -27.95 4.80 -8.81 -21.96 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 12.14 -11.19 -22.93 12.67 -12.95 -21.38 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 13.00 -6.56 -24.86 11.13 -7.93 -24.10 1mt5_c11 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 2 hits 1mt5_c11 naa= 3 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 M 142 LYS A 64 LYS^? 6.64 CL CL A 278 M 217 SER A 67 SER.? 14.21 CL CL A 278 M 241 SER A 70 SER.? 11.73 CL CL A 278 coo 57.83 99.61 24.25 54.90 95.14 20.60 14.97 -18.21 -2.39 15.88 -19.33 -8.52 coo 51.07 94.66 21.52 53.18 93.49 22.20 14.35 -11.91 -8.16 12.43 -11.38 -9.50 coo 51.67 94.23 16.93 51.60 92.47 18.57 19.33 -11.34 -7.00 17.75 -13.05 -7.65 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 M 142 LYS B 64 LYS^? 6.39 CL CL B 278 M 217 SER B 67 SER.? 13.79 CL CL B 278 M 241 SER B 70 SER.? 11.46 CL CL B 278 coo 57.83 99.61 24.25 54.90 95.14 20.60 5.21 -10.68 -27.95 4.80 -8.81 -21.96 coo 51.07 94.66 21.52 53.18 93.49 22.20 12.14 -11.19 -22.93 12.67 -12.95 -21.38 coo 51.67 94.23 16.93 51.60 92.47 18.57 13.00 -6.56 -24.86 11.13 -7.93 -24.10 1mt5_c12 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 2 hits 1mt5_c12 naa= 3 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 N 142 LYS A 64 LYS^? 6.64 CL CL A 278 N 217 SER A 67 SER.? 14.21 CL CL A 278 N 241 SER A 70 SER.? 11.73 CL CL A 278 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 14.97 -18.21 -2.39 15.88 -19.33 -8.52 coo 81.67 67.31 -0.58 79.53 68.28 0.00 14.35 -11.91 -8.16 12.43 -11.38 -9.50 coo 82.47 71.15 2.07 80.82 69.44 2.28 19.33 -11.34 -7.00 17.75 -13.05 -7.65 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 N 142 LYS B 64 LYS^? 6.39 CL CL B 278 N 217 SER B 67 SER.? 13.79 CL CL B 278 N 241 SER B 70 SER.? 11.46 CL CL B 278 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 5.21 -10.68 -27.95 4.80 -8.81 -21.96 coo 81.67 67.31 -0.58 79.53 68.28 0.00 12.14 -11.19 -22.93 12.67 -12.95 -21.38 coo 82.47 71.15 2.07 80.82 69.44 2.28 13.00 -6.56 -24.86 11.13 -7.93 -24.10 1mt5_c13 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 2 hits 1mt5_c13 naa= 3 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 O 142 LYS A 64 LYS^? 6.64 CL CL A 278 O 217 SER A 67 SER.? 14.21 CL CL A 278 O 241 SER A 70 SER.? 11.73 CL CL A 278 coo 81.67 70.12 58.71 78.82 64.87 57.22 14.97 -18.21 -2.39 15.88 -19.33 -8.52 coo 81.62 62.23 55.05 79.32 62.93 55.20 14.35 -11.91 -8.16 12.43 -11.38 -9.50 coo 79.39 59.54 58.42 78.72 60.00 56.11 19.33 -11.34 -7.00 17.75 -13.05 -7.65 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 O 142 LYS B 64 LYS^? 6.39 CL CL B 278 O 217 SER B 67 SER.? 13.79 CL CL B 278 O 241 SER B 70 SER.? 11.46 CL CL B 278 coo 81.67 70.12 58.71 78.82 64.87 57.22 5.21 -10.68 -27.95 4.80 -8.81 -21.96 coo 81.62 62.23 55.05 79.32 62.93 55.20 12.14 -11.19 -22.93 12.67 -12.95 -21.38 coo 79.39 59.54 58.42 78.72 60.00 56.11 13.00 -6.56 -24.86 11.13 -7.93 -24.10 1mt5_c14 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 2 hits 1mt5_c14 naa= 3 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 P 142 LYS A 64 LYS^? 6.64 CL CL A 278 P 217 SER A 67 SER.? 14.21 CL CL A 278 P 241 SER A 70 SER.? 11.73 CL CL A 278 coo 37.29 55.72 69.54 38.73 59.85 65.07 14.97 -18.21 -2.39 15.88 -19.33 -8.52 coo 35.55 61.40 62.96 37.72 60.41 62.66 14.35 -11.91 -8.16 12.43 -11.38 -9.50 coo 38.60 64.77 64.10 38.63 63.28 62.26 19.33 -11.34 -7.00 17.75 -13.05 -7.65 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 P 142 LYS B 64 LYS^? 6.39 CL CL B 278 P 217 SER B 67 SER.? 13.79 CL CL B 278 P 241 SER B 70 SER.? 11.46 CL CL B 278 coo 37.29 55.72 69.54 38.73 59.85 65.07 5.21 -10.68 -27.95 4.80 -8.81 -21.96 coo 35.55 61.40 62.96 37.72 60.41 62.66 12.14 -11.19 -22.93 12.67 -12.95 -21.38 coo 38.60 64.77 64.10 38.63 63.28 62.26 13.00 -6.56 -24.86 11.13 -7.93 -24.10 1mt5_c15 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 2 hits 1mt5_c15 naa= 3 ULMN 3 1myr_c00 MYROSINASE user 1 3 # 1 187 GLN A 220 GLN~? 25.18 CL CL A 278 328 ASN A 218 ASN~? 20.82 CL CL A 278 409 GLU A 221 GLU~? 17.05 CL CL A 278 coo 45.09 114.33 52.30 45.59 116.18 51.29 30.24 -44.25 -9.55 31.42 -45.05 -7.98 coo 41.10 116.46 52.80 42.09 116.00 54.64 24.13 -43.84 -11.70 26.14 -43.18 -11.76 coo 42.69 118.64 56.27 44.58 118.34 55.45 27.14 -39.98 -10.94 25.92 -39.21 -12.48 ULMN 3 1myr_c00 MYROSINASE user 2 3 # 2 187 GLN B 220 GLN~? 25.32 CL CL B 278 328 ASN B 218 ASN~? 21.19 CL CL B 278 409 GLU B 221 GLU~? 17.56 CL CL B 278 coo 45.09 114.33 52.30 45.59 116.18 51.29 -17.87 7.98 -19.75 -18.70 9.08 -21.40 coo 41.10 116.46 52.80 42.09 116.00 54.64 -17.80 2.35 -16.65 -17.00 4.26 -17.12 coo 42.69 118.64 56.27 44.58 118.34 55.45 -13.90 4.76 -18.50 -13.25 3.58 -16.87 ULMN 3 1myr_c00 MYROSINASE user 3 3 # 3 187 GLN B 257 GLN~? 21.23 CL CL B 278 328 ASN B 254 ASN~? 16.98 CL CL B 278 409 GLU B 253 GLU~? 21.95 CL CL B 278 coo 45.09 114.33 52.30 45.59 116.18 51.29 -19.30 -4.24 -23.09 -18.81 -3.62 -21.09 coo 41.10 116.46 52.80 42.09 116.00 54.64 -14.04 -4.32 -21.65 -14.71 -3.72 -19.71 coo 42.69 118.64 56.27 44.58 118.34 55.45 -18.69 -7.91 -20.45 -19.54 -8.29 -18.53 1myr_c00 source 1myr MYROSINASE : 3 hits 1myr_c00 naa= 3 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 1 3 # 1 A 114 HIS A 194 HIS.? 4.68 CL CL A 278 A 197 ASP A 168 ASP^? 12.27 CL CL A 278 A 223 ALA A 198 ALA.? 14.21 CL CL A 278 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 21.59 -27.03 -10.13 21.31 -25.37 -8.87 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 26.46 -30.73 -8.22 26.92 -32.42 -9.39 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 26.04 -31.95 -20.22 27.48 -32.27 -19.92 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 2 3 # 2 A 114 HIS A 194 HIS.? 4.68 CL CL A 278 A 197 ASP A 168 ASP^? 12.27 CL CL A 278 A 223 ALA A 255 ALA~? 16.66 CL CL A 278 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 21.59 -27.03 -10.13 21.31 -25.37 -8.87 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 26.46 -30.73 -8.22 26.92 -32.42 -9.39 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 17.52 -37.58 -2.40 16.49 -36.47 -2.16 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 3 3 # 3 A 114 HIS B 29 HIS.? 25.42 CL CL B 278 A 197 ASP B 268 ASP.? 26.26 CL CL B 278 A 223 ALA B 255 ALA~? 17.38 CL CL B 278 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -16.16 -16.38 -29.82 -17.24 -18.07 -29.20 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -14.31 -16.11 -36.83 -14.03 -14.11 -36.24 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -13.88 -5.94 -25.91 -12.91 -7.08 -26.16 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 4 3 # 4 A 114 HIS B 194 HIS.? 5.13 CL CL B 278 A 197 ASP B 168 ASP^? 12.80 CL CL B 278 A 223 ALA B 198 ALA.? 14.47 CL CL B 278 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -1.92 -2.21 -20.05 -0.53 -2.75 -21.52 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -5.42 2.81 -22.11 -6.82 3.76 -20.83 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -5.00 4.00 -10.23 -5.24 5.42 -10.67 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 5 3 # 5 A 114 HIS B 194 HIS.? 5.13 CL CL B 278 A 197 ASP B 168 ASP^? 12.80 CL CL B 278 A 223 ALA B 251 ALA~? 13.13 CL CL B 278 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -1.92 -2.21 -20.05 -0.53 -2.75 -21.52 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -5.42 2.81 -22.11 -6.82 3.76 -20.83 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -11.21 -8.27 -20.82 -9.88 -9.02 -21.02 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 6 3 # 6 A 114 HIS B 194 HIS.? 5.13 CL CL B 278 A 197 ASP B 168 ASP^? 12.80 CL CL B 278 A 223 ALA B 255 ALA~? 17.38 CL CL B 278 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -1.92 -2.21 -20.05 -0.53 -2.75 -21.52 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -5.42 2.81 -22.11 -6.82 3.76 -20.83 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -13.88 -5.94 -25.91 -12.91 -7.08 -26.16 1n2t_c02 source 1n2t L-CYSTEINE-CYSTINE LYASE C-DES : 6 hits 1n2t_c02 naa= 3 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 1 3 # 1 B 114 HIS A 194 HIS.? 4.68 CL CL A 278 B 197 ASP A 168 ASP^? 12.27 CL CL A 278 B 223 ALA A 198 ALA.? 14.21 CL CL A 278 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 21.59 -27.03 -10.13 21.31 -25.37 -8.87 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 26.46 -30.73 -8.22 26.92 -32.42 -9.39 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 26.04 -31.95 -20.22 27.48 -32.27 -19.92 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 2 3 # 2 B 114 HIS A 194 HIS.? 4.68 CL CL A 278 B 197 ASP A 168 ASP^? 12.27 CL CL A 278 B 223 ALA A 255 ALA~? 16.66 CL CL A 278 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 21.59 -27.03 -10.13 21.31 -25.37 -8.87 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 26.46 -30.73 -8.22 26.92 -32.42 -9.39 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 17.52 -37.58 -2.40 16.49 -36.47 -2.16 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 3 3 # 3 B 114 HIS B 29 HIS.? 25.42 CL CL B 278 B 197 ASP B 268 ASP.? 26.26 CL CL B 278 B 223 ALA B 255 ALA~? 17.38 CL CL B 278 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -16.16 -16.38 -29.82 -17.24 -18.07 -29.20 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -14.31 -16.11 -36.83 -14.03 -14.11 -36.24 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -13.88 -5.94 -25.91 -12.91 -7.08 -26.16 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 4 3 # 4 B 114 HIS B 194 HIS.? 5.13 CL CL B 278 B 197 ASP B 168 ASP^? 12.80 CL CL B 278 B 223 ALA B 198 ALA.? 14.47 CL CL B 278 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -1.92 -2.21 -20.05 -0.53 -2.75 -21.52 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -5.42 2.81 -22.11 -6.82 3.76 -20.83 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -5.00 4.00 -10.23 -5.24 5.42 -10.67 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 5 3 # 5 B 114 HIS B 194 HIS.? 5.13 CL CL B 278 B 197 ASP B 168 ASP^? 12.80 CL CL B 278 B 223 ALA B 251 ALA~? 13.13 CL CL B 278 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -1.92 -2.21 -20.05 -0.53 -2.75 -21.52 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -5.42 2.81 -22.11 -6.82 3.76 -20.83 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -11.21 -8.27 -20.82 -9.88 -9.02 -21.02 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 6 3 # 6 B 114 HIS B 194 HIS.? 5.13 CL CL B 278 B 197 ASP B 168 ASP^? 12.80 CL CL B 278 B 223 ALA B 255 ALA~? 17.38 CL CL B 278 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -1.92 -2.21 -20.05 -0.53 -2.75 -21.52 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -5.42 2.81 -22.11 -6.82 3.76 -20.83 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -13.88 -5.94 -25.91 -12.91 -7.08 -26.16 1n2t_c03 source 1n2t L-CYSTEINE-CYSTINE LYASE C-DES : 6 hits 1n2t_c03 naa= 3 ULMN 3 1naa_c02 CELLOBIOSE DEHYDROGENASE user 1 3 # 1 A 609 TYR A 215 TYR.? 13.87 CL CL A 278 A 689 HIS A 216 HIS.? 18.50 CL CL A 278 A 732 ASN A 218 ASN~? 20.82 CL CL A 278 coo 23.89 30.33 18.51 26.53 29.83 17.65 21.62 -36.04 -14.58 23.93 -37.55 -14.90 coo 24.69 23.24 17.44 26.23 24.43 18.22 17.97 -41.33 -12.21 17.58 -42.84 -10.82 coo 27.47 24.40 22.13 27.89 26.42 21.78 24.13 -43.84 -11.70 26.14 -43.18 -11.76 ULMN 3 1naa_c02 CELLOBIOSE DEHYDROGENASE user 2 3 # 2 A 609 TYR A 215 TYR.? 13.87 CL CL A 278 A 689 HIS A 216 HIS.? 18.50 CL CL A 278 A 732 ASN A 254 ASN~? 16.17 CL CL A 278 coo 23.89 30.33 18.51 26.53 29.83 17.65 21.62 -36.04 -14.58 23.93 -37.55 -14.90 coo 24.69 23.24 17.44 26.23 24.43 18.22 17.97 -41.33 -12.21 17.58 -42.84 -10.82 coo 27.47 24.40 22.13 27.89 26.42 21.78 18.50 -38.45 -6.68 18.86 -39.34 -8.59 ULMN 3 1naa_c02 CELLOBIOSE DEHYDROGENASE user 3 3 # 3 A 609 TYR A 217 TYR.? 13.45 CL CL A 278 A 689 HIS A 216 HIS.? 18.50 CL CL A 278 A 732 ASN A 218 ASN~? 20.82 CL CL A 278 coo 23.89 30.33 18.51 26.53 29.83 17.65 22.77 -37.42 -9.36 23.40 -34.73 -9.58 coo 24.69 23.24 17.44 26.23 24.43 18.22 17.97 -41.33 -12.21 17.58 -42.84 -10.82 coo 27.47 24.40 22.13 27.89 26.42 21.78 24.13 -43.84 -11.70 26.14 -43.18 -11.76 ULMN 3 1naa_c02 CELLOBIOSE DEHYDROGENASE user 4 3 # 4 A 609 TYR B 215 TYR.? 14.28 CL CL B 278 A 689 HIS B 216 HIS.? 19.24 CL CL B 278 A 732 ASN B 218 ASN~? 21.19 CL CL B 278 coo 23.89 30.33 18.51 26.53 29.83 17.65 -10.18 -0.68 -14.85 -11.32 1.86 -14.73 coo 24.69 23.24 17.44 26.23 24.43 18.22 -16.22 -3.98 -15.80 -17.90 -4.46 -16.96 coo 27.47 24.40 22.13 27.89 26.42 21.78 -17.80 2.35 -16.65 -17.00 4.26 -17.12 ULMN 3 1naa_c02 CELLOBIOSE DEHYDROGENASE user 5 3 # 5 A 609 TYR B 215 TYR.? 14.28 CL CL B 278 A 689 HIS B 216 HIS.? 19.24 CL CL B 278 A 732 ASN B 254 ASN~? 16.98 CL CL B 278 coo 23.89 30.33 18.51 26.53 29.83 17.65 -10.18 -0.68 -14.85 -11.32 1.86 -14.73 coo 24.69 23.24 17.44 26.23 24.43 18.22 -16.22 -3.98 -15.80 -17.90 -4.46 -16.96 coo 27.47 24.40 22.13 27.89 26.42 21.78 -14.04 -4.32 -21.65 -14.71 -3.72 -19.71 ULMN 3 1naa_c02 CELLOBIOSE DEHYDROGENASE user 6 3 # 6 A 609 TYR B 217 TYR.? 13.94 CL CL B 278 A 689 HIS B 216 HIS.? 19.24 CL CL B 278 A 732 ASN B 218 ASN~? 21.19 CL CL B 278 coo 23.89 30.33 18.51 26.53 29.83 17.65 -12.06 -0.05 -19.78 -9.32 0.42 -19.98 coo 24.69 23.24 17.44 26.23 24.43 18.22 -16.22 -3.98 -15.80 -17.90 -4.46 -16.96 coo 27.47 24.40 22.13 27.89 26.42 21.78 -17.80 2.35 -16.65 -17.00 4.26 -17.12 1naa_c02 source 1naa CELLOBIOSE DEHYDROGENASE : 6 hits 1naa_c02 naa= 3 ULMN 3 1naa_c03 CELLOBIOSE DEHYDROGENASE user 1 3 # 1 B 609 TYR A 215 TYR.? 13.87 CL CL A 278 B 689 HIS A 216 HIS.? 18.50 CL CL A 278 B 732 ASN A 218 ASN~? 20.82 CL CL A 278 coo 26.13 14.71 -23.89 27.40 13.01 -22.05 21.62 -36.04 -14.58 23.93 -37.55 -14.90 coo 31.95 18.02 -21.08 31.88 15.94 -21.37 17.97 -41.33 -12.21 17.58 -42.84 -10.82 coo 33.92 13.94 -24.42 32.27 12.62 -24.35 24.13 -43.84 -11.70 26.14 -43.18 -11.76 ULMN 3 1naa_c03 CELLOBIOSE DEHYDROGENASE user 2 3 # 2 B 609 TYR A 215 TYR.? 13.87 CL CL A 278 B 689 HIS A 216 HIS.? 18.50 CL CL A 278 B 732 ASN A 254 ASN~? 16.17 CL CL A 278 coo 26.13 14.71 -23.89 27.40 13.01 -22.05 21.62 -36.04 -14.58 23.93 -37.55 -14.90 coo 31.95 18.02 -21.08 31.88 15.94 -21.37 17.97 -41.33 -12.21 17.58 -42.84 -10.82 coo 33.92 13.94 -24.42 32.27 12.62 -24.35 18.50 -38.45 -6.68 18.86 -39.34 -8.59 ULMN 3 1naa_c03 CELLOBIOSE DEHYDROGENASE user 3 3 # 3 B 609 TYR A 217 TYR.? 13.45 CL CL A 278 B 689 HIS A 216 HIS.? 18.50 CL CL A 278 B 732 ASN A 218 ASN~? 20.82 CL CL A 278 coo 26.13 14.71 -23.89 27.40 13.01 -22.05 22.77 -37.42 -9.36 23.40 -34.73 -9.58 coo 31.95 18.02 -21.08 31.88 15.94 -21.37 17.97 -41.33 -12.21 17.58 -42.84 -10.82 coo 33.92 13.94 -24.42 32.27 12.62 -24.35 24.13 -43.84 -11.70 26.14 -43.18 -11.76 ULMN 3 1naa_c03 CELLOBIOSE DEHYDROGENASE user 4 3 # 4 B 609 TYR B 215 TYR.? 14.28 CL CL B 278 B 689 HIS B 216 HIS.? 19.24 CL CL B 278 B 732 ASN B 218 ASN~? 21.19 CL CL B 278 coo 26.13 14.71 -23.89 27.40 13.01 -22.05 -10.18 -0.68 -14.85 -11.32 1.86 -14.73 coo 31.95 18.02 -21.08 31.88 15.94 -21.37 -16.22 -3.98 -15.80 -17.90 -4.46 -16.96 coo 33.92 13.94 -24.42 32.27 12.62 -24.35 -17.80 2.35 -16.65 -17.00 4.26 -17.12 ULMN 3 1naa_c03 CELLOBIOSE DEHYDROGENASE user 5 3 # 5 B 609 TYR B 215 TYR.? 14.28 CL CL B 278 B 689 HIS B 216 HIS.? 19.24 CL CL B 278 B 732 ASN B 254 ASN~? 16.98 CL CL B 278 coo 26.13 14.71 -23.89 27.40 13.01 -22.05 -10.18 -0.68 -14.85 -11.32 1.86 -14.73 coo 31.95 18.02 -21.08 31.88 15.94 -21.37 -16.22 -3.98 -15.80 -17.90 -4.46 -16.96 coo 33.92 13.94 -24.42 32.27 12.62 -24.35 -14.04 -4.32 -21.65 -14.71 -3.72 -19.71 ULMN 3 1naa_c03 CELLOBIOSE DEHYDROGENASE user 6 3 # 6 B 609 TYR B 217 TYR.? 13.94 CL CL B 278 B 689 HIS B 216 HIS.? 19.24 CL CL B 278 B 732 ASN B 218 ASN~? 21.19 CL CL B 278 coo 26.13 14.71 -23.89 27.40 13.01 -22.05 -12.06 -0.05 -19.78 -9.32 0.42 -19.98 coo 31.95 18.02 -21.08 31.88 15.94 -21.37 -16.22 -3.98 -15.80 -17.90 -4.46 -16.96 coo 33.92 13.94 -24.42 32.27 12.62 -24.35 -17.80 2.35 -16.65 -17.00 4.26 -17.12 1naa_c03 source 1naa CELLOBIOSE DEHYDROGENASE : 6 hits 1naa_c03 naa= 3 ULMN 3 1nu3_c00 LIMONENE-1,2-EPOXIDE HYDROLASE user 1 3 # 1 A 99 ARG A 196 ARG.? 15.95 CL CL A 278 A 101 ASP A 168 ASP^? 12.27 CL CL A 278 A 132 ASP A 224 ASP~? 22.21 CL CL A 278 coo 11.61 22.83 17.30 14.06 21.71 15.78 27.49 -34.87 -12.70 29.46 -35.46 -10.43 coo 11.37 24.94 11.48 12.48 24.45 13.28 26.46 -30.73 -8.22 26.92 -32.42 -9.39 coo 16.14 18.17 13.37 15.92 19.81 14.71 30.83 -39.35 -6.18 31.71 -41.01 -7.15 ULMN 3 1nu3_c00 LIMONENE-1,2-EPOXIDE HYDROLASE user 2 3 # 2 A 99 ARG B 196 ARG.? 16.18 CL CL B 278 A 101 ASP B 168 ASP^? 12.80 CL CL B 278 A 132 ASP B 224 ASP~? 22.83 CL CL B 278 coo 11.61 22.83 17.30 14.06 21.71 15.78 -8.42 4.93 -17.56 -9.12 6.53 -20.07 coo 11.37 24.94 11.48 12.48 24.45 13.28 -5.42 2.81 -22.11 -6.82 3.76 -20.83 coo 16.14 18.17 13.37 15.92 19.81 14.71 -13.88 7.87 -23.86 -15.40 8.87 -22.81 1nu3_c00 source 1nu3 LIMONENE-1,2-EPOXIDE HYDROLASE : 2 hits 1nu3_c00 naa= 3 ULMN 3 1nu3_c01 LIMONENE-1,2-EPOXIDE HYDROLASE user 1 3 # 1 B 99 ARG A 196 ARG.? 15.95 CL CL A 278 B 101 ASP A 168 ASP^? 12.27 CL CL A 278 B 132 ASP A 224 ASP~? 22.21 CL CL A 278 coo 11.61 3.43 18.38 9.11 4.29 16.86 27.49 -34.87 -12.70 29.46 -35.46 -10.43 coo 11.74 0.51 12.98 10.75 1.32 14.67 26.46 -30.73 -8.22 26.92 -32.42 -9.39 coo 6.93 7.52 14.08 7.18 6.08 15.65 30.83 -39.35 -6.18 31.71 -41.01 -7.15 ULMN 3 1nu3_c01 LIMONENE-1,2-EPOXIDE HYDROLASE user 2 3 # 2 B 99 ARG B 196 ARG.? 16.18 CL CL B 278 B 101 ASP B 168 ASP^? 12.80 CL CL B 278 B 132 ASP B 224 ASP~? 22.83 CL CL B 278 coo 11.61 3.43 18.38 9.11 4.29 16.86 -8.42 4.93 -17.56 -9.12 6.53 -20.07 coo 11.74 0.51 12.98 10.75 1.32 14.67 -5.42 2.81 -22.11 -6.82 3.76 -20.83 coo 6.93 7.52 14.08 7.18 6.08 15.65 -13.88 7.87 -23.86 -15.40 8.87 -22.81 1nu3_c01 source 1nu3 LIMONENE-1,2-EPOXIDE HYDROLASE : 2 hits 1nu3_c01 naa= 3 ULMN 3 1nww_c02 LIMONENE-1,2-EPOXIDE HYDROLASE user 1 3 # 1 A 99 ARG A 196 ARG.? 15.95 CL CL A 278 A 101 ASP A 168 ASP^? 12.27 CL CL A 278 A 132 ASP A 224 ASP~? 22.21 CL CL A 278 coo 11.50 22.77 17.24 14.00 21.62 15.86 27.49 -34.87 -12.70 29.46 -35.46 -10.43 coo 11.19 25.00 11.76 12.16 24.45 13.59 26.46 -30.73 -8.22 26.92 -32.42 -9.39 coo 16.04 18.11 13.43 15.88 19.70 14.83 30.83 -39.35 -6.18 31.71 -41.01 -7.15 ULMN 3 1nww_c02 LIMONENE-1,2-EPOXIDE HYDROLASE user 2 3 # 2 A 99 ARG B 196 ARG.? 16.18 CL CL B 278 A 101 ASP B 168 ASP^? 12.80 CL CL B 278 A 132 ASP B 224 ASP~? 22.83 CL CL B 278 coo 11.50 22.77 17.24 14.00 21.62 15.86 -8.42 4.93 -17.56 -9.12 6.53 -20.07 coo 11.19 25.00 11.76 12.16 24.45 13.59 -5.42 2.81 -22.11 -6.82 3.76 -20.83 coo 16.04 18.11 13.43 15.88 19.70 14.83 -13.88 7.87 -23.86 -15.40 8.87 -22.81 1nww_c02 source 1nww LIMONENE-1,2-EPOXIDE HYDROLASE : 2 hits 1nww_c02 naa= 3 ULMN 3 1nww_c03 LIMONENE-1,2-EPOXIDE HYDROLASE user 1 3 # 1 B 99 ARG A 196 ARG.? 15.95 CL CL A 278 B 101 ASP A 168 ASP^? 12.27 CL CL A 278 B 132 ASP A 224 ASP~? 22.21 CL CL A 278 coo 11.48 3.09 18.25 9.01 4.07 16.77 27.49 -34.87 -12.70 29.46 -35.46 -10.43 coo 11.83 0.33 13.01 10.88 1.04 14.81 26.46 -30.73 -8.22 26.92 -32.42 -9.39 coo 6.85 7.33 14.07 7.10 5.88 15.60 30.83 -39.35 -6.18 31.71 -41.01 -7.15 ULMN 3 1nww_c03 LIMONENE-1,2-EPOXIDE HYDROLASE user 2 3 # 2 B 99 ARG B 196 ARG.? 16.18 CL CL B 278 B 101 ASP B 168 ASP^? 12.80 CL CL B 278 B 132 ASP B 224 ASP~? 22.83 CL CL B 278 coo 11.48 3.09 18.25 9.01 4.07 16.77 -8.42 4.93 -17.56 -9.12 6.53 -20.07 coo 11.83 0.33 13.01 10.88 1.04 14.81 -5.42 2.81 -22.11 -6.82 3.76 -20.83 coo 6.85 7.33 14.07 7.10 5.88 15.60 -13.88 7.87 -23.86 -15.40 8.87 -22.81 1nww_c03 source 1nww LIMONENE-1,2-EPOXIDE HYDROLASE : 2 hits 1nww_c03 naa= 3 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 A 24 ASP A 268 ASP.? 26.73 CL CL A 278 A 146 TYR A 24 TYR~? 29.31 CL CL A 278 A 177 LYS A 272 LYS.? 33.16 CL CL A 278 coo -3.50 124.89 25.05 -2.25 124.77 23.26 9.60 -34.57 10.49 9.97 -36.28 9.26 coo 1.87 119.38 16.45 1.41 122.11 16.84 0.87 -31.89 7.51 0.76 -33.22 9.95 coo -2.59 124.07 12.67 -0.91 126.17 18.42 -2.40 -40.27 7.96 -3.06 -34.63 9.73 1ok4_c00 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 1 hits 1ok4_c00 naa= 3 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 B 24 ASP A 268 ASP.? 26.73 CL CL A 278 B 146 TYR A 24 TYR~? 29.31 CL CL A 278 B 177 LYS A 272 LYS.? 33.16 CL CL A 278 coo -7.43 109.06 51.23 -5.84 110.54 50.86 9.60 -34.57 10.49 9.97 -36.28 9.26 coo 0.22 114.56 44.62 -0.76 115.18 47.18 0.87 -31.89 7.51 0.76 -33.22 9.95 coo -4.18 120.17 46.85 -4.02 115.31 51.00 -2.40 -40.27 7.96 -3.06 -34.63 9.73 1ok4_c01 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 1 hits 1ok4_c01 naa= 3 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 C 24 ASP A 268 ASP.? 26.73 CL CL A 278 C 146 TYR A 24 TYR~? 29.31 CL CL A 278 C 177 LYS A 272 LYS.? 33.16 CL CL A 278 coo -13.49 79.65 43.90 -12.13 80.29 45.45 9.60 -34.57 10.49 9.97 -36.28 9.26 coo -5.65 86.78 48.49 -7.16 84.72 49.65 0.87 -31.89 7.51 0.76 -33.22 9.95 coo -11.22 87.18 53.49 -10.94 81.64 50.31 -2.40 -40.27 7.96 -3.06 -34.63 9.73 1ok4_c02 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 1 hits 1ok4_c02 naa= 3 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 D 24 ASP A 268 ASP.? 26.73 CL CL A 278 D 146 TYR A 24 TYR~? 29.31 CL CL A 278 D 177 LYS A 272 LYS.? 33.16 CL CL A 278 coo -13.44 77.36 13.12 -12.53 75.97 14.48 9.60 -34.57 10.49 9.97 -36.28 9.26 coo -7.85 74.44 22.75 -9.22 72.86 20.89 0.87 -31.89 7.51 0.76 -33.22 9.95 coo -14.24 70.61 23.48 -12.55 71.73 17.42 -2.40 -40.27 7.96 -3.06 -34.63 9.73 1ok4_c03 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 1 hits 1ok4_c03 naa= 3 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 E 24 ASP A 268 ASP.? 26.73 CL CL A 278 E 146 TYR A 24 TYR~? 29.31 CL CL A 278 E 177 LYS A 272 LYS.? 33.16 CL CL A 278 coo -7.12 105.25 1.43 -6.30 103.34 0.77 9.60 -34.57 10.49 9.97 -36.28 9.26 coo -3.11 94.55 3.01 -3.83 95.92 0.66 0.87 -31.89 7.51 0.76 -33.22 9.95 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 -2.40 -40.27 7.96 -3.06 -34.63 9.73 1ok4_c04 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 1 hits 1ok4_c04 naa= 3 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 F 24 ASP A 268 ASP.? 26.73 CL CL A 278 F 146 TYR A 24 TYR~? 29.31 CL CL A 278 F 177 LYS A 272 LYS.? 33.16 CL CL A 278 coo -44.75 128.15 10.28 -45.68 129.67 11.55 9.60 -34.57 10.49 9.97 -36.28 9.26 coo -50.43 131.90 19.60 -49.04 133.31 17.60 0.87 -31.89 7.51 0.76 -33.22 9.95 coo -44.10 135.86 19.99 -45.67 134.21 14.07 -2.40 -40.27 7.96 -3.06 -34.63 9.73 1ok4_c05 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 1 hits 1ok4_c05 naa= 3 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 G 24 ASP A 268 ASP.? 26.73 CL CL A 278 G 146 TYR A 24 TYR~? 29.31 CL CL A 278 G 177 LYS A 272 LYS.? 33.16 CL CL A 278 coo -44.97 128.78 41.20 -46.32 128.26 42.83 9.60 -34.57 10.49 9.97 -36.28 9.26 coo -52.83 122.13 46.42 -51.31 124.30 47.39 0.87 -31.89 7.51 0.76 -33.22 9.95 coo -47.30 122.24 51.49 -47.46 127.44 47.81 -2.40 -40.27 7.96 -3.06 -34.63 9.73 1ok4_c06 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 1 hits 1ok4_c06 naa= 3 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 H 24 ASP A 268 ASP.? 26.73 CL CL A 278 H 146 TYR A 24 TYR~? 29.31 CL CL A 278 H 177 LYS A 272 LYS.? 33.16 CL CL A 278 coo -51.11 100.30 51.41 -52.67 98.82 51.12 9.60 -34.57 10.49 9.97 -36.28 9.26 coo -58.70 94.17 45.32 -57.76 93.82 47.92 0.87 -31.89 7.51 0.76 -33.22 9.95 coo -54.32 88.79 48.13 -54.61 94.04 51.74 -2.40 -40.27 7.96 -3.06 -34.63 9.73 1ok4_c07 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 1 hits 1ok4_c07 naa= 3 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 I 24 ASP A 268 ASP.? 26.73 CL CL A 278 I 146 TYR A 24 TYR~? 29.31 CL CL A 278 I 177 LYS A 272 LYS.? 33.16 CL CL A 278 coo -54.65 81.97 26.87 -55.88 81.89 25.07 9.60 -34.57 10.49 9.97 -36.28 9.26 coo -59.92 86.62 17.74 -59.42 83.94 18.40 0.87 -31.89 7.51 0.76 -33.22 9.95 coo -55.38 81.61 14.50 -57.11 80.05 20.41 -2.40 -40.27 7.96 -3.06 -34.63 9.73 1ok4_c08 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 1 hits 1ok4_c08 naa= 3 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 J 24 ASP A 268 ASP.? 26.73 CL CL A 278 J 146 TYR A 24 TYR~? 29.31 CL CL A 278 J 177 LYS A 272 LYS.? 33.16 CL CL A 278 coo -50.64 99.08 1.52 -51.52 100.83 0.67 9.60 -34.57 10.49 9.97 -36.28 9.26 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 0.87 -31.89 7.51 0.76 -33.22 9.95 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 -2.40 -40.27 7.96 -3.06 -34.63 9.73 1ok4_c09 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 1 hits 1ok4_c09 naa= 3 ULMN 3 1onr_c00 TRANSALDOLASE B user 1 3 # 1 A 17 ASP B 205 ASP.? 14.85 CL CL B 278 A 96 GLU A 46 GLU~? 24.48 CL CL B 278 A 132 LYS A 45 LYS~? 28.08 CL CL B 278 coo 31.23 12.29 16.44 30.82 11.56 18.39 1.45 -2.78 -3.16 -0.06 -4.27 -3.04 coo 26.82 3.20 24.36 27.99 4.86 24.98 -1.94 -12.84 6.51 -1.20 -10.99 5.75 coo 29.99 0.62 22.18 30.38 6.69 20.81 3.14 -12.38 5.65 4.44 -8.59 10.01 1onr_c00 source 1onr TRANSALDOLASE B : 1 hits 1onr_c00 naa= 3 ULMN 3 1onr_c01 TRANSALDOLASE B user 1 3 # 1 B 17 ASP B 205 ASP.? 14.85 CL CL B 278 B 96 GLU A 46 GLU~? 24.48 CL CL B 278 B 132 LYS A 45 LYS~? 28.08 CL CL B 278 coo 31.16 57.31 -0.94 30.73 56.64 1.01 1.45 -2.78 -3.16 -0.06 -4.27 -3.04 coo 26.69 48.45 7.18 27.85 50.13 7.74 -1.94 -12.84 6.51 -1.20 -10.99 5.75 coo 29.82 45.80 5.07 30.26 51.81 3.56 3.14 -12.38 5.65 4.44 -8.59 10.01 1onr_c01 source 1onr TRANSALDOLASE B : 1 hits 1onr_c01 naa= 3 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 1 3 # 1 A 170 SER A 143 SER~? 16.98 CL CL A 278 A 239 VAL A 177 VAL.? 11.64 CL CL A 278 A 413 ASN A 141 ASN~? 14.40 CL CL A 278 coo 80.14 40.76 52.28 77.73 40.59 51.94 35.06 -16.35 -13.19 33.34 -14.67 -12.92 coo 75.67 35.37 52.30 76.00 35.96 50.23 30.74 -23.61 -11.72 30.16 -22.31 -10.07 coo 81.75 35.21 52.13 80.92 37.12 51.69 29.69 -16.58 -13.36 30.76 -15.83 -15.01 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 2 3 # 2 A 170 SER A 143 SER~? 16.98 CL CL A 278 A 239 VAL A 177 VAL.? 11.64 CL CL A 278 A 413 ASN A 142 ASN~? 15.74 CL CL A 278 coo 80.14 40.76 52.28 77.73 40.59 51.94 35.06 -16.35 -13.19 33.34 -14.67 -12.92 coo 75.67 35.37 52.30 76.00 35.96 50.23 30.74 -23.61 -11.72 30.16 -22.31 -10.07 coo 81.75 35.21 52.13 80.92 37.12 51.69 33.76 -20.86 -14.08 33.88 -20.26 -16.14 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 3 3 # 3 A 170 SER A 143 SER~? 16.98 CL CL A 278 A 239 VAL A 177 VAL.? 11.64 CL CL A 278 A 413 ASN A 175 ASN.? 15.39 CL CL A 278 coo 80.14 40.76 52.28 77.73 40.59 51.94 35.06 -16.35 -13.19 33.34 -14.67 -12.92 coo 75.67 35.37 52.30 76.00 35.96 50.23 30.74 -23.61 -11.72 30.16 -22.31 -10.07 coo 81.75 35.21 52.13 80.92 37.12 51.69 30.44 -19.14 -17.48 31.94 -17.93 -18.43 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 4 3 # 4 A 170 SER A 163 SER^? 17.83 CL CL A 278 A 239 VAL A 183 VAL.? 22.24 CL CL A 278 A 413 ASN A 185 ASN.? 23.31 CL CL A 278 coo 80.14 40.76 52.28 77.73 40.59 51.94 27.49 -19.74 3.13 26.41 -21.87 3.58 coo 75.67 35.37 52.30 76.00 35.96 50.23 32.95 -24.44 4.02 32.36 -25.47 5.87 coo 81.75 35.21 52.13 80.92 37.12 51.69 29.16 -19.86 6.66 28.14 -19.34 8.46 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 5 3 # 5 A 170 SER A 163 SER^? 17.83 CL CL A 278 A 239 VAL A 189 VAL^? 19.06 CL CL A 278 A 413 ASN A 185 ASN.? 23.31 CL CL A 278 coo 80.14 40.76 52.28 77.73 40.59 51.94 27.49 -19.74 3.13 26.41 -21.87 3.58 coo 75.67 35.37 52.30 76.00 35.96 50.23 26.54 -25.33 4.52 28.31 -26.60 4.27 coo 81.75 35.21 52.13 80.92 37.12 51.69 29.16 -19.86 6.66 28.14 -19.34 8.46 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 6 3 # 6 A 170 SER B 143 SER.? 16.35 CL CL B 278 A 239 VAL B 177 VAL.? 11.35 CL CL B 278 A 413 ASN B 141 ASN.? 13.90 CL CL B 278 coo 80.14 40.76 52.28 77.73 40.59 51.94 10.39 10.06 -20.16 11.77 8.08 -20.34 coo 75.67 35.37 52.30 76.00 35.96 50.23 2.76 6.77 -20.34 3.49 5.15 -21.64 coo 81.75 35.21 52.13 80.92 37.12 51.69 9.53 4.91 -19.46 10.65 6.11 -18.14 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 7 3 # 7 A 170 SER B 143 SER.? 16.35 CL CL B 278 A 239 VAL B 177 VAL.? 11.35 CL CL B 278 A 413 ASN B 142 ASN.? 15.73 CL CL B 278 coo 80.14 40.76 52.28 77.73 40.59 51.94 10.39 10.06 -20.16 11.77 8.08 -20.34 coo 75.67 35.37 52.30 76.00 35.96 50.23 2.76 6.77 -20.34 3.49 5.15 -21.64 coo 81.75 35.21 52.13 80.92 37.12 51.69 5.89 9.56 -18.58 6.90 10.10 -16.77 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 8 3 # 8 A 170 SER B 143 SER.? 16.35 CL CL B 278 A 239 VAL B 177 VAL.? 11.35 CL CL B 278 A 413 ASN B 175 ASN.? 15.07 CL CL B 278 coo 80.14 40.76 52.28 77.73 40.59 51.94 10.39 10.06 -20.16 11.77 8.08 -20.34 coo 75.67 35.37 52.30 76.00 35.96 50.23 2.76 6.77 -20.34 3.49 5.15 -21.64 coo 81.75 35.21 52.13 80.92 37.12 51.69 7.70 6.80 -15.23 9.08 8.02 -14.14 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 9 3 # 9 A 170 SER B 163 SER^? 17.90 CL CL B 278 A 239 VAL B 183 VAL.? 22.28 CL CL B 278 A 413 ASN B 185 ASN.? 23.46 CL CL B 278 coo 80.14 40.76 52.28 77.73 40.59 51.94 4.21 1.28 -34.77 1.92 0.43 -34.82 coo 75.67 35.37 52.30 76.00 35.96 50.23 -0.21 7.01 -35.79 -1.63 6.32 -37.29 coo 81.75 35.21 52.13 80.92 37.12 51.69 3.74 2.53 -38.55 3.92 1.27 -40.29 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 10 3 # 10 A 170 SER B 163 SER^? 17.90 CL CL B 278 A 239 VAL B 189 VAL^? 19.19 CL CL B 278 A 413 ASN B 185 ASN.? 23.46 CL CL B 278 coo 80.14 40.76 52.28 77.73 40.59 51.94 4.21 1.28 -34.77 1.92 0.43 -34.82 coo 75.67 35.37 52.30 76.00 35.96 50.23 -1.62 0.87 -35.34 -2.61 2.80 -35.05 coo 81.75 35.21 52.13 80.92 37.12 51.69 3.74 2.53 -38.55 3.92 1.27 -40.29 1oqz_c00 source 1oqz GLUTARYL ACYLASE : 10 hits 1oqz_c00 naa= 3 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 1 3 # 1 B 170 SER A 143 SER~? 16.98 CL CL A 278 B 239 VAL A 177 VAL.? 11.64 CL CL A 278 B 413 ASN A 141 ASN~? 14.40 CL CL A 278 coo 25.22 6.41 2.90 27.67 6.33 3.11 35.06 -16.35 -13.19 33.34 -14.67 -12.92 coo 29.71 1.00 2.66 29.43 1.57 4.74 30.74 -23.61 -11.72 30.16 -22.31 -10.07 coo 23.72 0.88 2.95 24.56 2.79 3.34 29.69 -16.58 -13.36 30.76 -15.83 -15.01 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 2 3 # 2 B 170 SER A 143 SER~? 16.98 CL CL A 278 B 239 VAL A 177 VAL.? 11.64 CL CL A 278 B 413 ASN A 142 ASN~? 15.74 CL CL A 278 coo 25.22 6.41 2.90 27.67 6.33 3.11 35.06 -16.35 -13.19 33.34 -14.67 -12.92 coo 29.71 1.00 2.66 29.43 1.57 4.74 30.74 -23.61 -11.72 30.16 -22.31 -10.07 coo 23.72 0.88 2.95 24.56 2.79 3.34 33.76 -20.86 -14.08 33.88 -20.26 -16.14 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 3 3 # 3 B 170 SER A 143 SER~? 16.98 CL CL A 278 B 239 VAL A 177 VAL.? 11.64 CL CL A 278 B 413 ASN A 175 ASN.? 15.39 CL CL A 278 coo 25.22 6.41 2.90 27.67 6.33 3.11 35.06 -16.35 -13.19 33.34 -14.67 -12.92 coo 29.71 1.00 2.66 29.43 1.57 4.74 30.74 -23.61 -11.72 30.16 -22.31 -10.07 coo 23.72 0.88 2.95 24.56 2.79 3.34 30.44 -19.14 -17.48 31.94 -17.93 -18.43 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 4 3 # 4 B 170 SER A 163 SER^? 17.83 CL CL A 278 B 239 VAL A 183 VAL.? 22.24 CL CL A 278 B 413 ASN A 185 ASN.? 23.31 CL CL A 278 coo 25.22 6.41 2.90 27.67 6.33 3.11 27.49 -19.74 3.13 26.41 -21.87 3.58 coo 29.71 1.00 2.66 29.43 1.57 4.74 32.95 -24.44 4.02 32.36 -25.47 5.87 coo 23.72 0.88 2.95 24.56 2.79 3.34 29.16 -19.86 6.66 28.14 -19.34 8.46 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 5 3 # 5 B 170 SER A 163 SER^? 17.83 CL CL A 278 B 239 VAL A 189 VAL^? 19.06 CL CL A 278 B 413 ASN A 185 ASN.? 23.31 CL CL A 278 coo 25.22 6.41 2.90 27.67 6.33 3.11 27.49 -19.74 3.13 26.41 -21.87 3.58 coo 29.71 1.00 2.66 29.43 1.57 4.74 26.54 -25.33 4.52 28.31 -26.60 4.27 coo 23.72 0.88 2.95 24.56 2.79 3.34 29.16 -19.86 6.66 28.14 -19.34 8.46 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 6 3 # 6 B 170 SER B 143 SER.? 16.35 CL CL B 278 B 239 VAL B 177 VAL.? 11.35 CL CL B 278 B 413 ASN B 141 ASN.? 13.90 CL CL B 278 coo 25.22 6.41 2.90 27.67 6.33 3.11 10.39 10.06 -20.16 11.77 8.08 -20.34 coo 29.71 1.00 2.66 29.43 1.57 4.74 2.76 6.77 -20.34 3.49 5.15 -21.64 coo 23.72 0.88 2.95 24.56 2.79 3.34 9.53 4.91 -19.46 10.65 6.11 -18.14 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 7 3 # 7 B 170 SER B 143 SER.? 16.35 CL CL B 278 B 239 VAL B 177 VAL.? 11.35 CL CL B 278 B 413 ASN B 142 ASN.? 15.73 CL CL B 278 coo 25.22 6.41 2.90 27.67 6.33 3.11 10.39 10.06 -20.16 11.77 8.08 -20.34 coo 29.71 1.00 2.66 29.43 1.57 4.74 2.76 6.77 -20.34 3.49 5.15 -21.64 coo 23.72 0.88 2.95 24.56 2.79 3.34 5.89 9.56 -18.58 6.90 10.10 -16.77 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 8 3 # 8 B 170 SER B 143 SER.? 16.35 CL CL B 278 B 239 VAL B 177 VAL.? 11.35 CL CL B 278 B 413 ASN B 175 ASN.? 15.07 CL CL B 278 coo 25.22 6.41 2.90 27.67 6.33 3.11 10.39 10.06 -20.16 11.77 8.08 -20.34 coo 29.71 1.00 2.66 29.43 1.57 4.74 2.76 6.77 -20.34 3.49 5.15 -21.64 coo 23.72 0.88 2.95 24.56 2.79 3.34 7.70 6.80 -15.23 9.08 8.02 -14.14 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 9 3 # 9 B 170 SER B 163 SER^? 17.90 CL CL B 278 B 239 VAL B 183 VAL.? 22.28 CL CL B 278 B 413 ASN B 185 ASN.? 23.46 CL CL B 278 coo 25.22 6.41 2.90 27.67 6.33 3.11 4.21 1.28 -34.77 1.92 0.43 -34.82 coo 29.71 1.00 2.66 29.43 1.57 4.74 -0.21 7.01 -35.79 -1.63 6.32 -37.29 coo 23.72 0.88 2.95 24.56 2.79 3.34 3.74 2.53 -38.55 3.92 1.27 -40.29 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 10 3 # 10 B 170 SER B 163 SER^? 17.90 CL CL B 278 B 239 VAL B 189 VAL^? 19.19 CL CL B 278 B 413 ASN B 185 ASN.? 23.46 CL CL B 278 coo 25.22 6.41 2.90 27.67 6.33 3.11 4.21 1.28 -34.77 1.92 0.43 -34.82 coo 29.71 1.00 2.66 29.43 1.57 4.74 -1.62 0.87 -35.34 -2.61 2.80 -35.05 coo 23.72 0.88 2.95 24.56 2.79 3.34 3.74 2.53 -38.55 3.92 1.27 -40.29 1oqz_c01 source 1oqz GLUTARYL ACYLASE : 10 hits 1oqz_c01 naa= 3 ULMN 3 1oya_c00 OLD YELLOW ENZYME (OXIDIZED) (OYE) (user 1 3 # 1 191 HIS A 216 HIS.? 18.50 CL CL A 278 194 ASN A 218 ASN~? 20.82 CL CL A 278 196 TYR A 217 TYR.? 13.45 CL CL A 278 coo 40.21 70.60 24.49 39.36 69.94 22.74 17.97 -41.33 -12.21 17.58 -42.84 -10.82 coo 39.62 68.39 19.02 38.50 66.72 19.87 24.13 -43.84 -11.70 26.14 -43.18 -11.76 coo 40.89 73.30 19.79 38.36 73.12 18.60 22.77 -37.42 -9.36 23.40 -34.73 -9.58 ULMN 3 1oya_c00 OLD YELLOW ENZYME (OXIDIZED) (OYE) (user 2 3 # 2 191 HIS A 216 HIS.? 18.50 CL CL A 278 194 ASN A 254 ASN~? 16.17 CL CL A 278 196 TYR A 217 TYR.? 13.45 CL CL A 278 coo 40.21 70.60 24.49 39.36 69.94 22.74 17.97 -41.33 -12.21 17.58 -42.84 -10.82 coo 39.62 68.39 19.02 38.50 66.72 19.87 18.50 -38.45 -6.68 18.86 -39.34 -8.59 coo 40.89 73.30 19.79 38.36 73.12 18.60 22.77 -37.42 -9.36 23.40 -34.73 -9.58 ULMN 3 1oya_c00 OLD YELLOW ENZYME (OXIDIZED) (OYE) (user 3 3 # 3 191 HIS B 216 HIS.? 19.24 CL CL B 278 194 ASN B 218 ASN~? 21.19 CL CL B 278 196 TYR B 217 TYR.? 13.94 CL CL B 278 coo 40.21 70.60 24.49 39.36 69.94 22.74 -16.22 -3.98 -15.80 -17.90 -4.46 -16.96 coo 39.62 68.39 19.02 38.50 66.72 19.87 -17.80 2.35 -16.65 -17.00 4.26 -17.12 coo 40.89 73.30 19.79 38.36 73.12 18.60 -12.06 -0.05 -19.78 -9.32 0.42 -19.98 ULMN 3 1oya_c00 OLD YELLOW ENZYME (OXIDIZED) (OYE) (user 4 3 # 4 191 HIS B 216 HIS.? 19.24 CL CL B 278 194 ASN B 254 ASN~? 16.98 CL CL B 278 196 TYR B 217 TYR.? 13.94 CL CL B 278 coo 40.21 70.60 24.49 39.36 69.94 22.74 -16.22 -3.98 -15.80 -17.90 -4.46 -16.96 coo 39.62 68.39 19.02 38.50 66.72 19.87 -14.04 -4.32 -21.65 -14.71 -3.72 -19.71 coo 40.89 73.30 19.79 38.36 73.12 18.60 -12.06 -0.05 -19.78 -9.32 0.42 -19.98 1oya_c00 source 1oya OLD YELLOW ENZYME (OXIDIZED) (OYE) (E.C.1.6.99: 4 hits 1oya_c00 naa= 3 ULMN 3 1oyg_c00 LEVANSUCRASE user 1 3 # 1 A 86 ASP A 168 ASP^? 12.27 CL CL A 278 A 247 ASP A 224 ASP~? 22.21 CL CL A 278 A 342 GLU A 221 GLU~? 17.05 CL CL A 278 coo 44.36 35.68 9.71 43.29 36.20 11.51 26.46 -30.73 -8.22 26.92 -32.42 -9.39 coo 41.40 28.81 12.91 40.82 30.90 12.97 30.83 -39.35 -6.18 31.71 -41.01 -7.15 coo 40.37 33.11 18.06 39.99 34.93 17.06 27.14 -39.98 -10.94 25.92 -39.21 -12.48 ULMN 3 1oyg_c00 LEVANSUCRASE user 2 3 # 2 A 86 ASP B 168 ASP^? 12.80 CL CL B 278 A 247 ASP B 224 ASP~? 22.83 CL CL B 278 A 342 GLU B 221 GLU~? 17.56 CL CL B 278 coo 44.36 35.68 9.71 43.29 36.20 11.51 -5.42 2.81 -22.11 -6.82 3.76 -20.83 coo 41.40 28.81 12.91 40.82 30.90 12.97 -13.88 7.87 -23.86 -15.40 8.87 -22.81 coo 40.37 33.11 18.06 39.99 34.93 17.06 -13.90 4.76 -18.50 -13.25 3.58 -16.87 1oyg_c00 source 1oyg LEVANSUCRASE : 2 hits 1oyg_c00 naa= 3 ULMN 3 1p1x_c00 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 1 3 # 1 A 102 ASP B 205 ASP.? 14.85 CL CL B 278 A 167 LYS B 211 LYS~? 15.02 CL CL B 278 A 201 LYS B 210 LYS~? 12.46 CL CL B 278 coo 26.53 8.31 20.37 28.45 8.41 19.40 1.45 -2.78 -3.16 -0.06 -4.27 -3.04 coo 24.92 6.08 13.38 27.75 4.33 18.83 -4.12 -5.20 -9.45 -3.45 -5.07 -3.77 coo 29.08 5.53 11.69 30.46 5.61 17.93 -2.49 -8.60 -10.03 0.77 -12.84 -8.24 1p1x_c00 source 1p1x DEOXYRIBOSE-PHOSPHATE ALDOLASE : 1 hits 1p1x_c00 naa= 3 ULMN 3 1p1x_c01 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 1 3 # 1 B1102 ASP B 205 ASP.? 14.85 CL CL B 278 B1167 LYS B 211 LYS~? 15.02 CL CL B 278 B1201 LYS B 210 LYS~? 12.46 CL CL B 278 coo 26.10 12.11 49.61 24.19 12.48 50.51 1.45 -2.78 -3.16 -0.06 -4.27 -3.04 coo 27.70 11.69 56.92 24.82 8.55 52.12 -4.12 -5.20 -9.45 -3.45 -5.07 -3.77 coo 23.50 11.64 58.67 22.19 10.19 52.59 -2.49 -8.60 -10.03 0.77 -12.84 -8.24 1p1x_c01 source 1p1x DEOXYRIBOSE-PHOSPHATE ALDOLASE : 1 hits 1p1x_c01 naa= 3 ULMN 3 1p7m_c00 DNA-3-METHYLADENINE GLYCOSYLASE I user 1 3 # 1 A 16 TYR A 145 TYR~? 15.40 CL CL A 278 A 38 GLU A 138 GLU^? 6.67 CL CL A 278 A 46 TRP A 144 TRP~? 16.70 CL CL A 278 coo 141.05 24.62 -1.85 142.62 22.60 -2.97 34.36 -21.23 -8.52 32.31 -21.44 -6.65 coo 142.20 14.40 -6.46 142.04 16.49 -6.62 23.86 -20.99 -6.84 22.60 -22.69 -7.03 coo 137.32 22.45 -5.52 140.17 20.39 -3.63 31.42 -15.37 -9.61 32.18 -12.15 -7.51 ULMN 3 1p7m_c00 DNA-3-METHYLADENINE GLYCOSYLASE I user 2 3 # 2 A 16 TYR B 145 TYR.? 15.21 CL CL B 278 A 38 GLU B 138 GLU^? 6.70 CL CL B 278 A 46 TRP B 144 TRP.? 16.23 CL CL B 278 coo 141.05 24.62 -1.85 142.62 22.60 -2.97 5.06 9.55 -24.01 4.48 7.22 -25.41 coo 142.20 14.40 -6.46 142.04 16.49 -6.62 3.87 -1.10 -24.33 2.09 -2.15 -23.84 coo 137.32 22.45 -5.52 140.17 20.39 -3.63 10.64 6.20 -23.20 13.51 5.80 -25.85 1p7m_c00 source 1p7m DNA-3-METHYLADENINE GLYCOSYLASE I : 2 hits 1p7m_c00 naa= 3 ULMN 3 1pfq_c00 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 1 3 # 1 A 630 SER A 10 SER.? 17.45 CL CL A 278 A 708 ASP A 13 ASP~? 20.85 CL CL A 278 A 740 HIS A 12 HIS~? 14.78 CL CL A 278 coo -7.09 7.44 6.22 -7.53 5.14 5.59 3.77 -30.46 -4.30 3.68 -28.35 -5.48 coo -5.35 2.36 14.19 -6.28 2.60 12.26 3.80 -37.83 -7.42 4.89 -38.66 -9.05 coo -8.70 2.86 9.96 -8.03 3.92 8.29 9.03 -33.35 -4.93 10.37 -31.88 -5.56 ULMN 3 1pfq_c00 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 2 3 # 2 A 630 SER B 10 SER.? 17.86 CL CL B 278 A 708 ASP B 13 ASP~? 21.13 CL CL B 278 A 740 HIS B 12 HIS~? 15.42 CL CL B 278 coo -7.09 7.44 6.22 -7.53 5.14 5.59 -7.63 -19.97 -23.27 -5.38 -20.37 -22.44 coo -5.35 2.36 14.19 -6.28 2.60 12.26 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 coo -8.70 2.86 9.96 -8.03 3.92 8.29 -10.18 -14.51 -22.80 -8.49 -13.29 -22.60 1pfq_c00 source 1pfq DIPEPTIDYL PEPTIDASE IV SOLUBLE FORM : 2 hits 1pfq_c00 naa= 3 ULMN 3 1pfq_c01 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 1 3 # 1 B 630 SER A 10 SER.? 17.45 CL CL A 278 B 708 ASP A 13 ASP~? 20.85 CL CL A 278 B 740 HIS A 12 HIS~? 14.78 CL CL A 278 coo 4.44 13.29 37.64 6.01 11.66 38.49 3.77 -30.46 -4.30 3.68 -28.35 -5.48 coo 6.39 7.18 30.33 6.92 8.20 32.17 3.80 -37.83 -7.42 4.89 -38.66 -9.05 coo 8.57 10.09 34.47 7.10 10.73 35.82 9.03 -33.35 -4.93 10.37 -31.88 -5.56 ULMN 3 1pfq_c01 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 2 3 # 2 B 630 SER B 10 SER.? 17.86 CL CL B 278 B 708 ASP B 13 ASP~? 21.13 CL CL B 278 B 740 HIS B 12 HIS~? 15.42 CL CL B 278 coo 4.44 13.29 37.64 6.01 11.66 38.49 -7.63 -19.97 -23.27 -5.38 -20.37 -22.44 coo 6.39 7.18 30.33 6.92 8.20 32.17 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 coo 8.57 10.09 34.47 7.10 10.73 35.82 -10.18 -14.51 -22.80 -8.49 -13.29 -22.60 1pfq_c01 source 1pfq DIPEPTIDYL PEPTIDASE IV SOLUBLE FORM : 2 hits 1pfq_c01 naa= 3 ULMN 3 1pfq_c02 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 1 3 # 1 A 630 SER A 8 SER.? 12.69 CL CL A 278 A 709 ASP A 13 ASP~? 20.85 CL CL A 278 A 740 HIS A 12 HIS~? 14.78 CL CL A 278 coo -7.09 7.44 6.22 -7.53 5.14 5.59 8.88 -27.17 -3.98 8.36 -25.65 -5.80 coo -6.04 -3.54 13.59 -7.99 -3.21 12.73 3.80 -37.83 -7.42 4.89 -38.66 -9.05 coo -8.70 2.86 9.96 -8.03 3.92 8.29 9.03 -33.35 -4.93 10.37 -31.88 -5.56 ULMN 3 1pfq_c02 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 2 3 # 2 A 630 SER B 8 SER.? 14.26 CL CL B 278 A 709 ASP B 13 ASP~? 21.13 CL CL B 278 A 740 HIS B 12 HIS~? 15.42 CL CL B 278 coo -7.09 7.44 6.22 -7.53 5.14 5.59 -4.13 -15.22 -24.13 -4.29 -16.76 -22.25 coo -6.04 -3.54 13.59 -7.99 -3.21 12.73 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 coo -8.70 2.86 9.96 -8.03 3.92 8.29 -10.18 -14.51 -22.80 -8.49 -13.29 -22.60 1pfq_c02 source 1pfq DIPEPTIDYL PEPTIDASE IV SOLUBLE FORM : 2 hits 1pfq_c02 naa= 3 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 1 3 # 1 B 630 SER A 8 SER.? 12.69 CL CL A 278 B 709 ASP A 13 ASP~? 20.85 CL CL A 278 B 740 HIS A 12 HIS~? 14.78 CL CL A 278 coo 4.44 13.29 37.64 6.01 11.66 38.49 8.88 -27.17 -3.98 8.36 -25.65 -5.80 coo 10.26 2.81 31.69 11.64 4.30 32.43 3.80 -37.83 -7.42 4.89 -38.66 -9.05 coo 8.57 10.09 34.47 7.10 10.73 35.82 9.03 -33.35 -4.93 10.37 -31.88 -5.56 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 2 3 # 2 B 630 SER B 8 SER.? 14.26 CL CL B 278 B 709 ASP B 13 ASP~? 21.13 CL CL B 278 B 740 HIS B 12 HIS~? 15.42 CL CL B 278 coo 4.44 13.29 37.64 6.01 11.66 38.49 -4.13 -15.22 -24.13 -4.29 -16.76 -22.25 coo 10.26 2.81 31.69 11.64 4.30 32.43 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 coo 8.57 10.09 34.47 7.10 10.73 35.82 -10.18 -14.51 -22.80 -8.49 -13.29 -22.60 1pfq_c03 source 1pfq DIPEPTIDYL PEPTIDASE IV SOLUBLE FORM : 2 hits 1pfq_c03 naa= 3 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 1 3 # 1 A 225 HIS A 216 HIS.? 18.50 CL CL A 278 A 259 TYR A 215 TYR.? 13.87 CL CL A 278 A 552 ASP B 13 ASP~? 21.13 CL CL B 278 coo 11.34 95.90 25.54 12.13 96.42 23.67 17.97 -41.33 -12.21 17.58 -42.84 -10.82 coo 14.91 97.39 18.63 13.39 95.60 20.20 21.62 -36.04 -14.58 23.93 -37.55 -14.90 coo 46.37 82.54 38.83 45.97 84.66 38.77 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 2 3 # 2 A 225 HIS B 194 HIS.? 5.13 CL CL B 278 A 259 TYR B 215 TYR.? 14.28 CL CL B 278 A 552 ASP A 13 ASP~? 20.85 CL CL A 278 coo 11.34 95.90 25.54 12.13 96.42 23.67 -1.92 -2.21 -20.05 -0.53 -2.75 -21.52 coo 14.91 97.39 18.63 13.39 95.60 20.20 -10.18 -0.68 -14.85 -11.32 1.86 -14.73 coo 46.37 82.54 38.83 45.97 84.66 38.77 3.80 -37.83 -7.42 4.89 -38.66 -9.05 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 3 3 # 3 A 225 HIS B 194 HIS.? 5.13 CL CL B 278 A 259 TYR B 215 TYR.? 14.28 CL CL B 278 A 552 ASP A 275 ASP.? 34.16 CL CL A 278 coo 11.34 95.90 25.54 12.13 96.42 23.67 -1.92 -2.21 -20.05 -0.53 -2.75 -21.52 coo 14.91 97.39 18.63 13.39 95.60 20.20 -10.18 -0.68 -14.85 -11.32 1.86 -14.73 coo 46.37 82.54 38.83 45.97 84.66 38.77 -7.58 -36.49 2.30 -8.60 -35.44 3.90 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 4 3 # 4 A 225 HIS B 216 HIS.? 19.24 CL CL B 278 A 259 TYR B 215 TYR.? 14.28 CL CL B 278 A 552 ASP A 13 ASP~? 20.85 CL CL A 278 coo 11.34 95.90 25.54 12.13 96.42 23.67 -16.22 -3.98 -15.80 -17.90 -4.46 -16.96 coo 14.91 97.39 18.63 13.39 95.60 20.20 -10.18 -0.68 -14.85 -11.32 1.86 -14.73 coo 46.37 82.54 38.83 45.97 84.66 38.77 3.80 -37.83 -7.42 4.89 -38.66 -9.05 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 5 3 # 5 A 225 HIS B 216 HIS.? 19.24 CL CL B 278 A 259 TYR B 215 TYR.? 14.28 CL CL B 278 A 552 ASP A 275 ASP.? 34.16 CL CL A 278 coo 11.34 95.90 25.54 12.13 96.42 23.67 -16.22 -3.98 -15.80 -17.90 -4.46 -16.96 coo 14.91 97.39 18.63 13.39 95.60 20.20 -10.18 -0.68 -14.85 -11.32 1.86 -14.73 coo 46.37 82.54 38.83 45.97 84.66 38.77 -7.58 -36.49 2.30 -8.60 -35.44 3.90 1pj5_c00 source 1pj5 N,N-DIMETHYLGLYCINE OXIDASE : 5 hits 1pj5_c00 naa= 3 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 A 70 ALA A 104 ALA^? 17.29 CL CL A 278 A 126 LEU A 106 LEU^? 10.71 CL CL A 278 A 158 GLU A 34 GLU^? 8.78 CL CL A 278 coo -2.29 37.66 144.73 -1.46 37.12 145.87 18.93 -19.83 4.96 20.23 -20.34 4.40 coo -4.62 32.83 147.14 -5.50 32.85 149.12 18.65 -19.68 -1.57 19.62 -20.77 -3.18 coo -0.83 29.57 149.77 -0.39 31.47 148.95 14.76 -23.90 -2.78 16.42 -23.89 -4.11 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 A 70 ALA A 104 ALA^? 17.29 CL CL A 278 A 126 LEU A 188 LEU.? 20.58 CL CL A 278 A 158 GLU A 238 GLU^? 24.84 CL CL A 278 coo -2.29 37.66 144.73 -1.46 37.12 145.87 18.93 -19.83 4.96 20.23 -20.34 4.40 coo -4.62 32.83 147.14 -5.50 32.85 149.12 24.36 -22.96 7.77 23.84 -21.05 6.91 coo -0.83 29.57 149.77 -0.39 31.47 148.95 22.87 -26.18 11.53 21.04 -27.14 11.99 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 3 3 # 3 A 70 ALA A 136 ALA^? 14.58 CL CL A 278 A 126 LEU A 106 LEU^? 10.71 CL CL A 278 A 158 GLU A 34 GLU^? 8.78 CL CL A 278 coo -2.29 37.66 144.73 -1.46 37.12 145.87 23.46 -18.78 1.19 22.73 -20.09 1.10 coo -4.62 32.83 147.14 -5.50 32.85 149.12 18.65 -19.68 -1.57 19.62 -20.77 -3.18 coo -0.83 29.57 149.77 -0.39 31.47 148.95 14.76 -23.90 -2.78 16.42 -23.89 -4.11 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 4 3 # 4 A 70 ALA A 136 ALA^? 14.58 CL CL A 278 A 126 LEU A 106 LEU^? 10.71 CL CL A 278 A 158 GLU A 138 GLU^? 6.67 CL CL A 278 coo -2.29 37.66 144.73 -1.46 37.12 145.87 23.46 -18.78 1.19 22.73 -20.09 1.10 coo -4.62 32.83 147.14 -5.50 32.85 149.12 18.65 -19.68 -1.57 19.62 -20.77 -3.18 coo -0.83 29.57 149.77 -0.39 31.47 148.95 23.86 -20.99 -6.84 22.60 -22.69 -7.03 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 5 3 # 5 A 70 ALA A 223 ALA~? 23.86 CL CL A 278 A 126 LEU A 225 LEU~? 16.21 CL CL A 278 A 158 GLU A 221 GLU~? 17.05 CL CL A 278 coo -2.29 37.66 144.73 -1.46 37.12 145.87 28.06 -42.33 -3.47 28.69 -43.64 -3.86 coo -4.62 32.83 147.14 -5.50 32.85 149.12 26.75 -36.55 -4.37 26.44 -35.43 -6.22 coo -0.83 29.57 149.77 -0.39 31.47 148.95 27.14 -39.98 -10.94 25.92 -39.21 -12.48 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 6 3 # 6 A 70 ALA B 104 ALA^? 17.52 CL CL B 278 A 126 LEU B 106 LEU^? 10.66 CL CL B 278 A 158 GLU B 34 GLU^? 8.94 CL CL B 278 coo -2.29 37.66 144.73 -1.46 37.12 145.87 3.11 -7.43 -35.51 2.86 -5.96 -35.18 coo -4.62 32.83 147.14 -5.50 32.85 149.12 4.03 -6.95 -28.94 3.26 -5.63 -27.40 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -0.25 -10.10 -26.69 0.15 -8.25 -25.75 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 7 3 # 7 A 70 ALA B 104 ALA^? 17.52 CL CL B 278 A 126 LEU B 188 LEU^? 20.59 CL CL B 278 A 158 GLU B 238 GLU^? 25.19 CL CL B 278 coo -2.29 37.66 144.73 -1.46 37.12 145.87 3.11 -7.43 -35.51 2.86 -5.96 -35.18 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -0.13 -1.97 -38.65 1.51 -2.87 -37.57 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -3.49 -3.71 -41.35 -4.99 -5.08 -41.88 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 8 3 # 8 A 70 ALA B 136 ALA^? 14.67 CL CL B 278 A 126 LEU B 106 LEU^? 10.66 CL CL B 278 A 158 GLU B 34 GLU^? 8.94 CL CL B 278 coo -2.29 37.66 144.73 -1.46 37.12 145.87 5.19 -2.60 -32.46 3.80 -3.13 -32.19 coo -4.62 32.83 147.14 -5.50 32.85 149.12 4.03 -6.95 -28.94 3.26 -5.63 -27.40 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -0.25 -10.10 -26.69 0.15 -8.25 -25.75 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 9 3 # 9 A 70 ALA B 136 ALA^? 14.67 CL CL B 278 A 126 LEU B 106 LEU^? 10.66 CL CL B 278 A 158 GLU B 138 GLU^? 6.70 CL CL B 278 coo -2.29 37.66 144.73 -1.46 37.12 145.87 5.19 -2.60 -32.46 3.80 -3.13 -32.19 coo -4.62 32.83 147.14 -5.50 32.85 149.12 4.03 -6.95 -28.94 3.26 -5.63 -27.40 coo -0.83 29.57 149.77 -0.39 31.47 148.95 3.87 -1.10 -24.33 2.09 -2.15 -23.84 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 10 3 # 10 A 70 ALA B 223 ALA~? 24.43 CL CL B 278 A 126 LEU B 225 LEU~? 16.69 CL CL B 278 A 158 GLU B 221 GLU~? 17.56 CL CL B 278 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -17.41 4.99 -25.58 -18.60 5.80 -25.08 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -11.60 3.29 -25.22 -10.17 3.06 -23.58 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -13.90 4.76 -18.50 -13.25 3.58 -16.87 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 11 3 # 11 A 70 ALA B 236 ALA.? 23.79 CL CL B 278 A 126 LEU B 188 LEU^? 20.59 CL CL B 278 A 158 GLU B 238 GLU^? 25.19 CL CL B 278 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -4.32 3.96 -40.54 -4.01 3.42 -39.16 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -0.13 -1.97 -38.65 1.51 -2.87 -37.57 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -3.49 -3.71 -41.35 -4.99 -5.08 -41.88 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 12 3 # 12 A 70 ALA B 251 ALA~? 13.13 CL CL B 278 A 126 LEU B 6 LEU^? 15.01 CL CL B 278 A 158 GLU B 11 GLU.? 12.74 CL CL B 278 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -11.21 -8.27 -20.82 -9.88 -9.02 -21.02 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -8.34 -11.05 -25.38 -10.47 -10.65 -25.10 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -6.91 -15.96 -19.89 -5.75 -14.85 -18.47 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 13 3 # 13 A 70 ALA B 252 ALA~? 18.17 CL CL B 278 A 126 LEU B 6 LEU^? 15.01 CL CL B 278 A 158 GLU B 11 GLU.? 12.74 CL CL B 278 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -13.56 -10.31 -23.05 -13.89 -11.76 -22.86 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -8.34 -11.05 -25.38 -10.47 -10.65 -25.10 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -6.91 -15.96 -19.89 -5.75 -14.85 -18.47 1pjh_c00 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 13 hits 1pjh_c00 naa= 3 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 B 70 ALA A 104 ALA^? 17.29 CL CL A 278 B 126 LEU A 106 LEU^? 10.71 CL CL A 278 B 158 GLU A 34 GLU^? 8.78 CL CL A 278 coo -39.79 4.61 147.27 -39.61 5.56 148.47 18.93 -19.83 4.96 20.23 -20.34 4.40 coo -34.22 5.06 149.25 -33.65 4.24 151.15 18.65 -19.68 -1.57 19.62 -20.77 -3.18 coo -33.03 9.93 151.71 -34.98 9.38 151.11 14.76 -23.90 -2.78 16.42 -23.89 -4.11 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 B 70 ALA A 104 ALA^? 17.29 CL CL A 278 B 126 LEU A 188 LEU.? 20.58 CL CL A 278 B 158 GLU A 238 GLU^? 24.84 CL CL A 278 coo -39.79 4.61 147.27 -39.61 5.56 148.47 18.93 -19.83 4.96 20.23 -20.34 4.40 coo -34.22 5.06 149.25 -33.65 4.24 151.15 24.36 -22.96 7.77 23.84 -21.05 6.91 coo -33.03 9.93 151.71 -34.98 9.38 151.11 22.87 -26.18 11.53 21.04 -27.14 11.99 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 3 3 # 3 B 70 ALA A 136 ALA^? 14.58 CL CL A 278 B 126 LEU A 106 LEU^? 10.71 CL CL A 278 B 158 GLU A 34 GLU^? 8.78 CL CL A 278 coo -39.79 4.61 147.27 -39.61 5.56 148.47 23.46 -18.78 1.19 22.73 -20.09 1.10 coo -34.22 5.06 149.25 -33.65 4.24 151.15 18.65 -19.68 -1.57 19.62 -20.77 -3.18 coo -33.03 9.93 151.71 -34.98 9.38 151.11 14.76 -23.90 -2.78 16.42 -23.89 -4.11 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 4 3 # 4 B 70 ALA A 136 ALA^? 14.58 CL CL A 278 B 126 LEU A 106 LEU^? 10.71 CL CL A 278 B 158 GLU A 138 GLU^? 6.67 CL CL A 278 coo -39.79 4.61 147.27 -39.61 5.56 148.47 23.46 -18.78 1.19 22.73 -20.09 1.10 coo -34.22 5.06 149.25 -33.65 4.24 151.15 18.65 -19.68 -1.57 19.62 -20.77 -3.18 coo -33.03 9.93 151.71 -34.98 9.38 151.11 23.86 -20.99 -6.84 22.60 -22.69 -7.03 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 5 3 # 5 B 70 ALA A 223 ALA~? 23.86 CL CL A 278 B 126 LEU A 225 LEU~? 16.21 CL CL A 278 B 158 GLU A 221 GLU~? 17.05 CL CL A 278 coo -39.79 4.61 147.27 -39.61 5.56 148.47 28.06 -42.33 -3.47 28.69 -43.64 -3.86 coo -34.22 5.06 149.25 -33.65 4.24 151.15 26.75 -36.55 -4.37 26.44 -35.43 -6.22 coo -33.03 9.93 151.71 -34.98 9.38 151.11 27.14 -39.98 -10.94 25.92 -39.21 -12.48 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 6 3 # 6 B 70 ALA B 104 ALA^? 17.52 CL CL B 278 B 126 LEU B 106 LEU^? 10.66 CL CL B 278 B 158 GLU B 34 GLU^? 8.94 CL CL B 278 coo -39.79 4.61 147.27 -39.61 5.56 148.47 3.11 -7.43 -35.51 2.86 -5.96 -35.18 coo -34.22 5.06 149.25 -33.65 4.24 151.15 4.03 -6.95 -28.94 3.26 -5.63 -27.40 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -0.25 -10.10 -26.69 0.15 -8.25 -25.75 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 7 3 # 7 B 70 ALA B 104 ALA^? 17.52 CL CL B 278 B 126 LEU B 188 LEU^? 20.59 CL CL B 278 B 158 GLU B 238 GLU^? 25.19 CL CL B 278 coo -39.79 4.61 147.27 -39.61 5.56 148.47 3.11 -7.43 -35.51 2.86 -5.96 -35.18 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -0.13 -1.97 -38.65 1.51 -2.87 -37.57 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -3.49 -3.71 -41.35 -4.99 -5.08 -41.88 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 8 3 # 8 B 70 ALA B 136 ALA^? 14.67 CL CL B 278 B 126 LEU B 106 LEU^? 10.66 CL CL B 278 B 158 GLU B 34 GLU^? 8.94 CL CL B 278 coo -39.79 4.61 147.27 -39.61 5.56 148.47 5.19 -2.60 -32.46 3.80 -3.13 -32.19 coo -34.22 5.06 149.25 -33.65 4.24 151.15 4.03 -6.95 -28.94 3.26 -5.63 -27.40 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -0.25 -10.10 -26.69 0.15 -8.25 -25.75 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 9 3 # 9 B 70 ALA B 136 ALA^? 14.67 CL CL B 278 B 126 LEU B 106 LEU^? 10.66 CL CL B 278 B 158 GLU B 138 GLU^? 6.70 CL CL B 278 coo -39.79 4.61 147.27 -39.61 5.56 148.47 5.19 -2.60 -32.46 3.80 -3.13 -32.19 coo -34.22 5.06 149.25 -33.65 4.24 151.15 4.03 -6.95 -28.94 3.26 -5.63 -27.40 coo -33.03 9.93 151.71 -34.98 9.38 151.11 3.87 -1.10 -24.33 2.09 -2.15 -23.84 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 10 3 # 10 B 70 ALA B 223 ALA~? 24.43 CL CL B 278 B 126 LEU B 225 LEU~? 16.69 CL CL B 278 B 158 GLU B 221 GLU~? 17.56 CL CL B 278 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -17.41 4.99 -25.58 -18.60 5.80 -25.08 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -11.60 3.29 -25.22 -10.17 3.06 -23.58 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -13.90 4.76 -18.50 -13.25 3.58 -16.87 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 11 3 # 11 B 70 ALA B 236 ALA.? 23.79 CL CL B 278 B 126 LEU B 188 LEU^? 20.59 CL CL B 278 B 158 GLU B 238 GLU^? 25.19 CL CL B 278 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -4.32 3.96 -40.54 -4.01 3.42 -39.16 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -0.13 -1.97 -38.65 1.51 -2.87 -37.57 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -3.49 -3.71 -41.35 -4.99 -5.08 -41.88 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 12 3 # 12 B 70 ALA B 251 ALA~? 13.13 CL CL B 278 B 126 LEU B 6 LEU^? 15.01 CL CL B 278 B 158 GLU B 11 GLU.? 12.74 CL CL B 278 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -11.21 -8.27 -20.82 -9.88 -9.02 -21.02 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -8.34 -11.05 -25.38 -10.47 -10.65 -25.10 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -6.91 -15.96 -19.89 -5.75 -14.85 -18.47 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 13 3 # 13 B 70 ALA B 252 ALA~? 18.17 CL CL B 278 B 126 LEU B 6 LEU^? 15.01 CL CL B 278 B 158 GLU B 11 GLU.? 12.74 CL CL B 278 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -13.56 -10.31 -23.05 -13.89 -11.76 -22.86 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -8.34 -11.05 -25.38 -10.47 -10.65 -25.10 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -6.91 -15.96 -19.89 -5.75 -14.85 -18.47 1pjh_c01 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 13 hits 1pjh_c01 naa= 3 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 C 70 ALA A 104 ALA^? 17.29 CL CL A 278 C 126 LEU A 106 LEU^? 10.71 CL CL A 278 C 158 GLU A 34 GLU^? 8.78 CL CL A 278 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 18.93 -19.83 4.96 20.23 -20.34 4.40 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 18.65 -19.68 -1.57 19.62 -20.77 -3.18 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 14.76 -23.90 -2.78 16.42 -23.89 -4.11 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 C 70 ALA A 104 ALA^? 17.29 CL CL A 278 C 126 LEU A 188 LEU.? 20.58 CL CL A 278 C 158 GLU A 238 GLU^? 24.84 CL CL A 278 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 18.93 -19.83 4.96 20.23 -20.34 4.40 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 24.36 -22.96 7.77 23.84 -21.05 6.91 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 22.87 -26.18 11.53 21.04 -27.14 11.99 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 3 3 # 3 C 70 ALA A 136 ALA^? 14.58 CL CL A 278 C 126 LEU A 106 LEU^? 10.71 CL CL A 278 C 158 GLU A 34 GLU^? 8.78 CL CL A 278 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 23.46 -18.78 1.19 22.73 -20.09 1.10 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 18.65 -19.68 -1.57 19.62 -20.77 -3.18 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 14.76 -23.90 -2.78 16.42 -23.89 -4.11 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 4 3 # 4 C 70 ALA A 136 ALA^? 14.58 CL CL A 278 C 126 LEU A 106 LEU^? 10.71 CL CL A 278 C 158 GLU A 138 GLU^? 6.67 CL CL A 278 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 23.46 -18.78 1.19 22.73 -20.09 1.10 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 18.65 -19.68 -1.57 19.62 -20.77 -3.18 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 23.86 -20.99 -6.84 22.60 -22.69 -7.03 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 5 3 # 5 C 70 ALA A 223 ALA~? 23.86 CL CL A 278 C 126 LEU A 225 LEU~? 16.21 CL CL A 278 C 158 GLU A 221 GLU~? 17.05 CL CL A 278 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 28.06 -42.33 -3.47 28.69 -43.64 -3.86 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 26.75 -36.55 -4.37 26.44 -35.43 -6.22 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 27.14 -39.98 -10.94 25.92 -39.21 -12.48 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 6 3 # 6 C 70 ALA B 104 ALA^? 17.52 CL CL B 278 C 126 LEU B 106 LEU^? 10.66 CL CL B 278 C 158 GLU B 34 GLU^? 8.94 CL CL B 278 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 3.11 -7.43 -35.51 2.86 -5.96 -35.18 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 4.03 -6.95 -28.94 3.26 -5.63 -27.40 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -0.25 -10.10 -26.69 0.15 -8.25 -25.75 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 7 3 # 7 C 70 ALA B 104 ALA^? 17.52 CL CL B 278 C 126 LEU B 188 LEU^? 20.59 CL CL B 278 C 158 GLU B 238 GLU^? 25.19 CL CL B 278 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 3.11 -7.43 -35.51 2.86 -5.96 -35.18 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -0.13 -1.97 -38.65 1.51 -2.87 -37.57 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -3.49 -3.71 -41.35 -4.99 -5.08 -41.88 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 8 3 # 8 C 70 ALA B 136 ALA^? 14.67 CL CL B 278 C 126 LEU B 106 LEU^? 10.66 CL CL B 278 C 158 GLU B 34 GLU^? 8.94 CL CL B 278 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 5.19 -2.60 -32.46 3.80 -3.13 -32.19 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 4.03 -6.95 -28.94 3.26 -5.63 -27.40 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -0.25 -10.10 -26.69 0.15 -8.25 -25.75 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 9 3 # 9 C 70 ALA B 136 ALA^? 14.67 CL CL B 278 C 126 LEU B 106 LEU^? 10.66 CL CL B 278 C 158 GLU B 138 GLU^? 6.70 CL CL B 278 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 5.19 -2.60 -32.46 3.80 -3.13 -32.19 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 4.03 -6.95 -28.94 3.26 -5.63 -27.40 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 3.87 -1.10 -24.33 2.09 -2.15 -23.84 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 10 3 # 10 C 70 ALA B 223 ALA~? 24.43 CL CL B 278 C 126 LEU B 225 LEU~? 16.69 CL CL B 278 C 158 GLU B 221 GLU~? 17.56 CL CL B 278 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -17.41 4.99 -25.58 -18.60 5.80 -25.08 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -11.60 3.29 -25.22 -10.17 3.06 -23.58 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -13.90 4.76 -18.50 -13.25 3.58 -16.87 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 11 3 # 11 C 70 ALA B 236 ALA.? 23.79 CL CL B 278 C 126 LEU B 188 LEU^? 20.59 CL CL B 278 C 158 GLU B 238 GLU^? 25.19 CL CL B 278 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -4.32 3.96 -40.54 -4.01 3.42 -39.16 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -0.13 -1.97 -38.65 1.51 -2.87 -37.57 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -3.49 -3.71 -41.35 -4.99 -5.08 -41.88 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 12 3 # 12 C 70 ALA B 251 ALA~? 13.13 CL CL B 278 C 126 LEU B 6 LEU^? 15.01 CL CL B 278 C 158 GLU B 11 GLU.? 12.74 CL CL B 278 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -11.21 -8.27 -20.82 -9.88 -9.02 -21.02 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -8.34 -11.05 -25.38 -10.47 -10.65 -25.10 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -6.91 -15.96 -19.89 -5.75 -14.85 -18.47 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 13 3 # 13 C 70 ALA B 252 ALA~? 18.17 CL CL B 278 C 126 LEU B 6 LEU^? 15.01 CL CL B 278 C 158 GLU B 11 GLU.? 12.74 CL CL B 278 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -13.56 -10.31 -23.05 -13.89 -11.76 -22.86 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -8.34 -11.05 -25.38 -10.47 -10.65 -25.10 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -6.91 -15.96 -19.89 -5.75 -14.85 -18.47 1pjh_c02 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 13 hits 1pjh_c02 naa= 3 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 1 3 # 1 B 1 SER A 247 SER.? 8.71 CL CL A 278 B 69 ALA A 251 ALA~? 12.40 CL CL A 278 B 241 ASN A 245 ASN.? 11.79 CL CL A 278 coo 13.24 41.94 33.13 13.08 39.54 33.17 12.77 -32.05 -14.75 14.22 -30.30 -15.59 coo 9.15 37.89 36.69 10.55 37.76 37.22 14.98 -35.41 -7.43 14.47 -33.98 -7.30 coo 10.91 43.03 38.47 11.81 41.82 36.93 18.48 -33.48 -10.76 18.30 -34.93 -9.15 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 2 3 # 2 B 1 SER A 247 SER.? 8.71 CL CL A 278 B 69 ALA A 251 ALA~? 12.40 CL CL A 278 B 241 ASN A 246 ASN.? 12.85 CL CL A 278 coo 13.24 41.94 33.13 13.08 39.54 33.17 12.77 -32.05 -14.75 14.22 -30.30 -15.59 coo 9.15 37.89 36.69 10.55 37.76 37.22 14.98 -35.41 -7.43 14.47 -33.98 -7.30 coo 10.91 43.03 38.47 11.81 41.82 36.93 12.83 -32.17 -9.87 11.11 -33.32 -9.30 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 3 3 # 3 B 1 SER B 247 SER.? 9.35 CL CL B 278 B 69 ALA B 251 ALA~? 13.13 CL CL B 278 B 241 ASN B 245 ASN.? 12.34 CL CL B 278 coo 13.24 41.94 33.13 13.08 39.54 33.17 -7.15 -9.80 -13.65 -5.07 -8.65 -13.11 coo 9.15 37.89 36.69 10.55 37.76 37.22 -11.21 -8.27 -20.82 -9.88 -9.02 -21.02 coo 10.91 43.03 38.47 11.81 41.82 36.93 -8.45 -4.50 -18.19 -10.06 -4.59 -19.62 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 4 3 # 4 B 1 SER B 247 SER.? 9.35 CL CL B 278 B 69 ALA B 251 ALA~? 13.13 CL CL B 278 B 241 ASN B 246 ASN.? 13.30 CL CL B 278 coo 13.24 41.94 33.13 13.08 39.54 33.17 -7.15 -9.80 -13.65 -5.07 -8.65 -13.11 coo 9.15 37.89 36.69 10.55 37.76 37.22 -11.21 -8.27 -20.82 -9.88 -9.02 -21.02 coo 10.91 43.03 38.47 11.81 41.82 36.93 -7.71 -10.36 -18.40 -9.09 -11.94 -18.78 1pnl_c00 source 1pnl PENICILLIN AMIDOHYDROLASE : 4 hits 1pnl_c00 naa= 3 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 1 3 # 1 A 264 ARG A 3 ARG^? 24.49 CL CL A 278 A 479 PHE A 103 PHE^? 18.77 CL CL A 278 A 483 GLU A 238 GLU^? 24.84 CL CL A 278 coo 17.33 52.29 2.24 18.71 54.03 0.18 17.45 -29.65 8.35 18.11 -29.19 11.33 coo 20.06 57.44 1.28 18.39 56.19 3.12 18.98 -24.51 6.17 21.41 -25.88 6.12 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 22.87 -26.18 11.53 21.04 -27.14 11.99 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 2 3 # 2 A 264 ARG A 60 ARG^? 25.80 CL CL A 278 A 479 PHE A 103 PHE^? 18.77 CL CL A 278 A 483 GLU A 238 GLU^? 24.84 CL CL A 278 coo 17.33 52.29 2.24 18.71 54.03 0.18 16.05 -25.08 10.06 15.12 -25.70 12.91 coo 20.06 57.44 1.28 18.39 56.19 3.12 18.98 -24.51 6.17 21.41 -25.88 6.12 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 22.87 -26.18 11.53 21.04 -27.14 11.99 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 3 3 # 3 A 264 ARG B 3 ARG^? 24.44 CL CL B 278 A 479 PHE B 103 PHE^? 18.96 CL CL B 278 A 483 GLU B 238 GLU^? 25.19 CL CL B 278 coo 17.33 52.29 2.24 18.71 54.03 0.18 -7.40 -8.36 -37.36 -6.70 -7.91 -40.31 coo 20.06 57.44 1.28 18.39 56.19 3.12 -1.78 -6.89 -36.04 -2.91 -4.36 -36.20 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 -3.49 -3.71 -41.35 -4.99 -5.08 -41.88 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 4 3 # 4 A 264 ARG B 60 ARG^? 26.12 CL CL B 278 A 479 PHE B 103 PHE^? 18.96 CL CL B 278 A 483 GLU B 238 GLU^? 25.19 CL CL B 278 coo 17.33 52.29 2.24 18.71 54.03 0.18 -3.16 -10.36 -39.52 -4.20 -11.54 -42.16 coo 20.06 57.44 1.28 18.39 56.19 3.12 -1.78 -6.89 -36.04 -2.91 -4.36 -36.20 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 -3.49 -3.71 -41.35 -4.99 -5.08 -41.88 1pow_c02 source 1pow PYRUVATE OXIDASE (E.C.1.2.3.3) (WILD TYPE) : 4 hits 1pow_c02 naa= 3 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 1 3 # 1 B 264 ARG A 3 ARG^? 24.49 CL CL A 278 B 479 PHE A 103 PHE^? 18.77 CL CL A 278 B 483 GLU A 238 GLU^? 24.84 CL CL A 278 coo -26.72 93.28 20.13 -28.02 93.55 17.39 17.45 -29.65 8.35 18.11 -29.19 11.33 coo -29.34 90.48 15.69 -27.62 89.95 17.80 18.98 -24.51 6.17 21.41 -25.88 6.12 coo -26.63 95.49 14.65 -25.77 93.77 13.77 22.87 -26.18 11.53 21.04 -27.14 11.99 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 2 3 # 2 B 264 ARG A 60 ARG^? 25.80 CL CL A 278 B 479 PHE A 103 PHE^? 18.77 CL CL A 278 B 483 GLU A 238 GLU^? 24.84 CL CL A 278 coo -26.72 93.28 20.13 -28.02 93.55 17.39 16.05 -25.08 10.06 15.12 -25.70 12.91 coo -29.34 90.48 15.69 -27.62 89.95 17.80 18.98 -24.51 6.17 21.41 -25.88 6.12 coo -26.63 95.49 14.65 -25.77 93.77 13.77 22.87 -26.18 11.53 21.04 -27.14 11.99 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 3 3 # 3 B 264 ARG B 3 ARG^? 24.44 CL CL B 278 B 479 PHE B 103 PHE^? 18.96 CL CL B 278 B 483 GLU B 238 GLU^? 25.19 CL CL B 278 coo -26.72 93.28 20.13 -28.02 93.55 17.39 -7.40 -8.36 -37.36 -6.70 -7.91 -40.31 coo -29.34 90.48 15.69 -27.62 89.95 17.80 -1.78 -6.89 -36.04 -2.91 -4.36 -36.20 coo -26.63 95.49 14.65 -25.77 93.77 13.77 -3.49 -3.71 -41.35 -4.99 -5.08 -41.88 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 4 3 # 4 B 264 ARG B 60 ARG^? 26.12 CL CL B 278 B 479 PHE B 103 PHE^? 18.96 CL CL B 278 B 483 GLU B 238 GLU^? 25.19 CL CL B 278 coo -26.72 93.28 20.13 -28.02 93.55 17.39 -3.16 -10.36 -39.52 -4.20 -11.54 -42.16 coo -29.34 90.48 15.69 -27.62 89.95 17.80 -1.78 -6.89 -36.04 -2.91 -4.36 -36.20 coo -26.63 95.49 14.65 -25.77 93.77 13.77 -3.49 -3.71 -41.35 -4.99 -5.08 -41.88 1pow_c03 source 1pow PYRUVATE OXIDASE (E.C.1.2.3.3) (WILD TYPE) : 4 hits 1pow_c03 naa= 3 ULMN 3 1pp4_c02 RHAMNOGALACTURONAN ACETYLESTERASE user 1 3 # 1 A 74 ASN A 197 ASN.? 12.86 CL CL A 278 A 192 ASP A 168 ASP^? 12.27 CL CL A 278 A 195 HIS A 194 HIS.? 4.68 CL CL A 278 coo -4.84 51.77 30.37 -3.89 50.12 29.46 21.52 -32.98 -18.45 20.55 -33.92 -20.09 coo 2.03 47.14 19.75 1.72 46.26 21.64 26.46 -30.73 -8.22 26.92 -32.42 -9.39 coo 1.41 44.84 24.92 -0.49 45.70 25.19 21.59 -27.03 -10.13 21.31 -25.37 -8.87 ULMN 3 1pp4_c02 RHAMNOGALACTURONAN ACETYLESTERASE user 2 3 # 2 A 74 ASN A 246 ASN.? 12.85 CL CL A 278 A 192 ASP A 168 ASP^? 12.27 CL CL A 278 A 195 HIS A 194 HIS.? 4.68 CL CL A 278 coo -4.84 51.77 30.37 -3.89 50.12 29.46 12.83 -32.17 -9.87 11.11 -33.32 -9.30 coo 2.03 47.14 19.75 1.72 46.26 21.64 26.46 -30.73 -8.22 26.92 -32.42 -9.39 coo 1.41 44.84 24.92 -0.49 45.70 25.19 21.59 -27.03 -10.13 21.31 -25.37 -8.87 ULMN 3 1pp4_c02 RHAMNOGALACTURONAN ACETYLESTERASE user 3 3 # 3 A 74 ASN A 254 ASN~? 16.17 CL CL A 278 A 192 ASP A 13 ASP~? 20.85 CL CL A 278 A 195 HIS A 12 HIS~? 14.78 CL CL A 278 coo -4.84 51.77 30.37 -3.89 50.12 29.46 18.50 -38.45 -6.68 18.86 -39.34 -8.59 coo 2.03 47.14 19.75 1.72 46.26 21.64 3.80 -37.83 -7.42 4.89 -38.66 -9.05 coo 1.41 44.84 24.92 -0.49 45.70 25.19 9.03 -33.35 -4.93 10.37 -31.88 -5.56 ULMN 3 1pp4_c02 RHAMNOGALACTURONAN ACETYLESTERASE user 4 3 # 4 A 74 ASN B 246 ASN.? 13.30 CL CL B 278 A 192 ASP B 168 ASP^? 12.80 CL CL B 278 A 195 HIS B 194 HIS.? 5.13 CL CL B 278 coo -4.84 51.77 30.37 -3.89 50.12 29.46 -7.71 -10.36 -18.40 -9.09 -11.94 -18.78 coo 2.03 47.14 19.75 1.72 46.26 21.64 -5.42 2.81 -22.11 -6.82 3.76 -20.83 coo 1.41 44.84 24.92 -0.49 45.70 25.19 -1.92 -2.21 -20.05 -0.53 -2.75 -21.52 ULMN 3 1pp4_c02 RHAMNOGALACTURONAN ACETYLESTERASE user 5 3 # 5 A 74 ASN B 254 ASN~? 16.98 CL CL B 278 A 192 ASP B 13 ASP~? 21.13 CL CL B 278 A 195 HIS B 12 HIS~? 15.42 CL CL B 278 coo -4.84 51.77 30.37 -3.89 50.12 29.46 -14.04 -4.32 -21.65 -14.71 -3.72 -19.71 coo 2.03 47.14 19.75 1.72 46.26 21.64 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 coo 1.41 44.84 24.92 -0.49 45.70 25.19 -10.18 -14.51 -22.80 -8.49 -13.29 -22.60 1pp4_c02 source 1pp4 RHAMNOGALACTURONAN ACETYLESTERASE : 5 hits 1pp4_c02 naa= 3 ULMN 3 1pp4_c03 RHAMNOGALACTURONAN ACETYLESTERASE user 1 3 # 1 B 74 ASN A 197 ASN.? 12.86 CL CL A 278 B 192 ASP A 168 ASP^? 12.27 CL CL A 278 B 195 HIS A 194 HIS.? 4.68 CL CL A 278 coo -1.08 51.41 10.34 0.65 52.62 10.17 21.52 -32.98 -18.45 20.55 -33.92 -20.09 coo 11.36 52.33 5.59 10.18 53.87 6.47 26.46 -30.73 -8.22 26.92 -32.42 -9.39 coo 7.99 56.74 7.55 6.88 55.39 8.70 21.59 -27.03 -10.13 21.31 -25.37 -8.87 ULMN 3 1pp4_c03 RHAMNOGALACTURONAN ACETYLESTERASE user 2 3 # 2 B 74 ASN A 246 ASN.? 12.85 CL CL A 278 B 192 ASP A 168 ASP^? 12.27 CL CL A 278 B 195 HIS A 194 HIS.? 4.68 CL CL A 278 coo -1.08 51.41 10.34 0.65 52.62 10.17 12.83 -32.17 -9.87 11.11 -33.32 -9.30 coo 11.36 52.33 5.59 10.18 53.87 6.47 26.46 -30.73 -8.22 26.92 -32.42 -9.39 coo 7.99 56.74 7.55 6.88 55.39 8.70 21.59 -27.03 -10.13 21.31 -25.37 -8.87 ULMN 3 1pp4_c03 RHAMNOGALACTURONAN ACETYLESTERASE user 3 3 # 3 B 74 ASN A 254 ASN~? 16.17 CL CL A 278 B 192 ASP A 13 ASP~? 20.85 CL CL A 278 B 195 HIS A 12 HIS~? 14.78 CL CL A 278 coo -1.08 51.41 10.34 0.65 52.62 10.17 18.50 -38.45 -6.68 18.86 -39.34 -8.59 coo 11.36 52.33 5.59 10.18 53.87 6.47 3.80 -37.83 -7.42 4.89 -38.66 -9.05 coo 7.99 56.74 7.55 6.88 55.39 8.70 9.03 -33.35 -4.93 10.37 -31.88 -5.56 ULMN 3 1pp4_c03 RHAMNOGALACTURONAN ACETYLESTERASE user 4 3 # 4 B 74 ASN B 197 ASN.? 13.10 CL CL B 278 B 192 ASP B 168 ASP^? 12.80 CL CL B 278 B 195 HIS B 194 HIS.? 5.13 CL CL B 278 coo -1.08 51.41 10.34 0.65 52.62 10.17 -6.63 -0.56 -11.26 -7.23 -1.17 -9.32 coo 11.36 52.33 5.59 10.18 53.87 6.47 -5.42 2.81 -22.11 -6.82 3.76 -20.83 coo 7.99 56.74 7.55 6.88 55.39 8.70 -1.92 -2.21 -20.05 -0.53 -2.75 -21.52 ULMN 3 1pp4_c03 RHAMNOGALACTURONAN ACETYLESTERASE user 5 3 # 5 B 74 ASN B 246 ASN.? 13.30 CL CL B 278 B 192 ASP B 168 ASP^? 12.80 CL CL B 278 B 195 HIS B 194 HIS.? 5.13 CL CL B 278 coo -1.08 51.41 10.34 0.65 52.62 10.17 -7.71 -10.36 -18.40 -9.09 -11.94 -18.78 coo 11.36 52.33 5.59 10.18 53.87 6.47 -5.42 2.81 -22.11 -6.82 3.76 -20.83 coo 7.99 56.74 7.55 6.88 55.39 8.70 -1.92 -2.21 -20.05 -0.53 -2.75 -21.52 ULMN 3 1pp4_c03 RHAMNOGALACTURONAN ACETYLESTERASE user 6 3 # 6 B 74 ASN B 254 ASN~? 16.98 CL CL B 278 B 192 ASP B 13 ASP~? 21.13 CL CL B 278 B 195 HIS B 12 HIS~? 15.42 CL CL B 278 coo -1.08 51.41 10.34 0.65 52.62 10.17 -14.04 -4.32 -21.65 -14.71 -3.72 -19.71 coo 11.36 52.33 5.59 10.18 53.87 6.47 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 coo 7.99 56.74 7.55 6.88 55.39 8.70 -10.18 -14.51 -22.80 -8.49 -13.29 -22.60 1pp4_c03 source 1pp4 RHAMNOGALACTURONAN ACETYLESTERASE : 6 hits 1pp4_c03 naa= 3 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 1 3 # 1 A 48 LEU A 202 LEU.? 17.39 CL CL A 278 A 58 ASP A 205 ASP.? 14.79 CL CL A 278 A 120 LYS A 211 LYS~? 14.92 CL CL A 278 coo 34.02 69.29 75.26 34.82 67.82 76.74 21.71 -27.86 -28.46 22.45 -29.78 -29.19 coo 34.46 72.45 78.57 32.82 72.75 77.28 19.11 -25.60 -27.15 17.47 -26.92 -26.86 coo 28.96 77.64 81.19 29.05 74.53 77.51 17.07 -30.19 -20.07 15.73 -30.42 -25.42 1pym_c00 source 1pym PHOSPHOENOLPYRUVATE MUTASE : 1 hits 1pym_c00 naa= 3 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 1 3 # 1 B 48 LEU A 202 LEU.? 17.39 CL CL A 278 B 58 ASP A 205 ASP.? 14.79 CL CL A 278 B 120 LYS A 211 LYS~? 14.92 CL CL A 278 coo 54.50 104.32 58.69 55.83 105.69 59.81 21.71 -27.86 -28.46 22.45 -29.78 -29.19 coo 57.63 101.19 59.83 56.60 100.89 57.99 19.11 -25.60 -27.15 17.47 -26.92 -26.86 coo 61.58 95.88 55.22 58.18 99.30 54.71 17.07 -30.19 -20.07 15.73 -30.42 -25.42 1pym_c01 source 1pym PHOSPHOENOLPYRUVATE MUTASE : 1 hits 1pym_c01 naa= 3 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 1 3 # 1 A 67 ASP A 268 ASP.? 26.73 CL CL A 278 A 68 ALA A 27 ALA~? 23.88 CL CL A 278 A 72 LEU A 30 LEU.? 19.87 CL CL A 278 coo 46.76 7.59 18.65 45.27 6.01 18.52 9.60 -34.57 10.49 9.97 -36.28 9.26 coo 48.88 4.35 16.59 48.73 5.09 15.20 7.18 -32.62 5.90 6.84 -31.31 6.60 coo 53.89 6.25 15.09 52.88 7.92 14.14 12.41 -34.45 3.31 13.17 -35.75 1.72 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 2 3 # 2 A 67 ASP B 268 ASP.? 26.26 CL CL B 278 A 68 ALA B 27 ALA~? 24.20 CL CL B 278 A 72 LEU B 30 LEU.? 20.26 CL CL B 278 coo 46.76 7.59 18.65 45.27 6.01 18.52 -14.31 -16.11 -36.83 -14.03 -14.11 -36.24 coo 48.88 4.35 16.59 48.73 5.09 15.20 -10.91 -17.58 -33.32 -9.74 -18.04 -34.19 coo 53.89 6.25 15.09 52.88 7.92 14.14 -11.82 -11.94 -31.16 -12.78 -10.81 -29.57 1q6l_c05 source 1q6l 3-KETO-L-GULONATE 6-PHOSPHATE DECARBOXYLASE : 2 hits 1q6l_c05 naa= 3 ULMN 3 1qaz_c00 ALGINATE LYASE A1-III user 1 3 # 1 A 191 ASN A 197 ASN.? 12.86 CL CL A 278 A 239 ARG A 196 ARG.? 15.95 CL CL A 278 A 246 TYR A 215 TYR.? 13.87 CL CL A 278 coo 2.50 7.27 18.06 0.76 7.28 16.81 21.52 -32.98 -18.45 20.55 -33.92 -20.09 coo -1.16 0.95 13.41 -2.50 3.71 13.61 27.49 -34.87 -12.70 29.46 -35.46 -10.43 coo 1.59 5.18 12.30 -0.74 6.52 11.61 21.62 -36.04 -14.58 23.93 -37.55 -14.90 ULMN 3 1qaz_c00 ALGINATE LYASE A1-III user 2 3 # 2 A 191 ASN A 218 ASN~? 20.82 CL CL A 278 A 239 ARG A 196 ARG.? 15.95 CL CL A 278 A 246 TYR A 217 TYR.? 13.45 CL CL A 278 coo 2.50 7.27 18.06 0.76 7.28 16.81 24.13 -43.84 -11.70 26.14 -43.18 -11.76 coo -1.16 0.95 13.41 -2.50 3.71 13.61 27.49 -34.87 -12.70 29.46 -35.46 -10.43 coo 1.59 5.18 12.30 -0.74 6.52 11.61 22.77 -37.42 -9.36 23.40 -34.73 -9.58 ULMN 3 1qaz_c00 ALGINATE LYASE A1-III user 3 3 # 3 A 191 ASN A 245 ASN.? 11.79 CL CL A 278 A 239 ARG A 196 ARG.? 15.95 CL CL A 278 A 246 TYR A 215 TYR.? 13.87 CL CL A 278 coo 2.50 7.27 18.06 0.76 7.28 16.81 18.48 -33.48 -10.76 18.30 -34.93 -9.15 coo -1.16 0.95 13.41 -2.50 3.71 13.61 27.49 -34.87 -12.70 29.46 -35.46 -10.43 coo 1.59 5.18 12.30 -0.74 6.52 11.61 21.62 -36.04 -14.58 23.93 -37.55 -14.90 ULMN 3 1qaz_c00 ALGINATE LYASE A1-III user 4 3 # 4 A 191 ASN A 245 ASN.? 11.79 CL CL A 278 A 239 ARG A 196 ARG.? 15.95 CL CL A 278 A 246 TYR A 217 TYR.? 13.45 CL CL A 278 coo 2.50 7.27 18.06 0.76 7.28 16.81 18.48 -33.48 -10.76 18.30 -34.93 -9.15 coo -1.16 0.95 13.41 -2.50 3.71 13.61 27.49 -34.87 -12.70 29.46 -35.46 -10.43 coo 1.59 5.18 12.30 -0.74 6.52 11.61 22.77 -37.42 -9.36 23.40 -34.73 -9.58 ULMN 3 1qaz_c00 ALGINATE LYASE A1-III user 5 3 # 5 A 191 ASN B 197 ASN.? 13.10 CL CL B 278 A 239 ARG B 196 ARG.? 16.18 CL CL B 278 A 246 TYR B 215 TYR.? 14.28 CL CL B 278 coo 2.50 7.27 18.06 0.76 7.28 16.81 -6.63 -0.56 -11.26 -7.23 -1.17 -9.32 coo -1.16 0.95 13.41 -2.50 3.71 13.61 -8.42 4.93 -17.56 -9.12 6.53 -20.07 coo 1.59 5.18 12.30 -0.74 6.52 11.61 -10.18 -0.68 -14.85 -11.32 1.86 -14.73 ULMN 3 1qaz_c00 ALGINATE LYASE A1-III user 6 3 # 6 A 191 ASN B 218 ASN~? 21.19 CL CL B 278 A 239 ARG B 196 ARG.? 16.18 CL CL B 278 A 246 TYR B 217 TYR.? 13.94 CL CL B 278 coo 2.50 7.27 18.06 0.76 7.28 16.81 -17.80 2.35 -16.65 -17.00 4.26 -17.12 coo -1.16 0.95 13.41 -2.50 3.71 13.61 -8.42 4.93 -17.56 -9.12 6.53 -20.07 coo 1.59 5.18 12.30 -0.74 6.52 11.61 -12.06 -0.05 -19.78 -9.32 0.42 -19.98 ULMN 3 1qaz_c00 ALGINATE LYASE A1-III user 7 3 # 7 A 191 ASN B 245 ASN.? 12.34 CL CL B 278 A 239 ARG B 196 ARG.? 16.18 CL CL B 278 A 246 TYR B 215 TYR.? 14.28 CL CL B 278 coo 2.50 7.27 18.06 0.76 7.28 16.81 -8.45 -4.50 -18.19 -10.06 -4.59 -19.62 coo -1.16 0.95 13.41 -2.50 3.71 13.61 -8.42 4.93 -17.56 -9.12 6.53 -20.07 coo 1.59 5.18 12.30 -0.74 6.52 11.61 -10.18 -0.68 -14.85 -11.32 1.86 -14.73 ULMN 3 1qaz_c00 ALGINATE LYASE A1-III user 8 3 # 8 A 191 ASN B 245 ASN.? 12.34 CL CL B 278 A 239 ARG B 196 ARG.? 16.18 CL CL B 278 A 246 TYR B 217 TYR.? 13.94 CL CL B 278 coo 2.50 7.27 18.06 0.76 7.28 16.81 -8.45 -4.50 -18.19 -10.06 -4.59 -19.62 coo -1.16 0.95 13.41 -2.50 3.71 13.61 -8.42 4.93 -17.56 -9.12 6.53 -20.07 coo 1.59 5.18 12.30 -0.74 6.52 11.61 -12.06 -0.05 -19.78 -9.32 0.42 -19.98 1qaz_c00 source 1qaz ALGINATE LYASE A1-III : 8 hits 1qaz_c00 naa= 3 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 155 HIS A 0 HIS.? 29.82 CL CL A 278 A 236 ASP A 268 ASP.? 26.73 CL CL A 278 A 261 LYS A 272 LYS.? 33.16 CL CL A 278 coo 55.45 46.76 42.08 57.34 46.16 42.75 28.39 -31.84 13.78 30.11 -32.89 14.37 coo 48.87 29.19 44.63 49.10 27.34 43.63 9.60 -34.57 10.49 9.97 -36.28 9.26 coo 47.58 17.35 41.83 51.40 20.85 40.83 -2.40 -40.27 7.96 -3.06 -34.63 9.73 1qgn_c00 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c00 naa= 3 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 D 155 HIS A 0 HIS.? 29.82 CL CL A 278 D 236 ASP A 268 ASP.? 26.73 CL CL A 278 D 261 LYS A 272 LYS.? 33.16 CL CL A 278 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 28.39 -31.84 13.78 30.11 -32.89 14.37 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 9.60 -34.57 10.49 9.97 -36.28 9.26 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -2.40 -40.27 7.96 -3.06 -34.63 9.73 1qgn_c03 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c03 naa= 3 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 155 HIS A 0 HIS.? 29.82 CL CL A 278 E 236 ASP A 268 ASP.? 26.73 CL CL A 278 E 261 LYS A 272 LYS.? 33.16 CL CL A 278 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 28.39 -31.84 13.78 30.11 -32.89 14.37 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 9.60 -34.57 10.49 9.97 -36.28 9.26 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -2.40 -40.27 7.96 -3.06 -34.63 9.73 1qgn_c04 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c04 naa= 3 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 H 155 HIS A 0 HIS.? 29.82 CL CL A 278 H 236 ASP A 268 ASP.? 26.73 CL CL A 278 H 261 LYS A 272 LYS.? 33.16 CL CL A 278 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 28.39 -31.84 13.78 30.11 -32.89 14.37 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 9.60 -34.57 10.49 9.97 -36.28 9.26 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -2.40 -40.27 7.96 -3.06 -34.63 9.73 1qgn_c07 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c07 naa= 3 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 163 TYR A 217 TYR.? 13.45 CL CL A 278 A 236 ASP A 250 ASP~? 15.45 CL CL A 278 A 261 LYS A 211 LYS~? 14.92 CL CL A 278 coo 55.48 26.51 40.65 55.39 23.99 39.43 22.77 -37.42 -9.36 23.40 -34.73 -9.58 coo 48.87 29.19 44.63 49.10 27.34 43.63 15.24 -38.09 -11.21 14.62 -38.47 -13.19 coo 47.58 17.35 41.83 51.40 20.85 40.83 17.07 -30.19 -20.07 15.73 -30.42 -25.42 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 163 TYR B 26 TYR~? 19.09 CL CL B 278 A 236 ASP B 268 ASP.? 26.26 CL CL B 278 A 261 LYS B 53 LYS~? 32.92 CL CL B 278 coo 55.48 26.51 40.65 55.39 23.99 39.43 -9.51 -16.67 -28.98 -9.06 -13.93 -28.84 coo 48.87 29.19 44.63 49.10 27.34 43.63 -14.31 -16.11 -36.83 -14.03 -14.11 -36.24 coo 47.58 17.35 41.83 51.40 20.85 40.83 -3.36 -23.95 -38.76 0.61 -28.64 -40.43 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 163 TYR B 215 TYR.? 14.28 CL CL B 278 A 236 ASP B 250 ASP~? 16.15 CL CL B 278 A 261 LYS B 210 LYS~? 12.46 CL CL B 278 coo 55.48 26.51 40.65 55.39 23.99 39.43 -10.18 -0.68 -14.85 -11.32 1.86 -14.73 coo 48.87 29.19 44.63 49.10 27.34 43.63 -13.35 -7.01 -16.89 -13.59 -7.26 -14.81 coo 47.58 17.35 41.83 51.40 20.85 40.83 -2.49 -8.60 -10.03 0.77 -12.84 -8.24 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 A 163 TYR B 217 TYR.? 13.94 CL CL B 278 A 236 ASP B 250 ASP~? 16.15 CL CL B 278 A 261 LYS B 211 LYS~? 15.02 CL CL B 278 coo 55.48 26.51 40.65 55.39 23.99 39.43 -12.06 -0.05 -19.78 -9.32 0.42 -19.98 coo 48.87 29.19 44.63 49.10 27.34 43.63 -13.35 -7.01 -16.89 -13.59 -7.26 -14.81 coo 47.58 17.35 41.83 51.40 20.85 40.83 -4.12 -5.20 -9.45 -3.45 -5.07 -3.77 1qgn_c08 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 4 hits 1qgn_c08 naa= 3 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 163 TYR A 217 TYR.? 13.45 CL CL A 278 B 236 ASP A 250 ASP~? 15.45 CL CL A 278 B 261 LYS A 211 LYS~? 14.92 CL CL A 278 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 22.77 -37.42 -9.36 23.40 -34.73 -9.58 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 15.24 -38.09 -11.21 14.62 -38.47 -13.19 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 17.07 -30.19 -20.07 15.73 -30.42 -25.42 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 163 TYR B 26 TYR~? 19.09 CL CL B 278 B 236 ASP B 268 ASP.? 26.26 CL CL B 278 B 261 LYS B 53 LYS~? 32.92 CL CL B 278 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -9.51 -16.67 -28.98 -9.06 -13.93 -28.84 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -14.31 -16.11 -36.83 -14.03 -14.11 -36.24 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -3.36 -23.95 -38.76 0.61 -28.64 -40.43 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 163 TYR B 215 TYR.? 14.28 CL CL B 278 B 236 ASP B 250 ASP~? 16.15 CL CL B 278 B 261 LYS B 210 LYS~? 12.46 CL CL B 278 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -10.18 -0.68 -14.85 -11.32 1.86 -14.73 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -13.35 -7.01 -16.89 -13.59 -7.26 -14.81 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -2.49 -8.60 -10.03 0.77 -12.84 -8.24 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 B 163 TYR B 217 TYR.? 13.94 CL CL B 278 B 236 ASP B 250 ASP~? 16.15 CL CL B 278 B 261 LYS B 211 LYS~? 15.02 CL CL B 278 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -12.06 -0.05 -19.78 -9.32 0.42 -19.98 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -13.35 -7.01 -16.89 -13.59 -7.26 -14.81 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -4.12 -5.20 -9.45 -3.45 -5.07 -3.77 1qgn_c09 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 4 hits 1qgn_c09 naa= 3 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 C 163 TYR A 217 TYR.? 13.45 CL CL A 278 C 236 ASP A 250 ASP~? 15.45 CL CL A 278 C 261 LYS A 211 LYS~? 14.92 CL CL A 278 coo 39.51 34.34 13.63 37.63 32.61 14.79 22.77 -37.42 -9.36 23.40 -34.73 -9.58 coo 45.78 31.11 9.51 44.25 30.06 10.53 15.24 -38.09 -11.21 14.62 -38.47 -13.19 coo 37.54 22.37 12.10 37.83 27.55 13.24 17.07 -30.19 -20.07 15.73 -30.42 -25.42 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 C 163 TYR B 26 TYR~? 19.09 CL CL B 278 C 236 ASP B 268 ASP.? 26.26 CL CL B 278 C 261 LYS B 53 LYS~? 32.92 CL CL B 278 coo 39.51 34.34 13.63 37.63 32.61 14.79 -9.51 -16.67 -28.98 -9.06 -13.93 -28.84 coo 45.78 31.11 9.51 44.25 30.06 10.53 -14.31 -16.11 -36.83 -14.03 -14.11 -36.24 coo 37.54 22.37 12.10 37.83 27.55 13.24 -3.36 -23.95 -38.76 0.61 -28.64 -40.43 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 C 163 TYR B 215 TYR.? 14.28 CL CL B 278 C 236 ASP B 250 ASP~? 16.15 CL CL B 278 C 261 LYS B 210 LYS~? 12.46 CL CL B 278 coo 39.51 34.34 13.63 37.63 32.61 14.79 -10.18 -0.68 -14.85 -11.32 1.86 -14.73 coo 45.78 31.11 9.51 44.25 30.06 10.53 -13.35 -7.01 -16.89 -13.59 -7.26 -14.81 coo 37.54 22.37 12.10 37.83 27.55 13.24 -2.49 -8.60 -10.03 0.77 -12.84 -8.24 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 C 163 TYR B 217 TYR.? 13.94 CL CL B 278 C 236 ASP B 250 ASP~? 16.15 CL CL B 278 C 261 LYS B 211 LYS~? 15.02 CL CL B 278 coo 39.51 34.34 13.63 37.63 32.61 14.79 -12.06 -0.05 -19.78 -9.32 0.42 -19.98 coo 45.78 31.11 9.51 44.25 30.06 10.53 -13.35 -7.01 -16.89 -13.59 -7.26 -14.81 coo 37.54 22.37 12.10 37.83 27.55 13.24 -4.12 -5.20 -9.45 -3.45 -5.07 -3.77 1qgn_c10 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 4 hits 1qgn_c10 naa= 3 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 D 163 TYR A 217 TYR.? 13.45 CL CL A 278 D 236 ASP A 250 ASP~? 15.45 CL CL A 278 D 261 LYS A 211 LYS~? 14.92 CL CL A 278 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 22.77 -37.42 -9.36 23.40 -34.73 -9.58 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 15.24 -38.09 -11.21 14.62 -38.47 -13.19 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 17.07 -30.19 -20.07 15.73 -30.42 -25.42 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 D 163 TYR B 26 TYR~? 19.09 CL CL B 278 D 236 ASP B 268 ASP.? 26.26 CL CL B 278 D 261 LYS B 53 LYS~? 32.92 CL CL B 278 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -9.51 -16.67 -28.98 -9.06 -13.93 -28.84 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -14.31 -16.11 -36.83 -14.03 -14.11 -36.24 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -3.36 -23.95 -38.76 0.61 -28.64 -40.43 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 D 163 TYR B 215 TYR.? 14.28 CL CL B 278 D 236 ASP B 250 ASP~? 16.15 CL CL B 278 D 261 LYS B 210 LYS~? 12.46 CL CL B 278 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -10.18 -0.68 -14.85 -11.32 1.86 -14.73 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -13.35 -7.01 -16.89 -13.59 -7.26 -14.81 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -2.49 -8.60 -10.03 0.77 -12.84 -8.24 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 D 163 TYR B 217 TYR.? 13.94 CL CL B 278 D 236 ASP B 250 ASP~? 16.15 CL CL B 278 D 261 LYS B 211 LYS~? 15.02 CL CL B 278 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -12.06 -0.05 -19.78 -9.32 0.42 -19.98 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -13.35 -7.01 -16.89 -13.59 -7.26 -14.81 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -4.12 -5.20 -9.45 -3.45 -5.07 -3.77 1qgn_c11 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 4 hits 1qgn_c11 naa= 3 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 163 TYR B 26 TYR~? 19.09 CL CL B 278 E 236 ASP B 268 ASP.? 26.26 CL CL B 278 E 261 LYS B 53 LYS~? 32.92 CL CL B 278 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -9.51 -16.67 -28.98 -9.06 -13.93 -28.84 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -14.31 -16.11 -36.83 -14.03 -14.11 -36.24 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -3.36 -23.95 -38.76 0.61 -28.64 -40.43 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 E 163 TYR B 215 TYR.? 14.28 CL CL B 278 E 236 ASP B 250 ASP~? 16.15 CL CL B 278 E 261 LYS B 210 LYS~? 12.46 CL CL B 278 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -10.18 -0.68 -14.85 -11.32 1.86 -14.73 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -13.35 -7.01 -16.89 -13.59 -7.26 -14.81 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -2.49 -8.60 -10.03 0.77 -12.84 -8.24 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 E 163 TYR B 217 TYR.? 13.94 CL CL B 278 E 236 ASP B 250 ASP~? 16.15 CL CL B 278 E 261 LYS B 211 LYS~? 15.02 CL CL B 278 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -12.06 -0.05 -19.78 -9.32 0.42 -19.98 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -13.35 -7.01 -16.89 -13.59 -7.26 -14.81 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -4.12 -5.20 -9.45 -3.45 -5.07 -3.77 1qgn_c12 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1qgn_c12 naa= 3 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 163 TYR B 26 TYR~? 19.09 CL CL B 278 F 236 ASP B 268 ASP.? 26.26 CL CL B 278 F 261 LYS B 53 LYS~? 32.92 CL CL B 278 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -9.51 -16.67 -28.98 -9.06 -13.93 -28.84 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -14.31 -16.11 -36.83 -14.03 -14.11 -36.24 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -3.36 -23.95 -38.76 0.61 -28.64 -40.43 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 163 TYR B 215 TYR.? 14.28 CL CL B 278 F 236 ASP B 250 ASP~? 16.15 CL CL B 278 F 261 LYS B 210 LYS~? 12.46 CL CL B 278 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -10.18 -0.68 -14.85 -11.32 1.86 -14.73 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -13.35 -7.01 -16.89 -13.59 -7.26 -14.81 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -2.49 -8.60 -10.03 0.77 -12.84 -8.24 1qgn_c13 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c13 naa= 3 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 G 163 TYR A 217 TYR.? 13.45 CL CL A 278 G 236 ASP A 250 ASP~? 15.45 CL CL A 278 G 261 LYS A 211 LYS~? 14.92 CL CL A 278 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 22.77 -37.42 -9.36 23.40 -34.73 -9.58 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 15.24 -38.09 -11.21 14.62 -38.47 -13.19 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 17.07 -30.19 -20.07 15.73 -30.42 -25.42 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 G 163 TYR B 26 TYR~? 19.09 CL CL B 278 G 236 ASP B 268 ASP.? 26.26 CL CL B 278 G 261 LYS B 53 LYS~? 32.92 CL CL B 278 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -9.51 -16.67 -28.98 -9.06 -13.93 -28.84 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -14.31 -16.11 -36.83 -14.03 -14.11 -36.24 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -3.36 -23.95 -38.76 0.61 -28.64 -40.43 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 G 163 TYR B 215 TYR.? 14.28 CL CL B 278 G 236 ASP B 250 ASP~? 16.15 CL CL B 278 G 261 LYS B 210 LYS~? 12.46 CL CL B 278 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -10.18 -0.68 -14.85 -11.32 1.86 -14.73 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -13.35 -7.01 -16.89 -13.59 -7.26 -14.81 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -2.49 -8.60 -10.03 0.77 -12.84 -8.24 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 G 163 TYR B 217 TYR.? 13.94 CL CL B 278 G 236 ASP B 250 ASP~? 16.15 CL CL B 278 G 261 LYS B 211 LYS~? 15.02 CL CL B 278 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -12.06 -0.05 -19.78 -9.32 0.42 -19.98 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -13.35 -7.01 -16.89 -13.59 -7.26 -14.81 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -4.12 -5.20 -9.45 -3.45 -5.07 -3.77 1qgn_c14 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 4 hits 1qgn_c14 naa= 3 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 H 163 TYR A 217 TYR.? 13.45 CL CL A 278 H 236 ASP A 250 ASP~? 15.45 CL CL A 278 H 261 LYS A 211 LYS~? 14.92 CL CL A 278 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 22.77 -37.42 -9.36 23.40 -34.73 -9.58 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 15.24 -38.09 -11.21 14.62 -38.47 -13.19 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 17.07 -30.19 -20.07 15.73 -30.42 -25.42 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 H 163 TYR B 26 TYR~? 19.09 CL CL B 278 H 236 ASP B 268 ASP.? 26.26 CL CL B 278 H 261 LYS B 53 LYS~? 32.92 CL CL B 278 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -9.51 -16.67 -28.98 -9.06 -13.93 -28.84 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -14.31 -16.11 -36.83 -14.03 -14.11 -36.24 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -3.36 -23.95 -38.76 0.61 -28.64 -40.43 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 H 163 TYR B 215 TYR.? 14.28 CL CL B 278 H 236 ASP B 250 ASP~? 16.15 CL CL B 278 H 261 LYS B 210 LYS~? 12.46 CL CL B 278 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -10.18 -0.68 -14.85 -11.32 1.86 -14.73 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -13.35 -7.01 -16.89 -13.59 -7.26 -14.81 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -2.49 -8.60 -10.03 0.77 -12.84 -8.24 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 H 163 TYR B 217 TYR.? 13.94 CL CL B 278 H 236 ASP B 250 ASP~? 16.15 CL CL B 278 H 261 LYS B 211 LYS~? 15.02 CL CL B 278 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -12.06 -0.05 -19.78 -9.32 0.42 -19.98 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -13.35 -7.01 -16.89 -13.59 -7.26 -14.81 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -4.12 -5.20 -9.45 -3.45 -5.07 -3.77 1qgn_c15 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 4 hits 1qgn_c15 naa= 3 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 110 ARG B 209 ARG~? 8.42 CL CL B 278 C 163 TYR A 40 TYR~? 11.37 CL CL A 278 C 236 ASP A 36 ASP~? 8.69 CL CL A 278 coo 39.01 29.77 22.02 37.48 31.30 19.84 2.92 -11.07 -10.38 5.18 -10.70 -12.48 coo 39.51 34.34 13.63 37.63 32.61 14.79 8.64 -16.83 -9.73 10.24 -18.83 -10.81 coo 45.78 31.11 9.51 44.25 30.06 10.53 11.67 -20.98 -6.16 13.43 -22.16 -5.96 1qgn_c16 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c16 naa= 3 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 110 ARG B 209 ARG~? 8.42 CL CL B 278 D 163 TYR A 40 TYR~? 11.37 CL CL A 278 D 236 ASP A 36 ASP~? 8.69 CL CL A 278 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 2.92 -11.07 -10.38 5.18 -10.70 -12.48 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 8.64 -16.83 -9.73 10.24 -18.83 -10.81 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 11.67 -20.98 -6.16 13.43 -22.16 -5.96 1qgn_c17 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c17 naa= 3 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 163 TYR A 40 TYR~? 11.37 CL CL A 278 A 236 ASP A 36 ASP~? 8.69 CL CL A 278 C 110 ARG B 209 ARG~? 8.42 CL CL B 278 coo 55.48 26.51 40.65 55.39 23.99 39.43 8.64 -16.83 -9.73 10.24 -18.83 -10.81 coo 48.87 29.19 44.63 49.10 27.34 43.63 11.67 -20.98 -6.16 13.43 -22.16 -5.96 coo 52.39 23.42 32.10 54.51 23.27 34.29 2.92 -11.07 -10.38 5.18 -10.70 -12.48 1qgn_c18 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c18 naa= 3 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 163 TYR A 40 TYR~? 11.37 CL CL A 278 B 236 ASP A 36 ASP~? 8.69 CL CL A 278 D 110 ARG B 209 ARG~? 8.42 CL CL B 278 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 8.64 -16.83 -9.73 10.24 -18.83 -10.81 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 11.67 -20.98 -6.16 13.43 -22.16 -5.96 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 2.92 -11.07 -10.38 5.18 -10.70 -12.48 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 163 TYR B 40 TYR~? 11.18 CL CL B 278 B 236 ASP B 36 ASP~? 8.83 CL CL B 278 D 110 ARG A 209 ARG~? 8.75 CL CL A 278 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 6.88 -16.14 -20.02 5.01 -14.26 -19.13 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 2.64 -13.17 -23.36 1.59 -11.35 -23.67 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 12.19 -22.36 -19.55 12.55 -20.19 -17.38 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 163 TYR B 40 TYR~? 11.18 CL CL B 278 B 236 ASP B 36 ASP~? 8.83 CL CL B 278 D 110 ARG B 209 ARG~? 8.42 CL CL B 278 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 6.88 -16.14 -20.02 5.01 -14.26 -19.13 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 2.64 -13.17 -23.36 1.59 -11.35 -23.67 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 2.92 -11.07 -10.38 5.18 -10.70 -12.48 1qgn_c19 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1qgn_c19 naa= 3 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 110 ARG B 209 ARG~? 8.42 CL CL B 278 G 163 TYR A 40 TYR~? 11.37 CL CL A 278 G 236 ASP A 36 ASP~? 8.69 CL CL A 278 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 2.92 -11.07 -10.38 5.18 -10.70 -12.48 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 8.64 -16.83 -9.73 10.24 -18.83 -10.81 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 11.67 -20.98 -6.16 13.43 -22.16 -5.96 1qgn_c20 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c20 naa= 3 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 110 ARG A 209 ARG~? 8.75 CL CL A 278 H 163 TYR B 40 TYR~? 11.18 CL CL B 278 H 236 ASP B 36 ASP~? 8.83 CL CL B 278 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 12.19 -22.36 -19.55 12.55 -20.19 -17.38 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 6.88 -16.14 -20.02 5.01 -14.26 -19.13 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 2.64 -13.17 -23.36 1.59 -11.35 -23.67 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 110 ARG B 209 ARG~? 8.42 CL CL B 278 H 163 TYR A 40 TYR~? 11.37 CL CL A 278 H 236 ASP A 36 ASP~? 8.69 CL CL A 278 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 2.92 -11.07 -10.38 5.18 -10.70 -12.48 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 8.64 -16.83 -9.73 10.24 -18.83 -10.81 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 11.67 -20.98 -6.16 13.43 -22.16 -5.96 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 F 110 ARG B 209 ARG~? 8.42 CL CL B 278 H 163 TYR B 40 TYR~? 11.18 CL CL B 278 H 236 ASP B 36 ASP~? 8.83 CL CL B 278 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 2.92 -11.07 -10.38 5.18 -10.70 -12.48 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 6.88 -16.14 -20.02 5.01 -14.26 -19.13 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 2.64 -13.17 -23.36 1.59 -11.35 -23.67 1qgn_c21 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1qgn_c21 naa= 3 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 163 TYR A 40 TYR~? 11.37 CL CL A 278 E 236 ASP A 36 ASP~? 8.69 CL CL A 278 G 110 ARG B 209 ARG~? 8.42 CL CL B 278 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 8.64 -16.83 -9.73 10.24 -18.83 -10.81 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 11.67 -20.98 -6.16 13.43 -22.16 -5.96 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 2.92 -11.07 -10.38 5.18 -10.70 -12.48 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 E 163 TYR B 40 TYR~? 11.18 CL CL B 278 E 236 ASP B 36 ASP~? 8.83 CL CL B 278 G 110 ARG A 209 ARG~? 8.75 CL CL A 278 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 6.88 -16.14 -20.02 5.01 -14.26 -19.13 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 2.64 -13.17 -23.36 1.59 -11.35 -23.67 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 12.19 -22.36 -19.55 12.55 -20.19 -17.38 1qgn_c22 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c22 naa= 3 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 163 TYR A 40 TYR~? 11.37 CL CL A 278 F 236 ASP A 36 ASP~? 8.69 CL CL A 278 H 110 ARG B 209 ARG~? 8.42 CL CL B 278 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 8.64 -16.83 -9.73 10.24 -18.83 -10.81 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 11.67 -20.98 -6.16 13.43 -22.16 -5.96 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 2.92 -11.07 -10.38 5.18 -10.70 -12.48 1qgn_c23 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c23 naa= 3 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 1 3 # 1 A 49 ASP A 13 ASP~? 20.85 CL CL A 278 A 147 THR A 16 THR~? 23.56 CL CL A 278 A 294 ASP A 275 ASP.? 34.16 CL CL A 278 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 3.80 -37.83 -7.42 4.89 -38.66 -9.05 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 4.16 -38.93 -1.16 3.39 -36.96 -0.84 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 -7.58 -36.49 2.30 -8.60 -35.44 3.90 1qgx_c02 source 1qgx 3',5'-ADENOSINE BISPHOSPHATASE : 1 hits 1qgx_c02 naa= 3 ULMN 3 1qho_c04 ALPHA-AMYLASE user 1 3 # 1 A 228 ASP B 224 ASP~? 22.83 CL CL B 278 A 256 GLU B 221 GLU~? 17.56 CL CL B 278 A 329 ASP B 168 ASP^? 12.80 CL CL B 278 coo 28.46 69.88 26.74 30.40 70.70 26.53 -13.88 7.87 -23.86 -15.40 8.87 -22.81 coo 30.54 71.65 32.58 31.73 72.26 30.92 -13.90 4.76 -18.50 -13.25 3.58 -16.87 coo 37.87 70.12 31.80 36.61 69.74 30.15 -5.42 2.81 -22.11 -6.82 3.76 -20.83 1qho_c04 source 1qho ALPHA-AMYLASE : 1 hits 1qho_c04 naa= 3 ULMN 3 1qho_c07 ALPHA-AMYLASE user 1 3 # 1 A 228 ASP A 224 ASP~? 22.21 CL CL A 278 A 260 ASP A 250 ASP~? 15.45 CL CL A 278 A 329 ASP A 168 ASP^? 12.27 CL CL A 278 coo 28.46 69.88 26.74 30.40 70.70 26.53 30.83 -39.35 -6.18 31.71 -41.01 -7.15 coo 30.73 81.29 37.61 31.23 82.07 35.69 15.24 -38.09 -11.21 14.62 -38.47 -13.19 coo 37.87 70.12 31.80 36.61 69.74 30.15 26.46 -30.73 -8.22 26.92 -32.42 -9.39 ULMN 3 1qho_c07 ALPHA-AMYLASE user 2 3 # 2 A 228 ASP B 224 ASP~? 22.83 CL CL B 278 A 260 ASP B 250 ASP~? 16.15 CL CL B 278 A 329 ASP B 168 ASP^? 12.80 CL CL B 278 coo 28.46 69.88 26.74 30.40 70.70 26.53 -13.88 7.87 -23.86 -15.40 8.87 -22.81 coo 30.73 81.29 37.61 31.23 82.07 35.69 -13.35 -7.01 -16.89 -13.59 -7.26 -14.81 coo 37.87 70.12 31.80 36.61 69.74 30.15 -5.42 2.81 -22.11 -6.82 3.76 -20.83 1qho_c07 source 1qho ALPHA-AMYLASE : 2 hits 1qho_c07 naa= 3 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 A 51 ALA A 252 ALA~? 17.52 CL CL A 278 A 148 HIS A 12 HIS~? 14.78 CL CL A 278 A 163 ASP A 13 ASP~? 20.85 CL CL A 278 coo 1.42 19.18 21.84 1.11 19.57 23.28 12.87 -37.24 -4.82 11.40 -37.55 -4.97 coo 0.71 19.67 27.92 2.43 19.16 26.83 9.03 -33.35 -4.93 10.37 -31.88 -5.56 coo 7.15 16.22 27.50 6.15 18.00 27.94 3.80 -37.83 -7.42 4.89 -38.66 -9.05 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 A 51 ALA B 252 ALA~? 18.17 CL CL B 278 A 148 HIS B 12 HIS~? 15.42 CL CL B 278 A 163 ASP B 13 ASP~? 21.13 CL CL B 278 coo 1.42 19.18 21.84 1.11 19.57 23.28 -13.56 -10.31 -23.05 -13.89 -11.76 -22.86 coo 0.71 19.67 27.92 2.43 19.16 26.83 -10.18 -14.51 -22.80 -8.49 -13.29 -22.60 coo 7.15 16.22 27.50 6.15 18.00 27.94 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 1qol_c00 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 2 hits 1qol_c00 naa= 3 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 B 51 ALA A 252 ALA~? 17.52 CL CL A 278 B 148 HIS A 12 HIS~? 14.78 CL CL A 278 B 163 ASP A 13 ASP~? 20.85 CL CL A 278 coo -33.97 19.78 54.18 -33.40 20.11 52.82 12.87 -37.24 -4.82 11.40 -37.55 -4.97 coo -33.17 20.01 48.16 -34.95 19.37 49.06 9.03 -33.35 -4.93 10.37 -31.88 -5.56 coo -39.82 16.62 48.85 -38.59 18.24 48.48 3.80 -37.83 -7.42 4.89 -38.66 -9.05 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 B 51 ALA B 252 ALA~? 18.17 CL CL B 278 B 148 HIS B 12 HIS~? 15.42 CL CL B 278 B 163 ASP B 13 ASP~? 21.13 CL CL B 278 coo -33.97 19.78 54.18 -33.40 20.11 52.82 -13.56 -10.31 -23.05 -13.89 -11.76 -22.86 coo -33.17 20.01 48.16 -34.95 19.37 49.06 -10.18 -14.51 -22.80 -8.49 -13.29 -22.60 coo -39.82 16.62 48.85 -38.59 18.24 48.48 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 1qol_c01 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 2 hits 1qol_c01 naa= 3 ULMN 3 1qol_c02 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 C 51 ALA A 252 ALA~? 17.52 CL CL A 278 C 148 HIS A 12 HIS~? 14.78 CL CL A 278 C 163 ASP A 13 ASP~? 20.85 CL CL A 278 coo -26.36 -19.12 21.15 -25.71 -19.49 22.47 12.87 -37.24 -4.82 11.40 -37.55 -4.97 coo -25.01 -20.21 26.78 -26.91 -20.55 25.93 9.03 -33.35 -4.93 10.37 -31.88 -5.56 coo -32.17 -20.34 27.36 -30.15 -20.93 27.54 3.80 -37.83 -7.42 4.89 -38.66 -9.05 ULMN 3 1qol_c02 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 C 51 ALA B 252 ALA~? 18.17 CL CL B 278 C 148 HIS B 12 HIS~? 15.42 CL CL B 278 C 163 ASP B 13 ASP~? 21.13 CL CL B 278 coo -26.36 -19.12 21.15 -25.71 -19.49 22.47 -13.56 -10.31 -23.05 -13.89 -11.76 -22.86 coo -25.01 -20.21 26.78 -26.91 -20.55 25.93 -10.18 -14.51 -22.80 -8.49 -13.29 -22.60 coo -32.17 -20.34 27.36 -30.15 -20.93 27.54 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 1qol_c02 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 2 hits 1qol_c02 naa= 3 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 D 51 ALA A 252 ALA~? 17.52 CL CL A 278 D 148 HIS A 12 HIS~? 14.78 CL CL A 278 D 163 ASP A 13 ASP~? 20.85 CL CL A 278 coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 12.87 -37.24 -4.82 11.40 -37.55 -4.97 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 9.03 -33.35 -4.93 10.37 -31.88 -5.56 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 3.80 -37.83 -7.42 4.89 -38.66 -9.05 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 D 51 ALA B 252 ALA~? 18.17 CL CL B 278 D 148 HIS B 12 HIS~? 15.42 CL CL B 278 D 163 ASP B 13 ASP~? 21.13 CL CL B 278 coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 -13.56 -10.31 -23.05 -13.89 -11.76 -22.86 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 -10.18 -14.51 -22.80 -8.49 -13.29 -22.60 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 1qol_c03 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 2 hits 1qol_c03 naa= 3 ULMN 3 1qol_c04 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 E 51 ALA A 252 ALA~? 17.52 CL CL A 278 E 148 HIS A 12 HIS~? 14.78 CL CL A 278 E 163 ASP A 13 ASP~? 20.85 CL CL A 278 coo 5.48 -16.06 -47.92 6.03 -15.45 -46.65 12.87 -37.24 -4.82 11.40 -37.55 -4.97 coo 5.81 -16.05 -42.05 5.54 -17.84 -43.11 9.03 -33.35 -4.93 10.37 -31.88 -5.56 coo 2.75 -22.21 -43.08 4.67 -21.31 -42.96 3.80 -37.83 -7.42 4.89 -38.66 -9.05 ULMN 3 1qol_c04 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 E 51 ALA B 252 ALA~? 18.17 CL CL B 278 E 148 HIS B 12 HIS~? 15.42 CL CL B 278 E 163 ASP B 13 ASP~? 21.13 CL CL B 278 coo 5.48 -16.06 -47.92 6.03 -15.45 -46.65 -13.56 -10.31 -23.05 -13.89 -11.76 -22.86 coo 5.81 -16.05 -42.05 5.54 -17.84 -43.11 -10.18 -14.51 -22.80 -8.49 -13.29 -22.60 coo 2.75 -22.21 -43.08 4.67 -21.31 -42.96 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 1qol_c04 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 2 hits 1qol_c04 naa= 3 ULMN 3 1qol_c05 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 F 51 ALA A 252 ALA~? 17.52 CL CL A 278 F 148 HIS A 12 HIS~? 14.78 CL CL A 278 F 163 ASP A 13 ASP~? 20.85 CL CL A 278 coo 5.33 15.59 -14.28 5.80 15.15 -15.64 12.87 -37.24 -4.82 11.40 -37.55 -4.97 coo 5.79 15.50 -20.13 5.50 17.28 -19.05 9.03 -33.35 -4.93 10.37 -31.88 -5.56 coo 2.42 22.00 -18.97 4.23 20.92 -19.18 3.80 -37.83 -7.42 4.89 -38.66 -9.05 ULMN 3 1qol_c05 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 F 51 ALA B 252 ALA~? 18.17 CL CL B 278 F 148 HIS B 12 HIS~? 15.42 CL CL B 278 F 163 ASP B 13 ASP~? 21.13 CL CL B 278 coo 5.33 15.59 -14.28 5.80 15.15 -15.64 -13.56 -10.31 -23.05 -13.89 -11.76 -22.86 coo 5.79 15.50 -20.13 5.50 17.28 -19.05 -10.18 -14.51 -22.80 -8.49 -13.29 -22.60 coo 2.42 22.00 -18.97 4.23 20.92 -19.18 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 1qol_c05 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 2 hits 1qol_c05 naa= 3 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 G 51 ALA A 252 ALA~? 17.52 CL CL A 278 G 148 HIS A 12 HIS~? 14.78 CL CL A 278 G 163 ASP A 13 ASP~? 20.85 CL CL A 278 coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 12.87 -37.24 -4.82 11.40 -37.55 -4.97 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 9.03 -33.35 -4.93 10.37 -31.88 -5.56 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 3.80 -37.83 -7.42 4.89 -38.66 -9.05 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 G 51 ALA B 252 ALA~? 18.17 CL CL B 278 G 148 HIS B 12 HIS~? 15.42 CL CL B 278 G 163 ASP B 13 ASP~? 21.13 CL CL B 278 coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 -13.56 -10.31 -23.05 -13.89 -11.76 -22.86 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 -10.18 -14.51 -22.80 -8.49 -13.29 -22.60 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 1qol_c06 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 2 hits 1qol_c06 naa= 3 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 H 51 ALA A 252 ALA~? 17.52 CL CL A 278 H 148 HIS A 12 HIS~? 14.78 CL CL A 278 H 163 ASP A 13 ASP~? 20.85 CL CL A 278 coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 12.87 -37.24 -4.82 11.40 -37.55 -4.97 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 9.03 -33.35 -4.93 10.37 -31.88 -5.56 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 3.80 -37.83 -7.42 4.89 -38.66 -9.05 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 H 51 ALA B 252 ALA~? 18.17 CL CL B 278 H 148 HIS B 12 HIS~? 15.42 CL CL B 278 H 163 ASP B 13 ASP~? 21.13 CL CL B 278 coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 -13.56 -10.31 -23.05 -13.89 -11.76 -22.86 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 -10.18 -14.51 -22.80 -8.49 -13.29 -22.60 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 1qol_c07 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 2 hits 1qol_c07 naa= 3 ULMN 3 1qrr_c01 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 1 3 # 1 A 145 THR A 37 THR~? 16.54 CL CL A 278 A 182 TYR A 39 TYR~? 9.76 CL CL A 278 A 186 LYS A 64 LYS^? 6.64 CL CL A 278 coo 69.38 87.38 24.64 71.11 88.47 25.40 7.80 -18.70 -4.30 6.04 -19.24 -3.16 coo 73.61 90.42 31.12 71.36 89.66 29.64 13.19 -16.19 -7.99 14.85 -15.73 -10.18 coo 73.54 84.00 28.64 69.01 86.68 29.71 14.97 -18.21 -2.39 15.88 -19.33 -8.52 ULMN 3 1qrr_c01 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 2 3 # 2 A 145 THR B 37 THR~? 16.55 CL CL B 278 A 182 TYR B 39 TYR~? 9.53 CL CL B 278 A 186 LYS B 64 LYS^? 6.39 CL CL B 278 coo 69.38 87.38 24.64 71.11 88.47 25.40 4.16 -17.50 -24.96 3.23 -19.26 -25.80 coo 73.61 90.42 31.12 71.36 89.66 29.64 7.70 -12.06 -22.38 8.73 -10.22 -20.60 coo 73.54 84.00 28.64 69.01 86.68 29.71 5.21 -10.68 -27.95 4.80 -8.81 -21.96 1qrr_c01 source 1qrr SULFOLIPID BIOSYNTHESIS (SQD1) PROTEIN : 2 hits 1qrr_c01 naa= 3 ULMN 3 1qrz_c12 PLASMINOGEN user 1 3 # 1 A 603 HIS A 12 HIS~? 14.78 CL CL A 278 A 646 ASP A 13 ASP~? 20.85 CL CL A 278 A 741 SER A 8 SER.? 12.69 CL CL A 278 coo -20.72 2.99 34.37 -21.94 1.82 35.61 9.03 -33.35 -4.93 10.37 -31.88 -5.56 coo -18.83 7.68 26.86 -20.89 7.78 26.56 3.80 -37.83 -7.42 4.89 -38.66 -9.05 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 8.88 -27.17 -3.98 8.36 -25.65 -5.80 ULMN 3 1qrz_c12 PLASMINOGEN user 2 3 # 2 A 603 HIS B 12 HIS~? 15.42 CL CL B 278 A 646 ASP B 13 ASP~? 21.13 CL CL B 278 A 741 SER B 8 SER.? 14.26 CL CL B 278 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -10.18 -14.51 -22.80 -8.49 -13.29 -22.60 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 -4.13 -15.22 -24.13 -4.29 -16.76 -22.25 1qrz_c12 source 1qrz PLASMINOGEN : 2 hits 1qrz_c12 naa= 3 ULMN 3 1qrz_c13 PLASMINOGEN user 1 3 # 1 B 603 HIS A 12 HIS~? 14.78 CL CL A 278 B 646 ASP A 13 ASP~? 20.85 CL CL A 278 B 741 SER A 8 SER.? 12.69 CL CL A 278 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 9.03 -33.35 -4.93 10.37 -31.88 -5.56 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 3.80 -37.83 -7.42 4.89 -38.66 -9.05 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 8.88 -27.17 -3.98 8.36 -25.65 -5.80 ULMN 3 1qrz_c13 PLASMINOGEN user 2 3 # 2 B 603 HIS B 12 HIS~? 15.42 CL CL B 278 B 646 ASP B 13 ASP~? 21.13 CL CL B 278 B 741 SER B 8 SER.? 14.26 CL CL B 278 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -10.18 -14.51 -22.80 -8.49 -13.29 -22.60 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 -4.13 -15.22 -24.13 -4.29 -16.76 -22.25 1qrz_c13 source 1qrz PLASMINOGEN : 2 hits 1qrz_c13 naa= 3 ULMN 3 1qrz_c14 PLASMINOGEN user 1 3 # 1 C 603 HIS A 12 HIS~? 14.78 CL CL A 278 C 646 ASP A 13 ASP~? 20.85 CL CL A 278 C 741 SER A 8 SER.? 12.69 CL CL A 278 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 9.03 -33.35 -4.93 10.37 -31.88 -5.56 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 3.80 -37.83 -7.42 4.89 -38.66 -9.05 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 8.88 -27.17 -3.98 8.36 -25.65 -5.80 ULMN 3 1qrz_c14 PLASMINOGEN user 2 3 # 2 C 603 HIS B 12 HIS~? 15.42 CL CL B 278 C 646 ASP B 13 ASP~? 21.13 CL CL B 278 C 741 SER B 8 SER.? 14.26 CL CL B 278 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -10.18 -14.51 -22.80 -8.49 -13.29 -22.60 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 -4.13 -15.22 -24.13 -4.29 -16.76 -22.25 1qrz_c14 source 1qrz PLASMINOGEN : 2 hits 1qrz_c14 naa= 3 ULMN 3 1qrz_c15 PLASMINOGEN user 1 3 # 1 D 603 HIS A 12 HIS~? 14.78 CL CL A 278 D 646 ASP A 13 ASP~? 20.85 CL CL A 278 D 741 SER A 8 SER.? 12.69 CL CL A 278 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 9.03 -33.35 -4.93 10.37 -31.88 -5.56 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 3.80 -37.83 -7.42 4.89 -38.66 -9.05 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 8.88 -27.17 -3.98 8.36 -25.65 -5.80 ULMN 3 1qrz_c15 PLASMINOGEN user 2 3 # 2 D 603 HIS B 12 HIS~? 15.42 CL CL B 278 D 646 ASP B 13 ASP~? 21.13 CL CL B 278 D 741 SER B 8 SER.? 14.26 CL CL B 278 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -10.18 -14.51 -22.80 -8.49 -13.29 -22.60 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 -4.13 -15.22 -24.13 -4.29 -16.76 -22.25 1qrz_c15 source 1qrz PLASMINOGEN : 2 hits 1qrz_c15 naa= 3 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 1 3 # 1 A 10 ASP A 168 ASP^? 12.27 CL CL A 278 A 186 ASN A 244 ASN.? 5.40 CL CL A 278 A 260 ALA A 255 ALA~? 16.66 CL CL A 278 coo 11.81 33.10 11.71 13.07 31.45 11.40 26.46 -30.73 -8.22 26.92 -32.42 -9.39 coo 11.43 26.53 7.41 13.01 27.56 8.43 17.85 -28.42 -8.05 16.64 -26.87 -8.84 coo 21.53 26.33 6.96 20.26 25.69 7.52 17.52 -37.58 -2.40 16.49 -36.47 -2.16 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 2 3 # 2 A 10 ASP A 168 ASP^? 12.27 CL CL A 278 A 186 ASN A 245 ASN.? 11.79 CL CL A 278 A 260 ALA A 255 ALA~? 16.66 CL CL A 278 coo 11.81 33.10 11.71 13.07 31.45 11.40 26.46 -30.73 -8.22 26.92 -32.42 -9.39 coo 11.43 26.53 7.41 13.01 27.56 8.43 18.48 -33.48 -10.76 18.30 -34.93 -9.15 coo 21.53 26.33 6.96 20.26 25.69 7.52 17.52 -37.58 -2.40 16.49 -36.47 -2.16 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 3 3 # 3 A 10 ASP A 267 ASP.? 31.09 CL CL A 278 A 186 ASN A 58 ASN.? 28.29 CL CL A 278 A 260 ALA A 27 ALA~? 23.88 CL CL A 278 coo 11.81 33.10 11.71 13.07 31.45 11.40 11.77 -37.21 15.47 13.23 -35.63 15.60 coo 11.43 26.53 7.41 13.01 27.56 8.43 13.69 -30.36 14.12 12.82 -32.29 13.72 coo 21.53 26.33 6.96 20.26 25.69 7.52 7.18 -32.62 5.90 6.84 -31.31 6.60 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 4 3 # 4 A 10 ASP A 267 ASP.? 31.09 CL CL A 278 A 186 ASN A 270 ASN.? 33.57 CL CL A 278 A 260 ALA A 27 ALA~? 23.88 CL CL A 278 coo 11.81 33.10 11.71 13.07 31.45 11.40 11.77 -37.21 15.47 13.23 -35.63 15.60 coo 11.43 26.53 7.41 13.01 27.56 8.43 2.70 -38.53 12.07 1.72 -36.95 13.05 coo 21.53 26.33 6.96 20.26 25.69 7.52 7.18 -32.62 5.90 6.84 -31.31 6.60 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 5 3 # 5 A 10 ASP B 168 ASP^? 12.80 CL CL B 278 A 186 ASN B 244 ASN.? 5.94 CL CL B 278 A 260 ALA B 255 ALA~? 17.38 CL CL B 278 coo 11.81 33.10 11.71 13.07 31.45 11.40 -5.42 2.81 -22.11 -6.82 3.76 -20.83 coo 11.43 26.53 7.41 13.01 27.56 8.43 -3.88 -6.12 -21.35 -2.47 -7.43 -20.48 coo 21.53 26.33 6.96 20.26 25.69 7.52 -13.88 -5.94 -25.91 -12.91 -7.08 -26.16 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 6 3 # 6 A 10 ASP B 168 ASP^? 12.80 CL CL B 278 A 186 ASN B 245 ASN.? 12.34 CL CL B 278 A 260 ALA B 255 ALA~? 17.38 CL CL B 278 coo 11.81 33.10 11.71 13.07 31.45 11.40 -5.42 2.81 -22.11 -6.82 3.76 -20.83 coo 11.43 26.53 7.41 13.01 27.56 8.43 -8.45 -4.50 -18.19 -10.06 -4.59 -19.62 coo 21.53 26.33 6.96 20.26 25.69 7.52 -13.88 -5.94 -25.91 -12.91 -7.08 -26.16 1r4f_c00 source 1r4f IAG-NUCLEOSIDE HYDROLASE : 6 hits 1r4f_c00 naa= 3 ULMN 3 1req_c10 METHYLMALONYL-COA MUTASE user 1 3 # 1 A 608 ASP A 250 ASP~? 15.45 CL CL A 278 A 610 HIS A 216 HIS.? 18.50 CL CL A 278 A 661 HIS A 12 HIS~? 14.78 CL CL A 278 coo 75.99 81.56 1.86 73.91 81.34 2.28 15.24 -38.09 -11.21 14.62 -38.47 -13.19 coo 71.04 78.84 0.46 71.54 76.90 1.02 17.97 -41.33 -12.21 17.58 -42.84 -10.82 coo 75.40 81.38 12.06 74.88 79.42 12.63 9.03 -33.35 -4.93 10.37 -31.88 -5.56 ULMN 3 1req_c10 METHYLMALONYL-COA MUTASE user 2 3 # 2 A 608 ASP B 250 ASP~? 16.15 CL CL B 278 A 610 HIS B 216 HIS.? 19.24 CL CL B 278 A 661 HIS B 12 HIS~? 15.42 CL CL B 278 coo 75.99 81.56 1.86 73.91 81.34 2.28 -13.35 -7.01 -16.89 -13.59 -7.26 -14.81 coo 71.04 78.84 0.46 71.54 76.90 1.02 -16.22 -3.98 -15.80 -17.90 -4.46 -16.96 coo 75.40 81.38 12.06 74.88 79.42 12.63 -10.18 -14.51 -22.80 -8.49 -13.29 -22.60 1req_c10 source 1req METHYLMALONYL-COA MUTASE : 2 hits 1req_c10 naa= 3 ULMN 3 1req_c11 METHYLMALONYL-COA MUTASE user 1 3 # 1 C 608 ASP A 250 ASP~? 15.45 CL CL A 278 C 610 HIS A 216 HIS.? 18.50 CL CL A 278 C 661 HIS A 12 HIS~? 14.78 CL CL A 278 coo -17.65 80.52 58.00 -16.23 80.79 56.41 15.24 -38.09 -11.21 14.62 -38.47 -13.19 coo -16.56 83.18 53.03 -16.33 85.18 53.60 17.97 -41.33 -12.21 17.58 -42.84 -10.82 coo -8.38 80.78 62.24 -7.53 82.67 62.02 9.03 -33.35 -4.93 10.37 -31.88 -5.56 ULMN 3 1req_c11 METHYLMALONYL-COA MUTASE user 2 3 # 2 C 608 ASP B 250 ASP~? 16.15 CL CL B 278 C 610 HIS B 216 HIS.? 19.24 CL CL B 278 C 661 HIS B 12 HIS~? 15.42 CL CL B 278 coo -17.65 80.52 58.00 -16.23 80.79 56.41 -13.35 -7.01 -16.89 -13.59 -7.26 -14.81 coo -16.56 83.18 53.03 -16.33 85.18 53.60 -16.22 -3.98 -15.80 -17.90 -4.46 -16.96 coo -8.38 80.78 62.24 -7.53 82.67 62.02 -10.18 -14.51 -22.80 -8.49 -13.29 -22.60 1req_c11 source 1req METHYLMALONYL-COA MUTASE : 2 hits 1req_c11 naa= 3 ULMN 3 1rgq_c01 NS4A PEPTIDE user 1 3 # 1 B 60 HIS A 194 HIS.? 4.68 CL CL A 278 B 84 ASP A 168 ASP^? 12.27 CL CL A 278 B 140 GLY A 111 GLY.? 9.84 CL CL A 278 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 21.59 -27.03 -10.13 21.31 -25.37 -8.87 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 26.46 -30.73 -8.22 26.92 -32.42 -9.39 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 25.43 -16.70 -15.06 25.21 -15.89 -15.01 ULMN 3 1rgq_c01 NS4A PEPTIDE user 2 3 # 2 B 60 HIS B 194 HIS.? 5.13 CL CL B 278 B 84 ASP B 168 ASP^? 12.80 CL CL B 278 B 140 GLY B 111 GLY.? 9.20 CL CL B 278 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -1.92 -2.21 -20.05 -0.53 -2.75 -21.52 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -5.42 2.81 -22.11 -6.82 3.76 -20.83 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 9.34 0.80 -16.95 10.11 0.51 -17.10 1rgq_c01 source 1rgq NS4A PEPTIDE : 2 hits 1rgq_c01 naa= 3 ULMN 3 1rhc_c00 F420-DEPENDENT ALCOHOL DEHYDROGENASEuser 1 3 # 1 A 39 HIS A 128 HIS~? 28.74 CL CL A 278 A 43 TRP A 129 TRP~? 23.49 CL CL A 278 A 108 GLU A 83 GLU~? 26.70 CL CL B 278 coo 33.67 25.97 25.39 31.70 26.60 25.75 23.83 -2.68 5.16 23.03 -1.15 6.34 coo 29.43 26.12 28.46 27.08 29.25 29.01 20.10 -3.42 1.94 20.47 -4.28 -1.84 coo 29.13 31.14 24.26 29.28 29.08 24.66 17.51 1.49 1.14 18.83 0.42 2.44 ULMN 3 1rhc_c00 F420-DEPENDENT ALCOHOL DEHYDROGENASEuser 2 3 # 2 A 39 HIS B 128 HIS~? 28.44 CL CL B 278 A 43 TRP B 129 TRP~? 23.11 CL CL B 278 A 108 GLU B 83 GLU~? 26.47 CL CL A 278 coo 33.67 25.97 25.39 31.70 26.60 25.75 20.44 -4.42 -38.33 21.74 -5.60 -39.48 coo 29.43 26.12 28.46 27.08 29.25 29.01 19.76 -7.70 -34.49 19.52 -6.98 -30.65 coo 29.13 31.14 24.26 29.28 29.08 24.66 24.57 -10.93 -33.84 23.46 -9.16 -34.20 1rhc_c00 source 1rhc F420-DEPENDENT ALCOHOL DEHYDROGENASE : 2 hits 1rhc_c00 naa= 3 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 1 3 # 1 32 ASP A 268 ASP.? 26.73 CL CL A 278 35 SER A 28 SER.? 27.02 CL CL A 278 215 ASP A 267 ASP.? 31.09 CL CL A 278 coo 11.85 17.24 72.81 11.09 15.37 72.36 9.60 -34.57 10.49 9.97 -36.28 9.26 coo 12.20 12.71 75.45 13.69 13.84 74.03 6.29 -36.11 7.11 4.57 -37.31 5.85 coo 5.22 15.03 71.43 7.19 14.88 70.83 11.77 -37.21 15.47 13.23 -35.63 15.60 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 2 3 # 2 32 ASP B 268 ASP.? 26.26 CL CL B 278 35 SER B 28 SER.? 27.87 CL CL B 278 215 ASP B 267 ASP.? 32.55 CL CL B 278 coo 11.85 17.24 72.81 11.09 15.37 72.36 -14.31 -16.11 -36.83 -14.03 -14.11 -36.24 coo 12.20 12.71 75.45 13.69 13.84 74.03 -14.66 -18.25 -33.71 -14.43 -20.67 -33.62 coo 5.22 15.03 71.43 7.19 14.88 70.83 -15.25 -13.37 -42.11 -14.97 -14.80 -43.57 1rne_c04 source 1rne RENIN (ACTIVATED, GLYCOSYLATED, INHIBITED) (E.: 2 hits 1rne_c04 naa= 3 ULMN 3 1ro7_c03 ALPHA-2,3/8-SIALYLTRANSFERASE user 1 3 # 1 D 129 ARG A 140 ARG.? 3.74 CL CL A 278 D 156 TYR A 215 TYR.? 13.87 CL CL A 278 D 188 HIS A 194 HIS.? 4.68 CL CL A 278 coo -19.99 -38.81 30.91 -19.99 -39.90 28.04 24.77 -21.68 -10.23 22.52 -23.37 -11.49 coo -32.96 -44.88 30.49 -32.31 -42.65 28.92 21.62 -36.04 -14.58 23.93 -37.55 -14.90 coo -25.33 -42.26 31.79 -24.77 -40.56 30.70 21.59 -27.03 -10.13 21.31 -25.37 -8.87 ULMN 3 1ro7_c03 ALPHA-2,3/8-SIALYLTRANSFERASE user 2 3 # 2 D 129 ARG A 192 ARG^? 5.91 CL CL A 278 D 156 TYR A 215 TYR.? 13.87 CL CL A 278 D 188 HIS A 194 HIS.? 4.68 CL CL A 278 coo -19.99 -38.81 30.91 -19.99 -39.90 28.04 20.84 -24.38 -4.40 19.02 -23.24 -6.62 coo -32.96 -44.88 30.49 -32.31 -42.65 28.92 21.62 -36.04 -14.58 23.93 -37.55 -14.90 coo -25.33 -42.26 31.79 -24.77 -40.56 30.70 21.59 -27.03 -10.13 21.31 -25.37 -8.87 ULMN 3 1ro7_c03 ALPHA-2,3/8-SIALYLTRANSFERASE user 3 3 # 3 D 129 ARG B 140 ARG.? -3.53 CL CL B 278s D 156 TYR B 215 TYR.? 14.28 CL CL B 278 D 188 HIS B 194 HIS.? 5.13 CL CL B 278 coo -19.99 -38.81 30.91 -19.99 -39.90 28.04 3.71 0.22 -21.03 2.09 -1.69 -19.26 coo -32.96 -44.88 30.49 -32.31 -42.65 28.92 -10.18 -0.68 -14.85 -11.32 1.86 -14.73 coo -25.33 -42.26 31.79 -24.77 -40.56 30.70 -1.92 -2.21 -20.05 -0.53 -2.75 -21.52 ULMN 3 1ro7_c03 ALPHA-2,3/8-SIALYLTRANSFERASE user 4 3 # 4 D 129 ARG B 192 ARG^? 6.13 CL CL B 278 D 156 TYR B 215 TYR.? 14.28 CL CL B 278 D 188 HIS B 194 HIS.? 5.13 CL CL B 278 coo -19.99 -38.81 30.91 -19.99 -39.90 28.04 -0.17 -3.93 -26.09 1.00 -5.48 -23.71 coo -32.96 -44.88 30.49 -32.31 -42.65 28.92 -10.18 -0.68 -14.85 -11.32 1.86 -14.73 coo -25.33 -42.26 31.79 -24.77 -40.56 30.70 -1.92 -2.21 -20.05 -0.53 -2.75 -21.52 1ro7_c03 source 1ro7 ALPHA-2,3/8-SIALYLTRANSFERASE : 4 hits 1ro7_c03 naa= 3 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 1 3 # 1 A 137 GLU A 238 GLU^? 24.84 CL CL A 278 A 288 HIS A 29 HIS.? 25.16 CL CL A 278 A 329 LYS A 272 LYS.? 33.16 CL CL A 278 coo 29.27 18.78 14.99 27.16 18.62 14.76 22.87 -26.18 11.53 21.04 -27.14 11.99 coo 49.52 10.06 10.36 50.99 9.65 8.92 7.41 -38.44 3.20 5.56 -39.41 3.04 coo 57.80 12.92 13.83 53.77 8.42 12.15 -2.40 -40.27 7.96 -3.06 -34.63 9.73 1roz_c00 source 1roz DEOXYHYPUSINE SYNTHASE : 1 hits 1roz_c00 naa= 3 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 1 3 # 1 B 137 GLU A 238 GLU^? 24.84 CL CL A 278 B 288 HIS A 29 HIS.? 25.16 CL CL A 278 B 329 LYS A 272 LYS.? 33.16 CL CL A 278 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 22.87 -26.18 11.53 21.04 -27.14 11.99 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 7.41 -38.44 3.20 5.56 -39.41 3.04 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 -2.40 -40.27 7.96 -3.06 -34.63 9.73 1roz_c01 source 1roz DEOXYHYPUSINE SYNTHASE : 1 hits 1roz_c01 naa= 3 ULMN 3 1rtf_c03 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 1 3 # 1 B 57 HIS A 12 HIS~? 14.78 CL CL A 278 B 102 ASP A 13 ASP~? 20.85 CL CL A 278 B 195 SER A 10 SER.? 17.45 CL CL A 278 coo -4.60 27.52 42.88 -4.63 27.41 40.76 9.03 -33.35 -4.93 10.37 -31.88 -5.56 coo -0.27 31.24 43.51 -1.49 29.62 42.98 3.80 -37.83 -7.42 4.89 -38.66 -9.05 coo -2.83 25.96 36.71 -4.77 27.03 37.63 3.77 -30.46 -4.30 3.68 -28.35 -5.48 ULMN 3 1rtf_c03 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 2 3 # 2 B 57 HIS A 12 HIS~? 14.78 CL CL A 278 B 102 ASP A 13 ASP~? 20.85 CL CL A 278 B 195 SER A 21 SER.? 21.88 CL CL A 278 coo -4.60 27.52 42.88 -4.63 27.41 40.76 9.03 -33.35 -4.93 10.37 -31.88 -5.56 coo -0.27 31.24 43.51 -1.49 29.62 42.98 3.80 -37.83 -7.42 4.89 -38.66 -9.05 coo -2.83 25.96 36.71 -4.77 27.03 37.63 1.16 -33.17 -2.24 2.71 -34.86 -3.05 ULMN 3 1rtf_c03 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 3 3 # 3 B 57 HIS B 12 HIS~? 15.42 CL CL B 278 B 102 ASP B 13 ASP~? 21.13 CL CL B 278 B 195 SER B 10 SER.? 17.86 CL CL B 278 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -10.18 -14.51 -22.80 -8.49 -13.29 -22.60 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 coo -2.83 25.96 36.71 -4.77 27.03 37.63 -7.63 -19.97 -23.27 -5.38 -20.37 -22.44 ULMN 3 1rtf_c03 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 4 3 # 4 B 57 HIS B 12 HIS~? 15.42 CL CL B 278 B 102 ASP B 13 ASP~? 21.13 CL CL B 278 B 195 SER B 21 SER.? 21.23 CL CL B 278 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -10.18 -14.51 -22.80 -8.49 -13.29 -22.60 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 coo -2.83 25.96 36.71 -4.77 27.03 37.63 -10.65 -22.68 -24.42 -10.99 -20.31 -24.03 1rtf_c03 source 1rtf TWO CHAIN TISSUE PLASMINOGEN ACTIVATOR : 4 hits 1rtf_c03 naa= 3 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 1 3 # 1 B 57 HIS A 12 HIS~? 14.78 CL CL A 278 B 102 ASP A 13 ASP~? 20.85 CL CL A 278 B 193 GLY A 5 GLY^? 15.84 CL CL A 278 coo -4.60 27.52 42.88 -4.63 27.41 40.76 9.03 -33.35 -4.93 10.37 -31.88 -5.56 coo -0.27 31.24 43.51 -1.49 29.62 42.98 3.80 -37.83 -7.42 4.89 -38.66 -9.05 coo -6.81 22.81 34.74 -6.42 23.54 34.62 15.52 -31.61 0.74 16.07 -31.86 0.19 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 2 3 # 2 B 57 HIS B 12 HIS~? 15.42 CL CL B 278 B 102 ASP B 13 ASP~? 21.13 CL CL B 278 B 193 GLY B 5 GLY^? 16.39 CL CL B 278 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -10.18 -14.51 -22.80 -8.49 -13.29 -22.60 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -8.44 -9.04 -29.52 -8.55 -8.38 -29.05 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 3 3 # 3 B 57 HIS B 29 HIS.? 25.42 CL CL B 278 B 102 ASP B 268 ASP.? 26.26 CL CL B 278 B 193 GLY B 17 GLY~? 26.14 CL CL B 278 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -16.16 -16.38 -29.82 -17.24 -18.07 -29.20 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -14.31 -16.11 -36.83 -14.03 -14.11 -36.24 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -18.23 -20.62 -22.29 -17.41 -20.69 -22.32 1rtf_c06 source 1rtf TWO CHAIN TISSUE PLASMINOGEN ACTIVATOR : 3 hits 1rtf_c06 naa= 3 ULMN 3 1sca_c00 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 1 3 # 1 32 ASP A 13 ASP~? 20.85 CL CL A 278 64 HIS A 12 HIS~? 14.78 CL CL A 278 221 SER A 10 SER.? 17.45 CL CL A 278 coo 80.16 73.25 62.48 80.01 71.25 61.82 3.80 -37.83 -7.42 4.89 -38.66 -9.05 coo 78.27 67.69 61.83 79.58 67.76 60.19 9.03 -33.35 -4.93 10.37 -31.88 -5.56 coo 83.63 66.07 58.16 81.31 66.75 57.98 3.77 -30.46 -4.30 3.68 -28.35 -5.48 ULMN 3 1sca_c00 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 2 3 # 2 32 ASP A 13 ASP~? 20.85 CL CL A 278 64 HIS A 12 HIS~? 14.78 CL CL A 278 221 SER A 21 SER.? 21.88 CL CL A 278 coo 80.16 73.25 62.48 80.01 71.25 61.82 3.80 -37.83 -7.42 4.89 -38.66 -9.05 coo 78.27 67.69 61.83 79.58 67.76 60.19 9.03 -33.35 -4.93 10.37 -31.88 -5.56 coo 83.63 66.07 58.16 81.31 66.75 57.98 1.16 -33.17 -2.24 2.71 -34.86 -3.05 ULMN 3 1sca_c00 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 3 3 # 3 32 ASP B 13 ASP~? 21.13 CL CL B 278 64 HIS B 12 HIS~? 15.42 CL CL B 278 221 SER B 10 SER.? 17.86 CL CL B 278 coo 80.16 73.25 62.48 80.01 71.25 61.82 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 coo 78.27 67.69 61.83 79.58 67.76 60.19 -10.18 -14.51 -22.80 -8.49 -13.29 -22.60 coo 83.63 66.07 58.16 81.31 66.75 57.98 -7.63 -19.97 -23.27 -5.38 -20.37 -22.44 ULMN 3 1sca_c00 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 4 3 # 4 32 ASP B 13 ASP~? 21.13 CL CL B 278 64 HIS B 12 HIS~? 15.42 CL CL B 278 221 SER B 21 SER.? 21.23 CL CL B 278 coo 80.16 73.25 62.48 80.01 71.25 61.82 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 coo 78.27 67.69 61.83 79.58 67.76 60.19 -10.18 -14.51 -22.80 -8.49 -13.29 -22.60 coo 83.63 66.07 58.16 81.31 66.75 57.98 -10.65 -22.68 -24.42 -10.99 -20.31 -24.03 1sca_c00 source 1sca SUBTILISIN CARLSBERG (E.C.3.4.21.62) (AQUEOUS : 4 hits 1sca_c00 naa= 3 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 1 3 # 1 32 ASP A 13 ASP~? 20.85 CL CL A 278 64 HIS A 12 HIS~? 14.78 CL CL A 278 155 ASN A 244 ASN.? 5.40 CL CL A 278 coo 80.16 73.25 62.48 80.01 71.25 61.82 3.80 -37.83 -7.42 4.89 -38.66 -9.05 coo 78.27 67.69 61.83 79.58 67.76 60.19 9.03 -33.35 -4.93 10.37 -31.88 -5.56 coo 80.34 61.88 52.75 81.25 63.19 54.35 17.85 -28.42 -8.05 16.64 -26.87 -8.84 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 2 3 # 2 32 ASP A 13 ASP~? 20.85 CL CL A 278 64 HIS A 12 HIS~? 14.78 CL CL A 278 155 ASN A 245 ASN.? 11.79 CL CL A 278 coo 80.16 73.25 62.48 80.01 71.25 61.82 3.80 -37.83 -7.42 4.89 -38.66 -9.05 coo 78.27 67.69 61.83 79.58 67.76 60.19 9.03 -33.35 -4.93 10.37 -31.88 -5.56 coo 80.34 61.88 52.75 81.25 63.19 54.35 18.48 -33.48 -10.76 18.30 -34.93 -9.15 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 3 3 # 3 32 ASP A 13 ASP~? 20.85 CL CL A 278 64 HIS A 12 HIS~? 14.78 CL CL A 278 155 ASN A 254 ASN~? 16.17 CL CL A 278 coo 80.16 73.25 62.48 80.01 71.25 61.82 3.80 -37.83 -7.42 4.89 -38.66 -9.05 coo 78.27 67.69 61.83 79.58 67.76 60.19 9.03 -33.35 -4.93 10.37 -31.88 -5.56 coo 80.34 61.88 52.75 81.25 63.19 54.35 18.50 -38.45 -6.68 18.86 -39.34 -8.59 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 4 3 # 4 32 ASP A 168 ASP^? 12.27 CL CL A 278 64 HIS A 194 HIS.? 4.68 CL CL A 278 155 ASN A 246 ASN.? 12.85 CL CL A 278 coo 80.16 73.25 62.48 80.01 71.25 61.82 26.46 -30.73 -8.22 26.92 -32.42 -9.39 coo 78.27 67.69 61.83 79.58 67.76 60.19 21.59 -27.03 -10.13 21.31 -25.37 -8.87 coo 80.34 61.88 52.75 81.25 63.19 54.35 12.83 -32.17 -9.87 11.11 -33.32 -9.30 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 5 3 # 5 32 ASP B 13 ASP~? 21.13 CL CL B 278 64 HIS B 12 HIS~? 15.42 CL CL B 278 155 ASN B 244 ASN.? 5.94 CL CL B 278 coo 80.16 73.25 62.48 80.01 71.25 61.82 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 coo 78.27 67.69 61.83 79.58 67.76 60.19 -10.18 -14.51 -22.80 -8.49 -13.29 -22.60 coo 80.34 61.88 52.75 81.25 63.19 54.35 -3.88 -6.12 -21.35 -2.47 -7.43 -20.48 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 6 3 # 6 32 ASP B 13 ASP~? 21.13 CL CL B 278 64 HIS B 12 HIS~? 15.42 CL CL B 278 155 ASN B 245 ASN.? 12.34 CL CL B 278 coo 80.16 73.25 62.48 80.01 71.25 61.82 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 coo 78.27 67.69 61.83 79.58 67.76 60.19 -10.18 -14.51 -22.80 -8.49 -13.29 -22.60 coo 80.34 61.88 52.75 81.25 63.19 54.35 -8.45 -4.50 -18.19 -10.06 -4.59 -19.62 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 7 3 # 7 32 ASP B 13 ASP~? 21.13 CL CL B 278 64 HIS B 12 HIS~? 15.42 CL CL B 278 155 ASN B 254 ASN~? 16.98 CL CL B 278 coo 80.16 73.25 62.48 80.01 71.25 61.82 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 coo 78.27 67.69 61.83 79.58 67.76 60.19 -10.18 -14.51 -22.80 -8.49 -13.29 -22.60 coo 80.34 61.88 52.75 81.25 63.19 54.35 -14.04 -4.32 -21.65 -14.71 -3.72 -19.71 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 8 3 # 8 32 ASP B 168 ASP^? 12.80 CL CL B 278 64 HIS B 194 HIS.? 5.13 CL CL B 278 155 ASN B 246 ASN.? 13.30 CL CL B 278 coo 80.16 73.25 62.48 80.01 71.25 61.82 -5.42 2.81 -22.11 -6.82 3.76 -20.83 coo 78.27 67.69 61.83 79.58 67.76 60.19 -1.92 -2.21 -20.05 -0.53 -2.75 -21.52 coo 80.34 61.88 52.75 81.25 63.19 54.35 -7.71 -10.36 -18.40 -9.09 -11.94 -18.78 1sca_c01 source 1sca SUBTILISIN CARLSBERG (E.C.3.4.21.62) (AQUEOUS : 8 hits 1sca_c01 naa= 3 ULMN 3 1sll_c00 SIALIDASE L user 1 3 # 1 318 ASP A 13 ASP~? 20.85 CL CL A 278 595 GLU A 25 GLU~? 26.70 CL CL A 278 713 TYR A 26 TYR~? 18.66 CL CL A 278 coo 5.64 2.82 38.49 4.59 4.19 37.25 3.80 -37.83 -7.42 4.89 -38.66 -9.05 coo 4.35 13.73 37.63 3.39 12.18 36.55 0.23 -35.14 2.73 -1.02 -35.12 1.03 coo 3.76 10.25 31.38 3.16 9.87 34.10 7.77 -31.94 1.38 10.47 -31.53 0.90 ULMN 3 1sll_c00 SIALIDASE L user 2 3 # 2 318 ASP A 168 ASP^? 12.27 CL CL A 278 595 GLU A 221 GLU~? 17.05 CL CL A 278 713 TYR A 215 TYR.? 13.87 CL CL A 278 coo 5.64 2.82 38.49 4.59 4.19 37.25 26.46 -30.73 -8.22 26.92 -32.42 -9.39 coo 4.35 13.73 37.63 3.39 12.18 36.55 27.14 -39.98 -10.94 25.92 -39.21 -12.48 coo 3.76 10.25 31.38 3.16 9.87 34.10 21.62 -36.04 -14.58 23.93 -37.55 -14.90 ULMN 3 1sll_c00 SIALIDASE L user 3 3 # 3 318 ASP A 268 ASP.? 26.73 CL CL A 278 595 GLU A 25 GLU~? 26.70 CL CL A 278 713 TYR A 24 TYR~? 29.31 CL CL A 278 coo 5.64 2.82 38.49 4.59 4.19 37.25 9.60 -34.57 10.49 9.97 -36.28 9.26 coo 4.35 13.73 37.63 3.39 12.18 36.55 0.23 -35.14 2.73 -1.02 -35.12 1.03 coo 3.76 10.25 31.38 3.16 9.87 34.10 0.87 -31.89 7.51 0.76 -33.22 9.95 ULMN 3 1sll_c00 SIALIDASE L user 4 3 # 4 318 ASP A 268 ASP.? 26.73 CL CL A 278 595 GLU A 25 GLU~? 26.70 CL CL A 278 713 TYR A 26 TYR~? 18.66 CL CL A 278 coo 5.64 2.82 38.49 4.59 4.19 37.25 9.60 -34.57 10.49 9.97 -36.28 9.26 coo 4.35 13.73 37.63 3.39 12.18 36.55 0.23 -35.14 2.73 -1.02 -35.12 1.03 coo 3.76 10.25 31.38 3.16 9.87 34.10 7.77 -31.94 1.38 10.47 -31.53 0.90 ULMN 3 1sll_c00 SIALIDASE L user 5 3 # 5 318 ASP B 13 ASP~? 21.13 CL CL B 278 595 GLU B 25 GLU~? 26.94 CL CL B 278 713 TYR B 26 TYR~? 19.09 CL CL B 278 coo 5.64 2.82 38.49 4.59 4.19 37.25 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 coo 4.35 13.73 37.63 3.39 12.18 36.55 -13.37 -23.90 -28.96 -13.41 -24.80 -27.04 coo 3.76 10.25 31.38 3.16 9.87 34.10 -9.51 -16.67 -28.98 -9.06 -13.93 -28.84 ULMN 3 1sll_c00 SIALIDASE L user 6 3 # 6 318 ASP B 168 ASP^? 12.80 CL CL B 278 595 GLU B 221 GLU~? 17.56 CL CL B 278 713 TYR B 215 TYR.? 14.28 CL CL B 278 coo 5.64 2.82 38.49 4.59 4.19 37.25 -5.42 2.81 -22.11 -6.82 3.76 -20.83 coo 4.35 13.73 37.63 3.39 12.18 36.55 -13.90 4.76 -18.50 -13.25 3.58 -16.87 coo 3.76 10.25 31.38 3.16 9.87 34.10 -10.18 -0.68 -14.85 -11.32 1.86 -14.73 ULMN 3 1sll_c00 SIALIDASE L user 7 3 # 7 318 ASP B 268 ASP.? 26.26 CL CL B 278 595 GLU B 25 GLU~? 26.94 CL CL B 278 713 TYR B 24 TYR~? 29.69 CL CL B 278 coo 5.64 2.82 38.49 4.59 4.19 37.25 -14.31 -16.11 -36.83 -14.03 -14.11 -36.24 coo 4.35 13.73 37.63 3.39 12.18 36.55 -13.37 -23.90 -28.96 -13.41 -24.80 -27.04 coo 3.76 10.25 31.38 3.16 9.87 34.10 -10.93 -24.23 -34.16 -12.79 -24.53 -36.20 ULMN 3 1sll_c00 SIALIDASE L user 8 3 # 8 318 ASP B 268 ASP.? 26.26 CL CL B 278 595 GLU B 25 GLU~? 26.94 CL CL B 278 713 TYR B 26 TYR~? 19.09 CL CL B 278 coo 5.64 2.82 38.49 4.59 4.19 37.25 -14.31 -16.11 -36.83 -14.03 -14.11 -36.24 coo 4.35 13.73 37.63 3.39 12.18 36.55 -13.37 -23.90 -28.96 -13.41 -24.80 -27.04 coo 3.76 10.25 31.38 3.16 9.87 34.10 -9.51 -16.67 -28.98 -9.06 -13.93 -28.84 1sll_c00 source 1sll SIALIDASE L : 8 hits 1sll_c00 naa= 3 ULMN 3 1sme_c04 PLASMEPSIN II user 1 3 # 1 A 34 ASP A 268 ASP.? 26.73 CL CL A 278 A 37 SER A 28 SER.? 27.02 CL CL A 278 A 214 ASP A 267 ASP.? 31.09 CL CL A 278 coo 51.75 60.57 19.10 52.05 60.90 21.19 9.60 -34.57 10.49 9.97 -36.28 9.26 coo 51.10 65.11 20.73 52.62 63.74 19.42 6.29 -36.11 7.11 4.57 -37.31 5.85 coo 48.59 58.89 25.78 50.13 59.74 24.61 11.77 -37.21 15.47 13.23 -35.63 15.60 ULMN 3 1sme_c04 PLASMEPSIN II user 2 3 # 2 A 34 ASP B 268 ASP.? 26.26 CL CL B 278 A 37 SER B 28 SER.? 27.87 CL CL B 278 A 214 ASP B 267 ASP.? 32.55 CL CL B 278 coo 51.75 60.57 19.10 52.05 60.90 21.19 -14.31 -16.11 -36.83 -14.03 -14.11 -36.24 coo 51.10 65.11 20.73 52.62 63.74 19.42 -14.66 -18.25 -33.71 -14.43 -20.67 -33.62 coo 48.59 58.89 25.78 50.13 59.74 24.61 -15.25 -13.37 -42.11 -14.97 -14.80 -43.57 1sme_c04 source 1sme PLASMEPSIN II : 2 hits 1sme_c04 naa= 3 ULMN 3 1sme_c05 PLASMEPSIN II user 1 3 # 1 B 34 ASP A 268 ASP.? 26.73 CL CL A 278 B 37 SER A 28 SER.? 27.02 CL CL A 278 B 214 ASP A 267 ASP.? 31.09 CL CL A 278 coo 17.69 97.58 52.73 17.33 97.19 54.77 9.60 -34.57 10.49 9.97 -36.28 9.26 coo 20.67 100.44 55.84 20.21 98.51 54.45 6.29 -36.11 7.11 4.57 -37.31 5.85 coo 12.41 98.71 58.47 14.37 98.17 58.05 11.77 -37.21 15.47 13.23 -35.63 15.60 ULMN 3 1sme_c05 PLASMEPSIN II user 2 3 # 2 B 34 ASP B 268 ASP.? 26.26 CL CL B 278 B 37 SER B 28 SER.? 27.87 CL CL B 278 B 214 ASP B 267 ASP.? 32.55 CL CL B 278 coo 17.69 97.58 52.73 17.33 97.19 54.77 -14.31 -16.11 -36.83 -14.03 -14.11 -36.24 coo 20.67 100.44 55.84 20.21 98.51 54.45 -14.66 -18.25 -33.71 -14.43 -20.67 -33.62 coo 12.41 98.71 58.47 14.37 98.17 58.05 -15.25 -13.37 -42.11 -14.97 -14.80 -43.57 1sme_c05 source 1sme PLASMEPSIN II : 2 hits 1sme_c05 naa= 3 ULMN 3 1smn_c00 EXTRACELLULAR ENDONUCLEASE user 1 3 # 1 A 87 ARG A 212 ARG~? 4.63 CL CL A 278 A 89 HIS A 194 HIS.? 4.68 CL CL A 278 A 119 ASN A 197 ASN.? 12.86 CL CL A 278 coo 28.44 23.52 73.95 30.13 24.84 76.11 18.59 -24.77 -16.89 17.13 -22.12 -16.49 coo 21.34 20.13 69.47 22.14 19.11 71.12 21.59 -27.03 -10.13 21.31 -25.37 -8.87 coo 19.69 29.00 71.61 19.80 26.98 72.20 21.52 -32.98 -18.45 20.55 -33.92 -20.09 ULMN 3 1smn_c00 EXTRACELLULAR ENDONUCLEASE user 2 3 # 2 A 87 ARG A 212 ARG~? 4.63 CL CL A 278 A 89 HIS A 194 HIS.? 4.68 CL CL A 278 A 119 ASN A 246 ASN.? 12.85 CL CL A 278 coo 28.44 23.52 73.95 30.13 24.84 76.11 18.59 -24.77 -16.89 17.13 -22.12 -16.49 coo 21.34 20.13 69.47 22.14 19.11 71.12 21.59 -27.03 -10.13 21.31 -25.37 -8.87 coo 19.69 29.00 71.61 19.80 26.98 72.20 12.83 -32.17 -9.87 11.11 -33.32 -9.30 ULMN 3 1smn_c00 EXTRACELLULAR ENDONUCLEASE user 3 3 # 3 A 87 ARG B 212 ARG~? 4.30 CL CL B 278 A 89 HIS B 194 HIS.? 5.13 CL CL B 278 A 119 ASN B 197 ASN.? 13.10 CL CL B 278 coo 28.44 23.52 73.95 30.13 24.84 76.11 1.13 -4.70 -13.40 3.58 -6.46 -14.00 coo 21.34 20.13 69.47 22.14 19.11 71.12 -1.92 -2.21 -20.05 -0.53 -2.75 -21.52 coo 19.69 29.00 71.61 19.80 26.98 72.20 -6.63 -0.56 -11.26 -7.23 -1.17 -9.32 ULMN 3 1smn_c00 EXTRACELLULAR ENDONUCLEASE user 4 3 # 4 A 87 ARG B 212 ARG~? 4.30 CL CL B 278 A 89 HIS B 194 HIS.? 5.13 CL CL B 278 A 119 ASN B 246 ASN.? 13.30 CL CL B 278 coo 28.44 23.52 73.95 30.13 24.84 76.11 1.13 -4.70 -13.40 3.58 -6.46 -14.00 coo 21.34 20.13 69.47 22.14 19.11 71.12 -1.92 -2.21 -20.05 -0.53 -2.75 -21.52 coo 19.69 29.00 71.61 19.80 26.98 72.20 -7.71 -10.36 -18.40 -9.09 -11.94 -18.78 1smn_c00 source 1smn EXTRACELLULAR ENDONUCLEASE : 4 hits 1smn_c00 naa= 3 ULMN 3 1smn_c01 EXTRACELLULAR ENDONUCLEASE user 1 3 # 1 B 87 ARG A 212 ARG~? 4.63 CL CL A 278 B 89 HIS A 194 HIS.? 4.68 CL CL A 278 B 119 ASN A 197 ASN.? 12.86 CL CL A 278 coo -30.08 23.20 29.48 -31.80 24.60 27.35 18.59 -24.77 -16.89 17.13 -22.12 -16.49 coo -22.85 19.92 33.92 -23.63 18.94 32.24 21.59 -27.03 -10.13 21.31 -25.37 -8.87 coo -21.28 28.91 31.84 -21.35 26.90 31.17 21.52 -32.98 -18.45 20.55 -33.92 -20.09 ULMN 3 1smn_c01 EXTRACELLULAR ENDONUCLEASE user 2 3 # 2 B 87 ARG A 212 ARG~? 4.63 CL CL A 278 B 89 HIS A 194 HIS.? 4.68 CL CL A 278 B 119 ASN A 246 ASN.? 12.85 CL CL A 278 coo -30.08 23.20 29.48 -31.80 24.60 27.35 18.59 -24.77 -16.89 17.13 -22.12 -16.49 coo -22.85 19.92 33.92 -23.63 18.94 32.24 21.59 -27.03 -10.13 21.31 -25.37 -8.87 coo -21.28 28.91 31.84 -21.35 26.90 31.17 12.83 -32.17 -9.87 11.11 -33.32 -9.30 ULMN 3 1smn_c01 EXTRACELLULAR ENDONUCLEASE user 3 3 # 3 B 87 ARG B 212 ARG~? 4.30 CL CL B 278 B 89 HIS B 194 HIS.? 5.13 CL CL B 278 B 119 ASN B 197 ASN.? 13.10 CL CL B 278 coo -30.08 23.20 29.48 -31.80 24.60 27.35 1.13 -4.70 -13.40 3.58 -6.46 -14.00 coo -22.85 19.92 33.92 -23.63 18.94 32.24 -1.92 -2.21 -20.05 -0.53 -2.75 -21.52 coo -21.28 28.91 31.84 -21.35 26.90 31.17 -6.63 -0.56 -11.26 -7.23 -1.17 -9.32 ULMN 3 1smn_c01 EXTRACELLULAR ENDONUCLEASE user 4 3 # 4 B 87 ARG B 212 ARG~? 4.30 CL CL B 278 B 89 HIS B 194 HIS.? 5.13 CL CL B 278 B 119 ASN B 246 ASN.? 13.30 CL CL B 278 coo -30.08 23.20 29.48 -31.80 24.60 27.35 1.13 -4.70 -13.40 3.58 -6.46 -14.00 coo -22.85 19.92 33.92 -23.63 18.94 32.24 -1.92 -2.21 -20.05 -0.53 -2.75 -21.52 coo -21.28 28.91 31.84 -21.35 26.90 31.17 -7.71 -10.36 -18.40 -9.09 -11.94 -18.78 1smn_c01 source 1smn EXTRACELLULAR ENDONUCLEASE : 4 hits 1smn_c01 naa= 3 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 1 3 # 1 A 57 HIS A 12 HIS~? 14.78 CL CL A 278 A 102 ASP A 13 ASP~? 20.85 CL CL A 278 A 193 GLY A 5 GLY^? 15.84 CL CL A 278 coo 15.02 29.17 19.44 15.63 29.96 17.60 9.03 -33.35 -4.93 10.37 -31.88 -5.56 coo 19.67 30.58 22.61 18.30 29.87 21.17 3.80 -37.83 -7.42 4.89 -38.66 -9.05 coo 14.52 29.10 10.01 15.08 29.66 10.19 15.52 -31.61 0.74 16.07 -31.86 0.19 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 2 3 # 2 A 57 HIS B 12 HIS~? 15.42 CL CL B 278 A 102 ASP B 13 ASP~? 21.13 CL CL B 278 A 193 GLY B 5 GLY^? 16.39 CL CL B 278 coo 15.02 29.17 19.44 15.63 29.96 17.60 -10.18 -14.51 -22.80 -8.49 -13.29 -22.60 coo 19.67 30.58 22.61 18.30 29.87 21.17 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 coo 14.52 29.10 10.01 15.08 29.66 10.19 -8.44 -9.04 -29.52 -8.55 -8.38 -29.05 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 3 3 # 3 A 57 HIS B 29 HIS.? 25.42 CL CL B 278 A 102 ASP B 268 ASP.? 26.26 CL CL B 278 A 193 GLY B 5 GLY^? 16.39 CL CL B 278 coo 15.02 29.17 19.44 15.63 29.96 17.60 -16.16 -16.38 -29.82 -17.24 -18.07 -29.20 coo 19.67 30.58 22.61 18.30 29.87 21.17 -14.31 -16.11 -36.83 -14.03 -14.11 -36.24 coo 14.52 29.10 10.01 15.08 29.66 10.19 -8.44 -9.04 -29.52 -8.55 -8.38 -29.05 1ssx_c02 source 1ssx ALPHA-LYTIC PROTEASE : 3 hits 1ssx_c02 naa= 3 ULMN 3 1stc_c02 CAMP-DEPENDENT PROTEIN KINASE user 1 3 # 1 E 166 ASP A 36 ASP~? 8.69 CL CL A 278 E 168 LYS A 64 LYS^? 6.64 CL CL A 278 E 201 THR A 7 THR^? 8.89 CL CL A 278 coo 5.36 16.20 22.10 3.88 17.00 23.31 11.67 -20.98 -6.16 13.43 -22.16 -5.96 coo 5.06 22.32 18.11 1.02 22.08 22.74 14.97 -18.21 -2.39 15.88 -19.33 -8.52 coo -1.79 18.29 19.05 -1.19 20.28 19.71 12.66 -27.68 -4.47 14.06 -27.36 -6.07 ULMN 3 1stc_c02 CAMP-DEPENDENT PROTEIN KINASE user 2 3 # 2 E 166 ASP B 36 ASP~? 8.83 CL CL B 278 E 168 LYS B 64 LYS^? 6.39 CL CL B 278 E 201 THR B 7 THR^? 9.20 CL CL B 278 coo 5.36 16.20 22.10 3.88 17.00 23.31 2.64 -13.17 -23.36 1.59 -11.35 -23.67 coo 5.06 22.32 18.11 1.02 22.08 22.74 5.21 -10.68 -27.95 4.80 -8.81 -21.96 coo -1.79 18.29 19.05 -1.19 20.28 19.71 -4.08 -11.42 -24.47 -3.39 -9.92 -23.07 1stc_c02 source 1stc CAMP-DEPENDENT PROTEIN KINASE : 2 hits 1stc_c02 naa= 3 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 1 3 # 1 B 8 HIS A 12 HIS~? 14.78 CL CL A 278 B 80 GLU A 11 GLU.? 13.55 CL CL A 278 B 223 ARG A 127 ARG~? 22.81 CL CL A 278 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 9.03 -33.35 -4.93 10.37 -31.88 -5.56 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 7.22 -30.95 -8.53 7.59 -29.14 -7.55 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 27.01 -10.28 5.58 24.68 -12.12 6.31 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 2 3 # 2 B 8 HIS A 194 HIS.? 4.68 CL CL A 278 B 80 GLU A 169 GLU.? 7.63 CL CL A 278 B 223 ARG B 212 ARG~? 4.30 CL CL B 278 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 21.59 -27.03 -10.13 21.31 -25.37 -8.87 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 26.74 -26.14 -12.80 26.49 -24.16 -13.47 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 1.13 -4.70 -13.40 3.58 -6.46 -14.00 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 3 3 # 3 B 8 HIS B 12 HIS~? 15.42 CL CL B 278 B 80 GLU B 11 GLU.? 12.74 CL CL B 278 B 223 ARG B 127 ARG~? 22.49 CL CL B 278 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -10.18 -14.51 -22.80 -8.49 -13.29 -22.60 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 -6.91 -15.96 -19.89 -5.75 -14.85 -18.47 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 13.11 -0.63 -38.30 10.87 -2.72 -38.33 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 4 3 # 4 B 8 HIS B 194 HIS.? 5.13 CL CL B 278 B 80 GLU B 169 GLU.? 7.43 CL CL B 278 B 223 ARG A 212 ARG~? 4.63 CL CL A 278 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -1.92 -2.21 -20.05 -0.53 -2.75 -21.52 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 0.06 3.03 -18.46 2.10 2.57 -18.04 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 18.59 -24.77 -16.89 17.13 -22.12 -16.49 1t0u_c01 source 1t0u URIDINE PHOSPHORYLASE : 4 hits 1t0u_c01 naa= 3 ULMN 3 1t4c_c02 FORMYL-COENZYME A TRANSFERASE user 1 3 # 1 A 261 GLY A 68 GLY.? 16.36 CL CL B 278 B 17 GLN A 76 GLN~? 15.56 CL CL B 278 B 140 GLU A 74 GLU~? 12.23 CL CL B 278 coo 61.49 19.86 5.96 61.52 19.46 5.16 14.64 -8.15 -7.71 15.04 -8.75 -7.32 coo 63.76 11.90 7.93 65.18 13.07 6.77 13.60 0.77 -10.68 15.37 -0.40 -10.87 coo 66.44 19.00 7.38 67.69 17.67 8.37 14.45 -4.40 -13.52 13.94 -3.10 -15.11 ULMN 3 1t4c_c02 FORMYL-COENZYME A TRANSFERASE user 2 3 # 2 A 261 GLY A 73 GLY.? 14.13 CL CL B 278 B 17 GLN A 76 GLN~? 15.56 CL CL B 278 B 140 GLU A 74 GLU~? 12.23 CL CL B 278 coo 61.49 19.86 5.96 61.52 19.46 5.16 14.30 -8.81 -11.73 15.07 -8.55 -11.50 coo 63.76 11.90 7.93 65.18 13.07 6.77 13.60 0.77 -10.68 15.37 -0.40 -10.87 coo 66.44 19.00 7.38 67.69 17.67 8.37 14.45 -4.40 -13.52 13.94 -3.10 -15.11 ULMN 3 1t4c_c02 FORMYL-COENZYME A TRANSFERASE user 3 3 # 3 A 261 GLY A 73 GLY.? 14.13 CL CL B 278 B 17 GLN B 72 GLN.? 9.50 CL CL B 278 B 140 GLU A 74 GLU~? 12.23 CL CL B 278 coo 61.49 19.86 5.96 61.52 19.46 5.16 14.30 -8.81 -11.73 15.07 -8.55 -11.50 coo 63.76 11.90 7.93 65.18 13.07 6.77 11.42 -7.18 -19.22 10.79 -6.65 -21.16 coo 66.44 19.00 7.38 67.69 17.67 8.37 14.45 -4.40 -13.52 13.94 -3.10 -15.11 ULMN 3 1t4c_c02 FORMYL-COENZYME A TRANSFERASE user 4 3 # 4 A 261 GLY B 68 GLY.? 16.43 CL CL B 278 B 17 GLN B 76 GLN~? 15.88 CL CL A 278 B 140 GLU B 74 GLU~? 12.92 CL CL A 278 coo 61.49 19.86 5.96 61.52 19.46 5.16 15.79 -11.51 -23.95 15.19 -11.07 -24.30 coo 63.76 11.90 7.93 65.18 13.07 6.77 24.82 -13.19 -21.85 23.67 -11.43 -21.48 coo 66.44 19.00 7.38 67.69 17.67 8.37 20.28 -11.36 -18.58 21.63 -11.86 -17.04 ULMN 3 1t4c_c02 FORMYL-COENZYME A TRANSFERASE user 5 3 # 5 A 261 GLY B 73 GLY.? 14.67 CL CL A 278 B 17 GLN A 72 GLN.? 10.10 CL CL A 278 B 140 GLU B 74 GLU~? 12.92 CL CL A 278 coo 61.49 19.86 5.96 61.52 19.46 5.16 15.57 -11.40 -19.83 15.87 -10.68 -20.14 coo 63.76 11.90 7.93 65.18 13.07 6.77 18.00 -13.55 -12.17 18.65 -13.84 -10.18 coo 66.44 19.00 7.38 67.69 17.67 8.37 20.28 -11.36 -18.58 21.63 -11.86 -17.04 ULMN 3 1t4c_c02 FORMYL-COENZYME A TRANSFERASE user 6 3 # 6 A 261 GLY B 73 GLY.? 14.67 CL CL A 278 B 17 GLN B 76 GLN~? 15.88 CL CL A 278 B 140 GLU B 74 GLU~? 12.92 CL CL A 278 coo 61.49 19.86 5.96 61.52 19.46 5.16 15.57 -11.40 -19.83 15.87 -10.68 -20.14 coo 63.76 11.90 7.93 65.18 13.07 6.77 24.82 -13.19 -21.85 23.67 -11.43 -21.48 coo 66.44 19.00 7.38 67.69 17.67 8.37 20.28 -11.36 -18.58 21.63 -11.86 -17.04 1t4c_c02 source 1t4c FORMYL-COENZYME A TRANSFERASE : 6 hits 1t4c_c02 naa= 3 ULMN 3 1t7d_c00 SIGNAL PEPTIDASE I user 1 3 # 1 A 88 SER A 70 SER.? 11.73 CL CL A 278 A 90 SER A 67 SER.? 14.21 CL CL A 278 A 145 LYS A 64 LYS^? 6.64 CL CL A 278 coo -3.31 40.95 15.56 -0.94 40.79 14.97 19.33 -11.34 -7.00 17.75 -13.05 -7.65 coo 1.47 40.03 18.48 2.45 41.37 16.68 14.35 -11.91 -8.16 12.43 -11.38 -9.50 coo 7.35 44.71 16.29 4.71 40.98 14.52 14.97 -18.21 -2.39 15.88 -19.33 -8.52 ULMN 3 1t7d_c00 SIGNAL PEPTIDASE I user 2 3 # 2 A 88 SER B 70 SER.? 11.46 CL CL B 278 A 90 SER B 67 SER.? 13.79 CL CL B 278 A 145 LYS B 64 LYS^? 6.39 CL CL B 278 coo -3.31 40.95 15.56 -0.94 40.79 14.97 13.00 -6.56 -24.86 11.13 -7.93 -24.10 coo 1.47 40.03 18.48 2.45 41.37 16.68 12.14 -11.19 -22.93 12.67 -12.95 -21.38 coo 7.35 44.71 16.29 4.71 40.98 14.52 5.21 -10.68 -27.95 4.80 -8.81 -21.96 1t7d_c00 source 1t7d SIGNAL PEPTIDASE I : 2 hits 1t7d_c00 naa= 3 ULMN 3 1t7d_c01 SIGNAL PEPTIDASE I user 1 3 # 1 B 88 SER B 110 SER.? 9.89 CL CL B 278 B 90 SER B 70 SER.? 11.46 CL CL B 278 B 145 LYS B 64 LYS^? 6.39 CL CL B 278 coo 61.01 10.03 12.97 58.78 10.97 12.69 10.33 -2.26 -18.93 11.59 -2.13 -16.86 coo 56.85 12.22 16.37 55.62 11.34 14.45 13.00 -6.56 -24.86 11.13 -7.93 -24.10 coo 49.80 9.51 14.88 53.14 11.99 12.77 5.21 -10.68 -27.95 4.80 -8.81 -21.96 1t7d_c01 source 1t7d SIGNAL PEPTIDASE I : 1 hits 1t7d_c01 naa= 3 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 A 144 HIS B 29 HIS.? 25.42 CL CL B 278 A 174 ASP B 13 ASP~? 21.13 CL CL B 278 A 404 TYR B 24 TYR~? 29.69 CL CL B 278 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 -16.16 -16.38 -29.82 -17.24 -18.07 -29.20 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 -10.93 -24.23 -34.16 -12.79 -24.53 -36.20 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 2 3 # 2 A 144 HIS B 29 HIS.? 25.42 CL CL B 278 A 174 ASP B 268 ASP.? 26.26 CL CL B 278 A 404 TYR B 14 TYR~? 22.44 CL CL B 278 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 -16.16 -16.38 -29.82 -17.24 -18.07 -29.20 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 -14.31 -16.11 -36.83 -14.03 -14.11 -36.24 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 -17.87 -12.84 -21.07 -19.82 -11.02 -21.91 1ti6_c06 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 2 hits 1ti6_c06 naa= 3 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 C 144 HIS B 29 HIS.? 25.42 CL CL B 278 C 174 ASP B 13 ASP~? 21.13 CL CL B 278 C 404 TYR B 24 TYR~? 29.69 CL CL B 278 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 -16.16 -16.38 -29.82 -17.24 -18.07 -29.20 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 -10.93 -24.23 -34.16 -12.79 -24.53 -36.20 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 2 3 # 2 C 144 HIS B 29 HIS.? 25.42 CL CL B 278 C 174 ASP B 268 ASP.? 26.26 CL CL B 278 C 404 TYR B 14 TYR~? 22.44 CL CL B 278 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 -16.16 -16.38 -29.82 -17.24 -18.07 -29.20 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 -14.31 -16.11 -36.83 -14.03 -14.11 -36.24 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 -17.87 -12.84 -21.07 -19.82 -11.02 -21.91 1ti6_c07 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 2 hits 1ti6_c07 naa= 3 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 E 144 HIS B 29 HIS.? 25.42 CL CL B 278 E 174 ASP B 13 ASP~? 21.13 CL CL B 278 E 404 TYR B 24 TYR~? 29.69 CL CL B 278 coo -7.53-107.59 75.19 -8.14-106.04 76.47 -16.16 -16.38 -29.82 -17.24 -18.07 -29.20 coo -3.55-105.39 83.13 -5.21-106.24 82.09 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 coo -16.31-108.78 75.35 -14.20-107.14 76.16 -10.93 -24.23 -34.16 -12.79 -24.53 -36.20 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 2 3 # 2 E 144 HIS B 29 HIS.? 25.42 CL CL B 278 E 174 ASP B 268 ASP.? 26.26 CL CL B 278 E 404 TYR B 14 TYR~? 22.44 CL CL B 278 coo -7.53-107.59 75.19 -8.14-106.04 76.47 -16.16 -16.38 -29.82 -17.24 -18.07 -29.20 coo -3.55-105.39 83.13 -5.21-106.24 82.09 -14.31 -16.11 -36.83 -14.03 -14.11 -36.24 coo -16.31-108.78 75.35 -14.20-107.14 76.16 -17.87 -12.84 -21.07 -19.82 -11.02 -21.91 1ti6_c08 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 2 hits 1ti6_c08 naa= 3 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 G 144 HIS A 29 HIS.? 25.16 CL CL A 278 G 174 ASP A 268 ASP.? 26.73 CL CL A 278 G 404 TYR A 14 TYR~? 21.87 CL CL A 278 coo 60.48-101.16 45.95 60.56-101.20 43.85 7.41 -38.44 3.20 5.56 -39.41 3.04 coo 58.10-108.15 40.62 59.57-106.86 41.51 9.60 -34.57 10.49 9.97 -36.28 9.26 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 9.67 -41.27 -5.56 11.11 -43.55 -4.85 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 2 3 # 2 G 144 HIS B 29 HIS.? 25.42 CL CL B 278 G 174 ASP B 13 ASP~? 21.13 CL CL B 278 G 404 TYR B 24 TYR~? 29.69 CL CL B 278 coo 60.48-101.16 45.95 60.56-101.20 43.85 -16.16 -16.38 -29.82 -17.24 -18.07 -29.20 coo 58.10-108.15 40.62 59.57-106.86 41.51 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 -10.93 -24.23 -34.16 -12.79 -24.53 -36.20 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 3 3 # 3 G 144 HIS B 29 HIS.? 25.42 CL CL B 278 G 174 ASP B 268 ASP.? 26.26 CL CL B 278 G 404 TYR B 14 TYR~? 22.44 CL CL B 278 coo 60.48-101.16 45.95 60.56-101.20 43.85 -16.16 -16.38 -29.82 -17.24 -18.07 -29.20 coo 58.10-108.15 40.62 59.57-106.86 41.51 -14.31 -16.11 -36.83 -14.03 -14.11 -36.24 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 -17.87 -12.84 -21.07 -19.82 -11.02 -21.91 1ti6_c09 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 3 hits 1ti6_c09 naa= 3 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 I 144 HIS A 29 HIS.? 25.16 CL CL A 278 I 174 ASP A 268 ASP.? 26.73 CL CL A 278 I 404 TYR A 14 TYR~? 21.87 CL CL A 278 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 7.41 -38.44 3.20 5.56 -39.41 3.04 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 9.60 -34.57 10.49 9.97 -36.28 9.26 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 9.67 -41.27 -5.56 11.11 -43.55 -4.85 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 2 3 # 2 I 144 HIS B 29 HIS.? 25.42 CL CL B 278 I 174 ASP B 13 ASP~? 21.13 CL CL B 278 I 404 TYR B 24 TYR~? 29.69 CL CL B 278 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 -16.16 -16.38 -29.82 -17.24 -18.07 -29.20 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 -10.93 -24.23 -34.16 -12.79 -24.53 -36.20 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 3 3 # 3 I 144 HIS B 29 HIS.? 25.42 CL CL B 278 I 174 ASP B 268 ASP.? 26.26 CL CL B 278 I 404 TYR B 14 TYR~? 22.44 CL CL B 278 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 -16.16 -16.38 -29.82 -17.24 -18.07 -29.20 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 -14.31 -16.11 -36.83 -14.03 -14.11 -36.24 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 -17.87 -12.84 -21.07 -19.82 -11.02 -21.91 1ti6_c10 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 3 hits 1ti6_c10 naa= 3 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 K 144 HIS A 29 HIS.? 25.16 CL CL A 278 K 174 ASP A 268 ASP.? 26.73 CL CL A 278 K 404 TYR A 14 TYR~? 21.87 CL CL A 278 coo 100.18 26.45 -1.32 99.24 26.12 0.53 7.41 -38.44 3.20 5.56 -39.41 3.04 coo 102.36 30.86 6.31 102.45 29.08 5.12 9.60 -34.57 10.49 9.97 -36.28 9.26 coo 99.93 17.48 -0.85 99.14 19.86 0.39 9.67 -41.27 -5.56 11.11 -43.55 -4.85 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 2 3 # 2 K 144 HIS B 29 HIS.? 25.42 CL CL B 278 K 174 ASP B 13 ASP~? 21.13 CL CL B 278 K 404 TYR B 24 TYR~? 29.69 CL CL B 278 coo 100.18 26.45 -1.32 99.24 26.12 0.53 -16.16 -16.38 -29.82 -17.24 -18.07 -29.20 coo 102.36 30.86 6.31 102.45 29.08 5.12 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 coo 99.93 17.48 -0.85 99.14 19.86 0.39 -10.93 -24.23 -34.16 -12.79 -24.53 -36.20 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 3 3 # 3 K 144 HIS B 29 HIS.? 25.42 CL CL B 278 K 174 ASP B 268 ASP.? 26.26 CL CL B 278 K 404 TYR B 14 TYR~? 22.44 CL CL B 278 coo 100.18 26.45 -1.32 99.24 26.12 0.53 -16.16 -16.38 -29.82 -17.24 -18.07 -29.20 coo 102.36 30.86 6.31 102.45 29.08 5.12 -14.31 -16.11 -36.83 -14.03 -14.11 -36.24 coo 99.93 17.48 -0.85 99.14 19.86 0.39 -17.87 -12.84 -21.07 -19.82 -11.02 -21.91 1ti6_c11 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 3 hits 1ti6_c11 naa= 3 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 1 3 # 1 A 250 ALA B 251 ALA~? 13.13 CL CL B 278 A 251 GLY B 249 GLY.? 15.61 CL CL B 278 A 252 ASP B 250 ASP~? 16.15 CL CL B 278 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 -11.21 -8.27 -20.82 -9.88 -9.02 -21.02 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 -11.90 -11.51 -16.09 -11.99 -10.68 -16.03 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 -13.35 -7.01 -16.89 -13.59 -7.26 -14.81 1tz3_c02 source 1tz3 PUTATIVE SUGAR KINASE : 1 hits 1tz3_c02 naa= 3 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 1 3 # 1 B 250 ALA B 251 ALA~? 13.13 CL CL B 278 B 251 GLY B 249 GLY.? 15.61 CL CL B 278 B 252 ASP B 250 ASP~? 16.15 CL CL B 278 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 -11.21 -8.27 -20.82 -9.88 -9.02 -21.02 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 -11.90 -11.51 -16.09 -11.99 -10.68 -16.03 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 -13.35 -7.01 -16.89 -13.59 -7.26 -14.81 1tz3_c03 source 1tz3 PUTATIVE SUGAR KINASE : 1 hits 1tz3_c03 naa= 3 ULMN 3 1uag_c01 UDP-N-ACETYLMURAMOYL-L-ALANINE-:D-GLuser 1 3 # 1 115 LYS B 210 LYS~? 12.46 CL CL B 278 138 ASN B 197 ASN.? 13.10 CL CL B 278 183 HIS B 194 HIS.? 5.13 CL CL B 278 coo 36.44 -9.55 24.75 39.00 -9.24 20.52 -2.49 -8.60 -10.03 0.77 -12.84 -8.24 coo 42.86 -4.84 22.91 42.38 -4.90 20.84 -6.63 -0.56 -11.26 -7.23 -1.17 -9.32 coo 43.51 -9.99 13.57 42.49 -8.60 14.69 -1.92 -2.21 -20.05 -0.53 -2.75 -21.52 ULMN 3 1uag_c01 UDP-N-ACETYLMURAMOYL-L-ALANINE-:D-GLuser 2 3 # 2 115 LYS B 210 LYS~? 12.46 CL CL B 278 138 ASN B 246 ASN.? 13.30 CL CL B 278 183 HIS B 194 HIS.? 5.13 CL CL B 278 coo 36.44 -9.55 24.75 39.00 -9.24 20.52 -2.49 -8.60 -10.03 0.77 -12.84 -8.24 coo 42.86 -4.84 22.91 42.38 -4.90 20.84 -7.71 -10.36 -18.40 -9.09 -11.94 -18.78 coo 43.51 -9.99 13.57 42.49 -8.60 14.69 -1.92 -2.21 -20.05 -0.53 -2.75 -21.52 1uag_c01 source 1uag UDP-N-ACETYLMURAMOYL-L-ALANINE-:D-GLUTAMATE LI: 2 hits 1uag_c01 naa= 3 ULMN 3 1uaq_c00 CYTOSINE DEAMINASE user 1 3 # 1 A 64 GLU A 74 GLU~? 12.23 CL CL B 278 A 89 SER A 67 SER.? 14.21 CL CL A 278 A 91 CYH A 71 CYH.? 16.56 CL CL A 278 coo -18.27 -3.12 10.92 -16.30 -3.26 10.07 14.45 -4.40 -13.52 13.94 -3.10 -15.11 coo -16.83 -3.83 3.62 -17.28 -5.61 2.05 14.35 -11.91 -8.16 12.43 -11.38 -9.50 coo -13.84 -8.33 7.58 -13.00 -8.13 10.24 19.04 -8.88 -9.96 21.14 -7.72 -8.59 ULMN 3 1uaq_c00 CYTOSINE DEAMINASE user 2 3 # 2 A 64 GLU A 74 GLU~? 12.23 CL CL B 278 A 89 SER B 110 SER.? 9.89 CL CL B 278 A 91 CYH B 71 CYH.? 16.15 CL CL B 278 coo -18.27 -3.12 10.92 -16.30 -3.26 10.07 14.45 -4.40 -13.52 13.94 -3.10 -15.11 coo -16.83 -3.83 3.62 -17.28 -5.61 2.05 10.33 -2.26 -18.93 11.59 -2.13 -16.86 coo -13.84 -8.33 7.58 -13.00 -8.13 10.24 15.78 -6.77 -22.17 17.11 -4.88 -23.73 ULMN 3 1uaq_c00 CYTOSINE DEAMINASE user 3 3 # 3 A 64 GLU B 74 GLU~? 12.92 CL CL A 278 A 89 SER A 110 SER.? 10.17 CL CL A 278 A 91 CYH A 71 CYH.? 16.56 CL CL A 278 coo -18.27 -3.12 10.92 -16.30 -3.26 10.07 20.28 -11.36 -18.58 21.63 -11.86 -17.04 coo -16.83 -3.83 3.62 -17.28 -5.61 2.05 22.72 -15.16 -12.90 22.28 -14.43 -15.17 coo -13.84 -8.33 7.58 -13.00 -8.13 10.24 19.04 -8.88 -9.96 21.14 -7.72 -8.59 ULMN 3 1uaq_c00 CYTOSINE DEAMINASE user 4 3 # 4 A 64 GLU B 74 GLU~? 12.92 CL CL A 278 A 89 SER B 67 SER.? 13.79 CL CL B 278 A 91 CYH B 71 CYH.? 16.15 CL CL B 278 coo -18.27 -3.12 10.92 -16.30 -3.26 10.07 20.28 -11.36 -18.58 21.63 -11.86 -17.04 coo -16.83 -3.83 3.62 -17.28 -5.61 2.05 12.14 -11.19 -22.93 12.67 -12.95 -21.38 coo -13.84 -8.33 7.58 -13.00 -8.13 10.24 15.78 -6.77 -22.17 17.11 -4.88 -23.73 1uaq_c00 source 1uaq CYTOSINE DEAMINASE : 4 hits 1uaq_c00 naa= 3 ULMN 3 1uaq_c01 CYTOSINE DEAMINASE user 1 3 # 1 B 64 GLU A 74 GLU~? 12.23 CL CL B 278 B 89 SER A 67 SER.? 14.21 CL CL A 278 B 91 CYH A 71 CYH.? 16.56 CL CL A 278 coo -13.67 -17.67 21.70 -15.74 -17.78 22.24 14.45 -4.40 -13.52 13.94 -3.10 -15.11 coo -17.71 -23.81 20.93 -18.57 -24.92 18.94 14.35 -11.91 -8.16 12.43 -11.38 -9.50 coo -20.38 -18.31 18.13 -20.06 -15.64 18.96 19.04 -8.88 -9.96 21.14 -7.72 -8.59 ULMN 3 1uaq_c01 CYTOSINE DEAMINASE user 2 3 # 2 B 64 GLU A 74 GLU~? 12.23 CL CL B 278 B 89 SER B 110 SER.? 9.89 CL CL B 278 B 91 CYH B 71 CYH.? 16.15 CL CL B 278 coo -13.67 -17.67 21.70 -15.74 -17.78 22.24 14.45 -4.40 -13.52 13.94 -3.10 -15.11 coo -17.71 -23.81 20.93 -18.57 -24.92 18.94 10.33 -2.26 -18.93 11.59 -2.13 -16.86 coo -20.38 -18.31 18.13 -20.06 -15.64 18.96 15.78 -6.77 -22.17 17.11 -4.88 -23.73 ULMN 3 1uaq_c01 CYTOSINE DEAMINASE user 3 3 # 3 B 64 GLU B 74 GLU~? 12.92 CL CL A 278 B 89 SER A 110 SER.? 10.17 CL CL A 278 B 91 CYH A 71 CYH.? 16.56 CL CL A 278 coo -13.67 -17.67 21.70 -15.74 -17.78 22.24 20.28 -11.36 -18.58 21.63 -11.86 -17.04 coo -17.71 -23.81 20.93 -18.57 -24.92 18.94 22.72 -15.16 -12.90 22.28 -14.43 -15.17 coo -20.38 -18.31 18.13 -20.06 -15.64 18.96 19.04 -8.88 -9.96 21.14 -7.72 -8.59 ULMN 3 1uaq_c01 CYTOSINE DEAMINASE user 4 3 # 4 B 64 GLU B 74 GLU~? 12.92 CL CL A 278 B 89 SER B 67 SER.? 13.79 CL CL B 278 B 91 CYH B 71 CYH.? 16.15 CL CL B 278 coo -13.67 -17.67 21.70 -15.74 -17.78 22.24 20.28 -11.36 -18.58 21.63 -11.86 -17.04 coo -17.71 -23.81 20.93 -18.57 -24.92 18.94 12.14 -11.19 -22.93 12.67 -12.95 -21.38 coo -20.38 -18.31 18.13 -20.06 -15.64 18.96 15.78 -6.77 -22.17 17.11 -4.88 -23.73 1uaq_c01 source 1uaq CYTOSINE DEAMINASE : 4 hits 1uaq_c01 naa= 3 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 1 3 # 1 A 46 GLU A 50 GLU~? 27.20 CL CL B 278 A 126 LYS A 45 LYS~? 28.08 CL CL B 278 A 171 ALA A 49 ALA~? 28.24 CL CL A 278 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 -1.40 -20.04 6.08 -2.65 -20.05 4.33 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 3.14 -12.38 5.65 4.44 -8.59 10.01 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 3.04 -18.05 8.49 2.14 -17.09 9.22 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 2 3 # 2 A 46 GLU A 91 GLU~? 24.88 CL CL B 278 A 126 LYS A 45 LYS~? 28.08 CL CL B 278 A 171 ALA A 88 ALA~? 19.55 CL CL B 278 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 8.21 -5.59 7.14 7.20 -3.78 6.62 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 3.14 -12.38 5.65 4.44 -8.59 10.01 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 9.06 -5.65 2.11 8.64 -5.27 0.71 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 3 3 # 3 A 46 GLU A 91 GLU~? 24.88 CL CL B 278 A 126 LYS A 45 LYS~? 28.08 CL CL B 278 A 171 ALA A 94 ALA~? 27.93 CL CL A 278 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 8.21 -5.59 7.14 7.20 -3.78 6.62 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 3.14 -12.38 5.65 4.44 -8.59 10.01 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 8.97 -12.17 9.49 8.04 -11.02 9.88 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 4 3 # 4 A 46 GLU A 207 GLU~? 15.26 CL CL A 278 A 126 LYS A 211 LYS~? 14.92 CL CL A 278 A 171 ALA A 206 ALA.? 14.67 CL CL A 278 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 13.18 -27.21 -26.28 11.29 -26.78 -25.35 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 17.07 -30.19 -20.07 15.73 -30.42 -25.42 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 15.61 -22.83 -25.69 14.41 -22.21 -26.40 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 5 3 # 5 A 46 GLU B 207 GLU~? 15.42 CL CL B 278 A 126 LYS B 210 LYS~? 12.46 CL CL B 278 A 171 ALA B 206 ALA.? 14.57 CL CL B 278 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 -0.89 -8.41 -2.97 -0.49 -10.43 -3.58 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 -2.49 -8.60 -10.03 0.77 -12.84 -8.24 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 3.69 -6.74 -4.42 4.28 -7.90 -3.63 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 6 3 # 6 A 46 GLU B 207 GLU~? 15.42 CL CL B 278 A 126 LYS B 211 LYS~? 15.02 CL CL B 278 A 171 ALA B 206 ALA.? 14.57 CL CL B 278 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 -0.89 -8.41 -2.97 -0.49 -10.43 -3.58 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 -4.12 -5.20 -9.45 -3.45 -5.07 -3.77 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 3.69 -6.74 -4.42 4.28 -7.90 -3.63 1uf7_c00 source 1uf7 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLASE : 6 hits 1uf7_c00 naa= 3 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 1 3 # 1 B 46 GLU A 50 GLU~? 27.20 CL CL B 278 B 126 LYS A 45 LYS~? 28.08 CL CL B 278 B 171 ALA A 49 ALA~? 28.24 CL CL A 278 coo 20.47 87.42 16.54 20.16 87.17 14.45 -1.40 -20.04 6.08 -2.65 -20.05 4.33 coo 24.73 94.37 14.59 21.08 89.84 11.98 3.14 -12.38 5.65 4.44 -8.59 10.01 coo 24.38 86.32 12.71 22.88 86.54 12.71 3.04 -18.05 8.49 2.14 -17.09 9.22 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 2 3 # 2 B 46 GLU A 91 GLU~? 24.88 CL CL B 278 B 126 LYS A 45 LYS~? 28.08 CL CL B 278 B 171 ALA A 88 ALA~? 19.55 CL CL B 278 coo 20.47 87.42 16.54 20.16 87.17 14.45 8.21 -5.59 7.14 7.20 -3.78 6.62 coo 24.73 94.37 14.59 21.08 89.84 11.98 3.14 -12.38 5.65 4.44 -8.59 10.01 coo 24.38 86.32 12.71 22.88 86.54 12.71 9.06 -5.65 2.11 8.64 -5.27 0.71 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 3 3 # 3 B 46 GLU A 91 GLU~? 24.88 CL CL B 278 B 126 LYS A 45 LYS~? 28.08 CL CL B 278 B 171 ALA A 94 ALA~? 27.93 CL CL A 278 coo 20.47 87.42 16.54 20.16 87.17 14.45 8.21 -5.59 7.14 7.20 -3.78 6.62 coo 24.73 94.37 14.59 21.08 89.84 11.98 3.14 -12.38 5.65 4.44 -8.59 10.01 coo 24.38 86.32 12.71 22.88 86.54 12.71 8.97 -12.17 9.49 8.04 -11.02 9.88 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 4 3 # 4 B 46 GLU A 207 GLU~? 15.26 CL CL A 278 B 126 LYS A 211 LYS~? 14.92 CL CL A 278 B 171 ALA A 206 ALA.? 14.67 CL CL A 278 coo 20.47 87.42 16.54 20.16 87.17 14.45 13.18 -27.21 -26.28 11.29 -26.78 -25.35 coo 24.73 94.37 14.59 21.08 89.84 11.98 17.07 -30.19 -20.07 15.73 -30.42 -25.42 coo 24.38 86.32 12.71 22.88 86.54 12.71 15.61 -22.83 -25.69 14.41 -22.21 -26.40 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 5 3 # 5 B 46 GLU B 207 GLU~? 15.42 CL CL B 278 B 126 LYS B 210 LYS~? 12.46 CL CL B 278 B 171 ALA B 206 ALA.? 14.57 CL CL B 278 coo 20.47 87.42 16.54 20.16 87.17 14.45 -0.89 -8.41 -2.97 -0.49 -10.43 -3.58 coo 24.73 94.37 14.59 21.08 89.84 11.98 -2.49 -8.60 -10.03 0.77 -12.84 -8.24 coo 24.38 86.32 12.71 22.88 86.54 12.71 3.69 -6.74 -4.42 4.28 -7.90 -3.63 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 6 3 # 6 B 46 GLU B 207 GLU~? 15.42 CL CL B 278 B 126 LYS B 211 LYS~? 15.02 CL CL B 278 B 171 ALA B 206 ALA.? 14.57 CL CL B 278 coo 20.47 87.42 16.54 20.16 87.17 14.45 -0.89 -8.41 -2.97 -0.49 -10.43 -3.58 coo 24.73 94.37 14.59 21.08 89.84 11.98 -4.12 -5.20 -9.45 -3.45 -5.07 -3.77 coo 24.38 86.32 12.71 22.88 86.54 12.71 3.69 -6.74 -4.42 4.28 -7.90 -3.63 1uf7_c01 source 1uf7 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLASE : 6 hits 1uf7_c01 naa= 3 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 1 3 # 1 86 HIS A 194 HIS.? 4.68 CL CL A 278 89 GLU A 169 GLU.? 7.63 CL CL A 278 243 ASN A 218 ASN~? 20.82 CL CL A 278 coo 5.83 15.74 17.38 6.41 17.70 17.86 21.59 -27.03 -10.13 21.31 -25.37 -8.87 coo 3.11 16.19 13.44 4.96 17.09 13.42 26.74 -26.14 -12.80 26.49 -24.16 -13.47 coo 0.53 21.81 31.33 1.05 20.47 29.70 24.13 -43.84 -11.70 26.14 -43.18 -11.76 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 2 3 # 2 86 HIS B 194 HIS.? 5.13 CL CL B 278 89 GLU B 169 GLU.? 7.43 CL CL B 278 243 ASN B 218 ASN~? 21.19 CL CL B 278 coo 5.83 15.74 17.38 6.41 17.70 17.86 -1.92 -2.21 -20.05 -0.53 -2.75 -21.52 coo 3.11 16.19 13.44 4.96 17.09 13.42 0.06 3.03 -18.46 2.10 2.57 -18.04 coo 0.53 21.81 31.33 1.05 20.47 29.70 -17.80 2.35 -16.65 -17.00 4.26 -17.12 1ula_c00 source 1ula PURINE NUCLEOSIDE PHOSPHORYLASE (E.C.2.4.2.1) : 2 hits 1ula_c00 naa= 3 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP B 224 ASP~? 22.83 CL CL B 278 255 GLU B 221 GLU~? 17.56 CL CL B 278 329 ASP B 168 ASP^? 12.80 CL CL B 278 coo 49.16 35.16 15.19 51.08 34.43 15.65 -13.88 7.87 -23.86 -15.40 8.87 -22.81 coo 52.57 37.12 10.17 53.37 35.95 11.75 -13.90 4.76 -18.50 -13.25 3.58 -16.87 coo 59.16 37.82 13.95 57.63 37.03 15.12 -5.42 2.81 -22.11 -6.82 3.76 -20.83 1uok_c03 source 1uok OLIGO-1,6-GLUCOSIDASE : 1 hits 1uok_c03 naa= 3 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP A 13 ASP~? 20.85 CL CL A 278 218 GLU B 74 GLU~? 12.92 CL CL A 278 329 ASP A 250 ASP~? 15.45 CL CL A 278 coo 49.16 35.16 15.19 51.08 34.43 15.65 3.80 -37.83 -7.42 4.89 -38.66 -9.05 coo 70.09 11.71 8.46 70.56 12.89 6.77 20.28 -11.36 -18.58 21.63 -11.86 -17.04 coo 59.16 37.82 13.95 57.63 37.03 15.12 15.24 -38.09 -11.21 14.62 -38.47 -13.19 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 2 3 # 2 199 ASP A 224 ASP~? 22.21 CL CL A 278 218 GLU A 25 GLU~? 26.70 CL CL A 278 329 ASP A 168 ASP^? 12.27 CL CL A 278 coo 49.16 35.16 15.19 51.08 34.43 15.65 30.83 -39.35 -6.18 31.71 -41.01 -7.15 coo 70.09 11.71 8.46 70.56 12.89 6.77 0.23 -35.14 2.73 -1.02 -35.12 1.03 coo 59.16 37.82 13.95 57.63 37.03 15.12 26.46 -30.73 -8.22 26.92 -32.42 -9.39 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 3 3 # 3 199 ASP A 224 ASP~? 22.21 CL CL A 278 218 GLU A 57 GLU.? 33.27 CL CL A 278 329 ASP A 168 ASP^? 12.27 CL CL A 278 coo 49.16 35.16 15.19 51.08 34.43 15.65 30.83 -39.35 -6.18 31.71 -41.01 -7.15 coo 70.09 11.71 8.46 70.56 12.89 6.77 10.55 -27.52 17.40 10.69 -28.24 19.39 coo 59.16 37.82 13.95 57.63 37.03 15.12 26.46 -30.73 -8.22 26.92 -32.42 -9.39 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 4 3 # 4 199 ASP A 250 ASP~? 15.45 CL CL A 278 218 GLU A 57 GLU.? 33.27 CL CL A 278 329 ASP A 13 ASP~? 20.85 CL CL A 278 coo 49.16 35.16 15.19 51.08 34.43 15.65 15.24 -38.09 -11.21 14.62 -38.47 -13.19 coo 70.09 11.71 8.46 70.56 12.89 6.77 10.55 -27.52 17.40 10.69 -28.24 19.39 coo 59.16 37.82 13.95 57.63 37.03 15.12 3.80 -37.83 -7.42 4.89 -38.66 -9.05 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 5 3 # 5 199 ASP A 250 ASP~? 15.45 CL CL A 278 218 GLU B 11 GLU.? 12.74 CL CL B 278 329 ASP A 13 ASP~? 20.85 CL CL A 278 coo 49.16 35.16 15.19 51.08 34.43 15.65 15.24 -38.09 -11.21 14.62 -38.47 -13.19 coo 70.09 11.71 8.46 70.56 12.89 6.77 -6.91 -15.96 -19.89 -5.75 -14.85 -18.47 coo 59.16 37.82 13.95 57.63 37.03 15.12 3.80 -37.83 -7.42 4.89 -38.66 -9.05 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 6 3 # 6 199 ASP B 13 ASP~? 21.13 CL CL B 278 218 GLU A 74 GLU~? 12.23 CL CL B 278 329 ASP B 250 ASP~? 16.15 CL CL B 278 coo 49.16 35.16 15.19 51.08 34.43 15.65 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 coo 70.09 11.71 8.46 70.56 12.89 6.77 14.45 -4.40 -13.52 13.94 -3.10 -15.11 coo 59.16 37.82 13.95 57.63 37.03 15.12 -13.35 -7.01 -16.89 -13.59 -7.26 -14.81 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 7 3 # 7 199 ASP B 224 ASP~? 22.83 CL CL B 278 218 GLU B 25 GLU~? 26.94 CL CL B 278 329 ASP B 168 ASP^? 12.80 CL CL B 278 coo 49.16 35.16 15.19 51.08 34.43 15.65 -13.88 7.87 -23.86 -15.40 8.87 -22.81 coo 70.09 11.71 8.46 70.56 12.89 6.77 -13.37 -23.90 -28.96 -13.41 -24.80 -27.04 coo 59.16 37.82 13.95 57.63 37.03 15.12 -5.42 2.81 -22.11 -6.82 3.76 -20.83 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 8 3 # 8 199 ASP B 224 ASP~? 22.83 CL CL B 278 218 GLU B 57 GLU.? 32.46 CL CL B 278 329 ASP B 168 ASP^? 12.80 CL CL B 278 coo 49.16 35.16 15.19 51.08 34.43 15.65 -13.88 7.87 -23.86 -15.40 8.87 -22.81 coo 70.09 11.71 8.46 70.56 12.89 6.77 -7.18 -15.84 -45.66 -5.90 -17.20 -46.65 coo 59.16 37.82 13.95 57.63 37.03 15.12 -5.42 2.81 -22.11 -6.82 3.76 -20.83 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 9 3 # 9 199 ASP B 250 ASP~? 16.15 CL CL B 278 218 GLU A 11 GLU.? 13.55 CL CL A 278 329 ASP B 13 ASP~? 21.13 CL CL B 278 coo 49.16 35.16 15.19 51.08 34.43 15.65 -13.35 -7.01 -16.89 -13.59 -7.26 -14.81 coo 70.09 11.71 8.46 70.56 12.89 6.77 7.22 -30.95 -8.53 7.59 -29.14 -7.55 coo 59.16 37.82 13.95 57.63 37.03 15.12 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 10 3 # 10 199 ASP B 250 ASP~? 16.15 CL CL B 278 218 GLU B 57 GLU.? 32.46 CL CL B 278 329 ASP B 13 ASP~? 21.13 CL CL B 278 coo 49.16 35.16 15.19 51.08 34.43 15.65 -13.35 -7.01 -16.89 -13.59 -7.26 -14.81 coo 70.09 11.71 8.46 70.56 12.89 6.77 -7.18 -15.84 -45.66 -5.90 -17.20 -46.65 coo 59.16 37.82 13.95 57.63 37.03 15.12 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 1uok_c04 source 1uok OLIGO-1,6-GLUCOSIDASE : 10 hits 1uok_c04 naa= 3 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP A 13 ASP~? 20.85 CL CL A 278 242 GLU A 50 GLU~? 27.20 CL CL B 278 329 ASP A 250 ASP~? 15.45 CL CL A 278 coo 49.16 35.16 15.19 51.08 34.43 15.65 3.80 -37.83 -7.42 4.89 -38.66 -9.05 coo 30.42 34.74 5.00 29.09 35.09 3.38 -1.40 -20.04 6.08 -2.65 -20.05 4.33 coo 59.16 37.82 13.95 57.63 37.03 15.12 15.24 -38.09 -11.21 14.62 -38.47 -13.19 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 2 3 # 2 199 ASP A 168 ASP^? 12.27 CL CL A 278 242 GLU A 207 GLU~? 15.26 CL CL A 278 329 ASP A 224 ASP~? 22.21 CL CL A 278 coo 49.16 35.16 15.19 51.08 34.43 15.65 26.46 -30.73 -8.22 26.92 -32.42 -9.39 coo 30.42 34.74 5.00 29.09 35.09 3.38 13.18 -27.21 -26.28 11.29 -26.78 -25.35 coo 59.16 37.82 13.95 57.63 37.03 15.12 30.83 -39.35 -6.18 31.71 -41.01 -7.15 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 3 3 # 3 199 ASP B 13 ASP~? 21.13 CL CL B 278 242 GLU B 50 GLU~? 26.89 CL CL A 278 329 ASP B 250 ASP~? 16.15 CL CL B 278 coo 49.16 35.16 15.19 51.08 34.43 15.65 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 coo 30.42 34.74 5.00 29.09 35.09 3.38 0.53 -27.55 -33.66 0.79 -28.51 -31.75 coo 59.16 37.82 13.95 57.63 37.03 15.12 -13.35 -7.01 -16.89 -13.59 -7.26 -14.81 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 4 3 # 4 199 ASP B 168 ASP^? 12.80 CL CL B 278 242 GLU B 207 GLU~? 15.42 CL CL B 278 329 ASP B 224 ASP~? 22.83 CL CL B 278 coo 49.16 35.16 15.19 51.08 34.43 15.65 -5.42 2.81 -22.11 -6.82 3.76 -20.83 coo 30.42 34.74 5.00 29.09 35.09 3.38 -0.89 -8.41 -2.97 -0.49 -10.43 -3.58 coo 59.16 37.82 13.95 57.63 37.03 15.12 -13.88 7.87 -23.86 -15.40 8.87 -22.81 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 5 3 # 5 199 ASP B 250 ASP~? 16.15 CL CL B 278 242 GLU B 227 GLU~? 26.46 CL CL B 278 329 ASP B 13 ASP~? 21.13 CL CL B 278 coo 49.16 35.16 15.19 51.08 34.43 15.65 -13.35 -7.01 -16.89 -13.59 -7.26 -14.81 coo 30.42 34.74 5.00 29.09 35.09 3.38 -14.61 9.61 -30.38 -15.43 11.23 -29.27 coo 59.16 37.82 13.95 57.63 37.03 15.12 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 1uok_c05 source 1uok OLIGO-1,6-GLUCOSIDASE : 5 hits 1uok_c05 naa= 3 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 1 3 # 1 A 581 GLU A 34 GLU^? 8.78 CL CL A 278 A 596 ARG A 192 ARG^? 5.91 CL CL A 278 A 647 ARG A 140 ARG.? 3.74 CL CL A 278 coo 69.13 32.20 28.58 68.39 32.96 30.44 14.76 -23.90 -2.78 16.42 -23.89 -4.11 coo 70.89 37.31 29.70 69.54 36.29 32.39 20.84 -24.38 -4.40 19.02 -23.24 -6.62 coo 66.09 40.54 34.70 66.92 37.69 35.49 24.77 -21.68 -10.23 22.52 -23.37 -11.49 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 2 3 # 2 A 581 GLU A 138 GLU^? 6.67 CL CL A 278 A 596 ARG A 140 ARG.? 3.74 CL CL A 278 A 647 ARG A 212 ARG~? 4.63 CL CL A 278 coo 69.13 32.20 28.58 68.39 32.96 30.44 23.86 -20.99 -6.84 22.60 -22.69 -7.03 coo 70.89 37.31 29.70 69.54 36.29 32.39 24.77 -21.68 -10.23 22.52 -23.37 -11.49 coo 66.09 40.54 34.70 66.92 37.69 35.49 18.59 -24.77 -16.89 17.13 -22.12 -16.49 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 3 3 # 3 A 581 GLU A 169 GLU.? 7.63 CL CL A 278 A 596 ARG A 140 ARG.? 3.74 CL CL A 278 A 647 ARG A 192 ARG^? 5.91 CL CL A 278 coo 69.13 32.20 28.58 68.39 32.96 30.44 26.74 -26.14 -12.80 26.49 -24.16 -13.47 coo 70.89 37.31 29.70 69.54 36.29 32.39 24.77 -21.68 -10.23 22.52 -23.37 -11.49 coo 66.09 40.54 34.70 66.92 37.69 35.49 20.84 -24.38 -4.40 19.02 -23.24 -6.62 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 4 3 # 4 A 581 GLU A 169 GLU.? 7.63 CL CL A 278 A 596 ARG A 140 ARG.? 3.74 CL CL A 278 A 647 ARG A 212 ARG~? 4.63 CL CL A 278 coo 69.13 32.20 28.58 68.39 32.96 30.44 26.74 -26.14 -12.80 26.49 -24.16 -13.47 coo 70.89 37.31 29.70 69.54 36.29 32.39 24.77 -21.68 -10.23 22.52 -23.37 -11.49 coo 66.09 40.54 34.70 66.92 37.69 35.49 18.59 -24.77 -16.89 17.13 -22.12 -16.49 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 5 3 # 5 A 581 GLU B 34 GLU^? 8.94 CL CL B 278 A 596 ARG B 192 ARG^? 6.13 CL CL B 278 A 647 ARG B 140 ARG.? -3.53 CL CL B 278s coo 69.13 32.20 28.58 68.39 32.96 30.44 -0.25 -10.10 -26.69 0.15 -8.25 -25.75 coo 70.89 37.31 29.70 69.54 36.29 32.39 -0.17 -3.93 -26.09 1.00 -5.48 -23.71 coo 66.09 40.54 34.70 66.92 37.69 35.49 3.71 0.22 -21.03 2.09 -1.69 -19.26 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 6 3 # 6 A 581 GLU B 138 GLU^? 6.70 CL CL B 278 A 596 ARG B 140 ARG.? -3.53 CL CL B 278s A 647 ARG B 212 ARG~? 4.30 CL CL B 278 coo 69.13 32.20 28.58 68.39 32.96 30.44 3.87 -1.10 -24.33 2.09 -2.15 -23.84 coo 70.89 37.31 29.70 69.54 36.29 32.39 3.71 0.22 -21.03 2.09 -1.69 -19.26 coo 66.09 40.54 34.70 66.92 37.69 35.49 1.13 -4.70 -13.40 3.58 -6.46 -14.00 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 7 3 # 7 A 581 GLU B 169 GLU.? 7.43 CL CL B 278 A 596 ARG B 140 ARG.? -3.53 CL CL B 278s A 647 ARG B 192 ARG^? 6.13 CL CL B 278 coo 69.13 32.20 28.58 68.39 32.96 30.44 0.06 3.03 -18.46 2.10 2.57 -18.04 coo 70.89 37.31 29.70 69.54 36.29 32.39 3.71 0.22 -21.03 2.09 -1.69 -19.26 coo 66.09 40.54 34.70 66.92 37.69 35.49 -0.17 -3.93 -26.09 1.00 -5.48 -23.71 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 8 3 # 8 A 581 GLU B 169 GLU.? 7.43 CL CL B 278 A 596 ARG B 140 ARG.? -3.53 CL CL B 278s A 647 ARG B 212 ARG~? 4.30 CL CL B 278 coo 69.13 32.20 28.58 68.39 32.96 30.44 0.06 3.03 -18.46 2.10 2.57 -18.04 coo 70.89 37.31 29.70 69.54 36.29 32.39 3.71 0.22 -21.03 2.09 -1.69 -19.26 coo 66.09 40.54 34.70 66.92 37.69 35.49 1.13 -4.70 -13.40 3.58 -6.46 -14.00 1v0e_c00 source 1v0e ENDO-ALPHA-SIALIDASE : 8 hits 1v0e_c00 naa= 3 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 1 3 # 1 B 581 GLU A 34 GLU^? 8.78 CL CL A 278 B 596 ARG A 192 ARG^? 5.91 CL CL A 278 B 647 ARG A 140 ARG.? 3.74 CL CL A 278 coo 38.22 57.83 70.36 36.82 56.74 69.18 14.76 -23.90 -2.78 16.42 -23.89 -4.11 coo 34.24 60.89 68.08 33.31 57.93 67.63 20.84 -24.38 -4.40 19.02 -23.24 -6.62 coo 31.43 57.38 61.97 31.90 55.58 64.41 24.77 -21.68 -10.23 22.52 -23.37 -11.49 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 2 3 # 2 B 581 GLU A 138 GLU^? 6.67 CL CL A 278 B 596 ARG A 140 ARG.? 3.74 CL CL A 278 B 647 ARG A 212 ARG~? 4.63 CL CL A 278 coo 38.22 57.83 70.36 36.82 56.74 69.18 23.86 -20.99 -6.84 22.60 -22.69 -7.03 coo 34.24 60.89 68.08 33.31 57.93 67.63 24.77 -21.68 -10.23 22.52 -23.37 -11.49 coo 31.43 57.38 61.97 31.90 55.58 64.41 18.59 -24.77 -16.89 17.13 -22.12 -16.49 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 3 3 # 3 B 581 GLU A 169 GLU.? 7.63 CL CL A 278 B 596 ARG A 140 ARG.? 3.74 CL CL A 278 B 647 ARG A 192 ARG^? 5.91 CL CL A 278 coo 38.22 57.83 70.36 36.82 56.74 69.18 26.74 -26.14 -12.80 26.49 -24.16 -13.47 coo 34.24 60.89 68.08 33.31 57.93 67.63 24.77 -21.68 -10.23 22.52 -23.37 -11.49 coo 31.43 57.38 61.97 31.90 55.58 64.41 20.84 -24.38 -4.40 19.02 -23.24 -6.62 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 4 3 # 4 B 581 GLU A 169 GLU.? 7.63 CL CL A 278 B 596 ARG A 140 ARG.? 3.74 CL CL A 278 B 647 ARG A 212 ARG~? 4.63 CL CL A 278 coo 38.22 57.83 70.36 36.82 56.74 69.18 26.74 -26.14 -12.80 26.49 -24.16 -13.47 coo 34.24 60.89 68.08 33.31 57.93 67.63 24.77 -21.68 -10.23 22.52 -23.37 -11.49 coo 31.43 57.38 61.97 31.90 55.58 64.41 18.59 -24.77 -16.89 17.13 -22.12 -16.49 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 5 3 # 5 B 581 GLU B 34 GLU^? 8.94 CL CL B 278 B 596 ARG B 192 ARG^? 6.13 CL CL B 278 B 647 ARG B 140 ARG.? -3.53 CL CL B 278s coo 38.22 57.83 70.36 36.82 56.74 69.18 -0.25 -10.10 -26.69 0.15 -8.25 -25.75 coo 34.24 60.89 68.08 33.31 57.93 67.63 -0.17 -3.93 -26.09 1.00 -5.48 -23.71 coo 31.43 57.38 61.97 31.90 55.58 64.41 3.71 0.22 -21.03 2.09 -1.69 -19.26 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 6 3 # 6 B 581 GLU B 138 GLU^? 6.70 CL CL B 278 B 596 ARG B 140 ARG.? -3.53 CL CL B 278s B 647 ARG B 212 ARG~? 4.30 CL CL B 278 coo 38.22 57.83 70.36 36.82 56.74 69.18 3.87 -1.10 -24.33 2.09 -2.15 -23.84 coo 34.24 60.89 68.08 33.31 57.93 67.63 3.71 0.22 -21.03 2.09 -1.69 -19.26 coo 31.43 57.38 61.97 31.90 55.58 64.41 1.13 -4.70 -13.40 3.58 -6.46 -14.00 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 7 3 # 7 B 581 GLU B 169 GLU.? 7.43 CL CL B 278 B 596 ARG B 140 ARG.? -3.53 CL CL B 278s B 647 ARG B 192 ARG^? 6.13 CL CL B 278 coo 38.22 57.83 70.36 36.82 56.74 69.18 0.06 3.03 -18.46 2.10 2.57 -18.04 coo 34.24 60.89 68.08 33.31 57.93 67.63 3.71 0.22 -21.03 2.09 -1.69 -19.26 coo 31.43 57.38 61.97 31.90 55.58 64.41 -0.17 -3.93 -26.09 1.00 -5.48 -23.71 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 8 3 # 8 B 581 GLU B 169 GLU.? 7.43 CL CL B 278 B 596 ARG B 140 ARG.? -3.53 CL CL B 278s B 647 ARG B 212 ARG~? 4.30 CL CL B 278 coo 38.22 57.83 70.36 36.82 56.74 69.18 0.06 3.03 -18.46 2.10 2.57 -18.04 coo 34.24 60.89 68.08 33.31 57.93 67.63 3.71 0.22 -21.03 2.09 -1.69 -19.26 coo 31.43 57.38 61.97 31.90 55.58 64.41 1.13 -4.70 -13.40 3.58 -6.46 -14.00 1v0e_c01 source 1v0e ENDO-ALPHA-SIALIDASE : 8 hits 1v0e_c01 naa= 3 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 1 3 # 1 C 581 GLU A 34 GLU^? 8.78 CL CL A 278 C 596 ARG A 192 ARG^? 5.91 CL CL A 278 C 647 ARG A 140 ARG.? 3.74 CL CL A 278 coo 11.31 31.26 27.00 13.31 30.71 26.58 14.76 -23.90 -2.78 16.42 -23.89 -4.11 coo 13.44 32.78 22.07 15.56 30.91 23.37 20.84 -24.38 -4.40 19.02 -23.24 -6.62 coo 21.00 33.35 22.82 19.83 30.82 24.09 24.77 -21.68 -10.23 22.52 -23.37 -11.49 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 2 3 # 2 C 581 GLU A 169 GLU.? 7.63 CL CL A 278 C 596 ARG A 140 ARG.? 3.74 CL CL A 278 C 647 ARG A 192 ARG^? 5.91 CL CL A 278 coo 11.31 31.26 27.00 13.31 30.71 26.58 26.74 -26.14 -12.80 26.49 -24.16 -13.47 coo 13.44 32.78 22.07 15.56 30.91 23.37 24.77 -21.68 -10.23 22.52 -23.37 -11.49 coo 21.00 33.35 22.82 19.83 30.82 24.09 20.84 -24.38 -4.40 19.02 -23.24 -6.62 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 3 3 # 3 C 581 GLU A 169 GLU.? 7.63 CL CL A 278 C 596 ARG A 140 ARG.? 3.74 CL CL A 278 C 647 ARG A 212 ARG~? 4.63 CL CL A 278 coo 11.31 31.26 27.00 13.31 30.71 26.58 26.74 -26.14 -12.80 26.49 -24.16 -13.47 coo 13.44 32.78 22.07 15.56 30.91 23.37 24.77 -21.68 -10.23 22.52 -23.37 -11.49 coo 21.00 33.35 22.82 19.83 30.82 24.09 18.59 -24.77 -16.89 17.13 -22.12 -16.49 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 4 3 # 4 C 581 GLU B 34 GLU^? 8.94 CL CL B 278 C 596 ARG B 192 ARG^? 6.13 CL CL B 278 C 647 ARG B 140 ARG.? -3.53 CL CL B 278s coo 11.31 31.26 27.00 13.31 30.71 26.58 -0.25 -10.10 -26.69 0.15 -8.25 -25.75 coo 13.44 32.78 22.07 15.56 30.91 23.37 -0.17 -3.93 -26.09 1.00 -5.48 -23.71 coo 21.00 33.35 22.82 19.83 30.82 24.09 3.71 0.22 -21.03 2.09 -1.69 -19.26 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 5 3 # 5 C 581 GLU B 169 GLU.? 7.43 CL CL B 278 C 596 ARG B 140 ARG.? -3.53 CL CL B 278s C 647 ARG B 192 ARG^? 6.13 CL CL B 278 coo 11.31 31.26 27.00 13.31 30.71 26.58 0.06 3.03 -18.46 2.10 2.57 -18.04 coo 13.44 32.78 22.07 15.56 30.91 23.37 3.71 0.22 -21.03 2.09 -1.69 -19.26 coo 21.00 33.35 22.82 19.83 30.82 24.09 -0.17 -3.93 -26.09 1.00 -5.48 -23.71 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 6 3 # 6 C 581 GLU B 169 GLU.? 7.43 CL CL B 278 C 596 ARG B 140 ARG.? -3.53 CL CL B 278s C 647 ARG B 212 ARG~? 4.30 CL CL B 278 coo 11.31 31.26 27.00 13.31 30.71 26.58 0.06 3.03 -18.46 2.10 2.57 -18.04 coo 13.44 32.78 22.07 15.56 30.91 23.37 3.71 0.22 -21.03 2.09 -1.69 -19.26 coo 21.00 33.35 22.82 19.83 30.82 24.09 1.13 -4.70 -13.40 3.58 -6.46 -14.00 1v0e_c02 source 1v0e ENDO-ALPHA-SIALIDASE : 6 hits 1v0e_c02 naa= 3 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 1 3 # 1 D 581 GLU A 34 GLU^? 8.78 CL CL A 278 D 596 ARG A 192 ARG^? 5.91 CL CL A 278 D 647 ARG A 140 ARG.? 3.74 CL CL A 278 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 14.76 -23.90 -2.78 16.42 -23.89 -4.11 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 20.84 -24.38 -4.40 19.02 -23.24 -6.62 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 24.77 -21.68 -10.23 22.52 -23.37 -11.49 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 2 3 # 2 D 581 GLU A 138 GLU^? 6.67 CL CL A 278 D 596 ARG A 140 ARG.? 3.74 CL CL A 278 D 647 ARG A 212 ARG~? 4.63 CL CL A 278 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 23.86 -20.99 -6.84 22.60 -22.69 -7.03 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 24.77 -21.68 -10.23 22.52 -23.37 -11.49 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 18.59 -24.77 -16.89 17.13 -22.12 -16.49 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 3 3 # 3 D 581 GLU A 169 GLU.? 7.63 CL CL A 278 D 596 ARG A 140 ARG.? 3.74 CL CL A 278 D 647 ARG A 192 ARG^? 5.91 CL CL A 278 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 26.74 -26.14 -12.80 26.49 -24.16 -13.47 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 24.77 -21.68 -10.23 22.52 -23.37 -11.49 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 20.84 -24.38 -4.40 19.02 -23.24 -6.62 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 4 3 # 4 D 581 GLU A 169 GLU.? 7.63 CL CL A 278 D 596 ARG A 140 ARG.? 3.74 CL CL A 278 D 647 ARG A 212 ARG~? 4.63 CL CL A 278 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 26.74 -26.14 -12.80 26.49 -24.16 -13.47 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 24.77 -21.68 -10.23 22.52 -23.37 -11.49 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 18.59 -24.77 -16.89 17.13 -22.12 -16.49 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 5 3 # 5 D 581 GLU B 34 GLU^? 8.94 CL CL B 278 D 596 ARG B 192 ARG^? 6.13 CL CL B 278 D 647 ARG B 140 ARG.? -3.53 CL CL B 278s coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 -0.25 -10.10 -26.69 0.15 -8.25 -25.75 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 -0.17 -3.93 -26.09 1.00 -5.48 -23.71 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 3.71 0.22 -21.03 2.09 -1.69 -19.26 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 6 3 # 6 D 581 GLU B 138 GLU^? 6.70 CL CL B 278 D 596 ARG B 140 ARG.? -3.53 CL CL B 278s D 647 ARG B 212 ARG~? 4.30 CL CL B 278 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 3.87 -1.10 -24.33 2.09 -2.15 -23.84 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 3.71 0.22 -21.03 2.09 -1.69 -19.26 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 1.13 -4.70 -13.40 3.58 -6.46 -14.00 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 7 3 # 7 D 581 GLU B 169 GLU.? 7.43 CL CL B 278 D 596 ARG B 140 ARG.? -3.53 CL CL B 278s D 647 ARG B 192 ARG^? 6.13 CL CL B 278 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 0.06 3.03 -18.46 2.10 2.57 -18.04 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 3.71 0.22 -21.03 2.09 -1.69 -19.26 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 -0.17 -3.93 -26.09 1.00 -5.48 -23.71 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 8 3 # 8 D 581 GLU B 169 GLU.? 7.43 CL CL B 278 D 596 ARG B 140 ARG.? -3.53 CL CL B 278s D 647 ARG B 212 ARG~? 4.30 CL CL B 278 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 0.06 3.03 -18.46 2.10 2.57 -18.04 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 3.71 0.22 -21.03 2.09 -1.69 -19.26 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 1.13 -4.70 -13.40 3.58 -6.46 -14.00 1v0e_c03 source 1v0e ENDO-ALPHA-SIALIDASE : 8 hits 1v0e_c03 naa= 3 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 1 3 # 1 E 581 GLU A 34 GLU^? 8.78 CL CL A 278 E 596 ARG A 192 ARG^? 5.91 CL CL A 278 E 647 ARG A 140 ARG.? 3.74 CL CL A 278 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 14.76 -23.90 -2.78 16.42 -23.89 -4.11 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 20.84 -24.38 -4.40 19.02 -23.24 -6.62 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 24.77 -21.68 -10.23 22.52 -23.37 -11.49 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 2 3 # 2 E 581 GLU A 169 GLU.? 7.63 CL CL A 278 E 596 ARG A 140 ARG.? 3.74 CL CL A 278 E 647 ARG A 192 ARG^? 5.91 CL CL A 278 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 26.74 -26.14 -12.80 26.49 -24.16 -13.47 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 24.77 -21.68 -10.23 22.52 -23.37 -11.49 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 20.84 -24.38 -4.40 19.02 -23.24 -6.62 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 3 3 # 3 E 581 GLU B 34 GLU^? 8.94 CL CL B 278 E 596 ARG B 192 ARG^? 6.13 CL CL B 278 E 647 ARG B 140 ARG.? -3.53 CL CL B 278s coo 13.14 -15.80 20.26 11.08 -15.36 20.42 -0.25 -10.10 -26.69 0.15 -8.25 -25.75 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 -0.17 -3.93 -26.09 1.00 -5.48 -23.71 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 3.71 0.22 -21.03 2.09 -1.69 -19.26 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 4 3 # 4 E 581 GLU B 138 GLU^? 6.70 CL CL B 278 E 596 ARG B 140 ARG.? -3.53 CL CL B 278s E 647 ARG B 212 ARG~? 4.30 CL CL B 278 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 3.87 -1.10 -24.33 2.09 -2.15 -23.84 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 3.71 0.22 -21.03 2.09 -1.69 -19.26 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 1.13 -4.70 -13.40 3.58 -6.46 -14.00 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 5 3 # 5 E 581 GLU B 169 GLU.? 7.43 CL CL B 278 E 596 ARG B 140 ARG.? -3.53 CL CL B 278s E 647 ARG B 192 ARG^? 6.13 CL CL B 278 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 0.06 3.03 -18.46 2.10 2.57 -18.04 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 3.71 0.22 -21.03 2.09 -1.69 -19.26 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 -0.17 -3.93 -26.09 1.00 -5.48 -23.71 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 6 3 # 6 E 581 GLU B 169 GLU.? 7.43 CL CL B 278 E 596 ARG B 140 ARG.? -3.53 CL CL B 278s E 647 ARG B 212 ARG~? 4.30 CL CL B 278 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 0.06 3.03 -18.46 2.10 2.57 -18.04 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 3.71 0.22 -21.03 2.09 -1.69 -19.26 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 1.13 -4.70 -13.40 3.58 -6.46 -14.00 1v0e_c04 source 1v0e ENDO-ALPHA-SIALIDASE : 6 hits 1v0e_c04 naa= 3 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 1 3 # 1 F 581 GLU A 34 GLU^? 8.78 CL CL A 278 F 596 ARG A 192 ARG^? 5.91 CL CL A 278 F 647 ARG A 140 ARG.? 3.74 CL CL A 278 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 14.76 -23.90 -2.78 16.42 -23.89 -4.11 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 20.84 -24.38 -4.40 19.02 -23.24 -6.62 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 24.77 -21.68 -10.23 22.52 -23.37 -11.49 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 2 3 # 2 F 581 GLU A 138 GLU^? 6.67 CL CL A 278 F 596 ARG A 140 ARG.? 3.74 CL CL A 278 F 647 ARG A 212 ARG~? 4.63 CL CL A 278 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 23.86 -20.99 -6.84 22.60 -22.69 -7.03 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 24.77 -21.68 -10.23 22.52 -23.37 -11.49 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 18.59 -24.77 -16.89 17.13 -22.12 -16.49 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 3 3 # 3 F 581 GLU A 169 GLU.? 7.63 CL CL A 278 F 596 ARG A 140 ARG.? 3.74 CL CL A 278 F 647 ARG A 192 ARG^? 5.91 CL CL A 278 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 26.74 -26.14 -12.80 26.49 -24.16 -13.47 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 24.77 -21.68 -10.23 22.52 -23.37 -11.49 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 20.84 -24.38 -4.40 19.02 -23.24 -6.62 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 4 3 # 4 F 581 GLU A 169 GLU.? 7.63 CL CL A 278 F 596 ARG A 140 ARG.? 3.74 CL CL A 278 F 647 ARG A 212 ARG~? 4.63 CL CL A 278 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 26.74 -26.14 -12.80 26.49 -24.16 -13.47 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 24.77 -21.68 -10.23 22.52 -23.37 -11.49 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 18.59 -24.77 -16.89 17.13 -22.12 -16.49 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 5 3 # 5 F 581 GLU B 34 GLU^? 8.94 CL CL B 278 F 596 ARG B 192 ARG^? 6.13 CL CL B 278 F 647 ARG B 140 ARG.? -3.53 CL CL B 278s coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 -0.25 -10.10 -26.69 0.15 -8.25 -25.75 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 -0.17 -3.93 -26.09 1.00 -5.48 -23.71 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 3.71 0.22 -21.03 2.09 -1.69 -19.26 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 6 3 # 6 F 581 GLU B 138 GLU^? 6.70 CL CL B 278 F 596 ARG B 140 ARG.? -3.53 CL CL B 278s F 647 ARG B 212 ARG~? 4.30 CL CL B 278 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 3.87 -1.10 -24.33 2.09 -2.15 -23.84 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 3.71 0.22 -21.03 2.09 -1.69 -19.26 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 1.13 -4.70 -13.40 3.58 -6.46 -14.00 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 7 3 # 7 F 581 GLU B 169 GLU.? 7.43 CL CL B 278 F 596 ARG B 140 ARG.? -3.53 CL CL B 278s F 647 ARG B 192 ARG^? 6.13 CL CL B 278 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 0.06 3.03 -18.46 2.10 2.57 -18.04 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 3.71 0.22 -21.03 2.09 -1.69 -19.26 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 -0.17 -3.93 -26.09 1.00 -5.48 -23.71 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 8 3 # 8 F 581 GLU B 169 GLU.? 7.43 CL CL B 278 F 596 ARG B 140 ARG.? -3.53 CL CL B 278s F 647 ARG B 212 ARG~? 4.30 CL CL B 278 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 0.06 3.03 -18.46 2.10 2.57 -18.04 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 3.71 0.22 -21.03 2.09 -1.69 -19.26 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 1.13 -4.70 -13.40 3.58 -6.46 -14.00 1v0e_c05 source 1v0e ENDO-ALPHA-SIALIDASE : 8 hits 1v0e_c05 naa= 3 ULMN 3 1vom_c00 MYOSIN user 1 3 # 1 233 ASN A 244 ASN.? 5.40 CL CL A 278 457 GLY A 195 GLY.? 9.62 CL CL A 278 459 GLU A 169 GLU.? 7.63 CL CL A 278 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 17.85 -28.42 -8.05 16.64 -26.87 -8.84 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 22.19 -32.71 -12.39 22.72 -32.07 -12.32 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 26.74 -26.14 -12.80 26.49 -24.16 -13.47 ULMN 3 1vom_c00 MYOSIN user 2 3 # 2 233 ASN A 244 ASN.? 5.40 CL CL A 278 457 GLY A 249 GLY.? 14.98 CL CL A 278 459 GLU A 11 GLU.? 13.55 CL CL A 278 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 17.85 -28.42 -8.05 16.64 -26.87 -8.84 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 10.85 -36.22 -11.47 11.63 -36.38 -11.65 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 7.22 -30.95 -8.53 7.59 -29.14 -7.55 ULMN 3 1vom_c00 MYOSIN user 3 3 # 3 233 ASN B 244 ASN.? 5.94 CL CL B 278 457 GLY B 249 GLY.? 15.61 CL CL B 278 459 GLU B 11 GLU.? 12.74 CL CL B 278 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 -3.88 -6.12 -21.35 -2.47 -7.43 -20.48 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 -11.90 -11.51 -16.09 -11.99 -10.68 -16.03 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 -6.91 -15.96 -19.89 -5.75 -14.85 -18.47 1vom_c00 source 1vom MYOSIN : 3 hits 1vom_c00 naa= 3 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 1 3 # 1 A 100 PHE A 162 PHE.? 19.99 CL CL A 278 A 197 ASN A 185 ASN.? 23.31 CL CL A 278 A 198 PRO A 186 PRO.? 25.85 CL CL A 278 coo 5.24 -2.19 28.74 3.83 -0.30 30.29 27.97 -14.02 2.11 26.93 -11.47 1.71 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 29.16 -19.86 6.66 28.14 -19.34 8.46 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 32.31 -21.59 10.70 31.05 -22.64 9.15 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 2 3 # 2 A 100 PHE B 162 PHE.? 19.81 CL CL B 278 A 197 ASN B 185 ASN.? 23.46 CL CL B 278 A 198 PRO B 186 PRO.? 25.94 CL CL B 278 coo 5.24 -2.19 28.74 3.83 -0.30 30.29 10.02 1.15 -34.61 12.40 -0.26 -34.39 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 3.74 2.53 -38.55 3.92 1.27 -40.29 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 1.63 5.38 -42.65 0.76 4.40 -40.83 1vq1_c00 source 1vq1 N5-GLUTAMINE METHYLTRANSFERASE, HEMK : 2 hits 1vq1_c00 naa= 3 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 1 3 # 1 B 100 PHE A 162 PHE.? 19.99 CL CL A 278 B 197 ASN A 185 ASN.? 23.31 CL CL A 278 B 198 PRO A 186 PRO.? 25.85 CL CL A 278 coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 27.97 -14.02 2.11 26.93 -11.47 1.71 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 29.16 -19.86 6.66 28.14 -19.34 8.46 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 32.31 -21.59 10.70 31.05 -22.64 9.15 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 2 3 # 2 B 100 PHE B 162 PHE.? 19.81 CL CL B 278 B 197 ASN B 185 ASN.? 23.46 CL CL B 278 B 198 PRO B 186 PRO.? 25.94 CL CL B 278 coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 10.02 1.15 -34.61 12.40 -0.26 -34.39 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 3.74 2.53 -38.55 3.92 1.27 -40.29 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 1.63 5.38 -42.65 0.76 4.40 -40.83 1vq1_c01 source 1vq1 N5-GLUTAMINE METHYLTRANSFERASE, HEMK : 2 hits 1vq1_c01 naa= 3 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 1 3 # 1 A 16 TYR A 26 TYR~? 18.66 CL CL A 278 A 40 ASP A 13 ASP~? 20.85 CL CL A 278 A 103 LEU A 15 LEU~? 20.65 CL CL A 278 coo 12.09 16.13 10.57 11.28 18.80 10.73 7.77 -31.94 1.38 10.47 -31.53 0.90 coo 7.55 25.51 14.34 9.65 25.73 14.24 3.80 -37.83 -7.42 4.89 -38.66 -9.05 coo 11.83 18.73 16.99 10.99 19.71 15.26 9.02 -38.74 -1.13 9.14 -36.59 -0.84 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 2 3 # 2 A 16 TYR A 26 TYR~? 18.66 CL CL A 278 A 40 ASP A 268 ASP.? 26.73 CL CL A 278 A 103 LEU A 30 LEU.? 19.87 CL CL A 278 coo 12.09 16.13 10.57 11.28 18.80 10.73 7.77 -31.94 1.38 10.47 -31.53 0.90 coo 7.55 25.51 14.34 9.65 25.73 14.24 9.60 -34.57 10.49 9.97 -36.28 9.26 coo 11.83 18.73 16.99 10.99 19.71 15.26 12.41 -34.45 3.31 13.17 -35.75 1.72 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 3 3 # 3 A 16 TYR A 26 TYR~? 18.66 CL CL A 278 A 40 ASP A 268 ASP.? 26.73 CL CL A 278 A 103 LEU A 32 LEU^? 17.76 CL CL A 278 coo 12.09 16.13 10.57 11.28 18.80 10.73 7.77 -31.94 1.38 10.47 -31.53 0.90 coo 7.55 25.51 14.34 9.65 25.73 14.24 9.60 -34.57 10.49 9.97 -36.28 9.26 coo 11.83 18.73 16.99 10.99 19.71 15.26 15.70 -29.74 4.43 17.08 -28.09 4.08 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 4 3 # 4 A 16 TYR B 26 TYR~? 19.09 CL CL B 278 A 40 ASP B 13 ASP~? 21.13 CL CL B 278 A 103 LEU B 15 LEU~? 20.93 CL CL B 278 coo 12.09 16.13 10.57 11.28 18.80 10.73 -9.51 -16.67 -28.98 -9.06 -13.93 -28.84 coo 7.55 25.51 14.34 9.65 25.73 14.24 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 coo 11.83 18.73 16.99 10.99 19.71 15.26 -14.76 -14.99 -25.18 -14.15 -14.02 -27.01 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 5 3 # 5 A 16 TYR B 26 TYR~? 19.09 CL CL B 278 A 40 ASP B 268 ASP.? 26.26 CL CL B 278 A 103 LEU B 30 LEU.? 20.26 CL CL B 278 coo 12.09 16.13 10.57 11.28 18.80 10.73 -9.51 -16.67 -28.98 -9.06 -13.93 -28.84 coo 7.55 25.51 14.34 9.65 25.73 14.24 -14.31 -16.11 -36.83 -14.03 -14.11 -36.24 coo 11.83 18.73 16.99 10.99 19.71 15.26 -11.82 -11.94 -31.16 -12.78 -10.81 -29.57 1vzz_c00 source 1vzz STEROID DELTA-ISOMERASE : 5 hits 1vzz_c00 naa= 3 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 1 3 # 1 B 16 TYR A 26 TYR~? 18.66 CL CL A 278 B 40 ASP A 13 ASP~? 20.85 CL CL A 278 B 103 LEU A 15 LEU~? 20.65 CL CL A 278 coo 14.25 20.09 37.35 13.48 17.40 37.38 7.77 -31.94 1.38 10.47 -31.53 0.90 coo 9.39 10.77 34.53 11.50 10.63 34.41 3.80 -37.83 -7.42 4.89 -38.66 -9.05 coo 12.89 17.60 31.13 12.34 16.51 32.90 9.02 -38.74 -1.13 9.14 -36.59 -0.84 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 2 3 # 2 B 16 TYR A 26 TYR~? 18.66 CL CL A 278 B 40 ASP A 268 ASP.? 26.73 CL CL A 278 B 103 LEU A 30 LEU.? 19.87 CL CL A 278 coo 14.25 20.09 37.35 13.48 17.40 37.38 7.77 -31.94 1.38 10.47 -31.53 0.90 coo 9.39 10.77 34.53 11.50 10.63 34.41 9.60 -34.57 10.49 9.97 -36.28 9.26 coo 12.89 17.60 31.13 12.34 16.51 32.90 12.41 -34.45 3.31 13.17 -35.75 1.72 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 3 3 # 3 B 16 TYR A 26 TYR~? 18.66 CL CL A 278 B 40 ASP A 268 ASP.? 26.73 CL CL A 278 B 103 LEU A 32 LEU^? 17.76 CL CL A 278 coo 14.25 20.09 37.35 13.48 17.40 37.38 7.77 -31.94 1.38 10.47 -31.53 0.90 coo 9.39 10.77 34.53 11.50 10.63 34.41 9.60 -34.57 10.49 9.97 -36.28 9.26 coo 12.89 17.60 31.13 12.34 16.51 32.90 15.70 -29.74 4.43 17.08 -28.09 4.08 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 4 3 # 4 B 16 TYR B 26 TYR~? 19.09 CL CL B 278 B 40 ASP B 13 ASP~? 21.13 CL CL B 278 B 103 LEU B 15 LEU~? 20.93 CL CL B 278 coo 14.25 20.09 37.35 13.48 17.40 37.38 -9.51 -16.67 -28.98 -9.06 -13.93 -28.84 coo 9.39 10.77 34.53 11.50 10.63 34.41 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 coo 12.89 17.60 31.13 12.34 16.51 32.90 -14.76 -14.99 -25.18 -14.15 -14.02 -27.01 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 5 3 # 5 B 16 TYR B 26 TYR~? 19.09 CL CL B 278 B 40 ASP B 268 ASP.? 26.26 CL CL B 278 B 103 LEU B 30 LEU.? 20.26 CL CL B 278 coo 14.25 20.09 37.35 13.48 17.40 37.38 -9.51 -16.67 -28.98 -9.06 -13.93 -28.84 coo 9.39 10.77 34.53 11.50 10.63 34.41 -14.31 -16.11 -36.83 -14.03 -14.11 -36.24 coo 12.89 17.60 31.13 12.34 16.51 32.90 -11.82 -11.94 -31.16 -12.78 -10.81 -29.57 1vzz_c01 source 1vzz STEROID DELTA-ISOMERASE : 5 hits 1vzz_c01 naa= 3 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 1 3 # 1 A 105 HIS A 194 HIS.? 4.68 CL CL A 278 A 169 ASP A 250 ASP~? 15.45 CL CL A 278 A 288 GLU A 253 GLU~? 21.30 CL CL A 278 coo 67.72 35.99 30.87 69.77 36.13 31.33 21.59 -27.03 -10.13 21.31 -25.37 -8.87 coo 73.17 30.66 22.56 72.87 30.30 20.46 15.24 -38.09 -11.21 14.62 -38.47 -13.19 coo 74.06 28.51 15.92 73.77 29.56 17.73 14.60 -42.99 -6.59 14.44 -44.06 -8.42 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 2 3 # 2 A 105 HIS B 194 HIS.? 5.13 CL CL B 278 A 169 ASP B 250 ASP~? 16.15 CL CL B 278 A 288 GLU B 253 GLU~? 21.95 CL CL B 278 coo 67.72 35.99 30.87 69.77 36.13 31.33 -1.92 -2.21 -20.05 -0.53 -2.75 -21.52 coo 73.17 30.66 22.56 72.87 30.30 20.46 -13.35 -7.01 -16.89 -13.59 -7.26 -14.81 coo 74.06 28.51 15.92 73.77 29.56 17.73 -18.69 -7.91 -20.45 -19.54 -8.29 -18.53 1w1o_c00 source 1w1o CYTOKININ DEHYDROGENASE 1 : 2 hits 1w1o_c00 naa= 3 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 1 3 # 1 A 183 GLY B 248 GLY.? 14.76 CL CL B 278 B 419 GLY B 249 GLY.? 15.61 CL CL B 278 B 420 ALA B 251 ALA~? 13.13 CL CL B 278 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 -10.88 -9.81 -12.81 -10.61 -10.09 -13.55 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 -11.90 -11.51 -16.09 -11.99 -10.68 -16.03 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 -11.21 -8.27 -20.82 -9.88 -9.02 -21.02 1xny_c00 source 1xny PROPIONYL-COA CARBOXYLASE COMPLEX B SUBUNIT : 1 hits 1xny_c00 naa= 3 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 1 3 # 1 A 420 ALA A 251 ALA~? 12.40 CL CL A 278 B 182 GLY A 248 GLY.? 14.14 CL CL A 278 B 183 GLY A 249 GLY.? 14.98 CL CL A 278 coo 38.36-101.47-135.52 39.62-101.29-136.35 14.98 -35.41 -7.43 14.47 -33.98 -7.30 coo 41.93-102.35-126.87 41.52-101.89-126.30 12.18 -35.81 -15.03 12.11 -35.46 -14.29 coo 38.37-101.99-128.11 38.63-102.24-127.37 10.85 -36.22 -11.47 11.63 -36.38 -11.65 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 2 3 # 2 A 420 ALA A 252 ALA~? 17.52 CL CL A 278 B 182 GLY A 248 GLY.? 14.14 CL CL A 278 B 183 GLY A 249 GLY.? 14.98 CL CL A 278 coo 38.36-101.47-135.52 39.62-101.29-136.35 12.87 -37.24 -4.82 11.40 -37.55 -4.97 coo 41.93-102.35-126.87 41.52-101.89-126.30 12.18 -35.81 -15.03 12.11 -35.46 -14.29 coo 38.37-101.99-128.11 38.63-102.24-127.37 10.85 -36.22 -11.47 11.63 -36.38 -11.65 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 3 3 # 3 A 420 ALA B 251 ALA~? 13.13 CL CL B 278 B 182 GLY B 248 GLY.? 14.76 CL CL B 278 B 183 GLY B 249 GLY.? 15.61 CL CL B 278 coo 38.36-101.47-135.52 39.62-101.29-136.35 -11.21 -8.27 -20.82 -9.88 -9.02 -21.02 coo 41.93-102.35-126.87 41.52-101.89-126.30 -10.88 -9.81 -12.81 -10.61 -10.09 -13.55 coo 38.37-101.99-128.11 38.63-102.24-127.37 -11.90 -11.51 -16.09 -11.99 -10.68 -16.03 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 4 3 # 4 A 420 ALA B 252 ALA~? 18.17 CL CL B 278 B 182 GLY B 248 GLY.? 14.76 CL CL B 278 B 183 GLY B 249 GLY.? 15.61 CL CL B 278 coo 38.36-101.47-135.52 39.62-101.29-136.35 -13.56 -10.31 -23.05 -13.89 -11.76 -22.86 coo 41.93-102.35-126.87 41.52-101.89-126.30 -10.88 -9.81 -12.81 -10.61 -10.09 -13.55 coo 38.37-101.99-128.11 38.63-102.24-127.37 -11.90 -11.51 -16.09 -11.99 -10.68 -16.03 1xny_c01 source 1xny PROPIONYL-COA CARBOXYLASE COMPLEX B SUBUNIT : 4 hits 1xny_c01 naa= 3 ULMN 3 1xqd_c02 CYTOCHROME P450 55A1 user 1 3 # 1 A 243 THR A 112 THR.? 13.33 CL CL A 278 A 345 PHE A 109 PHE.? 13.59 CL CL A 278 A 352 CYH A 71 CYH.? 16.56 CL CL A 278 coo 9.58 21.79 21.50 11.25 23.03 20.90 26.24 -13.20 -16.26 24.44 -12.42 -17.13 coo 19.40 19.75 18.58 17.39 17.81 18.80 24.11 -13.43 -7.67 24.08 -11.73 -5.48 coo 21.57 22.52 22.79 19.20 21.13 23.26 19.04 -8.88 -9.96 21.14 -7.72 -8.59 ULMN 3 1xqd_c02 CYTOCHROME P450 55A1 user 2 3 # 2 A 243 THR B 112 THR.? 12.77 CL CL B 278 A 345 PHE B 109 PHE.? 13.18 CL CL B 278 A 352 CYH B 71 CYH.? 16.15 CL CL B 278 coo 9.58 21.79 21.50 11.25 23.03 20.90 13.02 1.47 -16.42 13.78 -0.22 -15.35 coo 19.40 19.75 18.58 17.39 17.81 18.80 11.45 -1.55 -24.49 13.03 -2.08 -26.71 coo 21.57 22.52 22.79 19.20 21.13 23.26 15.78 -6.77 -22.17 17.11 -4.88 -23.73 1xqd_c02 source 1xqd CYTOCHROME P450 55A1 : 2 hits 1xqd_c02 naa= 3 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 B 124 ALA B 136 ALA^? 14.67 CL CL B 278 B 126 ARG B 127 ARG~? 22.49 CL CL B 278 B 138 GLU B 138 GLU^? 6.70 CL CL B 278 coo 2.11 4.00 19.31 3.14 4.86 19.99 5.19 -2.60 -32.46 3.80 -3.13 -32.19 coo 2.45 5.53 11.28 3.59 7.56 13.29 13.11 -0.63 -38.30 10.87 -2.72 -38.33 coo 6.10 2.00 25.24 6.12 1.84 23.13 3.87 -1.10 -24.33 2.09 -2.15 -23.84 1xs1_c07 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 1 hits 1xs1_c07 naa= 3 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 1 3 # 1 B 137 GLY A 111 GLY.? 9.84 CL CL A 278 B 175 ARG A 212 ARG~? 4.63 CL CL A 278 B 242 TYR B 78 TYR~? 9.41 CL CL A 278 coo 99.45 58.28 3.33 99.57 58.61 4.10 25.43 -16.70 -15.06 25.21 -15.89 -15.01 coo 106.37 63.53 0.89 108.02 63.40 -1.62 18.59 -24.77 -16.89 17.13 -22.12 -16.49 coo 100.93 69.04 4.38 99.52 68.48 2.09 18.05 -20.46 -22.54 16.77 -21.06 -20.14 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 2 3 # 2 B 137 GLY B 111 GLY.? 9.20 CL CL B 278 B 175 ARG B 212 ARG~? 4.30 CL CL B 278 B 242 TYR A 78 TYR~? 9.12 CL CL B 278 coo 99.45 58.28 3.33 99.57 58.61 4.10 9.34 0.80 -16.95 10.11 0.51 -17.10 coo 106.37 63.53 0.89 108.02 63.40 -1.62 1.13 -4.70 -13.40 3.58 -6.46 -14.00 coo 100.93 69.04 4.38 99.52 68.48 2.09 5.93 -5.00 -8.22 4.93 -6.54 -10.31 1xva_c03 source 1xva GLYCINE N-METHYLTRANSFERASE : 2 hits 1xva_c03 naa= 3 ULMN 3 1zrz_c02 PROTEIN KINASE C, IOTA user 1 3 # 1 A 369 ASP A 36 ASP~? 8.69 CL CL A 278 A 371 LYS A 64 LYS^? 6.64 CL CL A 278 A 407 THR A 37 THR~? 16.54 CL CL A 278 coo -5.17 31.09 15.73 -7.07 31.12 16.73 11.67 -20.98 -6.16 13.43 -22.16 -5.96 coo -4.43 30.92 22.89 -6.61 31.91 19.71 14.97 -18.21 -2.39 15.88 -19.33 -8.52 coo -8.38 36.02 19.06 -8.83 34.10 19.89 7.80 -18.70 -4.30 6.04 -19.24 -3.16 ULMN 3 1zrz_c02 PROTEIN KINASE C, IOTA user 2 3 # 2 A 369 ASP B 36 ASP~? 8.83 CL CL B 278 A 371 LYS B 64 LYS^? 6.39 CL CL B 278 A 407 THR B 37 THR~? 16.55 CL CL B 278 coo -5.17 31.09 15.73 -7.07 31.12 16.73 2.64 -13.17 -23.36 1.59 -11.35 -23.67 coo -4.43 30.92 22.89 -6.61 31.91 19.71 5.21 -10.68 -27.95 4.80 -8.81 -21.96 coo -8.38 36.02 19.06 -8.83 34.10 19.89 4.16 -17.50 -24.96 3.23 -19.26 -25.80 1zrz_c02 source 1zrz PROTEIN KINASE C, IOTA : 2 hits 1zrz_c02 naa= 3 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 1 3 # 1 193 ASP B 224 ASP~? 22.83 CL CL B 278 219 GLU B 221 GLU~? 17.56 CL CL B 278 294 ASP B 168 ASP^? 12.80 CL CL B 278 coo 27.89 102.52 14.98 29.35 101.92 13.57 -13.88 7.87 -23.86 -15.40 8.87 -22.81 coo 25.84 105.87 9.06 27.86 105.55 8.74 -13.90 4.76 -18.50 -13.25 3.58 -16.87 coo 33.16 106.80 7.72 33.34 104.87 6.92 -5.42 2.81 -22.11 -6.82 3.76 -20.83 2amg_c02 source 2amg 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLASE : 1 hits 2amg_c02 naa= 3 ULMN 3 2apr_c04 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 1 3 # 1 35 ASP A 268 ASP.? 26.73 CL CL A 278 38 SER A 28 SER.? 27.02 CL CL A 278 218 ASP A 267 ASP.? 31.09 CL CL A 278 coo 41.14 58.72 105.19 42.39 59.85 103.92 9.60 -34.57 10.49 9.97 -36.28 9.26 coo 46.04 57.35 103.96 44.97 58.52 105.78 6.29 -36.11 7.11 4.57 -37.31 5.85 coo 41.33 60.20 97.63 42.00 60.96 99.49 11.77 -37.21 15.47 13.23 -35.63 15.60 ULMN 3 2apr_c04 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 2 3 # 2 35 ASP B 268 ASP.? 26.26 CL CL B 278 38 SER B 28 SER.? 27.87 CL CL B 278 218 ASP B 267 ASP.? 32.55 CL CL B 278 coo 41.14 58.72 105.19 42.39 59.85 103.92 -14.31 -16.11 -36.83 -14.03 -14.11 -36.24 coo 46.04 57.35 103.96 44.97 58.52 105.78 -14.66 -18.25 -33.71 -14.43 -20.67 -33.62 coo 41.33 60.20 97.63 42.00 60.96 99.49 -15.25 -13.37 -42.11 -14.97 -14.80 -43.57 2apr_c04 source 2apr ACID PROTEINASE (RHIZOPUSPEPSIN) (E.C.3.4.23.6: 2 hits 2apr_c04 naa= 3 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 1 3 # 1 B 46 HIS A 0 HIS.? 29.82 CL CL A 278 B 163 ALA A 236 ALA~? 23.78 CL CL A 278 B 182 SER A 233 SER~? 24.97 CL CL A 278 coo 30.42 1.98 4.36 29.07 0.41 4.68 28.39 -31.84 13.78 30.11 -32.89 14.37 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 30.05 -27.76 9.83 29.41 -27.47 8.49 coo 24.00 -0.17 2.07 24.51 1.00 0.04 29.21 -32.26 7.91 28.90 -34.64 7.58 2bhg_c02 source 2bhg FOOT-AND-MOUTH DISEASE VIRUS 3C PROTEASE : 1 hits 2bhg_c02 naa= 3 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 1 3 # 1 A 14 ARG A 47 ARG~? 19.53 CL CL B 278 A 161 ASP B 205 ASP.? 14.85 CL CL B 278 A 174 TYR A 78 TYR~? 9.12 CL CL B 278 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 1.19 -18.60 0.09 1.74 -17.18 -2.58 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 1.45 -2.78 -3.16 -0.06 -4.27 -3.04 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 5.93 -5.00 -8.22 4.93 -6.54 -10.31 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 2 3 # 2 A 14 ARG A 140 ARG.? 3.74 CL CL A 278 A 161 ASP A 36 ASP~? 8.69 CL CL A 278 A 174 TYR A 39 TYR~? 9.76 CL CL A 278 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 24.77 -21.68 -10.23 22.52 -23.37 -11.49 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 11.67 -20.98 -6.16 13.43 -22.16 -5.96 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 13.19 -16.19 -7.99 14.85 -15.73 -10.18 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 3 3 # 3 A 14 ARG A 192 ARG^? 5.91 CL CL A 278 A 161 ASP A 250 ASP~? 15.45 CL CL A 278 A 174 TYR A 215 TYR.? 13.87 CL CL A 278 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 20.84 -24.38 -4.40 19.02 -23.24 -6.62 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 15.24 -38.09 -11.21 14.62 -38.47 -13.19 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 21.62 -36.04 -14.58 23.93 -37.55 -14.90 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 4 3 # 4 A 14 ARG A 192 ARG^? 5.91 CL CL A 278 A 161 ASP A 250 ASP~? 15.45 CL CL A 278 A 174 TYR A 217 TYR.? 13.45 CL CL A 278 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 20.84 -24.38 -4.40 19.02 -23.24 -6.62 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 15.24 -38.09 -11.21 14.62 -38.47 -13.19 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 22.77 -37.42 -9.36 23.40 -34.73 -9.58 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 5 3 # 5 A 14 ARG A 209 ARG~? 8.75 CL CL A 278 A 161 ASP A 36 ASP~? 8.69 CL CL A 278 A 174 TYR A 39 TYR~? 9.76 CL CL A 278 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 12.19 -22.36 -19.55 12.55 -20.19 -17.38 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 11.67 -20.98 -6.16 13.43 -22.16 -5.96 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 13.19 -16.19 -7.99 14.85 -15.73 -10.18 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 6 3 # 6 A 14 ARG A 212 ARG~? 4.63 CL CL A 278 A 161 ASP A 36 ASP~? 8.69 CL CL A 278 A 174 TYR A 39 TYR~? 9.76 CL CL A 278 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 18.59 -24.77 -16.89 17.13 -22.12 -16.49 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 11.67 -20.98 -6.16 13.43 -22.16 -5.96 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 13.19 -16.19 -7.99 14.85 -15.73 -10.18 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 7 3 # 7 A 14 ARG A 212 ARG~? 4.63 CL CL A 278 A 161 ASP A 36 ASP~? 8.69 CL CL A 278 A 174 TYR A 40 TYR~? 11.37 CL CL A 278 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 18.59 -24.77 -16.89 17.13 -22.12 -16.49 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 11.67 -20.98 -6.16 13.43 -22.16 -5.96 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 8.64 -16.83 -9.73 10.24 -18.83 -10.81 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 8 3 # 8 A 14 ARG A 212 ARG~? 4.63 CL CL A 278 A 161 ASP A 250 ASP~? 15.45 CL CL A 278 A 174 TYR A 217 TYR.? 13.45 CL CL A 278 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 18.59 -24.77 -16.89 17.13 -22.12 -16.49 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 15.24 -38.09 -11.21 14.62 -38.47 -13.19 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 22.77 -37.42 -9.36 23.40 -34.73 -9.58 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 9 3 # 9 A 14 ARG B 47 ARG~? 19.59 CL CL A 278 A 161 ASP A 205 ASP.? 14.79 CL CL A 278 A 174 TYR B 78 TYR~? 9.41 CL CL A 278 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 3.13 -24.42 -28.62 4.84 -23.96 -26.11 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 19.11 -25.60 -27.15 17.47 -26.92 -26.86 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 18.05 -20.46 -22.54 16.77 -21.06 -20.14 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 10 3 # 10 A 14 ARG B 140 ARG.? -3.53 CL CL B 278s A 161 ASP B 36 ASP~? 8.83 CL CL B 278 A 174 TYR B 39 TYR~? 9.53 CL CL B 278 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 3.71 0.22 -21.03 2.09 -1.69 -19.26 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 2.64 -13.17 -23.36 1.59 -11.35 -23.67 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 7.70 -12.06 -22.38 8.73 -10.22 -20.60 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 11 3 # 11 A 14 ARG B 140 ARG.? -3.53 CL CL B 278s A 161 ASP B 36 ASP~? 8.83 CL CL B 278 A 174 TYR B 40 TYR~? 11.18 CL CL B 278 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 3.71 0.22 -21.03 2.09 -1.69 -19.26 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 2.64 -13.17 -23.36 1.59 -11.35 -23.67 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 6.88 -16.14 -20.02 5.01 -14.26 -19.13 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 12 3 # 12 A 14 ARG B 192 ARG^? 6.13 CL CL B 278 A 161 ASP B 250 ASP~? 16.15 CL CL B 278 A 174 TYR B 215 TYR.? 14.28 CL CL B 278 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 -0.17 -3.93 -26.09 1.00 -5.48 -23.71 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 -13.35 -7.01 -16.89 -13.59 -7.26 -14.81 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 -10.18 -0.68 -14.85 -11.32 1.86 -14.73 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 13 3 # 13 A 14 ARG B 192 ARG^? 6.13 CL CL B 278 A 161 ASP B 250 ASP~? 16.15 CL CL B 278 A 174 TYR B 217 TYR.? 13.94 CL CL B 278 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 -0.17 -3.93 -26.09 1.00 -5.48 -23.71 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 -13.35 -7.01 -16.89 -13.59 -7.26 -14.81 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 -12.06 -0.05 -19.78 -9.32 0.42 -19.98 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 14 3 # 14 A 14 ARG B 212 ARG~? 4.30 CL CL B 278 A 161 ASP B 250 ASP~? 16.15 CL CL B 278 A 174 TYR B 217 TYR.? 13.94 CL CL B 278 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 1.13 -4.70 -13.40 3.58 -6.46 -14.00 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 -13.35 -7.01 -16.89 -13.59 -7.26 -14.81 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 -12.06 -0.05 -19.78 -9.32 0.42 -19.98 2c7v_c08 source 2c7v PTERIDINE REDUCTASE : 14 hits 2c7v_c08 naa= 3 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 1 3 # 1 B 14 ARG A 140 ARG.? 3.74 CL CL A 278 B 161 ASP A 36 ASP~? 8.69 CL CL A 278 B 174 TYR A 39 TYR~? 9.76 CL CL A 278 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 24.77 -21.68 -10.23 22.52 -23.37 -11.49 coo -14.86 10.19 8.14 -14.82 12.31 8.42 11.67 -20.98 -6.16 13.43 -22.16 -5.96 coo -21.46 12.70 8.53 -19.04 12.30 7.24 13.19 -16.19 -7.99 14.85 -15.73 -10.18 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 2 3 # 2 B 14 ARG A 192 ARG^? 5.91 CL CL A 278 B 161 ASP A 250 ASP~? 15.45 CL CL A 278 B 174 TYR A 215 TYR.? 13.87 CL CL A 278 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 20.84 -24.38 -4.40 19.02 -23.24 -6.62 coo -14.86 10.19 8.14 -14.82 12.31 8.42 15.24 -38.09 -11.21 14.62 -38.47 -13.19 coo -21.46 12.70 8.53 -19.04 12.30 7.24 21.62 -36.04 -14.58 23.93 -37.55 -14.90 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 3 3 # 3 B 14 ARG A 192 ARG^? 5.91 CL CL A 278 B 161 ASP A 250 ASP~? 15.45 CL CL A 278 B 174 TYR A 217 TYR.? 13.45 CL CL A 278 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 20.84 -24.38 -4.40 19.02 -23.24 -6.62 coo -14.86 10.19 8.14 -14.82 12.31 8.42 15.24 -38.09 -11.21 14.62 -38.47 -13.19 coo -21.46 12.70 8.53 -19.04 12.30 7.24 22.77 -37.42 -9.36 23.40 -34.73 -9.58 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 4 3 # 4 B 14 ARG A 209 ARG~? 8.75 CL CL A 278 B 161 ASP A 36 ASP~? 8.69 CL CL A 278 B 174 TYR A 39 TYR~? 9.76 CL CL A 278 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 12.19 -22.36 -19.55 12.55 -20.19 -17.38 coo -14.86 10.19 8.14 -14.82 12.31 8.42 11.67 -20.98 -6.16 13.43 -22.16 -5.96 coo -21.46 12.70 8.53 -19.04 12.30 7.24 13.19 -16.19 -7.99 14.85 -15.73 -10.18 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 5 3 # 5 B 14 ARG A 212 ARG~? 4.63 CL CL A 278 B 161 ASP A 36 ASP~? 8.69 CL CL A 278 B 174 TYR A 39 TYR~? 9.76 CL CL A 278 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 18.59 -24.77 -16.89 17.13 -22.12 -16.49 coo -14.86 10.19 8.14 -14.82 12.31 8.42 11.67 -20.98 -6.16 13.43 -22.16 -5.96 coo -21.46 12.70 8.53 -19.04 12.30 7.24 13.19 -16.19 -7.99 14.85 -15.73 -10.18 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 6 3 # 6 B 14 ARG A 212 ARG~? 4.63 CL CL A 278 B 161 ASP A 36 ASP~? 8.69 CL CL A 278 B 174 TYR A 40 TYR~? 11.37 CL CL A 278 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 18.59 -24.77 -16.89 17.13 -22.12 -16.49 coo -14.86 10.19 8.14 -14.82 12.31 8.42 11.67 -20.98 -6.16 13.43 -22.16 -5.96 coo -21.46 12.70 8.53 -19.04 12.30 7.24 8.64 -16.83 -9.73 10.24 -18.83 -10.81 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 7 3 # 7 B 14 ARG A 212 ARG~? 4.63 CL CL A 278 B 161 ASP A 250 ASP~? 15.45 CL CL A 278 B 174 TYR A 217 TYR.? 13.45 CL CL A 278 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 18.59 -24.77 -16.89 17.13 -22.12 -16.49 coo -14.86 10.19 8.14 -14.82 12.31 8.42 15.24 -38.09 -11.21 14.62 -38.47 -13.19 coo -21.46 12.70 8.53 -19.04 12.30 7.24 22.77 -37.42 -9.36 23.40 -34.73 -9.58 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 8 3 # 8 B 14 ARG B 47 ARG~? 19.59 CL CL A 278 B 161 ASP A 205 ASP.? 14.79 CL CL A 278 B 174 TYR B 78 TYR~? 9.41 CL CL A 278 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 3.13 -24.42 -28.62 4.84 -23.96 -26.11 coo -14.86 10.19 8.14 -14.82 12.31 8.42 19.11 -25.60 -27.15 17.47 -26.92 -26.86 coo -21.46 12.70 8.53 -19.04 12.30 7.24 18.05 -20.46 -22.54 16.77 -21.06 -20.14 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 9 3 # 9 B 14 ARG B 140 ARG.? -3.53 CL CL B 278s B 161 ASP B 36 ASP~? 8.83 CL CL B 278 B 174 TYR B 39 TYR~? 9.53 CL CL B 278 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 3.71 0.22 -21.03 2.09 -1.69 -19.26 coo -14.86 10.19 8.14 -14.82 12.31 8.42 2.64 -13.17 -23.36 1.59 -11.35 -23.67 coo -21.46 12.70 8.53 -19.04 12.30 7.24 7.70 -12.06 -22.38 8.73 -10.22 -20.60 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 10 3 # 10 B 14 ARG B 192 ARG^? 6.13 CL CL B 278 B 161 ASP B 250 ASP~? 16.15 CL CL B 278 B 174 TYR B 215 TYR.? 14.28 CL CL B 278 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 -0.17 -3.93 -26.09 1.00 -5.48 -23.71 coo -14.86 10.19 8.14 -14.82 12.31 8.42 -13.35 -7.01 -16.89 -13.59 -7.26 -14.81 coo -21.46 12.70 8.53 -19.04 12.30 7.24 -10.18 -0.68 -14.85 -11.32 1.86 -14.73 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 11 3 # 11 B 14 ARG B 192 ARG^? 6.13 CL CL B 278 B 161 ASP B 250 ASP~? 16.15 CL CL B 278 B 174 TYR B 217 TYR.? 13.94 CL CL B 278 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 -0.17 -3.93 -26.09 1.00 -5.48 -23.71 coo -14.86 10.19 8.14 -14.82 12.31 8.42 -13.35 -7.01 -16.89 -13.59 -7.26 -14.81 coo -21.46 12.70 8.53 -19.04 12.30 7.24 -12.06 -0.05 -19.78 -9.32 0.42 -19.98 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 12 3 # 12 B 14 ARG B 212 ARG~? 4.30 CL CL B 278 B 161 ASP B 250 ASP~? 16.15 CL CL B 278 B 174 TYR B 217 TYR.? 13.94 CL CL B 278 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 1.13 -4.70 -13.40 3.58 -6.46 -14.00 coo -14.86 10.19 8.14 -14.82 12.31 8.42 -13.35 -7.01 -16.89 -13.59 -7.26 -14.81 coo -21.46 12.70 8.53 -19.04 12.30 7.24 -12.06 -0.05 -19.78 -9.32 0.42 -19.98 2c7v_c09 source 2c7v PTERIDINE REDUCTASE : 12 hits 2c7v_c09 naa= 3 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 1 3 # 1 C 14 ARG A 47 ARG~? 19.53 CL CL B 278 C 161 ASP B 205 ASP.? 14.85 CL CL B 278 C 174 TYR A 78 TYR~? 9.12 CL CL B 278 coo 2.84 19.43 40.34 1.59 20.35 37.65 1.19 -18.60 0.09 1.74 -17.18 -2.58 coo -0.62 11.10 28.05 -0.65 13.15 27.46 1.45 -2.78 -3.16 -0.06 -4.27 -3.04 coo 5.94 13.28 27.17 3.53 13.05 28.58 5.93 -5.00 -8.22 4.93 -6.54 -10.31 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 2 3 # 2 C 14 ARG A 140 ARG.? 3.74 CL CL A 278 C 161 ASP A 36 ASP~? 8.69 CL CL A 278 C 174 TYR A 39 TYR~? 9.76 CL CL A 278 coo 2.84 19.43 40.34 1.59 20.35 37.65 24.77 -21.68 -10.23 22.52 -23.37 -11.49 coo -0.62 11.10 28.05 -0.65 13.15 27.46 11.67 -20.98 -6.16 13.43 -22.16 -5.96 coo 5.94 13.28 27.17 3.53 13.05 28.58 13.19 -16.19 -7.99 14.85 -15.73 -10.18 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 3 3 # 3 C 14 ARG A 140 ARG.? 3.74 CL CL A 278 C 161 ASP A 36 ASP~? 8.69 CL CL A 278 C 174 TYR A 40 TYR~? 11.37 CL CL A 278 coo 2.84 19.43 40.34 1.59 20.35 37.65 24.77 -21.68 -10.23 22.52 -23.37 -11.49 coo -0.62 11.10 28.05 -0.65 13.15 27.46 11.67 -20.98 -6.16 13.43 -22.16 -5.96 coo 5.94 13.28 27.17 3.53 13.05 28.58 8.64 -16.83 -9.73 10.24 -18.83 -10.81 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 4 3 # 4 C 14 ARG A 192 ARG^? 5.91 CL CL A 278 C 161 ASP A 250 ASP~? 15.45 CL CL A 278 C 174 TYR A 215 TYR.? 13.87 CL CL A 278 coo 2.84 19.43 40.34 1.59 20.35 37.65 20.84 -24.38 -4.40 19.02 -23.24 -6.62 coo -0.62 11.10 28.05 -0.65 13.15 27.46 15.24 -38.09 -11.21 14.62 -38.47 -13.19 coo 5.94 13.28 27.17 3.53 13.05 28.58 21.62 -36.04 -14.58 23.93 -37.55 -14.90 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 5 3 # 5 C 14 ARG A 192 ARG^? 5.91 CL CL A 278 C 161 ASP A 250 ASP~? 15.45 CL CL A 278 C 174 TYR A 217 TYR.? 13.45 CL CL A 278 coo 2.84 19.43 40.34 1.59 20.35 37.65 20.84 -24.38 -4.40 19.02 -23.24 -6.62 coo -0.62 11.10 28.05 -0.65 13.15 27.46 15.24 -38.09 -11.21 14.62 -38.47 -13.19 coo 5.94 13.28 27.17 3.53 13.05 28.58 22.77 -37.42 -9.36 23.40 -34.73 -9.58 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 6 3 # 6 C 14 ARG A 209 ARG~? 8.75 CL CL A 278 C 161 ASP A 36 ASP~? 8.69 CL CL A 278 C 174 TYR A 39 TYR~? 9.76 CL CL A 278 coo 2.84 19.43 40.34 1.59 20.35 37.65 12.19 -22.36 -19.55 12.55 -20.19 -17.38 coo -0.62 11.10 28.05 -0.65 13.15 27.46 11.67 -20.98 -6.16 13.43 -22.16 -5.96 coo 5.94 13.28 27.17 3.53 13.05 28.58 13.19 -16.19 -7.99 14.85 -15.73 -10.18 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 7 3 # 7 C 14 ARG A 212 ARG~? 4.63 CL CL A 278 C 161 ASP A 36 ASP~? 8.69 CL CL A 278 C 174 TYR A 39 TYR~? 9.76 CL CL A 278 coo 2.84 19.43 40.34 1.59 20.35 37.65 18.59 -24.77 -16.89 17.13 -22.12 -16.49 coo -0.62 11.10 28.05 -0.65 13.15 27.46 11.67 -20.98 -6.16 13.43 -22.16 -5.96 coo 5.94 13.28 27.17 3.53 13.05 28.58 13.19 -16.19 -7.99 14.85 -15.73 -10.18 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 8 3 # 8 C 14 ARG A 212 ARG~? 4.63 CL CL A 278 C 161 ASP A 36 ASP~? 8.69 CL CL A 278 C 174 TYR A 40 TYR~? 11.37 CL CL A 278 coo 2.84 19.43 40.34 1.59 20.35 37.65 18.59 -24.77 -16.89 17.13 -22.12 -16.49 coo -0.62 11.10 28.05 -0.65 13.15 27.46 11.67 -20.98 -6.16 13.43 -22.16 -5.96 coo 5.94 13.28 27.17 3.53 13.05 28.58 8.64 -16.83 -9.73 10.24 -18.83 -10.81 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 9 3 # 9 C 14 ARG A 212 ARG~? 4.63 CL CL A 278 C 161 ASP A 250 ASP~? 15.45 CL CL A 278 C 174 TYR A 217 TYR.? 13.45 CL CL A 278 coo 2.84 19.43 40.34 1.59 20.35 37.65 18.59 -24.77 -16.89 17.13 -22.12 -16.49 coo -0.62 11.10 28.05 -0.65 13.15 27.46 15.24 -38.09 -11.21 14.62 -38.47 -13.19 coo 5.94 13.28 27.17 3.53 13.05 28.58 22.77 -37.42 -9.36 23.40 -34.73 -9.58 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 10 3 # 10 C 14 ARG B 47 ARG~? 19.59 CL CL A 278 C 161 ASP A 205 ASP.? 14.79 CL CL A 278 C 174 TYR B 78 TYR~? 9.41 CL CL A 278 coo 2.84 19.43 40.34 1.59 20.35 37.65 3.13 -24.42 -28.62 4.84 -23.96 -26.11 coo -0.62 11.10 28.05 -0.65 13.15 27.46 19.11 -25.60 -27.15 17.47 -26.92 -26.86 coo 5.94 13.28 27.17 3.53 13.05 28.58 18.05 -20.46 -22.54 16.77 -21.06 -20.14 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 11 3 # 11 C 14 ARG B 140 ARG.? -3.53 CL CL B 278s C 161 ASP B 36 ASP~? 8.83 CL CL B 278 C 174 TYR B 39 TYR~? 9.53 CL CL B 278 coo 2.84 19.43 40.34 1.59 20.35 37.65 3.71 0.22 -21.03 2.09 -1.69 -19.26 coo -0.62 11.10 28.05 -0.65 13.15 27.46 2.64 -13.17 -23.36 1.59 -11.35 -23.67 coo 5.94 13.28 27.17 3.53 13.05 28.58 7.70 -12.06 -22.38 8.73 -10.22 -20.60 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 12 3 # 12 C 14 ARG B 140 ARG.? -3.53 CL CL B 278s C 161 ASP B 36 ASP~? 8.83 CL CL B 278 C 174 TYR B 40 TYR~? 11.18 CL CL B 278 coo 2.84 19.43 40.34 1.59 20.35 37.65 3.71 0.22 -21.03 2.09 -1.69 -19.26 coo -0.62 11.10 28.05 -0.65 13.15 27.46 2.64 -13.17 -23.36 1.59 -11.35 -23.67 coo 5.94 13.28 27.17 3.53 13.05 28.58 6.88 -16.14 -20.02 5.01 -14.26 -19.13 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 13 3 # 13 C 14 ARG B 192 ARG^? 6.13 CL CL B 278 C 161 ASP B 250 ASP~? 16.15 CL CL B 278 C 174 TYR B 215 TYR.? 14.28 CL CL B 278 coo 2.84 19.43 40.34 1.59 20.35 37.65 -0.17 -3.93 -26.09 1.00 -5.48 -23.71 coo -0.62 11.10 28.05 -0.65 13.15 27.46 -13.35 -7.01 -16.89 -13.59 -7.26 -14.81 coo 5.94 13.28 27.17 3.53 13.05 28.58 -10.18 -0.68 -14.85 -11.32 1.86 -14.73 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 14 3 # 14 C 14 ARG B 192 ARG^? 6.13 CL CL B 278 C 161 ASP B 250 ASP~? 16.15 CL CL B 278 C 174 TYR B 217 TYR.? 13.94 CL CL B 278 coo 2.84 19.43 40.34 1.59 20.35 37.65 -0.17 -3.93 -26.09 1.00 -5.48 -23.71 coo -0.62 11.10 28.05 -0.65 13.15 27.46 -13.35 -7.01 -16.89 -13.59 -7.26 -14.81 coo 5.94 13.28 27.17 3.53 13.05 28.58 -12.06 -0.05 -19.78 -9.32 0.42 -19.98 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 15 3 # 15 C 14 ARG B 212 ARG~? 4.30 CL CL B 278 C 161 ASP B 168 ASP^? 12.80 CL CL B 278 C 174 TYR B 217 TYR.? 13.94 CL CL B 278 coo 2.84 19.43 40.34 1.59 20.35 37.65 1.13 -4.70 -13.40 3.58 -6.46 -14.00 coo -0.62 11.10 28.05 -0.65 13.15 27.46 -5.42 2.81 -22.11 -6.82 3.76 -20.83 coo 5.94 13.28 27.17 3.53 13.05 28.58 -12.06 -0.05 -19.78 -9.32 0.42 -19.98 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 16 3 # 16 C 14 ARG B 212 ARG~? 4.30 CL CL B 278 C 161 ASP B 250 ASP~? 16.15 CL CL B 278 C 174 TYR B 217 TYR.? 13.94 CL CL B 278 coo 2.84 19.43 40.34 1.59 20.35 37.65 1.13 -4.70 -13.40 3.58 -6.46 -14.00 coo -0.62 11.10 28.05 -0.65 13.15 27.46 -13.35 -7.01 -16.89 -13.59 -7.26 -14.81 coo 5.94 13.28 27.17 3.53 13.05 28.58 -12.06 -0.05 -19.78 -9.32 0.42 -19.98 2c7v_c10 source 2c7v PTERIDINE REDUCTASE : 16 hits 2c7v_c10 naa= 3 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 1 3 # 1 D 14 ARG A 47 ARG~? 19.53 CL CL B 278 D 161 ASP B 205 ASP.? 14.85 CL CL B 278 D 174 TYR A 78 TYR~? 9.12 CL CL B 278 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 1.19 -18.60 0.09 1.74 -17.18 -2.58 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 1.45 -2.78 -3.16 -0.06 -4.27 -3.04 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 5.93 -5.00 -8.22 4.93 -6.54 -10.31 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 2 3 # 2 D 14 ARG A 140 ARG.? 3.74 CL CL A 278 D 161 ASP A 36 ASP~? 8.69 CL CL A 278 D 174 TYR A 39 TYR~? 9.76 CL CL A 278 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 24.77 -21.68 -10.23 22.52 -23.37 -11.49 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 11.67 -20.98 -6.16 13.43 -22.16 -5.96 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 13.19 -16.19 -7.99 14.85 -15.73 -10.18 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 3 3 # 3 D 14 ARG A 192 ARG^? 5.91 CL CL A 278 D 161 ASP A 250 ASP~? 15.45 CL CL A 278 D 174 TYR A 215 TYR.? 13.87 CL CL A 278 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 20.84 -24.38 -4.40 19.02 -23.24 -6.62 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 15.24 -38.09 -11.21 14.62 -38.47 -13.19 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 21.62 -36.04 -14.58 23.93 -37.55 -14.90 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 4 3 # 4 D 14 ARG A 192 ARG^? 5.91 CL CL A 278 D 161 ASP A 250 ASP~? 15.45 CL CL A 278 D 174 TYR A 217 TYR.? 13.45 CL CL A 278 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 20.84 -24.38 -4.40 19.02 -23.24 -6.62 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 15.24 -38.09 -11.21 14.62 -38.47 -13.19 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 22.77 -37.42 -9.36 23.40 -34.73 -9.58 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 5 3 # 5 D 14 ARG A 209 ARG~? 8.75 CL CL A 278 D 161 ASP A 36 ASP~? 8.69 CL CL A 278 D 174 TYR A 39 TYR~? 9.76 CL CL A 278 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 12.19 -22.36 -19.55 12.55 -20.19 -17.38 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 11.67 -20.98 -6.16 13.43 -22.16 -5.96 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 13.19 -16.19 -7.99 14.85 -15.73 -10.18 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 6 3 # 6 D 14 ARG A 212 ARG~? 4.63 CL CL A 278 D 161 ASP A 36 ASP~? 8.69 CL CL A 278 D 174 TYR A 39 TYR~? 9.76 CL CL A 278 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 18.59 -24.77 -16.89 17.13 -22.12 -16.49 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 11.67 -20.98 -6.16 13.43 -22.16 -5.96 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 13.19 -16.19 -7.99 14.85 -15.73 -10.18 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 7 3 # 7 D 14 ARG A 212 ARG~? 4.63 CL CL A 278 D 161 ASP A 36 ASP~? 8.69 CL CL A 278 D 174 TYR A 40 TYR~? 11.37 CL CL A 278 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 18.59 -24.77 -16.89 17.13 -22.12 -16.49 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 11.67 -20.98 -6.16 13.43 -22.16 -5.96 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 8.64 -16.83 -9.73 10.24 -18.83 -10.81 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 8 3 # 8 D 14 ARG A 212 ARG~? 4.63 CL CL A 278 D 161 ASP A 250 ASP~? 15.45 CL CL A 278 D 174 TYR A 217 TYR.? 13.45 CL CL A 278 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 18.59 -24.77 -16.89 17.13 -22.12 -16.49 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 15.24 -38.09 -11.21 14.62 -38.47 -13.19 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 22.77 -37.42 -9.36 23.40 -34.73 -9.58 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 9 3 # 9 D 14 ARG B 47 ARG~? 19.59 CL CL A 278 D 161 ASP A 205 ASP.? 14.79 CL CL A 278 D 174 TYR B 78 TYR~? 9.41 CL CL A 278 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 3.13 -24.42 -28.62 4.84 -23.96 -26.11 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 19.11 -25.60 -27.15 17.47 -26.92 -26.86 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 18.05 -20.46 -22.54 16.77 -21.06 -20.14 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 10 3 # 10 D 14 ARG B 140 ARG.? -3.53 CL CL B 278s D 161 ASP B 36 ASP~? 8.83 CL CL B 278 D 174 TYR B 39 TYR~? 9.53 CL CL B 278 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 3.71 0.22 -21.03 2.09 -1.69 -19.26 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 2.64 -13.17 -23.36 1.59 -11.35 -23.67 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 7.70 -12.06 -22.38 8.73 -10.22 -20.60 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 11 3 # 11 D 14 ARG B 140 ARG.? -3.53 CL CL B 278s D 161 ASP B 36 ASP~? 8.83 CL CL B 278 D 174 TYR B 40 TYR~? 11.18 CL CL B 278 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 3.71 0.22 -21.03 2.09 -1.69 -19.26 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 2.64 -13.17 -23.36 1.59 -11.35 -23.67 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 6.88 -16.14 -20.02 5.01 -14.26 -19.13 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 12 3 # 12 D 14 ARG B 192 ARG^? 6.13 CL CL B 278 D 161 ASP B 250 ASP~? 16.15 CL CL B 278 D 174 TYR B 215 TYR.? 14.28 CL CL B 278 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 -0.17 -3.93 -26.09 1.00 -5.48 -23.71 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 -13.35 -7.01 -16.89 -13.59 -7.26 -14.81 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 -10.18 -0.68 -14.85 -11.32 1.86 -14.73 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 13 3 # 13 D 14 ARG B 192 ARG^? 6.13 CL CL B 278 D 161 ASP B 250 ASP~? 16.15 CL CL B 278 D 174 TYR B 217 TYR.? 13.94 CL CL B 278 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 -0.17 -3.93 -26.09 1.00 -5.48 -23.71 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 -13.35 -7.01 -16.89 -13.59 -7.26 -14.81 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 -12.06 -0.05 -19.78 -9.32 0.42 -19.98 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 14 3 # 14 D 14 ARG B 212 ARG~? 4.30 CL CL B 278 D 161 ASP B 168 ASP^? 12.80 CL CL B 278 D 174 TYR B 217 TYR.? 13.94 CL CL B 278 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 1.13 -4.70 -13.40 3.58 -6.46 -14.00 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 -5.42 2.81 -22.11 -6.82 3.76 -20.83 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 -12.06 -0.05 -19.78 -9.32 0.42 -19.98 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 15 3 # 15 D 14 ARG B 212 ARG~? 4.30 CL CL B 278 D 161 ASP B 250 ASP~? 16.15 CL CL B 278 D 174 TYR B 217 TYR.? 13.94 CL CL B 278 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 1.13 -4.70 -13.40 3.58 -6.46 -14.00 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 -13.35 -7.01 -16.89 -13.59 -7.26 -14.81 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 -12.06 -0.05 -19.78 -9.32 0.42 -19.98 2c7v_c11 source 2c7v PTERIDINE REDUCTASE : 15 hits 2c7v_c11 naa= 3 ULMN 3 2cnd_c01 NADH-DEPENDENT NITRATE REDUCTASE (CYuser 1 3 # 1 65 THR A 112 THR.? 13.33 CL CL A 278 242 CYH A 71 CYH.? 16.56 CL CL A 278 270 PHE A 109 PHE.? 13.59 CL CL A 278 coo 12.97 28.35 3.84 11.81 28.07 2.09 26.24 -13.20 -16.26 24.44 -12.42 -17.13 coo 8.65 19.49 -2.27 10.50 20.91 -0.59 19.04 -8.88 -9.96 21.14 -7.72 -8.59 coo 9.41 24.60 -3.66 7.52 26.57 -4.16 24.11 -13.43 -7.67 24.08 -11.73 -5.48 ULMN 3 2cnd_c01 NADH-DEPENDENT NITRATE REDUCTASE (CYuser 2 3 # 2 65 THR B 112 THR.? 12.77 CL CL B 278 242 CYH B 71 CYH.? 16.15 CL CL B 278 270 PHE B 109 PHE.? 13.18 CL CL B 278 coo 12.97 28.35 3.84 11.81 28.07 2.09 13.02 1.47 -16.42 13.78 -0.22 -15.35 coo 8.65 19.49 -2.27 10.50 20.91 -0.59 15.78 -6.77 -22.17 17.11 -4.88 -23.73 coo 9.41 24.60 -3.66 7.52 26.57 -4.16 11.45 -1.55 -24.49 13.03 -2.08 -26.71 2cnd_c01 source 2cnd NADH-DEPENDENT NITRATE REDUCTASE (CYTOCHROME B: 2 hits 2cnd_c01 naa= 3 ULMN 3 2cpu_c01 ALPHA-AMYLASE user 1 3 # 1 A 197 ASP A 13 ASP~? 20.85 CL CL A 278 A 233 GLU A 11 GLU.? 13.55 CL CL A 278 A 300 ASN A 246 ASN.? 12.85 CL CL A 278 coo 12.51 17.07 49.46 12.44 16.89 47.35 3.80 -37.83 -7.42 4.89 -38.66 -9.05 coo 6.52 19.14 48.16 7.77 18.42 46.61 7.22 -30.95 -8.53 7.59 -29.14 -7.55 coo 9.30 22.40 41.76 10.10 20.96 40.36 12.83 -32.17 -9.87 11.11 -33.32 -9.30 ULMN 3 2cpu_c01 ALPHA-AMYLASE user 2 3 # 2 A 197 ASP A 36 ASP~? 8.69 CL CL A 278 A 233 GLU A 34 GLU^? 8.78 CL CL A 278 A 300 ASN A 244 ASN.? 5.40 CL CL A 278 coo 12.51 17.07 49.46 12.44 16.89 47.35 11.67 -20.98 -6.16 13.43 -22.16 -5.96 coo 6.52 19.14 48.16 7.77 18.42 46.61 14.76 -23.90 -2.78 16.42 -23.89 -4.11 coo 9.30 22.40 41.76 10.10 20.96 40.36 17.85 -28.42 -8.05 16.64 -26.87 -8.84 ULMN 3 2cpu_c01 ALPHA-AMYLASE user 3 3 # 3 A 197 ASP B 13 ASP~? 21.13 CL CL B 278 A 233 GLU B 11 GLU.? 12.74 CL CL B 278 A 300 ASN B 246 ASN.? 13.30 CL CL B 278 coo 12.51 17.07 49.46 12.44 16.89 47.35 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 coo 6.52 19.14 48.16 7.77 18.42 46.61 -6.91 -15.96 -19.89 -5.75 -14.85 -18.47 coo 9.30 22.40 41.76 10.10 20.96 40.36 -7.71 -10.36 -18.40 -9.09 -11.94 -18.78 ULMN 3 2cpu_c01 ALPHA-AMYLASE user 4 3 # 4 A 197 ASP B 36 ASP~? 8.83 CL CL B 278 A 233 GLU B 34 GLU^? 8.94 CL CL B 278 A 300 ASN B 244 ASN.? 5.94 CL CL B 278 coo 12.51 17.07 49.46 12.44 16.89 47.35 2.64 -13.17 -23.36 1.59 -11.35 -23.67 coo 6.52 19.14 48.16 7.77 18.42 46.61 -0.25 -10.10 -26.69 0.15 -8.25 -25.75 coo 9.30 22.40 41.76 10.10 20.96 40.36 -3.88 -6.12 -21.35 -2.47 -7.43 -20.48 2cpu_c01 source 2cpu ALPHA-AMYLASE : 4 hits 2cpu_c01 naa= 3 ULMN 3 2dbt_c00 CHITINASE C user 1 3 # 1 A 147 GLU A 11 GLU.? 13.55 CL CL A 278 A 156 GLU A 34 GLU^? 8.78 CL CL A 278 A 194 ASN A 245 ASN.? 11.79 CL CL A 278 coo 74.14 15.91 8.55 72.08 15.36 8.63 7.22 -30.95 -8.53 7.59 -29.14 -7.55 coo 67.47 20.07 1.34 65.99 20.06 2.88 14.76 -23.90 -2.78 16.42 -23.89 -4.11 coo 67.44 25.26 13.91 67.54 23.65 15.28 18.48 -33.48 -10.76 18.30 -34.93 -9.15 ULMN 3 2dbt_c00 CHITINASE C user 2 3 # 2 A 147 GLU A 11 GLU.? 13.55 CL CL A 278 A 156 GLU A 34 GLU^? 8.78 CL CL A 278 A 194 ASN A 254 ASN~? 16.17 CL CL A 278 coo 74.14 15.91 8.55 72.08 15.36 8.63 7.22 -30.95 -8.53 7.59 -29.14 -7.55 coo 67.47 20.07 1.34 65.99 20.06 2.88 14.76 -23.90 -2.78 16.42 -23.89 -4.11 coo 67.44 25.26 13.91 67.54 23.65 15.28 18.50 -38.45 -6.68 18.86 -39.34 -8.59 ULMN 3 2dbt_c00 CHITINASE C user 3 3 # 3 A 147 GLU A 34 GLU^? 8.78 CL CL A 278 A 156 GLU A 11 GLU.? 13.55 CL CL A 278 A 194 ASN A 245 ASN.? 11.79 CL CL A 278 coo 74.14 15.91 8.55 72.08 15.36 8.63 14.76 -23.90 -2.78 16.42 -23.89 -4.11 coo 67.47 20.07 1.34 65.99 20.06 2.88 7.22 -30.95 -8.53 7.59 -29.14 -7.55 coo 67.44 25.26 13.91 67.54 23.65 15.28 18.48 -33.48 -10.76 18.30 -34.93 -9.15 ULMN 3 2dbt_c00 CHITINASE C user 4 3 # 4 A 147 GLU A 34 GLU^? 8.78 CL CL A 278 A 156 GLU A 138 GLU^? 6.67 CL CL A 278 A 194 ASN A 245 ASN.? 11.79 CL CL A 278 coo 74.14 15.91 8.55 72.08 15.36 8.63 14.76 -23.90 -2.78 16.42 -23.89 -4.11 coo 67.47 20.07 1.34 65.99 20.06 2.88 23.86 -20.99 -6.84 22.60 -22.69 -7.03 coo 67.44 25.26 13.91 67.54 23.65 15.28 18.48 -33.48 -10.76 18.30 -34.93 -9.15 ULMN 3 2dbt_c00 CHITINASE C user 5 3 # 5 A 147 GLU A 82 GLU~? 22.17 CL CL B 278 A 156 GLU A 74 GLU~? 12.23 CL CL B 278 A 194 ASN B 204 ASN.? 18.45 CL CL B 278 coo 74.14 15.91 8.55 72.08 15.36 8.63 18.08 -1.27 -4.95 20.15 -1.66 -5.22 coo 67.47 20.07 1.34 65.99 20.06 2.88 14.45 -4.40 -13.52 13.94 -3.10 -15.11 coo 67.44 25.26 13.91 67.54 23.65 15.28 6.62 -0.83 -1.08 7.92 0.83 -1.15 ULMN 3 2dbt_c00 CHITINASE C user 6 3 # 6 A 147 GLU A 138 GLU^? 6.67 CL CL A 278 A 156 GLU A 34 GLU^? 8.78 CL CL A 278 A 194 ASN A 245 ASN.? 11.79 CL CL A 278 coo 74.14 15.91 8.55 72.08 15.36 8.63 23.86 -20.99 -6.84 22.60 -22.69 -7.03 coo 67.47 20.07 1.34 65.99 20.06 2.88 14.76 -23.90 -2.78 16.42 -23.89 -4.11 coo 67.44 25.26 13.91 67.54 23.65 15.28 18.48 -33.48 -10.76 18.30 -34.93 -9.15 ULMN 3 2dbt_c00 CHITINASE C user 7 3 # 7 A 147 GLU B 11 GLU.? 12.74 CL CL B 278 A 156 GLU B 34 GLU^? 8.94 CL CL B 278 A 194 ASN B 245 ASN.? 12.34 CL CL B 278 coo 74.14 15.91 8.55 72.08 15.36 8.63 -6.91 -15.96 -19.89 -5.75 -14.85 -18.47 coo 67.47 20.07 1.34 65.99 20.06 2.88 -0.25 -10.10 -26.69 0.15 -8.25 -25.75 coo 67.44 25.26 13.91 67.54 23.65 15.28 -8.45 -4.50 -18.19 -10.06 -4.59 -19.62 ULMN 3 2dbt_c00 CHITINASE C user 8 3 # 8 A 147 GLU B 34 GLU^? 8.94 CL CL B 278 A 156 GLU B 11 GLU.? 12.74 CL CL B 278 A 194 ASN B 245 ASN.? 12.34 CL CL B 278 coo 74.14 15.91 8.55 72.08 15.36 8.63 -0.25 -10.10 -26.69 0.15 -8.25 -25.75 coo 67.47 20.07 1.34 65.99 20.06 2.88 -6.91 -15.96 -19.89 -5.75 -14.85 -18.47 coo 67.44 25.26 13.91 67.54 23.65 15.28 -8.45 -4.50 -18.19 -10.06 -4.59 -19.62 ULMN 3 2dbt_c00 CHITINASE C user 9 3 # 9 A 147 GLU B 34 GLU^? 8.94 CL CL B 278 A 156 GLU B 138 GLU^? 6.70 CL CL B 278 A 194 ASN B 245 ASN.? 12.34 CL CL B 278 coo 74.14 15.91 8.55 72.08 15.36 8.63 -0.25 -10.10 -26.69 0.15 -8.25 -25.75 coo 67.47 20.07 1.34 65.99 20.06 2.88 3.87 -1.10 -24.33 2.09 -2.15 -23.84 coo 67.44 25.26 13.91 67.54 23.65 15.28 -8.45 -4.50 -18.19 -10.06 -4.59 -19.62 ULMN 3 2dbt_c00 CHITINASE C user 10 3 # 10 A 147 GLU B 82 GLU~? 22.63 CL CL A 278 A 156 GLU B 74 GLU~? 12.92 CL CL A 278 A 194 ASN A 204 ASN.? 18.82 CL CL A 278 coo 74.14 15.91 8.55 72.08 15.36 8.63 22.63 -9.38 -27.83 22.57 -7.28 -27.71 coo 67.47 20.07 1.34 65.99 20.06 2.88 20.28 -11.36 -18.58 21.63 -11.86 -17.04 coo 67.44 25.26 13.91 67.54 23.65 15.28 21.41 -21.13 -30.21 23.24 -20.09 -30.49 ULMN 3 2dbt_c00 CHITINASE C user 11 3 # 11 A 147 GLU B 138 GLU^? 6.70 CL CL B 278 A 156 GLU B 34 GLU^? 8.94 CL CL B 278 A 194 ASN B 245 ASN.? 12.34 CL CL B 278 coo 74.14 15.91 8.55 72.08 15.36 8.63 3.87 -1.10 -24.33 2.09 -2.15 -23.84 coo 67.47 20.07 1.34 65.99 20.06 2.88 -0.25 -10.10 -26.69 0.15 -8.25 -25.75 coo 67.44 25.26 13.91 67.54 23.65 15.28 -8.45 -4.50 -18.19 -10.06 -4.59 -19.62 2dbt_c00 source 2dbt CHITINASE C : 11 hits 2dbt_c00 naa= 3 ULMN 3 2dbt_c01 CHITINASE C user 1 3 # 1 B 147 GLU A 11 GLU.? 13.55 CL CL A 278 B 156 GLU A 34 GLU^? 8.78 CL CL A 278 B 194 ASN A 245 ASN.? 11.79 CL CL A 278 coo 45.64 63.11 17.20 47.48 62.43 16.45 7.22 -30.95 -8.53 7.59 -29.14 -7.55 coo 54.43 67.89 19.82 55.62 67.90 18.07 14.76 -23.90 -2.78 16.42 -23.89 -4.11 coo 49.79 70.75 7.78 50.10 68.90 6.86 18.48 -33.48 -10.76 18.30 -34.93 -9.15 ULMN 3 2dbt_c01 CHITINASE C user 2 3 # 2 B 147 GLU A 34 GLU^? 8.78 CL CL A 278 B 156 GLU A 11 GLU.? 13.55 CL CL A 278 B 194 ASN A 245 ASN.? 11.79 CL CL A 278 coo 45.64 63.11 17.20 47.48 62.43 16.45 14.76 -23.90 -2.78 16.42 -23.89 -4.11 coo 54.43 67.89 19.82 55.62 67.90 18.07 7.22 -30.95 -8.53 7.59 -29.14 -7.55 coo 49.79 70.75 7.78 50.10 68.90 6.86 18.48 -33.48 -10.76 18.30 -34.93 -9.15 ULMN 3 2dbt_c01 CHITINASE C user 3 3 # 3 B 147 GLU A 34 GLU^? 8.78 CL CL A 278 B 156 GLU A 138 GLU^? 6.67 CL CL A 278 B 194 ASN A 245 ASN.? 11.79 CL CL A 278 coo 45.64 63.11 17.20 47.48 62.43 16.45 14.76 -23.90 -2.78 16.42 -23.89 -4.11 coo 54.43 67.89 19.82 55.62 67.90 18.07 23.86 -20.99 -6.84 22.60 -22.69 -7.03 coo 49.79 70.75 7.78 50.10 68.90 6.86 18.48 -33.48 -10.76 18.30 -34.93 -9.15 ULMN 3 2dbt_c01 CHITINASE C user 4 3 # 4 B 147 GLU A 82 GLU~? 22.17 CL CL B 278 B 156 GLU A 74 GLU~? 12.23 CL CL B 278 B 194 ASN B 204 ASN.? 18.45 CL CL B 278 coo 45.64 63.11 17.20 47.48 62.43 16.45 18.08 -1.27 -4.95 20.15 -1.66 -5.22 coo 54.43 67.89 19.82 55.62 67.90 18.07 14.45 -4.40 -13.52 13.94 -3.10 -15.11 coo 49.79 70.75 7.78 50.10 68.90 6.86 6.62 -0.83 -1.08 7.92 0.83 -1.15 ULMN 3 2dbt_c01 CHITINASE C user 5 3 # 5 B 147 GLU A 138 GLU^? 6.67 CL CL A 278 B 156 GLU A 34 GLU^? 8.78 CL CL A 278 B 194 ASN A 245 ASN.? 11.79 CL CL A 278 coo 45.64 63.11 17.20 47.48 62.43 16.45 23.86 -20.99 -6.84 22.60 -22.69 -7.03 coo 54.43 67.89 19.82 55.62 67.90 18.07 14.76 -23.90 -2.78 16.42 -23.89 -4.11 coo 49.79 70.75 7.78 50.10 68.90 6.86 18.48 -33.48 -10.76 18.30 -34.93 -9.15 ULMN 3 2dbt_c01 CHITINASE C user 6 3 # 6 B 147 GLU A 138 GLU^? 6.67 CL CL A 278 B 156 GLU A 169 GLU.? 7.63 CL CL A 278 B 194 ASN A 245 ASN.? 11.79 CL CL A 278 coo 45.64 63.11 17.20 47.48 62.43 16.45 23.86 -20.99 -6.84 22.60 -22.69 -7.03 coo 54.43 67.89 19.82 55.62 67.90 18.07 26.74 -26.14 -12.80 26.49 -24.16 -13.47 coo 49.79 70.75 7.78 50.10 68.90 6.86 18.48 -33.48 -10.76 18.30 -34.93 -9.15 ULMN 3 2dbt_c01 CHITINASE C user 7 3 # 7 B 147 GLU A 169 GLU.? 7.63 CL CL A 278 B 156 GLU A 138 GLU^? 6.67 CL CL A 278 B 194 ASN A 245 ASN.? 11.79 CL CL A 278 coo 45.64 63.11 17.20 47.48 62.43 16.45 26.74 -26.14 -12.80 26.49 -24.16 -13.47 coo 54.43 67.89 19.82 55.62 67.90 18.07 23.86 -20.99 -6.84 22.60 -22.69 -7.03 coo 49.79 70.75 7.78 50.10 68.90 6.86 18.48 -33.48 -10.76 18.30 -34.93 -9.15 ULMN 3 2dbt_c01 CHITINASE C user 8 3 # 8 B 147 GLU B 11 GLU.? 12.74 CL CL B 278 B 156 GLU B 34 GLU^? 8.94 CL CL B 278 B 194 ASN B 245 ASN.? 12.34 CL CL B 278 coo 45.64 63.11 17.20 47.48 62.43 16.45 -6.91 -15.96 -19.89 -5.75 -14.85 -18.47 coo 54.43 67.89 19.82 55.62 67.90 18.07 -0.25 -10.10 -26.69 0.15 -8.25 -25.75 coo 49.79 70.75 7.78 50.10 68.90 6.86 -8.45 -4.50 -18.19 -10.06 -4.59 -19.62 ULMN 3 2dbt_c01 CHITINASE C user 9 3 # 9 B 147 GLU B 34 GLU^? 8.94 CL CL B 278 B 156 GLU B 11 GLU.? 12.74 CL CL B 278 B 194 ASN B 245 ASN.? 12.34 CL CL B 278 coo 45.64 63.11 17.20 47.48 62.43 16.45 -0.25 -10.10 -26.69 0.15 -8.25 -25.75 coo 54.43 67.89 19.82 55.62 67.90 18.07 -6.91 -15.96 -19.89 -5.75 -14.85 -18.47 coo 49.79 70.75 7.78 50.10 68.90 6.86 -8.45 -4.50 -18.19 -10.06 -4.59 -19.62 ULMN 3 2dbt_c01 CHITINASE C user 10 3 # 10 B 147 GLU B 34 GLU^? 8.94 CL CL B 278 B 156 GLU B 138 GLU^? 6.70 CL CL B 278 B 194 ASN B 245 ASN.? 12.34 CL CL B 278 coo 45.64 63.11 17.20 47.48 62.43 16.45 -0.25 -10.10 -26.69 0.15 -8.25 -25.75 coo 54.43 67.89 19.82 55.62 67.90 18.07 3.87 -1.10 -24.33 2.09 -2.15 -23.84 coo 49.79 70.75 7.78 50.10 68.90 6.86 -8.45 -4.50 -18.19 -10.06 -4.59 -19.62 ULMN 3 2dbt_c01 CHITINASE C user 11 3 # 11 B 147 GLU B 138 GLU^? 6.70 CL CL B 278 B 156 GLU B 34 GLU^? 8.94 CL CL B 278 B 194 ASN B 245 ASN.? 12.34 CL CL B 278 coo 45.64 63.11 17.20 47.48 62.43 16.45 3.87 -1.10 -24.33 2.09 -2.15 -23.84 coo 54.43 67.89 19.82 55.62 67.90 18.07 -0.25 -10.10 -26.69 0.15 -8.25 -25.75 coo 49.79 70.75 7.78 50.10 68.90 6.86 -8.45 -4.50 -18.19 -10.06 -4.59 -19.62 2dbt_c01 source 2dbt CHITINASE C : 11 hits 2dbt_c01 naa= 3 ULMN 3 2dbt_c02 CHITINASE C user 1 3 # 1 C 147 GLU A 11 GLU.? 13.55 CL CL A 278 C 156 GLU A 34 GLU^? 8.78 CL CL A 278 C 194 ASN A 245 ASN.? 11.79 CL CL A 278 coo 41.23 29.31 13.28 43.03 29.85 12.29 7.22 -30.95 -8.53 7.59 -29.14 -7.55 coo 44.75 23.09 5.51 46.77 22.91 6.12 14.76 -23.90 -2.78 16.42 -23.89 -4.11 coo 49.75 21.00 18.12 50.45 23.02 18.26 18.48 -33.48 -10.76 18.30 -34.93 -9.15 ULMN 3 2dbt_c02 CHITINASE C user 2 3 # 2 C 147 GLU A 11 GLU.? 13.55 CL CL A 278 C 156 GLU A 34 GLU^? 8.78 CL CL A 278 C 194 ASN A 254 ASN~? 16.17 CL CL A 278 coo 41.23 29.31 13.28 43.03 29.85 12.29 7.22 -30.95 -8.53 7.59 -29.14 -7.55 coo 44.75 23.09 5.51 46.77 22.91 6.12 14.76 -23.90 -2.78 16.42 -23.89 -4.11 coo 49.75 21.00 18.12 50.45 23.02 18.26 18.50 -38.45 -6.68 18.86 -39.34 -8.59 ULMN 3 2dbt_c02 CHITINASE C user 3 3 # 3 C 147 GLU A 34 GLU^? 8.78 CL CL A 278 C 156 GLU A 11 GLU.? 13.55 CL CL A 278 C 194 ASN A 245 ASN.? 11.79 CL CL A 278 coo 41.23 29.31 13.28 43.03 29.85 12.29 14.76 -23.90 -2.78 16.42 -23.89 -4.11 coo 44.75 23.09 5.51 46.77 22.91 6.12 7.22 -30.95 -8.53 7.59 -29.14 -7.55 coo 49.75 21.00 18.12 50.45 23.02 18.26 18.48 -33.48 -10.76 18.30 -34.93 -9.15 ULMN 3 2dbt_c02 CHITINASE C user 4 3 # 4 C 147 GLU A 34 GLU^? 8.78 CL CL A 278 C 156 GLU A 138 GLU^? 6.67 CL CL A 278 C 194 ASN A 245 ASN.? 11.79 CL CL A 278 coo 41.23 29.31 13.28 43.03 29.85 12.29 14.76 -23.90 -2.78 16.42 -23.89 -4.11 coo 44.75 23.09 5.51 46.77 22.91 6.12 23.86 -20.99 -6.84 22.60 -22.69 -7.03 coo 49.75 21.00 18.12 50.45 23.02 18.26 18.48 -33.48 -10.76 18.30 -34.93 -9.15 ULMN 3 2dbt_c02 CHITINASE C user 5 3 # 5 C 147 GLU A 82 GLU~? 22.17 CL CL B 278 C 156 GLU A 74 GLU~? 12.23 CL CL B 278 C 194 ASN B 204 ASN.? 18.45 CL CL B 278 coo 41.23 29.31 13.28 43.03 29.85 12.29 18.08 -1.27 -4.95 20.15 -1.66 -5.22 coo 44.75 23.09 5.51 46.77 22.91 6.12 14.45 -4.40 -13.52 13.94 -3.10 -15.11 coo 49.75 21.00 18.12 50.45 23.02 18.26 6.62 -0.83 -1.08 7.92 0.83 -1.15 ULMN 3 2dbt_c02 CHITINASE C user 6 3 # 6 C 147 GLU A 138 GLU^? 6.67 CL CL A 278 C 156 GLU A 34 GLU^? 8.78 CL CL A 278 C 194 ASN A 245 ASN.? 11.79 CL CL A 278 coo 41.23 29.31 13.28 43.03 29.85 12.29 23.86 -20.99 -6.84 22.60 -22.69 -7.03 coo 44.75 23.09 5.51 46.77 22.91 6.12 14.76 -23.90 -2.78 16.42 -23.89 -4.11 coo 49.75 21.00 18.12 50.45 23.02 18.26 18.48 -33.48 -10.76 18.30 -34.93 -9.15 ULMN 3 2dbt_c02 CHITINASE C user 7 3 # 7 C 147 GLU B 11 GLU.? 12.74 CL CL B 278 C 156 GLU B 34 GLU^? 8.94 CL CL B 278 C 194 ASN B 245 ASN.? 12.34 CL CL B 278 coo 41.23 29.31 13.28 43.03 29.85 12.29 -6.91 -15.96 -19.89 -5.75 -14.85 -18.47 coo 44.75 23.09 5.51 46.77 22.91 6.12 -0.25 -10.10 -26.69 0.15 -8.25 -25.75 coo 49.75 21.00 18.12 50.45 23.02 18.26 -8.45 -4.50 -18.19 -10.06 -4.59 -19.62 ULMN 3 2dbt_c02 CHITINASE C user 8 3 # 8 C 147 GLU B 34 GLU^? 8.94 CL CL B 278 C 156 GLU B 138 GLU^? 6.70 CL CL B 278 C 194 ASN B 245 ASN.? 12.34 CL CL B 278 coo 41.23 29.31 13.28 43.03 29.85 12.29 -0.25 -10.10 -26.69 0.15 -8.25 -25.75 coo 44.75 23.09 5.51 46.77 22.91 6.12 3.87 -1.10 -24.33 2.09 -2.15 -23.84 coo 49.75 21.00 18.12 50.45 23.02 18.26 -8.45 -4.50 -18.19 -10.06 -4.59 -19.62 ULMN 3 2dbt_c02 CHITINASE C user 9 3 # 9 C 147 GLU B 82 GLU~? 22.63 CL CL A 278 C 156 GLU B 74 GLU~? 12.92 CL CL A 278 C 194 ASN A 204 ASN.? 18.82 CL CL A 278 coo 41.23 29.31 13.28 43.03 29.85 12.29 22.63 -9.38 -27.83 22.57 -7.28 -27.71 coo 44.75 23.09 5.51 46.77 22.91 6.12 20.28 -11.36 -18.58 21.63 -11.86 -17.04 coo 49.75 21.00 18.12 50.45 23.02 18.26 21.41 -21.13 -30.21 23.24 -20.09 -30.49 ULMN 3 2dbt_c02 CHITINASE C user 10 3 # 10 C 147 GLU B 138 GLU^? 6.70 CL CL B 278 C 156 GLU B 34 GLU^? 8.94 CL CL B 278 C 194 ASN B 245 ASN.? 12.34 CL CL B 278 coo 41.23 29.31 13.28 43.03 29.85 12.29 3.87 -1.10 -24.33 2.09 -2.15 -23.84 coo 44.75 23.09 5.51 46.77 22.91 6.12 -0.25 -10.10 -26.69 0.15 -8.25 -25.75 coo 49.75 21.00 18.12 50.45 23.02 18.26 -8.45 -4.50 -18.19 -10.06 -4.59 -19.62 2dbt_c02 source 2dbt CHITINASE C : 10 hits 2dbt_c02 naa= 3 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 1 3 # 1 A 150 TYR A 26 TYR~? 18.66 CL CL A 278 A 245 ASP A 268 ASP.? 26.73 CL CL A 278 A 273 LYS A 101 LYS.? 27.96 CL CL A 278 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 7.77 -31.94 1.38 10.47 -31.53 0.90 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 9.60 -34.57 10.49 9.97 -36.28 9.26 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 12.62 -22.66 11.02 6.99 -25.01 12.73 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 2 3 # 2 A 150 TYR A 26 TYR~? 18.66 CL CL A 278 A 245 ASP A 268 ASP.? 26.73 CL CL A 278 A 273 LYS A 272 LYS.? 33.16 CL CL A 278 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 7.77 -31.94 1.38 10.47 -31.53 0.90 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 9.60 -34.57 10.49 9.97 -36.28 9.26 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -2.40 -40.27 7.96 -3.06 -34.63 9.73 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 3 3 # 3 A 150 TYR A 79 TYR.? 15.56 CL CL B 278 A 245 ASP B 205 ASP.? 14.85 CL CL B 278 A 273 LYS A 45 LYS~? 28.08 CL CL B 278 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 9.48 -3.09 -3.95 8.21 -5.52 -3.44 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 1.45 -2.78 -3.16 -0.06 -4.27 -3.04 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 3.14 -12.38 5.65 4.44 -8.59 10.01 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 4 3 # 4 A 150 TYR A 217 TYR.? 13.45 CL CL A 278 A 245 ASP A 250 ASP~? 15.45 CL CL A 278 A 273 LYS A 211 LYS~? 14.92 CL CL A 278 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 22.77 -37.42 -9.36 23.40 -34.73 -9.58 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 15.24 -38.09 -11.21 14.62 -38.47 -13.19 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 17.07 -30.19 -20.07 15.73 -30.42 -25.42 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 5 3 # 5 A 150 TYR B 26 TYR~? 19.09 CL CL B 278 A 245 ASP B 268 ASP.? 26.26 CL CL B 278 A 273 LYS B 53 LYS~? 32.92 CL CL B 278 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 -9.51 -16.67 -28.98 -9.06 -13.93 -28.84 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -14.31 -16.11 -36.83 -14.03 -14.11 -36.24 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -3.36 -23.95 -38.76 0.61 -28.64 -40.43 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 6 3 # 6 A 150 TYR B 26 TYR~? 19.09 CL CL B 278 A 245 ASP B 268 ASP.? 26.26 CL CL B 278 A 273 LYS B 101 LYS.? 28.03 CL CL B 278 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 -9.51 -16.67 -28.98 -9.06 -13.93 -28.84 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -14.31 -16.11 -36.83 -14.03 -14.11 -36.24 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -1.11 -13.90 -40.24 -4.27 -19.39 -40.83 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 7 3 # 7 A 150 TYR B 215 TYR.? 14.28 CL CL B 278 A 245 ASP B 250 ASP~? 16.15 CL CL B 278 A 273 LYS B 210 LYS~? 12.46 CL CL B 278 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 -10.18 -0.68 -14.85 -11.32 1.86 -14.73 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -13.35 -7.01 -16.89 -13.59 -7.26 -14.81 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -2.49 -8.60 -10.03 0.77 -12.84 -8.24 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 8 3 # 8 A 150 TYR B 217 TYR.? 13.94 CL CL B 278 A 245 ASP B 250 ASP~? 16.15 CL CL B 278 A 273 LYS B 211 LYS~? 15.02 CL CL B 278 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 -12.06 -0.05 -19.78 -9.32 0.42 -19.98 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -13.35 -7.01 -16.89 -13.59 -7.26 -14.81 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -4.12 -5.20 -9.45 -3.45 -5.07 -3.77 2gsa_c02 source 2gsa GLUTAMATE SEMIALDEHYDE AMINOTRANSFERASE : 8 hits 2gsa_c02 naa= 3 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 1 3 # 1 A 157 PHE A 243 PHE^? 14.37 CL CL A 278 A 245 ASP A 250 ASP~? 15.45 CL CL A 278 A 273 LYS A 211 LYS~? 14.92 CL CL A 278 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 18.82 -34.33 -4.40 20.85 -36.01 -3.52 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 15.24 -38.09 -11.21 14.62 -38.47 -13.19 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 17.07 -30.19 -20.07 15.73 -30.42 -25.42 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 2 3 # 2 A 157 PHE B 243 PHE^? 14.91 CL CL B 278 A 245 ASP B 250 ASP~? 16.15 CL CL B 278 A 273 LYS B 210 LYS~? 12.46 CL CL B 278 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 -10.13 -4.72 -24.34 -11.77 -2.66 -25.27 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -13.35 -7.01 -16.89 -13.59 -7.26 -14.81 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -2.49 -8.60 -10.03 0.77 -12.84 -8.24 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 3 3 # 3 A 157 PHE B 243 PHE^? 14.91 CL CL B 278 A 245 ASP B 250 ASP~? 16.15 CL CL B 278 A 273 LYS B 211 LYS~? 15.02 CL CL B 278 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 -10.13 -4.72 -24.34 -11.77 -2.66 -25.27 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -13.35 -7.01 -16.89 -13.59 -7.26 -14.81 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -4.12 -5.20 -9.45 -3.45 -5.07 -3.77 2gsa_c04 source 2gsa GLUTAMATE SEMIALDEHYDE AMINOTRANSFERASE : 3 hits 2gsa_c04 naa= 3 ULMN 3 2hdh_c02 L-3-HYDROXYACYL COA DEHYDROGENASE user 1 3 # 1 B 137 SER B 8 SER.? 14.26 CL CL B 278 B 158 HIS B 12 HIS~? 15.42 CL CL B 278 B 208 ASN B 246 ASN.? 13.30 CL CL B 278 coo 50.29 50.10 71.46 47.85 50.06 71.46 -4.13 -15.22 -24.13 -4.29 -16.76 -22.25 coo 48.67 45.40 71.68 47.67 46.90 70.60 -10.18 -14.51 -22.80 -8.49 -13.29 -22.60 coo 48.91 49.12 65.17 47.29 49.14 66.54 -7.71 -10.36 -18.40 -9.09 -11.94 -18.78 2hdh_c02 source 2hdh L-3-HYDROXYACYL COA DEHYDROGENASE : 1 hits 2hdh_c02 naa= 3 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 1 3 # 1 A 311 HIS A 29 HIS.? 25.16 CL CL A 278 A 341 GLU A 25 GLU~? 26.70 CL CL A 278 A 356 HIS A 12 HIS~? 14.78 CL CL A 278 coo 121.00 36.37 19.26 121.57 38.37 19.56 7.41 -38.44 3.20 5.56 -39.41 3.04 coo 125.72 32.70 19.75 124.44 34.16 18.84 0.23 -35.14 2.73 -1.02 -35.12 1.03 coo 124.34 41.73 25.55 123.79 42.60 23.72 9.03 -33.35 -4.93 10.37 -31.88 -5.56 2isd_c00 source 2isd PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C, ISO: 1 hits 2isd_c00 naa= 3 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 1 3 # 1 B 311 HIS A 29 HIS.? 25.16 CL CL A 278 B 341 GLU A 25 GLU~? 26.70 CL CL A 278 B 356 HIS A 12 HIS~? 14.78 CL CL A 278 coo 77.20 37.63 -25.62 77.60 39.62 -25.06 7.41 -38.44 3.20 5.56 -39.41 3.04 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 0.23 -35.14 2.73 -1.02 -35.12 1.03 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 9.03 -33.35 -4.93 10.37 -31.88 -5.56 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 2 3 # 2 B 311 HIS B 29 HIS.? 25.42 CL CL B 278 B 341 GLU B 25 GLU~? 26.94 CL CL B 278 B 356 HIS B 12 HIS~? 15.42 CL CL B 278 coo 77.20 37.63 -25.62 77.60 39.62 -25.06 -16.16 -16.38 -29.82 -17.24 -18.07 -29.20 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 -13.37 -23.90 -28.96 -13.41 -24.80 -27.04 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 -10.18 -14.51 -22.80 -8.49 -13.29 -22.60 2isd_c01 source 2isd PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C, ISO: 2 hits 2isd_c01 naa= 3 ULMN 3 2jxr_c04 LIGAND CP-081282 user 1 3 # 1 A 32 ASP A 268 ASP.? 26.73 CL CL A 278 A 35 SER A 28 SER.? 27.02 CL CL A 278 A 215 ASP A 267 ASP.? 31.09 CL CL A 278 coo -14.00 61.45 43.99 -14.19 63.14 42.84 9.60 -34.57 10.49 9.97 -36.28 9.26 coo -13.21 66.21 45.84 -15.49 65.90 45.84 6.29 -36.11 7.11 4.57 -37.31 5.85 coo -10.72 64.19 37.77 -12.20 64.43 39.15 11.77 -37.21 15.47 13.23 -35.63 15.60 ULMN 3 2jxr_c04 LIGAND CP-081282 user 2 3 # 2 A 32 ASP B 268 ASP.? 26.26 CL CL B 278 A 35 SER B 28 SER.? 27.87 CL CL B 278 A 215 ASP B 267 ASP.? 32.55 CL CL B 278 coo -14.00 61.45 43.99 -14.19 63.14 42.84 -14.31 -16.11 -36.83 -14.03 -14.11 -36.24 coo -13.21 66.21 45.84 -15.49 65.90 45.84 -14.66 -18.25 -33.71 -14.43 -20.67 -33.62 coo -10.72 64.19 37.77 -12.20 64.43 39.15 -15.25 -13.37 -42.11 -14.97 -14.80 -43.57 2jxr_c04 source 2jxr LIGAND CP-081282 : 2 hits 2jxr_c04 naa= 3 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 1 3 # 1 A 57 HIS A 12 HIS~? 14.78 CL CL A 278 A 102 ASP A 13 ASP~? 20.85 CL CL A 278 A 193 GLY A 5 GLY^? 15.84 CL CL A 278 coo 14.96 29.22 19.55 15.62 29.93 17.67 9.03 -33.35 -4.93 10.37 -31.88 -5.56 coo 19.64 30.69 22.61 18.18 29.94 21.25 3.80 -37.83 -7.42 4.89 -38.66 -9.05 coo 14.54 28.99 9.76 15.06 29.59 10.02 15.52 -31.61 0.74 16.07 -31.86 0.19 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 2 3 # 2 A 57 HIS B 12 HIS~? 15.42 CL CL B 278 A 102 ASP B 13 ASP~? 21.13 CL CL B 278 A 193 GLY B 5 GLY^? 16.39 CL CL B 278 coo 14.96 29.22 19.55 15.62 29.93 17.67 -10.18 -14.51 -22.80 -8.49 -13.29 -22.60 coo 19.64 30.69 22.61 18.18 29.94 21.25 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 coo 14.54 28.99 9.76 15.06 29.59 10.02 -8.44 -9.04 -29.52 -8.55 -8.38 -29.05 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 3 3 # 3 A 57 HIS B 29 HIS.? 25.42 CL CL B 278 A 102 ASP B 268 ASP.? 26.26 CL CL B 278 A 193 GLY B 17 GLY~? 26.14 CL CL B 278 coo 14.96 29.22 19.55 15.62 29.93 17.67 -16.16 -16.38 -29.82 -17.24 -18.07 -29.20 coo 19.64 30.69 22.61 18.18 29.94 21.25 -14.31 -16.11 -36.83 -14.03 -14.11 -36.24 coo 14.54 28.99 9.76 15.06 29.59 10.02 -18.23 -20.62 -22.29 -17.41 -20.69 -22.32 2lpr_c02 source 2lpr ALPHA-LYTIC PROTEASE : 3 hits 2lpr_c02 naa= 3 ULMN 3 2phk_c02 MC-PEPTIDE user 1 3 # 1 A 149 ASP A 36 ASP~? 8.69 CL CL A 278 A 151 LYS A 64 LYS^? 6.64 CL CL A 278 A 186 THR A 7 THR^? 8.89 CL CL A 278 coo 41.42 17.90 44.98 43.39 18.36 45.61 11.67 -20.98 -6.16 13.43 -22.16 -5.96 coo 45.75 16.58 39.61 47.43 18.26 45.54 14.97 -18.21 -2.39 15.88 -19.33 -8.52 coo 45.88 23.02 44.72 46.99 21.16 44.68 12.66 -27.68 -4.47 14.06 -27.36 -6.07 ULMN 3 2phk_c02 MC-PEPTIDE user 2 3 # 2 A 149 ASP A 36 ASP~? 8.69 CL CL A 278 A 151 LYS A 64 LYS^? 6.64 CL CL A 278 A 186 THR A 37 THR~? 16.54 CL CL A 278 coo 41.42 17.90 44.98 43.39 18.36 45.61 11.67 -20.98 -6.16 13.43 -22.16 -5.96 coo 45.75 16.58 39.61 47.43 18.26 45.54 14.97 -18.21 -2.39 15.88 -19.33 -8.52 coo 45.88 23.02 44.72 46.99 21.16 44.68 7.80 -18.70 -4.30 6.04 -19.24 -3.16 ULMN 3 2phk_c02 MC-PEPTIDE user 3 3 # 3 A 149 ASP B 36 ASP~? 8.83 CL CL B 278 A 151 LYS B 64 LYS^? 6.39 CL CL B 278 A 186 THR B 7 THR^? 9.20 CL CL B 278 coo 41.42 17.90 44.98 43.39 18.36 45.61 2.64 -13.17 -23.36 1.59 -11.35 -23.67 coo 45.75 16.58 39.61 47.43 18.26 45.54 5.21 -10.68 -27.95 4.80 -8.81 -21.96 coo 45.88 23.02 44.72 46.99 21.16 44.68 -4.08 -11.42 -24.47 -3.39 -9.92 -23.07 ULMN 3 2phk_c02 MC-PEPTIDE user 4 3 # 4 A 149 ASP B 36 ASP~? 8.83 CL CL B 278 A 151 LYS B 64 LYS^? 6.39 CL CL B 278 A 186 THR B 37 THR~? 16.55 CL CL B 278 coo 41.42 17.90 44.98 43.39 18.36 45.61 2.64 -13.17 -23.36 1.59 -11.35 -23.67 coo 45.75 16.58 39.61 47.43 18.26 45.54 5.21 -10.68 -27.95 4.80 -8.81 -21.96 coo 45.88 23.02 44.72 46.99 21.16 44.68 4.16 -17.50 -24.96 3.23 -19.26 -25.80 2phk_c02 source 2phk MC-PEPTIDE : 4 hits 2phk_c02 naa= 3 ULMN 3 2pth_c00 PEPTIDYL-TRNA HYDROLASE user 1 3 # 1 10 ASN A 218 ASN~? 20.82 CL CL A 278 20 HIS A 216 HIS.? 18.50 CL CL A 278 93 ASP A 250 ASP~? 15.45 CL CL A 278 coo 45.21 45.27 48.24 46.79 44.92 46.88 24.13 -43.84 -11.70 26.14 -43.18 -11.76 coo 47.05 39.55 45.24 48.99 39.30 44.46 17.97 -41.33 -12.21 17.58 -42.84 -10.82 coo 46.96 34.22 47.29 47.91 35.95 46.52 15.24 -38.09 -11.21 14.62 -38.47 -13.19 ULMN 3 2pth_c00 PEPTIDYL-TRNA HYDROLASE user 2 3 # 2 10 ASN A 246 ASN.? 12.85 CL CL A 278 20 HIS A 12 HIS~? 14.78 CL CL A 278 93 ASP A 13 ASP~? 20.85 CL CL A 278 coo 45.21 45.27 48.24 46.79 44.92 46.88 12.83 -32.17 -9.87 11.11 -33.32 -9.30 coo 47.05 39.55 45.24 48.99 39.30 44.46 9.03 -33.35 -4.93 10.37 -31.88 -5.56 coo 46.96 34.22 47.29 47.91 35.95 46.52 3.80 -37.83 -7.42 4.89 -38.66 -9.05 ULMN 3 2pth_c00 PEPTIDYL-TRNA HYDROLASE user 3 3 # 3 10 ASN B 218 ASN~? 21.19 CL CL B 278 20 HIS B 216 HIS.? 19.24 CL CL B 278 93 ASP B 250 ASP~? 16.15 CL CL B 278 coo 45.21 45.27 48.24 46.79 44.92 46.88 -17.80 2.35 -16.65 -17.00 4.26 -17.12 coo 47.05 39.55 45.24 48.99 39.30 44.46 -16.22 -3.98 -15.80 -17.90 -4.46 -16.96 coo 46.96 34.22 47.29 47.91 35.95 46.52 -13.35 -7.01 -16.89 -13.59 -7.26 -14.81 ULMN 3 2pth_c00 PEPTIDYL-TRNA HYDROLASE user 4 3 # 4 10 ASN B 246 ASN.? 13.30 CL CL B 278 20 HIS B 12 HIS~? 15.42 CL CL B 278 93 ASP B 13 ASP~? 21.13 CL CL B 278 coo 45.21 45.27 48.24 46.79 44.92 46.88 -7.71 -10.36 -18.40 -9.09 -11.94 -18.78 coo 47.05 39.55 45.24 48.99 39.30 44.46 -10.18 -14.51 -22.80 -8.49 -13.29 -22.60 coo 46.96 34.22 47.29 47.91 35.95 46.52 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 2pth_c00 source 2pth PEPTIDYL-TRNA HYDROLASE : 4 hits 2pth_c00 naa= 3 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 1 3 # 1 141 ASP A 13 ASP~? 20.85 CL CL A 278 166 GLY A 195 GLY.? 9.62 CL CL A 278 169 GLU A 169 GLU.? 7.63 CL CL A 278 coo 8.28 6.87 1.62 10.08 5.77 1.34 3.80 -37.83 -7.42 4.89 -38.66 -9.05 coo -8.58 13.22 3.21 -8.90 13.15 4.05 22.19 -32.71 -12.39 22.72 -32.07 -12.32 coo -16.67 7.89 2.78 -17.65 6.56 1.49 26.74 -26.14 -12.80 26.49 -24.16 -13.47 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 2 3 # 2 141 ASP A 13 ASP~? 20.85 CL CL A 278 166 GLY A 195 GLY.? 9.62 CL CL A 278 169 GLU A 221 GLU~? 17.05 CL CL A 278 coo 8.28 6.87 1.62 10.08 5.77 1.34 3.80 -37.83 -7.42 4.89 -38.66 -9.05 coo -8.58 13.22 3.21 -8.90 13.15 4.05 22.19 -32.71 -12.39 22.72 -32.07 -12.32 coo -16.67 7.89 2.78 -17.65 6.56 1.49 27.14 -39.98 -10.94 25.92 -39.21 -12.48 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 3 3 # 3 141 ASP A 36 ASP~? 8.69 CL CL A 278 166 GLY A 195 GLY.? 9.62 CL CL A 278 169 GLU A 221 GLU~? 17.05 CL CL A 278 coo 8.28 6.87 1.62 10.08 5.77 1.34 11.67 -20.98 -6.16 13.43 -22.16 -5.96 coo -8.58 13.22 3.21 -8.90 13.15 4.05 22.19 -32.71 -12.39 22.72 -32.07 -12.32 coo -16.67 7.89 2.78 -17.65 6.56 1.49 27.14 -39.98 -10.94 25.92 -39.21 -12.48 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 4 3 # 4 141 ASP A 36 ASP~? 8.69 CL CL A 278 166 GLY B 73 GLY.? 14.67 CL CL A 278 169 GLU B 82 GLU~? 22.63 CL CL A 278 coo 8.28 6.87 1.62 10.08 5.77 1.34 11.67 -20.98 -6.16 13.43 -22.16 -5.96 coo -8.58 13.22 3.21 -8.90 13.15 4.05 15.57 -11.40 -19.83 15.87 -10.68 -20.14 coo -16.67 7.89 2.78 -17.65 6.56 1.49 22.63 -9.38 -27.83 22.57 -7.28 -27.71 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 5 3 # 5 141 ASP A 205 ASP.? 14.79 CL CL A 278 166 GLY A 195 GLY.? 9.62 CL CL A 278 169 GLU A 221 GLU~? 17.05 CL CL A 278 coo 8.28 6.87 1.62 10.08 5.77 1.34 19.11 -25.60 -27.15 17.47 -26.92 -26.86 coo -8.58 13.22 3.21 -8.90 13.15 4.05 22.19 -32.71 -12.39 22.72 -32.07 -12.32 coo -16.67 7.89 2.78 -17.65 6.56 1.49 27.14 -39.98 -10.94 25.92 -39.21 -12.48 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 6 3 # 6 141 ASP A 205 ASP.? 14.79 CL CL A 278 166 GLY B 73 GLY.? 14.67 CL CL A 278 169 GLU A 74 GLU~? 12.23 CL CL B 278 coo 8.28 6.87 1.62 10.08 5.77 1.34 19.11 -25.60 -27.15 17.47 -26.92 -26.86 coo -8.58 13.22 3.21 -8.90 13.15 4.05 15.57 -11.40 -19.83 15.87 -10.68 -20.14 coo -16.67 7.89 2.78 -17.65 6.56 1.49 14.45 -4.40 -13.52 13.94 -3.10 -15.11 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 7 3 # 7 141 ASP A 224 ASP~? 22.21 CL CL A 278 166 GLY A 240 GLY^? 17.38 CL CL A 278 169 GLU A 238 GLU^? 24.84 CL CL A 278 coo 8.28 6.87 1.62 10.08 5.77 1.34 30.83 -39.35 -6.18 31.71 -41.01 -7.15 coo -8.58 13.22 3.21 -8.90 13.15 4.05 21.72 -28.69 3.88 22.49 -28.89 3.61 coo -16.67 7.89 2.78 -17.65 6.56 1.49 22.87 -26.18 11.53 21.04 -27.14 11.99 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 8 3 # 8 141 ASP A 250 ASP~? 15.45 CL CL A 278 166 GLY A 240 GLY^? 17.38 CL CL A 278 169 GLU A 238 GLU^? 24.84 CL CL A 278 coo 8.28 6.87 1.62 10.08 5.77 1.34 15.24 -38.09 -11.21 14.62 -38.47 -13.19 coo -8.58 13.22 3.21 -8.90 13.15 4.05 21.72 -28.69 3.88 22.49 -28.89 3.61 coo -16.67 7.89 2.78 -17.65 6.56 1.49 22.87 -26.18 11.53 21.04 -27.14 11.99 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 9 3 # 9 141 ASP B 13 ASP~? 21.13 CL CL B 278 166 GLY B 195 GLY.? 10.21 CL CL B 278 169 GLU B 169 GLU.? 7.43 CL CL B 278 coo 8.28 6.87 1.62 10.08 5.77 1.34 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -7.22 -0.77 -17.24 -6.51 -0.37 -17.47 coo -16.67 7.89 2.78 -17.65 6.56 1.49 0.06 3.03 -18.46 2.10 2.57 -18.04 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 10 3 # 10 141 ASP B 13 ASP~? 21.13 CL CL B 278 166 GLY B 195 GLY.? 10.21 CL CL B 278 169 GLU B 221 GLU~? 17.56 CL CL B 278 coo 8.28 6.87 1.62 10.08 5.77 1.34 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -7.22 -0.77 -17.24 -6.51 -0.37 -17.47 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -13.90 4.76 -18.50 -13.25 3.58 -16.87 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 11 3 # 11 141 ASP B 36 ASP~? 8.83 CL CL B 278 166 GLY A 73 GLY.? 14.13 CL CL B 278 169 GLU A 82 GLU~? 22.17 CL CL B 278 coo 8.28 6.87 1.62 10.08 5.77 1.34 2.64 -13.17 -23.36 1.59 -11.35 -23.67 coo -8.58 13.22 3.21 -8.90 13.15 4.05 14.30 -8.81 -11.73 15.07 -8.55 -11.50 coo -16.67 7.89 2.78 -17.65 6.56 1.49 18.08 -1.27 -4.95 20.15 -1.66 -5.22 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 12 3 # 12 141 ASP B 36 ASP~? 8.83 CL CL B 278 166 GLY B 195 GLY.? 10.21 CL CL B 278 169 GLU B 221 GLU~? 17.56 CL CL B 278 coo 8.28 6.87 1.62 10.08 5.77 1.34 2.64 -13.17 -23.36 1.59 -11.35 -23.67 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -7.22 -0.77 -17.24 -6.51 -0.37 -17.47 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -13.90 4.76 -18.50 -13.25 3.58 -16.87 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 13 3 # 13 141 ASP B 205 ASP.? 14.85 CL CL B 278 166 GLY A 73 GLY.? 14.13 CL CL B 278 169 GLU B 74 GLU~? 12.92 CL CL A 278 coo 8.28 6.87 1.62 10.08 5.77 1.34 1.45 -2.78 -3.16 -0.06 -4.27 -3.04 coo -8.58 13.22 3.21 -8.90 13.15 4.05 14.30 -8.81 -11.73 15.07 -8.55 -11.50 coo -16.67 7.89 2.78 -17.65 6.56 1.49 20.28 -11.36 -18.58 21.63 -11.86 -17.04 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 14 3 # 14 141 ASP B 224 ASP~? 22.83 CL CL B 278 166 GLY B 240 GLY^? 17.65 CL CL B 278 169 GLU B 238 GLU^? 25.19 CL CL B 278 coo 8.28 6.87 1.62 10.08 5.77 1.34 -13.88 7.87 -23.86 -15.40 8.87 -22.81 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -5.33 -3.65 -33.67 -5.41 -2.84 -33.48 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -3.49 -3.71 -41.35 -4.99 -5.08 -41.88 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 15 3 # 15 141 ASP B 250 ASP~? 16.15 CL CL B 278 166 GLY B 240 GLY^? 17.65 CL CL B 278 169 GLU B 238 GLU^? 25.19 CL CL B 278 coo 8.28 6.87 1.62 10.08 5.77 1.34 -13.35 -7.01 -16.89 -13.59 -7.26 -14.81 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -5.33 -3.65 -33.67 -5.41 -2.84 -33.48 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -3.49 -3.71 -41.35 -4.99 -5.08 -41.88 2tdt_c00 source 2tdt TETRAHYDRODIPICOLINATE N-SUCCINYLTRANSFERASE : 15 hits 2tdt_c00 naa= 3 ULMN 3 2tmd_c00 TRIMETHYLAMINE DEHYDROGENASE user 1 3 # 1 A 169 TYR A 26 TYR~? 18.66 CL CL A 278 A 172 HIS A 12 HIS~? 14.78 CL CL A 278 A 267 ASP A 13 ASP~? 20.85 CL CL A 278 coo 26.78 20.44 0.03 28.51 18.26 0.09 7.77 -31.94 1.38 10.47 -31.53 0.90 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 9.03 -33.35 -4.93 10.37 -31.88 -5.56 coo 33.26 12.70 -5.86 33.92 14.66 -5.47 3.80 -37.83 -7.42 4.89 -38.66 -9.05 ULMN 3 2tmd_c00 TRIMETHYLAMINE DEHYDROGENASE user 2 3 # 2 A 169 TYR B 26 TYR~? 19.09 CL CL B 278 A 172 HIS B 12 HIS~? 15.42 CL CL B 278 A 267 ASP B 13 ASP~? 21.13 CL CL B 278 coo 26.78 20.44 0.03 28.51 18.26 0.09 -9.51 -16.67 -28.98 -9.06 -13.93 -28.84 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 -10.18 -14.51 -22.80 -8.49 -13.29 -22.60 coo 33.26 12.70 -5.86 33.92 14.66 -5.47 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 2tmd_c00 source 2tmd TRIMETHYLAMINE DEHYDROGENASE : 2 hits 2tmd_c00 naa= 3 ULMN 3 2tmd_c01 TRIMETHYLAMINE DEHYDROGENASE user 1 3 # 1 B 169 TYR A 26 TYR~? 18.66 CL CL A 278 B 172 HIS A 12 HIS~? 14.78 CL CL A 278 B 267 ASP A 13 ASP~? 20.85 CL CL A 278 coo 44.86 1.98 33.27 42.75 1.12 31.67 7.77 -31.94 1.38 10.47 -31.53 0.90 coo 40.83 -2.48 29.90 39.16 -2.39 31.17 9.03 -33.35 -4.93 10.37 -31.88 -5.56 coo 36.38 -5.89 31.55 36.22 -4.28 32.93 3.80 -37.83 -7.42 4.89 -38.66 -9.05 ULMN 3 2tmd_c01 TRIMETHYLAMINE DEHYDROGENASE user 2 3 # 2 B 169 TYR B 26 TYR~? 19.09 CL CL B 278 B 172 HIS B 12 HIS~? 15.42 CL CL B 278 B 267 ASP B 13 ASP~? 21.13 CL CL B 278 coo 44.86 1.98 33.27 42.75 1.12 31.67 -9.51 -16.67 -28.98 -9.06 -13.93 -28.84 coo 40.83 -2.48 29.90 39.16 -2.39 31.17 -10.18 -14.51 -22.80 -8.49 -13.29 -22.60 coo 36.38 -5.89 31.55 36.22 -4.28 32.93 -14.82 -18.84 -19.08 -14.87 -17.42 -17.52 2tmd_c01 source 2tmd TRIMETHYLAMINE DEHYDROGENASE : 2 hits 2tmd_c01 naa= 3 ULMN 3 2tmd_c02 TRIMETHYLAMINE DEHYDROGENASE user 1 3 # 1 A 169 TYR A 215 TYR.? 13.87 CL CL A 278 A 172 HIS A 216 HIS.? 18.50 CL CL A 278 A 174 TYR A 217 TYR.? 13.45 CL CL A 278 coo 26.78 20.44 0.03 28.51 18.26 0.09 21.62 -36.04 -14.58 23.93 -37.55 -14.90 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 17.97 -41.33 -12.21 17.58 -42.84 -10.82 coo 24.73 15.69 1.93 26.72 14.32 3.31 22.77 -37.42 -9.36 23.40 -34.73 -9.58 ULMN 3 2tmd_c02 TRIMETHYLAMINE DEHYDROGENASE user 2 3 # 2 A 169 TYR A 217 TYR.? 13.45 CL CL A 278 A 172 HIS A 216 HIS.? 18.50 CL CL A 278 A 174 TYR A 215 TYR.? 13.87 CL CL A 278 coo 26.78 20.44 0.03 28.51 18.26 0.09 22.77 -37.42 -9.36 23.40 -34.73 -9.58 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 17.97 -41.33 -12.21 17.58 -42.84 -10.82 coo 24.73 15.69 1.93 26.72 14.32 3.31 21.62 -36.04 -14.58 23.93 -37.55 -14.90 ULMN 3 2tmd_c02 TRIMETHYLAMINE DEHYDROGENASE user 3 3 # 3 A 169 TYR B 215 TYR.? 14.28 CL CL B 278 A 172 HIS B 216 HIS.? 19.24 CL CL B 278 A 174 TYR B 217 TYR.? 13.94 CL CL B 278 coo 26.78 20.44 0.03 28.51 18.26 0.09 -10.18 -0.68 -14.85 -11.32 1.86 -14.73 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 -16.22 -3.98 -15.80 -17.90 -4.46 -16.96 coo 24.73 15.69 1.93 26.72 14.32 3.31 -12.06 -0.05 -19.78 -9.32 0.42 -19.98 ULMN 3 2tmd_c02 TRIMETHYLAMINE DEHYDROGENASE user 4 3 # 4 A 169 TYR B 217 TYR.? 13.94 CL CL B 278 A 172 HIS B 216 HIS.? 19.24 CL CL B 278 A 174 TYR B 215 TYR.? 14.28 CL CL B 278 coo 26.78 20.44 0.03 28.51 18.26 0.09 -12.06 -0.05 -19.78 -9.32 0.42 -19.98 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 -16.22 -3.98 -15.80 -17.90 -4.46 -16.96 coo 24.73 15.69 1.93 26.72 14.32 3.31 -10.18 -0.68 -14.85 -11.32 1.86 -14.73 2tmd_c02 source 2tmd TRIMETHYLAMINE DEHYDROGENASE : 4 hits 2tmd_c02 naa= 3 ULMN 3 2tmd_c03 TRIMETHYLAMINE DEHYDROGENASE user 1 3 # 1 B 169 TYR A 215 TYR.? 13.87 CL CL A 278 B 172 HIS A 216 HIS.? 18.50 CL CL A 278 B 174 TYR A 217 TYR.? 13.45 CL CL A 278 coo 44.86 1.98 33.27 42.75 1.12 31.67 21.62 -36.04 -14.58 23.93 -37.55 -14.90 coo 40.83 -2.48 29.90 39.16 -2.39 31.17 17.97 -41.33 -12.21 17.58 -42.84 -10.82 coo 45.95 0.11 28.25 43.87 0.82 26.55 22.77 -37.42 -9.36 23.40 -34.73 -9.58 ULMN 3 2tmd_c03 TRIMETHYLAMINE DEHYDROGENASE user 2 3 # 2 B 169 TYR A 217 TYR.? 13.45 CL CL A 278 B 172 HIS A 216 HIS.? 18.50 CL CL A 278 B 174 TYR A 215 TYR.? 13.87 CL CL A 278 coo 44.86 1.98 33.27 42.75 1.12 31.67 22.77 -37.42 -9.36 23.40 -34.73 -9.58 coo 40.83 -2.48 29.90 39.16 -2.39 31.17 17.97 -41.33 -12.21 17.58 -42.84 -10.82 coo 45.95 0.11 28.25 43.87 0.82 26.55 21.62 -36.04 -14.58 23.93 -37.55 -14.90 ULMN 3 2tmd_c03 TRIMETHYLAMINE DEHYDROGENASE user 3 3 # 3 B 169 TYR B 215 TYR.? 14.28 CL CL B 278 B 172 HIS B 216 HIS.? 19.24 CL CL B 278 B 174 TYR B 217 TYR.? 13.94 CL CL B 278 coo 44.86 1.98 33.27 42.75 1.12 31.67 -10.18 -0.68 -14.85 -11.32 1.86 -14.73 coo 40.83 -2.48 29.90 39.16 -2.39 31.17 -16.22 -3.98 -15.80 -17.90 -4.46 -16.96 coo 45.95 0.11 28.25 43.87 0.82 26.55 -12.06 -0.05 -19.78 -9.32 0.42 -19.98 ULMN 3 2tmd_c03 TRIMETHYLAMINE DEHYDROGENASE user 4 3 # 4 B 169 TYR B 217 TYR.? 13.94 CL CL B 278 B 172 HIS B 216 HIS.? 19.24 CL CL B 278 B 174 TYR B 215 TYR.? 14.28 CL CL B 278 coo 44.86 1.98 33.27 42.75 1.12 31.67 -12.06 -0.05 -19.78 -9.32 0.42 -19.98 coo 40.83 -2.48 29.90 39.16 -2.39 31.17 -16.22 -3.98 -15.80 -17.90 -4.46 -16.96 coo 45.95 0.11 28.25 43.87 0.82 26.55 -10.18 -0.68 -14.85 -11.32 1.86 -14.73 2tmd_c03 source 2tmd TRIMETHYLAMINE DEHYDROGENASE : 4 hits 2tmd_c03 naa= 3 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 1 3 # 1 A 122 TYR A 14 TYR~? 21.87 CL CL A 278 A 214 ASP A 250 ASP~? 15.45 CL CL A 278 A 256 LYS A 211 LYS~? 14.92 CL CL A 278 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 9.67 -41.27 -5.56 11.11 -43.55 -4.85 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 15.24 -38.09 -11.21 14.62 -38.47 -13.19 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 17.07 -30.19 -20.07 15.73 -30.42 -25.42 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 2 3 # 2 A 122 TYR B 14 TYR~? 22.44 CL CL B 278 A 214 ASP B 250 ASP~? 16.15 CL CL B 278 A 256 LYS B 210 LYS~? 12.46 CL CL B 278 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 -17.87 -12.84 -21.07 -19.82 -11.02 -21.91 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -13.35 -7.01 -16.89 -13.59 -7.26 -14.81 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 -2.49 -8.60 -10.03 0.77 -12.84 -8.24 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 3 3 # 3 A 122 TYR B 14 TYR~? 22.44 CL CL B 278 A 214 ASP B 250 ASP~? 16.15 CL CL B 278 A 256 LYS B 211 LYS~? 15.02 CL CL B 278 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 -17.87 -12.84 -21.07 -19.82 -11.02 -21.91 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -13.35 -7.01 -16.89 -13.59 -7.26 -14.81 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 -4.12 -5.20 -9.45 -3.45 -5.07 -3.77 2tpl_c04 source 2tpl TYROSINE PHENOL-LYASE : 3 hits 2tpl_c04 naa= 3 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 1 3 # 1 B 122 TYR A 14 TYR~? 21.87 CL CL A 278 B 214 ASP A 250 ASP~? 15.45 CL CL A 278 B 256 LYS A 211 LYS~? 14.92 CL CL A 278 coo -32.67 22.74 10.17 -32.85 23.98 7.70 9.67 -41.27 -5.56 11.11 -43.55 -4.85 coo -26.88 17.61 16.89 -26.08 17.11 15.00 15.24 -38.09 -11.21 14.62 -38.47 -13.19 coo -16.04 12.06 11.09 -17.97 10.54 5.71 17.07 -30.19 -20.07 15.73 -30.42 -25.42 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 2 3 # 2 B 122 TYR B 14 TYR~? 22.44 CL CL B 278 B 214 ASP B 250 ASP~? 16.15 CL CL B 278 B 256 LYS B 210 LYS~? 12.46 CL CL B 278 coo -32.67 22.74 10.17 -32.85 23.98 7.70 -17.87 -12.84 -21.07 -19.82 -11.02 -21.91 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -13.35 -7.01 -16.89 -13.59 -7.26 -14.81 coo -16.04 12.06 11.09 -17.97 10.54 5.71 -2.49 -8.60 -10.03 0.77 -12.84 -8.24 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 3 3 # 3 B 122 TYR B 14 TYR~? 22.44 CL CL B 278 B 214 ASP B 250 ASP~? 16.15 CL CL B 278 B 256 LYS B 211 LYS~? 15.02 CL CL B 278 coo -32.67 22.74 10.17 -32.85 23.98 7.70 -17.87 -12.84 -21.07 -19.82 -11.02 -21.91 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -13.35 -7.01 -16.89 -13.59 -7.26 -14.81 coo -16.04 12.06 11.09 -17.97 10.54 5.71 -4.12 -5.20 -9.45 -3.45 -5.07 -3.77 2tpl_c05 source 2tpl TYROSINE PHENOL-LYASE : 3 hits 2tpl_c05 naa= 3 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 1 3 # 1 A 59 ARG A 192 ARG^? 5.91 CL CL A 278 A 130 SER A 8 SER.? 12.69 CL CL A 278 A 159 LYS A 64 LYS^? 6.64 CL CL A 278 coo 18.35 45.84 20.99 16.20 47.83 21.89 20.84 -24.38 -4.40 19.02 -23.24 -6.62 coo 15.14 43.67 10.77 15.61 44.43 13.04 8.88 -27.17 -3.98 8.36 -25.65 -5.80 coo 11.57 48.49 22.18 13.51 49.99 17.21 14.97 -18.21 -2.39 15.88 -19.33 -8.52 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 2 3 # 2 A 59 ARG A 192 ARG^? 5.91 CL CL A 278 A 130 SER A 110 SER.? 10.17 CL CL A 278 A 159 LYS A 64 LYS^? 6.64 CL CL A 278 coo 18.35 45.84 20.99 16.20 47.83 21.89 20.84 -24.38 -4.40 19.02 -23.24 -6.62 coo 15.14 43.67 10.77 15.61 44.43 13.04 22.72 -15.16 -12.90 22.28 -14.43 -15.17 coo 11.57 48.49 22.18 13.51 49.99 17.21 14.97 -18.21 -2.39 15.88 -19.33 -8.52 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 3 3 # 3 A 59 ARG A 192 ARG^? 5.91 CL CL A 278 A 130 SER A 163 SER^? 17.83 CL CL A 278 A 159 LYS A 64 LYS^? 6.64 CL CL A 278 coo 18.35 45.84 20.99 16.20 47.83 21.89 20.84 -24.38 -4.40 19.02 -23.24 -6.62 coo 15.14 43.67 10.77 15.61 44.43 13.04 27.49 -19.74 3.13 26.41 -21.87 3.58 coo 11.57 48.49 22.18 13.51 49.99 17.21 14.97 -18.21 -2.39 15.88 -19.33 -8.52 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 4 3 # 4 A 59 ARG B 192 ARG^? 6.13 CL CL B 278 A 130 SER B 8 SER.? 14.26 CL CL B 278 A 159 LYS B 64 LYS^? 6.39 CL CL B 278 coo 18.35 45.84 20.99 16.20 47.83 21.89 -0.17 -3.93 -26.09 1.00 -5.48 -23.71 coo 15.14 43.67 10.77 15.61 44.43 13.04 -4.13 -15.22 -24.13 -4.29 -16.76 -22.25 coo 11.57 48.49 22.18 13.51 49.99 17.21 5.21 -10.68 -27.95 4.80 -8.81 -21.96 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 5 3 # 5 A 59 ARG B 192 ARG^? 6.13 CL CL B 278 A 130 SER B 110 SER.? 9.89 CL CL B 278 A 159 LYS B 64 LYS^? 6.39 CL CL B 278 coo 18.35 45.84 20.99 16.20 47.83 21.89 -0.17 -3.93 -26.09 1.00 -5.48 -23.71 coo 15.14 43.67 10.77 15.61 44.43 13.04 10.33 -2.26 -18.93 11.59 -2.13 -16.86 coo 11.57 48.49 22.18 13.51 49.99 17.21 5.21 -10.68 -27.95 4.80 -8.81 -21.96 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 6 3 # 6 A 59 ARG B 192 ARG^? 6.13 CL CL B 278 A 130 SER B 163 SER^? 17.90 CL CL B 278 A 159 LYS B 64 LYS^? 6.39 CL CL B 278 coo 18.35 45.84 20.99 16.20 47.83 21.89 -0.17 -3.93 -26.09 1.00 -5.48 -23.71 coo 15.14 43.67 10.77 15.61 44.43 13.04 4.21 1.28 -34.77 1.92 0.43 -34.82 coo 11.57 48.49 22.18 13.51 49.99 17.21 5.21 -10.68 -27.95 4.80 -8.81 -21.96 2tps_c00 source 2tps THIAMIN PHOSPHATE SYNTHASE : 6 hits 2tps_c00 naa= 3 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 1 3 # 1 B 59 ARG A 192 ARG^? 5.91 CL CL A 278 B 130 SER A 110 SER.? 10.17 CL CL A 278 B 159 LYS A 64 LYS^? 6.64 CL CL A 278 coo 58.72 31.58 20.45 60.80 29.39 20.94 20.84 -24.38 -4.40 19.02 -23.24 -6.62 coo 61.66 35.17 10.39 61.29 34.14 12.56 22.72 -15.16 -12.90 22.28 -14.43 -15.17 coo 65.38 28.77 21.17 63.49 28.03 16.12 14.97 -18.21 -2.39 15.88 -19.33 -8.52 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 2 3 # 2 B 59 ARG A 192 ARG^? 5.91 CL CL A 278 B 130 SER A 163 SER^? 17.83 CL CL A 278 B 159 LYS A 64 LYS^? 6.64 CL CL A 278 coo 58.72 31.58 20.45 60.80 29.39 20.94 20.84 -24.38 -4.40 19.02 -23.24 -6.62 coo 61.66 35.17 10.39 61.29 34.14 12.56 27.49 -19.74 3.13 26.41 -21.87 3.58 coo 65.38 28.77 21.17 63.49 28.03 16.12 14.97 -18.21 -2.39 15.88 -19.33 -8.52 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 3 3 # 3 B 59 ARG B 192 ARG^? 6.13 CL CL B 278 B 130 SER B 110 SER.? 9.89 CL CL B 278 B 159 LYS B 64 LYS^? 6.39 CL CL B 278 coo 58.72 31.58 20.45 60.80 29.39 20.94 -0.17 -3.93 -26.09 1.00 -5.48 -23.71 coo 61.66 35.17 10.39 61.29 34.14 12.56 10.33 -2.26 -18.93 11.59 -2.13 -16.86 coo 65.38 28.77 21.17 63.49 28.03 16.12 5.21 -10.68 -27.95 4.80 -8.81 -21.96 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 4 3 # 4 B 59 ARG B 192 ARG^? 6.13 CL CL B 278 B 130 SER B 163 SER^? 17.90 CL CL B 278 B 159 LYS B 64 LYS^? 6.39 CL CL B 278 coo 58.72 31.58 20.45 60.80 29.39 20.94 -0.17 -3.93 -26.09 1.00 -5.48 -23.71 coo 61.66 35.17 10.39 61.29 34.14 12.56 4.21 1.28 -34.77 1.92 0.43 -34.82 coo 65.38 28.77 21.17 63.49 28.03 16.12 5.21 -10.68 -27.95 4.80 -8.81 -21.96 2tps_c01 source 2tps THIAMIN PHOSPHATE SYNTHASE : 4 hits 2tps_c01 naa= 3 ULMN 3 3cla_c00 TYPE III CHLORAMPHENICOL ACETYLTRANSuser 1 3 # 1 18 ARG A 196 ARG.? 15.95 CL CL A 278 195 HIS A 194 HIS.? 4.68 CL CL A 278 199 ASP A 168 ASP^? 12.27 CL CL A 278 coo 21.96 2.03 15.24 19.33 1.86 13.55 27.49 -34.87 -12.70 29.46 -35.46 -10.43 coo 13.48 -0.87 14.56 14.47 -2.14 15.92 21.59 -27.03 -10.13 21.31 -25.37 -8.87 coo 17.92 -0.05 18.55 18.90 -0.38 16.73 26.46 -30.73 -8.22 26.92 -32.42 -9.39 ULMN 3 3cla_c00 TYPE III CHLORAMPHENICOL ACETYLTRANSuser 2 3 # 2 18 ARG B 196 ARG.? 16.18 CL CL B 278 195 HIS B 194 HIS.? 5.13 CL CL B 278 199 ASP B 168 ASP^? 12.80 CL CL B 278 coo 21.96 2.03 15.24 19.33 1.86 13.55 -8.42 4.93 -17.56 -9.12 6.53 -20.07 coo 13.48 -0.87 14.56 14.47 -2.14 15.92 -1.92 -2.21 -20.05 -0.53 -2.75 -21.52 coo 17.92 -0.05 18.55 18.90 -0.38 16.73 -5.42 2.81 -22.11 -6.82 3.76 -20.83 3cla_c00 source 3cla TYPE III CHLORAMPHENICOL ACETYLTRANSFERASE ( C: 2 hits 3cla_c00 naa= 3 ULMN 3 4mdh_c02 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 1 3 # 1 A 158 ASP A 168 ASP^? 12.27 CL CL A 278 A 161 ARG A 196 ARG.? 15.95 CL CL A 278 A 186 HIS A 194 HIS.? 4.68 CL CL A 278 coo 18.62 26.83 58.17 18.48 28.64 57.08 26.46 -30.73 -8.22 26.92 -32.42 -9.39 coo 23.76 27.69 57.88 24.05 29.81 55.69 27.49 -34.87 -12.70 29.46 -35.46 -10.43 coo 16.67 31.22 54.64 18.74 31.15 54.14 21.59 -27.03 -10.13 21.31 -25.37 -8.87 ULMN 3 4mdh_c02 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 2 3 # 2 A 158 ASP B 168 ASP^? 12.80 CL CL B 278 A 161 ARG B 196 ARG.? 16.18 CL CL B 278 A 186 HIS B 194 HIS.? 5.13 CL CL B 278 coo 18.62 26.83 58.17 18.48 28.64 57.08 -5.42 2.81 -22.11 -6.82 3.76 -20.83 coo 23.76 27.69 57.88 24.05 29.81 55.69 -8.42 4.93 -17.56 -9.12 6.53 -20.07 coo 16.67 31.22 54.64 18.74 31.15 54.14 -1.92 -2.21 -20.05 -0.53 -2.75 -21.52 4mdh_c02 source 4mdh CYTOPLASMIC MALATE DEHYDROGENASE (E.C.1.1.1.37: 2 hits 4mdh_c02 naa= 3 ULMN 3 4mdh_c03 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 1 3 # 1 B 158 ASP A 168 ASP^? 12.27 CL CL A 278 B 161 ARG A 196 ARG.? 15.95 CL CL A 278 B 186 HIS A 194 HIS.? 4.68 CL CL A 278 coo 44.53 16.44 28.54 44.89 18.45 28.77 26.46 -30.73 -8.22 26.92 -32.42 -9.39 coo 39.64 19.27 28.15 40.19 21.74 29.94 27.49 -34.87 -12.70 29.46 -35.46 -10.43 coo 48.32 20.00 31.44 46.45 20.91 31.50 21.59 -27.03 -10.13 21.31 -25.37 -8.87 ULMN 3 4mdh_c03 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 2 3 # 2 B 158 ASP B 168 ASP^? 12.80 CL CL B 278 B 161 ARG B 196 ARG.? 16.18 CL CL B 278 B 186 HIS B 194 HIS.? 5.13 CL CL B 278 coo 44.53 16.44 28.54 44.89 18.45 28.77 -5.42 2.81 -22.11 -6.82 3.76 -20.83 coo 39.64 19.27 28.15 40.19 21.74 29.94 -8.42 4.93 -17.56 -9.12 6.53 -20.07 coo 48.32 20.00 31.44 46.45 20.91 31.50 -1.92 -2.21 -20.05 -0.53 -2.75 -21.52 4mdh_c03 source 4mdh CYTOPLASMIC MALATE DEHYDROGENASE (E.C.1.1.1.37: 2 hits 4mdh_c03 naa= 3 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 1 3 # 1 71 ARG A 3 ARG^? 24.49 CL CL A 278 127 ARG A 60 ARG^? 25.80 CL CL A 278 270 GLU A 34 GLU^? 8.78 CL CL A 278 coo -1.14 25.72 1.64 0.76 28.10 1.50 17.45 -29.65 8.35 18.11 -29.19 11.33 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 16.05 -25.08 10.06 15.12 -25.70 12.91 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 14.76 -23.90 -2.78 16.42 -23.89 -4.11 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 2 3 # 2 71 ARG A 60 ARG^? 25.80 CL CL A 278 127 ARG A 3 ARG^? 24.49 CL CL A 278 270 GLU A 34 GLU^? 8.78 CL CL A 278 coo -1.14 25.72 1.64 0.76 28.10 1.50 16.05 -25.08 10.06 15.12 -25.70 12.91 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 17.45 -29.65 8.35 18.11 -29.19 11.33 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 14.76 -23.90 -2.78 16.42 -23.89 -4.11 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 3 3 # 3 71 ARG A 209 ARG~? 8.75 CL CL A 278 127 ARG A 212 ARG~? 4.63 CL CL A 278 270 GLU B 74 GLU~? 12.92 CL CL A 278 coo -1.14 25.72 1.64 0.76 28.10 1.50 12.19 -22.36 -19.55 12.55 -20.19 -17.38 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 18.59 -24.77 -16.89 17.13 -22.12 -16.49 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 20.28 -11.36 -18.58 21.63 -11.86 -17.04 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 4 3 # 4 71 ARG A 212 ARG~? 4.63 CL CL A 278 127 ARG A 209 ARG~? 8.75 CL CL A 278 270 GLU B 74 GLU~? 12.92 CL CL A 278 coo -1.14 25.72 1.64 0.76 28.10 1.50 18.59 -24.77 -16.89 17.13 -22.12 -16.49 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 12.19 -22.36 -19.55 12.55 -20.19 -17.38 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 20.28 -11.36 -18.58 21.63 -11.86 -17.04 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 5 3 # 5 71 ARG B 3 ARG^? 24.44 CL CL B 278 127 ARG B 60 ARG^? 26.12 CL CL B 278 270 GLU B 34 GLU^? 8.94 CL CL B 278 coo -1.14 25.72 1.64 0.76 28.10 1.50 -7.40 -8.36 -37.36 -6.70 -7.91 -40.31 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -3.16 -10.36 -39.52 -4.20 -11.54 -42.16 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -0.25 -10.10 -26.69 0.15 -8.25 -25.75 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 6 3 # 6 71 ARG B 60 ARG^? 26.12 CL CL B 278 127 ARG B 3 ARG^? 24.44 CL CL B 278 270 GLU B 34 GLU^? 8.94 CL CL B 278 coo -1.14 25.72 1.64 0.76 28.10 1.50 -3.16 -10.36 -39.52 -4.20 -11.54 -42.16 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -7.40 -8.36 -37.36 -6.70 -7.91 -40.31 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -0.25 -10.10 -26.69 0.15 -8.25 -25.75 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 7 3 # 7 71 ARG B 209 ARG~? 8.42 CL CL B 278 127 ARG B 212 ARG~? 4.30 CL CL B 278 270 GLU A 74 GLU~? 12.23 CL CL B 278 coo -1.14 25.72 1.64 0.76 28.10 1.50 2.92 -11.07 -10.38 5.18 -10.70 -12.48 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 1.13 -4.70 -13.40 3.58 -6.46 -14.00 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 14.45 -4.40 -13.52 13.94 -3.10 -15.11 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 8 3 # 8 71 ARG B 212 ARG~? 4.30 CL CL B 278 127 ARG B 209 ARG~? 8.42 CL CL B 278 270 GLU A 74 GLU~? 12.23 CL CL B 278 coo -1.14 25.72 1.64 0.76 28.10 1.50 1.13 -4.70 -13.40 3.58 -6.46 -14.00 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 2.92 -11.07 -10.38 5.18 -10.70 -12.48 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 14.45 -4.40 -13.52 13.94 -3.10 -15.11 5cpa_c01 source 5cpa CARBOXYPEPTIDASE A=ALPHA= (COX) (E.C.3.4.17.1): 8 hits 5cpa_c01 naa= 3 ULMN 3 5fit_c00 FRAGILE HISTIDINE TRIAD PROTEIN user 1 3 # 1 83 GLN A 234 GLN~? 29.00 CL CL A 278 94 HIS A -1 HIS.? 31.67 CL CL A 278 96 HIS A 0 HIS.? 29.82 CL CL A 278 coo 12.06 13.83 19.61 9.96 13.82 20.00 32.99 -35.47 9.43 34.28 -36.74 8.33 coo 15.69 26.32 19.80 17.39 27.17 20.68 23.28 -34.51 17.18 21.28 -34.97 16.73 coo 14.38 20.59 22.16 12.49 20.21 21.35 28.39 -31.84 13.78 30.11 -32.89 14.37 5fit_c00 source 5fit FRAGILE HISTIDINE TRIAD PROTEIN : 1 hits 5fit_c00 naa= 3 ULMN 3 7atj_c00 PEROXIDASE C1A user 1 3 # 1 A 38 ARG A 140 ARG.? 3.74 CL CL A 278 A 42 HIS A 194 HIS.? 4.68 CL CL A 278 A 70 ASN A 244 ASN.? 5.40 CL CL A 278 coo 1.39 6.34 11.43 0.09 6.19 8.61 24.77 -21.68 -10.23 22.52 -23.37 -11.49 coo 5.40 8.25 8.15 4.09 6.62 7.93 21.59 -27.03 -10.13 21.31 -25.37 -8.87 coo 1.54 10.80 4.23 3.44 10.57 5.15 17.85 -28.42 -8.05 16.64 -26.87 -8.84 ULMN 3 7atj_c00 PEROXIDASE C1A user 2 3 # 2 A 38 ARG B 140 ARG.? -3.53 CL CL B 278s A 42 HIS B 194 HIS.? 5.13 CL CL B 278 A 70 ASN B 244 ASN.? 5.94 CL CL B 278 coo 1.39 6.34 11.43 0.09 6.19 8.61 3.71 0.22 -21.03 2.09 -1.69 -19.26 coo 5.40 8.25 8.15 4.09 6.62 7.93 -1.92 -2.21 -20.05 -0.53 -2.75 -21.52 coo 1.54 10.80 4.23 3.44 10.57 5.15 -3.88 -6.12 -21.35 -2.47 -7.43 -20.48 7atj_c00 source 7atj PEROXIDASE C1A : 2 hits 7atj_c00 naa= 3 ULMN 3 1hkd_p00 PEA LECTIN ALPHA CHAIN user 1 3 # 1 A 81 ASP A 168 ASP^? 12.27 CL CL A 278 A 99 GLY A 195 GLY.? 9.62 CL CL A 278 A 125 ASN A 244 ASN.? 5.40 CL CL A 278 coo -12.71 41.15 -12.81 -13.46 42.96 -13.57 26.46 -30.73 -8.22 26.92 -32.42 -9.39 coo -9.98 44.30 -14.04 -9.74 44.63 -13.34 22.19 -32.71 -12.39 22.72 -32.07 -12.32 coo -9.28 44.56 -19.45 -10.46 44.31 -17.70 17.85 -28.42 -8.05 16.64 -26.87 -8.84 ULMN 3 1hkd_p00 PEA LECTIN ALPHA CHAIN user 2 3 # 2 A 81 ASP A 168 ASP^? 12.27 CL CL A 278 A 99 GLY A 195 GLY.? 9.62 CL CL A 278 A 125 ASN A 245 ASN.? 11.79 CL CL A 278 coo -12.71 41.15 -12.81 -13.46 42.96 -13.57 26.46 -30.73 -8.22 26.92 -32.42 -9.39 coo -9.98 44.30 -14.04 -9.74 44.63 -13.34 22.19 -32.71 -12.39 22.72 -32.07 -12.32 coo -9.28 44.56 -19.45 -10.46 44.31 -17.70 18.48 -33.48 -10.76 18.30 -34.93 -9.15 ULMN 3 1hkd_p00 PEA LECTIN ALPHA CHAIN user 3 3 # 3 A 81 ASP A 250 ASP~? 15.45 CL CL A 278 A 99 GLY A 248 GLY.? 14.14 CL CL A 278 A 125 ASN A 246 ASN.? 12.85 CL CL A 278 coo -12.71 41.15 -12.81 -13.46 42.96 -13.57 15.24 -38.09 -11.21 14.62 -38.47 -13.19 coo -9.98 44.30 -14.04 -9.74 44.63 -13.34 12.18 -35.81 -15.03 12.11 -35.46 -14.29 coo -9.28 44.56 -19.45 -10.46 44.31 -17.70 12.83 -32.17 -9.87 11.11 -33.32 -9.30 ULMN 3 1hkd_p00 PEA LECTIN ALPHA CHAIN user 4 3 # 4 A 81 ASP A 250 ASP~? 15.45 CL CL A 278 A 99 GLY A 249 GLY.? 14.98 CL CL A 278 A 125 ASN A 246 ASN.? 12.85 CL CL A 278 coo -12.71 41.15 -12.81 -13.46 42.96 -13.57 15.24 -38.09 -11.21 14.62 -38.47 -13.19 coo -9.98 44.30 -14.04 -9.74 44.63 -13.34 10.85 -36.22 -11.47 11.63 -36.38 -11.65 coo -9.28 44.56 -19.45 -10.46 44.31 -17.70 12.83 -32.17 -9.87 11.11 -33.32 -9.30 ULMN 3 1hkd_p00 PEA LECTIN ALPHA CHAIN user 5 3 # 5 A 81 ASP B 250 ASP~? 16.15 CL CL B 278 A 99 GLY B 248 GLY.? 14.76 CL CL B 278 A 125 ASN B 246 ASN.? 13.30 CL CL B 278 coo -12.71 41.15 -12.81 -13.46 42.96 -13.57 -13.35 -7.01 -16.89 -13.59 -7.26 -14.81 coo -9.98 44.30 -14.04 -9.74 44.63 -13.34 -10.88 -9.81 -12.81 -10.61 -10.09 -13.55 coo -9.28 44.56 -19.45 -10.46 44.31 -17.70 -7.71 -10.36 -18.40 -9.09 -11.94 -18.78 ULMN 3 1hkd_p00 PEA LECTIN ALPHA CHAIN user 6 3 # 6 A 81 ASP B 250 ASP~? 16.15 CL CL B 278 A 99 GLY B 249 GLY.? 15.61 CL CL B 278 A 125 ASN B 246 ASN.? 13.30 CL CL B 278 coo -12.71 41.15 -12.81 -13.46 42.96 -13.57 -13.35 -7.01 -16.89 -13.59 -7.26 -14.81 coo -9.98 44.30 -14.04 -9.74 44.63 -13.34 -11.90 -11.51 -16.09 -11.99 -10.68 -16.03 coo -9.28 44.56 -19.45 -10.46 44.31 -17.70 -7.71 -10.36 -18.40 -9.09 -11.94 -18.78 1hkd_p00 source 1hkd PEA LECTIN ALPHA CHAIN : 6 hits 1hkd_p00 naa= 3 ULMN 3 1k12_p00 LECTIN user 1 3 # 1 A 52 HIS A 194 HIS.? 4.68 CL CL A 278 A 79 ARG A 140 ARG.? 3.74 CL CL A 278 A 86 ARG A 192 ARG^? 5.91 CL CL A 278 coo -5.53 26.98 5.69 -5.98 25.70 4.09 21.59 -27.03 -10.13 21.31 -25.37 -8.87 coo -12.15 26.35 6.05 -10.94 27.19 3.35 24.77 -21.68 -10.23 22.52 -23.37 -11.49 coo -9.59 20.48 4.28 -9.21 22.28 1.82 20.84 -24.38 -4.40 19.02 -23.24 -6.62 ULMN 3 1k12_p00 LECTIN user 2 3 # 2 A 52 HIS A 194 HIS.? 4.68 CL CL A 278 A 79 ARG A 192 ARG^? 5.91 CL CL A 278 A 86 ARG A 140 ARG.? 3.74 CL CL A 278 coo -5.53 26.98 5.69 -5.98 25.70 4.09 21.59 -27.03 -10.13 21.31 -25.37 -8.87 coo -12.15 26.35 6.05 -10.94 27.19 3.35 20.84 -24.38 -4.40 19.02 -23.24 -6.62 coo -9.59 20.48 4.28 -9.21 22.28 1.82 24.77 -21.68 -10.23 22.52 -23.37 -11.49 ULMN 3 1k12_p00 LECTIN user 3 3 # 3 A 52 HIS B 194 HIS.? 5.13 CL CL B 278 A 79 ARG B 140 ARG.? -3.53 CL CL B 278s A 86 ARG B 192 ARG^? 6.13 CL CL B 278 coo -5.53 26.98 5.69 -5.98 25.70 4.09 -1.92 -2.21 -20.05 -0.53 -2.75 -21.52 coo -12.15 26.35 6.05 -10.94 27.19 3.35 3.71 0.22 -21.03 2.09 -1.69 -19.26 coo -9.59 20.48 4.28 -9.21 22.28 1.82 -0.17 -3.93 -26.09 1.00 -5.48 -23.71 ULMN 3 1k12_p00 LECTIN user 4 3 # 4 A 52 HIS B 194 HIS.? 5.13 CL CL B 278 A 79 ARG B 192 ARG^? 6.13 CL CL B 278 A 86 ARG B 140 ARG.? -3.53 CL CL B 278s coo -5.53 26.98 5.69 -5.98 25.70 4.09 -1.92 -2.21 -20.05 -0.53 -2.75 -21.52 coo -12.15 26.35 6.05 -10.94 27.19 3.35 -0.17 -3.93 -26.09 1.00 -5.48 -23.71 coo -9.59 20.48 4.28 -9.21 22.28 1.82 3.71 0.22 -21.03 2.09 -1.69 -19.26 1k12_p00 source 1k12 LECTIN : 4 hits 1k12_p00 naa= 3 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 1 1 # 1 A 461 ASN A 58 ASN.? 28.29 CL CL A 278 coo 5.80 63.03 55.85 5.52 65.03 56.45 13.69 -30.36 14.12 12.82 -32.29 13.72 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 2 1 # 2 A 461 ASN A 119 ASN~? 18.19 CL CL A 278 coo 5.80 63.03 55.85 5.52 65.03 56.45 29.77 -8.48 -9.06 28.79 -8.44 -10.95 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 3 1 # 3 A 461 ASN A 141 ASN~? 14.40 CL CL A 278 coo 5.80 63.03 55.85 5.52 65.03 56.45 29.69 -16.58 -13.36 30.76 -15.83 -15.01 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 4 1 # 4 A 461 ASN A 142 ASN~? 15.74 CL CL A 278 coo 5.80 63.03 55.85 5.52 65.03 56.45 33.76 -20.86 -14.08 33.88 -20.26 -16.14 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 5 1 # 5 A 461 ASN A 148 ASN.? 24.86 CL CL A 278 coo 5.80 63.03 55.85 5.52 65.03 56.45 43.71 -14.72 -10.92 42.02 -14.43 -12.19 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 6 1 # 6 A 461 ASN A 160 ASN~? 24.70 CL CL A 278 coo 5.80 63.03 55.85 5.52 65.03 56.45 30.61 -11.30 3.89 31.69 -9.56 3.26 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 7 1 # 7 A 461 ASN A 175 ASN.? 15.39 CL CL A 278 coo 5.80 63.03 55.85 5.52 65.03 56.45 30.44 -19.14 -17.48 31.94 -17.93 -18.43 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 8 1 # 8 A 461 ASN A 185 ASN.? 23.31 CL CL A 278 coo 5.80 63.03 55.85 5.52 65.03 56.45 29.16 -19.86 6.66 28.14 -19.34 8.46 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 9 1 # 9 A 461 ASN A 187 ASN.? 27.58 CL CL A 278 coo 5.80 63.03 55.85 5.52 65.03 56.45 27.12 -21.23 11.57 28.22 -20.58 13.28 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 10 1 # 10 A 461 ASN A 197 ASN.? 12.86 CL CL A 278 coo 5.80 63.03 55.85 5.52 65.03 56.45 21.52 -32.98 -18.45 20.55 -33.92 -20.09 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 11 1 # 11 A 461 ASN A 204 ASN.? 18.82 CL CL A 278 coo 5.80 63.03 55.85 5.52 65.03 56.45 21.41 -21.13 -30.21 23.24 -20.09 -30.49 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 12 1 # 12 A 461 ASN A 218 ASN~? 20.82 CL CL A 278 coo 5.80 63.03 55.85 5.52 65.03 56.45 24.13 -43.84 -11.70 26.14 -43.18 -11.76 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 13 1 # 13 A 461 ASN A 244 ASN.? 5.40 CL CL A 278 coo 5.80 63.03 55.85 5.52 65.03 56.45 17.85 -28.42 -8.05 16.64 -26.87 -8.84 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 14 1 # 14 A 461 ASN A 245 ASN.? 11.79 CL CL A 278 coo 5.80 63.03 55.85 5.52 65.03 56.45 18.48 -33.48 -10.76 18.30 -34.93 -9.15 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 15 1 # 15 A 461 ASN A 246 ASN.? 12.85 CL CL A 278 coo 5.80 63.03 55.85 5.52 65.03 56.45 12.83 -32.17 -9.87 11.11 -33.32 -9.30 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 16 1 # 16 A 461 ASN A 254 ASN~? 16.17 CL CL A 278 coo 5.80 63.03 55.85 5.52 65.03 56.45 18.50 -38.45 -6.68 18.86 -39.34 -8.59 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 17 1 # 17 A 461 ASN A 263 ASN~? 31.02 CL CL A 278 coo 5.80 63.03 55.85 5.52 65.03 56.45 23.12 -44.40 7.58 22.32 -45.82 8.92 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 18 1 # 18 A 461 ASN A 270 ASN.? 33.57 CL CL A 278 coo 5.80 63.03 55.85 5.52 65.03 56.45 2.70 -38.53 12.07 1.72 -36.95 13.05 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 19 1 # 19 A 461 ASN B 58 ASN.? 27.93 CL CL B 278 coo 5.80 63.03 55.85 5.52 65.03 56.45 -10.15 -12.85 -41.76 -10.63 -10.76 -41.86 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 20 1 # 20 A 461 ASN B 119 ASN~? 17.69 CL CL B 278 coo 5.80 63.03 55.85 5.52 65.03 56.45 17.14 3.31 -24.51 17.47 2.47 -22.58 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 21 1 # 21 A 461 ASN B 141 ASN.? 13.90 CL CL B 278 coo 5.80 63.03 55.85 5.52 65.03 56.45 9.53 4.91 -19.46 10.65 6.11 -18.14 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 22 1 # 22 A 461 ASN B 142 ASN.? 15.73 CL CL B 278 coo 5.80 63.03 55.85 5.52 65.03 56.45 5.89 9.56 -18.58 6.90 10.10 -16.77 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 23 1 # 23 A 461 ASN B 148 ASN~? 24.62 CL CL B 278 coo 5.80 63.03 55.85 5.52 65.03 56.45 12.72 18.24 -23.93 13.08 16.64 -22.60 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 24 1 # 24 A 461 ASN B 160 ASN~? 24.49 CL CL B 278 coo 5.80 63.03 55.85 5.52 65.03 56.45 12.63 3.12 -37.15 14.44 4.19 -36.85 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 25 1 # 25 A 461 ASN B 175 ASN.? 15.07 CL CL B 278 coo 5.80 63.03 55.85 5.52 65.03 56.45 7.70 6.80 -15.23 9.08 8.02 -14.14 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 26 1 # 26 A 461 ASN B 185 ASN.? 23.46 CL CL B 278 coo 5.80 63.03 55.85 5.52 65.03 56.45 3.74 2.53 -38.55 3.92 1.27 -40.29 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 27 1 # 27 A 461 ASN B 187 ASN.? 27.72 CL CL B 278 coo 5.80 63.03 55.85 5.52 65.03 56.45 1.42 0.10 -42.91 1.86 0.83 -44.85 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 28 1 # 28 A 461 ASN B 197 ASN.? 13.10 CL CL B 278 coo 5.80 63.03 55.85 5.52 65.03 56.45 -6.63 -0.56 -11.26 -7.23 -1.17 -9.32 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 29 1 # 29 A 461 ASN B 204 ASN.? 18.45 CL CL B 278 coo 5.80 63.03 55.85 5.52 65.03 56.45 6.62 -0.83 -1.08 7.92 0.83 -1.15 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 30 1 # 30 A 461 ASN B 218 ASN~? 21.19 CL CL B 278 coo 5.80 63.03 55.85 5.52 65.03 56.45 -17.80 2.35 -16.65 -17.00 4.26 -17.12 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 31 1 # 31 A 461 ASN B 244 ASN.? 5.94 CL CL B 278 coo 5.80 63.03 55.85 5.52 65.03 56.45 -3.88 -6.12 -21.35 -2.47 -7.43 -20.48 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 32 1 # 32 A 461 ASN B 245 ASN.? 12.34 CL CL B 278 coo 5.80 63.03 55.85 5.52 65.03 56.45 -8.45 -4.50 -18.19 -10.06 -4.59 -19.62 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 33 1 # 33 A 461 ASN B 246 ASN.? 13.30 CL CL B 278 coo 5.80 63.03 55.85 5.52 65.03 56.45 -7.71 -10.36 -18.40 -9.09 -11.94 -18.78 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 34 1 # 34 A 461 ASN B 254 ASN~? 16.98 CL CL B 278 coo 5.80 63.03 55.85 5.52 65.03 56.45 -14.04 -4.32 -21.65 -14.71 -3.72 -19.71 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 35 1 # 35 A 461 ASN B 263 ASN.? 31.56 CL CL B 278 coo 5.80 63.03 55.85 5.52 65.03 56.45 -21.42 -0.91 -35.49 -22.77 -1.78 -36.88 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 36 1 # 36 A 461 ASN B 270 ASN.? 34.32 CL CL B 278 coo 5.80 63.03 55.85 5.52 65.03 56.45 -18.26 -22.22 -38.09 -17.05 -23.10 -39.57 1kbk_p00 source 1kbk ALPHA-AMYLASE, PANCREATIC : 36 hits 1kbk_p00 naa= 1 ULMN 3 1o8s_p00 PUTATIVE ENDO-XYLANASE user 1 3 # 1 A 56 TYR A 122 TYR~? 19.12 CL CL A 278 A 112 PHE A 109 PHE.? 13.59 CL CL A 278 A 140 ASN A 119 ASN~? 18.19 CL CL A 278 coo -6.29 44.15 17.65 -9.00 44.92 17.68 24.48 -6.24 -5.60 21.71 -6.48 -5.39 coo -7.38 52.77 16.75 -5.54 52.71 18.82 24.11 -13.43 -7.67 24.08 -11.73 -5.48 coo -4.46 50.64 12.29 -5.69 49.89 13.85 29.77 -8.48 -9.06 28.79 -8.44 -10.95 ULMN 3 1o8s_p00 PUTATIVE ENDO-XYLANASE user 2 3 # 2 A 56 TYR A 122 TYR~? 19.12 CL CL A 278 A 112 PHE A 113 PHE.? 15.17 CL CL A 278 A 140 ASN A 119 ASN~? 18.19 CL CL A 278 coo -6.29 44.15 17.65 -9.00 44.92 17.68 24.48 -6.24 -5.60 21.71 -6.48 -5.39 coo -7.38 52.77 16.75 -5.54 52.71 18.82 26.35 -11.75 -10.22 26.90 -10.33 -7.91 coo -4.46 50.64 12.29 -5.69 49.89 13.85 29.77 -8.48 -9.06 28.79 -8.44 -10.95 ULMN 3 1o8s_p00 PUTATIVE ENDO-XYLANASE user 3 3 # 3 A 56 TYR A 215 TYR.? 13.87 CL CL A 278 A 112 PHE A 243 PHE^? 14.37 CL CL A 278 A 140 ASN A 254 ASN~? 16.17 CL CL A 278 coo -6.29 44.15 17.65 -9.00 44.92 17.68 21.62 -36.04 -14.58 23.93 -37.55 -14.90 coo -7.38 52.77 16.75 -5.54 52.71 18.82 18.82 -34.33 -4.40 20.85 -36.01 -3.52 coo -4.46 50.64 12.29 -5.69 49.89 13.85 18.50 -38.45 -6.68 18.86 -39.34 -8.59 ULMN 3 1o8s_p00 PUTATIVE ENDO-XYLANASE user 4 3 # 4 A 56 TYR A 217 TYR.? 13.45 CL CL A 278 A 112 PHE A 243 PHE^? 14.37 CL CL A 278 A 140 ASN A 244 ASN.? 5.40 CL CL A 278 coo -6.29 44.15 17.65 -9.00 44.92 17.68 22.77 -37.42 -9.36 23.40 -34.73 -9.58 coo -7.38 52.77 16.75 -5.54 52.71 18.82 18.82 -34.33 -4.40 20.85 -36.01 -3.52 coo -4.46 50.64 12.29 -5.69 49.89 13.85 17.85 -28.42 -8.05 16.64 -26.87 -8.84 ULMN 3 1o8s_p00 PUTATIVE ENDO-XYLANASE user 5 3 # 5 A 56 TYR B 215 TYR.? 14.28 CL CL B 278 A 112 PHE B 193 PHE^? 13.71 CL CL B 278 A 140 ASN B 244 ASN.? 5.94 CL CL B 278 coo -6.29 44.15 17.65 -9.00 44.92 17.68 -10.18 -0.68 -14.85 -11.32 1.86 -14.73 coo -7.38 52.77 16.75 -5.54 52.71 18.82 -7.65 -0.48 -24.22 -8.51 0.77 -26.56 coo -4.46 50.64 12.29 -5.69 49.89 13.85 -3.88 -6.12 -21.35 -2.47 -7.43 -20.48 ULMN 3 1o8s_p00 PUTATIVE ENDO-XYLANASE user 6 3 # 6 A 56 TYR B 215 TYR.? 14.28 CL CL B 278 A 112 PHE B 243 PHE^? 14.91 CL CL B 278 A 140 ASN B 244 ASN.? 5.94 CL CL B 278 coo -6.29 44.15 17.65 -9.00 44.92 17.68 -10.18 -0.68 -14.85 -11.32 1.86 -14.73 coo -7.38 52.77 16.75 -5.54 52.71 18.82 -10.13 -4.72 -24.34 -11.77 -2.66 -25.27 coo -4.46 50.64 12.29 -5.69 49.89 13.85 -3.88 -6.12 -21.35 -2.47 -7.43 -20.48 ULMN 3 1o8s_p00 PUTATIVE ENDO-XYLANASE user 7 3 # 7 A 56 TYR B 215 TYR.? 14.28 CL CL B 278 A 112 PHE B 243 PHE^? 14.91 CL CL B 278 A 140 ASN B 254 ASN~? 16.98 CL CL B 278 coo -6.29 44.15 17.65 -9.00 44.92 17.68 -10.18 -0.68 -14.85 -11.32 1.86 -14.73 coo -7.38 52.77 16.75 -5.54 52.71 18.82 -10.13 -4.72 -24.34 -11.77 -2.66 -25.27 coo -4.46 50.64 12.29 -5.69 49.89 13.85 -14.04 -4.32 -21.65 -14.71 -3.72 -19.71 ULMN 3 1o8s_p00 PUTATIVE ENDO-XYLANASE user 8 3 # 8 A 56 TYR B 217 TYR.? 13.94 CL CL B 278 A 112 PHE B 243 PHE^? 14.91 CL CL B 278 A 140 ASN B 244 ASN.? 5.94 CL CL B 278 coo -6.29 44.15 17.65 -9.00 44.92 17.68 -12.06 -0.05 -19.78 -9.32 0.42 -19.98 coo -7.38 52.77 16.75 -5.54 52.71 18.82 -10.13 -4.72 -24.34 -11.77 -2.66 -25.27 coo -4.46 50.64 12.29 -5.69 49.89 13.85 -3.88 -6.12 -21.35 -2.47 -7.43 -20.48 1o8s_p00 source 1o8s PUTATIVE ENDO-XYLANASE : 8 hits 1o8s_p00 naa= 3 ULMN 3 1uy2_p00 ENDO-1,4-BETA-XYLANASE A user 1 3 # 1 A 51 TYR A 14 TYR~? 21.87 CL CL A 278 A 108 ASN A 245 ASN.? 11.79 CL CL A 278 A 135 ASN A 246 ASN.? 12.85 CL CL A 278 coo 17.59 4.66 17.88 15.38 5.96 18.97 9.67 -41.27 -5.56 11.11 -43.55 -4.85 coo 12.36 16.24 15.27 12.06 14.29 16.05 18.48 -33.48 -10.76 18.30 -34.93 -9.15 coo 18.05 11.56 12.71 17.57 10.75 14.60 12.83 -32.17 -9.87 11.11 -33.32 -9.30 ULMN 3 1uy2_p00 ENDO-1,4-BETA-XYLANASE A user 2 3 # 2 A 51 TYR A 14 TYR~? 21.87 CL CL A 278 A 108 ASN A 245 ASN.? 11.79 CL CL A 278 A 135 ASN A 254 ASN~? 16.17 CL CL A 278 coo 17.59 4.66 17.88 15.38 5.96 18.97 9.67 -41.27 -5.56 11.11 -43.55 -4.85 coo 12.36 16.24 15.27 12.06 14.29 16.05 18.48 -33.48 -10.76 18.30 -34.93 -9.15 coo 18.05 11.56 12.71 17.57 10.75 14.60 18.50 -38.45 -6.68 18.86 -39.34 -8.59 ULMN 3 1uy2_p00 ENDO-1,4-BETA-XYLANASE A user 3 3 # 3 A 51 TYR A 122 TYR~? 19.12 CL CL A 278 A 108 ASN A 141 ASN~? 14.40 CL CL A 278 A 135 ASN A 119 ASN~? 18.19 CL CL A 278 coo 17.59 4.66 17.88 15.38 5.96 18.97 24.48 -6.24 -5.60 21.71 -6.48 -5.39 coo 12.36 16.24 15.27 12.06 14.29 16.05 29.69 -16.58 -13.36 30.76 -15.83 -15.01 coo 18.05 11.56 12.71 17.57 10.75 14.60 29.77 -8.48 -9.06 28.79 -8.44 -10.95 ULMN 3 1uy2_p00 ENDO-1,4-BETA-XYLANASE A user 4 3 # 4 A 51 TYR A 145 TYR~? 15.40 CL CL A 278 A 108 ASN A 119 ASN~? 18.19 CL CL A 278 A 135 ASN A 141 ASN~? 14.40 CL CL A 278 coo 17.59 4.66 17.88 15.38 5.96 18.97 34.36 -21.23 -8.52 32.31 -21.44 -6.65 coo 12.36 16.24 15.27 12.06 14.29 16.05 29.77 -8.48 -9.06 28.79 -8.44 -10.95 coo 18.05 11.56 12.71 17.57 10.75 14.60 29.69 -16.58 -13.36 30.76 -15.83 -15.01 ULMN 3 1uy2_p00 ENDO-1,4-BETA-XYLANASE A user 5 3 # 5 A 51 TYR A 180 TYR.? 19.77 CL CL A 278 A 108 ASN A 141 ASN~? 14.40 CL CL A 278 A 135 ASN A 142 ASN~? 15.74 CL CL A 278 coo 17.59 4.66 17.88 15.38 5.96 18.97 35.72 -25.25 -4.91 38.35 -24.47 -4.37 coo 12.36 16.24 15.27 12.06 14.29 16.05 29.69 -16.58 -13.36 30.76 -15.83 -15.01 coo 18.05 11.56 12.71 17.57 10.75 14.60 33.76 -20.86 -14.08 33.88 -20.26 -16.14 ULMN 3 1uy2_p00 ENDO-1,4-BETA-XYLANASE A user 6 3 # 6 A 51 TYR A 182 TYR.? 22.89 CL CL A 278 A 108 ASN A 160 ASN~? 24.70 CL CL A 278 A 135 ASN A 185 ASN.? 23.31 CL CL A 278 coo 17.59 4.66 17.88 15.38 5.96 18.97 36.20 -24.23 0.74 38.03 -22.59 2.05 coo 12.36 16.24 15.27 12.06 14.29 16.05 30.61 -11.30 3.89 31.69 -9.56 3.26 coo 18.05 11.56 12.71 17.57 10.75 14.60 29.16 -19.86 6.66 28.14 -19.34 8.46 ULMN 3 1uy2_p00 ENDO-1,4-BETA-XYLANASE A user 7 3 # 7 A 51 TYR A 217 TYR.? 13.45 CL CL A 278 A 108 ASN A 246 ASN.? 12.85 CL CL A 278 A 135 ASN A 244 ASN.? 5.40 CL CL A 278 coo 17.59 4.66 17.88 15.38 5.96 18.97 22.77 -37.42 -9.36 23.40 -34.73 -9.58 coo 12.36 16.24 15.27 12.06 14.29 16.05 12.83 -32.17 -9.87 11.11 -33.32 -9.30 coo 18.05 11.56 12.71 17.57 10.75 14.60 17.85 -28.42 -8.05 16.64 -26.87 -8.84 ULMN 3 1uy2_p00 ENDO-1,4-BETA-XYLANASE A user 8 3 # 8 A 51 TYR B 14 TYR~? 22.44 CL CL B 278 A 108 ASN B 245 ASN.? 12.34 CL CL B 278 A 135 ASN B 254 ASN~? 16.98 CL CL B 278 coo 17.59 4.66 17.88 15.38 5.96 18.97 -17.87 -12.84 -21.07 -19.82 -11.02 -21.91 coo 12.36 16.24 15.27 12.06 14.29 16.05 -8.45 -4.50 -18.19 -10.06 -4.59 -19.62 coo 18.05 11.56 12.71 17.57 10.75 14.60 -14.04 -4.32 -21.65 -14.71 -3.72 -19.71 ULMN 3 1uy2_p00 ENDO-1,4-BETA-XYLANASE A user 9 3 # 9 A 51 TYR B 145 TYR.? 15.21 CL CL B 278 A 108 ASN B 119 ASN~? 17.69 CL CL B 278 A 135 ASN B 141 ASN.? 13.90 CL CL B 278 coo 17.59 4.66 17.88 15.38 5.96 18.97 5.06 9.55 -24.01 4.48 7.22 -25.41 coo 12.36 16.24 15.27 12.06 14.29 16.05 17.14 3.31 -24.51 17.47 2.47 -22.58 coo 18.05 11.56 12.71 17.57 10.75 14.60 9.53 4.91 -19.46 10.65 6.11 -18.14 ULMN 3 1uy2_p00 ENDO-1,4-BETA-XYLANASE A user 10 3 # 10 A 51 TYR B 180 TYR.? 19.79 CL CL B 278 A 108 ASN B 141 ASN.? 13.90 CL CL B 278 A 135 ASN B 142 ASN.? 15.73 CL CL B 278 coo 17.59 4.66 17.88 15.38 5.96 18.97 0.34 10.88 -27.32 1.25 13.08 -28.75 coo 12.36 16.24 15.27 12.06 14.29 16.05 9.53 4.91 -19.46 10.65 6.11 -18.14 coo 18.05 11.56 12.71 17.57 10.75 14.60 5.89 9.56 -18.58 6.90 10.10 -16.77 ULMN 3 1uy2_p00 ENDO-1,4-BETA-XYLANASE A user 11 3 # 11 A 51 TYR B 182 TYR.? 22.76 CL CL B 278 A 108 ASN B 160 ASN~? 24.49 CL CL B 278 A 135 ASN B 185 ASN.? 23.46 CL CL B 278 coo 17.59 4.66 17.88 15.38 5.96 18.97 0.96 10.51 -32.91 2.52 12.04 -34.64 coo 12.36 16.24 15.27 12.06 14.29 16.05 12.63 3.12 -37.15 14.44 4.19 -36.85 coo 18.05 11.56 12.71 17.57 10.75 14.60 3.74 2.53 -38.55 3.92 1.27 -40.29 ULMN 3 1uy2_p00 ENDO-1,4-BETA-XYLANASE A user 12 3 # 12 A 51 TYR B 217 TYR.? 13.94 CL CL B 278 A 108 ASN B 246 ASN.? 13.30 CL CL B 278 A 135 ASN B 244 ASN.? 5.94 CL CL B 278 coo 17.59 4.66 17.88 15.38 5.96 18.97 -12.06 -0.05 -19.78 -9.32 0.42 -19.98 coo 12.36 16.24 15.27 12.06 14.29 16.05 -7.71 -10.36 -18.40 -9.09 -11.94 -18.78 coo 18.05 11.56 12.71 17.57 10.75 14.60 -3.88 -6.12 -21.35 -2.47 -7.43 -20.48 1uy2_p00 source 1uy2 ENDO-1,4-BETA-XYLANASE A : 12 hits 1uy2_p00 naa= 3 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 1 3 # 1 A 51 TYR A 14 TYR~? 21.87 CL CL A 278 A 108 ASN A 245 ASN.? 11.79 CL CL A 278 A 135 ASN A 246 ASN.? 12.85 CL CL A 278 coo 17.50 4.57 17.85 15.28 5.88 18.97 9.67 -41.27 -5.56 11.11 -43.55 -4.85 coo 12.22 15.98 15.24 11.94 14.05 16.09 18.48 -33.48 -10.76 18.30 -34.93 -9.15 coo 17.94 11.43 12.65 17.42 10.61 14.53 12.83 -32.17 -9.87 11.11 -33.32 -9.30 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 2 3 # 2 A 51 TYR A 14 TYR~? 21.87 CL CL A 278 A 108 ASN A 245 ASN.? 11.79 CL CL A 278 A 135 ASN A 254 ASN~? 16.17 CL CL A 278 coo 17.50 4.57 17.85 15.28 5.88 18.97 9.67 -41.27 -5.56 11.11 -43.55 -4.85 coo 12.22 15.98 15.24 11.94 14.05 16.09 18.48 -33.48 -10.76 18.30 -34.93 -9.15 coo 17.94 11.43 12.65 17.42 10.61 14.53 18.50 -38.45 -6.68 18.86 -39.34 -8.59 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 3 3 # 3 A 51 TYR A 122 TYR~? 19.12 CL CL A 278 A 108 ASN A 141 ASN~? 14.40 CL CL A 278 A 135 ASN A 119 ASN~? 18.19 CL CL A 278 coo 17.50 4.57 17.85 15.28 5.88 18.97 24.48 -6.24 -5.60 21.71 -6.48 -5.39 coo 12.22 15.98 15.24 11.94 14.05 16.09 29.69 -16.58 -13.36 30.76 -15.83 -15.01 coo 17.94 11.43 12.65 17.42 10.61 14.53 29.77 -8.48 -9.06 28.79 -8.44 -10.95 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 4 3 # 4 A 51 TYR A 145 TYR~? 15.40 CL CL A 278 A 108 ASN A 119 ASN~? 18.19 CL CL A 278 A 135 ASN A 141 ASN~? 14.40 CL CL A 278 coo 17.50 4.57 17.85 15.28 5.88 18.97 34.36 -21.23 -8.52 32.31 -21.44 -6.65 coo 12.22 15.98 15.24 11.94 14.05 16.09 29.77 -8.48 -9.06 28.79 -8.44 -10.95 coo 17.94 11.43 12.65 17.42 10.61 14.53 29.69 -16.58 -13.36 30.76 -15.83 -15.01 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 5 3 # 5 A 51 TYR A 180 TYR.? 19.77 CL CL A 278 A 108 ASN A 141 ASN~? 14.40 CL CL A 278 A 135 ASN A 142 ASN~? 15.74 CL CL A 278 coo 17.50 4.57 17.85 15.28 5.88 18.97 35.72 -25.25 -4.91 38.35 -24.47 -4.37 coo 12.22 15.98 15.24 11.94 14.05 16.09 29.69 -16.58 -13.36 30.76 -15.83 -15.01 coo 17.94 11.43 12.65 17.42 10.61 14.53 33.76 -20.86 -14.08 33.88 -20.26 -16.14 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 6 3 # 6 A 51 TYR A 182 TYR.? 22.89 CL CL A 278 A 108 ASN A 160 ASN~? 24.70 CL CL A 278 A 135 ASN A 185 ASN.? 23.31 CL CL A 278 coo 17.50 4.57 17.85 15.28 5.88 18.97 36.20 -24.23 0.74 38.03 -22.59 2.05 coo 12.22 15.98 15.24 11.94 14.05 16.09 30.61 -11.30 3.89 31.69 -9.56 3.26 coo 17.94 11.43 12.65 17.42 10.61 14.53 29.16 -19.86 6.66 28.14 -19.34 8.46 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 7 3 # 7 A 51 TYR A 217 TYR.? 13.45 CL CL A 278 A 108 ASN A 246 ASN.? 12.85 CL CL A 278 A 135 ASN A 244 ASN.? 5.40 CL CL A 278 coo 17.50 4.57 17.85 15.28 5.88 18.97 22.77 -37.42 -9.36 23.40 -34.73 -9.58 coo 12.22 15.98 15.24 11.94 14.05 16.09 12.83 -32.17 -9.87 11.11 -33.32 -9.30 coo 17.94 11.43 12.65 17.42 10.61 14.53 17.85 -28.42 -8.05 16.64 -26.87 -8.84 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 8 3 # 8 A 51 TYR B 14 TYR~? 22.44 CL CL B 278 A 108 ASN B 245 ASN.? 12.34 CL CL B 278 A 135 ASN B 254 ASN~? 16.98 CL CL B 278 coo 17.50 4.57 17.85 15.28 5.88 18.97 -17.87 -12.84 -21.07 -19.82 -11.02 -21.91 coo 12.22 15.98 15.24 11.94 14.05 16.09 -8.45 -4.50 -18.19 -10.06 -4.59 -19.62 coo 17.94 11.43 12.65 17.42 10.61 14.53 -14.04 -4.32 -21.65 -14.71 -3.72 -19.71 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 9 3 # 9 A 51 TYR B 145 TYR.? 15.21 CL CL B 278 A 108 ASN B 119 ASN~? 17.69 CL CL B 278 A 135 ASN B 141 ASN.? 13.90 CL CL B 278 coo 17.50 4.57 17.85 15.28 5.88 18.97 5.06 9.55 -24.01 4.48 7.22 -25.41 coo 12.22 15.98 15.24 11.94 14.05 16.09 17.14 3.31 -24.51 17.47 2.47 -22.58 coo 17.94 11.43 12.65 17.42 10.61 14.53 9.53 4.91 -19.46 10.65 6.11 -18.14 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 10 3 # 10 A 51 TYR B 180 TYR.? 19.79 CL CL B 278 A 108 ASN B 141 ASN.? 13.90 CL CL B 278 A 135 ASN B 142 ASN.? 15.73 CL CL B 278 coo 17.50 4.57 17.85 15.28 5.88 18.97 0.34 10.88 -27.32 1.25 13.08 -28.75 coo 12.22 15.98 15.24 11.94 14.05 16.09 9.53 4.91 -19.46 10.65 6.11 -18.14 coo 17.94 11.43 12.65 17.42 10.61 14.53 5.89 9.56 -18.58 6.90 10.10 -16.77 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 11 3 # 11 A 51 TYR B 182 TYR.? 22.76 CL CL B 278 A 108 ASN B 160 ASN~? 24.49 CL CL B 278 A 135 ASN B 185 ASN.? 23.46 CL CL B 278 coo 17.50 4.57 17.85 15.28 5.88 18.97 0.96 10.51 -32.91 2.52 12.04 -34.64 coo 12.22 15.98 15.24 11.94 14.05 16.09 12.63 3.12 -37.15 14.44 4.19 -36.85 coo 17.94 11.43 12.65 17.42 10.61 14.53 3.74 2.53 -38.55 3.92 1.27 -40.29 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 12 3 # 12 A 51 TYR B 217 TYR.? 13.94 CL CL B 278 A 108 ASN B 246 ASN.? 13.30 CL CL B 278 A 135 ASN B 244 ASN.? 5.94 CL CL B 278 coo 17.50 4.57 17.85 15.28 5.88 18.97 -12.06 -0.05 -19.78 -9.32 0.42 -19.98 coo 12.22 15.98 15.24 11.94 14.05 16.09 -7.71 -10.36 -18.40 -9.09 -11.94 -18.78 coo 17.94 11.43 12.65 17.42 10.61 14.53 -3.88 -6.12 -21.35 -2.47 -7.43 -20.48 1uy4_p00 source 1uy4 ENDO-1,4-BETA-XYLANASE A : 12 hits 1uy4_p00 naa= 3 ULMN 3 1wbf_p00 PROTEIN (AGGLUTININ) user 1 3 # 1 A 44 ASN A 142 ASN~? 15.74 CL CL A 278 A 213 PRO A 178 PRO.? 14.92 CL CL A 278 A 219 ASN A 148 ASN.? 24.86 CL CL A 278 coo -7.34 -5.74 33.55 -6.42 -4.32 34.85 33.76 -20.86 -14.08 33.88 -20.26 -16.14 coo -10.08 -3.19 35.19 -11.51 -3.72 33.58 34.58 -24.99 -10.21 32.64 -25.93 -10.79 coo -15.60 -12.66 27.15 -15.94 -14.47 28.23 43.71 -14.72 -10.92 42.02 -14.43 -12.19 ULMN 3 1wbf_p00 PROTEIN (AGGLUTININ) user 2 3 # 2 A 44 ASN A 148 ASN.? 24.86 CL CL A 278 A 213 PRO A 147 PRO.? 24.32 CL CL A 278 A 219 ASN A 141 ASN~? 14.40 CL CL A 278 coo -7.34 -5.74 33.55 -6.42 -4.32 34.85 43.71 -14.72 -10.92 42.02 -14.43 -12.19 coo -10.08 -3.19 35.19 -11.51 -3.72 33.58 43.48 -20.52 -11.94 42.39 -19.36 -10.36 coo -15.60 -12.66 27.15 -15.94 -14.47 28.23 29.69 -16.58 -13.36 30.76 -15.83 -15.01 ULMN 3 1wbf_p00 PROTEIN (AGGLUTININ) user 3 3 # 3 A 44 ASN A 187 ASN.? 27.58 CL CL A 278 A 213 PRO A 186 PRO.? 25.85 CL CL A 278 A 219 ASN A 160 ASN~? 24.70 CL CL A 278 coo -7.34 -5.74 33.55 -6.42 -4.32 34.85 27.12 -21.23 11.57 28.22 -20.58 13.28 coo -10.08 -3.19 35.19 -11.51 -3.72 33.58 32.31 -21.59 10.70 31.05 -22.64 9.15 coo -15.60 -12.66 27.15 -15.94 -14.47 28.23 30.61 -11.30 3.89 31.69 -9.56 3.26 ULMN 3 1wbf_p00 PROTEIN (AGGLUTININ) user 4 3 # 4 A 44 ASN A 197 ASN.? 12.86 CL CL A 278 A 213 PRO A 170 PRO.? 8.77 CL CL A 278 A 219 ASN A 218 ASN~? 20.82 CL CL A 278 coo -7.34 -5.74 33.55 -6.42 -4.32 34.85 21.52 -32.98 -18.45 20.55 -33.92 -20.09 coo -10.08 -3.19 35.19 -11.51 -3.72 33.58 23.69 -29.38 -16.19 25.77 -29.37 -15.36 coo -15.60 -12.66 27.15 -15.94 -14.47 28.23 24.13 -43.84 -11.70 26.14 -43.18 -11.76 ULMN 3 1wbf_p00 PROTEIN (AGGLUTININ) user 5 3 # 5 A 44 ASN A 197 ASN.? 12.86 CL CL A 278 A 213 PRO A 170 PRO.? 8.77 CL CL A 278 A 219 ASN A 246 ASN.? 12.85 CL CL A 278 coo -7.34 -5.74 33.55 -6.42 -4.32 34.85 21.52 -32.98 -18.45 20.55 -33.92 -20.09 coo -10.08 -3.19 35.19 -11.51 -3.72 33.58 23.69 -29.38 -16.19 25.77 -29.37 -15.36 coo -15.60 -12.66 27.15 -15.94 -14.47 28.23 12.83 -32.17 -9.87 11.11 -33.32 -9.30 ULMN 3 1wbf_p00 PROTEIN (AGGLUTININ) user 6 3 # 6 A 44 ASN A 197 ASN.? 12.86 CL CL A 278 A 213 PRO A 170 PRO.? 8.77 CL CL A 278 A 219 ASN A 254 ASN~? 16.17 CL CL A 278 coo -7.34 -5.74 33.55 -6.42 -4.32 34.85 21.52 -32.98 -18.45 20.55 -33.92 -20.09 coo -10.08 -3.19 35.19 -11.51 -3.72 33.58 23.69 -29.38 -16.19 25.77 -29.37 -15.36 coo -15.60 -12.66 27.15 -15.94 -14.47 28.23 18.50 -38.45 -6.68 18.86 -39.34 -8.59 ULMN 3 1wbf_p00 PROTEIN (AGGLUTININ) user 7 3 # 7 A 44 ASN B 142 ASN.? 15.73 CL CL B 278 A 213 PRO B 178 PRO.? 14.98 CL CL B 278 A 219 ASN B 148 ASN~? 24.62 CL CL B 278 coo -7.34 -5.74 33.55 -6.42 -4.32 34.85 5.89 9.56 -18.58 6.90 10.10 -16.77 coo -10.08 -3.19 35.19 -11.51 -3.72 33.58 1.35 10.36 -22.35 0.44 8.64 -21.24 coo -15.60 -12.66 27.15 -15.94 -14.47 28.23 12.72 18.24 -23.93 13.08 16.64 -22.60 ULMN 3 1wbf_p00 PROTEIN (AGGLUTININ) user 8 3 # 8 A 44 ASN B 187 ASN.? 27.72 CL CL B 278 A 213 PRO B 186 PRO.? 25.94 CL CL B 278 A 219 ASN B 160 ASN~? 24.49 CL CL B 278 coo -7.34 -5.74 33.55 -6.42 -4.32 34.85 1.42 0.10 -42.91 1.86 0.83 -44.85 coo -10.08 -3.19 35.19 -11.51 -3.72 33.58 1.63 5.38 -42.65 0.76 4.40 -40.83 coo -15.60 -12.66 27.15 -15.94 -14.47 28.23 12.63 3.12 -37.15 14.44 4.19 -36.85 ULMN 3 1wbf_p00 PROTEIN (AGGLUTININ) user 9 3 # 9 A 44 ASN B 197 ASN.? 13.10 CL CL B 278 A 213 PRO B 170 PRO.? 8.94 CL CL B 278 A 219 ASN B 218 ASN~? 21.19 CL CL B 278 coo -7.34 -5.74 33.55 -6.42 -4.32 34.85 -6.63 -0.56 -11.26 -7.23 -1.17 -9.32 coo -10.08 -3.19 35.19 -11.51 -3.72 33.58 -3.16 0.82 -14.27 -3.00 2.79 -15.33 coo -15.60 -12.66 27.15 -15.94 -14.47 28.23 -17.80 2.35 -16.65 -17.00 4.26 -17.12 ULMN 3 1wbf_p00 PROTEIN (AGGLUTININ) user 10 3 # 10 A 44 ASN B 197 ASN.? 13.10 CL CL B 278 A 213 PRO B 170 PRO.? 8.94 CL CL B 278 A 219 ASN B 246 ASN.? 13.30 CL CL B 278 coo -7.34 -5.74 33.55 -6.42 -4.32 34.85 -6.63 -0.56 -11.26 -7.23 -1.17 -9.32 coo -10.08 -3.19 35.19 -11.51 -3.72 33.58 -3.16 0.82 -14.27 -3.00 2.79 -15.33 coo -15.60 -12.66 27.15 -15.94 -14.47 28.23 -7.71 -10.36 -18.40 -9.09 -11.94 -18.78 ULMN 3 1wbf_p00 PROTEIN (AGGLUTININ) user 11 3 # 11 A 44 ASN B 197 ASN.? 13.10 CL CL B 278 A 213 PRO B 170 PRO.? 8.94 CL CL B 278 A 219 ASN B 254 ASN~? 16.98 CL CL B 278 coo -7.34 -5.74 33.55 -6.42 -4.32 34.85 -6.63 -0.56 -11.26 -7.23 -1.17 -9.32 coo -10.08 -3.19 35.19 -11.51 -3.72 33.58 -3.16 0.82 -14.27 -3.00 2.79 -15.33 coo -15.60 -12.66 27.15 -15.94 -14.47 28.23 -14.04 -4.32 -21.65 -14.71 -3.72 -19.71 1wbf_p00 source 1wbf PROTEIN (AGGLUTININ) : 11 hits 1wbf_p00 naa= 3 ULMN 3 2c3x_p00 ALPHA-AMYLASE G-6 user 1 3 # 1 A 26 HIS A 12 HIS~? 14.78 CL CL A 278 A 76 ASN A 254 ASN~? 16.17 CL CL A 278 A 81 ASP A 250 ASP~? 15.45 CL CL A 278 coo 4.09 43.69 67.89 2.45 42.40 68.10 9.03 -33.35 -4.93 10.37 -31.88 -5.56 coo 4.75 48.17 75.81 4.99 47.30 77.74 18.50 -38.45 -6.68 18.86 -39.34 -8.59 coo 0.57 50.41 73.18 0.46 48.28 73.56 15.24 -38.09 -11.21 14.62 -38.47 -13.19 ULMN 3 2c3x_p00 ALPHA-AMYLASE G-6 user 2 3 # 2 A 26 HIS B 12 HIS~? 15.42 CL CL B 278 A 76 ASN B 254 ASN~? 16.98 CL CL B 278 A 81 ASP B 250 ASP~? 16.15 CL CL B 278 coo 4.09 43.69 67.89 2.45 42.40 68.10 -10.18 -14.51 -22.80 -8.49 -13.29 -22.60 coo 4.75 48.17 75.81 4.99 47.30 77.74 -14.04 -4.32 -21.65 -14.71 -3.72 -19.71 coo 0.57 50.41 73.18 0.46 48.28 73.56 -13.35 -7.01 -16.89 -13.59 -7.26 -14.81 ULMN 3 2c3x_p00 ALPHA-AMYLASE G-6 user 3 3 # 3 A 26 HIS B 29 HIS.? 25.42 CL CL B 278 A 76 ASN B 270 ASN.? 34.32 CL CL B 278 A 81 ASP B 268 ASP.? 26.26 CL CL B 278 coo 4.09 43.69 67.89 2.45 42.40 68.10 -16.16 -16.38 -29.82 -17.24 -18.07 -29.20 coo 4.75 48.17 75.81 4.99 47.30 77.74 -18.26 -22.22 -38.09 -17.05 -23.10 -39.57 coo 0.57 50.41 73.18 0.46 48.28 73.56 -14.31 -16.11 -36.83 -14.03 -14.11 -36.24 2c3x_p00 source 2c3x ALPHA-AMYLASE G-6 : 3 hits 2c3x_p00 naa= 3 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 1 3 # 1 A 459 ASN A 141 ASN~? 14.40 CL CL A 278 A 460 GLY A 111 GLY.? 9.84 CL CL A 278 A 461 ASN A 175 ASN.? 15.39 CL CL A 278 coo 15.00 94.38 6.97 13.00 93.59 6.99 29.69 -16.58 -13.36 30.76 -15.83 -15.01 coo 19.48 94.04 5.03 19.26 94.00 5.78 25.43 -16.70 -15.06 25.21 -15.89 -15.01 coo 20.23 95.69 9.16 21.55 97.37 9.20 30.44 -19.14 -17.48 31.94 -17.93 -18.43 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 2 3 # 2 A 459 ASN A 175 ASN.? 15.39 CL CL A 278 A 460 GLY A 111 GLY.? 9.84 CL CL A 278 A 461 ASN A 141 ASN~? 14.40 CL CL A 278 coo 15.00 94.38 6.97 13.00 93.59 6.99 30.44 -19.14 -17.48 31.94 -17.93 -18.43 coo 19.48 94.04 5.03 19.26 94.00 5.78 25.43 -16.70 -15.06 25.21 -15.89 -15.01 coo 20.23 95.69 9.16 21.55 97.37 9.20 29.69 -16.58 -13.36 30.76 -15.83 -15.01 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 3 3 # 3 A 459 ASN B 141 ASN.? 13.90 CL CL B 278 A 460 GLY B 111 GLY.? 9.20 CL CL B 278 A 461 ASN B 175 ASN.? 15.07 CL CL B 278 coo 15.00 94.38 6.97 13.00 93.59 6.99 9.53 4.91 -19.46 10.65 6.11 -18.14 coo 19.48 94.04 5.03 19.26 94.00 5.78 9.34 0.80 -16.95 10.11 0.51 -17.10 coo 20.23 95.69 9.16 21.55 97.37 9.20 7.70 6.80 -15.23 9.08 8.02 -14.14 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 4 3 # 4 A 459 ASN B 175 ASN.? 15.07 CL CL B 278 A 460 GLY B 111 GLY.? 9.20 CL CL B 278 A 461 ASN B 141 ASN.? 13.90 CL CL B 278 coo 15.00 94.38 6.97 13.00 93.59 6.99 7.70 6.80 -15.23 9.08 8.02 -14.14 coo 19.48 94.04 5.03 19.26 94.00 5.78 9.34 0.80 -16.95 10.11 0.51 -17.10 coo 20.23 95.69 9.16 21.55 97.37 9.20 9.53 4.91 -19.46 10.65 6.11 -18.14 2qv4_p00 source 2qv4 PANCREATIC ALPHA-AMYLASE : 4 hits 2qv4_p00 naa= 3 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 1 3 # 1 A 270 ASN A 119 ASN~? 18.19 CL CL A 278 A 384 ASN B 119 ASN~? 17.69 CL CL B 278 A 385 GLU B 118 GLU~? 24.50 CL CL B 278 coo 22.28 63.17 110.61 22.47 65.06 111.53 29.77 -8.48 -9.06 28.79 -8.44 -10.95 coo 7.06 50.07 96.17 8.50 48.54 96.31 17.14 3.31 -24.51 17.47 2.47 -22.58 coo 11.59 49.83 99.41 10.92 47.97 100.16 23.68 3.61 -23.61 23.81 5.46 -22.57 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 2 3 # 2 A 270 ASN A 142 ASN~? 15.74 CL CL A 278 A 384 ASN A 218 ASN~? 20.82 CL CL A 278 A 385 GLU A 221 GLU~? 17.05 CL CL A 278 coo 22.28 63.17 110.61 22.47 65.06 111.53 33.76 -20.86 -14.08 33.88 -20.26 -16.14 coo 7.06 50.07 96.17 8.50 48.54 96.31 24.13 -43.84 -11.70 26.14 -43.18 -11.76 coo 11.59 49.83 99.41 10.92 47.97 100.16 27.14 -39.98 -10.94 25.92 -39.21 -12.48 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 3 3 # 3 A 270 ASN A 160 ASN~? 24.70 CL CL A 278 A 384 ASN A 244 ASN.? 5.40 CL CL A 278 A 385 GLU A 34 GLU^? 8.78 CL CL A 278 coo 22.28 63.17 110.61 22.47 65.06 111.53 30.61 -11.30 3.89 31.69 -9.56 3.26 coo 7.06 50.07 96.17 8.50 48.54 96.31 17.85 -28.42 -8.05 16.64 -26.87 -8.84 coo 11.59 49.83 99.41 10.92 47.97 100.16 14.76 -23.90 -2.78 16.42 -23.89 -4.11 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 4 3 # 4 A 270 ASN A 175 ASN.? 15.39 CL CL A 278 A 384 ASN A 218 ASN~? 20.82 CL CL A 278 A 385 GLU A 221 GLU~? 17.05 CL CL A 278 coo 22.28 63.17 110.61 22.47 65.06 111.53 30.44 -19.14 -17.48 31.94 -17.93 -18.43 coo 7.06 50.07 96.17 8.50 48.54 96.31 24.13 -43.84 -11.70 26.14 -43.18 -11.76 coo 11.59 49.83 99.41 10.92 47.97 100.16 27.14 -39.98 -10.94 25.92 -39.21 -12.48 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 5 3 # 5 A 270 ASN A 187 ASN.? 27.58 CL CL A 278 A 384 ASN A 244 ASN.? 5.40 CL CL A 278 A 385 GLU A 34 GLU^? 8.78 CL CL A 278 coo 22.28 63.17 110.61 22.47 65.06 111.53 27.12 -21.23 11.57 28.22 -20.58 13.28 coo 7.06 50.07 96.17 8.50 48.54 96.31 17.85 -28.42 -8.05 16.64 -26.87 -8.84 coo 11.59 49.83 99.41 10.92 47.97 100.16 14.76 -23.90 -2.78 16.42 -23.89 -4.11 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 6 3 # 6 A 270 ASN A 244 ASN.? 5.40 CL CL A 278 A 384 ASN A 187 ASN.? 27.58 CL CL A 278 A 385 GLU A 238 GLU^? 24.84 CL CL A 278 coo 22.28 63.17 110.61 22.47 65.06 111.53 17.85 -28.42 -8.05 16.64 -26.87 -8.84 coo 7.06 50.07 96.17 8.50 48.54 96.31 27.12 -21.23 11.57 28.22 -20.58 13.28 coo 11.59 49.83 99.41 10.92 47.97 100.16 22.87 -26.18 11.53 21.04 -27.14 11.99 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 7 3 # 7 A 270 ASN A 254 ASN~? 16.17 CL CL A 278 A 384 ASN A 187 ASN.? 27.58 CL CL A 278 A 385 GLU A 238 GLU^? 24.84 CL CL A 278 coo 22.28 63.17 110.61 22.47 65.06 111.53 18.50 -38.45 -6.68 18.86 -39.34 -8.59 coo 7.06 50.07 96.17 8.50 48.54 96.31 27.12 -21.23 11.57 28.22 -20.58 13.28 coo 11.59 49.83 99.41 10.92 47.97 100.16 22.87 -26.18 11.53 21.04 -27.14 11.99 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 8 3 # 8 A 270 ASN A 263 ASN~? 31.02 CL CL A 278 A 384 ASN A 187 ASN.? 27.58 CL CL A 278 A 385 GLU A 238 GLU^? 24.84 CL CL A 278 coo 22.28 63.17 110.61 22.47 65.06 111.53 23.12 -44.40 7.58 22.32 -45.82 8.92 coo 7.06 50.07 96.17 8.50 48.54 96.31 27.12 -21.23 11.57 28.22 -20.58 13.28 coo 11.59 49.83 99.41 10.92 47.97 100.16 22.87 -26.18 11.53 21.04 -27.14 11.99 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 9 3 # 9 A 270 ASN B 58 ASN.? 27.93 CL CL B 278 A 384 ASN B 246 ASN.? 13.30 CL CL B 278 A 385 GLU B 11 GLU.? 12.74 CL CL B 278 coo 22.28 63.17 110.61 22.47 65.06 111.53 -10.15 -12.85 -41.76 -10.63 -10.76 -41.86 coo 7.06 50.07 96.17 8.50 48.54 96.31 -7.71 -10.36 -18.40 -9.09 -11.94 -18.78 coo 11.59 49.83 99.41 10.92 47.97 100.16 -6.91 -15.96 -19.89 -5.75 -14.85 -18.47 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 10 3 # 10 A 270 ASN B 119 ASN~? 17.69 CL CL B 278 A 384 ASN B 244 ASN.? 5.94 CL CL B 278 A 385 GLU B 34 GLU^? 8.94 CL CL B 278 coo 22.28 63.17 110.61 22.47 65.06 111.53 17.14 3.31 -24.51 17.47 2.47 -22.58 coo 7.06 50.07 96.17 8.50 48.54 96.31 -3.88 -6.12 -21.35 -2.47 -7.43 -20.48 coo 11.59 49.83 99.41 10.92 47.97 100.16 -0.25 -10.10 -26.69 0.15 -8.25 -25.75 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 11 3 # 11 A 270 ASN B 142 ASN.? 15.73 CL CL B 278 A 384 ASN B 218 ASN~? 21.19 CL CL B 278 A 385 GLU B 221 GLU~? 17.56 CL CL B 278 coo 22.28 63.17 110.61 22.47 65.06 111.53 5.89 9.56 -18.58 6.90 10.10 -16.77 coo 7.06 50.07 96.17 8.50 48.54 96.31 -17.80 2.35 -16.65 -17.00 4.26 -17.12 coo 11.59 49.83 99.41 10.92 47.97 100.16 -13.90 4.76 -18.50 -13.25 3.58 -16.87 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 12 3 # 12 A 270 ASN B 160 ASN~? 24.49 CL CL B 278 A 384 ASN B 244 ASN.? 5.94 CL CL B 278 A 385 GLU B 34 GLU^? 8.94 CL CL B 278 coo 22.28 63.17 110.61 22.47 65.06 111.53 12.63 3.12 -37.15 14.44 4.19 -36.85 coo 7.06 50.07 96.17 8.50 48.54 96.31 -3.88 -6.12 -21.35 -2.47 -7.43 -20.48 coo 11.59 49.83 99.41 10.92 47.97 100.16 -0.25 -10.10 -26.69 0.15 -8.25 -25.75 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 13 3 # 13 A 270 ASN B 175 ASN.? 15.07 CL CL B 278 A 384 ASN B 218 ASN~? 21.19 CL CL B 278 A 385 GLU B 221 GLU~? 17.56 CL CL B 278 coo 22.28 63.17 110.61 22.47 65.06 111.53 7.70 6.80 -15.23 9.08 8.02 -14.14 coo 7.06 50.07 96.17 8.50 48.54 96.31 -17.80 2.35 -16.65 -17.00 4.26 -17.12 coo 11.59 49.83 99.41 10.92 47.97 100.16 -13.90 4.76 -18.50 -13.25 3.58 -16.87 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 14 3 # 14 A 270 ASN B 187 ASN.? 27.72 CL CL B 278 A 384 ASN B 244 ASN.? 5.94 CL CL B 278 A 385 GLU B 34 GLU^? 8.94 CL CL B 278 coo 22.28 63.17 110.61 22.47 65.06 111.53 1.42 0.10 -42.91 1.86 0.83 -44.85 coo 7.06 50.07 96.17 8.50 48.54 96.31 -3.88 -6.12 -21.35 -2.47 -7.43 -20.48 coo 11.59 49.83 99.41 10.92 47.97 100.16 -0.25 -10.10 -26.69 0.15 -8.25 -25.75 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 15 3 # 15 A 270 ASN B 244 ASN.? 5.94 CL CL B 278 A 384 ASN B 187 ASN.? 27.72 CL CL B 278 A 385 GLU B 238 GLU^? 25.19 CL CL B 278 coo 22.28 63.17 110.61 22.47 65.06 111.53 -3.88 -6.12 -21.35 -2.47 -7.43 -20.48 coo 7.06 50.07 96.17 8.50 48.54 96.31 1.42 0.10 -42.91 1.86 0.83 -44.85 coo 11.59 49.83 99.41 10.92 47.97 100.16 -3.49 -3.71 -41.35 -4.99 -5.08 -41.88 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 16 3 # 16 A 270 ASN B 254 ASN~? 16.98 CL CL B 278 A 384 ASN B 187 ASN.? 27.72 CL CL B 278 A 385 GLU B 238 GLU^? 25.19 CL CL B 278 coo 22.28 63.17 110.61 22.47 65.06 111.53 -14.04 -4.32 -21.65 -14.71 -3.72 -19.71 coo 7.06 50.07 96.17 8.50 48.54 96.31 1.42 0.10 -42.91 1.86 0.83 -44.85 coo 11.59 49.83 99.41 10.92 47.97 100.16 -3.49 -3.71 -41.35 -4.99 -5.08 -41.88 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 17 3 # 17 A 270 ASN B 263 ASN.? 31.56 CL CL B 278 A 384 ASN B 187 ASN.? 27.72 CL CL B 278 A 385 GLU B 238 GLU^? 25.19 CL CL B 278 coo 22.28 63.17 110.61 22.47 65.06 111.53 -21.42 -0.91 -35.49 -22.77 -1.78 -36.88 coo 7.06 50.07 96.17 8.50 48.54 96.31 1.42 0.10 -42.91 1.86 0.83 -44.85 coo 11.59 49.83 99.41 10.92 47.97 100.16 -3.49 -3.71 -41.35 -4.99 -5.08 -41.88 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 18 3 # 18 A 270 ASN B 270 ASN.? 34.32 CL CL B 278 A 384 ASN B 246 ASN.? 13.30 CL CL B 278 A 385 GLU B 11 GLU.? 12.74 CL CL B 278 coo 22.28 63.17 110.61 22.47 65.06 111.53 -18.26 -22.22 -38.09 -17.05 -23.10 -39.57 coo 7.06 50.07 96.17 8.50 48.54 96.31 -7.71 -10.36 -18.40 -9.09 -11.94 -18.78 coo 11.59 49.83 99.41 10.92 47.97 100.16 -6.91 -15.96 -19.89 -5.75 -14.85 -18.47 2v3r_p00 source 2v3r EXOGLUCANASE 1 : 18 hits 2v3r_p00 naa= 3 ULMN 4 2v73_p00 PUTATIVE EXO-ALPHA-SIALIDASE user 1 4 # 1 A 79 GLU A 169 GLU.? 7.63 CL CL A 278 A 81 ARG A 140 ARG.? 3.74 CL CL A 278 A 151 ARG A 192 ARG^? 5.91 CL CL A 278 A 156 ASN A 244 ASN.? 5.40 CL CL A 278 coo 25.74 5.61 48.63 24.52 5.15 50.30 26.74 -26.14 -12.80 26.49 -24.16 -13.47 coo 27.07 3.11 52.61 25.23 3.35 55.08 24.77 -21.68 -10.23 22.52 -23.37 -11.49 coo 21.76 -2.20 51.78 21.90 0.24 53.63 20.84 -24.38 -4.40 19.02 -23.24 -6.62 coo 16.67 0.72 52.58 15.80 1.51 50.78 17.85 -28.42 -8.05 16.64 -26.87 -8.84 ULMN 4 2v73_p00 PUTATIVE EXO-ALPHA-SIALIDASE user 2 4 # 2 A 79 GLU B 169 GLU.? 7.43 CL CL B 278 A 81 ARG B 140 ARG.? -3.53 CL CL B 278s A 151 ARG B 192 ARG^? 6.13 CL CL B 278 A 156 ASN B 244 ASN.? 5.94 CL CL B 278 coo 25.74 5.61 48.63 24.52 5.15 50.30 0.06 3.03 -18.46 2.10 2.57 -18.04 coo 27.07 3.11 52.61 25.23 3.35 55.08 3.71 0.22 -21.03 2.09 -1.69 -19.26 coo 21.76 -2.20 51.78 21.90 0.24 53.63 -0.17 -3.93 -26.09 1.00 -5.48 -23.71 coo 16.67 0.72 52.58 15.80 1.51 50.78 -3.88 -6.12 -21.35 -2.47 -7.43 -20.48 2v73_p00 source 2v73 PUTATIVE EXO-ALPHA-SIALIDASE : 2 hits 2v73_p00 naa= 4 ULMN 3 1b01_d00 GENE REGULATION/DNA user 1 3 # 1 B 4 ARG A 212 ARG~? 4.63 CL CL A 278 B 6 THR B 77 THR~? 9.42 CL CL A 278 B 8 THR A 112 THR.? 13.33 CL CL A 278 coo 40.52 16.08 100.90 37.97 16.41 102.60 18.59 -24.77 -16.89 17.13 -22.12 -16.49 coo 36.11 13.64 95.03 34.54 14.86 95.91 20.96 -17.51 -20.66 19.31 -17.16 -19.33 coo 32.72 8.05 92.39 31.25 9.11 91.35 26.24 -13.20 -16.26 24.44 -12.42 -17.13 ULMN 3 1b01_d00 GENE REGULATION/DNA user 2 3 # 2 B 4 ARG B 212 ARG~? 4.30 CL CL B 278 B 6 THR A 77 THR~? 8.85 CL CL B 278 B 8 THR B 112 THR.? 12.77 CL CL B 278 coo 40.52 16.08 100.90 37.97 16.41 102.60 1.13 -4.70 -13.40 3.58 -6.46 -14.00 coo 36.11 13.64 95.03 34.54 14.86 95.91 8.85 -2.84 -10.84 8.85 -4.68 -11.96 coo 32.72 8.05 92.39 31.25 9.11 91.35 13.02 1.47 -16.42 13.78 -0.22 -15.35 1b01_d00 source 1b01 GENE REGULATION/DNA : 2 hits 1b01_d00 naa= 3 ULMN 4 1b8i_d01 PROTEIN (HOMEOBOX PROTEIN EXTRADENTIuser 1 4 # 1 B 205 ARG A 196 ARG.? 15.95 CL CL A 278 B 250 ASN A 245 ASN.? 11.79 CL CL A 278 B 254 ASN A 244 ASN.? 5.40 CL CL A 278 B 258 ARG A 192 ARG^? 5.91 CL CL A 278 coo 27.68 3.44 17.27 29.47 5.36 18.86 27.49 -34.87 -12.70 29.46 -35.46 -10.43 coo 23.91 13.92 17.72 21.96 13.28 18.24 18.48 -33.48 -10.76 18.30 -34.93 -9.15 coo 29.13 15.14 20.09 27.87 13.88 21.28 17.85 -28.42 -8.05 16.64 -26.87 -8.84 coo 32.99 14.40 22.49 30.92 12.16 22.53 20.84 -24.38 -4.40 19.02 -23.24 -6.62 ULMN 4 1b8i_d01 PROTEIN (HOMEOBOX PROTEIN EXTRADENTIuser 2 4 # 2 B 205 ARG B 196 ARG.? 16.18 CL CL B 278 B 250 ASN B 245 ASN.? 12.34 CL CL B 278 B 254 ASN B 244 ASN.? 5.94 CL CL B 278 B 258 ARG B 192 ARG^? 6.13 CL CL B 278 coo 27.68 3.44 17.27 29.47 5.36 18.86 -8.42 4.93 -17.56 -9.12 6.53 -20.07 coo 23.91 13.92 17.72 21.96 13.28 18.24 -8.45 -4.50 -18.19 -10.06 -4.59 -19.62 coo 29.13 15.14 20.09 27.87 13.88 21.28 -3.88 -6.12 -21.35 -2.47 -7.43 -20.48 coo 32.99 14.40 22.49 30.92 12.16 22.53 -0.17 -3.93 -26.09 1.00 -5.48 -23.71 1b8i_d01 source 1b8i PROTEIN (HOMEOBOX PROTEIN EXTRADENTICLE) : 2 hits 1b8i_d01 naa= 4 ULMN 3 1bdv_d00 GENE REGULATION/DNA user 1 3 # 1 A 9 GLN A 146 GLN~? 21.14 CL CL A 278 A 11 ASN A 141 ASN~? 14.40 CL CL A 278 A 13 ARG A 140 ARG.? 3.74 CL CL A 278 coo 33.45 2.10 7.21 34.51 1.09 5.67 38.62 -17.97 -13.61 38.61 -16.29 -14.92 coo 38.37 -1.60 11.46 39.03 -3.43 10.75 29.69 -16.58 -13.36 30.76 -15.83 -15.01 coo 41.73 -6.32 12.94 43.25 -5.49 10.40 24.77 -21.68 -10.23 22.52 -23.37 -11.49 ULMN 3 1bdv_d00 GENE REGULATION/DNA user 2 3 # 2 A 9 GLN B 146 GLN~? 19.83 CL CL B 278 A 11 ASN B 141 ASN.? 13.90 CL CL B 278 A 13 ARG B 140 ARG.? -3.53 CL CL B 278s coo 33.45 2.10 7.21 34.51 1.09 5.67 9.71 13.62 -20.26 8.45 13.92 -18.55 coo 38.37 -1.60 11.46 39.03 -3.43 10.75 9.53 4.91 -19.46 10.65 6.11 -18.14 coo 41.73 -6.32 12.94 43.25 -5.49 10.40 3.71 0.22 -21.03 2.09 -1.69 -19.26 1bdv_d00 source 1bdv GENE REGULATION/DNA : 2 hits 1bdv_d00 naa= 3 ULMN 4 1ckt_d00 GENE REGULATION/DNA user 1 4 # 1 A 15 TYR A 39 TYR~? 9.76 CL CL A 278 A 19 VAL A 65 VAL.? 14.50 CL CL A 278 A 37 PHE A 113 PHE.? 15.17 CL CL A 278 A 41 SER A 70 SER.? 11.73 CL CL A 278 coo 30.31 -14.95 20.82 28.24 -14.29 22.55 13.19 -16.19 -7.99 14.85 -15.73 -10.18 coo 24.83 -14.85 17.78 25.17 -13.31 19.32 14.94 -14.38 -2.30 16.99 -13.68 -1.87 coo 20.60 -4.04 22.72 21.46 -2.67 20.51 26.35 -11.75 -10.22 26.90 -10.33 -7.91 coo 23.13 -11.27 24.75 25.16 -10.10 25.52 19.33 -11.34 -7.00 17.75 -13.05 -7.65 ULMN 4 1ckt_d00 GENE REGULATION/DNA user 2 4 # 2 A 15 TYR A 66 TYR.? 15.11 CL CL B 278 A 19 VAL A 65 VAL.? 14.50 CL CL A 278 A 37 PHE A 113 PHE.? 15.17 CL CL A 278 A 41 SER A 70 SER.? 11.73 CL CL A 278 coo 30.31 -14.95 20.82 28.24 -14.29 22.55 11.56 -10.03 -5.26 10.21 -8.56 -7.21 coo 24.83 -14.85 17.78 25.17 -13.31 19.32 14.94 -14.38 -2.30 16.99 -13.68 -1.87 coo 20.60 -4.04 22.72 21.46 -2.67 20.51 26.35 -11.75 -10.22 26.90 -10.33 -7.91 coo 23.13 -11.27 24.75 25.16 -10.10 25.52 19.33 -11.34 -7.00 17.75 -13.05 -7.65 ULMN 4 1ckt_d00 GENE REGULATION/DNA user 3 4 # 3 A 15 TYR B 39 TYR~? 9.53 CL CL B 278 A 19 VAL B 65 VAL.? 14.29 CL CL B 278 A 37 PHE B 113 PHE.? 14.61 CL CL B 278 A 41 SER B 70 SER.? 11.46 CL CL B 278 coo 30.31 -14.95 20.82 28.24 -14.29 22.55 7.70 -12.06 -22.38 8.73 -10.22 -20.60 coo 24.83 -14.85 17.78 25.17 -13.31 19.32 8.95 -11.12 -28.45 9.75 -9.23 -29.22 coo 20.60 -4.04 22.72 21.46 -2.67 20.51 13.54 0.77 -22.59 14.65 0.88 -25.14 coo 23.13 -11.27 24.75 25.16 -10.10 25.52 13.00 -6.56 -24.86 11.13 -7.93 -24.10 ULMN 4 1ckt_d00 GENE REGULATION/DNA user 4 4 # 4 A 15 TYR B 66 TYR.? 15.55 CL CL A 278 A 19 VAL B 65 VAL.? 14.29 CL CL B 278 A 37 PHE B 113 PHE.? 14.61 CL CL B 278 A 41 SER B 70 SER.? 11.46 CL CL B 278 coo 30.31 -14.95 20.82 28.24 -14.29 22.55 13.28 -14.60 -25.62 14.79 -15.90 -23.67 coo 24.83 -14.85 17.78 25.17 -13.31 19.32 8.95 -11.12 -28.45 9.75 -9.23 -29.22 coo 20.60 -4.04 22.72 21.46 -2.67 20.51 13.54 0.77 -22.59 14.65 0.88 -25.14 coo 23.13 -11.27 24.75 25.16 -10.10 25.52 13.00 -6.56 -24.86 11.13 -7.93 -24.10 1ckt_d00 source 1ckt GENE REGULATION/DNA : 4 hits 1ckt_d00 naa= 4 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 1 3 # 1 I 303 TYR A 24 TYR~? 29.31 CL CL A 278 I 306 VAL A 55 VAL.? 25.14 CL CL A 278 I 308 VAL A 52 VAL~? 25.89 CL CL A 278 coo 26.18 35.24 6.87 24.33 35.18 8.97 0.87 -31.89 7.51 0.76 -33.22 9.95 coo 23.55 29.53 9.81 23.15 27.39 10.24 5.65 -28.25 9.47 6.85 -26.92 8.18 coo 16.43 30.18 9.35 15.05 30.67 11.01 5.60 -22.39 9.28 6.61 -20.82 10.47 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 2 3 # 2 I 303 TYR A 26 TYR~? 18.66 CL CL A 278 I 306 VAL A 33 VAL^? 16.22 CL CL A 278 I 308 VAL A 62 VAL^? 14.48 CL CL A 278 coo 26.18 35.24 6.87 24.33 35.18 8.97 7.77 -31.94 1.38 10.47 -31.53 0.90 coo 23.55 29.53 9.81 23.15 27.39 10.24 12.76 -27.92 1.57 10.63 -27.34 1.31 coo 16.43 30.18 9.35 15.05 30.67 11.01 15.63 -22.66 2.22 17.41 -23.55 1.28 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 3 3 # 3 I 303 TYR A 66 TYR.? 15.11 CL CL B 278 I 306 VAL A 65 VAL.? 14.50 CL CL A 278 I 308 VAL A 107 VAL^? 13.29 CL CL A 278 coo 26.18 35.24 6.87 24.33 35.18 8.97 11.56 -10.03 -5.26 10.21 -8.56 -7.21 coo 23.55 29.53 9.81 23.15 27.39 10.24 14.94 -14.38 -2.30 16.99 -13.68 -1.87 coo 16.43 30.18 9.35 15.05 30.67 11.01 20.51 -15.74 -3.18 20.99 -13.73 -2.46 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 4 3 # 4 I 303 TYR B 24 TYR~? 29.69 CL CL B 278 I 306 VAL B 55 VAL~? 25.37 CL CL B 278 I 308 VAL B 52 VAL~? 26.11 CL CL B 278 coo 26.18 35.24 6.87 24.33 35.18 8.97 -10.93 -24.23 -34.16 -12.79 -24.53 -36.20 coo 23.55 29.53 9.81 23.15 27.39 10.24 -7.15 -20.00 -37.19 -5.61 -18.76 -36.22 coo 16.43 30.18 9.35 15.05 30.67 11.01 -1.41 -20.79 -37.74 0.13 -20.17 -39.16 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 5 3 # 5 I 303 TYR B 26 TYR~? 19.09 CL CL B 278 I 306 VAL B 33 VAL^? 16.66 CL CL B 278 I 308 VAL B 62 VAL^? 14.56 CL CL B 278 coo 26.18 35.24 6.87 24.33 35.18 8.97 -9.51 -16.67 -28.98 -9.06 -13.93 -28.84 coo 23.55 29.53 9.81 23.15 27.39 10.24 -4.91 -12.25 -30.09 -5.12 -14.43 -30.23 coo 16.43 30.18 9.35 15.05 30.67 11.01 0.18 -10.00 -31.95 -0.47 -8.11 -31.00 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 6 3 # 6 I 303 TYR B 66 TYR.? 15.55 CL CL A 278 I 306 VAL B 65 VAL.? 14.29 CL CL B 278 I 308 VAL B 107 VAL^? 13.05 CL CL B 278 coo 26.18 35.24 6.87 24.33 35.18 8.97 13.28 -14.60 -25.62 14.79 -15.90 -23.67 coo 23.55 29.53 9.81 23.15 27.39 10.24 8.95 -11.12 -28.45 9.75 -9.23 -29.22 coo 16.43 30.18 9.35 15.05 30.67 11.01 8.31 -5.32 -28.11 10.23 -5.07 -29.17 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 7 3 # 7 I 303 TYR B 145 TYR.? 15.21 CL CL B 278 I 306 VAL B 177 VAL.? 11.35 CL CL B 278 I 308 VAL B 167 VAL^? 9.57 CL CL B 278 coo 26.18 35.24 6.87 24.33 35.18 8.97 5.06 9.55 -24.01 4.48 7.22 -25.41 coo 23.55 29.53 9.81 23.15 27.39 10.24 2.76 6.77 -20.34 3.49 5.15 -21.64 coo 16.43 30.18 9.35 15.05 30.67 11.01 -1.17 2.62 -24.20 0.60 1.81 -23.19 1cqt_d00 source 1cqt GENE REGULATION/DNA : 7 hits 1cqt_d00 naa= 3 ULMN 3 1emh_d00 HYDROLASE/DNA user 1 3 # 1 A 271 PRO A 134 PRO.? 21.54 CL CL A 278 A 272 LEU A 133 LEU.? 23.65 CL CL A 278 A 276 ARG A 127 ARG~? 22.81 CL CL A 278 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 19.71 -17.75 8.13 21.33 -16.26 7.69 coo 10.97 0.43 16.73 11.31 2.11 18.06 19.34 -13.01 8.06 17.44 -12.17 8.69 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 27.01 -10.28 5.58 24.68 -12.12 6.31 ULMN 3 1emh_d00 HYDROLASE/DNA user 2 3 # 2 A 271 PRO A 134 PRO.? 21.54 CL CL A 278 A 272 LEU A 188 LEU.? 20.58 CL CL A 278 A 276 ARG A 3 ARG^? 24.49 CL CL A 278 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 19.71 -17.75 8.13 21.33 -16.26 7.69 coo 10.97 0.43 16.73 11.31 2.11 18.06 24.36 -22.96 7.77 23.84 -21.05 6.91 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 17.45 -29.65 8.35 18.11 -29.19 11.33 ULMN 3 1emh_d00 HYDROLASE/DNA user 3 3 # 3 A 271 PRO B 134 PRO.? 21.62 CL CL B 278 A 272 LEU B 133 LEU.? 23.46 CL CL B 278 A 276 ARG B 127 ARG~? 22.49 CL CL B 278 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 4.74 -7.27 -39.07 6.42 -5.81 -38.91 coo 10.97 0.43 16.73 11.31 2.11 18.06 9.43 -8.17 -39.26 10.06 -10.23 -39.68 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 13.11 -0.63 -38.30 10.87 -2.72 -38.33 ULMN 3 1emh_d00 HYDROLASE/DNA user 4 3 # 4 A 271 PRO B 134 PRO.? 21.62 CL CL B 278 A 272 LEU B 188 LEU^? 20.59 CL CL B 278 A 276 ARG B 3 ARG^? 24.44 CL CL B 278 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 4.74 -7.27 -39.07 6.42 -5.81 -38.91 coo 10.97 0.43 16.73 11.31 2.11 18.06 -0.13 -1.97 -38.65 1.51 -2.87 -37.57 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -7.40 -8.36 -37.36 -6.70 -7.91 -40.31 1emh_d00 source 1emh HYDROLASE/DNA : 4 hits 1emh_d00 naa= 3 ULMN 4 1hbx_d00 GENE REGULATION user 1 4 # 1 D 140 THR A 77 THR~? 8.85 CL CL B 278 D 143 ARG B 140 ARG.? -3.53 CL CL B 278s D 158 TYR B 66 TYR.? 15.55 CL CL A 278 D 163 LYS B 64 LYS^? 6.39 CL CL B 278 coo 59.11 133.43 75.29 57.02 133.64 74.76 8.85 -2.84 -10.84 8.85 -4.68 -11.96 coo 52.93 123.10 78.03 50.59 121.17 78.38 3.71 0.22 -21.03 2.09 -1.69 -19.26 coo 39.29 134.52 82.26 37.39 135.28 80.34 13.28 -14.60 -25.62 14.79 -15.90 -23.67 coo 42.67 127.66 76.73 46.82 129.80 74.10 5.21 -10.68 -27.95 4.80 -8.81 -21.96 ULMN 4 1hbx_d00 GENE REGULATION user 2 4 # 2 D 140 THR A 112 THR.? 13.33 CL CL A 278 D 143 ARG A 140 ARG.? 3.74 CL CL A 278 D 158 TYR A 40 TYR~? 11.37 CL CL A 278 D 163 LYS A 64 LYS^? 6.64 CL CL A 278 coo 59.11 133.43 75.29 57.02 133.64 74.76 26.24 -13.20 -16.26 24.44 -12.42 -17.13 coo 52.93 123.10 78.03 50.59 121.17 78.38 24.77 -21.68 -10.23 22.52 -23.37 -11.49 coo 39.29 134.52 82.26 37.39 135.28 80.34 8.64 -16.83 -9.73 10.24 -18.83 -10.81 coo 42.67 127.66 76.73 46.82 129.80 74.10 14.97 -18.21 -2.39 15.88 -19.33 -8.52 ULMN 4 1hbx_d00 GENE REGULATION user 3 4 # 3 D 140 THR A 213 THR.? 5.23 CL CL A 278 D 143 ARG A 140 ARG.? 3.74 CL CL A 278 D 158 TYR A 66 TYR.? 15.11 CL CL B 278 D 163 LYS A 64 LYS^? 6.64 CL CL A 278 coo 59.11 133.43 75.29 57.02 133.64 74.76 17.89 -30.02 -14.53 16.90 -28.34 -13.63 coo 52.93 123.10 78.03 50.59 121.17 78.38 24.77 -21.68 -10.23 22.52 -23.37 -11.49 coo 39.29 134.52 82.26 37.39 135.28 80.34 11.56 -10.03 -5.26 10.21 -8.56 -7.21 coo 42.67 127.66 76.73 46.82 129.80 74.10 14.97 -18.21 -2.39 15.88 -19.33 -8.52 ULMN 4 1hbx_d00 GENE REGULATION user 4 4 # 4 D 140 THR B 77 THR~? 9.42 CL CL A 278 D 143 ARG A 140 ARG.? 3.74 CL CL A 278 D 158 TYR A 66 TYR.? 15.11 CL CL B 278 D 163 LYS A 64 LYS^? 6.64 CL CL A 278 coo 59.11 133.43 75.29 57.02 133.64 74.76 20.96 -17.51 -20.66 19.31 -17.16 -19.33 coo 52.93 123.10 78.03 50.59 121.17 78.38 24.77 -21.68 -10.23 22.52 -23.37 -11.49 coo 39.29 134.52 82.26 37.39 135.28 80.34 11.56 -10.03 -5.26 10.21 -8.56 -7.21 coo 42.67 127.66 76.73 46.82 129.80 74.10 14.97 -18.21 -2.39 15.88 -19.33 -8.52 1hbx_d00 source 1hbx GENE REGULATION : 4 hits 1hbx_d00 naa= 4 ULMN 3 1hwt_d00 GENE REGULATION/DNA user 1 3 # 1 C 70 ARG A 47 ARG~? 19.53 CL CL B 278 C 71 LYS A 45 LYS~? 28.08 CL CL B 278 C 72 VAL A 48 VAL~? 23.06 CL CL A 278 coo 23.89 33.54 29.21 26.59 34.86 28.68 1.19 -18.60 0.09 1.74 -17.18 -2.58 coo 25.82 26.89 29.68 23.33 22.98 25.84 3.14 -12.38 5.65 4.44 -8.59 10.01 coo 28.86 29.08 30.37 28.04 31.02 29.93 4.47 -17.50 5.00 6.32 -16.30 4.78 1hwt_d00 source 1hwt GENE REGULATION/DNA : 1 hits 1hwt_d00 naa= 3 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 1 3 # 1 E 40 ARG A 196 ARG.? 15.95 CL CL A 278 E 41 TYR A 217 TYR.? 13.45 CL CL A 278 E 83 ARG B 3 ARG^? 24.44 CL CL B 278 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 27.49 -34.87 -12.70 29.46 -35.46 -10.43 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 22.77 -37.42 -9.36 23.40 -34.73 -9.58 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 -7.40 -8.36 -37.36 -6.70 -7.91 -40.31 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 2 3 # 2 E 40 ARG B 196 ARG.? 16.18 CL CL B 278 E 41 TYR B 217 TYR.? 13.94 CL CL B 278 E 83 ARG A 3 ARG^? 24.49 CL CL A 278 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 -8.42 4.93 -17.56 -9.12 6.53 -20.07 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 -12.06 -0.05 -19.78 -9.32 0.42 -19.98 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 17.45 -29.65 8.35 18.11 -29.19 11.33 1id3_d00 source 1id3 STRUCTURAL PROTEIN/DNA : 2 hits 1id3_d00 naa= 3 ULMN 4 1mnm_d00 TRANSCRIPTION/DNA user 1 4 # 1 A 19 ARG B 60 ARG^? 26.12 CL CL B 278 A 30 THR B 184 THR.? 19.82 CL CL B 278 A 34 VAL B 189 VAL^? 19.19 CL CL B 278 A 38 LYS B 237 LYS.? 30.29 CL CL B 278 coo 30.09 31.19 5.41 30.53 28.24 4.72 -3.16 -10.36 -39.52 -4.20 -11.54 -42.16 coo 19.67 42.24 -1.18 20.37 41.83 -3.18 3.58 6.57 -36.17 4.31 5.82 -34.27 coo 18.16 36.88 2.14 19.60 35.97 0.73 -1.62 0.87 -35.34 -2.61 2.80 -35.05 coo 16.75 32.35 6.21 21.42 30.93 2.22 -4.88 0.83 -42.64 -0.61 0.76 -47.36 1mnm_d00 source 1mnm TRANSCRIPTION/DNA : 1 hits 1mnm_d00 naa= 4 ULMN 5 1puf_d01 TRANSCRIPTION/DNA user 1 5 # 1 B 237 ARG A 212 ARG~? 4.63 CL CL A 278 B 282 ASN A 245 ASN.? 11.79 CL CL A 278 B 286 ASN A 244 ASN.? 5.40 CL CL A 278 B 289 ILE A 242 ILE^? 11.45 CL CL A 278 B 290 ARG A 192 ARG^? 5.91 CL CL A 278 coo -5.10 15.13 5.71 -4.91 12.17 6.50 18.59 -24.77 -16.89 17.13 -22.12 -16.49 coo 2.51 20.44 4.28 1.26 22.15 4.11 18.48 -33.48 -10.76 18.30 -34.93 -9.15 coo 5.06 16.69 8.21 3.26 17.85 8.47 17.85 -28.42 -8.05 16.64 -26.87 -8.84 coo 9.09 18.34 13.23 8.90 18.41 14.03 18.39 -28.03 -2.31 17.09 -27.90 -1.64 coo 5.43 13.66 11.60 2.60 14.79 11.13 20.84 -24.38 -4.40 19.02 -23.24 -6.62 ULMN 5 1puf_d01 TRANSCRIPTION/DNA user 2 5 # 2 B 237 ARG B 212 ARG~? 4.30 CL CL B 278 B 282 ASN B 245 ASN.? 12.34 CL CL B 278 B 286 ASN B 244 ASN.? 5.94 CL CL B 278 B 289 ILE B 242 ILE^? 11.88 CL CL B 278 B 290 ARG B 192 ARG^? 6.13 CL CL B 278 coo -5.10 15.13 5.71 -4.91 12.17 6.50 1.13 -4.70 -13.40 3.58 -6.46 -14.00 coo 2.51 20.44 4.28 1.26 22.15 4.11 -8.45 -4.50 -18.19 -10.06 -4.59 -19.62 coo 5.06 16.69 8.21 3.26 17.85 8.47 -3.88 -6.12 -21.35 -2.47 -7.43 -20.48 coo 9.09 18.34 13.23 8.90 18.41 14.03 -4.34 -6.19 -27.20 -4.41 -7.61 -27.70 coo 5.43 13.66 11.60 2.60 14.79 11.13 -0.17 -3.93 -26.09 1.00 -5.48 -23.71 1puf_d01 source 1puf TRANSCRIPTION/DNA : 2 hits 1puf_d01 naa= 5 ULMN 3 1r4i_d00 TRANSCRIPTION/DNA user 1 3 # 1 A 563 LYS A 45 LYS~? 28.08 CL CL B 278 A 564 VAL A 48 VAL~? 23.06 CL CL A 278 A 568 ARG A 47 ARG~? 19.53 CL CL B 278 coo -6.60 80.79 55.64 -8.55 79.48 61.01 3.14 -12.38 5.65 4.44 -8.59 10.01 coo -9.25 78.14 55.31 -11.11 77.94 56.39 4.47 -17.50 5.00 6.32 -16.30 4.78 coo -12.31 74.86 52.32 -13.99 74.91 54.92 1.19 -18.60 0.09 1.74 -17.18 -2.58 1r4i_d00 source 1r4i TRANSCRIPTION/DNA : 1 hits 1r4i_d00 naa= 3 ULMN 3 2bsq_d00 TRANSCRIPTION user 1 3 # 1 E 3 SER A 92 SER~? 22.12 CL CL B 278 E 5 VAL A 48 VAL~? 23.06 CL CL A 278 E 7 ARG A 47 ARG~? 19.53 CL CL B 278 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 6.98 -10.92 4.56 6.84 -12.34 2.56 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 4.47 -17.50 5.00 6.32 -16.30 4.78 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 1.19 -18.60 0.09 1.74 -17.18 -2.58 ULMN 3 2bsq_d00 TRANSCRIPTION user 2 3 # 2 E 3 SER A 143 SER~? 16.98 CL CL A 278 E 5 VAL A 177 VAL.? 11.64 CL CL A 278 E 7 ARG A 140 ARG.? 3.74 CL CL A 278 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 35.06 -16.35 -13.19 33.34 -14.67 -12.92 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 30.74 -23.61 -11.72 30.16 -22.31 -10.07 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 24.77 -21.68 -10.23 22.52 -23.37 -11.49 ULMN 3 2bsq_d00 TRANSCRIPTION user 3 3 # 3 E 3 SER A 163 SER^? 17.83 CL CL A 278 E 5 VAL A 165 VAL.? 12.17 CL CL A 278 E 7 ARG A 192 ARG^? 5.91 CL CL A 278 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 27.49 -19.74 3.13 26.41 -21.87 3.58 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 26.59 -22.86 -1.99 24.50 -22.88 -2.67 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 20.84 -24.38 -4.40 19.02 -23.24 -6.62 ULMN 3 2bsq_d00 TRANSCRIPTION user 4 3 # 4 E 3 SER B 92 SER~? 22.36 CL CL A 278 E 5 VAL B 48 VAL~? 23.20 CL CL B 278 E 7 ARG B 47 ARG~? 19.59 CL CL A 278 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 10.76 -20.18 -34.61 9.57 -19.95 -32.48 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 3.78 -21.95 -34.04 5.12 -20.22 -34.23 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 3.13 -24.42 -28.62 4.84 -23.96 -26.11 ULMN 3 2bsq_d00 TRANSCRIPTION user 5 3 # 5 E 3 SER B 143 SER.? 16.35 CL CL B 278 E 5 VAL B 177 VAL.? 11.35 CL CL B 278 E 7 ARG B 140 ARG.? -3.53 CL CL B 278s coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 10.39 10.06 -20.16 11.77 8.08 -20.34 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 2.76 6.77 -20.34 3.49 5.15 -21.64 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 3.71 0.22 -21.03 2.09 -1.69 -19.26 ULMN 3 2bsq_d00 TRANSCRIPTION user 6 3 # 6 E 3 SER B 163 SER^? 17.90 CL CL B 278 E 5 VAL B 165 VAL.? 12.14 CL CL B 278 E 7 ARG B 192 ARG^? 6.13 CL CL B 278 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 4.21 1.28 -34.77 1.92 0.43 -34.82 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 1.67 1.23 -29.21 1.57 -0.75 -28.24 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 -0.17 -3.93 -26.09 1.00 -5.48 -23.71 2bsq_d00 source 2bsq TRANSCRIPTION : 6 hits 2bsq_d00 naa= 3 ULMN 3 2ky8_d00 TRANSCRIPTION/DNA user 1 3 # 1 A 24 ARG A 212 ARG~? 4.63 CL CL A 278 A 32 LYS A 211 LYS~? 14.92 CL CL A 278 A 46 ARG A 196 ARG.? 15.95 CL CL A 278 coo -8.00 4.27 27.74 -7.09 2.66 30.09 18.59 -24.77 -16.89 17.13 -22.12 -16.49 coo -5.15 8.65 26.69 -4.26 5.48 32.02 17.07 -30.19 -20.07 15.73 -30.42 -25.42 coo -0.17 -5.20 27.14 -1.15 -5.34 29.97 27.49 -34.87 -12.70 29.46 -35.46 -10.43 ULMN 3 2ky8_d00 TRANSCRIPTION/DNA user 2 3 # 2 A 24 ARG B 209 ARG~? 8.42 CL CL B 278 A 32 LYS B 210 LYS~? 12.46 CL CL B 278 A 46 ARG A 47 ARG~? 19.53 CL CL B 278 coo -8.00 4.27 27.74 -7.09 2.66 30.09 2.92 -11.07 -10.38 5.18 -10.70 -12.48 coo -5.15 8.65 26.69 -4.26 5.48 32.02 -2.49 -8.60 -10.03 0.77 -12.84 -8.24 coo -0.17 -5.20 27.14 -1.15 -5.34 29.97 1.19 -18.60 0.09 1.74 -17.18 -2.58 ULMN 3 2ky8_d00 TRANSCRIPTION/DNA user 3 3 # 3 A 24 ARG B 212 ARG~? 4.30 CL CL B 278 A 32 LYS B 210 LYS~? 12.46 CL CL B 278 A 46 ARG B 196 ARG.? 16.18 CL CL B 278 coo -8.00 4.27 27.74 -7.09 2.66 30.09 1.13 -4.70 -13.40 3.58 -6.46 -14.00 coo -5.15 8.65 26.69 -4.26 5.48 32.02 -2.49 -8.60 -10.03 0.77 -12.84 -8.24 coo -0.17 -5.20 27.14 -1.15 -5.34 29.97 -8.42 4.93 -17.56 -9.12 6.53 -20.07 ULMN 3 2ky8_d00 TRANSCRIPTION/DNA user 4 3 # 4 A 24 ARG B 212 ARG~? 4.30 CL CL B 278 A 32 LYS B 211 LYS~? 15.02 CL CL B 278 A 46 ARG B 196 ARG.? 16.18 CL CL B 278 coo -8.00 4.27 27.74 -7.09 2.66 30.09 1.13 -4.70 -13.40 3.58 -6.46 -14.00 coo -5.15 8.65 26.69 -4.26 5.48 32.02 -4.12 -5.20 -9.45 -3.45 -5.07 -3.77 coo -0.17 -5.20 27.14 -1.15 -5.34 29.97 -8.42 4.93 -17.56 -9.12 6.53 -20.07 2ky8_d00 source 2ky8 TRANSCRIPTION/DNA : 4 hits 2ky8_d00 naa= 3 ULMN 4 2ql2_d01 TRANSCRIPTION/DNA user 1 4 # 1 D 107 ASN A 187 ASN.? 27.58 CL CL A 278 D 110 GLU A 238 GLU^? 24.84 CL CL A 278 D 113 ARG A 3 ARG^? 24.49 CL CL A 278 D 114 MET A 1 MET^? 26.93 CL CL A 278 coo 4.24 -17.18 -6.47 5.26 -19.04 -6.43 27.12 -21.23 11.57 28.22 -20.58 13.28 coo 9.10 -12.85 -6.75 10.60 -11.45 -6.23 22.87 -26.18 11.53 21.04 -27.14 11.99 coo 10.57 -7.46 -3.65 12.70 -7.60 -5.87 17.45 -29.65 8.35 18.11 -29.19 11.33 coo 8.52 -6.62 -8.91 11.21 -8.26 -9.44 23.12 -32.37 11.71 19.29 -31.95 13.10 ULMN 4 2ql2_d01 TRANSCRIPTION/DNA user 2 4 # 2 D 107 ASN B 187 ASN.? 27.72 CL CL B 278 D 110 GLU B 238 GLU^? 25.19 CL CL B 278 D 113 ARG B 3 ARG^? 24.44 CL CL B 278 D 114 MET B 1 MET.? 26.77 CL CL B 278 coo 4.24 -17.18 -6.47 5.26 -19.04 -6.43 1.42 0.10 -42.91 1.86 0.83 -44.85 coo 9.10 -12.85 -6.75 10.60 -11.45 -6.23 -3.49 -3.71 -41.35 -4.99 -5.08 -41.88 coo 10.57 -7.46 -3.65 12.70 -7.60 -5.87 -7.40 -8.36 -37.36 -6.70 -7.91 -40.31 coo 8.52 -6.62 -8.91 11.21 -8.26 -9.44 -10.72 -2.79 -40.85 -10.60 -6.93 -41.17 2ql2_d01 source 2ql2 TRANSCRIPTION/DNA : 2 hits 2ql2_d01 naa= 4 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 1 3 # 1 B 34 SER A 143 SER~? 16.98 CL CL A 278 B 37 ASN A 142 ASN~? 15.74 CL CL A 278 B 45 THR B 77 THR~? 9.42 CL CL A 278 coo -19.49 41.97 71.08 -17.37 40.80 71.17 35.06 -16.35 -13.19 33.34 -14.67 -12.92 coo -23.05 39.62 69.74 -22.86 39.59 67.61 33.76 -20.86 -14.08 33.88 -20.26 -16.14 coo -30.87 34.84 80.57 -28.94 34.51 81.49 20.96 -17.51 -20.66 19.31 -17.16 -19.33 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 2 3 # 2 B 34 SER A 247 SER.? 8.71 CL CL A 278 B 37 ASN A 246 ASN.? 12.85 CL CL A 278 B 45 THR A 16 THR~? 23.56 CL CL A 278 coo -19.49 41.97 71.08 -17.37 40.80 71.17 12.77 -32.05 -14.75 14.22 -30.30 -15.59 coo -23.05 39.62 69.74 -22.86 39.59 67.61 12.83 -32.17 -9.87 11.11 -33.32 -9.30 coo -30.87 34.84 80.57 -28.94 34.51 81.49 4.16 -38.93 -1.16 3.39 -36.96 -0.84 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 3 3 # 3 B 34 SER A 247 SER.? 8.71 CL CL A 278 B 37 ASN A 246 ASN.? 12.85 CL CL A 278 B 45 THR A 37 THR~? 16.54 CL CL A 278 coo -19.49 41.97 71.08 -17.37 40.80 71.17 12.77 -32.05 -14.75 14.22 -30.30 -15.59 coo -23.05 39.62 69.74 -22.86 39.59 67.61 12.83 -32.17 -9.87 11.11 -33.32 -9.30 coo -30.87 34.84 80.57 -28.94 34.51 81.49 7.80 -18.70 -4.30 6.04 -19.24 -3.16 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 4 3 # 4 B 34 SER B 143 SER.? 16.35 CL CL B 278 B 37 ASN B 142 ASN.? 15.73 CL CL B 278 B 45 THR A 77 THR~? 8.85 CL CL B 278 coo -19.49 41.97 71.08 -17.37 40.80 71.17 10.39 10.06 -20.16 11.77 8.08 -20.34 coo -23.05 39.62 69.74 -22.86 39.59 67.61 5.89 9.56 -18.58 6.90 10.10 -16.77 coo -30.87 34.84 80.57 -28.94 34.51 81.49 8.85 -2.84 -10.84 8.85 -4.68 -11.96 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 5 3 # 5 B 34 SER B 247 SER.? 9.35 CL CL B 278 B 37 ASN B 246 ASN.? 13.30 CL CL B 278 B 45 THR B 16 THR~? 24.23 CL CL B 278 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -7.15 -9.80 -13.65 -5.07 -8.65 -13.11 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -7.71 -10.36 -18.40 -9.09 -11.94 -18.78 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -16.39 -19.02 -25.27 -14.79 -20.44 -25.32 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 6 3 # 6 B 34 SER B 247 SER.? 9.35 CL CL B 278 B 37 ASN B 246 ASN.? 13.30 CL CL B 278 B 45 THR B 37 THR~? 16.55 CL CL B 278 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -7.15 -9.80 -13.65 -5.07 -8.65 -13.11 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -7.71 -10.36 -18.40 -9.09 -11.94 -18.78 coo -30.87 34.84 80.57 -28.94 34.51 81.49 4.16 -17.50 -24.96 3.23 -19.26 -25.80 2z3x_d00 source 2z3x DNA BINDING PROTEIN/DNA : 6 hits 2z3x_d00 naa= 3 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 1 3 # 1 A 18 SER A 21 SER.? 21.88 CL CL A 278 A 20 HIS A 12 HIS~? 14.78 CL CL A 278 A 22 LEU A 30 LEU.? 19.87 CL CL A 278 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 1.16 -33.17 -2.24 2.71 -34.86 -3.05 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 9.03 -33.35 -4.93 10.37 -31.88 -5.56 coo -14.55 2.62 13.63 -14.94 2.66 11.50 12.41 -34.45 3.31 13.17 -35.75 1.72 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 2 3 # 2 A 18 SER B 21 SER.? 21.23 CL CL B 278 A 20 HIS B 12 HIS~? 15.42 CL CL B 278 A 22 LEU B 30 LEU.? 20.26 CL CL B 278 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 -10.65 -22.68 -24.42 -10.99 -20.31 -24.03 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 -10.18 -14.51 -22.80 -8.49 -13.29 -22.60 coo -14.55 2.62 13.63 -14.94 2.66 11.50 -11.82 -11.94 -31.16 -12.78 -10.81 -29.57 3gxq_d00 source 3gxq DNA BINDING PROTEIN/DNA : 2 hits 3gxq_d00 naa= 3 ULMN 4 3jxy_d00 HYDROLASE/DNA user 1 4 # 1 A 27 TYR A 66 TYR.? 15.11 CL CL B 278 A 109 TRP A 75 TRP~? 17.45 CL CL B 278 A 183 LYS A 125 LYS~? 24.29 CL CL A 278 A 215 ARG A 127 ARG~? 22.81 CL CL A 278 coo 2.04 -0.56 22.01 1.33 -2.36 20.00 11.56 -10.03 -5.26 10.21 -8.56 -7.21 coo 4.70 1.38 14.78 1.19 -0.08 15.75 16.36 -1.85 -7.78 14.64 1.65 -7.38 coo 8.54 -5.69 7.74 5.80 -7.55 12.05 25.36 -4.44 0.04 23.96 -1.21 -4.73 coo 11.90 -14.67 10.29 14.05 -12.67 11.19 27.01 -10.28 5.58 24.68 -12.12 6.31 ULMN 4 3jxy_d00 HYDROLASE/DNA user 2 4 # 2 A 27 TYR A 79 TYR.? 15.56 CL CL B 278 A 109 TRP A 75 TRP~? 17.45 CL CL B 278 A 183 LYS A 125 LYS~? 24.29 CL CL A 278 A 215 ARG A 127 ARG~? 22.81 CL CL A 278 coo 2.04 -0.56 22.01 1.33 -2.36 20.00 9.48 -3.09 -3.95 8.21 -5.52 -3.44 coo 4.70 1.38 14.78 1.19 -0.08 15.75 16.36 -1.85 -7.78 14.64 1.65 -7.38 coo 8.54 -5.69 7.74 5.80 -7.55 12.05 25.36 -4.44 0.04 23.96 -1.21 -4.73 coo 11.90 -14.67 10.29 14.05 -12.67 11.19 27.01 -10.28 5.58 24.68 -12.12 6.31 ULMN 4 3jxy_d00 HYDROLASE/DNA user 3 4 # 3 A 27 TYR B 79 TYR.? 15.95 CL CL A 278 A 109 TRP B 75 TRP~? 18.03 CL CL A 278 A 183 LYS B 125 LYS~? 24.18 CL CL B 278 A 215 ARG B 127 ARG~? 22.49 CL CL B 278 coo 2.04 -0.56 22.01 1.33 -2.36 20.00 19.67 -17.68 -27.47 17.12 -18.78 -27.53 coo 4.70 1.38 14.78 1.19 -0.08 15.75 22.28 -10.53 -24.61 25.52 -12.64 -25.30 coo 8.54 -5.69 7.74 5.80 -7.55 12.05 19.42 -2.26 -33.24 23.44 -3.28 -29.02 coo 11.90 -14.67 10.29 14.05 -12.67 11.19 13.11 -0.63 -38.30 10.87 -2.72 -38.33 3jxy_d00 source 3jxy HYDROLASE/DNA : 3 hits 3jxy_d00 naa= 4 ULMN 4 3odc_d00 DNA BINDING PROTEIN/DNA user 1 4 # 1 B 122 ARG A 127 ARG~? 22.81 CL CL A 278 B 148 LYS A 101 LYS.? 27.96 CL CL A 278 B 151 LEU A 96 LEU~? 21.92 CL CL A 278 B 154 ILE A 97 ILE~? 25.48 CL CL A 278 coo 13.00 32.05 60.31 16.02 31.73 59.80 27.01 -10.28 5.58 24.68 -12.12 6.31 coo 11.05 44.13 44.68 12.77 44.45 49.56 12.62 -22.66 11.02 6.99 -25.01 12.73 coo 11.72 38.91 44.77 13.11 39.67 46.23 9.99 -17.72 7.56 10.93 -19.38 6.53 coo 7.03 36.97 46.99 7.83 37.90 47.52 12.90 -14.32 10.49 13.68 -13.24 10.08 ULMN 4 3odc_d00 DNA BINDING PROTEIN/DNA user 2 4 # 2 B 122 ARG A 127 ARG~? 22.81 CL CL A 278 B 148 LYS A 101 LYS.? 27.96 CL CL A 278 B 151 LEU A 102 LEU^? 21.05 CL CL A 278 B 154 ILE A 97 ILE~? 25.48 CL CL A 278 coo 13.00 32.05 60.31 16.02 31.73 59.80 27.01 -10.28 5.58 24.68 -12.12 6.31 coo 11.05 44.13 44.68 12.77 44.45 49.56 12.62 -22.66 11.02 6.99 -25.01 12.73 coo 11.72 38.91 44.77 13.11 39.67 46.23 14.78 -19.15 8.42 15.47 -17.98 6.69 coo 7.03 36.97 46.99 7.83 37.90 47.52 12.90 -14.32 10.49 13.68 -13.24 10.08 ULMN 4 3odc_d00 DNA BINDING PROTEIN/DNA user 3 4 # 3 B 122 ARG B 127 ARG~? 22.49 CL CL B 278 B 148 LYS B 101 LYS.? 28.03 CL CL B 278 B 151 LEU B 96 LEU~? 22.08 CL CL B 278 B 154 ILE B 97 ILE~? 25.53 CL CL B 278 coo 13.00 32.05 60.31 16.02 31.73 59.80 13.11 -0.63 -38.30 10.87 -2.72 -38.33 coo 11.05 44.13 44.68 12.77 44.45 49.56 -1.11 -13.90 -40.24 -4.27 -19.39 -40.83 coo 11.72 38.91 44.77 13.11 39.67 46.23 3.77 -16.76 -37.17 2.31 -15.47 -36.20 coo 7.03 36.97 46.99 7.83 37.90 47.52 7.26 -14.80 -40.73 8.46 -14.00 -40.65 ULMN 4 3odc_d00 DNA BINDING PROTEIN/DNA user 4 4 # 4 B 122 ARG B 127 ARG~? 22.49 CL CL B 278 B 148 LYS B 101 LYS.? 28.03 CL CL B 278 B 151 LEU B 102 LEU^? 21.06 CL CL B 278 B 154 ILE B 97 ILE~? 25.53 CL CL B 278 coo 13.00 32.05 60.31 16.02 31.73 59.80 13.11 -0.63 -38.30 10.87 -2.72 -38.33 coo 11.05 44.13 44.68 12.77 44.45 49.56 -1.11 -13.90 -40.24 -4.27 -19.39 -40.83 coo 11.72 38.91 44.77 13.11 39.67 46.23 2.86 -11.82 -38.39 4.30 -11.10 -36.92 coo 7.03 36.97 46.99 7.83 37.90 47.52 7.26 -14.80 -40.73 8.46 -14.00 -40.65 3odc_d00 source 3odc DNA BINDING PROTEIN/DNA : 4 hits 3odc_d00 naa= 4 ULMN 3 3s57_d00 OXIDOREDUCTASE/DNA user 1 3 # 1 A 101 VAL A 65 VAL.? 14.50 CL CL A 278 A 102 PHE A 89 PHE~? 18.74 CL CL A 278 A 169 CYH A 71 CYH.? 16.56 CL CL A 278 coo -0.48 2.03 12.21 0.64 0.32 12.97 14.94 -14.38 -2.30 16.99 -13.68 -1.87 coo 0.51 5.20 15.97 0.26 4.09 18.50 12.57 -10.65 0.98 13.30 -13.32 0.73 coo 4.56 -7.03 18.26 5.32 -4.76 16.88 19.04 -8.88 -9.96 21.14 -7.72 -8.59 ULMN 3 3s57_d00 OXIDOREDUCTASE/DNA user 2 3 # 2 A 101 VAL B 65 VAL.? 14.29 CL CL B 278 A 102 PHE B 89 PHE~? 18.66 CL CL B 278 A 169 CYH B 71 CYH.? 16.15 CL CL B 278 coo -0.48 2.03 12.21 0.64 0.32 12.97 8.95 -11.12 -28.45 9.75 -9.23 -29.22 coo 0.51 5.20 15.97 0.26 4.09 18.50 11.97 -14.22 -31.93 9.43 -13.13 -31.57 coo 4.56 -7.03 18.26 5.32 -4.76 16.88 15.78 -6.77 -22.17 17.11 -4.88 -23.73 3s57_d00 source 3s57 OXIDOREDUCTASE/DNA : 2 hits 3s57_d00 naa= 3 ULMN 5 3sm4_d00 HYDROLASE/DNA user 1 5 # 1 B 53 MET A 258 MET~? 18.15 CL CL A 278 B 73 VAL A 165 VAL.? 12.17 CL CL A 278 B 75 ALA A 136 ALA^? 14.58 CL CL A 278 B 77 ALA A 104 ALA^? 17.29 CL CL A 278 B 78 LEU A 106 LEU^? 10.71 CL CL A 278 coo 6.68 -12.20 6.91 4.65 -8.54 6.72 21.36 -40.52 -0.58 23.01 -36.66 -0.53 coo 4.09 -11.16 -10.83 4.39 -11.22 -8.63 26.59 -22.86 -1.99 24.50 -22.88 -2.67 coo -0.13 -5.63 -11.43 -0.24 -5.75 -9.91 23.46 -18.78 1.19 22.73 -20.09 1.10 coo 0.92 -0.50 -9.34 0.65 -0.74 -7.86 18.93 -19.83 4.96 20.23 -20.34 4.40 coo 4.14 -4.02 -10.28 4.18 -5.28 -8.49 18.65 -19.68 -1.57 19.62 -20.77 -3.18 ULMN 5 3sm4_d00 HYDROLASE/DNA user 2 5 # 2 B 53 MET B 258 MET~? 18.63 CL CL B 278 B 73 VAL B 165 VAL.? 12.14 CL CL B 278 B 75 ALA B 136 ALA^? 14.67 CL CL B 278 B 77 ALA B 104 ALA^? 17.52 CL CL B 278 B 78 LEU B 106 LEU^? 10.66 CL CL B 278 coo 6.68 -12.20 6.91 4.65 -8.54 6.72 -16.46 -2.00 -27.87 -12.50 -0.83 -28.53 coo 4.09 -11.16 -10.83 4.39 -11.22 -8.63 1.67 1.23 -29.21 1.57 -0.75 -28.24 coo -0.13 -5.63 -11.43 -0.24 -5.75 -9.91 5.19 -2.60 -32.46 3.80 -3.13 -32.19 coo 0.92 -0.50 -9.34 0.65 -0.74 -7.86 3.11 -7.43 -35.51 2.86 -5.96 -35.18 coo 4.14 -4.02 -10.28 4.18 -5.28 -8.49 4.03 -6.95 -28.94 3.26 -5.63 -27.40 3sm4_d00 source 3sm4 HYDROLASE/DNA : 2 hits 3sm4_d00 naa= 5 ULMN 3 3ssc_d00 DNA BINDING PROTEIN/DNA user 1 3 # 1 A 21 GLN A 146 GLN~? 21.14 CL CL A 278 A 41 TYR A 145 TYR~? 15.40 CL CL A 278 A 43 ASN A 141 ASN~? 14.40 CL CL A 278 coo 22.03 6.35 12.16 20.71 6.08 10.54 38.62 -17.97 -13.61 38.61 -16.29 -14.92 coo 18.67 0.21 9.03 16.70 -1.66 8.55 34.36 -21.23 -8.52 32.31 -21.44 -6.65 coo 14.90 7.30 8.78 14.25 8.14 6.97 29.69 -16.58 -13.36 30.76 -15.83 -15.01 ULMN 3 3ssc_d00 DNA BINDING PROTEIN/DNA user 2 3 # 2 A 21 GLN A 257 GLN~? 20.84 CL CL A 278 A 41 TYR A 217 TYR.? 13.45 CL CL A 278 A 43 ASN A 218 ASN~? 20.82 CL CL A 278 coo 22.03 6.35 12.16 20.71 6.08 10.54 18.09 -43.63 -4.59 18.53 -43.67 -6.70 coo 18.67 0.21 9.03 16.70 -1.66 8.55 22.77 -37.42 -9.36 23.40 -34.73 -9.58 coo 14.90 7.30 8.78 14.25 8.14 6.97 24.13 -43.84 -11.70 26.14 -43.18 -11.76 ULMN 3 3ssc_d00 DNA BINDING PROTEIN/DNA user 3 3 # 3 A 21 GLN B 124 GLN~? 26.18 CL CL B 278 A 41 TYR B 122 TYR~? 18.80 CL CL B 278 A 43 ASN B 119 ASN~? 17.69 CL CL B 278 coo 22.03 6.35 12.16 20.71 6.08 10.54 18.23 3.51 -34.23 19.72 5.01 -34.40 coo 18.67 0.21 9.03 16.70 -1.66 8.55 18.54 -2.08 -27.38 17.99 -4.80 -27.12 coo 14.90 7.30 8.78 14.25 8.14 6.97 17.14 3.31 -24.51 17.47 2.47 -22.58 ULMN 3 3ssc_d00 DNA BINDING PROTEIN/DNA user 4 3 # 4 A 21 GLN B 146 GLN~? 19.83 CL CL B 278 A 41 TYR B 145 TYR.? 15.21 CL CL B 278 A 43 ASN B 141 ASN.? 13.90 CL CL B 278 coo 22.03 6.35 12.16 20.71 6.08 10.54 9.71 13.62 -20.26 8.45 13.92 -18.55 coo 18.67 0.21 9.03 16.70 -1.66 8.55 5.06 9.55 -24.01 4.48 7.22 -25.41 coo 14.90 7.30 8.78 14.25 8.14 6.97 9.53 4.91 -19.46 10.65 6.11 -18.14 ULMN 3 3ssc_d00 DNA BINDING PROTEIN/DNA user 5 3 # 5 A 21 GLN B 146 GLN~? 19.83 CL CL B 278 A 41 TYR B 145 TYR.? 15.21 CL CL B 278 A 43 ASN B 175 ASN.? 15.07 CL CL B 278 coo 22.03 6.35 12.16 20.71 6.08 10.54 9.71 13.62 -20.26 8.45 13.92 -18.55 coo 18.67 0.21 9.03 16.70 -1.66 8.55 5.06 9.55 -24.01 4.48 7.22 -25.41 coo 14.90 7.30 8.78 14.25 8.14 6.97 7.70 6.80 -15.23 9.08 8.02 -14.14 ULMN 3 3ssc_d00 DNA BINDING PROTEIN/DNA user 6 3 # 6 A 21 GLN B 257 GLN~? 21.23 CL CL B 278 A 41 TYR B 217 TYR.? 13.94 CL CL B 278 A 43 ASN B 218 ASN~? 21.19 CL CL B 278 coo 22.03 6.35 12.16 20.71 6.08 10.54 -19.30 -4.24 -23.09 -18.81 -3.62 -21.09 coo 18.67 0.21 9.03 16.70 -1.66 8.55 -12.06 -0.05 -19.78 -9.32 0.42 -19.98 coo 14.90 7.30 8.78 14.25 8.14 6.97 -17.80 2.35 -16.65 -17.00 4.26 -17.12 3ssc_d00 source 3ssc DNA BINDING PROTEIN/DNA : 6 hits 3ssc_d00 naa= 3 ULMN 3 3uby_d00 HYDROLASE/DNA user 1 3 # 1 A 162 TYR A 66 TYR.? 15.11 CL CL B 278 A 164 MET A 85 MET~? 17.61 CL CL B 278 A 165 TYR A 79 TYR.? 15.56 CL CL B 278 coo 9.07 -0.64 37.53 6.51 -1.49 38.21 11.56 -10.03 -5.26 10.21 -8.56 -7.21 coo 15.31 0.97 33.48 17.04 -1.81 36.11 12.23 -3.91 -1.48 14.05 -5.74 -4.79 coo 12.73 -3.12 32.95 14.22 -4.94 34.46 9.48 -3.09 -3.95 8.21 -5.52 -3.44 ULMN 3 3uby_d00 HYDROLASE/DNA user 2 3 # 2 A 162 TYR A 78 TYR~? 9.12 CL CL B 278 A 164 MET A 85 MET~? 17.61 CL CL B 278 A 165 TYR A 79 TYR.? 15.56 CL CL B 278 coo 9.07 -0.64 37.53 6.51 -1.49 38.21 5.93 -5.00 -8.22 4.93 -6.54 -10.31 coo 15.31 0.97 33.48 17.04 -1.81 36.11 12.23 -3.91 -1.48 14.05 -5.74 -4.79 coo 12.73 -3.12 32.95 14.22 -4.94 34.46 9.48 -3.09 -3.95 8.21 -5.52 -3.44 ULMN 3 3uby_d00 HYDROLASE/DNA user 3 3 # 3 A 162 TYR B 66 TYR.? 15.55 CL CL A 278 A 164 MET B 85 MET~? 18.07 CL CL A 278 A 165 TYR B 79 TYR.? 15.95 CL CL A 278 coo 9.07 -0.64 37.53 6.51 -1.49 38.21 13.28 -14.60 -25.62 14.79 -15.90 -23.67 coo 15.31 0.97 33.48 17.04 -1.81 36.11 18.92 -15.10 -30.17 17.74 -12.81 -26.91 coo 12.73 -3.12 32.95 14.22 -4.94 34.46 19.67 -17.68 -27.47 17.12 -18.78 -27.53 ULMN 3 3uby_d00 HYDROLASE/DNA user 4 3 # 4 A 162 TYR B 78 TYR~? 9.41 CL CL A 278 A 164 MET B 85 MET~? 18.07 CL CL A 278 A 165 TYR B 79 TYR.? 15.95 CL CL A 278 coo 9.07 -0.64 37.53 6.51 -1.49 38.21 18.05 -20.46 -22.54 16.77 -21.06 -20.14 coo 15.31 0.97 33.48 17.04 -1.81 36.11 18.92 -15.10 -30.17 17.74 -12.81 -26.91 coo 12.73 -3.12 32.95 14.22 -4.94 34.46 19.67 -17.68 -27.47 17.12 -18.78 -27.53 3uby_d00 source 3uby HYDROLASE/DNA : 4 hits 3uby_d00 naa= 3 ULMN 3 4er8_d00 DNA BINDING PROTEIN/DNA user 1 3 # 1 A 78 ARG A 47 ARG~? 19.53 CL CL B 278 A 82 LYS A 45 LYS~? 28.08 CL CL B 278 A 97 ARG B 209 ARG~? 8.42 CL CL B 278 coo 16.80 -30.32 -16.38 19.04 -32.25 -17.14 1.19 -18.60 0.09 1.74 -17.18 -2.58 coo 13.73 -24.92 -13.04 16.51 -30.06 -12.17 3.14 -12.38 5.65 4.44 -8.59 10.01 coo 12.19 -29.83 -26.51 14.22 -31.21 -28.36 2.92 -11.07 -10.38 5.18 -10.70 -12.48 ULMN 3 4er8_d00 DNA BINDING PROTEIN/DNA user 2 3 # 2 A 78 ARG A 192 ARG^? 5.91 CL CL A 278 A 82 LYS A 64 LYS^? 6.64 CL CL A 278 A 97 ARG A 212 ARG~? 4.63 CL CL A 278 coo 16.80 -30.32 -16.38 19.04 -32.25 -17.14 20.84 -24.38 -4.40 19.02 -23.24 -6.62 coo 13.73 -24.92 -13.04 16.51 -30.06 -12.17 14.97 -18.21 -2.39 15.88 -19.33 -8.52 coo 12.19 -29.83 -26.51 14.22 -31.21 -28.36 18.59 -24.77 -16.89 17.13 -22.12 -16.49 ULMN 3 4er8_d00 DNA BINDING PROTEIN/DNA user 3 3 # 3 A 78 ARG A 212 ARG~? 4.63 CL CL A 278 A 82 LYS A 211 LYS~? 14.92 CL CL A 278 A 97 ARG A 140 ARG.? 3.74 CL CL A 278 coo 16.80 -30.32 -16.38 19.04 -32.25 -17.14 18.59 -24.77 -16.89 17.13 -22.12 -16.49 coo 13.73 -24.92 -13.04 16.51 -30.06 -12.17 17.07 -30.19 -20.07 15.73 -30.42 -25.42 coo 12.19 -29.83 -26.51 14.22 -31.21 -28.36 24.77 -21.68 -10.23 22.52 -23.37 -11.49 ULMN 3 4er8_d00 DNA BINDING PROTEIN/DNA user 4 3 # 4 A 78 ARG B 192 ARG^? 6.13 CL CL B 278 A 82 LYS B 64 LYS^? 6.39 CL CL B 278 A 97 ARG B 212 ARG~? 4.30 CL CL B 278 coo 16.80 -30.32 -16.38 19.04 -32.25 -17.14 -0.17 -3.93 -26.09 1.00 -5.48 -23.71 coo 13.73 -24.92 -13.04 16.51 -30.06 -12.17 5.21 -10.68 -27.95 4.80 -8.81 -21.96 coo 12.19 -29.83 -26.51 14.22 -31.21 -28.36 1.13 -4.70 -13.40 3.58 -6.46 -14.00 ULMN 3 4er8_d00 DNA BINDING PROTEIN/DNA user 5 3 # 5 A 78 ARG B 209